data_1pmr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pmr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.531 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 40.1 t -69.43 85.96 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.116 -0.99 . . . . 0.0 108.666 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.7 83.44 1.6 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.593 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 1.8 tp -105.68 138.31 31.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.342 -0.849 . . . . 0.0 110.443 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -134.17 -157.75 0.83 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 69' ' ' SER . 42.2 t -127.55 68.75 74.53 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD3' HD11 ' A' ' 6' ' ' LEU . 37.3 Cg_endo -81.85 19.97 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.774 2.316 . . . . 0.0 110.712 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.532 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.306 -1.326 0 O-C-N 121.013 -1.054 . . . . 0.0 110.038 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 67' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.47 ' C ' HG12 ' A' ' 39' ' ' ILE . 18.4 m -158.21 133.34 8.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.992 . . . . 0.0 110.906 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.562 ' HA ' HG13 ' A' ' 39' ' ' ILE . 29.5 t -71.12 84.04 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.463 -0.773 . . . . 0.0 109.633 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -39.44 -60.58 0.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.897 . . . . 0.0 110.361 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.48 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 20.1 m -169.13 129.6 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.665 -1.272 . . . . 0.0 111.446 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.565 ' CG ' HG22 ' A' ' 37' ' ' VAL . 18.7 m95 -69.55 -167.54 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.584 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 16.9 m80 -152.68 23.65 0.59 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.556 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 7.1 tppt? -114.99 127.42 55.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.739 -0.6 . . . . 0.0 109.759 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.547 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -72.38 175.93 2.81 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.9 Cg_endo -70.46 95.62 0.62 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.957 1.771 . . . . 0.0 111.103 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.517 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 83.43 39.64 9.66 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.551 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 7.6 m-20 -65.5 -163.52 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.984 -1.304 . . . . 0.0 110.094 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.43 82.21 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.401 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -79.35 -170.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 110.203 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.577 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 2.6 m -133.61 -106.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 6.9 mtt180 -92.38 62.03 3.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.695 -1.253 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 7.6 m-20 153.7 96.06 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.56 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -94.18 -165.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.03 -1.043 . . . . 0.0 111.701 -178.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.556 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 7.3 p -51.88 162.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.758 0.79 . . . . 0.0 110.951 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.536 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.77 59.83 1.58 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.584 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 3.4 p -39.04 168.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-O 121.678 0.751 . . . . 0.0 110.616 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 20' ' ' ALA . 2.5 mt-10 -131.66 111.15 11.44 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 108.721 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.564 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 1.7 tt -95.06 -164.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 109.449 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 5.3 mt-10 -141.37 99.69 3.62 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.155 -0.966 . . . . 0.0 109.677 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.53 ' OG1' ' CD2' ' A' ' 46' ' ' LEU . 25.2 m -102.55 44.39 1.02 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.703 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 6.4 t70 76.49 65.61 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.9 ttmt 86.51 -25.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.827 -0.546 . . . . 0.0 109.708 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.469 HG21 ' HB ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -102.93 97.15 5.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.807 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 39' ' ' ILE . 42.8 t -89.87 112.56 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.852 . . . . 0.0 109.167 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.532 ' HG ' ' CB ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -81.6 -175.74 5.69 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.157 -0.964 . . . . 0.0 109.424 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 28.5 mt-10 -127.02 -178.42 4.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.238 -0.914 . . . . 0.0 109.649 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.7 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -149.5 79.0 8.24 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-O 122.266 1.031 . . . . 0.0 108.976 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.3 Cg_endo -82.5 106.41 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.916 2.41 . . . . 0.0 112.009 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -75.31 -160.5 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.573 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 2.2 p -138.52 12.8 2.76 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.423 -1.423 . . . . 0.0 110.818 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 159.43 165.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.937 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 69.81 -86.5 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.496 -0.752 . . . . 0.0 109.625 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 63.04 -9.76 0.16 Allowed Glycine 0 N--CA 1.496 2.635 0 O-C-N 120.886 -1.134 . . . . 0.0 111.879 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.517 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -41.93 98.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 118.927 1.363 . . . . 0.0 108.356 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.545 HD11 ' CD2' ' A' ' 76' ' ' LEU . 9.9 tp -54.92 98.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.503 -0.748 . . . . 0.0 109.628 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -112.69 -41.49 3.8 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.706 -0.621 . . . . 0.0 109.721 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -136.8 93.97 2.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.836 -1.165 . . . . 0.0 110.409 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.527 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 4.9 t -102.13 88.22 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.058 . . . . 0.0 108.381 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.77 -4.6 20.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.281 -0.887 . . . . 0.0 110.25 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.546 ' HA ' ' CB ' ' A' ' 65' ' ' THR . 3.7 mt-10 -127.35 50.7 1.97 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.071 -1.018 . . . . 0.0 108.846 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.8 m-20 -53.6 109.41 0.45 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.56 -0.713 . . . . 0.0 110.494 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.536 ' C ' ' O ' ' A' ' 62' ' ' ASP . 3.2 mp0 8.63 109.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' THR . . . 116.46 -35.37 4.25 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.546 ' CB ' ' HA ' ' A' ' 61' ' ' GLU . 71.4 m -45.08 146.05 0.92 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -1.186 . . . . 0.0 109.169 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.52 131.04 35.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.719 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.58 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.57 171.25 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.58 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 4.9 t -139.68 -149.43 0.28 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.232 -0.918 . . . . 0.0 109.279 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 62.7 p -98.91 74.85 2.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.114 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER 159.4 -21.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 6' ' ' LEU . 4.3 mt-30 -71.37 -171.65 0.64 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.551 -0.718 . . . . 0.0 109.106 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.9 tt -126.44 128.4 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.541 ' CD1' HG13 ' A' ' 37' ' ' VAL . 7.9 mt -64.53 -40.53 95.78 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.27 176.22 23.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 1.4 ptm180 -117.22 142.63 46.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.217 -1.167 . . . . 0.0 110.171 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 3.8 mp -112.36 -101.65 0.41 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.531 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 109.068 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.464 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 25.0 t -71.48 82.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.031 . . . . 0.0 108.785 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.89 82.86 2.18 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.59 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 3.9 tp -101.19 137.29 29.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.728 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -131.12 -148.22 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 69' ' ' SER . 93.7 t -129.88 92.14 37.87 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.264 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.49 17.97 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.774 2.316 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.572 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 O-C-N 120.871 -1.143 . . . . 0.0 110.152 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' A' ' 65' ' ' THR . 87.5 m -160.77 136.28 7.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.908 . . . . 0.0 110.07 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.8 t -58.87 143.28 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 108.974 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -115.24 -53.92 2.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.212 -0.93 . . . . 0.0 109.185 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 21' ' ' THR . 6.6 t -164.41 116.91 1.32 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.26 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.573 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 17.7 m95 -68.35 -167.5 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 19.4 m80 -152.47 23.65 0.61 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.579 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 5.7 tppt? -120.4 108.12 13.73 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.789 -0.569 . . . . 0.0 109.713 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.556 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -59.55 177.39 0.27 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.6 Cg_endo -69.8 96.02 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.812 1.675 . . . . 0.0 111.378 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.555 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 85.07 40.87 7.79 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.574 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 5.4 m-20 -57.95 -154.66 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.21 -1.171 . . . . 0.0 109.948 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' H ' ' HB3' ' A' ' 28' ' ' ASP . . . -163.89 87.34 0.51 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.569 -1.332 . . . . 0.0 109.461 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.583 ' CG1' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -96.24 178.76 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.329 -0.857 . . . . 0.0 109.725 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 1.3 p -135.76 -60.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.106 -0.996 . . . . 0.0 109.901 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.585 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -138.98 65.6 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.078 -1.014 . . . . 0.0 108.928 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 12.9 m-20 146.68 80.45 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.561 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -86.19 -171.48 3.58 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.083 0.944 . . . . 0.0 112.003 -177.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.579 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 3.1 p -41.97 159.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 122.066 0.936 . . . . 0.0 111.88 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.88 62.09 1.58 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.56 ' CG1' ' HB ' ' A' ' 48' ' ' VAL . 3.3 p -38.87 168.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.876 0.846 . . . . 0.0 110.744 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -127.41 98.59 5.3 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -80.12 -163.83 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.502 -0.749 . . . . 0.0 109.278 -179.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.547 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 3.8 mm-40 -152.85 104.99 2.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.892 -1.13 . . . . 0.0 110.007 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.527 ' CG2' HD23 ' A' ' 46' ' ' LEU . 1.2 p -99.31 -58.18 1.99 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.08 -1.013 . . . . 0.0 109.988 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.596 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 12.8 t0 176.77 83.55 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.2 tttp 86.12 -26.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.5 m -119.47 132.42 69.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.288 -0.883 . . . . 0.0 109.4 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 42.8 t -118.07 114.58 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.31 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -80.46 147.57 30.86 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.233 -0.917 . . . . 0.0 109.02 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -92.11 179.39 5.59 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.326 -0.859 . . . . 0.0 110.682 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.7 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -141.02 73.95 26.11 Favored Pre-proline 0 N--CA 1.489 1.511 0 CA-C-O 122.414 1.102 . . . . 0.0 108.366 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.28 107.63 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.873 2.382 . . . . 0.0 111.919 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -73.83 -165.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.557 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 0.9 OUTLIER -137.96 23.32 2.83 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.484 -1.385 . . . . 0.0 110.194 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 159.58 161.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.583 ' O ' ' CG1' ' A' ' 30' ' ' VAL . 6.4 m-20 60.85 -132.92 0.73 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.034 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 114.87 -18.71 16.45 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.558 ' CG1' ' O ' ' A' ' 28' ' ' ASP . 10.6 mt -36.04 99.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.538 HD13 ' CG2' ' A' ' 59' ' ' VAL . 10.9 tp -56.71 98.71 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.561 0.696 . . . . 0.0 109.712 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -117.68 -38.3 3.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.673 -0.642 . . . . 0.0 109.901 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 75' ' ' ARG . . . -133.97 91.19 2.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.862 -1.148 . . . . 0.0 110.515 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.538 ' CG2' HD13 ' A' ' 56' ' ' LEU . 2.4 t -106.97 84.5 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.435 HD13 ' HA2' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -69.98 -3.86 18.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 110.368 -178.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.523 ' OE1' ' CG1' ' A' ' 67' ' ' VAL . 7.7 mt-10 -127.06 46.25 2.55 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.083 -1.011 . . . . 0.0 108.982 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.9 m-20 -51.13 127.23 18.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.454 -0.779 . . . . 0.0 109.707 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' A' ' 62' ' ' ASP . 0.3 OUTLIER -17.62 132.98 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.321 0.582 . . . . 0.0 111.414 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.41 -31.35 7.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.487 ' O ' ' CG2' ' A' ' 18' ' ' THR . 24.1 m -70.19 170.54 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -1.162 . . . . 0.0 109.539 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 95.0 m -108.75 140.22 42.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.445 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.523 ' CG1' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -151.1 160.95 3.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.504 ' N ' HG21 ' A' ' 67' ' ' VAL . 1.3 m -117.44 -144.15 0.38 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.55 ' HA ' ' CG1' ' A' ' 7' ' ' VAL . 7.9 m -106.07 78.39 1.31 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.134 -0.979 . . . . 0.0 108.588 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 6.0 ttm180 159.34 -21.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.473 ' HB2' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -72.99 131.77 42.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.493 HG22 HD11 ' A' ' 72' ' ' ILE . 4.7 tt -79.18 111.92 16.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 110.098 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.547 ' CD1' HG13 ' A' ' 37' ' ' VAL . 13.1 mt -46.29 -38.99 9.34 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.435 ' HA2' HD13 ' A' ' 60' ' ' LEU . . . 154.17 169.96 19.57 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 2.1 ptm180 -110.94 137.06 49.04 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.304 -1.115 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.638 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 4.3 mp -102.69 -96.7 0.29 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.068 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.558 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.454 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 37.2 m . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 7.7 t -73.98 80.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 108.95 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.58 81.26 2.59 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.605 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 6.6 tp -99.34 152.18 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.027 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.52 ' CD2' ' HG2' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -139.97 -161.65 1.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 69' ' ' SER . 96.5 t -130.97 67.24 80.62 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.045 -1.034 . . . . 0.0 109.484 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HB3' ' HG3' ' A' ' 70' ' ' ARG . 36.1 Cg_endo -79.08 57.75 6.62 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.751 2.301 . . . . 0.0 110.878 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' HB3' ' CD2' ' A' ' 46' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.343 0 O-C-N 121.14 -0.975 . . . . 0.0 109.493 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' GLU . 17.6 m -160.75 143.83 13.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.001 -1.062 . . . . 0.0 110.693 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.513 ' HA ' HG13 ' A' ' 39' ' ' ILE . 1.9 t -65.73 149.09 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -126.96 -47.22 1.51 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.953 -1.092 . . . . 0.0 110.309 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.488 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -162.7 109.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.749 -1.219 . . . . 0.0 111.674 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.598 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 15.9 m95 -67.65 -162.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 0.0 108.503 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 33.4 m80 -158.1 34.82 0.25 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 56' ' ' LEU . 4.7 mmpt? -119.64 108.48 14.51 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.32 0.581 . . . . 0.0 110.376 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.568 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -59.56 -178.12 0.12 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.4 Cg_endo -67.99 89.99 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.105 1.203 . . . . 0.0 110.764 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.499 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 78.07 46.04 9.7 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 10.8 m-20 -59.55 -161.48 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.721 -1.458 . . . . 0.0 109.335 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.38 85.42 0.72 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.959 -1.088 . . . . 0.0 109.147 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.608 ' CG1' ' O ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -79.12 -176.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.357 -0.84 . . . . 0.0 109.894 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -142.47 -72.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.359 -0.838 . . . . 0.0 109.599 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.585 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 8.3 mmt180 -121.5 63.85 0.9 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.001 -1.062 . . . . 0.0 109.519 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 6.1 m-20 145.04 84.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.675 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 21.5 tt0 -84.89 170.15 13.39 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.218 1.009 . . . . 0.0 112.002 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 3.5 p -31.08 155.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.912 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.545 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -136.32 64.83 1.54 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 178.262 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.572 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.3 p -38.67 170.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.783 0.802 . . . . 0.0 110.725 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 2.8 mm-40 -125.8 96.59 4.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.132 -0.98 . . . . 0.0 109.098 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -79.88 -159.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.059 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.552 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 5.9 mm-40 -147.03 101.46 3.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.789 -1.194 . . . . 0.0 109.992 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -93.47 -152.0 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.337 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 20.4 t0 -94.16 88.0 5.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER 85.61 -23.85 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.755 -0.591 . . . . 0.0 109.612 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 41' ' ' THR . 23.0 t -116.33 137.12 51.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.236 -0.915 . . . . 0.0 109.503 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 39' ' ' ILE . 2.2 p -113.11 107.17 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.49 ' CD2' ' HB3' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -79.49 179.19 7.6 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.183 -0.948 . . . . 0.0 108.935 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -126.65 -163.75 1.27 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.981 -1.074 . . . . 0.0 110.269 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.704 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -151.26 75.76 7.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-O 122.278 1.037 . . . . 0.0 108.833 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.5 Cg_endo -81.01 115.32 2.99 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.801 2.334 . . . . 0.0 112.009 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.675 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -83.7 -167.65 1.81 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 2.0 p -131.54 18.09 4.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.129 -1.607 . . . . 0.0 111.135 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 159.46 160.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.608 ' O ' ' CG1' ' A' ' 30' ' ' VAL . 1.5 t70 64.7 -140.39 0.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 55' ' ' ILE . . . 116.71 -15.98 14.11 Favored Glycine 0 N--CA 1.489 2.22 0 O-C-N 120.218 -1.551 . . . . 0.0 110.671 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.569 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -32.01 94.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 117.884 0.842 . . . . 0.0 109.449 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.602 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -46.69 100.78 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.6 t70 -120.56 -46.02 2.39 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.201 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -135.55 107.55 7.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.749 -1.219 . . . . 0.0 110.818 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.602 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 1.4 t -113.17 90.86 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.81 -4.6 20.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.217 -0.927 . . . . 0.0 110.022 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.523 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 3.1 mt-10 -128.22 39.37 3.85 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.6 m-20 -40.67 136.15 1.44 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.732 -0.605 . . . . 0.0 109.699 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.598 ' OE2' ' CD1' ' A' ' 22' ' ' TRP . 67.4 mm-40 -27.82 146.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.537 0.684 . . . . 0.0 111.494 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.14 -2.11 87.62 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 18' ' ' THR . 24.2 m -94.15 154.96 17.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.165 -1.197 . . . . 0.0 109.352 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.422 ' C ' HG11 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -91.53 148.46 22.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.179 -0.951 . . . . 0.0 109.644 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.505 HG21 ' N ' ' A' ' 68' ' ' THR . 0.4 OUTLIER -150.32 155.33 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.46 -0.775 . . . . 0.0 108.931 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 69' ' ' SER . 7.4 t -100.78 -142.15 0.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.537 ' N ' ' CG2' ' A' ' 68' ' ' THR . 72.5 m -68.87 -99.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.779 -1.201 . . . . 0.0 108.239 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.52 ' HG2' ' CD2' ' A' ' 6' ' ' LEU . 7.4 ttp180 -75.11 76.22 2.28 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.376 -0.827 . . . . 0.0 109.88 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.462 ' HB2' HG21 ' A' ' 67' ' ' VAL . 2.3 mm-40 -113.92 95.34 5.26 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.514 ' N ' ' HB3' ' A' ' 6' ' ' LEU . 7.9 tt -38.7 109.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.649 -0.657 . . . . 0.0 110.807 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.563 ' CD1' HG13 ' A' ' 37' ' ' VAL . 12.1 mt -56.7 -39.94 74.74 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.98 -179.4 35.55 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -118.18 135.67 54.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.218 -1.166 . . . . 0.0 110.122 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.635 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 2.1 mp -99.25 -91.65 0.28 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.569 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 10.4 tpp180 . . . . . 0 C--N 1.295 -1.771 0 O-C-N 121.508 -0.745 . . . . 0.0 109.282 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.485 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 62.3 t -81.56 70.55 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 108.798 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -74.07 84.04 1.79 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.56 HG12 ' CG1' ' A' ' 48' ' ' VAL . 8.0 tp -99.73 163.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 111.297 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -147.31 -159.86 1.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.599 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 2.1 t -133.15 56.11 20.09 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.121 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.4 Cg_endo -80.58 35.94 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.5 2.134 . . . . 0.0 110.824 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.553 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.1 m-20 . . . . . 0 C--N 1.306 -1.283 0 O-C-N 120.801 -1.187 . . . . 0.0 109.966 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.53 ' CA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 121.167 0.508 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.495 ' N ' HG12 ' A' ' 67' ' ' VAL . 46.8 m -155.55 124.15 5.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 110.54 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.529 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 17.0 t -65.52 107.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.23 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -73.8 -59.62 2.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.614 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.552 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.6 m -168.69 128.52 1.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.628 -1.295 . . . . 0.0 111.775 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.537 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 17.6 m95 -69.2 -166.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.661 0.743 . . . . 0.0 109.24 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.1 m80 -152.7 26.47 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.6 tppt? -119.36 137.91 53.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.69 -0.631 . . . . 0.0 110.132 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.568 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.28 179.29 1.71 Allowed Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -69.64 104.91 1.37 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.664 1.576 . . . . 0.0 111.62 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.522 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 75.03 39.52 37.49 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 4.8 m-20 -59.45 -166.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.718 -1.46 . . . . 0.0 109.597 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.17 78.56 0.45 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.08 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.552 ' CG2' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -79.55 169.26 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.547 ' N ' HG11 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -110.06 -95.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 1.6 mtm180 -107.2 51.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.961 -1.087 . . . . 0.0 109.63 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.552 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 4.2 m-20 173.04 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.612 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 10.3 tp10 -102.29 163.62 12.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.058 -1.026 . . . . 0.0 111.008 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.538 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 2.5 p -30.36 160.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.57 1.176 . . . . 0.0 112.581 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.533 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.12 67.63 1.37 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.593 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.1 p -38.59 165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.102 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.27 145.71 46.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -134.77 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.573 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 13.1 mt-10 -149.35 138.51 21.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.923 -1.11 . . . . 0.0 109.708 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 5.9 t -132.72 26.22 4.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 41' ' ' THR . 2.2 t70 87.34 15.31 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.341 0.591 . . . . 0.0 110.459 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 160.52 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.552 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 1.1 t -103.99 148.57 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.613 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 39' ' ' ILE . 51.2 t -136.93 96.76 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.685 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.553 ' HG ' ' CB ' ' A' ' 9' ' ' ASP . 2.9 mm? -79.88 -176.0 5.21 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.309 -0.869 . . . . 0.0 108.728 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 1.3 pt-20 -142.39 -161.36 1.23 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.718 -1.239 . . . . 0.0 111.463 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.56 ' CG1' HG12 ' A' ' 5' ' ' ILE . 6.0 t -143.47 75.5 16.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.7 Cg_endo -80.73 110.82 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.487 2.125 . . . . 0.0 110.931 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.612 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -91.79 -169.38 2.26 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.558 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 5.1 p -132.36 14.68 4.57 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.265 -1.522 . . . . 0.0 111.183 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 161.62 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 109.951 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER 60.63 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.548 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 64.95 -13.65 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 O-C-N 121.324 -0.86 . . . . 0.0 112.093 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.522 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.81 96.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.674 -1.486 . . . . 0.0 108.551 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.58 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 7.8 tp -49.87 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ILE . 46.6 t0 -98.6 -41.59 7.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.97 -0.456 . . . . 0.0 110.544 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.37 78.71 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.577 -1.327 . . . . 0.0 111.677 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.58 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 60.7 t -80.86 82.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.37 -10.8 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 109.709 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 4.8 mm-40 -123.74 50.93 1.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -40.8 134.12 1.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.552 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.05 134.51 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.597 0.713 . . . . 0.0 111.015 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.75 -13.96 24.64 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -84.98 156.19 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -1.135 . . . . 0.0 109.405 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.41 166.43 20.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.681 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.534 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.04 169.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -147.78 -148.31 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 9.3 p -90.28 36.18 0.87 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mtt180 163.55 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.4 mt-30 -84.49 87.69 7.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 0.0 109.102 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.4 tt -45.0 108.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.543 ' CD1' HG23 ' A' ' 48' ' ' VAL . 10.6 mt -53.91 -42.86 69.21 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 156.55 -159.79 29.76 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -134.68 134.49 41.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.151 -1.206 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.604 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 4.4 mp -98.09 -96.72 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.34 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.542 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 77' ' ' ARG . 35.3 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.532 ' CG2' ' OE1' ' A' ' 34' ' ' GLU . 8.8 t -78.96 77.52 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.2 -0.937 . . . . 0.0 109.317 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.79 83.86 2.75 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.612 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -101.24 149.19 6.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.325 -0.859 . . . . 0.0 111.628 -177.032 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.43 -158.59 0.9 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.589 ' CG2' ' CD2' ' A' ' 73' ' ' LEU . 72.7 t -136.04 58.09 21.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.084 -1.01 . . . . 0.0 110.247 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.1 Cg_endo -80.7 19.81 1.06 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.39 2.06 . . . . 0.0 111.124 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 1.5 m-20 . . . . . 0 C--N 1.308 -1.201 0 O-C-N 120.769 -1.207 . . . . 0.0 109.913 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.424 ' C ' HG13 ' A' ' 39' ' ' ILE . 21.2 m -160.33 121.78 3.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.335 -0.853 . . . . 0.0 109.934 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 13.4 t -63.97 91.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.135 -0.978 . . . . 0.0 109.108 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -54.65 -57.83 9.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 110.707 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.588 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 40.3 m -166.5 122.88 1.25 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.709 -1.244 . . . . 0.0 111.654 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.558 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 18.4 m95 -67.85 -165.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 39.9 m80 -148.92 22.03 0.98 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.524 ' HE2' ' CA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -117.59 154.36 31.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.676 -0.64 . . . . 0.0 109.678 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.599 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -105.61 -173.41 0.28 Allowed Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.84 83.73 0.53 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.075 1.183 . . . . 0.0 111.247 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.546 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 81.11 48.08 6.21 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 18.2 m-20 -55.83 -113.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -1.182 . . . . 0.0 110.005 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 163.05 72.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.448 -1.408 . . . . 0.0 109.98 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.581 HG12 ' CA ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -79.66 157.09 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.112 -0.992 . . . . 0.0 110.652 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 2.6 m -97.51 -107.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 12.8 ttt-85 -104.9 74.84 1.15 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.693 -1.254 . . . . 0.0 108.965 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.594 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 11.4 m-20 143.96 102.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.581 ' CA ' HG12 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -112.21 -173.3 2.22 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.533 -177.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.511 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 13.1 p -27.68 153.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.953 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.1 58.82 1.7 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 178.019 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.1 p -37.75 168.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.731 0.776 . . . . 0.0 110.761 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.67 142.18 51.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.14 -179.63 3.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 121.276 -0.89 . . . . 0.0 109.387 -179.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 15.4 mt-10 -137.83 127.63 25.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.782 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 8.5 t -132.13 25.89 4.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 0.0 109.49 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.3 t0 81.32 87.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.709 -0.62 . . . . 0.0 110.544 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.9 tttp 85.72 -27.62 0.08 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.869 -0.519 . . . . 0.0 110.403 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.523 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 0.2 OUTLIER -114.81 142.19 28.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.961 -1.087 . . . . 0.0 109.964 -179.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.461 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 39.8 t -139.32 100.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.138 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.595 ' CD2' ' N ' ' A' ' 46' ' ' LEU . 3.3 mm? -81.65 -166.45 1.2 Allowed 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -143.45 -161.8 1.33 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.182 -0.949 . . . . 0.0 110.122 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.695 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -156.02 77.2 4.56 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 109.948 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.5 Cg_endo -79.89 107.63 2.12 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.419 2.079 . . . . 0.0 110.031 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.571 ' HB1' ' CG ' ' A' ' 34' ' ' GLU . . . -76.11 -167.22 0.71 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -143.06 24.02 1.84 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.461 -1.4 . . . . 0.0 110.819 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.63 ' O ' ' CB ' ' A' ' 53' ' ' ASP . . . 161.69 118.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.73 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.63 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 66.0 m-20 106.65 -117.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.559 ' CA ' ' OE1' ' A' ' 34' ' ' GLU . . . 100.28 -26.79 23.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.561 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 6.1 mt -43.78 98.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 108.089 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.572 ' CG ' ' CG2' ' A' ' 59' ' ' VAL . 10.6 tp -51.57 100.92 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.391 -0.818 . . . . 0.0 109.698 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -101.2 -46.75 4.95 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.754 -0.591 . . . . 0.0 109.598 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.64 96.79 2.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.884 -1.135 . . . . 0.0 110.529 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.572 ' CG2' ' CG ' ' A' ' 56' ' ' LEU . 2.6 t -94.71 90.9 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.965 . . . . 0.0 108.505 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.461 ' CD1' ' HA2' ' A' ' 74' ' ' GLY . 1.6 mt -71.23 -2.04 14.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.849 . . . . 0.0 110.329 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.526 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 7.7 mt-10 -135.61 54.3 1.92 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.155 -0.965 . . . . 0.0 108.471 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.4 m-20 -43.91 130.36 5.78 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.488 -0.758 . . . . 0.0 109.553 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.588 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -34.63 116.34 0.31 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.343 0.592 . . . . 0.0 110.953 -179.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.09 -6.39 7.27 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 m -95.18 162.92 13.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -1.179 . . . . 0.0 109.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -78.43 156.96 29.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.243 -0.911 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.584 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.74 174.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.584 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -143.82 -164.92 1.99 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 108.81 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 60.2 p -85.76 63.31 7.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.047 -1.033 . . . . 0.0 109.185 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.551 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.8 mmm-85 159.81 -16.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.606 -0.684 . . . . 0.0 109.923 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.46 ' HB2' HG22 ' A' ' 67' ' ' VAL . 21.1 mm100 -53.27 143.74 17.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.422 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 16.8 tt -95.59 112.06 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.3 -0.875 . . . . 0.0 109.682 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.589 ' CD2' ' CG2' ' A' ' 7' ' ' VAL . 9.3 mt -53.13 -31.46 42.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.461 ' HA2' ' CD1' ' A' ' 60' ' ' LEU . . . 139.63 -166.63 25.54 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.5 ptt85 -128.84 140.23 51.8 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.27 -1.135 . . . . 0.0 109.534 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' CD2' HD13 ' A' ' 56' ' ' LEU . 8.2 mt -100.74 -121.66 0.16 Allowed 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.128 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.561 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 19.2 ttt-85 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 120.595 -1.316 . . . . 0.0 110.015 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.6 ' CG1' ' CD1' ' A' ' 5' ' ' ILE . 15.7 t -88.91 63.22 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.292 -0.88 . . . . 0.0 109.652 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -85.26 89.44 7.65 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.602 HG13 ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -103.18 171.79 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 120.849 -1.157 . . . . 0.0 112.231 -177.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -142.12 -156.56 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.582 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 59.9 t -129.35 54.38 14.21 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.036 -1.04 . . . . 0.0 110.724 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.4 Cg_endo -80.3 28.02 0.54 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.473 2.115 . . . . 0.0 110.561 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.478 ' HB3' HD12 ' A' ' 46' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.307 -1.25 0 O-C-N 120.972 -1.08 . . . . 0.0 109.707 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.465 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 96.7 m -159.39 139.76 12.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.126 -0.984 . . . . 0.0 110.174 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.529 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 14.2 t -73.2 91.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.402 -0.811 . . . . 0.0 109.373 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -52.65 -62.92 1.34 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.389 -0.82 . . . . 0.0 110.431 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.563 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 2.9 m -161.62 122.67 2.75 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.499 -1.28 . . . . 0.0 111.812 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.535 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 13.7 m95 -67.93 -165.56 0.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.412 -0.805 . . . . 0.0 109.034 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.599 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 33.8 m80 -150.24 31.39 0.68 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HG2' ' HB ' ' A' ' 35' ' ' VAL . 2.8 mtpp -122.16 177.84 5.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.925 0.869 . . . . 0.0 110.844 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 8.2 mmmt -131.98 -177.62 0.72 Allowed Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -69.25 86.0 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.166 1.244 . . . . 0.0 110.646 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.548 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 86.07 47.36 5.02 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.567 ' O ' ' CG1' ' A' ' 55' ' ' ILE . 12.8 m-20 -54.31 -158.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -1.095 . . . . 0.0 110.055 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.33 86.74 0.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.54 -1.35 . . . . 0.0 109.179 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.578 HG11 ' N ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -95.13 170.46 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 110.011 -179.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 1.5 p -133.88 -57.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.317 -0.865 . . . . 0.0 109.386 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 3.2 mtp180 -141.18 64.16 1.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 108.82 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 11.6 m-20 149.6 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.653 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 11.9 tt0 -94.1 167.77 11.37 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.328 1.061 . . . . 0.0 111.726 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.531 ' HB ' ' HG2' ' A' ' 24' ' ' LYS . 2.4 p -31.16 156.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 122.174 0.987 . . . . 0.0 112.168 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.543 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.98 64.57 1.5 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 177.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.599 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.0 p -37.86 165.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.729 0.776 . . . . 0.0 110.268 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 2.4 mm-40 -128.37 98.47 5.07 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 108.806 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.75 -168.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.559 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 8.5 mt-10 -136.59 114.58 11.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.951 -1.093 . . . . 0.0 110.275 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.512 HG23 ' N ' ' A' ' 42' ' ' ASP . 98.1 m -106.33 -103.23 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.23 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 2.3 t70 -144.85 95.16 2.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.102 -0.998 . . . . 0.0 108.99 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.571 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 23.1 tttm 85.66 -28.02 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.307 0.575 . . . . 0.0 109.452 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.422 ' O ' HG21 ' A' ' 45' ' ' VAL . 2.0 t -118.95 -177.05 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.126 -0.984 . . . . 0.0 109.223 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 44.4 t -148.64 120.42 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 109.577 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -79.43 159.46 27.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 4.4 mt-10 -124.07 -173.45 2.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.058 -1.026 . . . . 0.0 110.132 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.66 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.9 OUTLIER -148.86 66.49 8.84 Favored Pre-proline 0 N--CA 1.487 1.409 0 CA-C-O 121.911 0.862 . . . . 0.0 109.041 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 33.8 Cg_endo -75.15 115.7 4.34 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.679 2.253 . . . . 0.0 110.998 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.653 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -91.91 -177.0 4.6 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.513 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 51.5 p -129.68 21.32 5.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.747 -1.221 . . . . 0.0 110.07 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 53' ' ' ASP . . . 162.69 161.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.432 -0.792 . . . . 0.0 109.076 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.578 ' N ' HG11 ' A' ' 30' ' ' VAL . 1.8 m-20 75.82 -145.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 117.03 -18.91 12.19 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 120.475 -1.391 . . . . 0.0 110.256 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.567 ' CG1' ' O ' ' A' ' 28' ' ' ASP . 18.9 mt -46.61 95.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.136 -1.214 . . . . 0.0 107.77 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.591 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 7.2 tp -53.27 109.42 0.43 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.375 -0.828 . . . . 0.0 109.398 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 20.1 t70 -113.54 -53.87 2.66 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.741 -0.599 . . . . 0.0 110.358 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.64 79.51 1.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.694 -1.254 . . . . 0.0 110.952 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.578 ' CG2' ' CG ' ' A' ' 56' ' ' LEU . 10.1 t -81.07 87.98 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.76 -1.6 12.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.465 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 51.8 mt-10 -134.03 52.51 2.06 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.013 -1.055 . . . . 0.0 108.456 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -43.5 131.59 4.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.599 -0.688 . . . . 0.0 109.769 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.563 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -36.1 111.38 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.327 0.584 . . . . 0.0 110.587 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.86 4.31 7.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -101.74 162.11 13.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -1.2 . . . . 0.0 109.596 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.23 151.61 36.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.595 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.565 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.98 173.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.565 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 5.2 t -140.33 -157.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 108.829 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 88.7 p -90.32 63.87 5.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.977 -1.077 . . . . 0.0 109.406 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.518 ' CB ' ' O ' ' A' ' 69' ' ' SER . 4.2 ttt180 159.54 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.648 -0.658 . . . . 0.0 109.458 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.505 ' O ' ' CA ' ' A' ' 6' ' ' LEU . 19.0 mm-40 -48.79 138.44 11.13 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.414 -0.804 . . . . 0.0 109.444 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.613 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.8 tt -87.55 114.36 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.383 -0.823 . . . . 0.0 109.818 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.534 ' CD1' HG13 ' A' ' 37' ' ' VAL . 5.2 mt -49.35 -39.64 32.61 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 146.86 -173.99 26.85 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -117.87 140.98 48.94 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.159 -1.2 . . . . 0.0 109.317 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.591 ' CD1' ' CD1' ' A' ' 56' ' ' LEU . 3.6 mm? -88.17 -92.33 0.11 Allowed 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.334 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.547 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 110.022 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.545 ' HB ' ' CG ' ' A' ' 76' ' ' LEU . 34.7 t -88.81 72.82 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.901 . . . . 0.0 109.411 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.63 80.99 4.09 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.541 HG12 ' CG1' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -94.32 156.7 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.28 -0.887 . . . . 0.0 111.327 -177.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -139.57 -155.54 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 39' ' ' ILE . 16.5 t -136.9 63.68 46.16 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.955 -1.091 . . . . 0.0 109.84 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 70' ' ' ARG . 36.5 Cg_endo -80.59 43.22 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.78 2.32 . . . . 0.0 110.252 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 O-C-N 121.179 -0.951 . . . . 0.0 109.957 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 16.0 m -159.69 134.91 8.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 110.546 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 23.8 t -70.42 84.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.455 -0.778 . . . . 0.0 109.251 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -41.18 -62.81 0.77 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.313 -0.867 . . . . 0.0 110.327 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.566 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.5 m -164.95 128.05 2.29 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.564 -1.255 . . . . 0.0 111.456 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.547 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 16.4 m95 -68.54 -167.69 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.546 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 23.4 m80 -149.56 35.38 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.484 ' HG3' ' HB2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -131.62 168.51 17.58 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.511 0.672 . . . . 0.0 110.195 -179.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.599 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -121.5 -171.09 0.21 Allowed Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 178.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -68.45 84.91 0.46 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 120.831 1.021 . . . . 0.0 111.262 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.551 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 77.05 48.86 8.0 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 20.8 m-20 -54.5 -112.13 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.253 -1.145 . . . . 0.0 110.911 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 157.48 103.63 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.573 HG13 ' CG ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -104.35 176.51 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 120.672 -1.268 . . . . 0.0 111.688 -177.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -114.37 -137.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -80.69 76.86 7.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.833 -1.167 . . . . 0.0 108.19 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 4.4 m-20 150.22 79.15 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.622 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 2.7 tm-20 -83.26 171.36 13.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 0.0 112.438 -177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.549 ' CG1' ' OE1' ' A' ' 34' ' ' GLU . 2.0 p -31.49 156.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.745 0.784 . . . . 0.0 111.687 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.539 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.05 63.27 1.34 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 178.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.547 ' CG2' ' HA ' ' A' ' 22' ' ' TRP . 3.2 p -39.38 168.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.681 0.753 . . . . 0.0 110.2 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 1.3 mt-10 -131.17 103.51 6.53 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 109.015 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 2.8 tt -84.14 -159.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.369 -0.832 . . . . 0.0 109.425 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.569 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 5.8 mm-40 -139.8 127.48 21.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.928 -1.108 . . . . 0.0 109.801 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 84.8 m -132.69 16.62 4.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.852 . . . . 0.0 109.665 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 15.2 t0 72.19 85.49 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.161 -0.962 . . . . 0.0 109.684 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 86.38 -27.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.24 0.543 . . . . 0.0 109.59 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.486 HG11 ' N ' ' A' ' 45' ' ' VAL . 66.9 t -115.47 144.97 21.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.143 -0.973 . . . . 0.0 109.281 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.486 ' N ' HG11 ' A' ' 44' ' ' VAL . 38.1 t -133.17 118.54 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.758 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -79.55 159.75 26.74 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.159 -0.963 . . . . 0.0 108.632 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -119.0 172.29 7.65 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.009 -1.057 . . . . 0.0 110.315 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.574 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 4.0 t -137.55 70.75 52.56 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.5 Cg_endo -79.72 116.3 3.47 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.838 2.358 . . . . 0.0 111.465 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.622 ' HB2' ' CB ' ' A' ' 34' ' ' GLU . . . -98.42 172.49 7.5 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 20.0 p -116.04 77.93 1.14 Allowed 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.087 -1.445 . . . . 0.0 110.618 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.585 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 88.81 160.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.245 0.545 . . . . 0.0 109.919 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.6 m-20 79.97 -76.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.699 -0.625 . . . . 0.0 110.219 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 40.94 22.51 0.06 OUTLIER Glycine 0 N--CA 1.493 2.455 0 O-C-N 121.033 -1.042 . . . . 0.0 110.788 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.556 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 12.5 mt -72.21 94.57 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.912 -1.346 . . . . 0.0 108.064 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.535 ' CB ' ' O ' ' A' ' 25' ' ' LYS . 5.1 tp -47.78 91.28 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.752 0.787 . . . . 0.0 110.389 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.2 t70 -84.0 -50.56 7.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.49 99.91 2.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.979 -1.076 . . . . 0.0 110.627 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.533 HG22 ' CD2' ' A' ' 56' ' ' LEU . 4.0 t -83.35 90.73 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.4 mt -69.09 -7.37 35.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 0.0 109.693 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 73' ' ' LEU . 2.9 mt-10 -131.72 52.76 2.04 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 63' ' ' GLU . 7.0 m-20 -40.93 134.17 2.0 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.46 0.648 . . . . 0.0 109.689 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.566 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.5 OUTLIER -36.08 125.7 0.75 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.485 0.66 . . . . 0.0 110.82 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.23 -4.57 21.95 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.515 ' CG2' ' N ' ' A' ' 66' ' ' THR . 21.5 m -84.15 166.33 17.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.227 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.515 ' N ' ' CG2' ' A' ' 65' ' ' THR . 90.0 m -93.73 137.58 32.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.731 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.504 HG23 ' CD1' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -150.22 153.54 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -116.22 -97.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.057 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 71' ' ' GLN . 28.7 p -94.99 -125.68 0.12 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.537 ' CG ' ' HB3' ' A' ' 8' ' ' PRO . 51.7 mtp180 -56.59 84.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.008 -1.058 . . . . 0.0 110.032 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -118.07 85.13 2.29 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.7 tt -34.25 107.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.885 -0.51 . . . . 0.0 111.107 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.54 ' CD1' HG23 ' A' ' 48' ' ' VAL . 15.7 mt -57.3 -38.36 73.87 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.79 -160.49 31.98 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.437 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -135.76 145.98 47.15 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.253 -1.145 . . . . 0.0 109.775 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.545 ' CG ' ' HB ' ' A' ' 3' ' ' VAL . 2.4 mt -129.45 -137.0 0.22 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.556 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 120.779 -1.201 . . . . 0.0 109.228 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.45 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 8.0 t -69.43 98.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 108.733 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -71.91 85.65 0.97 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.551 HG12 ' CG1' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -81.17 121.35 34.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.545 -0.722 . . . . 0.0 109.904 -178.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -145.47 -165.64 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.582 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 29.2 t -134.78 56.9 18.81 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.232 -0.918 . . . . 0.0 109.924 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.1 Cg_endo -80.48 36.82 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.495 2.13 . . . . 0.0 110.517 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.54 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.304 -1.392 0 O-C-N 120.948 -1.095 . . . . 0.0 109.593 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.292 0.568 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 20.4 m -153.39 131.71 12.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.375 -0.828 . . . . 0.0 110.317 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.505 ' HA ' HG13 ' A' ' 39' ' ' ILE . 11.4 t -70.18 83.69 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.386 -0.822 . . . . 0.0 109.493 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 38' ' ' GLU . . . -41.96 -63.27 0.76 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 110.493 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.483 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 5.4 m -166.94 129.05 1.71 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.59 -1.319 . . . . 0.0 111.479 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.531 ' CH2' HG13 ' A' ' 5' ' ' ILE . 21.9 m95 -69.66 -167.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.531 0.682 . . . . 0.0 109.292 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.577 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 24.5 m80 -151.83 28.26 0.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.556 ' CE ' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -118.1 167.52 11.4 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.714 0.768 . . . . 0.0 110.434 -178.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -115.54 -179.83 0.68 Allowed Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -70.74 87.23 0.68 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.426 1.417 . . . . 0.0 110.932 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.571 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 88.2 41.71 6.13 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD1' ' CG ' ' A' ' 25' ' ' LYS . 13.6 m-20 -55.52 -164.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.995 -1.297 . . . . 0.0 109.685 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.43 77.67 0.62 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.019 -1.051 . . . . 0.0 109.391 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.569 ' CG1' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -79.5 -179.06 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.373 -0.829 . . . . 0.0 109.609 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 32' ' ' ARG . 1.5 m -139.1 -48.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.098 -1.001 . . . . 0.0 110.241 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.563 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -150.83 62.27 0.93 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.4 m-20 150.73 75.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.569 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.55 -170.41 3.04 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.298 1.047 . . . . 0.0 111.871 -177.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.53 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 3.8 p -50.46 161.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.929 0.871 . . . . 0.0 111.639 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.546 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -140.2 61.4 1.53 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.577 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.2 p -38.52 168.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.773 0.797 . . . . 0.0 110.736 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 8.2 mt-10 -129.13 125.23 36.66 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.572 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -111.36 -172.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.298 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.572 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 6.1 mt-10 -134.98 128.78 33.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.998 . . . . 0.0 109.586 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.538 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 12.4 t -125.92 -32.08 2.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 110.042 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.591 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.1 t70 158.94 70.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.591 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.9 tttm 85.79 -25.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.465 ' O ' HG21 ' A' ' 41' ' ' THR . 92.7 t -108.27 133.78 52.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.34 -0.85 . . . . 0.0 109.267 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 55.9 t -118.36 112.52 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.117 -0.989 . . . . 0.0 109.729 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.29 -179.85 7.0 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.294 -0.878 . . . . 0.0 108.678 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 51.5 mt-10 -141.47 -171.38 3.29 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.86 -1.15 . . . . 0.0 110.451 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.551 ' CG1' HG12 ' A' ' 5' ' ' ILE . 14.8 p -146.35 75.4 12.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.388 -0.82 . . . . 0.0 109.678 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 35.0 Cg_endo -77.48 105.27 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.225 1.95 . . . . 0.0 110.385 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.569 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -77.56 -177.98 5.04 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.556 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 5.2 t -130.22 26.61 5.14 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.384 -1.448 . . . . 0.0 110.282 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 161.1 160.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.512 -0.743 . . . . 0.0 109.246 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.569 ' O ' ' CG1' ' A' ' 30' ' ' VAL . 12.4 m-20 62.24 -136.32 0.48 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.263 -0.898 . . . . 0.0 108.956 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 111.9 -17.83 24.66 Favored Glycine 0 N--CA 1.488 2.162 0 O-C-N 120.505 -1.372 . . . . 0.0 109.723 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.571 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 1.2 mt -34.24 102.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.789 -0.83 . . . . 0.0 109.371 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 12.2 tp -58.43 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.526 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -114.11 -29.49 6.96 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.405 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 75' ' ' ARG . . . -138.69 106.57 5.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.831 -1.168 . . . . 0.0 110.506 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 18.2 t -127.56 76.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.78 -4.15 18.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.554 -0.716 . . . . 0.0 110.563 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.532 ' HA ' ' CB ' ' A' ' 65' ' ' THR . 10.0 mt-10 -128.32 50.37 2.09 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 108.787 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 63' ' ' GLU . 7.2 m-20 -51.18 118.2 3.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.568 -0.707 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 62' ' ' ASP . 1.6 mp0 5.56 113.25 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.21 -32.3 6.2 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.532 ' CB ' ' HA ' ' A' ' 61' ' ' GLU . 78.9 m -54.3 153.23 5.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -1.135 . . . . 0.0 109.276 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.408 ' O ' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -69.82 155.56 40.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.367 -0.833 . . . . 0.0 109.588 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.577 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -149.6 174.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.577 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -139.83 -172.2 3.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.013 . . . . 0.0 109.408 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -86.19 46.76 1.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 109.133 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER 158.88 32.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 6' ' ' LEU . 77.2 mm-40 -112.94 149.89 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.992 -1.067 . . . . 0.0 109.125 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.526 HG12 ' N ' ' A' ' 74' ' ' GLY . 2.2 tt -97.07 113.22 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.483 -0.761 . . . . 0.0 110.686 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.534 ' HB2' HG22 ' A' ' 5' ' ' ILE . 1.3 mt -47.56 -36.99 11.36 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.526 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 163.99 -162.08 34.87 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 58' ' ' ALA . 1.1 ptt180 -136.12 150.09 48.95 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.625 -1.514 . . . . 0.0 110.053 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.607 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 5.3 mp -111.07 -115.03 0.31 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.537 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 20.3 ttt-85 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 120.863 -1.148 . . . . 0.0 109.304 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.459 ' HB3' ' N ' ' A' ' 77' ' ' ARG . 1.5 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.54 ' CG2' ' OE1' ' A' ' 34' ' ' GLU . 43.3 t -84.42 68.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.842 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -71.72 85.82 0.92 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.549 HG12 ' CG1' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -102.93 158.48 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.247 -0.908 . . . . 0.0 111.586 -177.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.567 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -137.62 -151.8 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.58 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 85.6 t -132.25 54.32 13.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.864 -1.148 . . . . 0.0 109.688 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.58 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 36.6 Cg_endo -77.04 67.0 7.67 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.557 2.171 . . . . 0.0 110.637 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 1.1 m-20 . . . . . 0 C--N 1.303 -1.434 0 O-C-N 121.086 -1.009 . . . . 0.0 109.831 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.357 0.599 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 39' ' ' ILE . 19.6 m -148.04 132.41 17.56 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.922 . . . . 0.0 110.192 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.533 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 16.6 t -69.0 87.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.937 . . . . 0.0 109.063 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 38' ' ' GLU . . . -51.01 -63.48 1.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 111.08 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.582 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 1.8 m -161.61 123.61 2.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.574 -1.329 . . . . 0.0 112.019 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.586 ' CZ2' HG21 ' A' ' 59' ' ' VAL . 16.9 m95 -68.6 -166.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.579 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 20.0 m80 -154.45 28.84 0.44 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.532 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 4.9 tppt? -123.07 122.89 39.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.714 -0.616 . . . . 0.0 110.247 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.557 ' CB ' ' OD1' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -71.3 179.06 1.01 Allowed Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -68.17 89.88 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.597 1.532 . . . . 0.0 111.672 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.553 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 78.86 45.15 9.43 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.557 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 13.6 m-20 -59.43 -117.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.077 -1.249 . . . . 0.0 110.331 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 159.1 101.79 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.772 -1.205 . . . . 0.0 108.534 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.596 ' CG1' ' N ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -102.16 -179.4 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.938 -1.101 . . . . 0.0 109.971 -179.36 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.596 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -105.09 -91.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 0.0 110.048 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -117.9 43.83 2.33 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.034 -1.041 . . . . 0.0 109.068 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.488 ' CG ' ' O ' ' A' ' 32' ' ' ARG . 17.8 m-20 171.74 99.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.591 ' CA ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -97.97 -160.38 0.8 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.348 -177.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.532 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 6.3 p -34.95 165.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.496 1.141 . . . . 0.0 112.94 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.517 HD13 ' ND1' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -148.74 58.11 1.05 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.579 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 2.3 p -39.39 167.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.88 0.848 . . . . 0.0 110.836 -177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 24.1 mt-10 -130.81 121.61 25.65 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.558 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -103.97 -170.17 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.313 -0.867 . . . . 0.0 109.483 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 2.5 mt-10 -153.2 101.37 2.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.122 -0.986 . . . . 0.0 109.767 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -97.12 -35.3 10.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.905 . . . . 0.0 109.9 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 11.4 t70 171.62 72.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.725 . . . . 0.0 109.704 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.4 tmmt? 85.8 -24.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.96 131.17 57.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.232 -0.917 . . . . 0.0 109.578 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 94.3 t -113.84 123.31 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.838 . . . . 0.0 109.475 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.555 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 5.9 mt -86.44 178.24 7.18 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.163 -0.961 . . . . 0.0 108.816 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 27.2 mt-10 -126.58 175.84 7.64 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.811 -1.181 . . . . 0.0 110.835 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.58 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 4.9 t -139.46 71.99 37.86 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.3 Cg_endo -79.29 116.27 3.59 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.534 2.156 . . . . 0.0 109.797 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.59 ' CB ' ' CD ' ' A' ' 34' ' ' GLU . . . -97.29 -175.66 3.29 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.945 -1.097 . . . . 0.0 108.524 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.634 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 12.3 p -131.5 70.16 1.47 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.644 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.638 ' O ' ' CB ' ' A' ' 53' ' ' ASP . . . 98.53 136.95 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 121.253 0.549 . . . . 0.0 112.029 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.638 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 8.3 t0 101.34 -76.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.504 0.669 . . . . 0.0 110.019 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.529 ' CA ' ' OE1' ' A' ' 34' ' ' GLU . . . 43.27 21.6 0.15 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.553 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 6.7 mt -77.65 90.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.835 -1.391 . . . . 0.0 107.583 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.54 ' CG ' HG13 ' A' ' 59' ' ' VAL . 7.2 tp -44.0 111.2 0.27 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.447 0.641 . . . . 0.0 110.144 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 12.5 t70 -134.28 -29.88 1.21 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.608 -0.682 . . . . 0.0 110.245 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 75' ' ' ARG . . . -137.65 39.56 2.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.622 -1.299 . . . . 0.0 110.964 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.586 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 9.1 p -83.82 71.52 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.53 0.38 10.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 110.756 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 73' ' ' LEU . 9.1 mm-40 -105.08 41.54 1.33 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.2 m-20 -37.94 124.83 1.17 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.422 0.63 . . . . 0.0 110.005 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.582 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -29.47 122.14 0.15 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.498 0.666 . . . . 0.0 111.35 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.35 -13.35 8.35 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.438 ' HB ' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -83.37 174.43 10.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -1.062 . . . . 0.0 109.367 179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -96.19 144.89 26.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 110.021 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.544 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.69 169.44 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.544 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -127.49 -143.14 0.28 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 7' ' ' VAL . 11.1 t -69.67 -102.09 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.008 -1.057 . . . . 0.0 108.972 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 71' ' ' GLN . 3.7 mtt180 -78.07 36.7 0.23 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.127 -0.983 . . . . 0.0 111.377 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.509 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 61.4 mm-40 -61.73 -113.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.49 -1.381 . . . . 0.0 107.991 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 16.0 tt 179.34 115.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.694 -1.254 . . . . 0.0 110.725 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 61' ' ' GLU . 7.8 mt -71.84 -44.47 63.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.38 -159.76 28.79 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 13.6 mtt180 -135.34 135.39 40.69 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.263 -1.14 . . . . 0.0 108.903 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.598 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -85.33 -105.23 0.05 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.353 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.524 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 120.928 -1.108 . . . . 0.0 109.799 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.473 ' CB ' ' HB2' ' A' ' 75' ' ' ARG . 7.6 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.525 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 14.1 t -80.58 75.62 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 108.916 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.441 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -78.74 78.17 5.2 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.541 HG12 ' CG1' ' A' ' 48' ' ' VAL . 4.5 tp -88.1 154.28 3.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.259 -0.901 . . . . 0.0 110.799 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.574 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.82 -151.44 0.45 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.334 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.544 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 59.6 t -133.63 60.59 47.78 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.034 -1.041 . . . . 0.0 110.167 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -81.14 34.02 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.538 2.159 . . . . 0.0 110.521 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.548 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.307 -1.269 0 O-C-N 121.008 -1.057 . . . . 0.0 109.689 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.512 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 33.6 m -160.1 119.11 2.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.862 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.528 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.8 t -48.43 134.11 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 108.996 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -106.76 -57.43 2.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.676 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.464 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 32.5 m -160.88 119.14 2.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.849 -1.157 . . . . 0.0 111.208 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.572 ' CE2' HG13 ' A' ' 59' ' ' VAL . 21.2 m95 -68.94 -165.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 18.6 m80 -156.17 48.22 0.48 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.579 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.12 119.72 13.23 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.493 -0.754 . . . . 0.0 110.179 -179.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -62.0 -179.25 0.22 Allowed Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.1 Cg_endo -67.69 88.88 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.277 1.318 . . . . 0.0 111.111 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.539 ' CA ' HG22 ' A' ' 55' ' ' ILE . . . 76.05 46.89 12.21 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 18.3 m-20 -59.1 -115.63 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.888 -1.36 . . . . 0.0 109.543 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 163.23 98.56 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.565 -1.334 . . . . 0.0 109.422 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.593 HG11 ' N ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -92.74 -176.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.111 -0.993 . . . . 0.0 109.742 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -141.79 -62.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.43 -0.794 . . . . 0.0 109.471 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -132.52 58.72 1.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -0.979 . . . . 0.0 108.986 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 14.8 m-20 151.51 76.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.611 ' CG ' ' HA3' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -71.94 -173.64 1.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.348 1.07 . . . . 0.0 111.773 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.525 ' CG1' ' OE2' ' A' ' 34' ' ' GLU . 14.0 p -45.2 168.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -147.96 61.37 1.12 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.537 ' CG1' HG22 ' A' ' 48' ' ' VAL . 2.7 p -39.46 166.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.728 0.775 . . . . 0.0 110.404 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 5.1 mm-40 -128.72 97.3 4.63 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.72 -165.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.473 -0.767 . . . . 0.0 109.254 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -139.68 141.03 37.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.937 -1.102 . . . . 0.0 110.097 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.502 ' O ' ' CG2' ' A' ' 41' ' ' THR . 97.5 m -146.4 21.28 1.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.44 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 18.8 t0 64.73 88.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 109.568 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 86.15 -26.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.434 ' O ' ' HB ' ' A' ' 41' ' ' THR . 55.3 t -116.22 142.21 30.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 39' ' ' ILE . 96.9 t -136.21 118.03 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.548 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 3.9 mt -82.77 162.47 21.7 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.307 -0.871 . . . . 0.0 108.969 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -119.54 175.44 5.84 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.039 -1.038 . . . . 0.0 110.176 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.593 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 4.8 t -140.54 68.69 31.6 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 109.182 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.51 110.13 2.15 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.633 2.222 . . . . 0.0 110.399 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.59 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -89.84 179.27 6.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.634 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -125.71 72.4 1.28 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.552 -1.343 . . . . 0.0 110.215 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.634 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 101.58 162.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.507 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.593 ' N ' HG11 ' A' ' 30' ' ' VAL . 11.9 m-20 64.78 -142.01 0.24 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.611 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 101.11 -7.41 56.89 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.077 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.539 HG22 ' CA ' ' A' ' 27' ' ' GLY . 6.1 mt -41.18 96.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -41.58 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.761 0.791 . . . . 0.0 109.416 -178.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ILE . 51.8 t0 -101.59 -52.24 3.26 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.699 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.93 105.42 3.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.895 -1.128 . . . . 0.0 110.531 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.59 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -102.02 90.03 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 mt -69.79 -5.01 22.54 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 110.083 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.525 ' CB ' ' HA ' ' A' ' 73' ' ' LEU . 3.6 mt-10 -124.51 40.96 3.62 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.156 -0.965 . . . . 0.0 108.922 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.6 m-20 -42.22 128.73 3.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.58 -0.7 . . . . 0.0 109.554 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.528 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -26.89 121.7 0.09 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.317 0.58 . . . . 0.0 110.972 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.86 -16.2 7.82 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 66' ' ' THR . 73.0 m -88.14 160.06 17.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -1.17 . . . . 0.0 109.58 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.496 HG21 ' N ' ' A' ' 67' ' ' VAL . 58.2 m -78.74 157.54 28.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 109.546 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.54 HG23 ' CG2' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.59 169.68 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.539 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 5.4 t -141.38 -152.05 0.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.362 -0.836 . . . . 0.0 109.123 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 12.8 p -93.38 58.68 2.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.051 -1.03 . . . . 0.0 109.624 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.7 mtp-105 160.3 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.542 -0.724 . . . . 0.0 109.755 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.51 ' CG ' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -46.87 133.92 10.54 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 11.5 tt -86.32 110.72 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.542 ' CD1' HG23 ' A' ' 48' ' ' VAL . 18.5 mt -50.17 -44.87 52.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.015 -1.053 . . . . 0.0 108.205 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.51 -175.36 34.16 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 2.6 ptt180 -118.46 143.75 46.48 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.248 -1.148 . . . . 0.0 109.804 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.562 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 6.4 mt -114.8 -79.75 0.59 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.935 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.784 0 O-C-N 121.257 -0.902 . . . . 0.0 109.251 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.529 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 8.6 m . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 9.6 t -69.53 84.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.046 -1.034 . . . . 0.0 108.464 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 2.5 m-20 -74.61 83.42 2.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.584 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 3.5 tp -104.31 146.27 11.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.172 -177.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -134.85 -164.63 1.55 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.524 ' CG1' HD11 ' A' ' 46' ' ' LEU . 20.9 t -133.03 86.96 41.17 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.979 -1.076 . . . . 0.0 110.418 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 36.8 Cg_endo -81.44 54.56 5.2 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.578 2.185 . . . . 0.0 110.082 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.288 0 O-C-N 121.101 -0.999 . . . . 0.0 110.256 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.321 0.582 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 16.0 m -153.21 138.49 17.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 110.347 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.562 ' HA ' HG13 ' A' ' 39' ' ' ILE . 11.2 t -76.79 99.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 0.0 109.53 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -57.49 -54.9 41.58 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 110.606 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.566 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 21.7 m -168.87 131.03 1.26 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.605 -1.31 . . . . 0.0 111.815 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.575 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 18.5 m95 -68.65 -162.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.587 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 26.3 m80 -155.14 34.13 0.38 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.576 ' CD ' ' HB ' ' A' ' 35' ' ' VAL . 1.6 mmmt -124.59 128.4 48.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.85 -0.531 . . . . 0.0 110.317 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.6 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -79.91 -174.68 0.51 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.37 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.6 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.5 Cg_endo -68.25 84.14 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.069 1.179 . . . . 0.0 111.564 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.539 ' CA ' ' CG2' ' A' ' 55' ' ' ILE . . . 78.83 47.46 7.75 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 18.0 m-20 -55.34 -110.74 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.047 -1.266 . . . . 0.0 110.426 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 157.86 99.78 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.926 -1.109 . . . . 0.0 108.67 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.58 ' CG1' ' N ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -102.56 -177.35 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.831 -1.168 . . . . 0.0 109.718 -179.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.58 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 5.8 m -130.03 -113.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.146 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 4.9 mtt180 -87.11 63.6 7.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.827 -1.171 . . . . 0.0 109.175 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 4.1 m-20 150.66 101.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.579 ' CB ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -97.73 -174.05 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.247 1.023 . . . . 0.0 111.656 -178.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.576 ' HB ' ' CD ' ' A' ' 24' ' ' LYS . 3.7 p -44.23 157.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-O 121.978 0.894 . . . . 0.0 111.704 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -134.55 63.38 1.62 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 178.119 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.587 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 5.5 p -38.92 168.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.78 0.8 . . . . 0.0 110.178 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -123.19 139.61 53.87 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 1.9 tt -121.94 -163.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.978 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.568 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 21.8 mm-40 -141.36 117.41 10.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.853 -1.154 . . . . 0.0 109.964 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -115.13 -64.17 1.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.566 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 49.0 t0 177.98 82.53 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.2 tttt 86.84 -26.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 41' ' ' THR . 1.9 t -113.18 163.31 10.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.309 -0.87 . . . . 0.0 109.201 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 39' ' ' ILE . 43.9 t -131.75 122.85 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.524 HD11 ' CG1' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -79.66 158.91 26.9 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.317 -0.864 . . . . 0.0 108.734 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.5 pm0 -120.82 178.15 4.82 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.007 -1.058 . . . . 0.0 110.226 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.692 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -145.04 77.97 12.76 Favored Pre-proline 0 N--CA 1.489 1.518 0 CA-C-O 122.285 1.04 . . . . 0.0 108.778 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.0 Cg_endo -81.24 108.84 2.05 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.89 2.393 . . . . 0.0 111.966 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.562 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -78.02 -157.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.576 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.2 p -140.37 10.92 2.32 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.541 -1.349 . . . . 0.0 111.196 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 160.04 159.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER 78.91 -73.82 0.07 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.459 0.647 . . . . 0.0 110.272 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.536 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 45.3 16.88 0.1 Allowed Glycine 0 N--CA 1.489 2.194 0 O-C-N 121.212 -0.93 . . . . 0.0 111.655 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.551 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 2.2 mt -68.6 88.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.678 -1.483 . . . . 0.0 108.041 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.603 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -40.81 103.45 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -123.21 -52.01 1.86 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 111.018 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -136.15 82.61 1.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.512 -1.368 . . . . 0.0 111.155 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.603 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -79.9 103.2 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 29.4 mt -69.34 -11.82 61.14 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.093 -1.005 . . . . 0.0 109.533 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 9.5 mm-40 -132.42 56.09 1.85 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 61' ' ' GLU . 3.2 m-20 -40.74 136.18 1.46 Allowed 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.579 -0.7 . . . . 0.0 109.715 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.566 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -39.49 125.56 1.74 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.426 0.632 . . . . 0.0 110.822 -179.248 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.76 -4.64 19.07 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -97.75 153.07 18.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -1.134 . . . . 0.0 109.365 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.75 155.48 40.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.932 . . . . 0.0 109.446 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.528 HG21 ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.32 162.43 3.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.557 -0.715 . . . . 0.0 109.279 -179.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.528 ' N ' HG21 ' A' ' 67' ' ' VAL . 2.8 m -116.34 -133.24 0.33 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.48 -0.762 . . . . 0.0 109.328 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 7' ' ' VAL . 7.3 p -69.59 -104.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.883 -1.136 . . . . 0.0 109.63 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.531 ' CG ' ' HA ' ' A' ' 8' ' ' PRO . 4.9 mtm180 -80.21 39.9 0.46 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.468 ' HB2' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -62.6 107.04 0.87 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.757 -1.214 . . . . 0.0 108.896 179.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.7 tt -43.28 110.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.574 ' HB3' ' CZ2' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -52.91 -36.9 60.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.415 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 154.32 165.58 14.02 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -107.48 137.2 45.95 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.241 -1.153 . . . . 0.0 109.781 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.61 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 5.5 mp -106.87 -94.11 0.38 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.552 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.551 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 4.2 tpt180 . . . . . 0 C--N 1.299 -1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.476 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 72.5 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 57.9 t -72.69 81.03 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.59 78.51 6.13 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.548 ' CG2' HG12 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -92.26 149.71 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.479 -0.763 . . . . 0.0 111.161 -177.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -132.8 -158.67 0.91 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.579 ' CG1' ' CD1' ' A' ' 46' ' ' LEU . 60.3 t -130.49 59.84 48.45 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 120.866 -1.146 . . . . 0.0 110.145 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HG3' ' CD1' ' A' ' 6' ' ' LEU . 37.9 Cg_endo -81.41 19.92 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.589 2.193 . . . . 0.0 110.531 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.554 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.298 0 O-C-N 120.891 -1.131 . . . . 0.0 110.579 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.518 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 79.5 m -158.76 134.79 9.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 110.681 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 22.0 t -69.18 84.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.412 -0.805 . . . . 0.0 109.231 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -43.6 -63.16 0.89 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.092 -1.005 . . . . 0.0 110.245 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.579 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 87.3 m -164.19 124.19 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.648 -1.283 . . . . 0.0 111.658 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.546 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 19.1 m95 -68.44 -167.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.562 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 17.3 m80 -152.14 24.1 0.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.526 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 2.2 tppm? -118.45 128.18 54.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.793 -0.567 . . . . 0.0 109.941 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.546 ' CB ' ' OD1' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -78.94 178.61 2.18 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.4 Cg_endo -69.21 93.26 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.644 1.562 . . . . 0.0 111.466 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.533 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 78.28 43.13 13.62 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.546 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 12.5 m-20 -61.36 -120.24 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.002 -1.293 . . . . 0.0 109.651 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 159.58 79.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.73 -1.231 . . . . 0.0 108.843 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -79.73 -168.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.12 -0.987 . . . . 0.0 109.652 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.572 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -134.99 -99.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.31 -0.869 . . . . 0.0 109.845 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.469 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 16.3 ttt-85 -98.37 38.5 1.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.871 -1.143 . . . . 0.0 109.522 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.547 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 2.6 m-20 178.5 91.42 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.599 ' CB ' ' CB ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -83.37 -170.24 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.263 1.03 . . . . 0.0 112.102 -178.041 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 23' ' ' HIS . 3.1 p -55.97 164.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.453 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -142.08 62.07 1.44 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.562 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 3.3 p -38.95 165.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-O 121.682 0.753 . . . . 0.0 110.204 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 2.3 mt-10 -128.37 97.58 4.78 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.76 -164.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 O-C-N 121.397 -0.814 . . . . 0.0 108.976 -179.48 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.574 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 3.9 mm-40 -134.48 112.83 11.23 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.974 -1.079 . . . . 0.0 109.775 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.463 ' OG1' HD22 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -108.16 -145.58 0.39 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -0.87 . . . . 0.0 109.196 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 6.8 t70 -96.73 83.24 3.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.086 -1.009 . . . . 0.0 109.592 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.2 tmtt? 85.98 -22.23 0.19 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.223 0.535 . . . . 0.0 109.585 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.5 HG13 ' N ' ' A' ' 45' ' ' VAL . 95.2 t -113.61 164.74 9.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.307 -0.871 . . . . 0.0 109.612 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.5 ' N ' HG13 ' A' ' 44' ' ' VAL . 54.9 t -127.64 125.64 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.579 ' CD1' ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -79.62 155.34 28.14 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.297 -0.877 . . . . 0.0 108.823 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -112.17 172.65 6.78 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.043 -1.036 . . . . 0.0 110.594 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.575 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 8.6 t -142.2 70.35 22.62 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.27 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.24 113.45 2.67 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.72 2.28 . . . . 0.0 111.288 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.599 ' CB ' ' CB ' ' A' ' 34' ' ' GLU . . . -88.5 -164.52 1.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.675 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 10.0 p -141.09 60.06 1.52 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.548 -1.261 . . . . 0.0 110.623 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.675 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 105.43 160.99 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.412 0.625 . . . . 0.0 110.658 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 74.95 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.619 -0.676 . . . . 0.0 110.188 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' OE2' ' A' ' 34' ' ' GLU . . . 54.56 8.51 1.28 Allowed Glycine 0 N--CA 1.495 2.582 0 O-C-N 121.051 -1.03 . . . . 0.0 111.778 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.545 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -55.11 92.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 120.612 -1.522 . . . . 0.0 107.797 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.546 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 8.8 tp -44.7 112.88 0.47 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.468 -0.77 . . . . 0.0 109.527 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -118.84 -43.36 2.67 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.653 -0.654 . . . . 0.0 110.07 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.06 78.12 1.59 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.858 -1.151 . . . . 0.0 110.776 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.546 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 8.4 t -79.46 87.59 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.8 mt -69.55 -4.42 18.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 0.0 110.334 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.517 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 2.5 mt-10 -129.21 50.89 2.1 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.0 m-20 -42.58 127.43 3.84 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.696 -0.627 . . . . 0.0 109.489 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.579 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.12 121.05 0.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.449 0.642 . . . . 0.0 111.079 -179.199 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.89 -1.45 19.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 66' ' ' THR . 22.5 m -97.89 159.98 14.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -1.137 . . . . 0.0 109.347 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.447 ' N ' HG23 ' A' ' 65' ' ' THR . 0.2 OUTLIER -70.99 149.33 46.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.64 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.537 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.24 169.45 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.537 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -138.63 -176.39 4.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.365 -0.834 . . . . 0.0 109.052 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -83.69 69.52 10.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.231 -0.918 . . . . 0.0 109.329 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 69' ' ' SER . 10.3 ttm180 158.61 -22.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.6 mm-40 -57.62 159.17 5.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.876 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 15.8 tt -103.81 113.25 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.696 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.55 ' CD1' HG23 ' A' ' 48' ' ' VAL . 9.3 mt -49.86 -47.1 51.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 108.269 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.72 -166.36 34.37 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -127.86 141.6 51.51 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.322 -1.104 . . . . 0.0 109.681 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.592 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 2.8 mp -101.29 -104.19 0.25 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.295 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.545 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 O-C-N 120.873 -1.142 . . . . 0.0 109.984 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.481 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 15.4 m . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 38.5 t -78.03 77.85 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.01 . . . . 0.0 108.52 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.71 85.88 0.92 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.605 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 3.5 tp -110.09 141.0 26.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 111.058 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -127.47 -145.54 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.52 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.535 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 69.1 t -132.94 58.82 38.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.957 -1.09 . . . . 0.0 109.315 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 34.5 Cg_endo -75.8 68.33 6.41 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.616 2.21 . . . . 0.0 111.108 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.535 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.304 -1.383 0 O-C-N 121.179 -0.951 . . . . 0.0 109.346 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.447 0.641 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.454 ' C ' HG13 ' A' ' 39' ' ' ILE . 18.4 m -160.23 125.9 4.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.398 -0.814 . . . . 0.0 109.519 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.6 t -52.54 141.62 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 109.071 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -117.7 -50.07 2.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.114 -0.991 . . . . 0.0 109.877 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.476 ' N ' ' HB3' ' A' ' 63' ' ' GLU . 52.6 m -164.56 114.12 1.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.885 -1.135 . . . . 0.0 111.128 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.579 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 18.2 m95 -68.56 -162.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.833 . . . . 0.0 108.756 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 20.8 m80 -160.08 26.14 0.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.566 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -114.63 114.5 25.76 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.595 -178.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.594 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 11.3 mmmt -59.55 173.34 0.52 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -66.92 96.5 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.516 1.477 . . . . 0.0 110.829 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.55 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 80.72 50.33 5.32 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 3.0 m-20 -55.72 -150.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.485 -1.009 . . . . 0.0 110.382 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HA ' HD13 ' A' ' 55' ' ' ILE . . . -175.39 96.61 0.07 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.541 -1.349 . . . . 0.0 108.57 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.613 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -110.58 -176.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.891 -179.004 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.444 ' N ' HG12 ' A' ' 30' ' ' VAL . 2.1 p -125.72 -49.6 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.598 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -157.13 61.49 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.367 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.598 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.5 m-20 146.0 100.6 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.613 ' HB3' ' CB ' ' A' ' 30' ' ' VAL . 1.9 pt-20 -131.39 -164.07 1.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.938 -1.101 . . . . 0.0 112.028 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 4.0 p -13.58 136.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.068 0.937 . . . . 0.0 113.309 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -130.55 62.86 1.58 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.585 ' CG1' ' CG1' ' A' ' 48' ' ' VAL . 4.2 p -37.56 166.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.891 0.853 . . . . 0.0 110.807 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 2.0 mt-10 -125.03 95.61 4.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.86 -160.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 121.419 -0.8 . . . . 0.0 109.18 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.577 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -136.62 151.55 49.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.872 -1.143 . . . . 0.0 109.973 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 41' ' ' THR . 98.4 m -156.41 31.8 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.593 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 10.8 t0 47.78 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 109.637 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 85.27 -27.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.845 -0.535 . . . . 0.0 109.741 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.464 ' O ' ' HB ' ' A' ' 41' ' ' THR . 1.8 t -120.85 152.43 24.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.154 -0.966 . . . . 0.0 109.538 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 24.1 t -149.38 97.57 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.384 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.581 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.67 164.65 23.59 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.211 -0.931 . . . . 0.0 109.153 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 48.0 mt-10 -112.37 -165.92 1.03 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.211 -0.93 . . . . 0.0 109.761 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.685 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -152.69 78.37 6.18 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 122.154 0.978 . . . . 0.0 109.187 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.66 110.08 2.35 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.838 2.359 . . . . 0.0 111.178 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.586 ' CB ' ' CG ' ' A' ' 34' ' ' GLU . . . -74.14 -162.67 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.583 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -148.48 33.9 0.79 Allowed 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.975 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 155.89 151.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.932 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.6 OUTLIER 65.84 -93.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.52 -0.738 . . . . 0.0 110.541 179.071 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 74.18 -9.73 9.11 Favored Glycine 0 N--CA 1.486 2.001 0 O-C-N 120.674 -1.267 . . . . 0.0 110.466 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.588 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 1.1 mp -40.29 94.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.555 1.178 . . . . 0.0 108.541 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.615 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -50.47 92.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 55' ' ' ILE . 8.6 t70 -111.69 -44.78 3.44 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.815 -0.553 . . . . 0.0 110.776 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -138.72 98.26 3.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.554 -1.342 . . . . 0.0 111.14 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.615 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 1.7 t -109.74 88.96 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 mt -69.48 -4.03 17.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 110.592 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 10.0 mt-10 -127.16 44.32 2.94 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.113 -0.992 . . . . 0.0 108.564 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -46.07 136.34 6.8 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.465 -0.772 . . . . 0.0 109.32 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.523 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -31.9 107.2 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.418 0.628 . . . . 0.0 110.481 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.41 -7.78 3.41 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.439 ' O ' HG21 ' A' ' 18' ' ' THR . 0.1 OUTLIER -100.01 178.83 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -1.17 . . . . 0.0 109.748 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 m -99.97 151.24 21.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.85 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.558 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.89 171.18 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.359 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.558 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 1.4 m -134.29 -141.38 0.19 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 108.975 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 7' ' ' VAL . 2.2 p -69.35 -104.48 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.945 -1.097 . . . . 0.0 109.054 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 70' ' ' ARG . 28.0 ttp180 -79.2 37.86 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.066 . . . . 0.0 110.755 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 68' ' ' THR . 12.6 mm100 -63.92 -112.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.76 -1.212 . . . . 0.0 108.582 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 12.4 tt -179.0 116.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.836 -1.165 . . . . 0.0 110.392 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.548 ' CD1' HG13 ' A' ' 37' ' ' VAL . 9.7 mt -72.96 -49.94 26.31 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.13 -0.981 . . . . 0.0 108.4 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 59' ' ' VAL . . . 161.57 169.73 25.27 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -110.73 138.57 46.95 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.13 -1.218 . . . . 0.0 110.089 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.624 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 5.0 mp -106.47 -88.63 0.45 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.588 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.5 ttt180 . . . . . 0 C--N 1.296 -1.758 0 O-C-N 121.568 -0.708 . . . . 0.0 109.453 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 77' ' ' ARG . 66.3 m . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.545 ' HB ' ' CG ' ' A' ' 76' ' ' LEU . 4.7 t -77.96 77.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -83.6 84.11 7.66 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.562 HG12 ' CG1' ' A' ' 48' ' ' VAL . 6.5 tp -89.48 158.04 2.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.375 -0.828 . . . . 0.0 111.583 -177.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -137.44 -151.56 0.4 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.571 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 33.2 t -138.21 57.25 12.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.7 -1.25 . . . . 0.0 110.085 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -79.94 47.56 2.57 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.617 2.211 . . . . 0.0 110.843 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.537 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 3.0 m-20 . . . . . 0 C--N 1.304 -1.388 0 O-C-N 120.945 -1.097 . . . . 0.0 109.616 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 40' ' ' GLU . 1.1 m -134.74 129.06 34.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.17 -0.956 . . . . 0.0 110.233 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 39' ' ' ILE . 7.0 t -75.61 103.93 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.378 -0.827 . . . . 0.0 109.188 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -65.02 -62.15 1.73 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.747 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.584 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 52.9 m -168.65 132.29 1.47 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.276 -1.37 . . . . 0.0 112.289 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.582 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 18.4 m95 -68.99 -168.77 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.8 m80 -150.91 30.98 0.63 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.528 ' HA ' ' CE ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -122.38 123.78 42.14 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.706 -0.621 . . . . 0.0 110.389 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.567 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -74.57 -178.87 0.88 Allowed Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -68.18 90.55 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.282 1.321 . . . . 0.0 111.001 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.548 ' CA ' HG22 ' A' ' 55' ' ' ILE . . . 76.47 46.23 12.47 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.542 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 14.1 m-20 -59.7 -118.07 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.933 -1.333 . . . . 0.0 109.794 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 162.91 100.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.583 -1.323 . . . . 0.0 109.493 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -100.99 -175.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.185 -0.947 . . . . 0.0 109.987 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.489 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -141.15 -73.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 109.608 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -119.81 61.55 0.84 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.055 -1.028 . . . . 0.0 109.426 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.7 m-20 145.32 84.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.578 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -76.1 -168.78 0.99 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.001 0.905 . . . . 0.0 111.533 -178.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.536 ' CG1' ' OE2' ' A' ' 34' ' ' GLU . 7.5 p -49.54 166.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.572 0.701 . . . . 0.0 110.836 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.516 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.85 59.05 1.31 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.593 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 2.7 p -39.18 166.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.63 0.728 . . . . 0.0 110.296 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -127.52 142.7 51.32 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.571 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -127.56 -166.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -143.9 88.48 1.98 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.86 -1.15 . . . . 0.0 110.056 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.455 ' OG1' HD23 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -84.44 -146.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.393 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 20.6 t0 -97.72 85.94 3.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.3 tttm 86.28 -25.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.273 0.558 . . . . 0.0 109.526 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.17 135.43 52.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.173 -0.955 . . . . 0.0 109.719 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 41.2 t -118.77 105.31 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 109.408 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.99 179.86 7.37 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.272 -0.892 . . . . 0.0 109.349 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 22.9 mt-10 -134.82 -148.9 0.33 Allowed 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.958 -1.089 . . . . 0.0 110.566 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.577 ' CG2' HG13 ' A' ' 37' ' ' VAL . 11.9 t -154.89 69.74 5.73 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.327 -0.858 . . . . 0.0 109.29 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.79 104.5 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.592 2.195 . . . . 0.0 111.023 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.578 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -83.27 -178.53 7.11 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.563 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 2.6 p -121.93 24.47 9.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.093 -1.629 . . . . 0.0 111.338 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 159.71 160.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.213 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.602 ' O ' ' CG1' ' A' ' 30' ' ' VAL . 2.5 t0 61.43 -139.39 0.51 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.04 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.559 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 115.29 -8.26 20.64 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.548 HG22 ' CA ' ' A' ' 27' ' ' GLY . 10.7 mt -42.39 98.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.542 HD13 ' CD2' ' A' ' 76' ' ' LEU . 9.6 tp -48.82 90.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.595 0.712 . . . . 0.0 109.648 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.8 t0 -82.18 -58.11 3.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.946 -0.471 . . . . 0.0 110.001 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -149.88 95.68 2.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.768 -1.207 . . . . 0.0 111.091 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.74 101.89 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.9 mt -69.15 -27.12 65.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 110.29 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 41.2 mm-40 -121.86 59.93 0.98 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -37.92 140.91 0.23 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.486 0.66 . . . . 0.0 109.691 -179.07 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.584 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -39.99 139.35 0.69 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.57 -0.706 . . . . 0.0 110.644 -179.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.26 -12.34 33.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.72 174.48 9.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.241 . . . . 0.0 109.633 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.6 m -93.36 154.44 17.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.551 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.77 168.96 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.585 ' CG2' ' CG ' ' A' ' 71' ' ' GLN . 15.0 t -133.39 -136.07 0.17 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.497 ' N ' ' CG2' ' A' ' 68' ' ' THR . 9.6 m -68.96 -119.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.592 -1.317 . . . . 0.0 108.015 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.467 ' HB2' ' HB3' ' A' ' 8' ' ' PRO . 8.0 ttm105 -72.89 80.68 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.678 -1.263 . . . . 0.0 109.786 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.585 ' CG ' ' CG2' ' A' ' 68' ' ' THR . 0.5 OUTLIER -98.43 -101.82 0.21 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.054 -1.028 . . . . 0.0 108.397 179.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 19.1 tt 177.72 112.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 110.264 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.553 ' CD2' HG13 ' A' ' 37' ' ' VAL . 10.5 tp -79.7 -39.42 31.29 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.821 -1.174 . . . . 0.0 108.206 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.69 158.61 8.97 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.211 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -101.03 148.57 24.89 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.373 -1.075 . . . . 0.0 109.559 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.545 ' CG ' ' HB ' ' A' ' 3' ' ' VAL . 5.5 mt -113.89 -132.43 0.33 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.732 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.532 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 O-C-N 120.804 -1.185 . . . . 0.0 110.402 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.46 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.615 ' CG1' ' CD1' ' A' ' 5' ' ' ILE . 6.4 t -83.82 89.07 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.32 95.82 0.21 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.615 ' CD1' ' CG1' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -103.76 129.76 55.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 109.949 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.586 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -153.39 -163.16 1.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.51 ' O ' ' O ' ' A' ' 69' ' ' SER . 11.4 t -121.01 78.23 32.26 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.874 -1.142 . . . . 0.0 108.982 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD3' HD11 ' A' ' 6' ' ' LEU . 36.7 Cg_endo -80.4 53.52 4.8 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.803 2.335 . . . . 0.0 110.815 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.502 ' CB ' HD12 ' A' ' 46' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.304 -1.377 0 O-C-N 121.076 -1.015 . . . . 0.0 109.717 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.525 ' CB ' ' OG1' ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 40' ' ' GLU . 93.3 m -156.63 148.81 23.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.125 -0.984 . . . . 0.0 109.643 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.551 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.3 t -78.73 147.24 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 108.636 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -118.83 -55.14 2.21 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.772 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 1.3 m -167.45 123.03 1.07 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.246 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.588 ' CE2' HD21 ' A' ' 73' ' ' LEU . 18.2 m95 -68.25 -167.41 0.08 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 16.3 m80 -152.31 24.18 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.558 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.5 tppt? -118.52 132.04 56.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.77 -0.581 . . . . 0.0 109.728 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.567 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -79.62 177.31 3.0 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.9 Cg_endo -70.26 101.63 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.731 1.62 . . . . 0.0 111.615 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.537 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 82.37 37.66 14.25 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.54 ' CB ' ' CD ' ' A' ' 24' ' ' LYS . 1.2 m-20 -59.3 -165.38 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.878 -1.366 . . . . 0.0 110.103 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -165.11 78.17 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 108.979 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.562 HG13 ' CB ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -79.54 -173.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.554 -179.011 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.527 ' N ' HG12 ' A' ' 30' ' ' VAL . 0.6 OUTLIER -125.41 -97.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 109.836 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 47.6 mtp180 -103.28 45.14 0.97 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.644 -1.285 . . . . 0.0 109.345 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.526 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 6.3 m-20 171.87 94.86 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.562 ' CB ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -93.1 -166.56 1.55 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.922 -1.112 . . . . 0.0 111.542 -178.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.558 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 2.5 p -52.74 164.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 122.058 0.932 . . . . 0.0 111.393 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.554 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.61 65.97 1.39 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.379 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 36' ' ' LEU . 4.1 p -38.0 164.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.582 0.706 . . . . 0.0 110.354 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.88 101.49 7.47 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -85.63 -159.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.58 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -154.59 99.03 2.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.609 -1.307 . . . . 0.0 110.265 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.525 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 10.0 m -116.64 90.11 3.26 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' THR . 11.2 t0 71.7 -143.33 0.05 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.372 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -17.27 57.52 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.51 HG11 ' N ' ' A' ' 45' ' ' VAL . 38.8 t -87.99 150.23 3.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.521 -0.737 . . . . 0.0 109.886 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.51 ' N ' HG11 ' A' ' 44' ' ' VAL . 7.2 p -130.39 105.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.502 HD12 ' CB ' ' A' ' 9' ' ' ASP . 1.3 mt -85.94 159.22 19.71 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.231 -0.918 . . . . 0.0 109.021 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 5.1 pt-20 -127.29 -164.75 1.39 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.053 -1.029 . . . . 0.0 110.314 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 14.6 p -146.49 88.05 6.27 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.339 -0.851 . . . . 0.0 110.025 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.44 104.79 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.566 2.177 . . . . 0.0 111.181 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.552 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -74.86 -165.71 0.4 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.591 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 19.2 m -141.46 24.81 2.07 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.325 -1.485 . . . . 0.0 110.648 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.591 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 156.12 165.63 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.27 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER 66.75 -88.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.615 -0.678 . . . . 0.0 109.585 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 63.32 -8.63 0.26 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.013 -1.055 . . . . 0.0 111.808 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.537 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.84 96.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.849 -1.383 . . . . 0.0 107.994 179.435 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 8.8 tp -51.66 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.469 -0.769 . . . . 0.0 109.376 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' ILE . 10.9 t0 -108.11 -35.52 6.56 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.583 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 75' ' ' ARG . . . -142.11 85.97 1.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.494 -1.379 . . . . 0.0 111.736 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.568 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 2.5 t -101.14 77.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.0 mt -69.66 -2.81 12.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 110.946 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.526 ' O ' ' CD1' ' A' ' 73' ' ' LEU . 18.9 mt-10 -136.16 51.49 2.02 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.882 -1.136 . . . . 0.0 109.283 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.488 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.6 m-20 -50.23 151.19 2.16 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.274 -0.891 . . . . 0.0 109.751 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.551 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -32.92 141.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.411 0.624 . . . . 0.0 110.818 -179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.58 -18.65 32.18 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.472 ' O ' HG21 ' A' ' 18' ' ' THR . 0.9 OUTLIER -83.57 -179.72 7.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -1.194 . . . . 0.0 109.874 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -113.3 153.82 27.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 109.715 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.537 HG13 ' CD1' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -151.25 169.72 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.583 ' CG2' ' CG ' ' A' ' 71' ' ' GLN . 7.8 t -127.6 -124.6 0.23 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 7' ' ' VAL . 6.0 p -69.63 -114.95 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.337 -1.477 . . . . 0.0 108.967 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HG3' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -83.28 52.98 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.903 -1.123 . . . . 0.0 110.8 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.583 ' CG ' ' CG2' ' A' ' 68' ' ' THR . 1.3 mm-40 -65.25 -111.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.75 -1.219 . . . . 0.0 108.293 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.548 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 16.2 tt 178.33 116.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.83 -1.168 . . . . 0.0 110.474 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.588 HD21 ' CE2' ' A' ' 22' ' ' TRP . 14.0 tp -77.38 -17.36 58.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.941 -1.099 . . . . 0.0 108.456 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.33 162.43 9.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.465 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -111.61 149.11 31.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -1.141 . . . . 0.0 109.495 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.539 ' CD2' HD13 ' A' ' 56' ' ' LEU . 8.2 mt -117.52 -78.31 0.58 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.444 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.833 0 O-C-N 121.305 -0.872 . . . . 0.0 109.268 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.54 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 68.1 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 70.1 t -76.99 77.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 109.207 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.6 84.83 1.57 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.609 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 2.1 tp -106.57 151.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.347 -0.846 . . . . 0.0 110.985 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -134.09 -166.06 1.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.54 ' CG2' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -126.04 72.81 70.83 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.144 -0.973 . . . . 0.0 109.625 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 36.9 Cg_endo -80.99 27.33 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.719 2.279 . . . . 0.0 110.955 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 17.6 m-20 . . . . . 0 C--N 1.307 -1.256 0 O-C-N 120.899 -1.126 . . . . 0.0 109.856 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.471 ' O ' HG13 ' A' ' 39' ' ' ILE . 17.7 m -155.15 126.14 7.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.178 -0.951 . . . . 0.0 110.457 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.506 ' HA ' HG13 ' A' ' 39' ' ' ILE . 3.3 t -67.33 93.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.338 -0.851 . . . . 0.0 108.999 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -58.02 -59.35 5.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.151 -0.968 . . . . 0.0 110.763 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.615 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 34.8 m -166.68 125.71 1.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.574 -1.329 . . . . 0.0 111.982 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.546 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 24.0 m95 -67.76 -165.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.56 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 21.9 m80 -154.67 51.61 0.63 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.56 ' CG ' ' HB ' ' A' ' 35' ' ' VAL . 2.2 mmpt? -134.26 175.19 9.73 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.024 0.916 . . . . 0.0 110.995 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.623 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 2.1 mmmt -127.62 -174.86 0.39 Allowed Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.623 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.76 106.4 1.47 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.14 1.227 . . . . 0.0 111.242 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.491 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 65.21 45.84 89.81 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.548 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 1.4 m-20 -54.13 -167.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.885 -1.362 . . . . 0.0 110.198 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.89 80.81 0.42 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.401 -0.812 . . . . 0.0 108.927 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.553 HG13 ' CG ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.06 -173.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.506 -0.746 . . . . 0.0 110.596 -178.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.554 ' O ' ' CA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -132.65 -96.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.641 -0.662 . . . . 0.0 110.014 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.475 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 3.2 mtt180 -99.8 36.03 1.89 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.686 -1.259 . . . . 0.0 109.472 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.507 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 18.8 m-20 -179.57 81.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.591 -0.693 . . . . 0.0 109.162 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.594 ' CB ' ' CB ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -69.5 -160.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.998 -1.064 . . . . 0.0 111.621 -178.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.56 ' HB ' ' CG ' ' A' ' 24' ' ' LYS . 7.2 p -62.95 163.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.613 0.721 . . . . 0.0 110.542 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.47 59.76 1.63 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 178.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.56 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.4 p -38.48 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.54 0.686 . . . . 0.0 109.913 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -124.02 140.76 52.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.534 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.06 -177.05 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.375 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.534 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 5.7 mm-40 -138.71 115.77 10.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.92 . . . . 0.0 109.374 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 2.8 t -110.03 -27.97 8.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 0.0 110.002 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 7.3 t0 161.28 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.597 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.9 tttp 85.85 -24.92 0.12 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.01 136.81 35.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 0.0 109.227 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 39' ' ' ILE . 46.5 t -116.67 109.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.918 . . . . 0.0 109.739 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 9' ' ' ASP . 4.2 mm? -79.78 -168.57 1.64 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.15 -0.969 . . . . 0.0 108.719 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.3 pt-20 -144.36 -166.81 2.47 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.075 -1.016 . . . . 0.0 110.717 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.687 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -155.95 82.91 3.55 Favored Pre-proline 0 N--CA 1.489 1.484 0 CA-C-O 122.076 0.941 . . . . 0.0 109.583 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.2 Cg_endo -81.81 117.88 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.77 2.313 . . . . 0.0 111.749 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.594 ' CB ' ' CB ' ' A' ' 34' ' ' GLU . . . -89.41 178.84 6.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.613 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 18.3 p -122.72 72.85 1.1 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 120.532 -1.355 . . . . 0.0 110.436 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.613 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 93.23 169.37 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.118 0.485 . . . . 0.0 110.132 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 13.2 m-20 69.74 -101.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 55' ' ' ILE . . . 68.6 -16.56 0.54 Allowed Glycine 0 N--CA 1.496 2.638 0 O-C-N 120.433 -1.417 . . . . 0.0 111.902 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.539 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -36.03 99.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.104 1.452 . . . . 0.0 109.438 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 1.4 mm? -48.61 104.82 0.07 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.634 0.73 . . . . 0.0 109.936 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -108.16 -48.03 3.44 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.19 86.45 1.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.775 -1.203 . . . . 0.0 111.404 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 1.6 t -79.81 87.66 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 177.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.46 -3.92 16.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.934 . . . . 0.0 110.414 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 3.1 mt-10 -132.58 51.77 2.13 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.9 m-20 -40.58 131.11 2.34 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.744 0.783 . . . . 0.0 109.749 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.615 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -36.12 123.39 0.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.481 0.658 . . . . 0.0 111.079 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.13 -11.07 8.21 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.38 162.7 15.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -1.13 . . . . 0.0 109.501 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.2 m -72.2 162.49 29.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 109.603 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.19 173.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.473 -0.767 . . . . 0.0 109.097 -178.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.572 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 5.7 t -145.66 -162.29 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.357 -0.839 . . . . 0.0 109.098 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 2.7 p -85.58 37.41 0.69 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.035 -1.041 . . . . 0.0 109.816 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.544 ' O ' ' CG ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER 168.63 34.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.598 -0.689 . . . . 0.0 109.212 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.517 ' HG3' ' N ' ' A' ' 68' ' ' THR . 3.1 mm-40 -97.61 103.04 14.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.921 -1.112 . . . . 0.0 109.287 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 9.1 tt -56.72 109.22 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.848 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.54 HD13 ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -51.37 -42.72 61.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.72 -155.45 26.56 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 10.8 ptt85 -138.21 137.37 37.5 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.098 -1.237 . . . . 0.0 109.945 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 5.8 mp -106.16 -95.93 0.35 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.455 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.54 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 2.7 tpm_? . . . . . 0 C--N 1.297 -1.702 0 O-C-N 121.443 -0.786 . . . . 0.0 109.243 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.602 HG11 ' CD1' ' A' ' 5' ' ' ILE . 2.4 t -69.67 87.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.039 -1.038 . . . . 0.0 108.807 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.402 ' C ' HD11 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -73.08 103.71 3.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.602 ' CD1' HG11 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -104.25 140.1 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.089 -1.007 . . . . 0.0 110.59 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -149.54 -162.19 1.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.59 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 60.1 t -133.63 56.61 21.09 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.957 -1.09 . . . . 0.0 110.373 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.4 Cg_endo -81.16 34.37 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.507 2.138 . . . . 0.0 110.83 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.521 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 16.8 m-20 . . . . . 0 C--N 1.307 -1.248 0 O-C-N 120.711 -1.243 . . . . 0.0 110.256 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.51 ' HB3' ' CA ' ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.468 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 45.2 m -160.13 121.99 3.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.229 -0.92 . . . . 0.0 110.137 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.533 ' CG1' ' OE1' ' A' ' 63' ' ' GLU . 2.1 t -50.59 147.47 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.536 ' N ' ' OE1' ' A' ' 63' ' ' GLU . . . -126.25 -48.11 1.59 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.945 -1.097 . . . . 0.0 110.749 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.536 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 45.4 m -159.87 109.03 1.79 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.558 -1.339 . . . . 0.0 112.08 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 22.3 m95 -67.5 -163.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 33.3 m80 -159.35 42.52 0.23 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.565 ' HB2' ' CD2' ' A' ' 56' ' ' LEU . 3.1 mmmt -132.19 124.08 28.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.594 -0.691 . . . . 0.0 110.707 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.565 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -70.56 -178.17 0.51 Allowed Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.9 Cg_endo -66.82 93.23 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.107 1.205 . . . . 0.0 111.143 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.539 ' CA ' HG22 ' A' ' 55' ' ' ILE . . . 68.53 47.85 54.36 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 17.4 m-20 -56.96 -112.61 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.056 -1.261 . . . . 0.0 110.039 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 161.96 99.66 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.758 -1.214 . . . . 0.0 109.151 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -100.58 175.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.084 -1.01 . . . . 0.0 110.359 -179.411 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -134.07 -70.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.434 -0.791 . . . . 0.0 110.048 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.583 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -127.45 64.8 1.33 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.814 -1.179 . . . . 0.0 109.681 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 15.5 m-20 144.94 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.59 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -93.01 -176.7 4.26 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.426 1.108 . . . . 0.0 112.196 -177.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.541 ' HB ' ' CG ' ' A' ' 24' ' ' LYS . 7.4 p -39.35 159.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.136 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.91 62.47 1.51 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.537 ' CG1' HG13 ' A' ' 48' ' ' VAL . 5.2 p -37.96 163.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.687 0.756 . . . . 0.0 110.139 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 2.1 mm-40 -122.57 100.06 6.73 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.216 -0.928 . . . . 0.0 108.857 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -84.82 -165.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.561 -0.712 . . . . 0.0 109.358 -179.295 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.567 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 16.5 mm-40 -150.83 88.31 1.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.016 . . . . 0.0 110.074 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.51 ' CA ' ' HB3' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -83.2 -179.92 7.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.296 -0.878 . . . . 0.0 109.31 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.588 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.6 t0 -80.12 99.96 8.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 4.7 ttpm? 84.98 -21.52 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.807 -0.558 . . . . 0.0 109.628 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.524 HG11 ' CD2' ' A' ' 46' ' ' LEU . 97.8 t -118.23 146.27 23.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.204 -0.935 . . . . 0.0 109.954 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.499 ' N ' HG11 ' A' ' 44' ' ' VAL . 53.3 t -134.45 100.96 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.865 . . . . 0.0 109.09 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.524 ' CD2' HG11 ' A' ' 44' ' ' VAL . 3.4 mm? -94.97 -169.43 2.0 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.214 -0.929 . . . . 0.0 110.058 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.516 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 2.3 pt-20 -147.66 -156.07 0.68 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.557 -0.714 . . . . 0.0 109.278 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.578 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 7.8 p -157.62 79.9 3.34 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.868 -1.145 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.516 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.3 Cg_endo -80.31 104.09 1.6 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.416 2.077 . . . . 0.0 110.337 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.59 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -73.81 -175.1 1.99 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.4 p -130.83 23.37 4.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.455 -1.403 . . . . 0.0 110.218 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 159.55 161.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.557 -0.714 . . . . 0.0 109.203 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.565 ' O ' ' CG1' ' A' ' 30' ' ' VAL . 7.2 m-20 67.25 -137.76 0.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.497 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 101.88 -7.84 55.53 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.33 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.567 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 4.5 mt -47.63 96.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.025 -1.279 . . . . 0.0 107.673 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.592 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -42.48 100.36 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.687 0.756 . . . . 0.0 109.574 -178.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 55' ' ' ILE . 6.9 t0 -104.13 -53.33 2.76 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.966 -0.459 . . . . 0.0 109.871 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.99 103.66 3.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.682 -1.261 . . . . 0.0 110.979 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.592 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.46 88.12 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.305 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.519 ' CD2' ' HA2' ' A' ' 74' ' ' GLY . 0.4 OUTLIER -69.2 -7.1 33.41 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.127 -0.983 . . . . 0.0 110.172 -178.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.526 ' CB ' ' HA ' ' A' ' 73' ' ' LEU . 1.3 mm-40 -119.24 37.85 4.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.133 -0.979 . . . . 0.0 108.381 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.515 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.2 m-20 -40.25 135.23 1.47 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.678 -0.639 . . . . 0.0 110.106 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.596 ' OE2' ' CD1' ' A' ' 22' ' ' TRP . 67.1 mm-40 -22.93 141.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.54 0.686 . . . . 0.0 111.783 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.1 -11.27 67.63 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 62' ' ' ASP . 1.3 m -84.47 156.18 21.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -1.154 . . . . 0.0 109.583 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 m -77.73 158.28 29.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.913 . . . . 0.0 109.525 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.559 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.7 171.39 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -139.66 -145.91 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.004 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 3.3 m -99.48 52.16 0.94 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.103 -0.998 . . . . 0.0 109.467 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER 161.01 -19.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.419 -0.801 . . . . 0.0 110.031 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 2.2 mm-40 -48.44 125.87 10.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.328 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.3 tt -80.18 111.8 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.573 ' CG ' HG23 ' A' ' 5' ' ' ILE . 30.4 mt -47.02 -37.53 9.4 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.519 ' HA2' ' CD2' ' A' ' 60' ' ' LEU . . . 157.01 -158.53 28.92 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.426 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -137.69 145.16 42.26 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.203 -1.175 . . . . 0.0 110.0 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.523 ' O ' ' CB ' ' A' ' 2' ' ' SER . 2.1 mt -106.48 -128.4 0.26 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.567 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 120.645 -1.284 . . . . 0.0 109.817 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.445 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.592 ' CG1' ' CG2' ' A' ' 5' ' ' ILE . 28.9 t -81.5 73.44 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.036 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -83.2 68.12 9.47 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.56 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.592 ' CG2' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -80.96 165.34 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.755 0.788 . . . . 0.0 112.579 -177.309 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -139.61 -164.48 1.69 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 39' ' ' ILE . 45.4 t -136.55 66.88 58.6 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.948 . . . . 0.0 109.935 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HD3' HD11 ' A' ' 6' ' ' LEU . 36.5 Cg_endo -80.38 38.84 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.715 2.276 . . . . 0.0 110.655 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.546 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.307 -1.269 0 O-C-N 120.988 -1.07 . . . . 0.0 110.289 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.356 0.598 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' HG13 ' A' ' 39' ' ' ILE . 90.0 m -151.61 131.24 13.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.307 -0.87 . . . . 0.0 110.525 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.539 ' CG1' HD12 ' A' ' 73' ' ' LEU . 2.1 t -70.15 85.35 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 109.089 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.467 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -47.33 -63.79 0.95 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.934 -1.104 . . . . 0.0 110.404 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.61 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 36.3 m -165.83 127.13 1.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.539 -1.351 . . . . 0.0 111.9 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.576 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 15.1 m95 -67.4 -163.08 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 22.5 m80 -156.21 30.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.548 ' HG2' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -116.83 159.1 22.87 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.7 0.762 . . . . 0.0 110.264 -179.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.567 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -106.14 -176.98 0.45 Allowed Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.0 Cg_endo -68.6 111.04 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.179 1.252 . . . . 0.0 110.768 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.491 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 57.65 43.51 94.33 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 8.6 m-20 -57.9 -164.27 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.831 -1.393 . . . . 0.0 110.209 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.16 87.52 0.5 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.606 HG11 ' N ' ' A' ' 53' ' ' ASP . 0.6 OUTLIER -78.91 -177.27 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -0.826 . . . . 0.0 110.654 -178.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -123.28 -80.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.47 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 11.8 mtt180 -123.77 40.3 3.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.108 -0.995 . . . . 0.0 108.681 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.516 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 10.9 m-20 178.05 83.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.585 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -81.5 -170.58 2.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 111.375 -178.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 7.6 p -48.98 161.53 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 121.87 0.843 . . . . 0.0 111.431 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -141.2 62.21 1.47 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.561 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 2.5 p -38.15 165.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.688 0.756 . . . . 0.0 110.619 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -127.39 131.69 50.27 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -117.35 -172.28 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.277 -0.89 . . . . 0.0 109.315 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 2.3 mt-10 -133.4 123.98 26.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.001 -1.062 . . . . 0.0 110.206 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.525 ' OG1' ' CG1' ' A' ' 44' ' ' VAL . 4.6 p -119.63 -104.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.327 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 28.9 t0 -130.32 75.11 1.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.326 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 87.46 -22.75 0.14 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.525 ' CG1' ' OG1' ' A' ' 41' ' ' THR . 12.1 p -103.8 144.65 13.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.411 -0.806 . . . . 0.0 109.479 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 2.3 t -120.14 105.63 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 109.702 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.546 ' HG ' ' CB ' ' A' ' 9' ' ' ASP . 4.0 mm? -79.99 -179.38 6.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.291 -0.881 . . . . 0.0 109.049 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.2 pt-20 -150.65 -163.19 1.72 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.027 -1.046 . . . . 0.0 110.219 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.569 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 9.7 p -154.96 81.0 4.29 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.133 -0.979 . . . . 0.0 110.216 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.79 113.49 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.587 2.192 . . . . 0.0 110.81 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.585 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -80.7 -168.01 1.59 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.3 p -133.37 16.34 4.07 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.361 -1.462 . . . . 0.0 110.806 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 160.63 160.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.513 -0.742 . . . . 0.0 109.16 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.606 ' N ' HG11 ' A' ' 30' ' ' VAL . 1.2 t70 64.96 -140.09 0.23 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.326 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.526 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 112.23 -12.71 26.27 Favored Glycine 0 N--CA 1.489 2.209 0 O-C-N 120.508 -1.37 . . . . 0.0 109.851 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.542 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -34.82 97.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.744 -0.857 . . . . 0.0 109.59 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.548 ' CD2' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -45.06 104.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -113.93 -47.18 2.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.532 -0.73 . . . . 0.0 110.195 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.36 77.59 1.58 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.785 -1.197 . . . . 0.0 111.106 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 56' ' ' LEU . 56.0 t -81.79 86.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.6 mt -69.63 -0.94 7.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -0.783 . . . . 0.0 111.255 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.514 ' CB ' HD13 ' A' ' 73' ' ' LEU . 21.1 mt-10 -134.54 55.44 1.89 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.778 -1.201 . . . . 0.0 108.199 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.451 ' HA ' HG13 ' A' ' 59' ' ' VAL . 6.5 m-20 -43.93 127.06 5.13 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.702 0.763 . . . . 0.0 109.746 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.61 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -35.7 127.14 0.66 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.469 0.652 . . . . 0.0 111.284 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.48 -9.78 13.03 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 66' ' ' THR . 86.5 m -94.46 167.84 11.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -1.148 . . . . 0.0 109.386 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.466 ' N ' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -81.62 158.93 24.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.683 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.571 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.31 171.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.571 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 5.3 t -134.14 -161.48 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 0.0 109.237 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 29.9 t -85.91 40.88 0.88 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.629 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 69' ' ' SER . 4.8 ttm180 168.11 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.572 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.478 ' HG3' ' CG2' ' A' ' 68' ' ' THR . 1.6 mm-40 -105.61 97.59 7.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.94 . . . . 0.0 109.233 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.1 tt -42.25 112.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.463 -0.773 . . . . 0.0 109.86 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.539 HD12 ' CG1' ' A' ' 19' ' ' VAL . 10.3 tp -57.71 -42.67 84.26 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . 165.47 158.1 10.39 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.864 -1.636 . . . . 0.0 110.442 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.472 ' HB3' ' OD2' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -102.17 139.32 37.94 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.513 -0.993 . . . . 0.0 108.913 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 2.9 mp -105.14 -105.5 0.31 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.376 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.542 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.8 tpt180 . . . . . 0 C--N 1.301 -1.53 0 O-C-N 120.988 -1.07 . . . . 0.0 109.461 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 1.3 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 16.5 t -79.75 76.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.61 77.46 7.43 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.561 HG12 ' CG1' ' A' ' 48' ' ' VAL . 5.2 tp -91.89 154.04 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.372 -0.83 . . . . 0.0 111.283 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -140.46 -157.93 0.81 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.603 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 2.9 t -131.14 54.57 15.06 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 120.868 -1.145 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.6 Cg_endo -81.21 40.85 1.04 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.238 1.959 . . . . 0.0 110.008 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.533 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 O-C-N 121.016 -1.052 . . . . 0.0 110.176 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.506 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 16.1 m -161.05 127.55 3.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.087 -1.008 . . . . 0.0 110.162 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.535 ' HA ' HG13 ' A' ' 39' ' ' ILE . 2.5 t -53.87 157.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 108.708 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -127.42 -58.63 1.25 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.418 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.458 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 22.2 m -162.08 119.43 2.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.981 -1.074 . . . . 0.0 110.903 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.579 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 25.0 m95 -68.7 -170.58 0.22 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.867 0.842 . . . . 0.0 109.189 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.589 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 10.6 m80 -152.81 38.77 0.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.566 ' CA ' ' OD2' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -130.97 115.98 17.23 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.541 -178.167 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.562 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -65.41 177.32 0.69 Allowed Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.17 93.54 0.4 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.793 1.662 . . . . 0.0 111.464 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.595 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 80.15 47.91 6.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.566 ' OD2' ' CA ' ' A' ' 24' ' ' LYS . 4.0 m-20 -58.58 -134.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.285 -1.127 . . . . 0.0 110.394 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . 170.54 95.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.913 -1.117 . . . . 0.0 108.929 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.595 ' CG1' ' OE2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -103.25 -170.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.083 -1.01 . . . . 0.0 109.424 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.572 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 4.2 m -134.18 -112.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 108.903 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 8.2 mmt-85 -87.08 64.68 8.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.758 -1.214 . . . . 0.0 108.721 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.4 m-20 150.73 102.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.595 ' OE2' ' CG1' ' A' ' 30' ' ' VAL . 0.9 OUTLIER -101.52 -167.66 1.45 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.075 -1.016 . . . . 0.0 111.928 -178.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.563 ' HB ' ' CG ' ' A' ' 24' ' ' LYS . 3.7 p -53.88 166.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.105 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.55 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.92 65.23 1.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 178.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.589 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 6.2 p -40.36 170.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.665 0.745 . . . . 0.0 110.117 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 21.5 mt-10 -123.56 107.92 12.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.003 -1.061 . . . . 0.0 108.903 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -91.71 -162.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 121.421 -0.799 . . . . 0.0 109.159 -179.339 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.559 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 39.4 mt-10 -153.06 102.18 2.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 110.105 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 42' ' ' ASP . 88.2 m -97.81 -112.2 0.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.271 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.576 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.1 t70 -126.56 87.73 2.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.918 -1.114 . . . . 0.0 109.391 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.3 tptp 85.2 -28.5 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.25 145.79 23.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.232 -0.917 . . . . 0.0 109.231 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 39' ' ' ILE . 1.8 p -123.39 122.44 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.486 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.65 170.91 15.86 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.173 -0.954 . . . . 0.0 108.864 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -122.16 179.66 4.47 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.106 -0.996 . . . . 0.0 110.406 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.587 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 3.2 t -130.83 73.18 81.38 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.491 -0.756 . . . . 0.0 109.013 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.2 Cg_endo -80.6 104.0 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.585 2.19 . . . . 0.0 111.527 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.577 ' CB ' ' CB ' ' A' ' 34' ' ' GLU . . . -79.1 -156.87 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.581 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.1 p -144.33 13.31 1.59 Allowed 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.695 -1.253 . . . . 0.0 110.733 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 158.93 155.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.393 -0.817 . . . . 0.0 110.216 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 75.34 -81.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.501 -0.749 . . . . 0.0 110.659 179.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.529 ' N ' ' OE2' ' A' ' 34' ' ' GLU . . . 55.34 6.52 1.0 Allowed Glycine 0 N--CA 1.494 2.539 0 O-C-N 121.111 -0.993 . . . . 0.0 111.434 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.595 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 3.3 mt -54.97 98.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.643 -1.504 . . . . 0.0 108.061 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.589 ' CD1' ' CD2' ' A' ' 76' ' ' LEU . 9.5 tp -51.21 90.14 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.536 -0.728 . . . . 0.0 109.328 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.5 t0 -99.11 -40.62 7.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.608 -0.683 . . . . 0.0 110.049 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -142.64 107.55 4.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.804 -1.185 . . . . 0.0 111.0 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.527 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 2.0 t -118.91 107.26 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mt -98.43 -31.9 11.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.025 . . . . 0.0 110.014 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 3.0 mt-10 -98.61 35.44 1.82 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.518 ' OD1' ' CG1' ' A' ' 59' ' ' VAL . 2.2 m-20 -43.67 157.16 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.605 -0.684 . . . . 0.0 110.162 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.529 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -38.85 140.39 0.37 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.353 0.597 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.28 -19.86 47.02 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.463 ' O ' HG21 ' A' ' 18' ' ' THR . 2.2 m -86.18 161.51 18.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -82.74 163.27 21.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.571 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.554 ' CG2' ' CG2' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.51 169.2 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.419 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.523 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -145.71 -147.75 0.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.57 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 13.3 p -89.83 33.29 0.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.354 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER 171.82 26.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.528 -0.733 . . . . 0.0 110.268 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 13.7 mm100 -87.51 121.47 29.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.666 -1.271 . . . . 0.0 109.183 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 4.0 tt -69.2 111.36 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.609 -0.682 . . . . 0.0 110.581 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.577 ' CD1' ' CG1' ' A' ' 37' ' ' VAL . 3.8 mt -55.43 -36.25 66.31 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.42 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 154.82 164.31 12.84 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.7 OUTLIER -111.96 140.68 46.42 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.37 -1.076 . . . . 0.0 108.997 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.619 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 3.9 mp -116.2 -133.87 0.34 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.541 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 120.659 -1.276 . . . . 0.0 109.118 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.456 ' HB3' ' CA ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 8.6 t -69.81 90.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.182 -0.949 . . . . 0.0 109.246 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.97 78.74 5.4 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.595 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -93.64 137.85 21.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.405 -0.809 . . . . 0.0 111.239 -176.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -136.02 -164.27 1.53 Allowed 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 54.6 t -132.32 66.44 77.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.995 -1.066 . . . . 0.0 109.325 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HG3' ' CD1' ' A' ' 6' ' ' LEU . 36.5 Cg_endo -80.24 41.61 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.733 2.289 . . . . 0.0 110.589 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' HB2' HD11 ' A' ' 46' ' ' LEU . 2.4 m-20 . . . . . 0 C--N 1.305 -1.34 0 O-C-N 121.035 -1.041 . . . . 0.0 110.113 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 39' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.442 ' C ' HG13 ' A' ' 39' ' ' ILE . 12.5 m -150.42 117.18 5.84 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.103 -0.998 . . . . 0.0 110.165 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.543 ' CG1' ' OE1' ' A' ' 63' ' ' GLU . 2.1 t -50.77 151.27 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.53 ' N ' ' OE1' ' A' ' 63' ' ' GLU . . . -134.67 -43.0 0.75 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.105 -0.997 . . . . 0.0 110.924 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.526 ' N ' ' OE1' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -164.03 108.91 1.01 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.106 -1.438 . . . . 0.0 112.578 -179.152 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.6 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 18.4 m95 -67.84 -165.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.511 ' HB2' HG21 ' A' ' 35' ' ' VAL . 48.5 m80 -149.97 28.57 0.75 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.57 ' CD ' ' HB ' ' A' ' 35' ' ' VAL . 12.3 mmmm -123.57 146.59 48.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.641 -0.662 . . . . 0.0 110.393 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.619 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -97.73 -170.6 0.22 Allowed Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.1 Cg_endo -68.6 84.06 0.5 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 120.839 1.026 . . . . 0.0 111.321 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.555 ' CA ' HG22 ' A' ' 55' ' ' ILE . . . 78.15 48.48 7.56 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 18.4 m-20 -56.48 -114.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.113 -1.228 . . . . 0.0 110.363 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 158.18 100.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.848 -1.158 . . . . 0.0 108.27 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.578 ' CG1' ' HA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -102.64 -175.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.838 -1.164 . . . . 0.0 110.292 -178.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -129.29 -98.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 109.899 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.453 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -100.74 38.53 1.51 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.974 -1.078 . . . . 0.0 109.826 -179.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.523 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 4.0 m-20 -178.01 89.42 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.681 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 9.6 tp10 -87.7 168.35 13.06 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.281 1.039 . . . . 0.0 111.647 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.57 ' HB ' ' CD ' ' A' ' 24' ' ' LYS . 4.6 p -33.08 157.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 122.128 0.966 . . . . 0.0 112.471 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.33 62.1 1.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.578 ' CG1' ' CG1' ' A' ' 48' ' ' VAL . 4.3 p -38.01 166.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.773 0.797 . . . . 0.0 110.385 -177.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -118.7 150.74 39.24 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -138.34 -171.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.369 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 19.7 mt-10 -126.86 119.92 27.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.039 -1.038 . . . . 0.0 109.892 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.2 -143.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.429 -0.795 . . . . 0.0 109.128 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 65.1 t0 -90.62 72.14 6.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 109.607 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.4 tttt 87.21 -23.32 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 45' ' ' VAL . 72.8 t -100.63 160.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.38 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.498 ' N ' HG13 ' A' ' 44' ' ' VAL . 36.2 t -127.73 106.24 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.324 -0.86 . . . . 0.0 109.738 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -79.44 166.3 22.15 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.22 -0.925 . . . . 0.0 108.92 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -126.99 -163.75 1.28 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.091 -1.006 . . . . 0.0 110.258 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.637 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -152.79 91.52 3.47 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.679 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.5 Cg_endo -83.5 123.57 3.4 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.759 2.306 . . . . 0.0 111.894 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.681 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -97.6 173.54 7.09 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.611 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 19.8 p -120.14 75.3 1.09 Allowed 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.205 -1.398 . . . . 0.0 110.315 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.611 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 90.65 164.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.5 0.667 . . . . 0.0 110.105 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.2 m-20 67.65 -100.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.713 -0.617 . . . . 0.0 110.618 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' HA2' ' CG2' ' A' ' 3' ' ' VAL . . . 54.79 5.58 0.59 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 120.911 -1.118 . . . . 0.0 111.543 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.555 HG22 ' CA ' ' A' ' 27' ' ' GLY . 7.2 mt -47.41 98.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.47 -1.606 . . . . 0.0 108.021 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.562 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 5.2 tp -43.88 108.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.618 0.723 . . . . 0.0 110.287 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 2.5 t0 -131.91 -35.15 1.26 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.618 -0.676 . . . . 0.0 110.031 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -135.61 62.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.68 -1.262 . . . . 0.0 111.014 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.562 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 26.2 t -79.7 83.33 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.759 -1.213 . . . . 0.0 108.467 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 mt -73.56 -6.66 47.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.277 -0.889 . . . . 0.0 110.741 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 4.1 mt-10 -124.15 47.88 2.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.876 -1.14 . . . . 0.0 108.371 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -48.73 139.01 10.24 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.628 -0.67 . . . . 0.0 109.966 -179.673 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.6 ' OE2' ' CD1' ' A' ' 22' ' ' TRP . 69.7 mm-40 -26.86 145.57 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.436 0.636 . . . . 0.0 111.414 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.11 -12.78 67.95 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 19' ' ' VAL . 1.3 m -90.12 154.18 19.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -1.178 . . . . 0.0 109.661 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.15 161.31 28.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.597 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.595 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.63 174.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.02 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.595 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 3.6 t -135.09 -166.35 1.82 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.069 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -90.62 36.29 0.89 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.196 -0.94 . . . . 0.0 108.886 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER 172.0 33.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.493 -0.754 . . . . 0.0 109.452 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.59 ' CG ' ' CG2' ' A' ' 68' ' ' THR . 5.1 mm-40 -107.02 145.57 32.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 109.182 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.5 tt -86.77 112.25 22.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.982 -1.074 . . . . 0.0 110.346 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.524 ' CD1' HG13 ' A' ' 37' ' ' VAL . 16.6 mt -54.04 -24.3 16.64 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.472 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 141.11 -168.31 25.4 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 9.5 ptt85 -127.64 146.78 50.44 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.283 -1.128 . . . . 0.0 109.443 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.599 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -99.31 -92.77 0.27 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.361 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.534 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.772 0 O-C-N 121.279 -0.888 . . . . 0.0 109.972 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.549 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 18.8 t -75.26 79.48 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 108.5 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.36 83.91 1.94 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.592 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 3.6 tp -104.45 147.5 10.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.849 -177.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.529 ' HB3' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -139.06 -158.83 0.89 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.505 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.499 ' CG2' HD11 ' A' ' 39' ' ' ILE . 41.6 t -129.02 65.37 73.73 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.947 -1.096 . . . . 0.0 109.6 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HB3' ' CG ' ' A' ' 70' ' ' ARG . 36.5 Cg_endo -79.72 61.79 8.3 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.805 2.337 . . . . 0.0 110.387 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.555 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.303 -1.414 0 O-C-N 121.014 -1.054 . . . . 0.0 109.732 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.509 ' N ' HG12 ' A' ' 67' ' ' VAL . 17.5 m -152.88 137.16 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.527 ' CG2' HD12 ' A' ' 73' ' ' LEU . 2.2 t -72.94 84.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.41 -0.807 . . . . 0.0 109.252 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.452 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -46.61 -63.52 0.99 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.059 -1.025 . . . . 0.0 110.537 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.582 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 96.8 m -165.44 124.94 1.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.589 -1.319 . . . . 0.0 111.781 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.577 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 15.7 m95 -67.75 -168.48 0.09 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 12.0 m80 -153.3 24.15 0.54 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.558 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.1 tppt? -115.4 120.21 38.82 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.382 0.61 . . . . 0.0 109.593 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.543 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -67.1 175.61 1.43 Allowed Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.443 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 30.6 Cg_endo -71.31 94.66 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.073 1.849 . . . . 0.0 111.057 -178.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.525 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 85.33 37.42 9.81 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.549 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 8.9 m-20 -63.13 -162.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.784 -1.421 . . . . 0.0 109.61 178.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -162.85 79.36 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.92 -1.112 . . . . 0.0 110.069 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -78.9 -173.55 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 0.0 109.541 179.797 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.578 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -134.07 -86.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 0.0 109.36 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.568 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 2.6 tpt180 -107.88 61.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.939 -1.101 . . . . 0.0 109.725 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.568 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.3 m-20 147.81 91.02 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.57 ' CB ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -88.68 -166.91 1.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 111.336 -178.7 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.558 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 2.5 p -49.63 164.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.805 0.812 . . . . 0.0 111.311 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.551 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -140.17 63.64 1.47 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.603 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.569 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 3.3 p -38.59 166.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.701 0.762 . . . . 0.0 110.398 -177.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 1.4 mt-10 -128.05 112.63 14.83 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.263 -0.898 . . . . 0.0 108.729 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.57 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.05 -167.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.498 -0.751 . . . . 0.0 109.03 -179.341 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.57 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 5.5 mt-10 -135.46 136.72 41.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 0.0 110.065 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.447 ' HB ' HG11 ' A' ' 44' ' ' VAL . 2.1 m -135.81 -136.32 0.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.6 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 23.5 t0 -96.0 74.21 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.907 -1.121 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.6 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.7 tmtt? 86.74 -23.3 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.788 -0.57 . . . . 0.0 109.543 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 45' ' ' VAL . 2.3 p -105.11 164.36 4.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.524 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 44.5 t -144.39 112.77 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.373 -0.829 . . . . 0.0 109.454 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.82 168.54 19.15 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.136 -0.977 . . . . 0.0 108.869 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.472 ' OE1' ' O ' ' A' ' 36' ' ' LEU . 3.0 mm-40 -116.79 -171.4 2.01 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.927 -1.108 . . . . 0.0 110.639 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.706 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -147.55 77.32 10.54 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-O 122.409 1.099 . . . . 0.0 108.622 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.0 Cg_endo -81.62 113.02 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.781 2.321 . . . . 0.0 112.14 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.531 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . . . -80.17 -160.18 0.27 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 177.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.564 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -139.62 11.92 2.51 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.497 -1.377 . . . . 0.0 110.891 -179.53 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 160.19 169.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.318 -0.864 . . . . 0.0 109.995 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER 67.85 -87.87 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.426 -0.796 . . . . 0.0 109.323 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 65.55 -13.57 0.28 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.219 -0.926 . . . . 0.0 112.15 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.525 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -42.83 96.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 119.124 1.462 . . . . 0.0 108.181 179.475 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.594 ' CD1' ' CD2' ' A' ' 76' ' ' LEU . 7.8 tp -54.11 97.12 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.47 -0.769 . . . . 0.0 109.64 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -109.0 -39.9 5.16 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.796 -0.565 . . . . 0.0 110.002 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -139.0 90.4 2.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.69 -1.256 . . . . 0.0 110.877 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.528 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 6.6 t -94.71 91.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 mt -70.08 -1.76 10.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 110.887 -178.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 5.7 mt-10 -137.41 55.26 1.81 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.024 -1.048 . . . . 0.0 108.449 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 63' ' ' GLU . 24.0 m-20 -43.79 126.01 4.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.526 -0.733 . . . . 0.0 109.452 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.582 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.5 OUTLIER -33.94 122.5 0.46 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.626 0.727 . . . . 0.0 111.435 -179.236 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.49 -6.03 12.87 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.6 -172.75 3.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -1.132 . . . . 0.0 109.317 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -93.84 153.13 18.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.835 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.57 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.35 171.4 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.378 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.57 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 13.7 t -148.04 -137.65 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 108.83 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.491 ' N ' ' CG2' ' A' ' 68' ' ' THR . 6.2 p -69.2 -110.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.691 -1.256 . . . . 0.0 108.021 179.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.517 ' CG ' ' HB3' ' A' ' 8' ' ' PRO . 3.4 mtm180 -71.3 79.4 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 109.419 179.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.45 ' CG ' HG23 ' A' ' 68' ' ' THR . 2.7 mm-40 -115.63 96.28 5.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.121 -0.987 . . . . 0.0 108.451 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.529 ' N ' ' HB3' ' A' ' 6' ' ' LEU . 4.0 tt -42.26 109.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.341 -0.85 . . . . 0.0 110.194 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.527 HD12 ' CG2' ' A' ' 19' ' ' VAL . 10.7 tp -62.23 -27.86 69.29 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 59' ' ' VAL . . . 154.46 154.82 7.0 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.126 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 5.2 ptt180 -104.41 136.84 43.23 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.429 -1.042 . . . . 0.0 109.489 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.631 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 4.0 mp -112.86 -103.87 0.4 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.478 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.549 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 109.391 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.406 0.622 . . . . 0.0 109.59 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.536 ' HB ' ' CG ' ' A' ' 76' ' ' LEU . 24.9 t -80.93 75.96 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.395 -0.815 . . . . 0.0 109.189 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.429 ' CG ' ' HB3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -81.51 94.17 6.81 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.781 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.543 HG12 ' CG1' ' A' ' 48' ' ' VAL . 5.7 tp -106.57 159.3 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.344 -177.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -141.35 -161.03 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.367 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.639 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 48.2 t -130.75 50.07 5.57 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.754 -1.216 . . . . 0.0 111.501 -179.183 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.9 Cg_endo -82.63 39.91 0.9 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.072 1.848 . . . . 0.0 109.757 178.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.533 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 4.2 m-20 . . . . . 0 C--N 1.306 -1.286 0 O-C-N 121.125 -0.984 . . . . 0.0 111.186 -178.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.511 ' CB ' ' HA ' ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.375 0.607 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.48 ' CA ' ' CG1' ' A' ' 67' ' ' VAL . 92.5 m -160.23 130.35 5.36 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.33 -0.856 . . . . 0.0 110.068 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.542 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 4.2 t -68.05 111.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.335 -0.853 . . . . 0.0 109.031 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.496 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -76.61 -57.53 3.8 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.144 -0.973 . . . . 0.0 109.901 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.546 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 17.9 m -170.75 126.83 0.74 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.682 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.579 ' CG ' HG22 ' A' ' 37' ' ' VAL . 14.8 m95 -68.84 -168.56 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 108.819 177.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.574 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 13.9 m80 -151.22 39.05 0.66 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.555 ' CG ' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -130.86 138.81 50.0 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.673 0.749 . . . . 0.0 110.867 -178.509 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.596 ' CB ' ' OD1' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -88.79 179.41 1.63 Allowed Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.039 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.8 Cg_endo -66.03 105.31 0.81 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.561 1.508 . . . . 0.0 112.284 -178.044 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.484 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 60.35 48.0 88.33 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.596 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 3.6 m-20 -59.52 -119.44 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.046 -1.267 . . . . 0.0 110.363 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 159.67 99.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.056 -1.027 . . . . 0.0 109.035 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.579 ' CG1' ' N ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -103.41 -178.99 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 109.62 -179.546 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.579 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 3.2 m -127.48 -110.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 14.3 mtp180 -90.2 66.68 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.778 -1.201 . . . . 0.0 108.785 179.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 15.0 m-20 150.59 103.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -179.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.575 ' CB ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -108.17 -171.46 1.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.391 1.091 . . . . 0.0 111.959 -178.21 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.555 ' HB ' ' CG ' ' A' ' 24' ' ' LYS . 9.0 p -45.8 169.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.145 0.974 . . . . 0.0 111.389 -179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.495 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -149.71 59.14 1.0 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.579 HG22 ' CG ' ' A' ' 22' ' ' TRP . 2.7 p -39.3 165.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.807 0.813 . . . . 0.0 110.192 -178.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -123.48 146.53 47.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -134.5 -173.72 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.272 -179.262 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.547 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 8.9 mt-10 -146.73 95.91 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.672 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.511 ' HA ' ' CB ' ' A' ' 17' ' ' ALA . 27.0 p -86.94 -48.8 7.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 109.725 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 55.1 t0 176.7 77.6 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.636 -0.665 . . . . 0.0 109.295 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER 87.28 -26.47 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.419 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.46 154.98 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.337 -0.852 . . . . 0.0 109.34 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.27 114.92 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -0.974 . . . . 0.0 109.822 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -79.67 159.3 26.75 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.299 -0.875 . . . . 0.0 108.755 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.518 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -121.96 -178.6 3.89 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.035 -1.041 . . . . 0.0 110.502 -179.298 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.569 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 11.4 t -142.91 68.26 18.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.4 Cg_endo -80.31 106.41 1.88 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.679 2.253 . . . . 0.0 110.886 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -89.38 -161.73 0.8 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.2 p -142.95 17.21 1.95 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.748 -1.22 . . . . 0.0 110.888 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 160.35 163.3 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.115 -0.991 . . . . 0.0 110.668 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER 78.26 -77.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.646 179.64 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.501 ' CA ' ' CD ' ' A' ' 34' ' ' GLU . . . 40.34 22.4 0.04 OUTLIER Glycine 0 N--CA 1.489 2.216 0 O-C-N 121.442 -0.786 . . . . 0.0 111.634 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 2.9 mt -83.61 94.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.549 -1.559 . . . . 0.0 107.329 178.256 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.603 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 2.1 tp -43.73 115.99 0.89 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.579 -0.701 . . . . 0.0 110.179 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 1.2 t0 -132.11 -42.73 0.98 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.491 -0.755 . . . . 0.0 109.895 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.543 ' CB ' ' NE ' ' A' ' 75' ' ' ARG . . . -132.82 76.65 1.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.785 -1.197 . . . . 0.0 110.873 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.554 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 60.6 t -93.33 81.52 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.436 ' CD1' ' HG3' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -69.04 -27.92 66.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.397 -0.814 . . . . 0.0 110.658 -178.423 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.5 ' OE2' ' NE2' ' A' ' 71' ' ' GLN . 7.7 mt-10 -106.73 47.79 0.86 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.463 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -39.14 139.31 0.51 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.597 0.713 . . . . 0.0 109.712 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -37.87 135.72 0.63 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.626 0.727 . . . . 0.0 110.999 -179.249 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.41 -6.37 36.17 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -95.72 158.38 15.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.244 . . . . 0.0 109.701 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.65 162.02 28.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.257 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.575 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.41 174.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.359 -0.838 . . . . 0.0 109.004 -178.802 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.575 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 4.8 t -150.26 -152.86 0.46 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 108.975 179.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.559 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 12.5 p -89.48 54.96 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.064 -1.022 . . . . 0.0 109.558 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' A' ' 69' ' ' SER . 3.5 mtp85 159.36 -12.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.565 -0.709 . . . . 0.0 110.654 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.5 mt-30 -54.2 102.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.943 -1.098 . . . . 0.0 109.641 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 3.1 tt -54.94 111.5 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.538 HD12 ' CG1' ' A' ' 19' ' ' VAL . 8.4 tp -54.32 -29.89 49.38 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.483 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 144.69 153.34 5.84 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.543 ' NE ' ' CB ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -93.99 145.39 24.68 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.515 -0.991 . . . . 0.0 108.332 179.181 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.603 ' CD1' ' CD1' ' A' ' 56' ' ' LEU . 3.4 mm? -85.45 -111.7 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.73 -178.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.536 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 3.4 ttp85 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 120.732 -1.23 . . . . 0.0 110.479 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.485 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 62.3 t -81.56 70.55 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 108.798 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -74.07 84.04 1.79 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.407 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.56 HG12 ' CG1' ' A' ' 48' ' ' VAL . 8.0 tp -99.73 163.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 111.297 -177.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -147.31 -159.86 1.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.313 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.599 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 2.1 t -133.15 56.11 20.09 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.121 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.4 Cg_endo -80.58 35.94 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.5 2.134 . . . . 0.0 110.824 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.553 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.1 m-20 . . . . . 0 C--N 1.306 -1.283 0 O-C-N 120.801 -1.187 . . . . 0.0 109.966 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.53 ' CA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 121.167 0.508 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.495 ' N ' HG12 ' A' ' 67' ' ' VAL . 46.8 m -155.55 124.15 5.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 110.54 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.529 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 17.0 t -65.52 107.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.23 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -73.8 -59.62 2.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.614 -179.314 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.552 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.6 m -168.69 128.52 1.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.628 -1.295 . . . . 0.0 111.775 -179.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.537 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 17.6 m95 -69.2 -166.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.661 0.743 . . . . 0.0 109.24 178.346 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.1 m80 -152.7 26.47 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.6 tppt? -119.36 137.91 53.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.69 -0.631 . . . . 0.0 110.132 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.568 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.28 179.29 1.71 Allowed Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.676 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -69.64 104.91 1.37 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.664 1.576 . . . . 0.0 111.62 -178.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.522 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 75.03 39.52 37.49 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 4.8 m-20 -59.45 -166.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.718 -1.46 . . . . 0.0 109.597 178.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.17 78.56 0.45 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.08 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.552 ' CG2' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -79.55 169.26 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.009 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.547 ' N ' HG11 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -110.06 -95.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 1.6 mtm180 -107.2 51.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.961 -1.087 . . . . 0.0 109.63 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.552 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 4.2 m-20 173.04 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.612 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 10.3 tp10 -102.29 163.62 12.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.058 -1.026 . . . . 0.0 111.008 -178.235 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.538 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 2.5 p -30.36 160.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.57 1.176 . . . . 0.0 112.581 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.533 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.12 67.63 1.37 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.087 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.593 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.1 p -38.59 165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.102 -177.394 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.27 145.71 46.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -134.77 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.334 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.573 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 13.1 mt-10 -149.35 138.51 21.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.923 -1.11 . . . . 0.0 109.708 -179.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 5.9 t -132.72 26.22 4.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 41' ' ' THR . 2.2 t70 87.34 15.31 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.341 0.591 . . . . 0.0 110.459 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 160.52 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.552 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 1.1 t -103.99 148.57 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.613 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 39' ' ' ILE . 51.2 t -136.93 96.76 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.685 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.553 ' HG ' ' CB ' ' A' ' 9' ' ' ASP . 2.9 mm? -79.88 -176.0 5.21 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.309 -0.869 . . . . 0.0 108.728 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 1.3 pt-20 -142.39 -161.36 1.23 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.718 -1.239 . . . . 0.0 111.463 -178.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.56 ' CG1' HG12 ' A' ' 5' ' ' ILE . 6.0 t -143.47 75.5 16.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.7 Cg_endo -80.73 110.82 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.487 2.125 . . . . 0.0 110.931 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.612 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -91.79 -169.38 2.26 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.137 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.558 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 5.1 p -132.36 14.68 4.57 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.265 -1.522 . . . . 0.0 111.183 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 161.62 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 109.951 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER 60.63 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 179.816 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.548 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 64.95 -13.65 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 O-C-N 121.324 -0.86 . . . . 0.0 112.093 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.522 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.81 96.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.674 -1.486 . . . . 0.0 108.551 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.58 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 7.8 tp -49.87 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ILE . 46.6 t0 -98.6 -41.59 7.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.97 -0.456 . . . . 0.0 110.544 -178.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.37 78.71 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.577 -1.327 . . . . 0.0 111.677 -179.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.58 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 60.7 t -80.86 82.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.37 -10.8 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 109.709 -178.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 4.8 mm-40 -123.74 50.93 1.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -40.8 134.12 1.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.552 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.05 134.51 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.597 0.713 . . . . 0.0 111.015 -178.897 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.75 -13.96 24.64 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -84.98 156.19 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -1.135 . . . . 0.0 109.405 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.41 166.43 20.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.681 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.534 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.04 169.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.242 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -147.78 -148.31 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 -179.652 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 9.3 p -90.28 36.18 0.87 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mtt180 163.55 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.4 mt-30 -84.49 87.69 7.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 0.0 109.102 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.4 tt -45.0 108.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.543 ' CD1' HG23 ' A' ' 48' ' ' VAL . 10.6 mt -53.91 -42.86 69.21 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 156.55 -159.79 29.76 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -134.68 134.49 41.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.151 -1.206 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.604 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 4.4 mp -98.09 -96.72 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.34 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.542 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.538 ' HB ' ' CG ' ' A' ' 76' ' ' LEU . 3.0 t -75.94 79.76 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -86.73 80.47 8.52 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.031 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.566 HG12 ' CG1' ' A' ' 48' ' ' VAL . 6.0 tp -86.98 161.7 2.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 111.738 -177.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -144.69 -166.02 2.29 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.133 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.581 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 38.9 t -133.31 57.11 24.62 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.15 -0.969 . . . . 0.0 110.005 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -79.97 38.33 0.74 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.392 2.061 . . . . 0.0 110.534 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.555 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.292 0 O-C-N 120.869 -1.145 . . . . 0.0 109.962 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.458 ' C ' HG13 ' A' ' 39' ' ' ILE . 77.0 m -161.16 113.98 1.92 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.293 -0.88 . . . . 0.0 110.116 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.52 ' CG1' ' OE1' ' A' ' 63' ' ' GLU . 2.3 t -46.78 137.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.527 ' N ' ' OE1' ' A' ' 63' ' ' GLU . . . -116.73 -51.14 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.985 -1.072 . . . . 0.0 110.958 -178.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.52 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -158.55 109.89 2.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.563 -1.335 . . . . 0.0 112.066 -179.214 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.598 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 17.7 m95 -68.11 -164.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.579 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 17.2 m80 -155.23 30.44 0.39 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 177.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.559 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 1.3 tppm? -124.4 139.23 54.09 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.407 0.622 . . . . 0.0 110.513 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.57 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -89.26 -176.4 0.66 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.015 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.6 Cg_endo -66.13 90.14 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.917 1.078 . . . . 0.0 111.321 -178.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.532 ' CA ' HG22 ' A' ' 55' ' ' ILE . . . 72.92 47.65 24.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.569 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 14.6 m-20 -58.4 -113.4 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.057 -1.261 . . . . 0.0 110.388 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 158.9 102.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.96 -1.088 . . . . 0.0 108.574 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -101.93 -173.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.05 . . . . 0.0 109.929 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.572 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 5.7 m -131.86 -114.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.183 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.566 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -87.41 64.62 8.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.691 -1.256 . . . . 0.0 109.182 179.735 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 5.0 m-20 149.65 99.16 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.584 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -95.04 -176.06 3.72 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.414 1.102 . . . . 0.0 111.898 -178.22 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.534 ' CG1' ' OE2' ' A' ' 34' ' ' GLU . 11.5 p -39.7 166.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.953 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -147.32 61.97 1.16 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 179.017 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.579 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 3.3 p -39.29 166.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.683 0.754 . . . . 0.0 110.273 -177.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 4.1 mt-10 -128.75 95.26 4.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.192 -0.943 . . . . 0.0 109.146 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -79.62 -167.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 109.123 -179.658 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.553 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 24.3 mt-10 -153.75 121.24 5.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.922 -1.111 . . . . 0.0 110.193 -179.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -116.26 -95.19 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.434 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 31.1 t0 -146.15 86.73 1.71 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.385 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 16.5 tttt 86.72 -24.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 41' ' ' THR . 2.1 t -107.07 161.61 5.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 39' ' ' ILE . 54.1 t -150.85 98.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.558 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.59 168.91 18.76 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.213 -0.929 . . . . 0.0 108.864 179.945 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -124.94 -162.89 1.13 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.001 -1.062 . . . . 0.0 110.819 -178.78 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.566 ' CG1' HG12 ' A' ' 5' ' ' ILE . 3.8 t -144.23 74.57 15.74 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.525 -0.735 . . . . 0.0 109.289 -179.345 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -82.19 101.84 1.15 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.887 2.392 . . . . 0.0 111.316 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.584 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -80.19 -161.36 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.559 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.4 p -135.1 10.14 3.54 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.466 -1.396 . . . . 0.0 111.275 -179.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 161.18 157.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.079 -1.013 . . . . 0.0 110.295 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER 79.1 -73.41 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.675 -0.641 . . . . 0.0 110.518 179.05 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 43.54 17.85 0.06 OUTLIER Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.154 -0.966 . . . . 0.0 111.315 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.55 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 20.5 mt -68.85 91.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.596 -1.532 . . . . 0.0 107.285 179.058 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -44.17 91.34 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.639 0.733 . . . . 0.0 110.366 -178.291 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 55' ' ' ILE . 36.3 t70 -87.29 -53.86 4.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.738 -0.601 . . . . 0.0 109.732 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.35 104.66 3.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.794 -1.191 . . . . 0.0 110.71 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.533 ' CG2' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -90.91 92.12 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.553 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.56 -5.55 25.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.186 -0.946 . . . . 0.0 110.076 -178.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 73' ' ' LEU . 2.9 mt-10 -128.89 41.93 3.4 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 108.7 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.513 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.0 m-20 -42.72 131.13 4.06 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.596 -0.69 . . . . 0.0 109.593 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.598 ' OE2' ' CD1' ' A' ' 22' ' ' TRP . 67.2 mm-40 -20.91 140.05 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.661 0.743 . . . . 0.0 112.322 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.25 -15.61 61.12 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -80.07 162.82 24.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -1.232 . . . . 0.0 109.528 179.942 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.1 m -90.61 162.83 14.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 109.721 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.573 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.56 171.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.214 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.573 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 5.1 t -137.98 -152.31 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.05 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.495 ' C ' ' CG ' ' A' ' 70' ' ' ARG . 84.3 p -89.3 39.39 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 0.0 109.174 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.495 ' CG ' ' C ' ' A' ' 69' ' ' SER . 4.7 ptt180 165.78 34.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.95 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 6.4 mm-40 -97.37 119.44 35.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.287 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 1.9 tt -70.14 111.33 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -0.925 . . . . 0.0 110.032 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.548 ' CD1' HG23 ' A' ' 48' ' ' VAL . 13.8 mt -47.97 -42.23 27.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 162.04 -165.72 36.0 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.434 ' C ' HD22 ' A' ' 76' ' ' LEU . 2.9 ptt-85 -129.22 149.25 51.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.293 -1.122 . . . . 0.0 109.364 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.538 ' CG ' ' HB ' ' A' ' 3' ' ' VAL . 4.5 mt -116.01 -132.21 0.32 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.403 -179.164 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.55 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 11.1 tpt85 . . . . . 0 N--CA 1.495 1.782 0 O-C-N 120.584 -1.323 . . . . 0.0 110.313 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.552 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 3.7 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 37.4 t -69.48 83.38 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.133 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.35 84.24 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.592 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 4.9 tp -110.55 143.82 19.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.291 -177.138 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -128.48 -134.82 0.23 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.306 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 6' ' ' LEU . 45.9 t -161.85 67.41 2.13 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.717 -1.239 . . . . 0.0 109.168 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.509 ' HD3' ' CD1' ' A' ' 6' ' ' LEU . 35.4 Cg_endo -77.25 67.03 7.78 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.551 2.167 . . . . 0.0 110.584 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.533 ' HB3' ' CD2' ' A' ' 46' ' ' LEU . 1.2 m-20 . . . . . 0 C--N 1.305 -1.337 0 O-C-N 121.284 -0.885 . . . . 0.0 109.416 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.247 0.546 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 40' ' ' GLU . 24.1 m -157.38 137.53 12.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.113 -0.992 . . . . 0.0 110.72 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 79.0 t -67.18 86.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.424 -0.797 . . . . 0.0 109.46 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -42.76 -62.97 0.86 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.216 -0.927 . . . . 0.0 109.938 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.476 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 2.6 m -166.91 130.05 1.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.482 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.531 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 22.0 m95 -68.78 -167.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.524 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 29.0 m80 -149.3 24.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.011 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.531 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 10.7 tppt? -119.78 126.11 50.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.683 -0.636 . . . . 0.0 109.959 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.612 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 3.1 mmmt -79.99 -171.84 0.31 Allowed Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -68.45 104.94 1.17 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.026 1.151 . . . . 0.0 112.123 -177.282 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.547 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 57.97 48.5 82.14 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.533 ' OD1' ' HB2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -56.35 -115.9 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.192 -1.181 . . . . 0.0 110.486 179.628 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 162.0 100.39 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.761 -1.212 . . . . 0.0 108.312 -178.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.573 ' CG2' ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -102.08 173.95 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 111.082 -178.75 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -123.62 -92.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.068 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 6.7 mtp180 -112.18 66.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.08 -1.013 . . . . 0.0 108.396 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 8.2 m-20 155.13 80.55 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.621 ' OE1' ' CG1' ' A' ' 35' ' ' VAL . 1.1 tm-20 -87.81 175.08 7.99 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.179 0.99 . . . . 0.0 112.365 -177.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.621 ' CG1' ' OE1' ' A' ' 34' ' ' GLU . 2.4 p -32.14 156.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.93 0.871 . . . . 0.0 112.114 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.551 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -141.9 59.98 1.47 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.218 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.551 ' O ' ' O ' ' A' ' 36' ' ' LEU . 3.4 p -38.57 169.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.685 0.755 . . . . 0.0 110.571 -177.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 14.2 mt-10 -133.43 102.75 5.65 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.163 -0.961 . . . . 0.0 108.724 -179.294 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 2.1 tt -81.01 -165.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.327 -0.858 . . . . 0.0 109.411 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.551 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 19.6 mm-40 -141.61 89.91 2.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.029 -1.044 . . . . 0.0 110.004 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.513 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 87.8 m -90.95 28.97 1.44 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.296 -0.878 . . . . 0.0 109.335 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.8 t70 77.6 73.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.685 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.2 tttt 87.24 -26.58 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.449 ' O ' ' HB ' ' A' ' 41' ' ' THR . 41.1 t -105.44 94.12 2.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.242 -0.911 . . . . 0.0 109.5 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 81.4 t -94.77 104.72 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.409 -0.807 . . . . 0.0 109.443 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' A' ' 9' ' ' ASP . 0.8 OUTLIER -79.5 174.45 11.56 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.225 -0.922 . . . . 0.0 108.865 -179.759 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 8.4 pm0 -118.05 -179.58 3.8 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.994 -1.066 . . . . 0.0 110.758 -178.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.702 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -144.19 79.08 13.21 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-O 122.331 1.062 . . . . 0.0 108.381 179.666 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.58 120.18 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.826 2.35 . . . . 0.0 111.888 -178.453 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.617 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -96.45 169.84 9.63 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.07 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.606 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 22.9 p -118.32 77.9 1.21 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 120.354 -1.466 . . . . 0.0 110.242 -178.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.606 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 94.48 168.45 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.509 ' N ' HG11 ' A' ' 30' ' ' VAL . 59.4 m-20 61.96 -126.4 0.76 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.533 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 84.56 -7.7 71.96 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.055 -1.545 . . . . 0.0 109.704 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.547 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 8.2 mt -42.97 98.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.594 ' CD1' ' CD2' ' A' ' 76' ' ' LEU . 6.0 tp -43.44 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.666 0.746 . . . . 0.0 110.318 -177.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' ILE . 23.0 t70 -106.35 -36.37 6.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.704 -0.622 . . . . 0.0 109.327 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -147.35 100.12 3.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.071 . . . . 0.0 110.383 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.53 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 13.5 t -107.55 90.3 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.0 mt -69.63 -4.82 20.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.071 -179.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 10.9 mt-10 -127.63 52.34 1.85 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.7 m-20 -49.45 125.28 10.87 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.734 -0.604 . . . . 0.0 110.77 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.549 ' C ' ' O ' ' A' ' 62' ' ' ASP . 5.1 mt-10 -7.55 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.477 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 65' ' ' THR . . . 128.74 -38.09 2.11 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.439 178.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.488 ' OG1' ' HA ' ' A' ' 61' ' ' GLU . 5.6 m -43.1 145.38 0.52 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -1.189 . . . . 0.0 109.442 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 m -86.72 141.1 29.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.967 . . . . 0.0 110.189 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.529 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.8 168.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.757 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.529 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 5.2 t -120.4 -47.66 2.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.49 ' CA ' ' O ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -170.31 -75.27 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.728 0.775 . . . . 0.0 109.714 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -78.95 37.18 0.3 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.672 -0.643 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' A' ' 67' ' ' VAL . 3.7 mt-30 -103.34 97.53 7.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.185 . . . . 0.0 108.543 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 3.7 tt -40.6 111.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.795 . . . . 0.0 110.404 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.542 ' HA ' ' CG ' ' A' ' 61' ' ' GLU . 12.0 mt -55.47 -41.2 72.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.84 167.99 21.2 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 4.7 ptt180 -109.87 138.77 45.76 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.109 -1.23 . . . . 0.0 109.833 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.614 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.3 mp -115.72 -101.87 0.42 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.795 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.552 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 109.51 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.531 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -148.39 169.27 20.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 109.475 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 40.1 t -69.43 85.96 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.116 -0.99 . . . . 0.0 108.666 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.7 83.44 1.6 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.593 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 1.8 tp -105.68 138.31 31.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.342 -0.849 . . . . 0.0 110.443 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -134.17 -157.75 0.83 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 69' ' ' SER . 42.2 t -127.55 68.75 74.53 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD3' HD11 ' A' ' 6' ' ' LEU . 37.3 Cg_endo -81.85 19.97 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.774 2.316 . . . . 0.0 110.712 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.532 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -86.06 16.59 4.13 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.013 -1.054 . . . . 0.0 110.038 -179.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.542 ' CA ' ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -39.98 100.44 0.22 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.426 -0.796 . . . . 0.0 109.979 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 9' ' ' ASP . 36.2 Cg_endo -79.08 -84.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.587 2.191 . . . . 0.0 110.3 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -148.83 33.91 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 109.52 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.0 t -164.74 144.46 7.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -0.942 . . . . 0.0 109.524 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 14' ' ' VAL . 5.2 p -131.01 51.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.915 . . . . 0.0 109.448 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 16' ' ' ASP . . . -90.0 36.61 0.87 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.219 -0.925 . . . . 0.0 109.453 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 1.8 m-20 70.86 -174.75 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.882 . . . . 0.0 109.422 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 67' ' ' VAL . . . -170.46 -164.87 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.645 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.47 ' C ' HG12 ' A' ' 39' ' ' ILE . 18.4 m -158.21 133.34 8.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.992 . . . . 0.0 110.906 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.562 ' HA ' HG13 ' A' ' 39' ' ' ILE . 29.5 t -71.12 84.04 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.463 -0.773 . . . . 0.0 109.633 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -39.44 -60.58 0.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.897 . . . . 0.0 110.361 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.48 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 20.1 m -169.13 129.6 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.665 -1.272 . . . . 0.0 111.446 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.565 ' CG ' HG22 ' A' ' 37' ' ' VAL . 18.7 m95 -69.55 -167.54 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.584 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 16.9 m80 -152.68 23.65 0.59 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.556 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 7.1 tppt? -114.99 127.42 55.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.739 -0.6 . . . . 0.0 109.759 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.547 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -72.38 175.93 2.81 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.9 Cg_endo -70.46 95.62 0.62 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.957 1.771 . . . . 0.0 111.103 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.517 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 83.43 39.64 9.66 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.551 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 7.6 m-20 -65.5 -163.52 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.984 -1.304 . . . . 0.0 110.094 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.43 82.21 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.401 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -79.35 -170.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 110.203 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.577 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 2.6 m -133.61 -106.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 6.9 mtt180 -92.38 62.03 3.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.695 -1.253 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 7.6 m-20 153.7 96.06 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.56 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -94.18 -165.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.03 -1.043 . . . . 0.0 111.701 -178.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.556 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 7.3 p -51.88 162.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.758 0.79 . . . . 0.0 110.951 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.536 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.77 59.83 1.58 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.584 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 3.4 p -39.04 168.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-O 121.678 0.751 . . . . 0.0 110.616 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 20' ' ' ALA . 2.5 mt-10 -131.66 111.15 11.44 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 108.721 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.564 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 1.7 tt -95.06 -164.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 109.449 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 5.3 mt-10 -141.37 99.69 3.62 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.155 -0.966 . . . . 0.0 109.677 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.53 ' OG1' ' CD2' ' A' ' 46' ' ' LEU . 25.2 m -102.55 44.39 1.02 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.703 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 6.4 t70 76.49 65.61 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.9 ttmt 86.51 -25.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.827 -0.546 . . . . 0.0 109.708 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.469 HG21 ' HB ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -102.93 97.15 5.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.807 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 39' ' ' ILE . 42.8 t -89.87 112.56 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.852 . . . . 0.0 109.167 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.532 ' HG ' ' CB ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -81.6 -175.74 5.69 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.157 -0.964 . . . . 0.0 109.424 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 28.5 mt-10 -127.02 -178.42 4.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.238 -0.914 . . . . 0.0 109.649 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.7 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -149.5 79.0 8.24 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-O 122.266 1.031 . . . . 0.0 108.976 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.3 Cg_endo -82.5 106.41 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.916 2.41 . . . . 0.0 112.009 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.56 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -75.31 -160.5 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.573 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 2.2 p -138.52 12.8 2.76 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.423 -1.423 . . . . 0.0 110.818 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 159.43 165.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.937 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 69.81 -86.5 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.496 -0.752 . . . . 0.0 109.625 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 63.04 -9.76 0.16 Allowed Glycine 0 N--CA 1.496 2.635 0 O-C-N 120.886 -1.134 . . . . 0.0 111.879 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.517 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -41.93 98.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 118.927 1.363 . . . . 0.0 108.356 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.545 HD11 ' CD2' ' A' ' 76' ' ' LEU . 9.9 tp -54.92 98.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.503 -0.748 . . . . 0.0 109.628 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -112.69 -41.49 3.8 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.706 -0.621 . . . . 0.0 109.721 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -136.8 93.97 2.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.836 -1.165 . . . . 0.0 110.409 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.527 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 4.9 t -102.13 88.22 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.058 . . . . 0.0 108.381 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.77 -4.6 20.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.281 -0.887 . . . . 0.0 110.25 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.546 ' HA ' ' CB ' ' A' ' 65' ' ' THR . 3.7 mt-10 -127.35 50.7 1.97 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.071 -1.018 . . . . 0.0 108.846 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.8 m-20 -53.6 109.41 0.45 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.56 -0.713 . . . . 0.0 110.494 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.536 ' C ' ' O ' ' A' ' 62' ' ' ASP . 3.2 mp0 8.63 109.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' THR . . . 116.46 -35.37 4.25 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.546 ' CB ' ' HA ' ' A' ' 61' ' ' GLU . 71.4 m -45.08 146.05 0.92 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -1.186 . . . . 0.0 109.169 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.52 131.04 35.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.719 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.58 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.57 171.25 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.58 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 4.9 t -139.68 -149.43 0.28 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.232 -0.918 . . . . 0.0 109.279 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.542 ' HB2' ' CA ' ' A' ' 10' ' ' LEU . 62.7 p -98.91 74.85 2.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.114 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER 159.4 -21.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 6' ' ' LEU . 4.3 mt-30 -71.37 -171.65 0.64 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.551 -0.718 . . . . 0.0 109.106 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.9 tt -126.44 128.4 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.541 ' CD1' HG13 ' A' ' 37' ' ' VAL . 7.9 mt -64.53 -40.53 95.78 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.27 176.22 23.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 1.4 ptm180 -117.22 142.63 46.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.217 -1.167 . . . . 0.0 110.171 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 3.8 mp -112.36 -101.65 0.41 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.531 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.3 OUTLIER -143.59 164.42 30.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 109.068 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.469 ' HA ' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -166.73 -170.5 1.6 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.608 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 80' ' ' ASN . . . -148.8 -145.32 4.12 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 79' ' ' GLY . 31.4 t-20 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.197 -1.178 . . . . 0.0 109.55 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.464 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -161.49 179.14 8.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 25.0 t -71.48 82.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.031 . . . . 0.0 108.785 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.89 82.86 2.18 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.59 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 3.9 tp -101.19 137.29 29.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.728 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -131.12 -148.22 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 69' ' ' SER . 93.7 t -129.88 92.14 37.87 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.264 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.49 17.97 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.774 2.316 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.572 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -95.25 45.52 1.1 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.871 -1.143 . . . . 0.0 110.152 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.599 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -53.25 -45.02 98.57 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 111.09 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 33.8 Cg_endo -76.89 -177.61 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.76 1.64 . . . . 0.0 110.472 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 11' ' ' PRO . 4.6 tp10 73.67 33.11 1.07 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.37 -0.831 . . . . 0.0 109.67 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.9 t 55.05 98.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.304 -0.873 . . . . 0.0 109.922 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 10' ' ' LEU . 13.9 p -161.43 72.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.933 . . . . 0.0 109.551 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 16' ' ' ASP . . . -78.41 3.45 15.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.818 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.527 ' HA ' ' CG2' ' A' ' 68' ' ' THR . 4.0 p-10 170.98 165.75 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.144 -0.973 . . . . 0.0 109.487 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -164.65 -165.65 0.96 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' A' ' 65' ' ' THR . 87.5 m -160.77 136.28 7.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.908 . . . . 0.0 110.07 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.8 t -58.87 143.28 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 108.974 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -115.24 -53.92 2.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.212 -0.93 . . . . 0.0 109.185 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 21' ' ' THR . 6.6 t -164.41 116.91 1.32 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.26 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.573 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 17.7 m95 -68.35 -167.5 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 19.4 m80 -152.47 23.65 0.61 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.579 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 5.7 tppt? -120.4 108.12 13.73 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.789 -0.569 . . . . 0.0 109.713 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.556 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -59.55 177.39 0.27 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.6 Cg_endo -69.8 96.02 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.812 1.675 . . . . 0.0 111.378 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.555 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 85.07 40.87 7.79 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.574 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 5.4 m-20 -57.95 -154.66 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.21 -1.171 . . . . 0.0 109.948 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' H ' ' HB3' ' A' ' 28' ' ' ASP . . . -163.89 87.34 0.51 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.569 -1.332 . . . . 0.0 109.461 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.583 ' CG1' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -96.24 178.76 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.329 -0.857 . . . . 0.0 109.725 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 1.3 p -135.76 -60.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.106 -0.996 . . . . 0.0 109.901 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.585 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -138.98 65.6 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.078 -1.014 . . . . 0.0 108.928 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 12.9 m-20 146.68 80.45 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.561 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -86.19 -171.48 3.58 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.083 0.944 . . . . 0.0 112.003 -177.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.579 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 3.1 p -41.97 159.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 122.066 0.936 . . . . 0.0 111.88 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.88 62.09 1.58 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.56 ' CG1' ' HB ' ' A' ' 48' ' ' VAL . 3.3 p -38.87 168.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.876 0.846 . . . . 0.0 110.744 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -127.41 98.59 5.3 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -80.12 -163.83 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.502 -0.749 . . . . 0.0 109.278 -179.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.547 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 3.8 mm-40 -152.85 104.99 2.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.892 -1.13 . . . . 0.0 110.007 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.527 ' CG2' HD23 ' A' ' 46' ' ' LEU . 1.2 p -99.31 -58.18 1.99 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.08 -1.013 . . . . 0.0 109.988 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.596 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 12.8 t0 176.77 83.55 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.2 tttp 86.12 -26.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.5 m -119.47 132.42 69.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.288 -0.883 . . . . 0.0 109.4 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 42.8 t -118.07 114.58 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.31 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -80.46 147.57 30.86 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.233 -0.917 . . . . 0.0 109.02 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -92.11 179.39 5.59 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.326 -0.859 . . . . 0.0 110.682 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.7 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -141.02 73.95 26.11 Favored Pre-proline 0 N--CA 1.489 1.511 0 CA-C-O 122.414 1.102 . . . . 0.0 108.366 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.28 107.63 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.873 2.382 . . . . 0.0 111.919 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -73.83 -165.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.557 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 0.9 OUTLIER -137.96 23.32 2.83 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.484 -1.385 . . . . 0.0 110.194 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 159.58 161.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.583 ' O ' ' CG1' ' A' ' 30' ' ' VAL . 6.4 m-20 60.85 -132.92 0.73 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.034 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 114.87 -18.71 16.45 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.558 ' CG1' ' O ' ' A' ' 28' ' ' ASP . 10.6 mt -36.04 99.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.538 HD13 ' CG2' ' A' ' 59' ' ' VAL . 10.9 tp -56.71 98.71 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.561 0.696 . . . . 0.0 109.712 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -117.68 -38.3 3.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.673 -0.642 . . . . 0.0 109.901 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 75' ' ' ARG . . . -133.97 91.19 2.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.862 -1.148 . . . . 0.0 110.515 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.538 ' CG2' HD13 ' A' ' 56' ' ' LEU . 2.4 t -106.97 84.5 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.435 HD13 ' HA2' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -69.98 -3.86 18.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 110.368 -178.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.523 ' OE1' ' CG1' ' A' ' 67' ' ' VAL . 7.7 mt-10 -127.06 46.25 2.55 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.083 -1.011 . . . . 0.0 108.982 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.9 m-20 -51.13 127.23 18.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.454 -0.779 . . . . 0.0 109.707 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' A' ' 62' ' ' ASP . 0.3 OUTLIER -17.62 132.98 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.321 0.582 . . . . 0.0 111.414 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.41 -31.35 7.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.487 ' O ' ' CG2' ' A' ' 18' ' ' THR . 24.1 m -70.19 170.54 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -1.162 . . . . 0.0 109.539 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 95.0 m -108.75 140.22 42.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.445 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.523 ' CG1' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -151.1 160.95 3.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.527 ' CG2' ' HA ' ' A' ' 16' ' ' ASP . 1.3 m -117.44 -144.15 0.38 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.588 ' CB ' ' HA ' ' A' ' 10' ' ' LEU . 7.9 m -106.07 78.39 1.31 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.134 -0.979 . . . . 0.0 108.588 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 6.0 ttm180 159.34 -21.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.473 ' HB2' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -72.99 131.77 42.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.493 HG22 HD11 ' A' ' 72' ' ' ILE . 4.7 tt -79.18 111.92 16.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 110.098 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.547 ' CD1' HG13 ' A' ' 37' ' ' VAL . 13.1 mt -46.29 -38.99 9.34 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.435 ' HA2' HD13 ' A' ' 60' ' ' LEU . . . 154.17 169.96 19.57 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 2.1 ptm180 -110.94 137.06 49.04 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.304 -1.115 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.638 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 4.3 mp -102.69 -96.7 0.29 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.068 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.558 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -146.86 152.45 38.73 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HA ' ' CG ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -136.02 -163.15 1.36 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.298 -0.876 . . . . 0.0 109.537 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.75 -73.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.237 -1.155 . . . . 0.0 109.391 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.454 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 37.2 m -141.18 175.26 9.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.284 -0.885 . . . . 0.0 109.562 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 7.7 t -73.98 80.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 108.95 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.58 81.26 2.59 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.605 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 6.6 tp -99.34 152.18 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.027 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.52 ' CD2' ' HG2' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -139.97 -161.65 1.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 69' ' ' SER . 96.5 t -130.97 67.24 80.62 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.045 -1.034 . . . . 0.0 109.484 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HB3' ' HG3' ' A' ' 70' ' ' ARG . 36.1 Cg_endo -79.08 57.75 6.62 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.751 2.301 . . . . 0.0 110.878 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -116.38 11.2 14.9 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.14 -0.975 . . . . 0.0 109.493 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -32.48 108.92 0.3 Allowed Pre-proline 0 N--CA 1.501 2.117 0 O-C-N 121.831 -0.543 . . . . 0.0 110.5 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.46 -45.78 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.304 2.002 . . . . 0.0 110.131 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.61 -88.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.582 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 m -51.53 177.84 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.499 -0.75 . . . . 0.0 109.535 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.502 ' CG2' ' O ' ' A' ' 14' ' ' VAL . 6.1 p -116.48 48.58 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.346 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -68.93 -6.67 28.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.865 . . . . 0.0 109.788 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 4.9 m-20 68.77 -159.03 0.19 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -170.67 -165.08 0.42 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.283 -0.886 . . . . 0.0 109.165 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 40' ' ' GLU . 17.6 m -160.75 143.83 13.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.001 -1.062 . . . . 0.0 110.693 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.513 ' HA ' HG13 ' A' ' 39' ' ' ILE . 1.9 t -65.73 149.09 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -126.96 -47.22 1.51 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.953 -1.092 . . . . 0.0 110.309 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.488 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -162.7 109.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.749 -1.219 . . . . 0.0 111.674 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.598 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 15.9 m95 -67.65 -162.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 0.0 108.503 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 33.4 m80 -158.1 34.82 0.25 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 56' ' ' LEU . 4.7 mmpt? -119.64 108.48 14.51 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.32 0.581 . . . . 0.0 110.376 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.568 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -59.56 -178.12 0.12 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.4 Cg_endo -67.99 89.99 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.105 1.203 . . . . 0.0 110.764 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.499 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 78.07 46.04 9.7 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 10.8 m-20 -59.55 -161.48 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.721 -1.458 . . . . 0.0 109.335 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.38 85.42 0.72 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.959 -1.088 . . . . 0.0 109.147 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.608 ' CG1' ' O ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -79.12 -176.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.357 -0.84 . . . . 0.0 109.894 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -142.47 -72.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.359 -0.838 . . . . 0.0 109.599 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.585 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 8.3 mmt180 -121.5 63.85 0.9 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.001 -1.062 . . . . 0.0 109.519 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 6.1 m-20 145.04 84.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.675 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 21.5 tt0 -84.89 170.15 13.39 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.218 1.009 . . . . 0.0 112.002 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 3.5 p -31.08 155.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.912 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.545 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -136.32 64.83 1.54 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 178.262 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.572 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.3 p -38.67 170.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.783 0.802 . . . . 0.0 110.725 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 2.8 mm-40 -125.8 96.59 4.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.132 -0.98 . . . . 0.0 109.098 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -79.88 -159.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.059 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.552 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 5.9 mm-40 -147.03 101.46 3.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.789 -1.194 . . . . 0.0 109.992 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -93.47 -152.0 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.337 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 20.4 t0 -94.16 88.0 5.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER 85.61 -23.85 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.755 -0.591 . . . . 0.0 109.612 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 41' ' ' THR . 23.0 t -116.33 137.12 51.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.236 -0.915 . . . . 0.0 109.503 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 39' ' ' ILE . 2.2 p -113.11 107.17 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.49 ' CD2' ' HB3' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -79.49 179.19 7.6 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.183 -0.948 . . . . 0.0 108.935 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -126.65 -163.75 1.27 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.981 -1.074 . . . . 0.0 110.269 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.704 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -151.26 75.76 7.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-O 122.278 1.037 . . . . 0.0 108.833 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.5 Cg_endo -81.01 115.32 2.99 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.801 2.334 . . . . 0.0 112.009 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.675 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -83.7 -167.65 1.81 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 2.0 p -131.54 18.09 4.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.129 -1.607 . . . . 0.0 111.135 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 159.46 160.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.608 ' O ' ' CG1' ' A' ' 30' ' ' VAL . 1.5 t70 64.7 -140.39 0.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 55' ' ' ILE . . . 116.71 -15.98 14.11 Favored Glycine 0 N--CA 1.489 2.22 0 O-C-N 120.218 -1.551 . . . . 0.0 110.671 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.569 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -32.01 94.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 117.884 0.842 . . . . 0.0 109.449 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.602 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -46.69 100.78 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.6 t70 -120.56 -46.02 2.39 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.201 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -135.55 107.55 7.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.749 -1.219 . . . . 0.0 110.818 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.602 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 1.4 t -113.17 90.86 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.81 -4.6 20.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.217 -0.927 . . . . 0.0 110.022 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.523 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 3.1 mt-10 -128.22 39.37 3.85 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.6 m-20 -40.67 136.15 1.44 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.732 -0.605 . . . . 0.0 109.699 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.598 ' OE2' ' CD1' ' A' ' 22' ' ' TRP . 67.4 mm-40 -27.82 146.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.537 0.684 . . . . 0.0 111.494 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.14 -2.11 87.62 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 18' ' ' THR . 24.2 m -94.15 154.96 17.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.165 -1.197 . . . . 0.0 109.352 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.422 ' C ' HG11 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -91.53 148.46 22.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.179 -0.951 . . . . 0.0 109.644 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.505 HG21 ' N ' ' A' ' 68' ' ' THR . 0.4 OUTLIER -150.32 155.33 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.46 -0.775 . . . . 0.0 108.931 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 69' ' ' SER . 7.4 t -100.78 -142.15 0.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.537 ' N ' ' CG2' ' A' ' 68' ' ' THR . 72.5 m -68.87 -99.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.779 -1.201 . . . . 0.0 108.239 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.52 ' HG2' ' CD2' ' A' ' 6' ' ' LEU . 7.4 ttp180 -75.11 76.22 2.28 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.376 -0.827 . . . . 0.0 109.88 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.462 ' HB2' HG21 ' A' ' 67' ' ' VAL . 2.3 mm-40 -113.92 95.34 5.26 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.514 ' N ' ' HB3' ' A' ' 6' ' ' LEU . 7.9 tt -38.7 109.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.649 -0.657 . . . . 0.0 110.807 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.563 ' CD1' HG13 ' A' ' 37' ' ' VAL . 12.1 mt -56.7 -39.94 74.74 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.98 -179.4 35.55 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -118.18 135.67 54.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.218 -1.166 . . . . 0.0 110.122 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.635 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 2.1 mp -99.25 -91.65 0.28 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.569 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 10.4 tpp180 -153.84 152.98 31.29 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.508 -0.745 . . . . 0.0 109.282 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.467 ' HA ' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -161.39 -170.4 2.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.604 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.61 -148.27 7.99 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.23 -1.159 . . . . 0.0 109.431 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.485 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -167.71 -179.04 4.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 62.3 t -81.56 70.55 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 108.798 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -74.07 84.04 1.79 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.56 HG12 ' CG1' ' A' ' 48' ' ' VAL . 8.0 tp -99.73 163.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 111.297 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -147.31 -159.86 1.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.599 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 2.1 t -133.15 56.11 20.09 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.121 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.4 Cg_endo -80.58 35.94 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.5 2.134 . . . . 0.0 110.824 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.553 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.1 m-20 -102.95 -2.68 27.28 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.801 -1.187 . . . . 0.0 109.966 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.475 ' HG ' ' HA ' ' A' ' 69' ' ' SER . 0.7 OUTLIER -128.19 66.54 72.89 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 9' ' ' ASP . 35.7 Cg_endo -77.55 -58.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.583 2.189 . . . . 0.0 110.373 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' PRO . 7.0 mm-40 -43.94 154.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.357 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.471 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 p 44.5 -155.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.293 -0.879 . . . . 0.0 109.232 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 13' ' ' SER . 15.9 t -157.03 58.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.509 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.75 -11.21 58.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.146 -0.971 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 0.6 OUTLIER 60.89 -153.16 0.38 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.33 -0.856 . . . . 0.0 108.796 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.53 ' CA ' ' O ' ' A' ' 40' ' ' GLU . . . -170.15 -159.76 0.21 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.036 -1.04 . . . . 0.0 109.844 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.495 ' N ' HG12 ' A' ' 67' ' ' VAL . 46.8 m -155.55 124.15 5.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 110.54 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.529 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 17.0 t -65.52 107.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.23 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -73.8 -59.62 2.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.614 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.552 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.6 m -168.69 128.52 1.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.628 -1.295 . . . . 0.0 111.775 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.537 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 17.6 m95 -69.2 -166.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.661 0.743 . . . . 0.0 109.24 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.1 m80 -152.7 26.47 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.6 tppt? -119.36 137.91 53.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.69 -0.631 . . . . 0.0 110.132 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.568 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.28 179.29 1.71 Allowed Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -69.64 104.91 1.37 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.664 1.576 . . . . 0.0 111.62 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.522 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 75.03 39.52 37.49 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 4.8 m-20 -59.45 -166.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.718 -1.46 . . . . 0.0 109.597 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.17 78.56 0.45 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.08 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.552 ' CG2' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -79.55 169.26 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.547 ' N ' HG11 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -110.06 -95.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 1.6 mtm180 -107.2 51.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.961 -1.087 . . . . 0.0 109.63 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.552 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 4.2 m-20 173.04 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.612 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 10.3 tp10 -102.29 163.62 12.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.058 -1.026 . . . . 0.0 111.008 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.538 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 2.5 p -30.36 160.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.57 1.176 . . . . 0.0 112.581 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.533 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.12 67.63 1.37 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.593 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.1 p -38.59 165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.102 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.27 145.71 46.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -134.77 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.573 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 13.1 mt-10 -149.35 138.51 21.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.923 -1.11 . . . . 0.0 109.708 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 5.9 t -132.72 26.22 4.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 41' ' ' THR . 2.2 t70 87.34 15.31 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.341 0.591 . . . . 0.0 110.459 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 160.52 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.552 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 1.1 t -103.99 148.57 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.613 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 39' ' ' ILE . 51.2 t -136.93 96.76 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.685 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.553 ' HG ' ' CB ' ' A' ' 9' ' ' ASP . 2.9 mm? -79.88 -176.0 5.21 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.309 -0.869 . . . . 0.0 108.728 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 1.3 pt-20 -142.39 -161.36 1.23 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.718 -1.239 . . . . 0.0 111.463 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.56 ' CG1' HG12 ' A' ' 5' ' ' ILE . 6.0 t -143.47 75.5 16.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.7 Cg_endo -80.73 110.82 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.487 2.125 . . . . 0.0 110.931 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.612 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -91.79 -169.38 2.26 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.558 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 5.1 p -132.36 14.68 4.57 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.265 -1.522 . . . . 0.0 111.183 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 161.62 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 109.951 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER 60.63 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.548 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 64.95 -13.65 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 O-C-N 121.324 -0.86 . . . . 0.0 112.093 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.522 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.81 96.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.674 -1.486 . . . . 0.0 108.551 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.58 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 7.8 tp -49.87 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ILE . 46.6 t0 -98.6 -41.59 7.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.97 -0.456 . . . . 0.0 110.544 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.37 78.71 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.577 -1.327 . . . . 0.0 111.677 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.58 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 60.7 t -80.86 82.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.37 -10.8 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 109.709 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 4.8 mm-40 -123.74 50.93 1.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -40.8 134.12 1.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.552 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.05 134.51 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.597 0.713 . . . . 0.0 111.015 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.75 -13.96 24.64 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -84.98 156.19 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -1.135 . . . . 0.0 109.405 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.41 166.43 20.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.681 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.534 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.04 169.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -147.78 -148.31 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 9.3 p -90.28 36.18 0.87 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mtt180 163.55 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.4 mt-30 -84.49 87.69 7.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 0.0 109.102 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.4 tt -45.0 108.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.543 ' CD1' HG23 ' A' ' 48' ' ' VAL . 10.6 mt -53.91 -42.86 69.21 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 156.55 -159.79 29.76 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -134.68 134.49 41.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.151 -1.206 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.604 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 4.4 mp -98.09 -96.72 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.34 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -153.73 163.19 40.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.542 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.49 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 1.1 tt0 -160.81 -163.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 121.63 2.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.246 -1.149 . . . . 0.0 109.507 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.43 ' CA ' ' HG3' ' A' ' 78' ' ' GLU . 5.4 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.529 ' N ' ' HB2' ' A' ' 78' ' ' GLU . 35.3 m -69.78 -165.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.398 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.532 ' CG2' ' OE1' ' A' ' 34' ' ' GLU . 8.8 t -78.96 77.52 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.2 -0.937 . . . . 0.0 109.317 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.79 83.86 2.75 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.612 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -101.24 149.19 6.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.325 -0.859 . . . . 0.0 111.628 -177.032 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.43 -158.59 0.9 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.589 ' CG2' ' CD2' ' A' ' 73' ' ' LEU . 72.7 t -136.04 58.09 21.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.084 -1.01 . . . . 0.0 110.247 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.1 Cg_endo -80.7 19.81 1.06 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.39 2.06 . . . . 0.0 111.124 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 1.5 m-20 -109.46 62.45 0.6 Allowed 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.769 -1.207 . . . . 0.0 109.913 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.492 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 22.5 mt -135.5 140.14 33.25 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.24 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.07 135.98 14.28 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.455 2.103 . . . . 0.0 110.35 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 13' ' ' SER . 8.3 mt-10 -67.4 102.3 1.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER 171.63 -26.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.378 -0.826 . . . . 0.0 109.815 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.513 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 74.0 t -85.69 -97.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.419 -0.801 . . . . 0.0 109.601 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 14' ' ' VAL . . . 162.23 -22.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.754 . . . . 0.0 109.651 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 67' ' ' VAL . 0.6 OUTLIER 172.37 144.38 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.648 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -97.48 -151.57 0.37 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.309 -0.87 . . . . 0.0 109.371 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.424 ' C ' HG13 ' A' ' 39' ' ' ILE . 21.2 m -160.33 121.78 3.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.335 -0.853 . . . . 0.0 109.934 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 13.4 t -63.97 91.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.135 -0.978 . . . . 0.0 109.108 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -54.65 -57.83 9.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 110.707 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.588 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 40.3 m -166.5 122.88 1.25 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.709 -1.244 . . . . 0.0 111.654 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.558 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 18.4 m95 -67.85 -165.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 39.9 m80 -148.92 22.03 0.98 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.524 ' HE2' ' CA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -117.59 154.36 31.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.676 -0.64 . . . . 0.0 109.678 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.599 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -105.61 -173.41 0.28 Allowed Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.84 83.73 0.53 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.075 1.183 . . . . 0.0 111.247 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.546 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 81.11 48.08 6.21 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 18.2 m-20 -55.83 -113.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -1.182 . . . . 0.0 110.005 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 163.05 72.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.448 -1.408 . . . . 0.0 109.98 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.581 HG12 ' CA ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -79.66 157.09 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.112 -0.992 . . . . 0.0 110.652 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 2.6 m -97.51 -107.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 12.8 ttt-85 -104.9 74.84 1.15 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.693 -1.254 . . . . 0.0 108.965 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.594 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 11.4 m-20 143.96 102.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.581 ' CA ' HG12 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -112.21 -173.3 2.22 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.533 -177.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.511 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 13.1 p -27.68 153.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.953 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.1 58.82 1.7 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 178.019 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.1 p -37.75 168.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.731 0.776 . . . . 0.0 110.761 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.67 142.18 51.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.14 -179.63 3.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 121.276 -0.89 . . . . 0.0 109.387 -179.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 15.4 mt-10 -137.83 127.63 25.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.782 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 8.5 t -132.13 25.89 4.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 0.0 109.49 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.3 t0 81.32 87.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.709 -0.62 . . . . 0.0 110.544 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.9 tttp 85.72 -27.62 0.08 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.869 -0.519 . . . . 0.0 110.403 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.523 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 0.2 OUTLIER -114.81 142.19 28.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.961 -1.087 . . . . 0.0 109.964 -179.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.461 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 39.8 t -139.32 100.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.138 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.595 ' CD2' ' N ' ' A' ' 46' ' ' LEU . 3.3 mm? -81.65 -166.45 1.2 Allowed 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -143.45 -161.8 1.33 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.182 -0.949 . . . . 0.0 110.122 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.695 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -156.02 77.2 4.56 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 109.948 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.5 Cg_endo -79.89 107.63 2.12 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.419 2.079 . . . . 0.0 110.031 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.571 ' HB1' ' CG ' ' A' ' 34' ' ' GLU . . . -76.11 -167.22 0.71 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -143.06 24.02 1.84 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.461 -1.4 . . . . 0.0 110.819 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.63 ' O ' ' CB ' ' A' ' 53' ' ' ASP . . . 161.69 118.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.73 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.63 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 66.0 m-20 106.65 -117.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.559 ' CA ' ' OE1' ' A' ' 34' ' ' GLU . . . 100.28 -26.79 23.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.561 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 6.1 mt -43.78 98.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 108.089 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.572 ' CG ' ' CG2' ' A' ' 59' ' ' VAL . 10.6 tp -51.57 100.92 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.391 -0.818 . . . . 0.0 109.698 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -101.2 -46.75 4.95 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.754 -0.591 . . . . 0.0 109.598 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.64 96.79 2.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.884 -1.135 . . . . 0.0 110.529 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.572 ' CG2' ' CG ' ' A' ' 56' ' ' LEU . 2.6 t -94.71 90.9 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.965 . . . . 0.0 108.505 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.461 ' CD1' ' HA2' ' A' ' 74' ' ' GLY . 1.6 mt -71.23 -2.04 14.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.849 . . . . 0.0 110.329 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.526 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 7.7 mt-10 -135.61 54.3 1.92 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.155 -0.965 . . . . 0.0 108.471 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.4 m-20 -43.91 130.36 5.78 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.488 -0.758 . . . . 0.0 109.553 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.588 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -34.63 116.34 0.31 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.343 0.592 . . . . 0.0 110.953 -179.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.09 -6.39 7.27 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 m -95.18 162.92 13.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -1.179 . . . . 0.0 109.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -78.43 156.96 29.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.243 -0.911 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.584 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.74 174.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.584 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -143.82 -164.92 1.99 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 108.81 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 60.2 p -85.76 63.31 7.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.047 -1.033 . . . . 0.0 109.185 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.551 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.8 mmm-85 159.81 -16.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.606 -0.684 . . . . 0.0 109.923 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.46 ' HB2' HG22 ' A' ' 67' ' ' VAL . 21.1 mm100 -53.27 143.74 17.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.422 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 16.8 tt -95.59 112.06 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.3 -0.875 . . . . 0.0 109.682 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.589 ' CD2' ' CG2' ' A' ' 7' ' ' VAL . 9.3 mt -53.13 -31.46 42.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.461 ' HA2' ' CD1' ' A' ' 60' ' ' LEU . . . 139.63 -166.63 25.54 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.5 ptt85 -128.84 140.23 51.8 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.27 -1.135 . . . . 0.0 109.534 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' CD2' HD13 ' A' ' 56' ' ' LEU . 8.2 mt -100.74 -121.66 0.16 Allowed 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.128 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.561 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 19.2 ttt-85 -114.8 163.78 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.595 -1.316 . . . . 0.0 110.015 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.529 ' HB2' ' N ' ' A' ' 2' ' ' SER . 2.2 tm-20 -110.72 147.0 35.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 0.0 109.363 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 53' ' ' ASP . . . -71.09 -151.74 0.9 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.423 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.461 ' CB ' ' HG2' ' A' ' 78' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.533 ' CA ' ' HB2' ' A' ' 78' ' ' GLU . 5.6 m -69.81 -171.25 0.39 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.385 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.6 ' CG1' ' CD1' ' A' ' 5' ' ' ILE . 15.7 t -88.91 63.22 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.292 -0.88 . . . . 0.0 109.652 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -85.26 89.44 7.65 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.602 HG13 ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -103.18 171.79 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 120.849 -1.157 . . . . 0.0 112.231 -177.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -142.12 -156.56 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.582 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 59.9 t -129.35 54.38 14.21 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.036 -1.04 . . . . 0.0 110.724 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.4 Cg_endo -80.3 28.02 0.54 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.473 2.115 . . . . 0.0 110.561 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' HB3' HD12 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -112.39 -2.48 14.74 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 120.972 -1.08 . . . . 0.0 109.707 -179.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.533 ' HB3' ' CG1' ' A' ' 14' ' ' VAL . 55.3 mt -68.09 140.29 93.31 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.219 -0.926 . . . . 0.0 109.608 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HD2' HG13 ' A' ' 14' ' ' VAL . 36.2 Cg_endo -78.82 -159.88 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.517 2.145 . . . . 0.0 110.416 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.02 21.32 9.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.433 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -136.7 58.49 1.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 109.338 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 14' ' ' VAL . 14.6 p -159.67 84.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.235 -0.916 . . . . 0.0 109.403 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' VAL . . . -43.12 -26.09 0.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 14' ' ' VAL . 2.7 p30 -178.7 158.9 1.06 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.393 -0.817 . . . . 0.0 109.773 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -120.74 -163.48 1.02 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.465 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 96.7 m -159.39 139.76 12.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.126 -0.984 . . . . 0.0 110.174 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.529 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 14.2 t -73.2 91.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.402 -0.811 . . . . 0.0 109.373 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -52.65 -62.92 1.34 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.389 -0.82 . . . . 0.0 110.431 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.563 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 2.9 m -161.62 122.67 2.75 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.499 -1.28 . . . . 0.0 111.812 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.535 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 13.7 m95 -67.93 -165.56 0.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.412 -0.805 . . . . 0.0 109.034 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.599 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 33.8 m80 -150.24 31.39 0.68 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HG2' ' HB ' ' A' ' 35' ' ' VAL . 2.8 mtpp -122.16 177.84 5.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.925 0.869 . . . . 0.0 110.844 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 8.2 mmmt -131.98 -177.62 0.72 Allowed Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -69.25 86.0 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.166 1.244 . . . . 0.0 110.646 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.548 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 86.07 47.36 5.02 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.567 ' O ' ' CG1' ' A' ' 55' ' ' ILE . 12.8 m-20 -54.31 -158.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -1.095 . . . . 0.0 110.055 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.33 86.74 0.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.54 -1.35 . . . . 0.0 109.179 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.578 HG11 ' N ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -95.13 170.46 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 110.011 -179.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 1.5 p -133.88 -57.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.317 -0.865 . . . . 0.0 109.386 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 3.2 mtp180 -141.18 64.16 1.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 108.82 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 11.6 m-20 149.6 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.653 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 11.9 tt0 -94.1 167.77 11.37 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.328 1.061 . . . . 0.0 111.726 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.531 ' HB ' ' HG2' ' A' ' 24' ' ' LYS . 2.4 p -31.16 156.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 122.174 0.987 . . . . 0.0 112.168 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.543 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.98 64.57 1.5 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 177.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.599 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.0 p -37.86 165.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.729 0.776 . . . . 0.0 110.268 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 2.4 mm-40 -128.37 98.47 5.07 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 108.806 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.75 -168.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.559 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 8.5 mt-10 -136.59 114.58 11.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.951 -1.093 . . . . 0.0 110.275 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.512 HG23 ' N ' ' A' ' 42' ' ' ASP . 98.1 m -106.33 -103.23 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.23 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 2.3 t70 -144.85 95.16 2.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.102 -0.998 . . . . 0.0 108.99 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.571 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 23.1 tttm 85.66 -28.02 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.307 0.575 . . . . 0.0 109.452 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.422 ' O ' HG21 ' A' ' 45' ' ' VAL . 2.0 t -118.95 -177.05 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.126 -0.984 . . . . 0.0 109.223 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 44.4 t -148.64 120.42 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 109.577 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -79.43 159.46 27.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 4.4 mt-10 -124.07 -173.45 2.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.058 -1.026 . . . . 0.0 110.132 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.66 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.9 OUTLIER -148.86 66.49 8.84 Favored Pre-proline 0 N--CA 1.487 1.409 0 CA-C-O 121.911 0.862 . . . . 0.0 109.041 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 33.8 Cg_endo -75.15 115.7 4.34 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.679 2.253 . . . . 0.0 110.998 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.653 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -91.91 -177.0 4.6 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.513 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 51.5 p -129.68 21.32 5.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.747 -1.221 . . . . 0.0 110.07 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 53' ' ' ASP . . . 162.69 161.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.432 -0.792 . . . . 0.0 109.076 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.578 ' N ' HG11 ' A' ' 30' ' ' VAL . 1.8 m-20 75.82 -145.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 117.03 -18.91 12.19 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 120.475 -1.391 . . . . 0.0 110.256 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.567 ' CG1' ' O ' ' A' ' 28' ' ' ASP . 18.9 mt -46.61 95.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.136 -1.214 . . . . 0.0 107.77 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.591 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 7.2 tp -53.27 109.42 0.43 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.375 -0.828 . . . . 0.0 109.398 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 20.1 t70 -113.54 -53.87 2.66 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.741 -0.599 . . . . 0.0 110.358 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.64 79.51 1.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.694 -1.254 . . . . 0.0 110.952 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.578 ' CG2' ' CG ' ' A' ' 56' ' ' LEU . 10.1 t -81.07 87.98 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.76 -1.6 12.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.465 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 51.8 mt-10 -134.03 52.51 2.06 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.013 -1.055 . . . . 0.0 108.456 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -43.5 131.59 4.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.599 -0.688 . . . . 0.0 109.769 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.563 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -36.1 111.38 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.327 0.584 . . . . 0.0 110.587 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.86 4.31 7.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -101.74 162.11 13.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -1.2 . . . . 0.0 109.596 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.23 151.61 36.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.595 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.565 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.98 173.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.565 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 5.2 t -140.33 -157.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 108.829 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 88.7 p -90.32 63.87 5.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.977 -1.077 . . . . 0.0 109.406 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.518 ' CB ' ' O ' ' A' ' 69' ' ' SER . 4.2 ttt180 159.54 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.648 -0.658 . . . . 0.0 109.458 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.505 ' O ' ' CA ' ' A' ' 6' ' ' LEU . 19.0 mm-40 -48.79 138.44 11.13 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.414 -0.804 . . . . 0.0 109.444 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.613 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.8 tt -87.55 114.36 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.383 -0.823 . . . . 0.0 109.818 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.534 ' CD1' HG13 ' A' ' 37' ' ' VAL . 5.2 mt -49.35 -39.64 32.61 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 146.86 -173.99 26.85 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -117.87 140.98 48.94 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.159 -1.2 . . . . 0.0 109.317 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.591 ' CD1' ' CD1' ' A' ' 56' ' ' LEU . 3.6 mm? -88.17 -92.33 0.11 Allowed 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.334 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.547 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -161.41 174.47 13.43 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 110.022 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.533 ' HB2' ' CA ' ' A' ' 2' ' ' SER . 7.8 tp10 -174.69 124.9 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 109.662 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.527 ' O ' ' CZ ' ' A' ' 77' ' ' ARG . . . 43.76 -94.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 78' ' ' GLU . 53.2 p-10 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 109.446 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.309 0.576 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.518 ' N ' ' HB2' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -167.53 168.88 12.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.421 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.545 ' HB ' ' CG ' ' A' ' 76' ' ' LEU . 34.7 t -88.81 72.82 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.901 . . . . 0.0 109.411 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.63 80.99 4.09 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.541 HG12 ' CG1' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -94.32 156.7 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.28 -0.887 . . . . 0.0 111.327 -177.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -139.57 -155.54 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 39' ' ' ILE . 16.5 t -136.9 63.68 46.16 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.955 -1.091 . . . . 0.0 109.84 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 70' ' ' ARG . 36.5 Cg_endo -80.59 43.22 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.78 2.32 . . . . 0.0 110.252 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -128.37 31.05 5.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.179 -0.951 . . . . 0.0 109.957 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.545 ' CD2' ' CB ' ' A' ' 69' ' ' SER . 1.8 pt? -70.99 144.79 90.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.003 . . . . 0.0 109.898 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.532 ' HG3' ' CG2' ' A' ' 41' ' ' THR . 36.5 Cg_endo -80.53 -11.17 13.06 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.631 2.221 . . . . 0.0 110.187 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 63.43 16.66 9.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.347 -0.846 . . . . 0.0 109.453 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.8 m -135.11 6.21 3.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 99.0 t -108.45 -97.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.434 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 14' ' ' VAL . . . 166.45 -21.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.155 -0.966 . . . . 0.0 110.512 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -175.97 -163.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.084 -1.01 . . . . 0.0 109.996 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -167.76 -171.78 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.303 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 16.0 m -159.69 134.91 8.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 110.546 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 23.8 t -70.42 84.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.455 -0.778 . . . . 0.0 109.251 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -41.18 -62.81 0.77 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.313 -0.867 . . . . 0.0 110.327 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.566 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.5 m -164.95 128.05 2.29 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.564 -1.255 . . . . 0.0 111.456 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.547 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 16.4 m95 -68.54 -167.69 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.546 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 23.4 m80 -149.56 35.38 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.484 ' HG3' ' HB2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -131.62 168.51 17.58 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.511 0.672 . . . . 0.0 110.195 -179.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.599 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -121.5 -171.09 0.21 Allowed Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 178.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -68.45 84.91 0.46 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 120.831 1.021 . . . . 0.0 111.262 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.551 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 77.05 48.86 8.0 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 20.8 m-20 -54.5 -112.13 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.253 -1.145 . . . . 0.0 110.911 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 157.48 103.63 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.573 HG13 ' CG ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -104.35 176.51 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 120.672 -1.268 . . . . 0.0 111.688 -177.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -114.37 -137.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -80.69 76.86 7.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.833 -1.167 . . . . 0.0 108.19 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 4.4 m-20 150.22 79.15 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.622 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . 2.7 tm-20 -83.26 171.36 13.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 0.0 112.438 -177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.549 ' CG1' ' OE1' ' A' ' 34' ' ' GLU . 2.0 p -31.49 156.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.745 0.784 . . . . 0.0 111.687 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.539 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.05 63.27 1.34 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 178.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.547 ' CG2' ' HA ' ' A' ' 22' ' ' TRP . 3.2 p -39.38 168.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.681 0.753 . . . . 0.0 110.2 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 1.3 mt-10 -131.17 103.51 6.53 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 109.015 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 2.8 tt -84.14 -159.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.369 -0.832 . . . . 0.0 109.425 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.569 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 5.8 mm-40 -139.8 127.48 21.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.928 -1.108 . . . . 0.0 109.801 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.532 ' CG2' ' HG3' ' A' ' 11' ' ' PRO . 84.8 m -132.69 16.62 4.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.852 . . . . 0.0 109.665 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 15.2 t0 72.19 85.49 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.161 -0.962 . . . . 0.0 109.684 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 86.38 -27.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.24 0.543 . . . . 0.0 109.59 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.486 HG11 ' N ' ' A' ' 45' ' ' VAL . 66.9 t -115.47 144.97 21.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.143 -0.973 . . . . 0.0 109.281 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.486 ' N ' HG11 ' A' ' 44' ' ' VAL . 38.1 t -133.17 118.54 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.758 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -79.55 159.75 26.74 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.159 -0.963 . . . . 0.0 108.632 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -119.0 172.29 7.65 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.009 -1.057 . . . . 0.0 110.315 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.574 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 4.0 t -137.55 70.75 52.56 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.5 Cg_endo -79.72 116.3 3.47 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.838 2.358 . . . . 0.0 111.465 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.622 ' HB2' ' CB ' ' A' ' 34' ' ' GLU . . . -98.42 172.49 7.5 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 20.0 p -116.04 77.93 1.14 Allowed 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.087 -1.445 . . . . 0.0 110.618 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.585 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 88.81 160.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.245 0.545 . . . . 0.0 109.919 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.6 m-20 79.97 -76.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.699 -0.625 . . . . 0.0 110.219 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 40.94 22.51 0.06 OUTLIER Glycine 0 N--CA 1.493 2.455 0 O-C-N 121.033 -1.042 . . . . 0.0 110.788 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.556 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 12.5 mt -72.21 94.57 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.912 -1.346 . . . . 0.0 108.064 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.535 ' CB ' ' O ' ' A' ' 25' ' ' LYS . 5.1 tp -47.78 91.28 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.752 0.787 . . . . 0.0 110.389 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.2 t70 -84.0 -50.56 7.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.49 99.91 2.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.979 -1.076 . . . . 0.0 110.627 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.533 HG22 ' CD2' ' A' ' 56' ' ' LEU . 4.0 t -83.35 90.73 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.4 mt -69.09 -7.37 35.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 0.0 109.693 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 73' ' ' LEU . 2.9 mt-10 -131.72 52.76 2.04 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 63' ' ' GLU . 7.0 m-20 -40.93 134.17 2.0 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.46 0.648 . . . . 0.0 109.689 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.566 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.5 OUTLIER -36.08 125.7 0.75 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.485 0.66 . . . . 0.0 110.82 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.23 -4.57 21.95 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.515 ' CG2' ' N ' ' A' ' 66' ' ' THR . 21.5 m -84.15 166.33 17.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.227 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.515 ' N ' ' CG2' ' A' ' 65' ' ' THR . 90.0 m -93.73 137.58 32.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.731 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.504 HG23 ' CD1' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -150.22 153.54 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -116.22 -97.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.057 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.545 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . 28.7 p -94.99 -125.68 0.12 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.537 ' CG ' ' HB3' ' A' ' 8' ' ' PRO . 51.7 mtp180 -56.59 84.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.008 -1.058 . . . . 0.0 110.032 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -118.07 85.13 2.29 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.7 tt -34.25 107.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.885 -0.51 . . . . 0.0 111.107 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.54 ' CD1' HG23 ' A' ' 48' ' ' VAL . 15.7 mt -57.3 -38.36 73.87 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.79 -160.49 31.98 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.437 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -135.76 145.98 47.15 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.253 -1.145 . . . . 0.0 109.775 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.545 ' CG ' ' HB ' ' A' ' 3' ' ' VAL . 2.4 mt -129.45 -137.0 0.22 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.556 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -118.48 151.62 37.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.779 -1.201 . . . . 0.0 109.228 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.518 ' HB2' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -137.56 -166.47 1.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.72 -153.76 30.04 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.302 -1.117 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.429 ' C ' ' HB3' ' A' ' 78' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.529 ' CA ' ' HB2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -170.13 166.66 8.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.309 -0.87 . . . . 0.0 109.49 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 8.0 t -69.43 98.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 108.733 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -71.91 85.65 0.97 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.551 HG12 ' CG1' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -81.17 121.35 34.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.545 -0.722 . . . . 0.0 109.904 -178.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -145.47 -165.64 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.582 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 29.2 t -134.78 56.9 18.81 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.232 -0.918 . . . . 0.0 109.924 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.1 Cg_endo -80.48 36.82 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.495 2.13 . . . . 0.0 110.517 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.54 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -89.97 -15.28 32.29 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.948 -1.095 . . . . 0.0 109.593 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.533 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 1.0 OUTLIER 28.05 59.9 0.64 Allowed Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.27 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 10' ' ' LEU . 36.4 Cg_endo -79.32 -74.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.534 2.156 . . . . 0.0 110.059 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 11' ' ' PRO . 29.4 mt-10 -157.63 27.63 0.28 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.529 ' CA ' ' OG1' ' A' ' 41' ' ' THR . 22.8 t -45.71 151.2 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.446 -0.784 . . . . 0.0 109.843 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.3 t -95.25 -91.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 109.281 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 16' ' ' ASP . . . -102.47 -4.11 25.89 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.509 -0.744 . . . . 0.0 109.633 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 3.0 p30 162.24 152.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.392 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -100.04 -168.03 1.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 20.4 m -153.39 131.71 12.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.375 -0.828 . . . . 0.0 110.317 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.505 ' HA ' HG13 ' A' ' 39' ' ' ILE . 11.4 t -70.18 83.69 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.386 -0.822 . . . . 0.0 109.493 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 38' ' ' GLU . . . -41.96 -63.27 0.76 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 110.493 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.483 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 5.4 m -166.94 129.05 1.71 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.59 -1.319 . . . . 0.0 111.479 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.531 ' CH2' HG13 ' A' ' 5' ' ' ILE . 21.9 m95 -69.66 -167.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.531 0.682 . . . . 0.0 109.292 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.577 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 24.5 m80 -151.83 28.26 0.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.556 ' CE ' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -118.1 167.52 11.4 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.714 0.768 . . . . 0.0 110.434 -178.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -115.54 -179.83 0.68 Allowed Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -70.74 87.23 0.68 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.426 1.417 . . . . 0.0 110.932 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.571 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 88.2 41.71 6.13 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD1' ' CG ' ' A' ' 25' ' ' LYS . 13.6 m-20 -55.52 -164.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.995 -1.297 . . . . 0.0 109.685 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.43 77.67 0.62 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.019 -1.051 . . . . 0.0 109.391 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.569 ' CG1' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -79.5 -179.06 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.373 -0.829 . . . . 0.0 109.609 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 32' ' ' ARG . 1.5 m -139.1 -48.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.098 -1.001 . . . . 0.0 110.241 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.563 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -150.83 62.27 0.93 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.4 m-20 150.73 75.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.569 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.55 -170.41 3.04 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.298 1.047 . . . . 0.0 111.871 -177.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.53 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 3.8 p -50.46 161.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.929 0.871 . . . . 0.0 111.639 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.546 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -140.2 61.4 1.53 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.577 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.2 p -38.52 168.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.773 0.797 . . . . 0.0 110.736 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 8.2 mt-10 -129.13 125.23 36.66 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.572 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -111.36 -172.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.298 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.572 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 6.1 mt-10 -134.98 128.78 33.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.998 . . . . 0.0 109.586 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.538 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 12.4 t -125.92 -32.08 2.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 110.042 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.591 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.1 t70 158.94 70.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.591 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.9 tttm 85.79 -25.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.465 ' O ' HG21 ' A' ' 41' ' ' THR . 92.7 t -108.27 133.78 52.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.34 -0.85 . . . . 0.0 109.267 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 55.9 t -118.36 112.52 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.117 -0.989 . . . . 0.0 109.729 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.29 -179.85 7.0 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.294 -0.878 . . . . 0.0 108.678 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 51.5 mt-10 -141.47 -171.38 3.29 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.86 -1.15 . . . . 0.0 110.451 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.551 ' CG1' HG12 ' A' ' 5' ' ' ILE . 14.8 p -146.35 75.4 12.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.388 -0.82 . . . . 0.0 109.678 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 35.0 Cg_endo -77.48 105.27 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.225 1.95 . . . . 0.0 110.385 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.569 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -77.56 -177.98 5.04 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.556 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 5.2 t -130.22 26.61 5.14 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.384 -1.448 . . . . 0.0 110.282 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 161.1 160.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.512 -0.743 . . . . 0.0 109.246 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.569 ' O ' ' CG1' ' A' ' 30' ' ' VAL . 12.4 m-20 62.24 -136.32 0.48 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.263 -0.898 . . . . 0.0 108.956 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 111.9 -17.83 24.66 Favored Glycine 0 N--CA 1.488 2.162 0 O-C-N 120.505 -1.372 . . . . 0.0 109.723 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.571 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 1.2 mt -34.24 102.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.789 -0.83 . . . . 0.0 109.371 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 12.2 tp -58.43 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.526 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -114.11 -29.49 6.96 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.405 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 75' ' ' ARG . . . -138.69 106.57 5.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.831 -1.168 . . . . 0.0 110.506 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 18.2 t -127.56 76.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.78 -4.15 18.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.554 -0.716 . . . . 0.0 110.563 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.532 ' HA ' ' CB ' ' A' ' 65' ' ' THR . 10.0 mt-10 -128.32 50.37 2.09 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 108.787 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 63' ' ' GLU . 7.2 m-20 -51.18 118.2 3.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.568 -0.707 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 62' ' ' ASP . 1.6 mp0 5.56 113.25 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.21 -32.3 6.2 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.532 ' CB ' ' HA ' ' A' ' 61' ' ' GLU . 78.9 m -54.3 153.23 5.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -1.135 . . . . 0.0 109.276 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.408 ' O ' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -69.82 155.56 40.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.367 -0.833 . . . . 0.0 109.588 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.577 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -149.6 174.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.577 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -139.83 -172.2 3.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.013 . . . . 0.0 109.408 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.523 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -86.19 46.76 1.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 109.133 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER 158.88 32.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 6' ' ' LEU . 77.2 mm-40 -112.94 149.89 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.992 -1.067 . . . . 0.0 109.125 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.526 HG12 ' N ' ' A' ' 74' ' ' GLY . 2.2 tt -97.07 113.22 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.483 -0.761 . . . . 0.0 110.686 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.534 ' HB2' HG22 ' A' ' 5' ' ' ILE . 1.3 mt -47.56 -36.99 11.36 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.526 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 163.99 -162.08 34.87 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 58' ' ' ALA . 1.1 ptt180 -136.12 150.09 48.95 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.625 -1.514 . . . . 0.0 110.053 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.607 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 5.3 mp -111.07 -115.03 0.31 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.537 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 20.3 ttt-85 -134.38 153.69 51.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.863 -1.148 . . . . 0.0 109.304 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.529 ' HB2' ' CA ' ' A' ' 2' ' ' SER . 45.4 tt0 -141.61 164.63 29.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 109.461 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 78' ' ' GLU . . . 67.65 133.92 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.29 -1.124 . . . . 0.0 109.421 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.434 ' C ' ' HB3' ' A' ' 78' ' ' GLU . 20.5 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.469 ' N ' ' HB3' ' A' ' 78' ' ' GLU . 1.5 m -69.97 -168.22 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.519 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.54 ' CG2' ' OE1' ' A' ' 34' ' ' GLU . 43.3 t -84.42 68.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.842 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -71.72 85.82 0.92 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.549 HG12 ' CG1' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -102.93 158.48 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.247 -0.908 . . . . 0.0 111.586 -177.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.567 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -137.62 -151.8 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.58 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 85.6 t -132.25 54.32 13.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.864 -1.148 . . . . 0.0 109.688 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.58 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 36.6 Cg_endo -77.04 67.0 7.67 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.557 2.171 . . . . 0.0 110.637 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 1.1 m-20 -129.11 -4.58 5.0 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.086 -1.009 . . . . 0.0 109.831 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.522 ' CG ' ' O ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -133.28 73.96 73.16 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.265 -0.897 . . . . 0.0 109.351 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.0 42.73 1.37 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.88 2.387 . . . . 0.0 110.853 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 12' ' ' GLU . 5.9 mm-40 -146.01 -116.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.071 -1.018 . . . . 0.0 109.52 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 12' ' ' GLU . 14.2 t -43.29 165.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.944 -1.097 . . . . 0.0 109.766 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.32 64.11 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.06 1.6 53.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.598 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 0.9 OUTLIER 67.6 -170.06 0.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.578 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -166.05 -171.9 2.14 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.229 -0.92 . . . . 0.0 109.585 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 39' ' ' ILE . 19.6 m -148.04 132.41 17.56 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.922 . . . . 0.0 110.192 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.533 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 16.6 t -69.0 87.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.937 . . . . 0.0 109.063 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 38' ' ' GLU . . . -51.01 -63.48 1.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 111.08 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.582 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 1.8 m -161.61 123.61 2.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.574 -1.329 . . . . 0.0 112.019 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.586 ' CZ2' HG21 ' A' ' 59' ' ' VAL . 16.9 m95 -68.6 -166.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.579 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 20.0 m80 -154.45 28.84 0.44 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.532 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 4.9 tppt? -123.07 122.89 39.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.714 -0.616 . . . . 0.0 110.247 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.557 ' CB ' ' OD1' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -71.3 179.06 1.01 Allowed Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -68.17 89.88 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.597 1.532 . . . . 0.0 111.672 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.553 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 78.86 45.15 9.43 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.557 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 13.6 m-20 -59.43 -117.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.077 -1.249 . . . . 0.0 110.331 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 159.1 101.79 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.772 -1.205 . . . . 0.0 108.534 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.596 ' CG1' ' N ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -102.16 -179.4 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.938 -1.101 . . . . 0.0 109.971 -179.36 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.596 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -105.09 -91.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 0.0 110.048 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -117.9 43.83 2.33 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.034 -1.041 . . . . 0.0 109.068 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.488 ' CG ' ' O ' ' A' ' 32' ' ' ARG . 17.8 m-20 171.74 99.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.591 ' CA ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -97.97 -160.38 0.8 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.348 -177.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.532 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 6.3 p -34.95 165.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.496 1.141 . . . . 0.0 112.94 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.517 HD13 ' ND1' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -148.74 58.11 1.05 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.579 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 2.3 p -39.39 167.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.88 0.848 . . . . 0.0 110.836 -177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.461 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 24.1 mt-10 -130.81 121.61 25.65 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.558 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -103.97 -170.17 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.313 -0.867 . . . . 0.0 109.483 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 2.5 mt-10 -153.2 101.37 2.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.122 -0.986 . . . . 0.0 109.767 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -97.12 -35.3 10.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.905 . . . . 0.0 109.9 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 11.4 t70 171.62 72.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.725 . . . . 0.0 109.704 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.4 tmmt? 85.8 -24.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.96 131.17 57.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.232 -0.917 . . . . 0.0 109.578 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 94.3 t -113.84 123.31 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.838 . . . . 0.0 109.475 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.555 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 5.9 mt -86.44 178.24 7.18 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.163 -0.961 . . . . 0.0 108.816 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 27.2 mt-10 -126.58 175.84 7.64 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.811 -1.181 . . . . 0.0 110.835 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.58 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 4.9 t -139.46 71.99 37.86 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.3 Cg_endo -79.29 116.27 3.59 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.534 2.156 . . . . 0.0 109.797 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.59 ' CB ' ' CD ' ' A' ' 34' ' ' GLU . . . -97.29 -175.66 3.29 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.945 -1.097 . . . . 0.0 108.524 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.634 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 12.3 p -131.5 70.16 1.47 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.644 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.638 ' O ' ' CB ' ' A' ' 53' ' ' ASP . . . 98.53 136.95 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 121.253 0.549 . . . . 0.0 112.029 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.638 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 8.3 t0 101.34 -76.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.504 0.669 . . . . 0.0 110.019 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.529 ' CA ' ' OE1' ' A' ' 34' ' ' GLU . . . 43.27 21.6 0.15 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.553 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 6.7 mt -77.65 90.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.835 -1.391 . . . . 0.0 107.583 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.54 ' CG ' HG13 ' A' ' 59' ' ' VAL . 7.2 tp -44.0 111.2 0.27 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.447 0.641 . . . . 0.0 110.144 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 12.5 t70 -134.28 -29.88 1.21 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.608 -0.682 . . . . 0.0 110.245 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 75' ' ' ARG . . . -137.65 39.56 2.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.622 -1.299 . . . . 0.0 110.964 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.586 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 9.1 p -83.82 71.52 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.53 0.38 10.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 110.756 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 73' ' ' LEU . 9.1 mm-40 -105.08 41.54 1.33 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.2 m-20 -37.94 124.83 1.17 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.422 0.63 . . . . 0.0 110.005 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.582 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -29.47 122.14 0.15 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.498 0.666 . . . . 0.0 111.35 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.35 -13.35 8.35 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.438 ' HB ' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -83.37 174.43 10.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -1.062 . . . . 0.0 109.367 179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -96.19 144.89 26.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 110.021 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.544 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.69 169.44 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.544 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -127.49 -143.14 0.28 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 7' ' ' VAL . 11.1 t -69.67 -102.09 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.008 -1.057 . . . . 0.0 108.972 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 71' ' ' GLN . 3.7 mtt180 -78.07 36.7 0.23 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.127 -0.983 . . . . 0.0 111.377 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.509 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 61.4 mm-40 -61.73 -113.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.49 -1.381 . . . . 0.0 107.991 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 16.0 tt 179.34 115.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.694 -1.254 . . . . 0.0 110.725 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 61' ' ' GLU . 7.8 mt -71.84 -44.47 63.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.38 -159.76 28.79 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 13.6 mtt180 -135.34 135.39 40.69 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.263 -1.14 . . . . 0.0 108.903 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.598 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -85.33 -105.23 0.05 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.353 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.524 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -142.5 163.68 32.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.928 -1.108 . . . . 0.0 109.799 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.511 ' CA ' ' OD2' ' A' ' 53' ' ' ASP . 8.9 pt-20 -119.72 -173.38 2.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.693 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.26 143.54 10.65 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.5 m120 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.173 -1.192 . . . . 0.0 109.405 -179.97 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.326 0.584 . . . . 0.0 109.456 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.473 ' CB ' ' HB2' ' A' ' 75' ' ' ARG . 7.6 m -166.92 162.16 15.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.927 . . . . 0.0 109.525 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.525 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 14.1 t -80.58 75.62 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 108.916 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.441 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -78.74 78.17 5.2 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.541 HG12 ' CG1' ' A' ' 48' ' ' VAL . 4.5 tp -88.1 154.28 3.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.259 -0.901 . . . . 0.0 110.799 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.574 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.82 -151.44 0.45 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.334 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.544 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 59.6 t -133.63 60.59 47.78 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.034 -1.041 . . . . 0.0 110.167 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -81.14 34.02 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.538 2.159 . . . . 0.0 110.521 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.548 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -107.83 22.26 16.22 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.008 -1.057 . . . . 0.0 109.689 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.525 ' HB2' ' CB ' ' A' ' 69' ' ' SER . 5.4 mt -130.26 70.44 82.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.323 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' SER . 35.7 Cg_endo -77.98 -171.41 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.692 2.261 . . . . 0.0 110.532 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 39.05 -93.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.67 -0.644 . . . . 0.0 110.217 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' PRO . 5.5 m -71.0 174.29 6.41 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.342 -0.849 . . . . 0.0 109.52 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.6 t -143.37 74.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 109.377 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' O ' ' CG ' ' A' ' 16' ' ' ASP . . . -85.74 14.0 6.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.646 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 1.2 p30 48.37 -163.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.389 -0.819 . . . . 0.0 109.194 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -170.37 -164.4 0.39 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.306 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.512 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 33.6 m -160.1 119.11 2.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.862 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.528 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.8 t -48.43 134.11 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 108.996 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -106.76 -57.43 2.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.676 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.464 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 32.5 m -160.88 119.14 2.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.849 -1.157 . . . . 0.0 111.208 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.572 ' CE2' HG13 ' A' ' 59' ' ' VAL . 21.2 m95 -68.94 -165.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 18.6 m80 -156.17 48.22 0.48 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.579 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.12 119.72 13.23 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.493 -0.754 . . . . 0.0 110.179 -179.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -62.0 -179.25 0.22 Allowed Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.1 Cg_endo -67.69 88.88 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.277 1.318 . . . . 0.0 111.111 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.539 ' CA ' HG22 ' A' ' 55' ' ' ILE . . . 76.05 46.89 12.21 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 18.3 m-20 -59.1 -115.63 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.888 -1.36 . . . . 0.0 109.543 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 163.23 98.56 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.565 -1.334 . . . . 0.0 109.422 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.593 HG11 ' N ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -92.74 -176.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.111 -0.993 . . . . 0.0 109.742 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -141.79 -62.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.43 -0.794 . . . . 0.0 109.471 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -132.52 58.72 1.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -0.979 . . . . 0.0 108.986 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 14.8 m-20 151.51 76.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.611 ' CG ' ' HA3' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -71.94 -173.64 1.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.348 1.07 . . . . 0.0 111.773 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.525 ' CG1' ' OE2' ' A' ' 34' ' ' GLU . 14.0 p -45.2 168.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -147.96 61.37 1.12 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.537 ' CG1' HG22 ' A' ' 48' ' ' VAL . 2.7 p -39.46 166.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.728 0.775 . . . . 0.0 110.404 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 5.1 mm-40 -128.72 97.3 4.63 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.72 -165.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.473 -0.767 . . . . 0.0 109.254 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -139.68 141.03 37.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.937 -1.102 . . . . 0.0 110.097 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 41' ' ' THR . 97.5 m -146.4 21.28 1.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.44 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 18.8 t0 64.73 88.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 109.568 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 86.15 -26.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.434 ' O ' ' HB ' ' A' ' 41' ' ' THR . 55.3 t -116.22 142.21 30.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 39' ' ' ILE . 96.9 t -136.21 118.03 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.548 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 3.9 mt -82.77 162.47 21.7 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.307 -0.871 . . . . 0.0 108.969 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -119.54 175.44 5.84 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.039 -1.038 . . . . 0.0 110.176 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.593 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 4.8 t -140.54 68.69 31.6 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 109.182 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.51 110.13 2.15 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.633 2.222 . . . . 0.0 110.399 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.59 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -89.84 179.27 6.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.634 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -125.71 72.4 1.28 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.552 -1.343 . . . . 0.0 110.215 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.634 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 101.58 162.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.507 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.593 ' N ' HG11 ' A' ' 30' ' ' VAL . 11.9 m-20 64.78 -142.01 0.24 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.611 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 101.11 -7.41 56.89 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.077 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.539 HG22 ' CA ' ' A' ' 27' ' ' GLY . 6.1 mt -41.18 96.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -41.58 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.761 0.791 . . . . 0.0 109.416 -178.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ILE . 51.8 t0 -101.59 -52.24 3.26 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.699 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.93 105.42 3.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.895 -1.128 . . . . 0.0 110.531 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.59 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -102.02 90.03 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 mt -69.79 -5.01 22.54 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 110.083 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.525 ' CB ' ' HA ' ' A' ' 73' ' ' LEU . 3.6 mt-10 -124.51 40.96 3.62 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.156 -0.965 . . . . 0.0 108.922 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.6 m-20 -42.22 128.73 3.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.58 -0.7 . . . . 0.0 109.554 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.528 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -26.89 121.7 0.09 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.317 0.58 . . . . 0.0 110.972 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.86 -16.2 7.82 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 66' ' ' THR . 73.0 m -88.14 160.06 17.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -1.17 . . . . 0.0 109.58 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.496 HG21 ' N ' ' A' ' 67' ' ' VAL . 58.2 m -78.74 157.54 28.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 109.546 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.54 HG23 ' CG2' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.59 169.68 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.539 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 5.4 t -141.38 -152.05 0.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.362 -0.836 . . . . 0.0 109.123 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 12.8 p -93.38 58.68 2.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.051 -1.03 . . . . 0.0 109.624 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.7 mtp-105 160.3 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.542 -0.724 . . . . 0.0 109.755 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.51 ' CG ' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -46.87 133.92 10.54 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 11.5 tt -86.32 110.72 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.542 ' CD1' HG23 ' A' ' 48' ' ' VAL . 18.5 mt -50.17 -44.87 52.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.015 -1.053 . . . . 0.0 108.205 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.51 -175.36 34.16 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 2.6 ptt180 -118.46 143.75 46.48 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.248 -1.148 . . . . 0.0 109.804 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.562 HD12 ' CZ3' ' A' ' 22' ' ' TRP . 6.4 mt -114.8 -79.75 0.59 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.935 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -160.75 141.63 11.71 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.257 -0.902 . . . . 0.0 109.251 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.482 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 4.3 tt0 -164.42 74.98 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.127 -0.983 . . . . 0.0 109.565 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.36 -141.29 11.21 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.232 -1.158 . . . . 0.0 109.455 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.301 0.572 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.529 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 8.6 m -160.89 173.8 14.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.352 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 9.6 t -69.53 84.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.046 -1.034 . . . . 0.0 108.464 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 2.5 m-20 -74.61 83.42 2.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.584 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 3.5 tp -104.31 146.27 11.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.172 -177.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -134.85 -164.63 1.55 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.524 ' CG1' HD11 ' A' ' 46' ' ' LEU . 20.9 t -133.03 86.96 41.17 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.979 -1.076 . . . . 0.0 110.418 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 36.8 Cg_endo -81.44 54.56 5.2 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.578 2.185 . . . . 0.0 110.082 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -119.55 7.14 11.08 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.101 -0.999 . . . . 0.0 110.256 -179.167 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.557 ' HB3' ' CB ' ' A' ' 69' ' ' SER . 1.1 pp -41.38 115.0 1.3 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 109.77 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.81 -159.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.402 2.068 . . . . 0.0 110.381 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -89.0 36.19 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.525 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -153.81 149.95 27.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 14' ' ' VAL . 4.2 p -102.42 54.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.422 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.12 6.43 32.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.494 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 61.22 -163.25 0.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.179 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -170.09 -171.36 1.13 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.107 -0.995 . . . . 0.0 109.925 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 16.0 m -153.21 138.49 17.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 110.347 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.562 ' HA ' HG13 ' A' ' 39' ' ' ILE . 11.2 t -76.79 99.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 0.0 109.53 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -57.49 -54.9 41.58 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 110.606 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.566 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 21.7 m -168.87 131.03 1.26 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.605 -1.31 . . . . 0.0 111.815 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.575 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 18.5 m95 -68.65 -162.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.587 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 26.3 m80 -155.14 34.13 0.38 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.576 ' CD ' ' HB ' ' A' ' 35' ' ' VAL . 1.6 mmmt -124.59 128.4 48.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.85 -0.531 . . . . 0.0 110.317 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.6 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -79.91 -174.68 0.51 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.37 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.6 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.5 Cg_endo -68.25 84.14 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.069 1.179 . . . . 0.0 111.564 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.539 ' CA ' ' CG2' ' A' ' 55' ' ' ILE . . . 78.83 47.46 7.75 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 18.0 m-20 -55.34 -110.74 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.047 -1.266 . . . . 0.0 110.426 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 157.86 99.78 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.926 -1.109 . . . . 0.0 108.67 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.58 ' CG1' ' N ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -102.56 -177.35 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.831 -1.168 . . . . 0.0 109.718 -179.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.58 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 5.8 m -130.03 -113.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.146 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 4.9 mtt180 -87.11 63.6 7.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.827 -1.171 . . . . 0.0 109.175 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 4.1 m-20 150.66 101.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.579 ' CB ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -97.73 -174.05 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.247 1.023 . . . . 0.0 111.656 -178.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.576 ' HB ' ' CD ' ' A' ' 24' ' ' LYS . 3.7 p -44.23 157.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-O 121.978 0.894 . . . . 0.0 111.704 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -134.55 63.38 1.62 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 178.119 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.587 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 5.5 p -38.92 168.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.78 0.8 . . . . 0.0 110.178 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -123.19 139.61 53.87 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 1.9 tt -121.94 -163.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.978 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.568 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 21.8 mm-40 -141.36 117.41 10.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.853 -1.154 . . . . 0.0 109.964 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -115.13 -64.17 1.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.566 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 49.0 t0 177.98 82.53 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.2 tttt 86.84 -26.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 41' ' ' THR . 1.9 t -113.18 163.31 10.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.309 -0.87 . . . . 0.0 109.201 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 39' ' ' ILE . 43.9 t -131.75 122.85 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.524 HD11 ' CG1' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -79.66 158.91 26.9 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.317 -0.864 . . . . 0.0 108.734 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.5 pm0 -120.82 178.15 4.82 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.007 -1.058 . . . . 0.0 110.226 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.692 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -145.04 77.97 12.76 Favored Pre-proline 0 N--CA 1.489 1.518 0 CA-C-O 122.285 1.04 . . . . 0.0 108.778 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.0 Cg_endo -81.24 108.84 2.05 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.89 2.393 . . . . 0.0 111.966 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.562 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -78.02 -157.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.576 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.2 p -140.37 10.92 2.32 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.541 -1.349 . . . . 0.0 111.196 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 160.04 159.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER 78.91 -73.82 0.07 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.459 0.647 . . . . 0.0 110.272 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.536 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 45.3 16.88 0.1 Allowed Glycine 0 N--CA 1.489 2.194 0 O-C-N 121.212 -0.93 . . . . 0.0 111.655 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.551 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 2.2 mt -68.6 88.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.678 -1.483 . . . . 0.0 108.041 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.603 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -40.81 103.45 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -123.21 -52.01 1.86 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 111.018 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -136.15 82.61 1.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.512 -1.368 . . . . 0.0 111.155 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.603 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -79.9 103.2 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 29.4 mt -69.34 -11.82 61.14 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.093 -1.005 . . . . 0.0 109.533 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 9.5 mm-40 -132.42 56.09 1.85 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 61' ' ' GLU . 3.2 m-20 -40.74 136.18 1.46 Allowed 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.579 -0.7 . . . . 0.0 109.715 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.566 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -39.49 125.56 1.74 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.426 0.632 . . . . 0.0 110.822 -179.248 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.76 -4.64 19.07 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -97.75 153.07 18.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -1.134 . . . . 0.0 109.365 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.75 155.48 40.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.932 . . . . 0.0 109.446 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.528 HG21 ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.32 162.43 3.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.557 -0.715 . . . . 0.0 109.279 -179.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.528 ' N ' HG21 ' A' ' 67' ' ' VAL . 2.8 m -116.34 -133.24 0.33 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.48 -0.762 . . . . 0.0 109.328 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.557 ' CB ' ' HB3' ' A' ' 10' ' ' LEU . 7.3 p -69.59 -104.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.883 -1.136 . . . . 0.0 109.63 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.531 ' CG ' ' HA ' ' A' ' 8' ' ' PRO . 4.9 mtm180 -80.21 39.9 0.46 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.468 ' HB2' HG21 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -62.6 107.04 0.87 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.757 -1.214 . . . . 0.0 108.896 179.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.7 tt -43.28 110.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.574 ' HB3' ' CZ2' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -52.91 -36.9 60.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.415 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 154.32 165.58 14.02 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -107.48 137.2 45.95 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.241 -1.153 . . . . 0.0 109.781 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.61 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 5.5 mp -106.87 -94.11 0.38 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.552 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.551 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 4.2 tpt180 -150.63 157.77 43.37 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.472 ' HA ' ' OD2' ' A' ' 53' ' ' ASP . 32.4 tt0 -150.59 163.12 39.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.913 . . . . 0.0 109.573 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.445 ' O ' ' OXT' ' A' ' 80' ' ' ASN . . . -159.76 22.64 0.28 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.445 ' OXT' ' O ' ' A' ' 79' ' ' GLY . 4.2 m120 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.296 -1.12 . . . . 0.0 109.475 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.476 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 72.5 m -168.37 162.7 12.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.414 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 57.9 t -72.69 81.03 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.59 78.51 6.13 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.548 ' CG2' HG12 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -92.26 149.71 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.479 -0.763 . . . . 0.0 111.161 -177.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -132.8 -158.67 0.91 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.579 ' CG1' ' CD1' ' A' ' 46' ' ' LEU . 60.3 t -130.49 59.84 48.45 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 120.866 -1.146 . . . . 0.0 110.145 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HG3' ' CD1' ' A' ' 6' ' ' LEU . 37.9 Cg_endo -81.41 19.92 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.589 2.193 . . . . 0.0 110.531 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.554 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -80.68 9.43 6.19 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.891 -1.131 . . . . 0.0 110.579 -179.059 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.564 ' HB3' ' CB ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -39.69 100.59 0.22 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.298 -0.876 . . . . 0.0 109.949 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 9' ' ' ASP . 36.2 Cg_endo -78.51 -40.57 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.473 2.115 . . . . 0.0 109.947 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 13' ' ' SER . 1.5 tt0 -165.38 -94.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.411 -0.806 . . . . 0.0 109.014 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.522 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 83.8 p -87.91 130.81 34.8 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 109.164 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 13' ' ' SER . 71.1 t -159.61 83.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.958 . . . . 0.0 109.345 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' CB ' ' A' ' 16' ' ' ASP . . . -71.44 -3.19 19.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.902 . . . . 0.0 109.931 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER 164.5 -174.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.139 -0.976 . . . . 0.0 109.809 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -168.11 -171.25 1.49 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.856 . . . . 0.0 109.342 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.518 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 79.5 m -158.76 134.79 9.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 110.681 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 22.0 t -69.18 84.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.412 -0.805 . . . . 0.0 109.231 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -43.6 -63.16 0.89 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.092 -1.005 . . . . 0.0 110.245 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.579 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 87.3 m -164.19 124.19 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.648 -1.283 . . . . 0.0 111.658 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.546 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 19.1 m95 -68.44 -167.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.562 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 17.3 m80 -152.14 24.1 0.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.526 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 2.2 tppm? -118.45 128.18 54.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.793 -0.567 . . . . 0.0 109.941 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.546 ' CB ' ' OD1' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -78.94 178.61 2.18 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.4 Cg_endo -69.21 93.26 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.644 1.562 . . . . 0.0 111.466 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.533 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 78.28 43.13 13.62 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.546 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 12.5 m-20 -61.36 -120.24 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.002 -1.293 . . . . 0.0 109.651 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 159.58 79.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.73 -1.231 . . . . 0.0 108.843 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -79.73 -168.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.12 -0.987 . . . . 0.0 109.652 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.572 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -134.99 -99.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.31 -0.869 . . . . 0.0 109.845 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.469 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 16.3 ttt-85 -98.37 38.5 1.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.871 -1.143 . . . . 0.0 109.522 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.547 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 2.6 m-20 178.5 91.42 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.599 ' CB ' ' CB ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -83.37 -170.24 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.263 1.03 . . . . 0.0 112.102 -178.041 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 23' ' ' HIS . 3.1 p -55.97 164.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.453 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -142.08 62.07 1.44 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.562 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 3.3 p -38.95 165.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-O 121.682 0.753 . . . . 0.0 110.204 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 2.3 mt-10 -128.37 97.58 4.78 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.76 -164.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 O-C-N 121.397 -0.814 . . . . 0.0 108.976 -179.48 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.574 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 3.9 mm-40 -134.48 112.83 11.23 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.974 -1.079 . . . . 0.0 109.775 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.463 ' OG1' HD22 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -108.16 -145.58 0.39 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -0.87 . . . . 0.0 109.196 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 6.8 t70 -96.73 83.24 3.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.086 -1.009 . . . . 0.0 109.592 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.2 tmtt? 85.98 -22.23 0.19 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.223 0.535 . . . . 0.0 109.585 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.5 HG13 ' N ' ' A' ' 45' ' ' VAL . 95.2 t -113.61 164.74 9.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.307 -0.871 . . . . 0.0 109.612 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.5 ' N ' HG13 ' A' ' 44' ' ' VAL . 54.9 t -127.64 125.64 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.579 ' CD1' ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -79.62 155.34 28.14 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.297 -0.877 . . . . 0.0 108.823 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -112.17 172.65 6.78 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.043 -1.036 . . . . 0.0 110.594 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.575 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 8.6 t -142.2 70.35 22.62 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.27 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.24 113.45 2.67 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.72 2.28 . . . . 0.0 111.288 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.599 ' CB ' ' CB ' ' A' ' 34' ' ' GLU . . . -88.5 -164.52 1.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.675 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 10.0 p -141.09 60.06 1.52 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.548 -1.261 . . . . 0.0 110.623 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.675 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 105.43 160.99 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.412 0.625 . . . . 0.0 110.658 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 74.95 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.619 -0.676 . . . . 0.0 110.188 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' OE2' ' A' ' 34' ' ' GLU . . . 54.56 8.51 1.28 Allowed Glycine 0 N--CA 1.495 2.582 0 O-C-N 121.051 -1.03 . . . . 0.0 111.778 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.545 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -55.11 92.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 120.612 -1.522 . . . . 0.0 107.797 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.546 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 8.8 tp -44.7 112.88 0.47 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.468 -0.77 . . . . 0.0 109.527 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -118.84 -43.36 2.67 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.653 -0.654 . . . . 0.0 110.07 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.06 78.12 1.59 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.858 -1.151 . . . . 0.0 110.776 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.546 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 8.4 t -79.46 87.59 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.8 mt -69.55 -4.42 18.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 0.0 110.334 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.517 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 2.5 mt-10 -129.21 50.89 2.1 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.0 m-20 -42.58 127.43 3.84 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.696 -0.627 . . . . 0.0 109.489 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.579 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.12 121.05 0.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.449 0.642 . . . . 0.0 111.079 -179.199 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.89 -1.45 19.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 66' ' ' THR . 22.5 m -97.89 159.98 14.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -1.137 . . . . 0.0 109.347 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.447 ' N ' HG23 ' A' ' 65' ' ' THR . 0.2 OUTLIER -70.99 149.33 46.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.64 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.537 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.24 169.45 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.537 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -138.63 -176.39 4.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.365 -0.834 . . . . 0.0 109.052 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.564 ' CB ' ' HB3' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -83.69 69.52 10.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.231 -0.918 . . . . 0.0 109.329 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 69' ' ' SER . 10.3 ttm180 158.61 -22.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.6 mm-40 -57.62 159.17 5.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.876 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 15.8 tt -103.81 113.25 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.696 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.55 ' CD1' HG23 ' A' ' 48' ' ' VAL . 9.3 mt -49.86 -47.1 51.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 108.269 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.72 -166.36 34.37 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -127.86 141.6 51.51 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.322 -1.104 . . . . 0.0 109.681 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 2.8 mp -101.29 -104.19 0.25 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.295 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.545 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -154.66 158.91 40.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.873 -1.142 . . . . 0.0 109.984 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.463 ' O ' ' OG ' ' A' ' 1' ' ' SER . 5.1 tt0 179.35 71.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.418 ' O ' ' ND2' ' A' ' 80' ' ' ASN . . . -84.34 -49.67 4.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 79' ' ' GLY . 20.2 m120 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.453 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.275 0.56 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.481 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 15.4 m -159.91 -179.74 8.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.374 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 38.5 t -78.03 77.85 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.01 . . . . 0.0 108.52 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.71 85.88 0.92 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.605 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 3.5 tp -110.09 141.0 26.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 111.058 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -127.47 -145.54 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.52 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.535 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 69.1 t -132.94 58.82 38.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.957 -1.09 . . . . 0.0 109.315 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 34.5 Cg_endo -75.8 68.33 6.41 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.616 2.21 . . . . 0.0 111.108 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.535 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -123.17 -8.23 8.22 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.179 -0.951 . . . . 0.0 109.346 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.465 ' C ' ' O ' ' A' ' 9' ' ' ASP . 6.4 mt 35.8 84.49 0.18 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.741 -0.6 . . . . 0.0 110.421 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.524 ' CB ' HG22 ' A' ' 41' ' ' THR . 35.3 Cg_endo -77.84 164.14 28.01 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.578 2.186 . . . . 0.0 110.242 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.68 39.91 3.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.686 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.536 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -122.94 -10.91 8.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.935 . . . . 0.0 109.618 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 13' ' ' SER . 48.3 t -161.51 -97.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -0.816 . . . . 0.0 109.514 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 14' ' ' VAL . . . 163.31 41.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 109.413 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.3 p30 176.42 -168.03 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.356 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -170.46 -175.11 1.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.397 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.454 ' C ' HG13 ' A' ' 39' ' ' ILE . 18.4 m -160.23 125.9 4.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.398 -0.814 . . . . 0.0 109.519 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.6 t -52.54 141.62 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 109.071 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -117.7 -50.07 2.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.114 -0.991 . . . . 0.0 109.877 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.476 ' N ' ' HB3' ' A' ' 63' ' ' GLU . 52.6 m -164.56 114.12 1.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.885 -1.135 . . . . 0.0 111.128 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.579 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 18.2 m95 -68.56 -162.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.833 . . . . 0.0 108.756 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 20.8 m80 -160.08 26.14 0.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.566 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -114.63 114.5 25.76 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.595 -178.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.594 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 11.3 mmmt -59.55 173.34 0.52 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -66.92 96.5 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.516 1.477 . . . . 0.0 110.829 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.55 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 80.72 50.33 5.32 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 3.0 m-20 -55.72 -150.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.485 -1.009 . . . . 0.0 110.382 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HA ' HD13 ' A' ' 55' ' ' ILE . . . -175.39 96.61 0.07 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.541 -1.349 . . . . 0.0 108.57 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.613 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -110.58 -176.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.891 -179.004 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.444 ' N ' HG12 ' A' ' 30' ' ' VAL . 2.1 p -125.72 -49.6 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.598 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -157.13 61.49 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.367 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.598 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.5 m-20 146.0 100.6 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.613 ' HB3' ' CB ' ' A' ' 30' ' ' VAL . 1.9 pt-20 -131.39 -164.07 1.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.938 -1.101 . . . . 0.0 112.028 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 4.0 p -13.58 136.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.068 0.937 . . . . 0.0 113.309 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -130.55 62.86 1.58 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.585 ' CG1' ' CG1' ' A' ' 48' ' ' VAL . 4.2 p -37.56 166.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.891 0.853 . . . . 0.0 110.807 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 2.0 mt-10 -125.03 95.61 4.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.86 -160.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 121.419 -0.8 . . . . 0.0 109.18 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.577 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -136.62 151.55 49.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.872 -1.143 . . . . 0.0 109.973 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.524 HG22 ' CB ' ' A' ' 11' ' ' PRO . 98.4 m -156.41 31.8 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.593 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 10.8 t0 47.78 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 109.637 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 85.27 -27.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.845 -0.535 . . . . 0.0 109.741 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.464 ' O ' ' HB ' ' A' ' 41' ' ' THR . 1.8 t -120.85 152.43 24.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.154 -0.966 . . . . 0.0 109.538 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 24.1 t -149.38 97.57 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.384 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.581 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.67 164.65 23.59 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.211 -0.931 . . . . 0.0 109.153 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 48.0 mt-10 -112.37 -165.92 1.03 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.211 -0.93 . . . . 0.0 109.761 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.685 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -152.69 78.37 6.18 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 122.154 0.978 . . . . 0.0 109.187 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.66 110.08 2.35 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.838 2.359 . . . . 0.0 111.178 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.586 ' CB ' ' CG ' ' A' ' 34' ' ' GLU . . . -74.14 -162.67 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.583 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -148.48 33.9 0.79 Allowed 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.975 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 155.89 151.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.932 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 79' ' ' GLY . 0.6 OUTLIER 65.84 -93.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.52 -0.738 . . . . 0.0 110.541 179.071 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 74.18 -9.73 9.11 Favored Glycine 0 N--CA 1.486 2.001 0 O-C-N 120.674 -1.267 . . . . 0.0 110.466 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.588 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 1.1 mp -40.29 94.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.555 1.178 . . . . 0.0 108.541 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.615 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -50.47 92.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 55' ' ' ILE . 8.6 t70 -111.69 -44.78 3.44 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.815 -0.553 . . . . 0.0 110.776 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -138.72 98.26 3.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.554 -1.342 . . . . 0.0 111.14 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.615 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 1.7 t -109.74 88.96 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 mt -69.48 -4.03 17.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 110.592 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 10.0 mt-10 -127.16 44.32 2.94 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.113 -0.992 . . . . 0.0 108.564 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -46.07 136.34 6.8 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.465 -0.772 . . . . 0.0 109.32 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.523 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -31.9 107.2 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.418 0.628 . . . . 0.0 110.481 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.41 -7.78 3.41 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.439 ' O ' HG21 ' A' ' 18' ' ' THR . 0.1 OUTLIER -100.01 178.83 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -1.17 . . . . 0.0 109.748 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 m -99.97 151.24 21.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.85 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.558 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.89 171.18 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.359 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.558 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 1.4 m -134.29 -141.38 0.19 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 108.975 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 7' ' ' VAL . 2.2 p -69.35 -104.48 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.945 -1.097 . . . . 0.0 109.054 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 70' ' ' ARG . 28.0 ttp180 -79.2 37.86 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.066 . . . . 0.0 110.755 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 68' ' ' THR . 12.6 mm100 -63.92 -112.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.76 -1.212 . . . . 0.0 108.582 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 12.4 tt -179.0 116.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.836 -1.165 . . . . 0.0 110.392 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.548 ' CD1' HG13 ' A' ' 37' ' ' VAL . 9.7 mt -72.96 -49.94 26.31 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.13 -0.981 . . . . 0.0 108.4 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 59' ' ' VAL . . . 161.57 169.73 25.27 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -110.73 138.57 46.95 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.13 -1.218 . . . . 0.0 110.089 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.624 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 5.0 mp -106.47 -88.63 0.45 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.588 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.5 ttt180 -158.33 161.18 37.61 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.568 -0.708 . . . . 0.0 109.453 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ASP . 56.3 tt0 -166.07 46.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.518 ' N ' ' OD2' ' A' ' 53' ' ' ASP . . . -66.47 -60.8 5.9 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 79' ' ' GLY . 2.2 t-20 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.25 -1.147 . . . . 0.0 109.52 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 77' ' ' ARG . 46.3 m . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.534 ' CA ' ' HB3' ' A' ' 78' ' ' GLU . 66.3 m -170.1 155.2 5.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.251 -0.906 . . . . 0.0 109.366 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.545 ' HB ' ' CG ' ' A' ' 76' ' ' LEU . 4.7 t -77.96 77.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -83.6 84.11 7.66 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.562 HG12 ' CG1' ' A' ' 48' ' ' VAL . 6.5 tp -89.48 158.04 2.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.375 -0.828 . . . . 0.0 111.583 -177.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -137.44 -151.56 0.4 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.571 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 33.2 t -138.21 57.25 12.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.7 -1.25 . . . . 0.0 110.085 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -79.94 47.56 2.57 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.617 2.211 . . . . 0.0 110.843 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.537 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 3.0 m-20 -119.87 -1.04 10.54 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.945 -1.097 . . . . 0.0 109.616 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 69' ' ' SER . 5.6 mp -86.22 133.54 40.5 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.876 . . . . 0.0 109.552 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 12' ' ' GLU . 36.1 Cg_endo -78.88 -53.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.556 2.171 . . . . 0.0 110.177 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -49.91 177.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 109.398 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.0 m -88.7 -11.28 45.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.125 -0.985 . . . . 0.0 109.368 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.514 ' CG1' ' O ' ' A' ' 14' ' ' VAL . 9.8 p -170.02 54.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.828 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 16' ' ' ASP . . . -65.1 -11.03 35.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.174 -0.954 . . . . 0.0 109.257 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 15' ' ' ALA . 3.8 m-20 55.64 163.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.776 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -166.39 179.73 5.43 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 40' ' ' GLU . 1.1 m -134.74 129.06 34.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.17 -0.956 . . . . 0.0 110.233 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.533 HG21 ' CG1' ' A' ' 67' ' ' VAL . 7.0 t -75.61 103.93 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.378 -0.827 . . . . 0.0 109.188 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -65.02 -62.15 1.73 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.747 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.584 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 52.9 m -168.65 132.29 1.47 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.276 -1.37 . . . . 0.0 112.289 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.582 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 18.4 m95 -68.99 -168.77 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.8 m80 -150.91 30.98 0.63 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -122.38 123.78 42.14 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.706 -0.621 . . . . 0.0 110.389 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.567 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -74.57 -178.87 0.88 Allowed Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -68.18 90.55 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.282 1.321 . . . . 0.0 111.001 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.548 ' CA ' HG22 ' A' ' 55' ' ' ILE . . . 76.47 46.23 12.47 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.542 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 14.1 m-20 -59.7 -118.07 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.933 -1.333 . . . . 0.0 109.794 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 162.91 100.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.583 -1.323 . . . . 0.0 109.493 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -100.99 -175.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.185 -0.947 . . . . 0.0 109.987 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.489 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -141.15 -73.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 109.608 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -119.81 61.55 0.84 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.055 -1.028 . . . . 0.0 109.426 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.7 m-20 145.32 84.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.578 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -76.1 -168.78 0.99 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.001 0.905 . . . . 0.0 111.533 -178.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.536 ' CG1' ' OE2' ' A' ' 34' ' ' GLU . 7.5 p -49.54 166.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.572 0.701 . . . . 0.0 110.836 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.516 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.85 59.05 1.31 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.593 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 2.7 p -39.18 166.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.63 0.728 . . . . 0.0 110.296 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -127.52 142.7 51.32 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.571 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -127.56 -166.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -143.9 88.48 1.98 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.86 -1.15 . . . . 0.0 110.056 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.525 HG22 ' CD2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -84.44 -146.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.393 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 20.6 t0 -97.72 85.94 3.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.3 tttm 86.28 -25.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.273 0.558 . . . . 0.0 109.526 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.17 135.43 52.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.173 -0.955 . . . . 0.0 109.719 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 41.2 t -118.77 105.31 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 109.408 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.99 179.86 7.37 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.272 -0.892 . . . . 0.0 109.349 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 22.9 mt-10 -134.82 -148.9 0.33 Allowed 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.958 -1.089 . . . . 0.0 110.566 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.577 ' CG2' HG13 ' A' ' 37' ' ' VAL . 11.9 t -154.89 69.74 5.73 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.327 -0.858 . . . . 0.0 109.29 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.79 104.5 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.592 2.195 . . . . 0.0 111.023 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.578 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -83.27 -178.53 7.11 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.563 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 2.6 p -121.93 24.47 9.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.093 -1.629 . . . . 0.0 111.338 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 159.71 160.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.213 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.602 ' O ' ' CG1' ' A' ' 30' ' ' VAL . 2.5 t0 61.43 -139.39 0.51 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.04 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.559 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 115.29 -8.26 20.64 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.548 HG22 ' CA ' ' A' ' 27' ' ' GLY . 10.7 mt -42.39 98.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.542 HD13 ' CD2' ' A' ' 76' ' ' LEU . 9.6 tp -48.82 90.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.595 0.712 . . . . 0.0 109.648 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.8 t0 -82.18 -58.11 3.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.946 -0.471 . . . . 0.0 110.001 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -149.88 95.68 2.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.768 -1.207 . . . . 0.0 111.091 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.74 101.89 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.9 mt -69.15 -27.12 65.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 110.29 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 41.2 mm-40 -121.86 59.93 0.98 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -37.92 140.91 0.23 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.486 0.66 . . . . 0.0 109.691 -179.07 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.584 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -39.99 139.35 0.69 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.57 -0.706 . . . . 0.0 110.644 -179.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.26 -12.34 33.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.72 174.48 9.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.241 . . . . 0.0 109.633 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.6 m -93.36 154.44 17.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.551 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.77 168.96 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.585 ' CG2' ' CG ' ' A' ' 71' ' ' GLN . 15.0 t -133.39 -136.07 0.17 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.53 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 9.6 m -68.96 -119.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.592 -1.317 . . . . 0.0 108.015 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.467 ' HB2' ' HB3' ' A' ' 8' ' ' PRO . 8.0 ttm105 -72.89 80.68 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.678 -1.263 . . . . 0.0 109.786 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.585 ' CG ' ' CG2' ' A' ' 68' ' ' THR . 0.5 OUTLIER -98.43 -101.82 0.21 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.054 -1.028 . . . . 0.0 108.397 179.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 19.1 tt 177.72 112.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 110.264 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.553 ' CD2' HG13 ' A' ' 37' ' ' VAL . 10.5 tp -79.7 -39.42 31.29 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.821 -1.174 . . . . 0.0 108.206 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.69 158.61 8.97 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.211 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -101.03 148.57 24.89 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.373 -1.075 . . . . 0.0 109.559 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.545 ' CG ' ' HB ' ' A' ' 3' ' ' VAL . 5.5 mt -113.89 -132.43 0.33 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.732 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.532 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -109.52 -51.2 2.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.804 -1.185 . . . . 0.0 110.402 -179.333 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.559 ' HA ' ' CB ' ' A' ' 53' ' ' ASP . 13.7 tt0 54.26 170.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.951 -1.093 . . . . 0.0 109.428 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' OD2' ' A' ' 53' ' ' ASP . . . 51.7 -134.85 34.55 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.5 m120 . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.233 -1.157 . . . . 0.0 109.442 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.46 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 0.8 OUTLIER -153.45 -179.57 7.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 109.447 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.615 ' CG1' ' CD1' ' A' ' 5' ' ' ILE . 6.4 t -83.82 89.07 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.32 95.82 0.21 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.615 ' CD1' ' CG1' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -103.76 129.76 55.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 109.949 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.586 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -153.39 -163.16 1.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.51 ' O ' ' O ' ' A' ' 69' ' ' SER . 11.4 t -121.01 78.23 32.26 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.874 -1.142 . . . . 0.0 108.982 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD3' HD11 ' A' ' 6' ' ' LEU . 36.7 Cg_endo -80.4 53.52 4.8 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.803 2.335 . . . . 0.0 110.815 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.502 ' CB ' HD12 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -122.21 -5.72 8.88 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.076 -1.015 . . . . 0.0 109.717 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER 38.89 84.82 0.17 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.578 -0.701 . . . . 0.0 110.131 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.569 ' CB ' ' CG2' ' A' ' 41' ' ' THR . 35.8 Cg_endo -78.44 141.84 18.18 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.567 2.178 . . . . 0.0 110.274 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -133.96 168.57 18.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 109.661 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 23.9 t 65.77 8.73 5.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.389 -0.819 . . . . 0.0 109.668 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 1.3 p -126.95 -97.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.296 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 14' ' ' VAL . . . 165.24 -24.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.775 -1.203 . . . . 0.0 109.911 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 15' ' ' ALA . 16.8 p30 174.37 -163.55 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 109.238 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.525 ' CB ' ' OG1' ' A' ' 41' ' ' THR . . . -149.63 -167.1 2.73 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.145 -0.972 . . . . 0.0 109.016 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 40' ' ' GLU . 93.3 m -156.63 148.81 23.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.125 -0.984 . . . . 0.0 109.643 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.551 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.3 t -78.73 147.24 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 108.636 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -118.83 -55.14 2.21 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.772 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 1.3 m -167.45 123.03 1.07 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.246 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.588 ' CE2' HD21 ' A' ' 73' ' ' LEU . 18.2 m95 -68.25 -167.41 0.08 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 16.3 m80 -152.31 24.18 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.558 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.5 tppt? -118.52 132.04 56.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.77 -0.581 . . . . 0.0 109.728 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.567 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -79.62 177.31 3.0 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.9 Cg_endo -70.26 101.63 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.731 1.62 . . . . 0.0 111.615 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.537 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 82.37 37.66 14.25 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.54 ' CB ' ' CD ' ' A' ' 24' ' ' LYS . 1.2 m-20 -59.3 -165.38 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.878 -1.366 . . . . 0.0 110.103 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -165.11 78.17 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 108.979 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.562 HG13 ' CB ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -79.54 -173.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.554 -179.011 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.527 ' N ' HG12 ' A' ' 30' ' ' VAL . 0.6 OUTLIER -125.41 -97.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 109.836 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 47.6 mtp180 -103.28 45.14 0.97 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.644 -1.285 . . . . 0.0 109.345 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.526 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 6.3 m-20 171.87 94.86 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.562 ' CB ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -93.1 -166.56 1.55 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.922 -1.112 . . . . 0.0 111.542 -178.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.558 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 2.5 p -52.74 164.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 122.058 0.932 . . . . 0.0 111.393 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.554 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.61 65.97 1.39 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.379 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 36' ' ' LEU . 4.1 p -38.0 164.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.582 0.706 . . . . 0.0 110.354 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.88 101.49 7.47 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -85.63 -159.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.58 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -154.59 99.03 2.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.609 -1.307 . . . . 0.0 110.265 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.569 ' CG2' ' CB ' ' A' ' 11' ' ' PRO . 10.0 m -116.64 90.11 3.26 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' THR . 11.2 t0 71.7 -143.33 0.05 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.372 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -17.27 57.52 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.51 HG11 ' N ' ' A' ' 45' ' ' VAL . 38.8 t -87.99 150.23 3.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.521 -0.737 . . . . 0.0 109.886 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.51 ' N ' HG11 ' A' ' 44' ' ' VAL . 7.2 p -130.39 105.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.502 HD12 ' CB ' ' A' ' 9' ' ' ASP . 1.3 mt -85.94 159.22 19.71 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.231 -0.918 . . . . 0.0 109.021 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 5.1 pt-20 -127.29 -164.75 1.39 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.053 -1.029 . . . . 0.0 110.314 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 14.6 p -146.49 88.05 6.27 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.339 -0.851 . . . . 0.0 110.025 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.44 104.79 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.566 2.177 . . . . 0.0 111.181 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.552 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -74.86 -165.71 0.4 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.591 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 19.2 m -141.46 24.81 2.07 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.325 -1.485 . . . . 0.0 110.648 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.591 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 156.12 165.63 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.27 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.517 ' OD2' ' N ' ' A' ' 78' ' ' GLU . 0.5 OUTLIER 66.75 -88.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.615 -0.678 . . . . 0.0 109.585 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 63.32 -8.63 0.26 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.013 -1.055 . . . . 0.0 111.808 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.537 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.84 96.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.849 -1.383 . . . . 0.0 107.994 179.435 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 8.8 tp -51.66 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.469 -0.769 . . . . 0.0 109.376 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' ILE . 10.9 t0 -108.11 -35.52 6.56 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.583 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 75' ' ' ARG . . . -142.11 85.97 1.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.494 -1.379 . . . . 0.0 111.736 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.568 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 2.5 t -101.14 77.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.0 mt -69.66 -2.81 12.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 110.946 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.526 ' O ' ' CD1' ' A' ' 73' ' ' LEU . 18.9 mt-10 -136.16 51.49 2.02 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.882 -1.136 . . . . 0.0 109.283 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.488 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.6 m-20 -50.23 151.19 2.16 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.274 -0.891 . . . . 0.0 109.751 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.551 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -32.92 141.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.411 0.624 . . . . 0.0 110.818 -179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.58 -18.65 32.18 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.472 ' O ' HG21 ' A' ' 18' ' ' THR . 0.9 OUTLIER -83.57 -179.72 7.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -1.194 . . . . 0.0 109.874 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -113.3 153.82 27.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 109.715 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.537 HG13 ' CD1' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -151.25 169.72 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.583 ' CG2' ' CG ' ' A' ' 71' ' ' GLN . 7.8 t -127.6 -124.6 0.23 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 7' ' ' VAL . 6.0 p -69.63 -114.95 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.337 -1.477 . . . . 0.0 108.967 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HG3' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -83.28 52.98 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.903 -1.123 . . . . 0.0 110.8 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.583 ' CG ' ' CG2' ' A' ' 68' ' ' THR . 1.3 mm-40 -65.25 -111.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.75 -1.219 . . . . 0.0 108.293 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.548 ' CG2' ' O ' ' A' ' 72' ' ' ILE . 16.2 tt 178.33 116.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.83 -1.168 . . . . 0.0 110.474 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.588 HD21 ' CE2' ' A' ' 22' ' ' TRP . 14.0 tp -77.38 -17.36 58.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.941 -1.099 . . . . 0.0 108.456 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.33 162.43 9.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.465 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -111.61 149.11 31.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -1.141 . . . . 0.0 109.495 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.539 ' CD2' HD13 ' A' ' 56' ' ' LEU . 8.2 mt -117.52 -78.31 0.58 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.444 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -163.28 157.25 19.99 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.305 -0.872 . . . . 0.0 109.268 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.517 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 4.1 tp10 179.29 111.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.33 -61.36 0.05 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.184 -1.186 . . . . 0.0 109.484 179.986 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.292 0.567 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.54 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 68.1 m -154.51 173.5 16.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 70.1 t -76.99 77.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 109.207 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.6 84.83 1.57 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.609 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 2.1 tp -106.57 151.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.347 -0.846 . . . . 0.0 110.985 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -134.09 -166.06 1.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.54 ' CG2' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -126.04 72.81 70.83 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.144 -0.973 . . . . 0.0 109.625 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 36.9 Cg_endo -80.99 27.33 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.719 2.279 . . . . 0.0 110.955 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 17.6 m-20 -113.64 72.22 0.77 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 120.899 -1.126 . . . . 0.0 109.856 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 69' ' ' SER . 92.3 mt -154.29 62.04 3.55 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.943 . . . . 0.0 109.822 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 10' ' ' LEU . 36.0 Cg_endo -78.59 -159.27 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.572 2.181 . . . . 0.0 110.476 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.01 -163.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.557 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.3 m -85.49 47.18 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 25.4 t -144.05 75.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.213 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.4 47.91 1.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.764 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.44 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -158.8 144.39 16.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.937 . . . . 0.0 109.765 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -149.27 -157.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.455 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.471 ' O ' HG13 ' A' ' 39' ' ' ILE . 17.7 m -155.15 126.14 7.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.178 -0.951 . . . . 0.0 110.457 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.506 ' HA ' HG13 ' A' ' 39' ' ' ILE . 3.3 t -67.33 93.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.338 -0.851 . . . . 0.0 108.999 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -58.02 -59.35 5.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.151 -0.968 . . . . 0.0 110.763 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.615 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 34.8 m -166.68 125.71 1.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.574 -1.329 . . . . 0.0 111.982 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.546 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 24.0 m95 -67.76 -165.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.56 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 21.9 m80 -154.67 51.61 0.63 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.56 ' CG ' ' HB ' ' A' ' 35' ' ' VAL . 2.2 mmpt? -134.26 175.19 9.73 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.024 0.916 . . . . 0.0 110.995 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.623 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 2.1 mmmt -127.62 -174.86 0.39 Allowed Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.623 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.76 106.4 1.47 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.14 1.227 . . . . 0.0 111.242 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.491 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 65.21 45.84 89.81 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.548 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 1.4 m-20 -54.13 -167.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.885 -1.362 . . . . 0.0 110.198 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.89 80.81 0.42 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.401 -0.812 . . . . 0.0 108.927 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.553 HG13 ' CG ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.06 -173.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.506 -0.746 . . . . 0.0 110.596 -178.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.554 ' O ' ' CA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -132.65 -96.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.641 -0.662 . . . . 0.0 110.014 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.475 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 3.2 mtt180 -99.8 36.03 1.89 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.686 -1.259 . . . . 0.0 109.472 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.507 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 18.8 m-20 -179.57 81.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.591 -0.693 . . . . 0.0 109.162 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.594 ' CB ' ' CB ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -69.5 -160.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.998 -1.064 . . . . 0.0 111.621 -178.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.56 ' HB ' ' CG ' ' A' ' 24' ' ' LYS . 7.2 p -62.95 163.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.613 0.721 . . . . 0.0 110.542 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.47 59.76 1.63 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 178.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.56 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.4 p -38.48 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.54 0.686 . . . . 0.0 109.913 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -124.02 140.76 52.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.534 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.06 -177.05 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.375 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.534 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 5.7 mm-40 -138.71 115.77 10.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.92 . . . . 0.0 109.374 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.529 ' HB ' ' CD2' ' A' ' 10' ' ' LEU . 2.8 t -110.03 -27.97 8.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 0.0 110.002 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 7.3 t0 161.28 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.597 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.9 tttp 85.85 -24.92 0.12 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.01 136.81 35.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 0.0 109.227 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 39' ' ' ILE . 46.5 t -116.67 109.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.918 . . . . 0.0 109.739 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 9' ' ' ASP . 4.2 mm? -79.78 -168.57 1.64 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.15 -0.969 . . . . 0.0 108.719 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.3 pt-20 -144.36 -166.81 2.47 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.075 -1.016 . . . . 0.0 110.717 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.687 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -155.95 82.91 3.55 Favored Pre-proline 0 N--CA 1.489 1.484 0 CA-C-O 122.076 0.941 . . . . 0.0 109.583 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.2 Cg_endo -81.81 117.88 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.77 2.313 . . . . 0.0 111.749 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.594 ' CB ' ' CB ' ' A' ' 34' ' ' GLU . . . -89.41 178.84 6.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.613 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 18.3 p -122.72 72.85 1.1 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 120.532 -1.355 . . . . 0.0 110.436 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.613 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 93.23 169.37 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.118 0.485 . . . . 0.0 110.132 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 13.2 m-20 69.74 -101.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 55' ' ' ILE . . . 68.6 -16.56 0.54 Allowed Glycine 0 N--CA 1.496 2.638 0 O-C-N 120.433 -1.417 . . . . 0.0 111.902 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.539 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -36.03 99.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.104 1.452 . . . . 0.0 109.438 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 1.4 mm? -48.61 104.82 0.07 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.634 0.73 . . . . 0.0 109.936 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -108.16 -48.03 3.44 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.19 86.45 1.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.775 -1.203 . . . . 0.0 111.404 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 1.6 t -79.81 87.66 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 177.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.46 -3.92 16.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.934 . . . . 0.0 110.414 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 3.1 mt-10 -132.58 51.77 2.13 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.9 m-20 -40.58 131.11 2.34 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.744 0.783 . . . . 0.0 109.749 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.615 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -36.12 123.39 0.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.481 0.658 . . . . 0.0 111.079 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.13 -11.07 8.21 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.38 162.7 15.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -1.13 . . . . 0.0 109.501 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.2 m -72.2 162.49 29.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 109.603 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.19 173.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.473 -0.767 . . . . 0.0 109.097 -178.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.572 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 5.7 t -145.66 -162.29 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.357 -0.839 . . . . 0.0 109.098 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.531 ' CB ' ' HB2' ' A' ' 10' ' ' LEU . 2.7 p -85.58 37.41 0.69 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.035 -1.041 . . . . 0.0 109.816 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER 168.63 34.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.598 -0.689 . . . . 0.0 109.212 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.517 ' HG3' ' N ' ' A' ' 68' ' ' THR . 3.1 mm-40 -97.61 103.04 14.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.921 -1.112 . . . . 0.0 109.287 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 9.1 tt -56.72 109.22 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.848 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.54 HD13 ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -51.37 -42.72 61.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.72 -155.45 26.56 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 10.8 ptt85 -138.21 137.37 37.5 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.098 -1.237 . . . . 0.0 109.945 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 5.8 mp -106.16 -95.93 0.35 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.455 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.54 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 2.7 tpm_? -149.83 144.17 25.81 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.443 -0.786 . . . . 0.0 109.243 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.527 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 36.8 tt0 -157.88 145.81 18.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 109.515 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 80' ' ' ASN . . . 109.86 123.05 4.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' ' 79' ' ' GLY . 6.8 t-20 . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.247 -1.149 . . . . 0.0 109.537 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.446 ' C ' ' HB3' ' A' ' 78' ' ' GLU . 2.5 m . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -170.81 177.38 3.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.602 HG11 ' CD1' ' A' ' 5' ' ' ILE . 2.4 t -69.67 87.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.039 -1.038 . . . . 0.0 108.807 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' C ' HD11 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -73.08 103.71 3.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.602 ' CD1' HG11 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -104.25 140.1 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.089 -1.007 . . . . 0.0 110.59 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -149.54 -162.19 1.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.59 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 60.1 t -133.63 56.61 21.09 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.957 -1.09 . . . . 0.0 110.373 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.4 Cg_endo -81.16 34.37 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.507 2.138 . . . . 0.0 110.83 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.521 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 16.8 m-20 -99.21 9.33 43.63 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 120.711 -1.243 . . . . 0.0 110.256 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.593 ' CD2' ' CG2' ' A' ' 41' ' ' THR . 1.0 OUTLIER -130.55 108.6 15.92 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.986 -1.071 . . . . 0.0 109.606 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 12' ' ' GLU . 35.4 Cg_endo -77.8 -85.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.41 2.073 . . . . 0.0 110.471 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 11' ' ' PRO . 6.2 mt-10 -44.56 160.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.49 131.42 36.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.905 . . . . 0.0 109.486 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 46.4 t -124.34 -97.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.564 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -141.02 -68.59 0.4 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.523 ' OD1' ' CG2' ' A' ' 68' ' ' THR . 0.5 OUTLIER 164.15 -178.14 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.711 -0.618 . . . . 0.0 109.53 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.51 ' HB3' ' CA ' ' A' ' 41' ' ' THR . . . -140.92 -167.09 2.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.283 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.468 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 45.2 m -160.13 121.99 3.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.229 -0.92 . . . . 0.0 110.137 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.533 ' CG1' ' OE1' ' A' ' 63' ' ' GLU . 2.1 t -50.59 147.47 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.536 ' N ' ' OE1' ' A' ' 63' ' ' GLU . . . -126.25 -48.11 1.59 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.945 -1.097 . . . . 0.0 110.749 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.536 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 45.4 m -159.87 109.03 1.79 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.558 -1.339 . . . . 0.0 112.08 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 22.3 m95 -67.5 -163.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 33.3 m80 -159.35 42.52 0.23 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.565 ' HB2' ' CD2' ' A' ' 56' ' ' LEU . 3.1 mmmt -132.19 124.08 28.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.594 -0.691 . . . . 0.0 110.707 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.565 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -70.56 -178.17 0.51 Allowed Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.9 Cg_endo -66.82 93.23 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.107 1.205 . . . . 0.0 111.143 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.539 ' CA ' HG22 ' A' ' 55' ' ' ILE . . . 68.53 47.85 54.36 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 17.4 m-20 -56.96 -112.61 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.056 -1.261 . . . . 0.0 110.039 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 161.96 99.66 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.758 -1.214 . . . . 0.0 109.151 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -100.58 175.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.084 -1.01 . . . . 0.0 110.359 -179.411 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -134.07 -70.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.434 -0.791 . . . . 0.0 110.048 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.583 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -127.45 64.8 1.33 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.814 -1.179 . . . . 0.0 109.681 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 15.5 m-20 144.94 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.59 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -93.01 -176.7 4.26 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.426 1.108 . . . . 0.0 112.196 -177.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.541 ' HB ' ' CG ' ' A' ' 24' ' ' LYS . 7.4 p -39.35 159.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.136 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -139.91 62.47 1.51 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.537 ' CG1' HG13 ' A' ' 48' ' ' VAL . 5.2 p -37.96 163.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.687 0.756 . . . . 0.0 110.139 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 2.1 mm-40 -122.57 100.06 6.73 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.216 -0.928 . . . . 0.0 108.857 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -84.82 -165.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.561 -0.712 . . . . 0.0 109.358 -179.295 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.567 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 16.5 mm-40 -150.83 88.31 1.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.016 . . . . 0.0 110.074 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.593 ' CG2' ' CD2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -83.2 -179.92 7.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.296 -0.878 . . . . 0.0 109.31 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.588 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.6 t0 -80.12 99.96 8.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 4.7 ttpm? 84.98 -21.52 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.807 -0.558 . . . . 0.0 109.628 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.524 HG11 ' CD2' ' A' ' 46' ' ' LEU . 97.8 t -118.23 146.27 23.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.204 -0.935 . . . . 0.0 109.954 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.499 ' N ' HG11 ' A' ' 44' ' ' VAL . 53.3 t -134.45 100.96 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.865 . . . . 0.0 109.09 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.524 ' CD2' HG11 ' A' ' 44' ' ' VAL . 3.4 mm? -94.97 -169.43 2.0 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.214 -0.929 . . . . 0.0 110.058 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.516 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 2.3 pt-20 -147.66 -156.07 0.68 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.557 -0.714 . . . . 0.0 109.278 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.578 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 7.8 p -157.62 79.9 3.34 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.868 -1.145 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.516 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.3 Cg_endo -80.31 104.09 1.6 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.416 2.077 . . . . 0.0 110.337 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.59 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -73.81 -175.1 1.99 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.4 p -130.83 23.37 4.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.455 -1.403 . . . . 0.0 110.218 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 159.55 161.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.557 -0.714 . . . . 0.0 109.203 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.565 ' O ' ' CG1' ' A' ' 30' ' ' VAL . 7.2 m-20 67.25 -137.76 0.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.497 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 101.88 -7.84 55.53 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.33 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.567 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 4.5 mt -47.63 96.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.025 -1.279 . . . . 0.0 107.673 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.592 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -42.48 100.36 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.687 0.756 . . . . 0.0 109.574 -178.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 55' ' ' ILE . 6.9 t0 -104.13 -53.33 2.76 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.966 -0.459 . . . . 0.0 109.871 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.99 103.66 3.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.682 -1.261 . . . . 0.0 110.979 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.592 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.46 88.12 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.305 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.519 ' CD2' ' HA2' ' A' ' 74' ' ' GLY . 0.4 OUTLIER -69.2 -7.1 33.41 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.127 -0.983 . . . . 0.0 110.172 -178.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.526 ' CB ' ' HA ' ' A' ' 73' ' ' LEU . 1.3 mm-40 -119.24 37.85 4.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.133 -0.979 . . . . 0.0 108.381 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.2 m-20 -40.25 135.23 1.47 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.678 -0.639 . . . . 0.0 110.106 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.596 ' OE2' ' CD1' ' A' ' 22' ' ' TRP . 67.1 mm-40 -22.93 141.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.54 0.686 . . . . 0.0 111.783 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.1 -11.27 67.63 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 62' ' ' ASP . 1.3 m -84.47 156.18 21.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -1.154 . . . . 0.0 109.583 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 m -77.73 158.28 29.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.913 . . . . 0.0 109.525 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.559 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.7 171.39 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -139.66 -145.91 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.004 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 3.3 m -99.48 52.16 0.94 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.103 -0.998 . . . . 0.0 109.467 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER 161.01 -19.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.419 -0.801 . . . . 0.0 110.031 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 2.2 mm-40 -48.44 125.87 10.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.328 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.3 tt -80.18 111.8 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.573 ' CG ' HG23 ' A' ' 5' ' ' ILE . 30.4 mt -47.02 -37.53 9.4 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.519 ' HA2' ' CD2' ' A' ' 60' ' ' LEU . . . 157.01 -158.53 28.92 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.426 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -137.69 145.16 42.26 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.203 -1.175 . . . . 0.0 110.0 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.523 ' O ' ' CB ' ' A' ' 2' ' ' SER . 2.1 mt -106.48 -128.4 0.26 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.567 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -123.32 177.8 5.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.645 -1.284 . . . . 0.0 109.817 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 53' ' ' ASP . 30.6 tt0 -169.67 133.75 1.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.353 -0.842 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 80' ' ' ASN . . . -92.95 -151.6 28.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 18.9 t30 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.26 -1.141 . . . . 0.0 109.475 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.422 ' C ' ' CB ' ' A' ' 78' ' ' GLU . 4.1 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.248 0.547 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.514 ' N ' ' HB2' ' A' ' 78' ' ' GLU . 0.5 OUTLIER -169.19 170.25 8.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.881 . . . . 0.0 109.43 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.592 ' CG1' ' CG2' ' A' ' 5' ' ' ILE . 28.9 t -81.5 73.44 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.036 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -83.2 68.12 9.47 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.56 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.592 ' CG2' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -80.96 165.34 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.755 0.788 . . . . 0.0 112.579 -177.309 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -139.61 -164.48 1.69 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 39' ' ' ILE . 45.4 t -136.55 66.88 58.6 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.948 . . . . 0.0 109.935 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HD3' HD11 ' A' ' 6' ' ' LEU . 36.5 Cg_endo -80.38 38.84 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.715 2.276 . . . . 0.0 110.655 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.546 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -124.14 81.71 1.95 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.988 -1.07 . . . . 0.0 110.289 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.51 HD13 ' N ' ' A' ' 69' ' ' SER . 20.7 mt -122.45 146.84 48.45 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 109.532 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HG2' ' HB ' ' A' ' 14' ' ' VAL . 36.0 Cg_endo -78.64 -158.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.684 2.256 . . . . 0.0 110.432 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -112.05 -6.17 14.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 109.814 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 1.3 m -115.44 15.78 16.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.24 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 13' ' ' SER . 24.1 t -164.83 89.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.29 45.13 1.0 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 0.0 109.913 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.85 145.03 12.07 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.264 -0.897 . . . . 0.0 108.98 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -135.9 -166.07 1.81 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.721 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' HG13 ' A' ' 39' ' ' ILE . 90.0 m -151.61 131.24 13.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.307 -0.87 . . . . 0.0 110.525 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.539 ' CG1' HD12 ' A' ' 73' ' ' LEU . 2.1 t -70.15 85.35 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 109.089 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -47.33 -63.79 0.95 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.934 -1.104 . . . . 0.0 110.404 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.61 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 36.3 m -165.83 127.13 1.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.539 -1.351 . . . . 0.0 111.9 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.576 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 15.1 m95 -67.4 -163.08 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 22.5 m80 -156.21 30.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.548 ' HG2' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -116.83 159.1 22.87 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.7 0.762 . . . . 0.0 110.264 -179.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.567 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -106.14 -176.98 0.45 Allowed Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.0 Cg_endo -68.6 111.04 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.179 1.252 . . . . 0.0 110.768 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.491 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 57.65 43.51 94.33 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 8.6 m-20 -57.9 -164.27 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.831 -1.393 . . . . 0.0 110.209 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.16 87.52 0.5 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.606 HG11 ' N ' ' A' ' 53' ' ' ASP . 0.6 OUTLIER -78.91 -177.27 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -0.826 . . . . 0.0 110.654 -178.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -123.28 -80.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.47 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 11.8 mtt180 -123.77 40.3 3.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.108 -0.995 . . . . 0.0 108.681 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.516 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 10.9 m-20 178.05 83.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.585 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -81.5 -170.58 2.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 111.375 -178.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 7.6 p -48.98 161.53 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 121.87 0.843 . . . . 0.0 111.431 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -141.2 62.21 1.47 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.561 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 2.5 p -38.15 165.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.688 0.756 . . . . 0.0 110.619 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -127.39 131.69 50.27 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -117.35 -172.28 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.277 -0.89 . . . . 0.0 109.315 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 2.3 mt-10 -133.4 123.98 26.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.001 -1.062 . . . . 0.0 110.206 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.525 ' OG1' ' CG1' ' A' ' 44' ' ' VAL . 4.6 p -119.63 -104.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.327 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 28.9 t0 -130.32 75.11 1.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.326 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 87.46 -22.75 0.14 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' CG1' ' OG1' ' A' ' 41' ' ' THR . 12.1 p -103.8 144.65 13.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.411 -0.806 . . . . 0.0 109.479 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 2.3 t -120.14 105.63 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 109.702 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.546 ' HG ' ' CB ' ' A' ' 9' ' ' ASP . 4.0 mm? -79.99 -179.38 6.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.291 -0.881 . . . . 0.0 109.049 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.2 pt-20 -150.65 -163.19 1.72 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.027 -1.046 . . . . 0.0 110.219 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.569 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 9.7 p -154.96 81.0 4.29 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.133 -0.979 . . . . 0.0 110.216 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.79 113.49 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.587 2.192 . . . . 0.0 110.81 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.585 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -80.7 -168.01 1.59 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.3 p -133.37 16.34 4.07 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.361 -1.462 . . . . 0.0 110.806 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 160.63 160.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.513 -0.742 . . . . 0.0 109.16 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.606 ' N ' HG11 ' A' ' 30' ' ' VAL . 1.2 t70 64.96 -140.09 0.23 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.326 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.526 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 112.23 -12.71 26.27 Favored Glycine 0 N--CA 1.489 2.209 0 O-C-N 120.508 -1.37 . . . . 0.0 109.851 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.542 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -34.82 97.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.744 -0.857 . . . . 0.0 109.59 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.548 ' CD2' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -45.06 104.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -113.93 -47.18 2.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.532 -0.73 . . . . 0.0 110.195 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.36 77.59 1.58 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.785 -1.197 . . . . 0.0 111.106 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 56' ' ' LEU . 56.0 t -81.79 86.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.6 mt -69.63 -0.94 7.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -0.783 . . . . 0.0 111.255 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.514 ' CB ' HD13 ' A' ' 73' ' ' LEU . 21.1 mt-10 -134.54 55.44 1.89 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.778 -1.201 . . . . 0.0 108.199 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.451 ' HA ' HG13 ' A' ' 59' ' ' VAL . 6.5 m-20 -43.93 127.06 5.13 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.702 0.763 . . . . 0.0 109.746 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.61 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -35.7 127.14 0.66 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.469 0.652 . . . . 0.0 111.284 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.48 -9.78 13.03 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 66' ' ' THR . 86.5 m -94.46 167.84 11.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -1.148 . . . . 0.0 109.386 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.466 ' N ' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -81.62 158.93 24.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.683 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.571 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.31 171.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.571 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 5.3 t -134.14 -161.48 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 0.0 109.237 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.51 ' N ' HD13 ' A' ' 10' ' ' LEU . 29.9 t -85.91 40.88 0.88 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.629 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 69' ' ' SER . 4.8 ttm180 168.11 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.572 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.478 ' HG3' ' CG2' ' A' ' 68' ' ' THR . 1.6 mm-40 -105.61 97.59 7.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.94 . . . . 0.0 109.233 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.1 tt -42.25 112.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.463 -0.773 . . . . 0.0 109.86 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.539 HD12 ' CG1' ' A' ' 19' ' ' VAL . 10.3 tp -57.71 -42.67 84.26 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . 165.47 158.1 10.39 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.864 -1.636 . . . . 0.0 110.442 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.472 ' HB3' ' OD2' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -102.17 139.32 37.94 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.513 -0.993 . . . . 0.0 108.913 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.595 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 2.9 mp -105.14 -105.5 0.31 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.376 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.542 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.8 tpt180 -152.65 153.59 33.61 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.988 -1.07 . . . . 0.0 109.461 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.514 ' HB2' ' N ' ' A' ' 2' ' ' SER . 3.7 tm-20 -149.95 45.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 109.426 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.26 164.55 38.93 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.214 -1.168 . . . . 0.0 109.43 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 1.3 p -169.18 166.43 10.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.592 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 16.5 t -79.75 76.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.61 77.46 7.43 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.561 HG12 ' CG1' ' A' ' 48' ' ' VAL . 5.2 tp -91.89 154.04 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.372 -0.83 . . . . 0.0 111.283 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -140.46 -157.93 0.81 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.603 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 2.9 t -131.14 54.57 15.06 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 120.868 -1.145 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.6 Cg_endo -81.21 40.85 1.04 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.238 1.959 . . . . 0.0 110.008 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.533 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -104.33 -1.42 26.95 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.016 -1.052 . . . . 0.0 110.176 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' A' ' 69' ' ' SER . 0.8 OUTLIER -120.12 93.34 47.89 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.081 -1.012 . . . . 0.0 109.781 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.39 -90.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.531 2.154 . . . . 0.0 110.131 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' SER . 39.5 mm-40 -60.09 175.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 109.002 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' GLU . 31.2 t 51.35 98.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.987 . . . . 0.0 109.227 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.16 44.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.818 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.72 -17.23 64.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.239 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 66.55 -161.28 0.25 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.428 -0.795 . . . . 0.0 109.252 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -163.56 -162.42 0.73 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.259 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.506 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 16.1 m -161.05 127.55 3.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.087 -1.008 . . . . 0.0 110.162 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.535 ' HA ' HG13 ' A' ' 39' ' ' ILE . 2.5 t -53.87 157.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 108.708 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -127.42 -58.63 1.25 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.418 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.458 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 22.2 m -162.08 119.43 2.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.981 -1.074 . . . . 0.0 110.903 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.579 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 25.0 m95 -68.7 -170.58 0.22 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.867 0.842 . . . . 0.0 109.189 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.589 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 10.6 m80 -152.81 38.77 0.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.566 ' CA ' ' OD2' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -130.97 115.98 17.23 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.541 -178.167 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.562 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -65.41 177.32 0.69 Allowed Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.17 93.54 0.4 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.793 1.662 . . . . 0.0 111.464 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.595 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 80.15 47.91 6.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.566 ' OD2' ' CA ' ' A' ' 24' ' ' LYS . 4.0 m-20 -58.58 -134.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.285 -1.127 . . . . 0.0 110.394 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . 170.54 95.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.913 -1.117 . . . . 0.0 108.929 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.595 ' CG1' ' OE2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -103.25 -170.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.083 -1.01 . . . . 0.0 109.424 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.572 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 4.2 m -134.18 -112.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 108.903 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 8.2 mmt-85 -87.08 64.68 8.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.758 -1.214 . . . . 0.0 108.721 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.4 m-20 150.73 102.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.595 ' OE2' ' CG1' ' A' ' 30' ' ' VAL . 0.9 OUTLIER -101.52 -167.66 1.45 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.075 -1.016 . . . . 0.0 111.928 -178.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.563 ' HB ' ' CG ' ' A' ' 24' ' ' LYS . 3.7 p -53.88 166.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.105 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.55 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.92 65.23 1.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 178.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.589 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 6.2 p -40.36 170.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.665 0.745 . . . . 0.0 110.117 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 21.5 mt-10 -123.56 107.92 12.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.003 -1.061 . . . . 0.0 108.903 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -91.71 -162.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 121.421 -0.799 . . . . 0.0 109.159 -179.339 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.559 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 39.4 mt-10 -153.06 102.18 2.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 110.105 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 42' ' ' ASP . 88.2 m -97.81 -112.2 0.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.271 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.576 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.1 t70 -126.56 87.73 2.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.918 -1.114 . . . . 0.0 109.391 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.3 tptp 85.2 -28.5 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.25 145.79 23.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.232 -0.917 . . . . 0.0 109.231 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 39' ' ' ILE . 1.8 p -123.39 122.44 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.486 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.65 170.91 15.86 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.173 -0.954 . . . . 0.0 108.864 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -122.16 179.66 4.47 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.106 -0.996 . . . . 0.0 110.406 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.587 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 3.2 t -130.83 73.18 81.38 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.491 -0.756 . . . . 0.0 109.013 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.2 Cg_endo -80.6 104.0 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.585 2.19 . . . . 0.0 111.527 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.577 ' CB ' ' CB ' ' A' ' 34' ' ' GLU . . . -79.1 -156.87 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.581 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.1 p -144.33 13.31 1.59 Allowed 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.695 -1.253 . . . . 0.0 110.733 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 158.93 155.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.393 -0.817 . . . . 0.0 110.216 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER 75.34 -81.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.501 -0.749 . . . . 0.0 110.659 179.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.529 ' N ' ' OE2' ' A' ' 34' ' ' GLU . . . 55.34 6.52 1.0 Allowed Glycine 0 N--CA 1.494 2.539 0 O-C-N 121.111 -0.993 . . . . 0.0 111.434 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.595 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 3.3 mt -54.97 98.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.643 -1.504 . . . . 0.0 108.061 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.589 ' CD1' ' CD2' ' A' ' 76' ' ' LEU . 9.5 tp -51.21 90.14 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.536 -0.728 . . . . 0.0 109.328 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.5 t0 -99.11 -40.62 7.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.608 -0.683 . . . . 0.0 110.049 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -142.64 107.55 4.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.804 -1.185 . . . . 0.0 111.0 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.527 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 2.0 t -118.91 107.26 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mt -98.43 -31.9 11.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.025 . . . . 0.0 110.014 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 3.0 mt-10 -98.61 35.44 1.82 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.518 ' OD1' ' CG1' ' A' ' 59' ' ' VAL . 2.2 m-20 -43.67 157.16 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.605 -0.684 . . . . 0.0 110.162 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.529 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -38.85 140.39 0.37 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.353 0.597 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.28 -19.86 47.02 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.463 ' O ' HG21 ' A' ' 18' ' ' THR . 2.2 m -86.18 161.51 18.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -82.74 163.27 21.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.571 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.554 ' CG2' ' CG2' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.51 169.2 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.419 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.523 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -145.71 -147.75 0.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.57 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.524 ' HB3' ' CD1' ' A' ' 10' ' ' LEU . 13.3 p -89.83 33.29 0.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.354 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER 171.82 26.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.528 -0.733 . . . . 0.0 110.268 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 13.7 mm100 -87.51 121.47 29.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.666 -1.271 . . . . 0.0 109.183 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 4.0 tt -69.2 111.36 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.609 -0.682 . . . . 0.0 110.581 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.577 ' CD1' ' CG1' ' A' ' 37' ' ' VAL . 3.8 mt -55.43 -36.25 66.31 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.42 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 154.82 164.31 12.84 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.7 OUTLIER -111.96 140.68 46.42 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.37 -1.076 . . . . 0.0 108.997 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.619 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 3.9 mp -116.2 -133.87 0.34 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.541 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -113.07 166.19 11.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.659 -1.276 . . . . 0.0 109.118 179.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.52 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 1.1 tm-20 -170.77 43.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.92 . . . . 0.0 109.404 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 50.26 -168.71 0.29 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.27 -1.135 . . . . 0.0 109.609 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.519 ' CA ' ' HG3' ' A' ' 78' ' ' GLU . 66.2 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.531 ' N ' ' HB2' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -69.64 -169.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 8.6 t -69.81 90.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.182 -0.949 . . . . 0.0 109.246 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.97 78.74 5.4 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.595 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -93.64 137.85 21.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.405 -0.809 . . . . 0.0 111.239 -176.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -136.02 -164.27 1.53 Allowed 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 54.6 t -132.32 66.44 77.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.995 -1.066 . . . . 0.0 109.325 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HG3' ' CD1' ' A' ' 6' ' ' LEU . 36.5 Cg_endo -80.24 41.61 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.733 2.289 . . . . 0.0 110.589 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 10' ' ' LEU . 2.4 m-20 -92.55 47.99 1.35 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.035 -1.041 . . . . 0.0 110.113 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.562 HD21 ' CB ' ' A' ' 69' ' ' SER . 3.2 mm? -26.37 97.77 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 122.11 -0.369 . . . . 0.0 111.199 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.506 ' CG ' ' HB ' ' A' ' 14' ' ' VAL . 35.7 Cg_endo -77.95 -176.73 3.4 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.613 2.209 . . . . 0.0 110.548 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -5.08 18.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 109.609 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -165.22 58.95 0.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 109.346 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 13' ' ' SER . 99.4 t -159.52 84.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.308 -0.87 . . . . 0.0 109.098 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.06 -18.74 2.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.834 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 2.6 p-10 -163.11 147.59 11.25 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.712 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 39' ' ' ILE . . . -108.71 -160.48 0.72 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.397 -0.814 . . . . 0.0 108.825 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.442 ' C ' HG13 ' A' ' 39' ' ' ILE . 12.5 m -150.42 117.18 5.84 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.103 -0.998 . . . . 0.0 110.165 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.543 ' CG1' ' OE1' ' A' ' 63' ' ' GLU . 2.1 t -50.77 151.27 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.53 ' N ' ' OE1' ' A' ' 63' ' ' GLU . . . -134.67 -43.0 0.75 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.105 -0.997 . . . . 0.0 110.924 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.526 ' N ' ' OE1' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -164.03 108.91 1.01 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.106 -1.438 . . . . 0.0 112.578 -179.152 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.6 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 18.4 m95 -67.84 -165.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.511 ' HB2' HG21 ' A' ' 35' ' ' VAL . 48.5 m80 -149.97 28.57 0.75 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.57 ' CD ' ' HB ' ' A' ' 35' ' ' VAL . 12.3 mmmm -123.57 146.59 48.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.641 -0.662 . . . . 0.0 110.393 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.619 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -97.73 -170.6 0.22 Allowed Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.1 Cg_endo -68.6 84.06 0.5 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 120.839 1.026 . . . . 0.0 111.321 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.555 ' CA ' HG22 ' A' ' 55' ' ' ILE . . . 78.15 48.48 7.56 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 18.4 m-20 -56.48 -114.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.113 -1.228 . . . . 0.0 110.363 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 158.18 100.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.848 -1.158 . . . . 0.0 108.27 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.578 ' CG1' ' HA ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -102.64 -175.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.838 -1.164 . . . . 0.0 110.292 -178.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -129.29 -98.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 109.899 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.453 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -100.74 38.53 1.51 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.974 -1.078 . . . . 0.0 109.826 -179.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.523 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 4.0 m-20 -178.01 89.42 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.681 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 9.6 tp10 -87.7 168.35 13.06 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.281 1.039 . . . . 0.0 111.647 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.57 ' HB ' ' CD ' ' A' ' 24' ' ' LYS . 4.6 p -33.08 157.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 122.128 0.966 . . . . 0.0 112.471 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.33 62.1 1.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.578 ' CG1' ' CG1' ' A' ' 48' ' ' VAL . 4.3 p -38.01 166.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.773 0.797 . . . . 0.0 110.385 -177.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -118.7 150.74 39.24 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -138.34 -171.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.369 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 19.7 mt-10 -126.86 119.92 27.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.039 -1.038 . . . . 0.0 109.892 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.2 -143.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.429 -0.795 . . . . 0.0 109.128 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 65.1 t0 -90.62 72.14 6.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 109.607 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.4 tttt 87.21 -23.32 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 45' ' ' VAL . 72.8 t -100.63 160.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.38 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.498 ' N ' HG13 ' A' ' 44' ' ' VAL . 36.2 t -127.73 106.24 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.324 -0.86 . . . . 0.0 109.738 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -79.44 166.3 22.15 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.22 -0.925 . . . . 0.0 108.92 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -126.99 -163.75 1.28 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.091 -1.006 . . . . 0.0 110.258 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.637 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -152.79 91.52 3.47 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.679 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.5 Cg_endo -83.5 123.57 3.4 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.759 2.306 . . . . 0.0 111.894 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.681 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -97.6 173.54 7.09 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.611 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 19.8 p -120.14 75.3 1.09 Allowed 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.205 -1.398 . . . . 0.0 110.315 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.611 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 90.65 164.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.5 0.667 . . . . 0.0 110.105 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.2 m-20 67.65 -100.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.713 -0.617 . . . . 0.0 110.618 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' HA2' ' CG2' ' A' ' 3' ' ' VAL . . . 54.79 5.58 0.59 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 120.911 -1.118 . . . . 0.0 111.543 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.555 HG22 ' CA ' ' A' ' 27' ' ' GLY . 7.2 mt -47.41 98.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.47 -1.606 . . . . 0.0 108.021 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.562 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 5.2 tp -43.88 108.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.618 0.723 . . . . 0.0 110.287 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 2.5 t0 -131.91 -35.15 1.26 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.618 -0.676 . . . . 0.0 110.031 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -135.61 62.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.68 -1.262 . . . . 0.0 111.014 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.562 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 26.2 t -79.7 83.33 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.759 -1.213 . . . . 0.0 108.467 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 mt -73.56 -6.66 47.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.277 -0.889 . . . . 0.0 110.741 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 4.1 mt-10 -124.15 47.88 2.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.876 -1.14 . . . . 0.0 108.371 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -48.73 139.01 10.24 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.628 -0.67 . . . . 0.0 109.966 -179.673 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.6 ' OE2' ' CD1' ' A' ' 22' ' ' TRP . 69.7 mm-40 -26.86 145.57 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.436 0.636 . . . . 0.0 111.414 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.11 -12.78 67.95 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 19' ' ' VAL . 1.3 m -90.12 154.18 19.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -1.178 . . . . 0.0 109.661 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.15 161.31 28.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.597 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.595 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.63 174.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.02 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.595 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 3.6 t -135.09 -166.35 1.82 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.069 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.562 ' CB ' HD21 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -90.62 36.29 0.89 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.196 -0.94 . . . . 0.0 108.886 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER 172.0 33.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.493 -0.754 . . . . 0.0 109.452 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.59 ' CG ' ' CG2' ' A' ' 68' ' ' THR . 5.1 mm-40 -107.02 145.57 32.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 109.182 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.5 tt -86.77 112.25 22.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.982 -1.074 . . . . 0.0 110.346 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.524 ' CD1' HG13 ' A' ' 37' ' ' VAL . 16.6 mt -54.04 -24.3 16.64 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.472 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 141.11 -168.31 25.4 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 9.5 ptt85 -127.64 146.78 50.44 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.283 -1.128 . . . . 0.0 109.443 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.599 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -99.31 -92.77 0.27 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.361 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.534 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -144.84 157.98 43.96 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.279 -0.888 . . . . 0.0 109.972 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.531 ' HB2' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -110.63 156.92 20.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 109.374 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.48 ' N ' ' OE1' ' A' ' 78' ' ' GLU . . . -156.41 107.97 0.34 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.5 p30 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 0.0 109.492 179.978 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.471 ' CA ' ' HB3' ' A' ' 78' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.294 0.569 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.549 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 1.0 OUTLIER -149.41 159.19 44.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.484 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 18.8 t -75.26 79.48 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 108.5 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.36 83.91 1.94 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.592 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 3.6 tp -104.45 147.5 10.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.849 -177.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.529 ' HB3' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -139.06 -158.83 0.89 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.505 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.499 ' CG2' HD11 ' A' ' 39' ' ' ILE . 41.6 t -129.02 65.37 73.73 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.947 -1.096 . . . . 0.0 109.6 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HB3' ' CG ' ' A' ' 70' ' ' ARG . 36.5 Cg_endo -79.72 61.79 8.3 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.805 2.337 . . . . 0.0 110.387 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.555 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -114.27 -19.9 11.09 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.014 -1.054 . . . . 0.0 109.732 -179.777 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 9' ' ' ASP . 0.8 OUTLIER 31.93 97.34 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 122.194 -0.316 . . . . 0.0 110.988 179.021 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.537 ' HG3' ' CG2' ' A' ' 41' ' ' THR . 34.5 Cg_endo -77.07 -167.25 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.483 2.122 . . . . 0.0 110.422 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.41 13.09 7.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -147.69 169.15 20.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.952 . . . . 0.0 109.496 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.509 ' CG2' ' O ' ' A' ' 14' ' ' VAL . 3.6 p -125.69 56.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.537 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 16' ' ' ASP . . . -95.3 14.91 20.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.946 . . . . 0.0 109.046 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 76.65 -154.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.344 -0.847 . . . . 0.0 109.533 179.901 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -170.61 -170.6 0.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.866 . . . . 0.0 109.308 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.509 ' N ' HG12 ' A' ' 67' ' ' VAL . 17.5 m -152.88 137.16 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.527 ' CG2' HD12 ' A' ' 73' ' ' LEU . 2.2 t -72.94 84.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.41 -0.807 . . . . 0.0 109.252 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.452 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -46.61 -63.52 0.99 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.059 -1.025 . . . . 0.0 110.537 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.582 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 96.8 m -165.44 124.94 1.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.589 -1.319 . . . . 0.0 111.781 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.577 ' O ' ' CD2' ' A' ' 23' ' ' HIS . 15.7 m95 -67.75 -168.48 0.09 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 12.0 m80 -153.3 24.15 0.54 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.558 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.1 tppt? -115.4 120.21 38.82 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.382 0.61 . . . . 0.0 109.593 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.543 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -67.1 175.61 1.43 Allowed Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.443 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 30.6 Cg_endo -71.31 94.66 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.073 1.849 . . . . 0.0 111.057 -178.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.525 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 85.33 37.42 9.81 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.549 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 8.9 m-20 -63.13 -162.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.784 -1.421 . . . . 0.0 109.61 178.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -162.85 79.36 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.92 -1.112 . . . . 0.0 110.069 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -78.9 -173.55 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 0.0 109.541 179.797 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.578 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -134.07 -86.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 0.0 109.36 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 2.6 tpt180 -107.88 61.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.939 -1.101 . . . . 0.0 109.725 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.568 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.3 m-20 147.81 91.02 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.57 ' CB ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -88.68 -166.91 1.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 111.336 -178.7 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.558 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 2.5 p -49.63 164.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.805 0.812 . . . . 0.0 111.311 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.551 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -140.17 63.64 1.47 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.603 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.569 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 3.3 p -38.59 166.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.701 0.762 . . . . 0.0 110.398 -177.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 1.4 mt-10 -128.05 112.63 14.83 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.263 -0.898 . . . . 0.0 108.729 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.57 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.05 -167.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.498 -0.751 . . . . 0.0 109.03 -179.341 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.57 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 5.5 mt-10 -135.46 136.72 41.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 0.0 110.065 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.537 ' CG2' ' HG3' ' A' ' 11' ' ' PRO . 2.1 m -135.81 -136.32 0.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.6 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 23.5 t0 -96.0 74.21 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.907 -1.121 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.7 tmtt? 86.74 -23.3 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.788 -0.57 . . . . 0.0 109.543 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 45' ' ' VAL . 2.3 p -105.11 164.36 4.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.524 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 44.5 t -144.39 112.77 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.373 -0.829 . . . . 0.0 109.454 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.82 168.54 19.15 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.136 -0.977 . . . . 0.0 108.869 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' OE1' ' O ' ' A' ' 36' ' ' LEU . 3.0 mm-40 -116.79 -171.4 2.01 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.927 -1.108 . . . . 0.0 110.639 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.706 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -147.55 77.32 10.54 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-O 122.409 1.099 . . . . 0.0 108.622 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.0 Cg_endo -81.62 113.02 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.781 2.321 . . . . 0.0 112.14 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.531 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . . . -80.17 -160.18 0.27 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 177.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.564 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -139.62 11.92 2.51 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.497 -1.377 . . . . 0.0 110.891 -179.53 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 160.19 169.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.318 -0.864 . . . . 0.0 109.995 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER 67.85 -87.87 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.426 -0.796 . . . . 0.0 109.323 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 65.55 -13.57 0.28 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.219 -0.926 . . . . 0.0 112.15 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.525 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -42.83 96.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 119.124 1.462 . . . . 0.0 108.181 179.475 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.594 ' CD1' ' CD2' ' A' ' 76' ' ' LEU . 7.8 tp -54.11 97.12 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.47 -0.769 . . . . 0.0 109.64 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -109.0 -39.9 5.16 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.796 -0.565 . . . . 0.0 110.002 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -139.0 90.4 2.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.69 -1.256 . . . . 0.0 110.877 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.528 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 6.6 t -94.71 91.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 mt -70.08 -1.76 10.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 110.887 -178.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 5.7 mt-10 -137.41 55.26 1.81 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.024 -1.048 . . . . 0.0 108.449 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 63' ' ' GLU . 24.0 m-20 -43.79 126.01 4.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.526 -0.733 . . . . 0.0 109.452 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.582 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.5 OUTLIER -33.94 122.5 0.46 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.626 0.727 . . . . 0.0 111.435 -179.236 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.49 -6.03 12.87 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.6 -172.75 3.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -1.132 . . . . 0.0 109.317 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -93.84 153.13 18.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.835 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.57 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.35 171.4 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.378 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.57 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 13.7 t -148.04 -137.65 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 108.83 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.491 ' N ' ' CG2' ' A' ' 68' ' ' THR . 6.2 p -69.2 -110.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.691 -1.256 . . . . 0.0 108.021 179.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.517 ' CG ' ' HB3' ' A' ' 8' ' ' PRO . 3.4 mtm180 -71.3 79.4 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 109.419 179.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.45 ' CG ' HG23 ' A' ' 68' ' ' THR . 2.7 mm-40 -115.63 96.28 5.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.121 -0.987 . . . . 0.0 108.451 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.529 ' N ' ' HB3' ' A' ' 6' ' ' LEU . 4.0 tt -42.26 109.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.341 -0.85 . . . . 0.0 110.194 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.527 HD12 ' CG2' ' A' ' 19' ' ' VAL . 10.7 tp -62.23 -27.86 69.29 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 59' ' ' VAL . . . 154.46 154.82 7.0 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.126 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 5.2 ptt180 -104.41 136.84 43.23 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.429 -1.042 . . . . 0.0 109.489 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.631 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 4.0 mp -112.86 -103.87 0.4 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.478 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.549 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -138.06 164.45 29.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 109.391 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.52 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 1.9 tt0 -141.86 146.95 36.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.528 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 53' ' ' ASP . . . -48.59 -92.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.19 -1.182 . . . . 0.0 109.49 179.978 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.444 ' HB3' ' OE2' ' A' ' 78' ' ' GLU . 1.2 t . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.195 0.521 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -86.29 160.63 19.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.59 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.536 ' HB ' ' CG ' ' A' ' 76' ' ' LEU . 24.9 t -80.93 75.96 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.395 -0.815 . . . . 0.0 109.189 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.429 ' CG ' ' HB3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -81.51 94.17 6.81 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.781 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.543 HG12 ' CG1' ' A' ' 48' ' ' VAL . 5.7 tp -106.57 159.3 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.344 -177.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -141.35 -161.03 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.367 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.639 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 48.2 t -130.75 50.07 5.57 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.754 -1.216 . . . . 0.0 111.501 -179.183 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.9 Cg_endo -82.63 39.91 0.9 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.072 1.848 . . . . 0.0 109.757 178.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.533 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 4.2 m-20 -115.13 -17.04 11.51 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.125 -0.984 . . . . 0.0 111.186 -178.397 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -42.58 102.82 0.28 Allowed Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.268 -0.895 . . . . 0.0 109.727 -179.309 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 9' ' ' ASP . 36.2 Cg_endo -78.82 80.3 3.11 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.463 2.109 . . . . 0.0 110.42 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 23.0 tt0 58.27 61.41 2.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.177 -0.952 . . . . 0.0 109.528 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 8.6 m -90.21 -148.29 0.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 76.7 t -81.82 -28.42 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.191 -0.943 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 14' ' ' VAL . . . 159.79 -21.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.488 0.661 . . . . 0.0 109.43 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 2.8 p30 -158.32 -164.37 1.47 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.469 -0.769 . . . . 0.0 109.445 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.511 ' CB ' ' HA ' ' A' ' 41' ' ' THR . . . -146.47 -155.19 0.6 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.154 -0.966 . . . . 0.0 109.619 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.48 ' CA ' ' CG1' ' A' ' 67' ' ' VAL . 92.5 m -160.23 130.35 5.36 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.33 -0.856 . . . . 0.0 110.068 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.542 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 4.2 t -68.05 111.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.335 -0.853 . . . . 0.0 109.031 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.496 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -76.61 -57.53 3.8 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.144 -0.973 . . . . 0.0 109.901 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.546 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 17.9 m -170.75 126.83 0.74 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.682 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.579 ' CG ' HG22 ' A' ' 37' ' ' VAL . 14.8 m95 -68.84 -168.56 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 108.819 177.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.574 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 13.9 m80 -151.22 39.05 0.66 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.555 ' CG ' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -130.86 138.81 50.0 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.673 0.749 . . . . 0.0 110.867 -178.509 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.596 ' CB ' ' OD1' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -88.79 179.41 1.63 Allowed Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.039 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.8 Cg_endo -66.03 105.31 0.81 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.561 1.508 . . . . 0.0 112.284 -178.044 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.484 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 60.35 48.0 88.33 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.596 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 3.6 m-20 -59.52 -119.44 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.046 -1.267 . . . . 0.0 110.363 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 159.67 99.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.056 -1.027 . . . . 0.0 109.035 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.579 ' CG1' ' N ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -103.41 -178.99 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 109.62 -179.546 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.579 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 3.2 m -127.48 -110.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 14.3 mtp180 -90.2 66.68 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.778 -1.201 . . . . 0.0 108.785 179.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 15.0 m-20 150.59 103.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -179.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.575 ' CB ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -108.17 -171.46 1.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.391 1.091 . . . . 0.0 111.959 -178.21 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.555 ' HB ' ' CG ' ' A' ' 24' ' ' LYS . 9.0 p -45.8 169.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.145 0.974 . . . . 0.0 111.389 -179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.495 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -149.71 59.14 1.0 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.579 HG22 ' CG ' ' A' ' 22' ' ' TRP . 2.7 p -39.3 165.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.807 0.813 . . . . 0.0 110.192 -178.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -123.48 146.53 47.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -134.5 -173.72 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.272 -179.262 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.547 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 8.9 mt-10 -146.73 95.91 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.672 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.511 ' HA ' ' CB ' ' A' ' 17' ' ' ALA . 27.0 p -86.94 -48.8 7.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 109.725 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 55.1 t0 176.7 77.6 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.636 -0.665 . . . . 0.0 109.295 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER 87.28 -26.47 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.419 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.46 154.98 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.337 -0.852 . . . . 0.0 109.34 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.27 114.92 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -0.974 . . . . 0.0 109.822 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -79.67 159.3 26.75 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.299 -0.875 . . . . 0.0 108.755 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.518 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -121.96 -178.6 3.89 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.035 -1.041 . . . . 0.0 110.502 -179.298 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.569 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 11.4 t -142.91 68.26 18.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.4 Cg_endo -80.31 106.41 1.88 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.679 2.253 . . . . 0.0 110.886 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -89.38 -161.73 0.8 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.2 p -142.95 17.21 1.95 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.748 -1.22 . . . . 0.0 110.888 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 160.35 163.3 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.115 -0.991 . . . . 0.0 110.668 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER 78.26 -77.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.646 179.64 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.501 ' CA ' ' CD ' ' A' ' 34' ' ' GLU . . . 40.34 22.4 0.04 OUTLIER Glycine 0 N--CA 1.489 2.216 0 O-C-N 121.442 -0.786 . . . . 0.0 111.634 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 2.9 mt -83.61 94.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.549 -1.559 . . . . 0.0 107.329 178.256 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.603 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 2.1 tp -43.73 115.99 0.89 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.579 -0.701 . . . . 0.0 110.179 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 1.2 t0 -132.11 -42.73 0.98 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.491 -0.755 . . . . 0.0 109.895 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.543 ' CB ' ' NE ' ' A' ' 75' ' ' ARG . . . -132.82 76.65 1.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.785 -1.197 . . . . 0.0 110.873 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.554 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 60.6 t -93.33 81.52 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.436 ' CD1' ' HG3' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -69.04 -27.92 66.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.397 -0.814 . . . . 0.0 110.658 -178.423 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.5 ' OE2' ' NE2' ' A' ' 71' ' ' GLN . 7.7 mt-10 -106.73 47.79 0.86 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.463 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -39.14 139.31 0.51 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.597 0.713 . . . . 0.0 109.712 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -37.87 135.72 0.63 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.626 0.727 . . . . 0.0 110.999 -179.249 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.41 -6.37 36.17 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -95.72 158.38 15.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.244 . . . . 0.0 109.701 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.65 162.02 28.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.257 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.575 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.41 174.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.359 -0.838 . . . . 0.0 109.004 -178.802 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.575 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 4.8 t -150.26 -152.86 0.46 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 108.975 179.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.559 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 12.5 p -89.48 54.96 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.064 -1.022 . . . . 0.0 109.558 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' A' ' 69' ' ' SER . 3.5 mtp85 159.36 -12.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.565 -0.709 . . . . 0.0 110.654 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.5 mt-30 -54.2 102.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.943 -1.098 . . . . 0.0 109.641 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 3.1 tt -54.94 111.5 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.538 HD12 ' CG1' ' A' ' 19' ' ' VAL . 8.4 tp -54.32 -29.89 49.38 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.483 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 144.69 153.34 5.84 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.543 ' NE ' ' CB ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -93.99 145.39 24.68 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.515 -0.991 . . . . 0.0 108.332 179.181 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.603 ' CD1' ' CD1' ' A' ' 56' ' ' LEU . 3.4 mm? -85.45 -111.7 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.73 -178.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.536 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 3.4 ttp85 -116.8 157.42 25.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.732 -1.23 . . . . 0.0 110.479 -179.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 2' ' ' SER . 22.6 tt0 -178.61 138.24 0.16 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.165 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.85 -157.61 22.48 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.247 -1.149 . . . . 0.0 109.418 179.954 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.485 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -167.71 -179.04 4.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 62.3 t -81.56 70.55 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 108.798 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -74.07 84.04 1.79 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.407 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.56 HG12 ' CG1' ' A' ' 48' ' ' VAL . 8.0 tp -99.73 163.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 111.297 -177.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -147.31 -159.86 1.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.313 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.599 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 2.1 t -133.15 56.11 20.09 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.121 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.4 Cg_endo -80.58 35.94 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.5 2.134 . . . . 0.0 110.824 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.553 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.1 m-20 -102.95 -2.68 27.28 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.801 -1.187 . . . . 0.0 109.966 -179.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.475 ' HG ' ' HA ' ' A' ' 69' ' ' SER . 0.7 OUTLIER -128.19 66.54 72.89 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.925 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 9' ' ' ASP . 35.7 Cg_endo -77.55 -58.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.583 2.189 . . . . 0.0 110.373 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' PRO . 7.0 mm-40 -43.94 154.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.357 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.471 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 p 44.5 -155.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.293 -0.879 . . . . 0.0 109.232 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 13' ' ' SER . 15.9 t -157.03 58.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.509 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.75 -11.21 58.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.146 -0.971 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 0.6 OUTLIER 60.89 -153.16 0.38 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.33 -0.856 . . . . 0.0 108.796 -179.85 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.53 ' CA ' ' O ' ' A' ' 40' ' ' GLU . . . -170.15 -159.76 0.21 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.036 -1.04 . . . . 0.0 109.844 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.495 ' N ' HG12 ' A' ' 67' ' ' VAL . 46.8 m -155.55 124.15 5.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 110.54 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.529 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 17.0 t -65.52 107.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.23 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -73.8 -59.62 2.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.614 -179.314 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.552 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.6 m -168.69 128.52 1.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.628 -1.295 . . . . 0.0 111.775 -179.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.537 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 17.6 m95 -69.2 -166.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.661 0.743 . . . . 0.0 109.24 178.346 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.593 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.1 m80 -152.7 26.47 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.6 tppt? -119.36 137.91 53.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.69 -0.631 . . . . 0.0 110.132 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.568 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.28 179.29 1.71 Allowed Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.676 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -69.64 104.91 1.37 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.664 1.576 . . . . 0.0 111.62 -178.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.522 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 75.03 39.52 37.49 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 4.8 m-20 -59.45 -166.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.718 -1.46 . . . . 0.0 109.597 178.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.17 78.56 0.45 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.08 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.552 ' CG2' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -79.55 169.26 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.009 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.547 ' N ' HG11 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -110.06 -95.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 1.6 mtm180 -107.2 51.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.961 -1.087 . . . . 0.0 109.63 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.552 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 4.2 m-20 173.04 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.612 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 10.3 tp10 -102.29 163.62 12.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.058 -1.026 . . . . 0.0 111.008 -178.235 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.538 ' HB ' ' CE ' ' A' ' 24' ' ' LYS . 2.5 p -30.36 160.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.57 1.176 . . . . 0.0 112.581 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.533 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.12 67.63 1.37 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.087 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.593 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 4.1 p -38.59 165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.102 -177.394 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.27 145.71 46.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -134.77 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.334 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.573 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 13.1 mt-10 -149.35 138.51 21.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.923 -1.11 . . . . 0.0 109.708 -179.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 5.9 t -132.72 26.22 4.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 41' ' ' THR . 2.2 t70 87.34 15.31 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.341 0.591 . . . . 0.0 110.459 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 160.52 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.552 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 1.1 t -103.99 148.57 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.613 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 39' ' ' ILE . 51.2 t -136.93 96.76 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.685 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.553 ' HG ' ' CB ' ' A' ' 9' ' ' ASP . 2.9 mm? -79.88 -176.0 5.21 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.309 -0.869 . . . . 0.0 108.728 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 1.3 pt-20 -142.39 -161.36 1.23 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.718 -1.239 . . . . 0.0 111.463 -178.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.56 ' CG1' HG12 ' A' ' 5' ' ' ILE . 6.0 t -143.47 75.5 16.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.7 Cg_endo -80.73 110.82 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.487 2.125 . . . . 0.0 110.931 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.612 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -91.79 -169.38 2.26 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.137 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.558 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 5.1 p -132.36 14.68 4.57 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.265 -1.522 . . . . 0.0 111.183 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 161.62 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 109.951 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER 60.63 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 179.816 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.548 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 64.95 -13.65 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 O-C-N 121.324 -0.86 . . . . 0.0 112.093 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.522 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.81 96.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.674 -1.486 . . . . 0.0 108.551 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.58 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 7.8 tp -49.87 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ILE . 46.6 t0 -98.6 -41.59 7.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.97 -0.456 . . . . 0.0 110.544 -178.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.37 78.71 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.577 -1.327 . . . . 0.0 111.677 -179.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.58 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 60.7 t -80.86 82.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.37 -10.8 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 109.709 -178.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 4.8 mm-40 -123.74 50.93 1.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -40.8 134.12 1.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.552 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.05 134.51 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.597 0.713 . . . . 0.0 111.015 -178.897 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.75 -13.96 24.64 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -84.98 156.19 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -1.135 . . . . 0.0 109.405 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.41 166.43 20.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.681 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.534 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.04 169.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.242 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -147.78 -148.31 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 -179.652 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 9.3 p -90.28 36.18 0.87 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mtt180 163.55 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.4 mt-30 -84.49 87.69 7.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 0.0 109.102 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.4 tt -45.0 108.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.543 ' CD1' HG23 ' A' ' 48' ' ' VAL . 10.6 mt -53.91 -42.86 69.21 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 156.55 -159.79 29.76 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -134.68 134.49 41.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.151 -1.206 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.604 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 4.4 mp -98.09 -96.72 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.34 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -153.73 163.19 40.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.542 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.49 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 1.1 tt0 -160.81 -163.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 121.63 2.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.246 -1.149 . . . . 0.0 109.507 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.495 ' HA ' ' CB ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -170.04 158.65 7.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 0.0 109.562 -179.985 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.538 ' HB ' ' CG ' ' A' ' 76' ' ' LEU . 3.0 t -75.94 79.76 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -86.73 80.47 8.52 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.031 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.566 HG12 ' CG1' ' A' ' 48' ' ' VAL . 6.0 tp -86.98 161.7 2.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 111.738 -177.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -144.69 -166.02 2.29 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.133 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.581 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 38.9 t -133.31 57.11 24.62 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.15 -0.969 . . . . 0.0 110.005 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -79.97 38.33 0.74 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.392 2.061 . . . . 0.0 110.534 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.555 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -111.1 34.8 3.84 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.869 -1.145 . . . . 0.0 109.962 -179.46 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.527 ' CB ' ' HA ' ' A' ' 15' ' ' ALA . 2.6 mp -141.51 77.92 18.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 12' ' ' GLU . 35.7 Cg_endo -78.34 -37.64 0.7 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.614 2.21 . . . . 0.0 110.745 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 11' ' ' PRO . 5.7 mt-10 -53.52 -172.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.682 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.0 t -73.4 -2.27 21.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 14' ' ' VAL . 7.4 p -100.85 57.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.285 -0.884 . . . . 0.0 108.865 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HA ' ' CB ' ' A' ' 10' ' ' LEU . . . -83.38 44.76 0.98 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.587 -0.696 . . . . 0.0 110.007 -179.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -136.89 141.5 42.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.103 -0.998 . . . . 0.0 109.545 179.728 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 41' ' ' THR . . . -147.83 -161.17 1.28 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 0.0 109.254 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.458 ' C ' HG13 ' A' ' 39' ' ' ILE . 77.0 m -161.16 113.98 1.92 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.293 -0.88 . . . . 0.0 110.116 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.52 ' CG1' ' OE1' ' A' ' 63' ' ' GLU . 2.3 t -46.78 137.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.527 ' N ' ' OE1' ' A' ' 63' ' ' GLU . . . -116.73 -51.14 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.985 -1.072 . . . . 0.0 110.958 -178.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.52 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -158.55 109.89 2.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.563 -1.335 . . . . 0.0 112.066 -179.214 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.598 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 17.7 m95 -68.11 -164.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.579 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 17.2 m80 -155.23 30.44 0.39 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 177.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.559 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 1.3 tppm? -124.4 139.23 54.09 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.407 0.622 . . . . 0.0 110.513 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.57 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -89.26 -176.4 0.66 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.015 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.6 Cg_endo -66.13 90.14 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.917 1.078 . . . . 0.0 111.321 -178.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.532 ' CA ' HG22 ' A' ' 55' ' ' ILE . . . 72.92 47.65 24.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.569 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 14.6 m-20 -58.4 -113.4 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.057 -1.261 . . . . 0.0 110.388 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 158.9 102.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.96 -1.088 . . . . 0.0 108.574 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -101.93 -173.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.05 . . . . 0.0 109.929 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.572 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 5.7 m -131.86 -114.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.183 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.566 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -87.41 64.62 8.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.691 -1.256 . . . . 0.0 109.182 179.735 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 5.0 m-20 149.65 99.16 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.584 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -95.04 -176.06 3.72 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.414 1.102 . . . . 0.0 111.898 -178.22 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.534 ' CG1' ' OE2' ' A' ' 34' ' ' GLU . 11.5 p -39.7 166.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.953 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -147.32 61.97 1.16 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 179.017 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.579 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 3.3 p -39.29 166.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.683 0.754 . . . . 0.0 110.273 -177.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 4.1 mt-10 -128.75 95.26 4.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.192 -0.943 . . . . 0.0 109.146 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -79.62 -167.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 109.123 -179.658 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.553 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 24.3 mt-10 -153.75 121.24 5.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.922 -1.111 . . . . 0.0 110.193 -179.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -116.26 -95.19 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.434 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 31.1 t0 -146.15 86.73 1.71 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.385 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 16.5 tttt 86.72 -24.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 41' ' ' THR . 2.1 t -107.07 161.61 5.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 39' ' ' ILE . 54.1 t -150.85 98.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.558 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.59 168.91 18.76 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.213 -0.929 . . . . 0.0 108.864 179.945 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -124.94 -162.89 1.13 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.001 -1.062 . . . . 0.0 110.819 -178.78 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.566 ' CG1' HG12 ' A' ' 5' ' ' ILE . 3.8 t -144.23 74.57 15.74 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.525 -0.735 . . . . 0.0 109.289 -179.345 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -82.19 101.84 1.15 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.887 2.392 . . . . 0.0 111.316 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.584 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -80.19 -161.36 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.559 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 1.4 p -135.1 10.14 3.54 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.466 -1.396 . . . . 0.0 111.275 -179.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 161.18 157.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.079 -1.013 . . . . 0.0 110.295 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.541 ' CB ' ' HA ' ' A' ' 78' ' ' GLU . 0.5 OUTLIER 79.1 -73.41 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.675 -0.641 . . . . 0.0 110.518 179.05 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 43.54 17.85 0.06 OUTLIER Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.154 -0.966 . . . . 0.0 111.315 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.55 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 20.5 mt -68.85 91.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.596 -1.532 . . . . 0.0 107.285 179.058 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -44.17 91.34 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.639 0.733 . . . . 0.0 110.366 -178.291 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 55' ' ' ILE . 36.3 t70 -87.29 -53.86 4.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.738 -0.601 . . . . 0.0 109.732 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.35 104.66 3.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.794 -1.191 . . . . 0.0 110.71 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.533 ' CG2' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -90.91 92.12 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.553 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.56 -5.55 25.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.186 -0.946 . . . . 0.0 110.076 -178.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 73' ' ' LEU . 2.9 mt-10 -128.89 41.93 3.4 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 108.7 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.513 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.0 m-20 -42.72 131.13 4.06 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.596 -0.69 . . . . 0.0 109.593 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.598 ' OE2' ' CD1' ' A' ' 22' ' ' TRP . 67.2 mm-40 -20.91 140.05 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.661 0.743 . . . . 0.0 112.322 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.25 -15.61 61.12 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -80.07 162.82 24.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -1.232 . . . . 0.0 109.528 179.942 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.1 m -90.61 162.83 14.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 109.721 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.573 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.56 171.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.214 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.573 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 5.1 t -137.98 -152.31 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.05 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.523 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 84.3 p -89.3 39.39 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 0.0 109.174 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.495 ' CG ' ' C ' ' A' ' 69' ' ' SER . 4.7 ptt180 165.78 34.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.95 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 6.4 mm-40 -97.37 119.44 35.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.287 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 1.9 tt -70.14 111.33 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -0.925 . . . . 0.0 110.032 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.548 ' CD1' HG23 ' A' ' 48' ' ' VAL . 13.8 mt -47.97 -42.23 27.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 162.04 -165.72 36.0 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.434 ' C ' HD22 ' A' ' 76' ' ' LEU . 2.9 ptt-85 -129.22 149.25 51.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.293 -1.122 . . . . 0.0 109.364 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.538 ' CG ' ' HB ' ' A' ' 3' ' ' VAL . 4.5 mt -116.01 -132.21 0.32 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.403 -179.164 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.55 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 11.1 tpt85 -106.26 -51.28 2.99 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.584 -1.323 . . . . 0.0 110.313 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.541 ' HA ' ' CB ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER 44.97 -169.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 -179.641 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.3 -143.58 18.75 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.4 t30 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.236 -1.156 . . . . 0.0 109.465 179.946 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.301 0.572 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.552 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 3.7 p -158.22 164.64 36.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.599 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 37.4 t -69.48 83.38 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.133 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.35 84.24 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.592 ' CG1' ' CG2' ' A' ' 48' ' ' VAL . 4.9 tp -110.55 143.82 19.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.291 -177.138 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -128.48 -134.82 0.23 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.306 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 6' ' ' LEU . 45.9 t -161.85 67.41 2.13 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.717 -1.239 . . . . 0.0 109.168 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.509 ' HD3' ' CD1' ' A' ' 6' ' ' LEU . 35.4 Cg_endo -77.25 67.03 7.78 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.551 2.167 . . . . 0.0 110.584 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.533 ' HB3' ' CD2' ' A' ' 46' ' ' LEU . 1.2 m-20 -132.18 13.28 4.68 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.284 -0.885 . . . . 0.0 109.416 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' N ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -33.04 94.91 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.941 -0.474 . . . . 0.0 110.467 -179.638 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.529 ' HG2' ' CG2' ' A' ' 41' ' ' THR . 36.1 Cg_endo -79.05 -156.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.667 2.245 . . . . 0.0 110.03 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -41.96 124.04 2.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -43.22 108.23 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.719 -179.818 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.7 -83.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.867 . . . . 0.0 109.423 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -171.28 -33.04 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.656 -0.653 . . . . 0.0 109.941 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER 170.57 -154.94 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.518 -0.739 . . . . 0.0 109.352 179.932 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -168.21 -169.51 1.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -0.999 . . . . 0.0 109.546 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 40' ' ' GLU . 24.1 m -157.38 137.53 12.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.113 -0.992 . . . . 0.0 110.72 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 79.0 t -67.18 86.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.424 -0.797 . . . . 0.0 109.46 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 38' ' ' GLU . . . -42.76 -62.97 0.86 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.216 -0.927 . . . . 0.0 109.938 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.476 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 2.6 m -166.91 130.05 1.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.482 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.531 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 22.0 m95 -68.78 -167.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.524 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 29.0 m80 -149.3 24.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.011 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.531 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 10.7 tppt? -119.78 126.11 50.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.683 -0.636 . . . . 0.0 109.959 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.612 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 3.1 mmmt -79.99 -171.84 0.31 Allowed Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -68.45 104.94 1.17 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.026 1.151 . . . . 0.0 112.123 -177.282 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.547 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 57.97 48.5 82.14 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.533 ' OD1' ' HB2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -56.35 -115.9 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.192 -1.181 . . . . 0.0 110.486 179.628 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . 162.0 100.39 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.761 -1.212 . . . . 0.0 108.312 -178.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.573 ' CG2' ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -102.08 173.95 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 111.082 -178.75 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -123.62 -92.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.068 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 6.7 mtp180 -112.18 66.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.08 -1.013 . . . . 0.0 108.396 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 8.2 m-20 155.13 80.55 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.621 ' OE1' ' CG1' ' A' ' 35' ' ' VAL . 1.1 tm-20 -87.81 175.08 7.99 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.179 0.99 . . . . 0.0 112.365 -177.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.621 ' CG1' ' OE1' ' A' ' 34' ' ' GLU . 2.4 p -32.14 156.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.93 0.871 . . . . 0.0 112.114 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.551 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -141.9 59.98 1.47 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.218 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.551 ' O ' ' O ' ' A' ' 36' ' ' LEU . 3.4 p -38.57 169.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.685 0.755 . . . . 0.0 110.571 -177.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 14.2 mt-10 -133.43 102.75 5.65 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.163 -0.961 . . . . 0.0 108.724 -179.294 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 2.1 tt -81.01 -165.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.327 -0.858 . . . . 0.0 109.411 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.551 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 19.6 mm-40 -141.61 89.91 2.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.029 -1.044 . . . . 0.0 110.004 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.529 ' CG2' ' HG2' ' A' ' 11' ' ' PRO . 87.8 m -90.95 28.97 1.44 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.296 -0.878 . . . . 0.0 109.335 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.8 t70 77.6 73.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.685 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.2 tttt 87.24 -26.58 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.449 ' O ' ' HB ' ' A' ' 41' ' ' THR . 41.1 t -105.44 94.12 2.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.242 -0.911 . . . . 0.0 109.5 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 39' ' ' ILE . 81.4 t -94.77 104.72 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.409 -0.807 . . . . 0.0 109.443 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' A' ' 9' ' ' ASP . 0.8 OUTLIER -79.5 174.45 11.56 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.225 -0.922 . . . . 0.0 108.865 -179.759 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 8.4 pm0 -118.05 -179.58 3.8 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.994 -1.066 . . . . 0.0 110.758 -178.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.702 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -144.19 79.08 13.21 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-O 122.331 1.062 . . . . 0.0 108.381 179.666 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.58 120.18 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.826 2.35 . . . . 0.0 111.888 -178.453 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.617 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . . . -96.45 169.84 9.63 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.07 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.606 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 22.9 p -118.32 77.9 1.21 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 120.354 -1.466 . . . . 0.0 110.242 -178.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.606 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 94.48 168.45 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.509 ' N ' HG11 ' A' ' 30' ' ' VAL . 59.4 m-20 61.96 -126.4 0.76 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.533 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 84.56 -7.7 71.96 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.055 -1.545 . . . . 0.0 109.704 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.547 ' CG2' ' HA2' ' A' ' 27' ' ' GLY . 8.2 mt -42.97 98.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.594 ' CD1' ' CD2' ' A' ' 76' ' ' LEU . 6.0 tp -43.44 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.666 0.746 . . . . 0.0 110.318 -177.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' ILE . 23.0 t70 -106.35 -36.37 6.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.704 -0.622 . . . . 0.0 109.327 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -147.35 100.12 3.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.071 . . . . 0.0 110.383 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.53 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 13.5 t -107.55 90.3 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.0 mt -69.63 -4.82 20.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.071 -179.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 10.9 mt-10 -127.63 52.34 1.85 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.7 m-20 -49.45 125.28 10.87 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.734 -0.604 . . . . 0.0 110.77 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.549 ' C ' ' O ' ' A' ' 62' ' ' ASP . 5.1 mt-10 -7.55 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.477 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 65' ' ' THR . . . 128.74 -38.09 2.11 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.439 178.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.488 ' OG1' ' HA ' ' A' ' 61' ' ' GLU . 5.6 m -43.1 145.38 0.52 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -1.189 . . . . 0.0 109.442 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 m -86.72 141.1 29.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.967 . . . . 0.0 110.189 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.529 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.8 168.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.757 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.529 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 5.2 t -120.4 -47.66 2.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -170.31 -75.27 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.728 0.775 . . . . 0.0 109.714 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -78.95 37.18 0.3 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.672 -0.643 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' A' ' 67' ' ' VAL . 3.7 mt-30 -103.34 97.53 7.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.185 . . . . 0.0 108.543 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 3.7 tt -40.6 111.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.795 . . . . 0.0 110.404 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.542 ' HA ' ' CG ' ' A' ' 61' ' ' GLU . 12.0 mt -55.47 -41.2 72.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.84 167.99 21.2 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 4.7 ptt180 -109.87 138.77 45.76 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.109 -1.23 . . . . 0.0 109.833 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.614 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 4.3 mp -115.72 -101.87 0.42 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.795 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.552 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -129.59 153.46 48.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 109.51 -179.715 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.522 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 1.9 tp10 -160.21 -164.79 1.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.58 -170.25 13.85 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.228 -1.16 . . . . 0.0 109.398 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.544 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.797 HG21 ' OE1' ' A' ' 34' ' ' GLU . 40.1 t -69.43 85.96 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.116 -0.99 . . . . 0.0 108.666 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.7 83.44 1.6 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.026 ' CG1' HG22 ' A' ' 48' ' ' VAL . 1.8 tp -105.68 138.31 31.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.342 -0.849 . . . . 0.0 110.443 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.822 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -134.17 -157.75 0.83 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.854 ' CG2' HD21 ' A' ' 73' ' ' LEU . 42.2 t -127.55 68.75 74.53 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 37.3 Cg_endo -81.85 19.97 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.774 2.316 . . . . 0.0 110.712 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.547 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.306 -1.326 0 O-C-N 121.013 -1.054 . . . . 0.0 110.038 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.499 ' C ' HG12 ' A' ' 39' ' ' ILE . 18.4 m -158.21 133.34 8.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.992 . . . . 0.0 110.906 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.598 HG21 ' HB3' ' A' ' 61' ' ' GLU . 29.5 t -71.12 84.04 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.463 -0.773 . . . . 0.0 109.633 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -39.44 -60.58 0.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.897 . . . . 0.0 110.361 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 22' ' ' TRP . 20.1 m -169.13 129.6 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.665 -1.272 . . . . 0.0 111.446 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 1.033 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.7 m95 -69.55 -167.54 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.545 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.4 m-70 -152.68 23.65 0.59 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.582 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 7.1 tppt? -114.99 127.42 55.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.739 -0.6 . . . . 0.0 109.759 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.565 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -72.38 175.93 2.81 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.9 Cg_endo -70.46 95.62 0.62 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.957 1.771 . . . . 0.0 111.103 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.626 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 83.43 39.64 9.66 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.582 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 7.6 m-20 -65.5 -163.52 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.984 -1.304 . . . . 0.0 110.094 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.43 82.21 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.401 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.809 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -79.35 -170.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 110.203 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.809 ' N ' HG13 ' A' ' 30' ' ' VAL . 2.6 m -133.61 -106.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 6.9 mtt180 -92.38 62.03 3.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.695 -1.253 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.659 ' O ' HG21 ' A' ' 30' ' ' VAL . 7.6 m-20 153.7 96.06 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.085 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -94.18 -165.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.03 -1.043 . . . . 0.0 111.701 -178.429 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.823 HG12 ' OE2' ' A' ' 34' ' ' GLU . 7.3 p -51.88 162.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.758 0.79 . . . . 0.0 110.951 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.577 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -139.77 59.83 1.58 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.033 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.4 p -39.04 168.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-O 121.678 0.751 . . . . 0.0 110.616 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.5 mt-10 -131.66 111.15 11.44 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 108.721 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.856 ' O ' HG22 ' A' ' 45' ' ' VAL . 1.7 tt -95.06 -164.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 109.449 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.784 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.3 mt-10 -141.37 99.69 3.62 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.155 -0.966 . . . . 0.0 109.677 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.892 ' HB ' HG23 ' A' ' 44' ' ' VAL . 25.2 m -102.55 44.39 1.02 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.703 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 6.4 t70 76.49 65.61 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.9 ttmt 86.51 -25.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.827 -0.546 . . . . 0.0 109.708 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.892 HG23 ' HB ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -102.93 97.15 5.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.807 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.856 HG22 ' O ' ' A' ' 39' ' ' ILE . 42.8 t -89.87 112.56 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.852 . . . . 0.0 109.167 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.78 ' H ' HD22 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -81.6 -175.74 5.69 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.157 -0.964 . . . . 0.0 109.424 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 28.5 mt-10 -127.02 -178.42 4.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.238 -0.914 . . . . 0.0 109.649 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.026 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -149.5 79.0 8.24 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-O 122.266 1.031 . . . . 0.0 108.976 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.3 Cg_endo -82.5 106.41 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.916 2.41 . . . . 0.0 112.009 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.085 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -75.31 -160.5 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.2 p -138.52 12.8 2.76 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.423 -1.423 . . . . 0.0 110.818 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.43 165.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.937 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 69.81 -86.5 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.496 -0.752 . . . . 0.0 109.625 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.515 ' O ' HD23 ' A' ' 76' ' ' LEU . . . 63.04 -9.76 0.16 Allowed Glycine 0 N--CA 1.496 2.635 0 O-C-N 120.886 -1.134 . . . . 0.0 111.879 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.626 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -41.93 98.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 118.927 1.363 . . . . 0.0 108.356 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.949 HD12 ' HG ' ' A' ' 76' ' ' LEU . 9.9 tp -54.92 98.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.503 -0.748 . . . . 0.0 109.628 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -112.69 -41.49 3.8 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.706 -0.621 . . . . 0.0 109.721 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -136.8 93.97 2.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.836 -1.165 . . . . 0.0 110.409 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.623 HG22 HD11 ' A' ' 56' ' ' LEU . 4.9 t -102.13 88.22 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.058 . . . . 0.0 108.381 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.77 -4.6 20.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.281 -0.887 . . . . 0.0 110.25 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.598 ' HB3' HG21 ' A' ' 19' ' ' VAL . 3.7 mt-10 -127.35 50.7 1.97 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.071 -1.018 . . . . 0.0 108.846 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.8 m-20 -53.6 109.41 0.45 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.56 -0.713 . . . . 0.0 110.494 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.536 ' C ' ' O ' ' A' ' 62' ' ' ASP . 3.2 mp0 8.63 109.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' THR . . . 116.46 -35.37 4.25 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.561 ' CB ' ' HA ' ' A' ' 61' ' ' GLU . 71.4 m -45.08 146.05 0.92 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -1.186 . . . . 0.0 109.169 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.52 131.04 35.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.719 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.804 ' CG1' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.57 171.25 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.766 HG22 ' HG3' ' A' ' 71' ' ' GLN . 4.9 t -139.68 -149.43 0.28 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.232 -0.918 . . . . 0.0 109.279 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.747 ' N ' HG23 ' A' ' 68' ' ' THR . 62.7 p -98.91 74.85 2.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.114 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER 159.4 -21.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.766 ' HG3' HG22 ' A' ' 68' ' ' THR . 4.3 mt-30 -71.37 -171.65 0.64 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.551 -0.718 . . . . 0.0 109.106 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.9 tt -126.44 128.4 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.854 HD21 ' CG2' ' A' ' 7' ' ' VAL . 7.9 mt -64.53 -40.53 95.78 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.27 176.22 23.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.815 ' C ' HD12 ' A' ' 76' ' ' LEU . 1.4 ptm180 -117.22 142.63 46.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.217 -1.167 . . . . 0.0 110.171 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.949 ' HG ' HD12 ' A' ' 56' ' ' LEU . 3.8 mp -112.36 -101.65 0.41 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.544 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 109.068 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.479 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.659 ' O ' HG12 ' A' ' 3' ' ' VAL . 25.0 t -71.48 82.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.031 . . . . 0.0 108.785 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.89 82.86 2.18 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.065 ' CG1' HG22 ' A' ' 48' ' ' VAL . 3.9 tp -101.19 137.29 29.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.728 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.841 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -131.12 -148.22 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.565 ' CG1' ' HA ' ' A' ' 69' ' ' SER . 93.7 t -129.88 92.14 37.87 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.264 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.49 17.97 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.774 2.316 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.584 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 O-C-N 120.871 -1.143 . . . . 0.0 110.152 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.862 HG23 ' O ' ' A' ' 65' ' ' THR . 87.5 m -160.77 136.28 7.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.908 . . . . 0.0 110.07 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.8 t -58.87 143.28 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 108.974 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.811 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -115.24 -53.92 2.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.212 -0.93 . . . . 0.0 109.185 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.681 ' O ' HG23 ' A' ' 21' ' ' THR . 6.6 t -164.41 116.91 1.32 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.26 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.987 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.7 m95 -68.35 -167.5 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.582 ' HB2' HG23 ' A' ' 35' ' ' VAL . 19.4 m80 -152.47 23.65 0.61 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.976 ' O ' HD22 ' A' ' 56' ' ' LEU . 5.7 tppt? -120.4 108.12 13.73 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.789 -0.569 . . . . 0.0 109.713 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -59.55 177.39 0.27 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 29.6 Cg_endo -69.8 96.02 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.812 1.675 . . . . 0.0 111.378 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 85.07 40.87 7.79 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.613 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 5.4 m-20 -57.95 -154.66 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.21 -1.171 . . . . 0.0 109.948 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.89 87.34 0.51 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.569 -1.332 . . . . 0.0 109.461 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.004 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -96.24 178.76 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.329 -0.857 . . . . 0.0 109.725 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.683 HG13 ' H ' ' A' ' 32' ' ' ARG . 1.3 p -135.76 -60.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.106 -0.996 . . . . 0.0 109.901 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.683 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -138.98 65.6 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.078 -1.014 . . . . 0.0 108.928 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 12.9 m-20 146.68 80.45 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.014 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -86.19 -171.48 3.58 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.083 0.944 . . . . 0.0 112.003 -177.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.818 HG12 ' CD ' ' A' ' 34' ' ' GLU . 3.1 p -41.97 159.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 122.066 0.936 . . . . 0.0 111.88 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.88 62.09 1.58 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.3 p -38.87 168.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.876 0.846 . . . . 0.0 110.744 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.811 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -127.41 98.59 5.3 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.783 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -80.12 -163.83 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.502 -0.749 . . . . 0.0 109.278 -179.485 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.783 ' N ' HG23 ' A' ' 39' ' ' ILE . 3.8 mm-40 -152.85 104.99 2.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.892 -1.13 . . . . 0.0 110.007 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.819 HG21 HD21 ' A' ' 46' ' ' LEU . 1.2 p -99.31 -58.18 1.99 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.08 -1.013 . . . . 0.0 109.988 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.596 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 12.8 t0 176.77 83.55 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.2 tttp 86.12 -26.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 44' ' ' VAL . 11.5 m -119.47 132.42 69.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.288 -0.883 . . . . 0.0 109.4 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 39' ' ' ILE . 42.8 t -118.07 114.58 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.31 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.862 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -80.46 147.57 30.86 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.233 -0.917 . . . . 0.0 109.02 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -92.11 179.39 5.59 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.326 -0.859 . . . . 0.0 110.682 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.065 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -141.02 73.95 26.11 Favored Pre-proline 0 N--CA 1.489 1.511 0 CA-C-O 122.414 1.102 . . . . 0.0 108.366 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.28 107.63 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.873 2.382 . . . . 0.0 111.919 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.014 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -73.83 -165.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.715 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.9 OUTLIER -137.96 23.32 2.83 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.484 -1.385 . . . . 0.0 110.194 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.58 161.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.699 ' O ' HG12 ' A' ' 30' ' ' VAL . 6.4 m-20 60.85 -132.92 0.73 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.034 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.664 ' O ' HD23 ' A' ' 76' ' ' LEU . . . 114.87 -18.71 16.45 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.941 HG23 ' HA2' ' A' ' 27' ' ' GLY . 10.6 mt -36.04 99.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.989 HD12 ' HG ' ' A' ' 76' ' ' LEU . 10.9 tp -56.71 98.71 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.561 0.696 . . . . 0.0 109.712 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.402 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 20.1 t70 -117.68 -38.3 3.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.673 -0.642 . . . . 0.0 109.901 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -133.97 91.19 2.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.862 -1.148 . . . . 0.0 110.515 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.523 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 2.4 t -106.97 84.5 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.703 HD12 ' HA2' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -69.98 -3.86 18.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 110.368 -178.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.523 ' OE1' ' CG1' ' A' ' 67' ' ' VAL . 7.7 mt-10 -127.06 46.25 2.55 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.083 -1.011 . . . . 0.0 108.982 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.9 m-20 -51.13 127.23 18.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.454 -0.779 . . . . 0.0 109.707 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' A' ' 62' ' ' ASP . 0.3 OUTLIER -17.62 132.98 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.321 0.582 . . . . 0.0 111.414 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.41 -31.35 7.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.862 ' O ' HG23 ' A' ' 18' ' ' THR . 24.1 m -70.19 170.54 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -1.162 . . . . 0.0 109.539 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.574 ' N ' HG22 ' A' ' 65' ' ' THR . 95.0 m -108.75 140.22 42.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.445 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.727 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -151.1 160.95 3.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.491 ' O ' ' HB ' ' A' ' 7' ' ' VAL . 1.3 m -117.44 -144.15 0.38 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.565 ' HA ' ' CG1' ' A' ' 7' ' ' VAL . 7.9 m -106.07 78.39 1.31 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.134 -0.979 . . . . 0.0 108.588 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 6.0 ttm180 159.34 -21.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.575 ' HB2' HG23 ' A' ' 67' ' ' VAL . 11.0 mm-40 -72.99 131.77 42.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 72' ' ' ILE . 4.7 tt -79.18 111.92 16.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 110.098 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.685 ' CD1' HG11 ' A' ' 37' ' ' VAL . 13.1 mt -46.29 -38.99 9.34 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.703 ' HA2' HD12 ' A' ' 60' ' ' LEU . . . 154.17 169.96 19.57 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.785 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 2.1 ptm180 -110.94 137.06 49.04 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.304 -1.115 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.989 ' HG ' HD12 ' A' ' 56' ' ' LEU . 4.3 mp -102.69 -96.7 0.29 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.068 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.585 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 37.2 m . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.057 HG21 ' OE2' ' A' ' 34' ' ' GLU . 7.7 t -73.98 80.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 108.95 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.58 81.26 2.59 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.076 ' CG1' HG22 ' A' ' 48' ' ' VAL . 6.6 tp -99.34 152.18 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.027 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.962 HD22 ' HG2' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -139.97 -161.65 1.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.081 HG21 HD13 ' A' ' 39' ' ' ILE . 96.5 t -130.97 67.24 80.62 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.045 -1.034 . . . . 0.0 109.484 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.518 ' HG3' HD13 ' A' ' 6' ' ' LEU . 36.1 Cg_endo -79.08 57.75 6.62 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.751 2.301 . . . . 0.0 110.878 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 1.003 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.343 0 O-C-N 121.14 -0.975 . . . . 0.0 109.493 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 65' ' ' THR . 17.6 m -160.75 143.83 13.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.001 -1.062 . . . . 0.0 110.693 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.941 HG12 ' OE1' ' A' ' 63' ' ' GLU . 1.9 t -65.73 149.09 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -126.96 -47.22 1.51 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.953 -1.092 . . . . 0.0 110.309 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.521 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -162.7 109.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.749 -1.219 . . . . 0.0 111.674 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.964 ' HA ' HG23 ' A' ' 37' ' ' VAL . 15.9 m95 -67.65 -162.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 0.0 108.503 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.747 ' HB2' HG23 ' A' ' 35' ' ' VAL . 33.4 m80 -158.1 34.82 0.25 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.906 ' CB ' HD23 ' A' ' 56' ' ' LEU . 4.7 mmpt? -119.64 108.48 14.51 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.32 0.581 . . . . 0.0 110.376 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -59.56 -178.12 0.12 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.4 Cg_endo -67.99 89.99 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.105 1.203 . . . . 0.0 110.764 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.549 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 78.07 46.04 9.7 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 10.8 m-20 -59.55 -161.48 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.721 -1.458 . . . . 0.0 109.335 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.38 85.42 0.72 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.959 -1.088 . . . . 0.0 109.147 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.013 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.12 -176.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.357 -0.84 . . . . 0.0 109.894 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.687 HG13 ' H ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -142.47 -72.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.359 -0.838 . . . . 0.0 109.599 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.687 ' H ' HG13 ' A' ' 31' ' ' VAL . 8.3 mmt180 -121.5 63.85 0.9 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.001 -1.062 . . . . 0.0 109.519 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 6.1 m-20 145.04 84.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.066 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 21.5 tt0 -84.89 170.15 13.39 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.218 1.009 . . . . 0.0 112.002 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.747 HG23 ' HB2' ' A' ' 23' ' ' HIS . 3.5 p -31.08 155.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.912 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.771 ' H ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -136.32 64.83 1.54 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 178.262 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.964 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.3 p -38.67 170.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.783 0.802 . . . . 0.0 110.725 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.801 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.8 mm-40 -125.8 96.59 4.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.132 -0.98 . . . . 0.0 109.098 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.081 HD13 HG21 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -79.88 -159.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.059 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.795 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.9 mm-40 -147.03 101.46 3.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.789 -1.194 . . . . 0.0 109.992 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -93.47 -152.0 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.337 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 20.4 t0 -94.16 88.0 5.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER 85.61 -23.85 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.755 -0.591 . . . . 0.0 109.612 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 41' ' ' THR . 23.0 t -116.33 137.12 51.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.236 -0.915 . . . . 0.0 109.503 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 39' ' ' ILE . 2.2 p -113.11 107.17 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.003 HD13 ' HB2' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -79.49 179.19 7.6 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.183 -0.948 . . . . 0.0 108.935 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -126.65 -163.75 1.27 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.981 -1.074 . . . . 0.0 110.269 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.076 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -151.26 75.76 7.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-O 122.278 1.037 . . . . 0.0 108.833 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.5 Cg_endo -81.01 115.32 2.99 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.801 2.334 . . . . 0.0 112.009 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.066 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -83.7 -167.65 1.81 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.73 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.0 p -131.54 18.09 4.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.129 -1.607 . . . . 0.0 111.135 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.46 160.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.869 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.5 t70 64.7 -140.39 0.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 55' ' ' ILE . . . 116.71 -15.98 14.11 Favored Glycine 0 N--CA 1.489 2.22 0 O-C-N 120.218 -1.551 . . . . 0.0 110.671 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.575 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -32.01 94.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 117.884 0.842 . . . . 0.0 109.449 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.927 HD11 HG21 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -46.69 100.78 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.521 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.6 t70 -120.56 -46.02 2.39 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.201 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -135.55 107.55 7.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.749 -1.219 . . . . 0.0 110.818 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.927 HG21 HD11 ' A' ' 56' ' ' LEU . 1.4 t -113.17 90.86 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.81 -4.6 20.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.217 -0.927 . . . . 0.0 110.022 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 3.1 mt-10 -128.22 39.37 3.85 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.6 m-20 -40.67 136.15 1.44 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.732 -0.605 . . . . 0.0 109.699 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.941 ' OE1' HG12 ' A' ' 19' ' ' VAL . 67.4 mm-40 -27.82 146.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.537 0.684 . . . . 0.0 111.494 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.14 -2.11 87.62 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 18' ' ' THR . 24.2 m -94.15 154.96 17.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.165 -1.197 . . . . 0.0 109.352 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.53 148.46 22.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.179 -0.951 . . . . 0.0 109.644 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.733 HG11 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -150.32 155.33 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.46 -0.775 . . . . 0.0 108.931 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.791 HG23 ' N ' ' A' ' 69' ' ' SER . 7.4 t -100.78 -142.15 0.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.791 ' N ' HG23 ' A' ' 68' ' ' THR . 72.5 m -68.87 -99.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.779 -1.201 . . . . 0.0 108.239 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.962 ' HG2' HD22 ' A' ' 6' ' ' LEU . 7.4 ttp180 -75.11 76.22 2.28 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.376 -0.827 . . . . 0.0 109.88 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.636 ' HB2' HG23 ' A' ' 67' ' ' VAL . 2.3 mm-40 -113.92 95.34 5.26 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 72' ' ' ILE . 7.9 tt -38.7 109.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.649 -0.657 . . . . 0.0 110.807 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.927 HD21 HG23 ' A' ' 7' ' ' VAL . 12.1 mt -56.7 -39.94 74.74 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.98 -179.4 35.55 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -118.18 135.67 54.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.218 -1.166 . . . . 0.0 110.122 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.927 ' HG ' HD22 ' A' ' 56' ' ' LEU . 2.1 mp -99.25 -91.65 0.28 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.575 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 10.4 tpp180 . . . . . 0 C--N 1.295 -1.771 0 O-C-N 121.508 -0.745 . . . . 0.0 109.282 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 62.3 t -81.56 70.55 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 108.798 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -74.07 84.04 1.79 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.822 HG12 HG13 ' A' ' 48' ' ' VAL . 8.0 tp -99.73 163.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 111.297 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.859 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -147.31 -159.86 1.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.815 HG21 ' CG2' ' A' ' 67' ' ' VAL . 2.1 t -133.15 56.11 20.09 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.121 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -80.58 35.94 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.5 2.134 . . . . 0.0 110.824 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.568 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.1 m-20 . . . . . 0 C--N 1.306 -1.283 0 O-C-N 120.801 -1.187 . . . . 0.0 109.966 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 121.167 0.508 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.485 ' N ' HG13 ' A' ' 67' ' ' VAL . 46.8 m -155.55 124.15 5.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 110.54 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.938 HG22 HD11 ' A' ' 39' ' ' ILE . 17.0 t -65.52 107.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.23 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -73.8 -59.62 2.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.614 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.586 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.6 m -168.69 128.52 1.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.628 -1.295 . . . . 0.0 111.775 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.995 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.6 m95 -69.2 -166.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.661 0.743 . . . . 0.0 109.24 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.1 m80 -152.7 26.47 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.549 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.6 tppt? -119.36 137.91 53.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.69 -0.631 . . . . 0.0 110.132 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.599 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.28 179.29 1.71 Allowed Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -69.64 104.91 1.37 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.664 1.576 . . . . 0.0 111.62 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 75.03 39.52 37.49 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 4.8 m-20 -59.45 -166.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.718 -1.46 . . . . 0.0 109.597 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.17 78.56 0.45 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.08 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.698 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -79.55 169.26 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.009 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -110.06 -95.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 1.6 mtm180 -107.2 51.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.961 -1.087 . . . . 0.0 109.63 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.698 ' O ' HG21 ' A' ' 30' ' ' VAL . 4.2 m-20 173.04 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.949 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 10.3 tp10 -102.29 163.62 12.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.058 -1.026 . . . . 0.0 111.008 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.598 HG12 ' HG3' ' A' ' 34' ' ' GLU . 2.5 p -30.36 160.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.57 1.176 . . . . 0.0 112.581 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.533 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.12 67.63 1.37 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.087 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.995 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.1 p -38.59 165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.102 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.27 145.71 46.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.938 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -134.77 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.722 ' N ' HG23 ' A' ' 39' ' ' ILE . 13.1 mt-10 -149.35 138.51 21.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.923 -1.11 . . . . 0.0 109.708 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 5.9 t -132.72 26.22 4.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 41' ' ' THR . 2.2 t70 87.34 15.31 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.341 0.591 . . . . 0.0 110.459 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 160.52 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 1.1 t -103.99 148.57 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.613 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 39' ' ' ILE . 51.2 t -136.93 96.76 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.685 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.769 ' N ' HD22 ' A' ' 46' ' ' LEU . 2.9 mm? -79.88 -176.0 5.21 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.309 -0.869 . . . . 0.0 108.728 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 1.3 pt-20 -142.39 -161.36 1.23 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.718 -1.239 . . . . 0.0 111.463 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.822 HG13 HG12 ' A' ' 5' ' ' ILE . 6.0 t -143.47 75.5 16.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.7 Cg_endo -80.73 110.82 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.487 2.125 . . . . 0.0 110.931 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.949 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -91.79 -169.38 2.26 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.1 p -132.36 14.68 4.57 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.265 -1.522 . . . . 0.0 111.183 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.62 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 109.951 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER 60.63 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.548 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 64.95 -13.65 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 O-C-N 121.324 -0.86 . . . . 0.0 112.093 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.651 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.81 96.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.674 -1.486 . . . . 0.0 108.551 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.925 HD12 ' HG ' ' A' ' 76' ' ' LEU . 7.8 tp -49.87 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ILE . 46.6 t0 -98.6 -41.59 7.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.97 -0.456 . . . . 0.0 110.544 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -147.37 78.71 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.577 -1.327 . . . . 0.0 111.677 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.74 ' CG2' HD11 ' A' ' 56' ' ' LEU . 60.7 t -80.86 82.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.37 -10.8 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 109.709 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 4.8 mm-40 -123.74 50.93 1.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -40.8 134.12 1.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.586 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.05 134.51 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.597 0.713 . . . . 0.0 111.015 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.75 -13.96 24.64 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -84.98 156.19 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -1.135 . . . . 0.0 109.405 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.41 166.43 20.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.681 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.815 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.04 169.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -147.78 -148.31 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 9.3 p -90.28 36.18 0.87 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mtt180 163.55 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.4 mt-30 -84.49 87.69 7.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 0.0 109.102 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.4 tt -45.0 108.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 48' ' ' VAL . 10.6 mt -53.91 -42.86 69.21 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 156.55 -159.79 29.76 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.549 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -134.68 134.49 41.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.151 -1.206 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.925 ' HG ' HD12 ' A' ' 56' ' ' LEU . 4.4 mp -98.09 -96.72 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.34 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.542 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 77' ' ' ARG . 35.3 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.873 HG21 ' OE1' ' A' ' 34' ' ' GLU . 8.8 t -78.96 77.52 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.2 -0.937 . . . . 0.0 109.317 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.79 83.86 2.75 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.85 HG12 HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -101.24 149.19 6.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.325 -0.859 . . . . 0.0 111.628 -177.032 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.849 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.43 -158.59 0.9 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.101 ' CG2' HD21 ' A' ' 73' ' ' LEU . 72.7 t -136.04 58.09 21.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.084 -1.01 . . . . 0.0 110.247 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.1 Cg_endo -80.7 19.81 1.06 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.39 2.06 . . . . 0.0 111.124 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.578 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 1.5 m-20 . . . . . 0 C--N 1.308 -1.201 0 O-C-N 120.769 -1.207 . . . . 0.0 109.913 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.588 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 21.2 m -160.33 121.78 3.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.335 -0.853 . . . . 0.0 109.934 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.667 HG22 HD11 ' A' ' 39' ' ' ILE . 13.4 t -63.97 91.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.135 -0.978 . . . . 0.0 109.108 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -54.65 -57.83 9.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 110.707 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.626 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 40.3 m -166.5 122.88 1.25 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.709 -1.244 . . . . 0.0 111.654 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 1.027 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.4 m95 -67.85 -165.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.681 ' HB2' HG23 ' A' ' 35' ' ' VAL . 75.5 m-70 -148.92 22.03 0.98 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.521 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.59 154.36 31.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.676 -0.64 . . . . 0.0 109.678 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.642 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -105.61 -173.41 0.28 Allowed Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.642 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.84 83.73 0.53 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.075 1.183 . . . . 0.0 111.247 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.711 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 81.11 48.08 6.21 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.757 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.2 m-20 -55.83 -113.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -1.182 . . . . 0.0 110.005 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 163.05 72.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.448 -1.408 . . . . 0.0 109.98 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.981 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -79.66 157.09 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.112 -0.992 . . . . 0.0 110.652 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 2.6 m -97.51 -107.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 12.8 ttt-85 -104.9 74.84 1.15 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.693 -1.254 . . . . 0.0 108.965 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.594 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 11.4 m-20 143.96 102.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.981 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -112.21 -173.3 2.22 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.533 -177.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.775 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 13.1 p -27.68 153.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.953 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.1 58.82 1.7 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 178.019 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.027 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.1 p -37.75 168.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.731 0.776 . . . . 0.0 110.761 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.413 ' H ' HG22 ' A' ' 37' ' ' VAL . 2.7 mt-10 -126.67 142.18 51.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.889 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -128.14 -179.63 3.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 121.276 -0.89 . . . . 0.0 109.387 -179.038 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.638 ' N ' HG23 ' A' ' 39' ' ' ILE . 15.4 mt-10 -137.83 127.63 25.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.782 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 44' ' ' VAL . 8.5 t -132.13 25.89 4.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 0.0 109.49 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.3 t0 81.32 87.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.709 -0.62 . . . . 0.0 110.544 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.9 tttp 85.72 -27.62 0.08 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.869 -0.519 . . . . 0.0 110.403 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.57 ' O ' HG22 ' A' ' 41' ' ' THR . 0.2 OUTLIER -114.81 142.19 28.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.961 -1.087 . . . . 0.0 109.964 -179.753 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.889 HG13 ' O ' ' A' ' 39' ' ' ILE . 39.8 t -139.32 100.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.138 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 3.3 mm? -81.65 -166.45 1.2 Allowed 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.537 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -143.45 -161.8 1.33 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.182 -0.949 . . . . 0.0 110.122 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.85 HG22 HG12 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -156.02 77.2 4.56 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 109.948 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.5 Cg_endo -79.89 107.63 2.12 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.419 2.079 . . . . 0.0 110.031 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.888 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . . . -76.11 -167.22 0.71 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -143.06 24.02 1.84 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.461 -1.4 . . . . 0.0 110.819 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.69 118.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.73 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.63 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 66.0 m-20 106.65 -117.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.559 ' CA ' ' OE1' ' A' ' 34' ' ' GLU . . . 100.28 -26.79 23.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.797 HD12 ' HD3' ' A' ' 77' ' ' ARG . 6.1 mt -43.78 98.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 108.089 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.109 HD12 HD22 ' A' ' 76' ' ' LEU . 10.6 tp -51.57 100.92 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.391 -0.818 . . . . 0.0 109.698 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.446 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 33.4 t0 -101.2 -46.75 4.95 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.754 -0.591 . . . . 0.0 109.598 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.64 96.79 2.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.884 -1.135 . . . . 0.0 110.529 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.923 HG21 HD21 ' A' ' 56' ' ' LEU . 2.6 t -94.71 90.9 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.965 . . . . 0.0 108.505 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.982 HD12 ' HA2' ' A' ' 74' ' ' GLY . 1.6 mt -71.23 -2.04 14.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.849 . . . . 0.0 110.329 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.513 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 7.7 mt-10 -135.61 54.3 1.92 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.155 -0.965 . . . . 0.0 108.471 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.4 m-20 -43.91 130.36 5.78 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.488 -0.758 . . . . 0.0 109.553 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -34.63 116.34 0.31 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.343 0.592 . . . . 0.0 110.953 -179.366 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.09 -6.39 7.27 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 m -95.18 162.92 13.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -1.179 . . . . 0.0 109.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -78.43 156.96 29.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.243 -0.911 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.801 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.74 174.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.584 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -143.82 -164.92 1.99 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 108.81 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.554 ' H ' HG22 ' A' ' 68' ' ' THR . 60.2 p -85.76 63.31 7.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.047 -1.033 . . . . 0.0 109.185 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.551 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.8 mmm-85 159.81 -16.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.606 -0.684 . . . . 0.0 109.923 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HB2' HG23 ' A' ' 67' ' ' VAL . 21.1 mm100 -53.27 143.74 17.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.422 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 72' ' ' ILE . 16.8 tt -95.59 112.06 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.3 -0.875 . . . . 0.0 109.682 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.101 HD21 ' CG2' ' A' ' 7' ' ' VAL . 9.3 mt -53.13 -31.46 42.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.982 ' HA2' HD12 ' A' ' 60' ' ' LEU . . . 139.63 -166.63 25.54 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.517 ' C ' HD23 ' A' ' 76' ' ' LEU . 1.5 ptt85 -128.84 140.23 51.8 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.27 -1.135 . . . . 0.0 109.534 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.109 HD22 HD12 ' A' ' 56' ' ' LEU . 8.2 mt -100.74 -121.66 0.16 Allowed 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.128 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.797 ' HD3' HD12 ' A' ' 55' ' ' ILE . 19.2 ttt-85 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 120.595 -1.316 . . . . 0.0 110.015 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.123 HG12 ' CD1' ' A' ' 5' ' ' ILE . 15.7 t -88.91 63.22 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.292 -0.88 . . . . 0.0 109.652 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -85.26 89.44 7.65 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.123 ' CD1' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -103.18 171.79 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 120.849 -1.157 . . . . 0.0 112.231 -177.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.869 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -142.12 -156.56 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.168 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 67' ' ' VAL . 59.9 t -129.35 54.38 14.21 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.036 -1.04 . . . . 0.0 110.724 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.695 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -80.3 28.02 0.54 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.473 2.115 . . . . 0.0 110.561 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.851 ' CB ' HD13 ' A' ' 46' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.307 -1.25 0 O-C-N 120.972 -1.08 . . . . 0.0 109.707 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.487 ' C ' HG13 ' A' ' 39' ' ' ILE . 96.7 m -159.39 139.76 12.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.126 -0.984 . . . . 0.0 110.174 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.543 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 14.2 t -73.2 91.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.402 -0.811 . . . . 0.0 109.373 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -52.65 -62.92 1.34 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.389 -0.82 . . . . 0.0 110.431 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.611 HG23 ' OE1' ' A' ' 63' ' ' GLU . 2.9 m -161.62 122.67 2.75 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.499 -1.28 . . . . 0.0 111.812 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.99 ' HA ' HG23 ' A' ' 37' ' ' VAL . 13.7 m95 -67.93 -165.56 0.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.412 -0.805 . . . . 0.0 109.034 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.716 ' HB2' HG23 ' A' ' 35' ' ' VAL . 33.8 m80 -150.24 31.39 0.68 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.563 ' HG2' ' HB ' ' A' ' 35' ' ' VAL . 2.8 mtpp -122.16 177.84 5.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.925 0.869 . . . . 0.0 110.844 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.681 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 8.2 mmmt -131.98 -177.62 0.72 Allowed Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.681 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -69.25 86.0 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.166 1.244 . . . . 0.0 110.646 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.817 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 86.07 47.36 5.02 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.567 ' O ' ' CG1' ' A' ' 55' ' ' ILE . 12.8 m-20 -54.31 -158.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -1.095 . . . . 0.0 110.055 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.33 86.74 0.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.54 -1.35 . . . . 0.0 109.179 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.044 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -95.13 170.46 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 110.011 -179.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.667 HG13 ' H ' ' A' ' 32' ' ' ARG . 1.5 p -133.88 -57.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.317 -0.865 . . . . 0.0 109.386 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.667 ' H ' HG13 ' A' ' 31' ' ' VAL . 3.2 mtp180 -141.18 64.16 1.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 108.82 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 11.6 m-20 149.6 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.044 ' HA ' HG21 ' A' ' 30' ' ' VAL . 11.9 tt0 -94.1 167.77 11.37 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.328 1.061 . . . . 0.0 111.726 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.716 HG23 ' HB2' ' A' ' 23' ' ' HIS . 2.4 p -31.16 156.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 122.174 0.987 . . . . 0.0 112.168 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.543 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.98 64.57 1.5 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 177.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.99 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.0 p -37.86 165.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.729 0.776 . . . . 0.0 110.268 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.4 mm-40 -128.37 98.47 5.07 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 108.806 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.93 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -79.75 -168.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.743 ' N ' HG23 ' A' ' 39' ' ' ILE . 8.5 mt-10 -136.59 114.58 11.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.951 -1.093 . . . . 0.0 110.275 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.532 HG22 ' N ' ' A' ' 42' ' ' ASP . 98.1 m -106.33 -103.23 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.23 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 2.3 t70 -144.85 95.16 2.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.102 -0.998 . . . . 0.0 108.99 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.571 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 23.1 tttm 85.66 -28.02 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.307 0.575 . . . . 0.0 109.452 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 45' ' ' VAL . 2.0 t -118.95 -177.05 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.126 -0.984 . . . . 0.0 109.223 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 39' ' ' ILE . 44.4 t -148.64 120.42 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 109.577 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.851 HD13 ' CB ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -79.43 159.46 27.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 4.4 mt-10 -124.07 -173.45 2.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.058 -1.026 . . . . 0.0 110.132 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.987 HG22 HG21 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -148.86 66.49 8.84 Favored Pre-proline 0 N--CA 1.487 1.409 0 CA-C-O 121.911 0.862 . . . . 0.0 109.041 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 33.8 Cg_endo -75.15 115.7 4.34 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.679 2.253 . . . . 0.0 110.998 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.02 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -91.91 -177.0 4.6 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.72 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 51.5 p -129.68 21.32 5.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.747 -1.221 . . . . 0.0 110.07 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 162.69 161.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.432 -0.792 . . . . 0.0 109.076 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.716 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.8 m-20 75.82 -145.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 117.03 -18.91 12.19 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 120.475 -1.391 . . . . 0.0 110.256 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.817 HG23 ' HA2' ' A' ' 27' ' ' GLY . 18.9 mt -46.61 95.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.136 -1.214 . . . . 0.0 107.77 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.101 HD12 ' CD1' ' A' ' 76' ' ' LEU . 7.2 tp -53.27 109.42 0.43 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.375 -0.828 . . . . 0.0 109.398 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 20.1 t70 -113.54 -53.87 2.66 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.741 -0.599 . . . . 0.0 110.358 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.666 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -132.64 79.51 1.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.694 -1.254 . . . . 0.0 110.952 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.921 HG21 HD21 ' A' ' 56' ' ' LEU . 10.1 t -81.07 87.98 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.76 -1.6 12.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.465 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 51.8 mt-10 -134.03 52.51 2.06 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.013 -1.055 . . . . 0.0 108.456 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -43.5 131.59 4.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.599 -0.688 . . . . 0.0 109.769 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.611 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.2 OUTLIER -36.1 111.38 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.327 0.584 . . . . 0.0 110.587 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.86 4.31 7.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -101.74 162.11 13.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -1.2 . . . . 0.0 109.596 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.23 151.61 36.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.595 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.98 173.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.931 HG22 ' HG2' ' A' ' 71' ' ' GLN . 5.2 t -140.33 -157.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 108.829 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.596 ' N ' HG23 ' A' ' 68' ' ' THR . 88.7 p -90.32 63.87 5.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.977 -1.077 . . . . 0.0 109.406 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.518 ' CB ' ' O ' ' A' ' 69' ' ' SER . 4.2 ttt180 159.54 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.648 -0.658 . . . . 0.0 109.458 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.931 ' HG2' HG22 ' A' ' 68' ' ' THR . 19.0 mm-40 -48.79 138.44 11.13 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.414 -0.804 . . . . 0.0 109.444 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 72' ' ' ILE . 5.8 tt -87.55 114.36 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.383 -0.823 . . . . 0.0 109.818 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.588 HD13 HG11 ' A' ' 37' ' ' VAL . 5.2 mt -49.35 -39.64 32.61 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 146.86 -173.99 26.85 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.666 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -117.87 140.98 48.94 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.159 -1.2 . . . . 0.0 109.317 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.101 ' CD1' HD12 ' A' ' 56' ' ' LEU . 3.6 mm? -88.17 -92.33 0.11 Allowed 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.334 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.576 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 110.022 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.77 ' O ' HG12 ' A' ' 3' ' ' VAL . 34.7 t -88.81 72.82 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.901 . . . . 0.0 109.411 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.63 80.99 4.09 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.791 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -94.32 156.7 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.28 -0.887 . . . . 0.0 111.327 -177.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.886 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -139.57 -155.54 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.993 ' CG1' HD12 ' A' ' 46' ' ' LEU . 16.5 t -136.9 63.68 46.16 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.955 -1.091 . . . . 0.0 109.84 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HB3' ' CG ' ' A' ' 70' ' ' ARG . 36.5 Cg_endo -80.59 43.22 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.78 2.32 . . . . 0.0 110.252 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.983 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 O-C-N 121.179 -0.951 . . . . 0.0 109.957 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 16.0 m -159.69 134.91 8.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 110.546 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.568 ' HA ' HG13 ' A' ' 39' ' ' ILE . 23.8 t -70.42 84.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.455 -0.778 . . . . 0.0 109.251 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -41.18 -62.81 0.77 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.313 -0.867 . . . . 0.0 110.327 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.865 HG23 ' OE1' ' A' ' 63' ' ' GLU . 22.5 m -164.95 128.05 2.29 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.564 -1.255 . . . . 0.0 111.456 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 1.022 ' HA ' HG23 ' A' ' 37' ' ' VAL . 16.4 m95 -68.54 -167.69 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.632 ' HB2' HG23 ' A' ' 35' ' ' VAL . 60.9 m-70 -149.56 35.38 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.665 ' HB3' HD13 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -131.62 168.51 17.58 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.511 0.672 . . . . 0.0 110.195 -179.049 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.648 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -121.5 -171.09 0.21 Allowed Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 178.365 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.648 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -68.45 84.91 0.46 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 120.831 1.021 . . . . 0.0 111.262 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.758 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 77.05 48.86 8.0 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.715 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 20.8 m-20 -54.5 -112.13 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.253 -1.145 . . . . 0.0 110.911 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 157.48 103.63 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.975 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -104.35 176.51 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 120.672 -1.268 . . . . 0.0 111.688 -177.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.617 ' H ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -114.37 -137.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -80.69 76.86 7.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.833 -1.167 . . . . 0.0 108.19 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 4.4 m-20 150.22 79.15 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.004 ' OE1' HG12 ' A' ' 35' ' ' VAL . 2.7 tm-20 -83.26 171.36 13.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 0.0 112.438 -177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.004 HG12 ' OE1' ' A' ' 34' ' ' GLU . 2.0 p -31.49 156.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.745 0.784 . . . . 0.0 111.687 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.539 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.05 63.27 1.34 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 178.482 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.022 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.2 p -39.38 168.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.681 0.753 . . . . 0.0 110.2 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.684 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.3 mt-10 -131.17 103.51 6.53 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 109.015 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.816 HG23 ' N ' ' A' ' 40' ' ' GLU . 2.8 tt -84.14 -159.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.369 -0.832 . . . . 0.0 109.425 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.816 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.8 mm-40 -139.8 127.48 21.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.928 -1.108 . . . . 0.0 109.801 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 41' ' ' THR . 84.8 m -132.69 16.62 4.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.852 . . . . 0.0 109.665 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 15.2 t0 72.19 85.49 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.161 -0.962 . . . . 0.0 109.684 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 86.38 -27.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.24 0.543 . . . . 0.0 109.59 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.9 t -115.47 144.97 21.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.143 -0.973 . . . . 0.0 109.281 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 39' ' ' ILE . 38.1 t -133.17 118.54 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.758 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.993 HD12 ' CG1' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -79.55 159.75 26.74 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.159 -0.963 . . . . 0.0 108.632 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -119.0 172.29 7.65 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.009 -1.057 . . . . 0.0 110.315 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.901 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.0 t -137.55 70.75 52.56 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.5 Cg_endo -79.72 116.3 3.47 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.838 2.358 . . . . 0.0 111.465 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.794 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -98.42 172.49 7.5 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 20.0 p -116.04 77.93 1.14 Allowed 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.087 -1.445 . . . . 0.0 110.618 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 88.81 160.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.245 0.545 . . . . 0.0 109.919 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.6 m-20 79.97 -76.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.699 -0.625 . . . . 0.0 110.219 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.561 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 40.94 22.51 0.06 OUTLIER Glycine 0 N--CA 1.493 2.455 0 O-C-N 121.033 -1.042 . . . . 0.0 110.788 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.758 HG23 ' CA ' ' A' ' 27' ' ' GLY . 12.5 mt -72.21 94.57 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.912 -1.346 . . . . 0.0 108.064 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.936 HD21 HG21 ' A' ' 59' ' ' VAL . 5.1 tp -47.78 91.28 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.752 0.787 . . . . 0.0 110.389 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.2 t70 -84.0 -50.56 7.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.49 99.91 2.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.979 -1.076 . . . . 0.0 110.627 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.936 HG21 HD21 ' A' ' 56' ' ' LEU . 4.0 t -83.35 90.73 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 60' ' ' LEU . 55.4 mt -69.09 -7.37 35.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 0.0 109.693 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 73' ' ' LEU . 2.9 mt-10 -131.72 52.76 2.04 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 63' ' ' GLU . 7.0 m-20 -40.93 134.17 2.0 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.46 0.648 . . . . 0.0 109.689 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.865 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -36.08 125.7 0.75 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.485 0.66 . . . . 0.0 110.82 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.23 -4.57 21.95 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 66' ' ' THR . 21.5 m -84.15 166.33 17.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.227 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.604 ' N ' HG22 ' A' ' 65' ' ' THR . 90.0 m -93.73 137.58 32.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.731 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.849 HG21 HG21 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -150.22 153.54 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.492 HG23 ' H ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -116.22 -97.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.057 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.492 ' H ' HG23 ' A' ' 68' ' ' THR . 28.7 p -94.99 -125.68 0.12 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.54 ' CG ' ' HB3' ' A' ' 8' ' ' PRO . 51.7 mtp180 -56.59 84.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.008 -1.058 . . . . 0.0 110.032 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -118.07 85.13 2.29 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.7 tt -34.25 107.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.885 -0.51 . . . . 0.0 111.107 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.874 ' CD1' HG21 ' A' ' 48' ' ' VAL . 15.7 mt -57.3 -38.36 73.87 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.79 -160.49 31.98 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.806 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -135.76 145.98 47.15 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.253 -1.145 . . . . 0.0 109.775 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.806 HD23 ' O ' ' A' ' 75' ' ' ARG . 2.4 mt -129.45 -137.0 0.22 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.568 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 120.779 -1.201 . . . . 0.0 109.228 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.463 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 8.0 t -69.43 98.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 108.733 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -71.91 85.65 0.97 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.903 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -81.17 121.35 34.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.545 -0.722 . . . . 0.0 109.904 -178.475 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.88 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -145.47 -165.64 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.94 HG21 HG21 ' A' ' 67' ' ' VAL . 29.2 t -134.78 56.9 18.81 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.232 -0.918 . . . . 0.0 109.924 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.668 ' CD ' HD13 ' A' ' 6' ' ' LEU . 37.1 Cg_endo -80.48 36.82 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.495 2.13 . . . . 0.0 110.517 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.549 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.304 -1.392 0 O-C-N 120.948 -1.095 . . . . 0.0 109.593 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.708 ' HB3' HG22 ' A' ' 67' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.292 0.568 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 20.4 m -153.39 131.71 12.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.375 -0.828 . . . . 0.0 110.317 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.741 HG22 HD11 ' A' ' 39' ' ' ILE . 11.4 t -70.18 83.69 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.386 -0.822 . . . . 0.0 109.493 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 19' ' ' VAL . . . -41.96 -63.27 0.76 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 110.493 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 5.4 m -166.94 129.05 1.71 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.59 -1.319 . . . . 0.0 111.479 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.903 ' CZ2' HG21 ' A' ' 5' ' ' ILE . 21.9 m95 -69.66 -167.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.531 0.682 . . . . 0.0 109.292 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.601 ' HB2' HG23 ' A' ' 35' ' ' VAL . 50.3 m-70 -151.83 28.26 0.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.551 ' CE ' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -118.1 167.52 11.4 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.714 0.768 . . . . 0.0 110.434 -178.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.636 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -115.54 -179.83 0.68 Allowed Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -70.74 87.23 0.68 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.426 1.417 . . . . 0.0 110.932 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.605 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 88.2 41.71 6.13 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD1' ' CG ' ' A' ' 25' ' ' LYS . 13.6 m-20 -55.52 -164.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.995 -1.297 . . . . 0.0 109.685 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.43 77.67 0.62 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.019 -1.051 . . . . 0.0 109.391 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.977 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -79.5 -179.06 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.373 -0.829 . . . . 0.0 109.609 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.634 ' N ' HG13 ' A' ' 30' ' ' VAL . 1.5 m -139.1 -48.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.098 -1.001 . . . . 0.0 110.241 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.563 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -150.83 62.27 0.93 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.4 m-20 150.73 75.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.024 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.55 -170.41 3.04 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.298 1.047 . . . . 0.0 111.871 -177.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.849 HG12 ' CD ' ' A' ' 34' ' ' GLU . 3.8 p -50.46 161.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.929 0.871 . . . . 0.0 111.639 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -140.2 61.4 1.53 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.503 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.08 HG12 HG12 ' A' ' 48' ' ' VAL . 4.2 p -38.52 168.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.773 0.797 . . . . 0.0 110.736 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.662 ' HB3' HG11 ' A' ' 45' ' ' VAL . 8.2 mt-10 -129.13 125.23 36.66 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.905 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -111.36 -172.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.298 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.706 ' N ' HG23 ' A' ' 39' ' ' ILE . 6.1 mt-10 -134.98 128.78 33.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.998 . . . . 0.0 109.586 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 44' ' ' VAL . 12.4 t -125.92 -32.08 2.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 110.042 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.591 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.1 t70 158.94 70.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.591 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.9 tttm 85.79 -25.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 41' ' ' THR . 92.7 t -108.27 133.78 52.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.34 -0.85 . . . . 0.0 109.267 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.905 HG13 ' O ' ' A' ' 39' ' ' ILE . 55.9 t -118.36 112.52 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.117 -0.989 . . . . 0.0 109.729 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.827 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.29 -179.85 7.0 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.294 -0.878 . . . . 0.0 108.678 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 51.5 mt-10 -141.47 -171.38 3.29 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.86 -1.15 . . . . 0.0 110.451 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.08 HG12 HG12 ' A' ' 37' ' ' VAL . 14.8 p -146.35 75.4 12.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.388 -0.82 . . . . 0.0 109.678 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.749 ' HB3' HD23 ' A' ' 36' ' ' LEU . 35.0 Cg_endo -77.48 105.27 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.225 1.95 . . . . 0.0 110.385 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.024 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -77.56 -177.98 5.04 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.709 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.2 t -130.22 26.61 5.14 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.384 -1.448 . . . . 0.0 110.282 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.1 160.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.512 -0.743 . . . . 0.0 109.246 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.758 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.4 m-20 62.24 -136.32 0.48 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.263 -0.898 . . . . 0.0 108.956 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.745 ' O ' HD23 ' A' ' 76' ' ' LEU . . . 111.9 -17.83 24.66 Favored Glycine 0 N--CA 1.488 2.162 0 O-C-N 120.505 -1.372 . . . . 0.0 109.723 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.605 HG22 ' HA2' ' A' ' 27' ' ' GLY . 1.2 mt -34.24 102.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.789 -0.83 . . . . 0.0 109.371 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.876 HD12 ' HG ' ' A' ' 76' ' ' LEU . 12.2 tp -58.43 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.526 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -114.11 -29.49 6.96 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.405 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.851 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -138.69 106.57 5.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.831 -1.168 . . . . 0.0 110.506 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.809 ' CG2' HD11 ' A' ' 56' ' ' LEU . 18.2 t -127.56 76.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.78 -4.15 18.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.554 -0.716 . . . . 0.0 110.563 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.59 ' HG2' HG21 ' A' ' 65' ' ' THR . 10.0 mt-10 -128.32 50.37 2.09 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 108.787 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 63' ' ' GLU . 7.2 m-20 -51.18 118.2 3.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.568 -0.707 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 62' ' ' ASP . 1.6 mp0 5.56 113.25 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.21 -32.3 6.2 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.59 HG21 ' HG2' ' A' ' 61' ' ' GLU . 78.9 m -54.3 153.23 5.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -1.135 . . . . 0.0 109.276 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.408 ' O ' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -69.82 155.56 40.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.367 -0.833 . . . . 0.0 109.588 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.94 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -149.6 174.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.233 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -139.83 -172.2 3.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.013 . . . . 0.0 109.408 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.604 ' H ' HG22 ' A' ' 68' ' ' THR . 0.2 OUTLIER -86.19 46.76 1.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 109.133 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER 158.88 32.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 6' ' ' LEU . 77.2 mm-40 -112.94 149.89 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.992 -1.067 . . . . 0.0 109.125 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.2 tt -97.07 113.22 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.483 -0.761 . . . . 0.0 110.686 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.578 HD12 HG13 ' A' ' 5' ' ' ILE . 1.3 mt -47.56 -36.99 11.36 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.691 ' O ' HG22 ' A' ' 5' ' ' ILE . . . 163.99 -162.08 34.87 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.851 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 1.1 ptt180 -136.12 150.09 48.95 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.625 -1.514 . . . . 0.0 110.053 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.876 ' HG ' HD12 ' A' ' 56' ' ' LEU . 5.3 mp -111.07 -115.03 0.31 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.544 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 20.3 ttt-85 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 120.863 -1.148 . . . . 0.0 109.304 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.463 ' HB3' ' N ' ' A' ' 77' ' ' ARG . 1.5 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.773 HG21 ' OE1' ' A' ' 34' ' ' GLU . 43.3 t -84.42 68.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.842 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -71.72 85.82 0.92 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.51 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.857 HG12 HG13 ' A' ' 48' ' ' VAL . 0.7 OUTLIER -102.93 158.48 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.247 -0.908 . . . . 0.0 111.586 -177.33 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.848 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -137.62 -151.8 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 7' ' ' VAL . 85.6 t -132.25 54.32 13.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.864 -1.148 . . . . 0.0 109.688 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 36.6 Cg_endo -77.04 67.0 7.67 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.557 2.171 . . . . 0.0 110.637 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 1.016 ' HB2' HD13 ' A' ' 46' ' ' LEU . 1.1 m-20 . . . . . 0 C--N 1.303 -1.434 0 O-C-N 121.086 -1.009 . . . . 0.0 109.831 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.357 0.599 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.484 ' C ' HG13 ' A' ' 39' ' ' ILE . 19.6 m -148.04 132.41 17.56 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.922 . . . . 0.0 110.192 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.657 HG22 HD11 ' A' ' 39' ' ' ILE . 16.6 t -69.0 87.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.937 . . . . 0.0 109.063 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -51.01 -63.48 1.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 111.08 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.909 HG23 ' OE1' ' A' ' 63' ' ' GLU . 1.8 m -161.61 123.61 2.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.574 -1.329 . . . . 0.0 112.019 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 1.036 ' HA ' HG23 ' A' ' 37' ' ' VAL . 16.9 m95 -68.6 -166.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.766 ' CD2' HD12 ' A' ' 36' ' ' LEU . 33.6 m-70 -154.45 28.84 0.44 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.693 ' O ' HD22 ' A' ' 56' ' ' LEU . 4.9 tppt? -123.07 122.89 39.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.714 -0.616 . . . . 0.0 110.247 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.593 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -71.3 179.06 1.01 Allowed Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -68.17 89.88 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.597 1.532 . . . . 0.0 111.672 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.666 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 78.86 45.15 9.43 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.754 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 13.6 m-20 -59.43 -117.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.077 -1.249 . . . . 0.0 110.331 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 159.1 101.79 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.772 -1.205 . . . . 0.0 108.534 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.93 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -102.16 -179.4 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.938 -1.101 . . . . 0.0 109.971 -179.36 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.716 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -105.09 -91.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 0.0 110.048 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.519 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -117.9 43.83 2.33 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.034 -1.041 . . . . 0.0 109.068 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.565 ' C ' HG11 ' A' ' 30' ' ' VAL . 17.8 m-20 171.74 99.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.93 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -97.97 -160.38 0.8 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.348 -177.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.942 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 6.3 p -34.95 165.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.496 1.141 . . . . 0.0 112.94 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.766 HD12 ' CD2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -148.74 58.11 1.05 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.036 HG23 ' HA ' ' A' ' 22' ' ' TRP . 2.3 p -39.39 167.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.88 0.848 . . . . 0.0 110.836 -177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.577 ' HB3' HG11 ' A' ' 45' ' ' VAL . 24.1 mt-10 -130.81 121.61 25.65 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.952 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -103.97 -170.17 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.313 -0.867 . . . . 0.0 109.483 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.753 ' N ' HG23 ' A' ' 39' ' ' ILE . 2.5 mt-10 -153.2 101.37 2.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.122 -0.986 . . . . 0.0 109.767 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -97.12 -35.3 10.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.905 . . . . 0.0 109.9 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 11.4 t70 171.62 72.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.725 . . . . 0.0 109.704 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.4 tmmt? 85.8 -24.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.96 131.17 57.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.232 -0.917 . . . . 0.0 109.578 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.952 HG13 ' O ' ' A' ' 39' ' ' ILE . 94.3 t -113.84 123.31 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.838 . . . . 0.0 109.475 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD13 ' HB2' ' A' ' 9' ' ' ASP . 5.9 mt -86.44 178.24 7.18 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.163 -0.961 . . . . 0.0 108.816 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 27.2 mt-10 -126.58 175.84 7.64 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.811 -1.181 . . . . 0.0 110.835 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.916 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.9 t -139.46 71.99 37.86 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.3 Cg_endo -79.29 116.27 3.59 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.534 2.156 . . . . 0.0 109.797 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 34' ' ' GLU . . . -97.29 -175.66 3.29 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.945 -1.097 . . . . 0.0 108.524 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.7 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 12.3 p -131.5 70.16 1.47 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.644 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 98.53 136.95 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 121.253 0.549 . . . . 0.0 112.029 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.638 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 8.3 t0 101.34 -76.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.504 0.669 . . . . 0.0 110.019 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.605 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . 43.27 21.6 0.15 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.666 HG23 ' CA ' ' A' ' 27' ' ' GLY . 6.7 mt -77.65 90.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.835 -1.391 . . . . 0.0 107.583 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.889 HD12 ' HG ' ' A' ' 76' ' ' LEU . 7.2 tp -44.0 111.2 0.27 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.447 0.641 . . . . 0.0 110.144 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 12.5 t70 -134.28 -29.88 1.21 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.608 -0.682 . . . . 0.0 110.245 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -137.65 39.56 2.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.622 -1.299 . . . . 0.0 110.964 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 59' ' ' VAL . 9.1 p -83.82 71.52 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.53 0.38 10.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 110.756 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 73' ' ' LEU . 9.1 mm-40 -105.08 41.54 1.33 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.2 m-20 -37.94 124.83 1.17 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.422 0.63 . . . . 0.0 110.005 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.909 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.2 OUTLIER -29.47 122.14 0.15 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.498 0.666 . . . . 0.0 111.35 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.35 -13.35 8.35 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.445 ' HB ' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -83.37 174.43 10.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -1.062 . . . . 0.0 109.367 179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -96.19 144.89 26.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 110.021 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.612 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.69 169.44 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.544 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -127.49 -143.14 0.28 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 7' ' ' VAL . 11.1 t -69.67 -102.09 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.008 -1.057 . . . . 0.0 108.972 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 71' ' ' GLN . 3.7 mtt180 -78.07 36.7 0.23 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.127 -0.983 . . . . 0.0 111.377 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.518 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 61.4 mm-40 -61.73 -113.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.49 -1.381 . . . . 0.0 107.991 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 72' ' ' ILE . 16.0 tt 179.34 115.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.694 -1.254 . . . . 0.0 110.725 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.65 ' CD1' HG21 ' A' ' 48' ' ' VAL . 7.8 mt -71.84 -44.47 63.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.38 -159.76 28.79 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.772 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 13.6 mtt180 -135.34 135.39 40.69 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.263 -1.14 . . . . 0.0 108.903 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.889 ' HG ' HD12 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -85.33 -105.23 0.05 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.353 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.541 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 120.928 -1.108 . . . . 0.0 109.799 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.484 ' CB ' ' HB2' ' A' ' 75' ' ' ARG . 7.6 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.869 HG21 ' OE1' ' A' ' 34' ' ' GLU . 14.1 t -80.58 75.62 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 108.916 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.584 ' OD2' HD11 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -78.74 78.17 5.2 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.814 HG12 HG13 ' A' ' 48' ' ' VAL . 4.5 tp -88.1 154.28 3.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.259 -0.901 . . . . 0.0 110.799 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.843 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.82 -151.44 0.45 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.334 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.1 HG21 HG21 ' A' ' 67' ' ' VAL . 59.6 t -133.63 60.59 47.78 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.034 -1.041 . . . . 0.0 110.167 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -81.14 34.02 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.538 2.159 . . . . 0.0 110.521 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 1.008 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.307 -1.269 0 O-C-N 121.008 -1.057 . . . . 0.0 109.689 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.522 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 33.6 m -160.1 119.11 2.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.862 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.8 t -48.43 134.11 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 108.996 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -106.76 -57.43 2.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.676 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 32.5 m -160.88 119.14 2.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.849 -1.157 . . . . 0.0 111.208 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.901 ' HA ' HG23 ' A' ' 37' ' ' VAL . 21.2 m95 -68.94 -165.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.521 ' CD2' HD12 ' A' ' 36' ' ' LEU . 38.2 m-70 -156.17 48.22 0.48 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.774 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.12 119.72 13.23 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.493 -0.754 . . . . 0.0 110.179 -179.215 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.607 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -62.0 -179.25 0.22 Allowed Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.295 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.1 Cg_endo -67.69 88.88 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.277 1.318 . . . . 0.0 111.111 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.698 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 76.05 46.89 12.21 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.742 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.3 m-20 -59.1 -115.63 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.888 -1.36 . . . . 0.0 109.543 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.742 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 163.23 98.56 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.565 -1.334 . . . . 0.0 109.422 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.921 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -92.74 -176.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.111 -0.993 . . . . 0.0 109.742 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.712 HG13 ' H ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -141.79 -62.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.43 -0.794 . . . . 0.0 109.471 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.712 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -132.52 58.72 1.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -0.979 . . . . 0.0 108.986 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.732 ' O ' HG21 ' A' ' 30' ' ' VAL . 14.8 m-20 151.51 76.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.056 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -71.94 -173.64 1.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.348 1.07 . . . . 0.0 111.773 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.761 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 14.0 p -45.2 168.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.603 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -147.96 61.37 1.12 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.939 HG12 ' HB ' ' A' ' 48' ' ' VAL . 2.7 p -39.46 166.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.728 0.775 . . . . 0.0 110.404 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.844 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 5.1 mm-40 -128.72 97.3 4.63 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.776 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.72 -165.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.473 -0.767 . . . . 0.0 109.254 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.776 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -139.68 141.03 37.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.937 -1.102 . . . . 0.0 110.097 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.76 HG22 ' O ' ' A' ' 41' ' ' THR . 97.5 m -146.4 21.28 1.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.44 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 18.8 t0 64.73 88.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 109.568 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 86.15 -26.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.443 ' O ' ' HB ' ' A' ' 41' ' ' THR . 55.3 t -116.22 142.21 30.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 39' ' ' ILE . 96.9 t -136.21 118.03 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD13 ' HB2' ' A' ' 9' ' ' ASP . 3.9 mt -82.77 162.47 21.7 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.307 -0.871 . . . . 0.0 108.969 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -119.54 175.44 5.84 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.039 -1.038 . . . . 0.0 110.176 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.939 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.8 t -140.54 68.69 31.6 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 109.182 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.51 110.13 2.15 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.633 2.222 . . . . 0.0 110.399 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.056 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -89.84 179.27 6.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.672 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -125.71 72.4 1.28 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.552 -1.343 . . . . 0.0 110.215 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 101.58 162.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.507 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.857 ' O ' HG12 ' A' ' 30' ' ' VAL . 11.9 m-20 64.78 -142.01 0.24 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.641 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 101.11 -7.41 56.89 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.077 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.698 HG23 ' CA ' ' A' ' 27' ' ' GLY . 6.1 mt -41.18 96.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.836 ' CD1' HG22 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -41.58 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.761 0.791 . . . . 0.0 109.416 -178.234 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ILE . 51.8 t0 -101.59 -52.24 3.26 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.699 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.93 105.42 3.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.895 -1.128 . . . . 0.0 110.531 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.836 HG22 ' CD1' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -102.02 90.03 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 mt -69.79 -5.01 22.54 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 110.083 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' A' ' 73' ' ' LEU . 3.6 mt-10 -124.51 40.96 3.62 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.156 -0.965 . . . . 0.0 108.922 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.6 m-20 -42.22 128.73 3.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.58 -0.7 . . . . 0.0 109.554 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.545 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -26.89 121.7 0.09 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.317 0.58 . . . . 0.0 110.972 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.86 -16.2 7.82 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 66' ' ' THR . 73.0 m -88.14 160.06 17.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -1.17 . . . . 0.0 109.58 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.498 ' N ' HG22 ' A' ' 65' ' ' THR . 58.2 m -78.74 157.54 28.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 109.546 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.1 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.59 169.68 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.144 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.725 HG22 ' CG ' ' A' ' 71' ' ' GLN . 5.4 t -141.38 -152.05 0.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.362 -0.836 . . . . 0.0 109.123 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.677 ' N ' HG23 ' A' ' 68' ' ' THR . 12.8 p -93.38 58.68 2.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.051 -1.03 . . . . 0.0 109.624 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.7 mtp-105 160.3 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.542 -0.724 . . . . 0.0 109.755 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.725 ' CG ' HG22 ' A' ' 68' ' ' THR . 8.2 mm-40 -46.87 133.92 10.54 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.668 HG23 ' O ' ' A' ' 72' ' ' ILE . 11.5 tt -86.32 110.72 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.827 ' CD1' HG21 ' A' ' 48' ' ' VAL . 18.5 mt -50.17 -44.87 52.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.015 -1.053 . . . . 0.0 108.205 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.51 -175.36 34.16 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.746 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.6 ptt180 -118.46 143.75 46.48 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.248 -1.148 . . . . 0.0 109.804 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.888 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 6.4 mt -114.8 -79.75 0.59 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.935 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.784 0 O-C-N 121.257 -0.902 . . . . 0.0 109.251 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.543 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 8.6 m . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.707 ' O ' HG12 ' A' ' 3' ' ' VAL . 9.6 t -69.53 84.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.046 -1.034 . . . . 0.0 108.464 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 2.5 m-20 -74.61 83.42 2.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.101 ' CG1' HG22 ' A' ' 48' ' ' VAL . 3.5 tp -104.31 146.27 11.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.172 -177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.784 ' O ' HG23 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -134.85 -164.63 1.55 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.592 HG21 HD12 ' A' ' 39' ' ' ILE . 20.9 t -133.03 86.96 41.17 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.979 -1.076 . . . . 0.0 110.418 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.532 ' CA ' ' HG2' ' A' ' 70' ' ' ARG . 36.8 Cg_endo -81.44 54.56 5.2 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.578 2.185 . . . . 0.0 110.082 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.926 ' CB ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.288 0 O-C-N 121.101 -0.999 . . . . 0.0 110.256 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.321 0.582 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 16.0 m -153.21 138.49 17.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 110.347 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.587 ' HA ' HG13 ' A' ' 39' ' ' ILE . 11.2 t -76.79 99.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 0.0 109.53 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -57.49 -54.9 41.58 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 110.606 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.597 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 21.7 m -168.87 131.03 1.26 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.605 -1.31 . . . . 0.0 111.815 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 1.052 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.5 m95 -68.65 -162.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.7 ' HB2' HG23 ' A' ' 35' ' ' VAL . 71.1 m-70 -155.14 34.13 0.38 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.927 ' CB ' HD23 ' A' ' 56' ' ' LEU . 1.6 mmmt -124.59 128.4 48.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.85 -0.531 . . . . 0.0 110.317 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.638 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -79.91 -174.68 0.51 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.37 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.5 Cg_endo -68.25 84.14 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.069 1.179 . . . . 0.0 111.564 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.559 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 78.83 47.46 7.75 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.742 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.0 m-20 -55.34 -110.74 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.047 -1.266 . . . . 0.0 110.426 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.742 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 157.86 99.78 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.926 -1.109 . . . . 0.0 108.67 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.828 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -102.56 -177.35 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.831 -1.168 . . . . 0.0 109.718 -179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.725 ' N ' HG13 ' A' ' 30' ' ' VAL . 5.8 m -130.03 -113.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.146 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 4.9 mtt180 -87.11 63.6 7.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.827 -1.171 . . . . 0.0 109.175 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 4.1 m-20 150.66 101.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.028 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -97.73 -174.05 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.247 1.023 . . . . 0.0 111.656 -178.507 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.866 HG12 ' OE2' ' A' ' 34' ' ' GLU . 3.7 p -44.23 157.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-O 121.978 0.894 . . . . 0.0 111.704 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -134.55 63.38 1.62 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 178.119 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.052 HG23 ' HA ' ' A' ' 22' ' ' TRP . 5.5 p -38.92 168.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.78 0.8 . . . . 0.0 110.178 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' N ' HG22 ' A' ' 37' ' ' VAL . 4.8 mt-10 -123.19 139.61 53.87 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.933 HD11 HG21 ' A' ' 67' ' ' VAL . 1.9 tt -121.94 -163.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.978 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.802 ' N ' HG23 ' A' ' 39' ' ' ILE . 21.8 mm-40 -141.36 117.41 10.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.853 -1.154 . . . . 0.0 109.964 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.634 HG21 HD21 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -115.13 -64.17 1.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.566 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 49.0 t0 177.98 82.53 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.2 tttt 86.84 -26.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 41' ' ' THR . 1.9 t -113.18 163.31 10.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.309 -0.87 . . . . 0.0 109.201 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 39' ' ' ILE . 43.9 t -131.75 122.85 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.926 HD13 ' CB ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -79.66 158.91 26.9 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.317 -0.864 . . . . 0.0 108.734 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.5 pm0 -120.82 178.15 4.82 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.007 -1.058 . . . . 0.0 110.226 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.101 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -145.04 77.97 12.76 Favored Pre-proline 0 N--CA 1.489 1.518 0 CA-C-O 122.285 1.04 . . . . 0.0 108.778 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.0 Cg_endo -81.24 108.84 2.05 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.89 2.393 . . . . 0.0 111.966 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.028 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -78.02 -157.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.739 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.2 p -140.37 10.92 2.32 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.541 -1.349 . . . . 0.0 111.196 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.04 159.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER 78.91 -73.82 0.07 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.459 0.647 . . . . 0.0 110.272 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.551 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 45.3 16.88 0.1 Allowed Glycine 0 N--CA 1.489 2.194 0 O-C-N 121.212 -0.93 . . . . 0.0 111.655 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.56 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 2.2 mt -68.6 88.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.678 -1.483 . . . . 0.0 108.041 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.927 HD23 ' CB ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -40.81 103.45 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.438 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 1.1 t0 -123.21 -52.01 1.86 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 111.018 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -136.15 82.61 1.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.512 -1.368 . . . . 0.0 111.155 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.859 ' CG2' HD11 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -79.9 103.2 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.563 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 29.4 mt -69.34 -11.82 61.14 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.093 -1.005 . . . . 0.0 109.533 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 9.5 mm-40 -132.42 56.09 1.85 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 61' ' ' GLU . 3.2 m-20 -40.74 136.18 1.46 Allowed 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.579 -0.7 . . . . 0.0 109.715 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.597 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -39.49 125.56 1.74 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.426 0.632 . . . . 0.0 110.822 -179.248 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.76 -4.64 19.07 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -97.75 153.07 18.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -1.134 . . . . 0.0 109.365 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.75 155.48 40.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.932 . . . . 0.0 109.446 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.933 HG21 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.32 162.43 3.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.557 -0.715 . . . . 0.0 109.279 -179.178 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.423 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 2.8 m -116.34 -133.24 0.33 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.48 -0.762 . . . . 0.0 109.328 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 7' ' ' VAL . 7.3 p -69.59 -104.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.883 -1.136 . . . . 0.0 109.63 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.588 ' HD2' HD22 ' A' ' 6' ' ' LEU . 4.9 mtm180 -80.21 39.9 0.46 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.55 ' HB2' HG23 ' A' ' 67' ' ' VAL . 2.3 mm-40 -62.6 107.04 0.87 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.757 -1.214 . . . . 0.0 108.896 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.7 tt -43.28 110.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.011 ' CD1' HG11 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -52.91 -36.9 60.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 154.32 165.58 14.02 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.729 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.48 137.2 45.95 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.241 -1.153 . . . . 0.0 109.781 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.772 HD12 ' N ' ' A' ' 76' ' ' LEU . 5.5 mp -106.87 -94.11 0.38 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.552 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.56 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 4.2 tpt180 . . . . . 0 C--N 1.299 -1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 72.5 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 76' ' ' LEU . 57.9 t -72.69 81.03 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.59 78.51 6.13 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.775 HG12 HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -92.26 149.71 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.479 -0.763 . . . . 0.0 111.161 -177.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -132.8 -158.67 0.91 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.04 ' CG1' HD12 ' A' ' 46' ' ' LEU . 60.3 t -130.49 59.84 48.45 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 120.866 -1.146 . . . . 0.0 110.145 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.9 Cg_endo -81.41 19.92 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.589 2.193 . . . . 0.0 110.531 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 1.033 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.298 0 O-C-N 120.891 -1.131 . . . . 0.0 110.579 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.539 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 79.5 m -158.76 134.79 9.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 110.681 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.639 HG22 ' CD1' ' A' ' 39' ' ' ILE . 22.0 t -69.18 84.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.412 -0.805 . . . . 0.0 109.231 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -43.6 -63.16 0.89 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.092 -1.005 . . . . 0.0 110.245 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.608 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 87.3 m -164.19 124.19 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.648 -1.283 . . . . 0.0 111.658 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.997 ' HA ' HG23 ' A' ' 37' ' ' VAL . 19.1 m95 -68.44 -167.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.636 ' HB2' HG23 ' A' ' 35' ' ' VAL . 38.8 m-70 -152.14 24.1 0.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.544 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 2.2 tppm? -118.45 128.18 54.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.793 -0.567 . . . . 0.0 109.941 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.569 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -78.94 178.61 2.18 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.647 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.4 Cg_endo -69.21 93.26 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.644 1.562 . . . . 0.0 111.466 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.685 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 78.28 43.13 13.62 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.756 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 12.5 m-20 -61.36 -120.24 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.002 -1.293 . . . . 0.0 109.651 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 159.58 79.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.73 -1.231 . . . . 0.0 108.843 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.851 HG12 ' OE2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -79.73 -168.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.12 -0.987 . . . . 0.0 109.652 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.817 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -134.99 -99.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.31 -0.869 . . . . 0.0 109.845 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.469 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 16.3 ttt-85 -98.37 38.5 1.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.871 -1.143 . . . . 0.0 109.522 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.731 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.6 m-20 178.5 91.42 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.108 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -83.37 -170.24 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.263 1.03 . . . . 0.0 112.102 -178.041 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.636 HG23 ' HB2' ' A' ' 23' ' ' HIS . 3.1 p -55.97 164.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.453 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.568 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -142.08 62.07 1.44 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.011 HG12 ' HB ' ' A' ' 48' ' ' VAL . 3.3 p -38.95 165.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-O 121.682 0.753 . . . . 0.0 110.204 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.787 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.3 mt-10 -128.37 97.58 4.78 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.786 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.76 -164.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 O-C-N 121.397 -0.814 . . . . 0.0 108.976 -179.48 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.786 ' N ' HG23 ' A' ' 39' ' ' ILE . 3.9 mm-40 -134.48 112.83 11.23 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.974 -1.079 . . . . 0.0 109.775 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.556 ' OG1' HD21 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -108.16 -145.58 0.39 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -0.87 . . . . 0.0 109.196 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 6.8 t70 -96.73 83.24 3.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.086 -1.009 . . . . 0.0 109.592 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.2 tmtt? 85.98 -22.23 0.19 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.223 0.535 . . . . 0.0 109.585 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 45' ' ' VAL . 95.2 t -113.61 164.74 9.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.307 -0.871 . . . . 0.0 109.612 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.59 HG11 ' OE1' ' A' ' 38' ' ' GLU . 54.9 t -127.64 125.64 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.04 HD12 ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -79.62 155.34 28.14 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.297 -0.877 . . . . 0.0 108.823 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -112.17 172.65 6.78 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.043 -1.036 . . . . 0.0 110.594 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.011 ' HB ' HG12 ' A' ' 37' ' ' VAL . 8.6 t -142.2 70.35 22.62 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.27 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.24 113.45 2.67 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.72 2.28 . . . . 0.0 111.288 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.108 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -88.5 -164.52 1.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.675 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 10.0 p -141.09 60.06 1.52 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.548 -1.261 . . . . 0.0 110.623 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.675 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 105.43 160.99 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.412 0.625 . . . . 0.0 110.658 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 74.95 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.619 -0.676 . . . . 0.0 110.188 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' OE2' ' A' ' 34' ' ' GLU . . . 54.56 8.51 1.28 Allowed Glycine 0 N--CA 1.495 2.582 0 O-C-N 121.051 -1.03 . . . . 0.0 111.778 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.685 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -55.11 92.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 120.612 -1.522 . . . . 0.0 107.797 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.871 HD12 ' HG ' ' A' ' 76' ' ' LEU . 8.8 tp -44.7 112.88 0.47 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.468 -0.77 . . . . 0.0 109.527 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -118.84 -43.36 2.67 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.653 -0.654 . . . . 0.0 110.07 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.552 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -143.06 78.12 1.59 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.858 -1.151 . . . . 0.0 110.776 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.815 HG21 HD21 ' A' ' 56' ' ' LEU . 8.4 t -79.46 87.59 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.8 mt -69.55 -4.42 18.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 0.0 110.334 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.502 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 2.5 mt-10 -129.21 50.89 2.1 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.0 m-20 -42.58 127.43 3.84 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.696 -0.627 . . . . 0.0 109.489 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.608 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.12 121.05 0.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.449 0.642 . . . . 0.0 111.079 -179.199 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.89 -1.45 19.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 66' ' ' THR . 22.5 m -97.89 159.98 14.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -1.137 . . . . 0.0 109.347 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.492 ' N ' HG22 ' A' ' 65' ' ' THR . 0.2 OUTLIER -70.99 149.33 46.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.64 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.724 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.24 169.45 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.537 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -138.63 -176.39 4.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.365 -0.834 . . . . 0.0 109.052 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -83.69 69.52 10.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.231 -0.918 . . . . 0.0 109.329 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 69' ' ' SER . 10.3 ttm180 158.61 -22.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.6 mm-40 -57.62 159.17 5.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.876 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 72' ' ' ILE . 15.8 tt -103.81 113.25 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.696 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.877 ' CD1' HG21 ' A' ' 48' ' ' VAL . 9.3 mt -49.86 -47.1 51.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 108.269 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.72 -166.36 34.37 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.552 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.86 141.6 51.51 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.322 -1.104 . . . . 0.0 109.681 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.871 ' HG ' HD12 ' A' ' 56' ' ' LEU . 2.8 mp -101.29 -104.19 0.25 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.295 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.554 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 O-C-N 120.873 -1.142 . . . . 0.0 109.984 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 15.4 m . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 77' ' ' ARG . 38.5 t -78.03 77.85 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.01 . . . . 0.0 108.52 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.71 85.88 0.92 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.012 HG12 HG22 ' A' ' 48' ' ' VAL . 3.5 tp -110.09 141.0 26.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 111.058 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.855 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -127.47 -145.54 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.52 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.91 HG23 HD21 ' A' ' 73' ' ' LEU . 69.1 t -132.94 58.82 38.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.957 -1.09 . . . . 0.0 109.315 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 34.5 Cg_endo -75.8 68.33 6.41 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.616 2.21 . . . . 0.0 111.108 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.543 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.304 -1.383 0 O-C-N 121.179 -0.951 . . . . 0.0 109.346 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.447 0.641 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 65' ' ' THR . 18.4 m -160.23 125.9 4.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.398 -0.814 . . . . 0.0 109.519 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 61' ' ' GLU . 2.6 t -52.54 141.62 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 109.071 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -117.7 -50.07 2.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.114 -0.991 . . . . 0.0 109.877 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.501 ' N ' ' HB3' ' A' ' 63' ' ' GLU . 52.6 m -164.56 114.12 1.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.885 -1.135 . . . . 0.0 111.128 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.902 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.2 m95 -68.56 -162.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.833 . . . . 0.0 108.756 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.492 ' CG ' ' O ' ' A' ' 22' ' ' TRP . 39.8 m-70 -160.08 26.14 0.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.867 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -114.63 114.5 25.76 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.595 -178.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.651 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 11.3 mmmt -59.55 173.34 0.52 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -66.92 96.5 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.516 1.477 . . . . 0.0 110.829 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.816 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 80.72 50.33 5.32 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 3.0 m-20 -55.72 -150.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.485 -1.009 . . . . 0.0 110.382 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -175.39 96.61 0.07 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.541 -1.349 . . . . 0.0 108.57 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.657 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -110.58 -176.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.891 -179.004 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.657 ' N ' HG13 ' A' ' 30' ' ' VAL . 2.1 p -125.72 -49.6 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.598 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -157.13 61.49 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.367 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.598 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.5 m-20 146.0 100.6 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.145 ' CG ' ' HB3' ' A' ' 50' ' ' ALA . 1.9 pt-20 -131.39 -164.07 1.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.938 -1.101 . . . . 0.0 112.028 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.826 HG21 ' HE3' ' A' ' 22' ' ' TRP . 4.0 p -13.58 136.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.068 0.937 . . . . 0.0 113.309 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -130.55 62.86 1.58 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.902 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.2 p -37.56 166.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.891 0.853 . . . . 0.0 110.807 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.0 mt-10 -125.03 95.61 4.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.938 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -79.86 -160.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 121.419 -0.8 . . . . 0.0 109.18 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.814 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -136.62 151.55 49.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.872 -1.143 . . . . 0.0 109.973 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 41' ' ' THR . 98.4 m -156.41 31.8 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.593 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 10.8 t0 47.78 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 109.637 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 85.27 -27.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.845 -0.535 . . . . 0.0 109.741 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.476 ' HB ' ' HB ' ' A' ' 41' ' ' THR . 1.8 t -120.85 152.43 24.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.154 -0.966 . . . . 0.0 109.538 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.938 HG13 ' O ' ' A' ' 39' ' ' ILE . 24.1 t -149.38 97.57 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.384 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.854 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.67 164.65 23.59 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.211 -0.931 . . . . 0.0 109.153 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 48.0 mt-10 -112.37 -165.92 1.03 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.211 -0.93 . . . . 0.0 109.761 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.012 HG22 HG12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -152.69 78.37 6.18 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 122.154 0.978 . . . . 0.0 109.187 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.66 110.08 2.35 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.838 2.359 . . . . 0.0 111.178 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.145 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . . . -74.14 -162.67 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -148.48 33.9 0.79 Allowed 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.975 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 155.89 151.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.932 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.6 OUTLIER 65.84 -93.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.52 -0.738 . . . . 0.0 110.541 179.071 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 74.18 -9.73 9.11 Favored Glycine 0 N--CA 1.486 2.001 0 O-C-N 120.674 -1.267 . . . . 0.0 110.466 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.816 HG23 ' HA2' ' A' ' 27' ' ' GLY . 1.1 mp -40.29 94.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.555 1.178 . . . . 0.0 108.541 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.895 HD11 HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -50.47 92.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.2 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 55' ' ' ILE . 8.6 t70 -111.69 -44.78 3.44 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.815 -0.553 . . . . 0.0 110.776 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -138.72 98.26 3.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.554 -1.342 . . . . 0.0 111.14 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 56' ' ' LEU . 1.7 t -109.74 88.96 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 mt -69.48 -4.03 17.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 110.592 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.685 ' O ' HG21 ' A' ' 19' ' ' VAL . 10.0 mt-10 -127.16 44.32 2.94 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.113 -0.992 . . . . 0.0 108.564 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -46.07 136.34 6.8 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.465 -0.772 . . . . 0.0 109.32 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.54 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -31.9 107.2 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.418 0.628 . . . . 0.0 110.481 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.41 -7.78 3.41 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.776 ' O ' HG23 ' A' ' 18' ' ' THR . 0.1 OUTLIER -100.01 178.83 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -1.17 . . . . 0.0 109.748 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 m -99.97 151.24 21.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.85 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.882 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.89 171.18 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.359 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.558 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 1.4 m -134.29 -141.38 0.19 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 108.975 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 7' ' ' VAL . 2.2 p -69.35 -104.48 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.945 -1.097 . . . . 0.0 109.054 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.709 ' HG2' HD22 ' A' ' 6' ' ' LEU . 28.0 ttp180 -79.2 37.86 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.066 . . . . 0.0 110.755 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.766 ' O ' HD23 ' A' ' 6' ' ' LEU . 12.6 mm100 -63.92 -112.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.76 -1.212 . . . . 0.0 108.582 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 72' ' ' ILE . 12.4 tt -179.0 116.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.836 -1.165 . . . . 0.0 110.392 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.91 HD21 HG23 ' A' ' 7' ' ' VAL . 9.7 mt -72.96 -49.94 26.31 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.13 -0.981 . . . . 0.0 108.4 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 59' ' ' VAL . . . 161.57 169.73 25.27 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.723 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -110.73 138.57 46.95 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.13 -1.218 . . . . 0.0 110.089 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.778 HD12 ' N ' ' A' ' 76' ' ' LEU . 5.0 mp -106.47 -88.63 0.45 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.702 ' O ' HG23 ' A' ' 3' ' ' VAL . 5.5 ttt180 . . . . . 0 C--N 1.296 -1.758 0 O-C-N 121.568 -0.708 . . . . 0.0 109.453 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 77' ' ' ARG . 66.3 m . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.785 ' O ' HG12 ' A' ' 3' ' ' VAL . 4.7 t -77.96 77.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -83.6 84.11 7.66 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.827 HG12 HG13 ' A' ' 48' ' ' VAL . 6.5 tp -89.48 158.04 2.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.375 -0.828 . . . . 0.0 111.583 -177.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.858 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -137.44 -151.56 0.4 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.683 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 67' ' ' VAL . 33.2 t -138.21 57.25 12.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.7 -1.25 . . . . 0.0 110.085 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -79.94 47.56 2.57 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.617 2.211 . . . . 0.0 110.843 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.563 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 3.0 m-20 . . . . . 0 C--N 1.304 -1.388 0 O-C-N 120.945 -1.097 . . . . 0.0 109.616 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.514 ' C ' HG12 ' A' ' 39' ' ' ILE . 1.1 m -134.74 129.06 34.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.17 -0.956 . . . . 0.0 110.233 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.988 ' CG1' HD11 ' A' ' 73' ' ' LEU . 7.0 t -75.61 103.93 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.378 -0.827 . . . . 0.0 109.188 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -65.02 -62.15 1.73 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.747 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.624 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 52.9 m -168.65 132.29 1.47 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.276 -1.37 . . . . 0.0 112.289 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 1.067 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.4 m95 -68.99 -168.77 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.582 ' HB2' HG23 ' A' ' 35' ' ' VAL . 38.7 m-70 -150.91 30.98 0.63 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.745 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -122.38 123.78 42.14 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.706 -0.621 . . . . 0.0 110.389 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.595 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -74.57 -178.87 0.88 Allowed Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.271 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -68.18 90.55 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.282 1.321 . . . . 0.0 111.001 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.796 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 76.47 46.23 12.47 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.727 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 14.1 m-20 -59.7 -118.07 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.933 -1.333 . . . . 0.0 109.794 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 162.91 100.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.583 -1.323 . . . . 0.0 109.493 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.884 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -100.99 -175.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.185 -0.947 . . . . 0.0 109.987 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.719 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -141.15 -73.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 109.608 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.676 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -119.81 61.55 0.84 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.055 -1.028 . . . . 0.0 109.426 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.608 ' O ' HG21 ' A' ' 30' ' ' VAL . 3.7 m-20 145.32 84.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.069 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -76.1 -168.78 0.99 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.001 0.905 . . . . 0.0 111.533 -178.032 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.862 HG12 ' OE2' ' A' ' 34' ' ' GLU . 7.5 p -49.54 166.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.572 0.701 . . . . 0.0 110.836 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.618 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -144.85 59.05 1.31 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.078 HG21 HD21 ' A' ' 73' ' ' LEU . 2.7 p -39.18 166.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.63 0.728 . . . . 0.0 110.296 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -127.52 142.7 51.32 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.964 HD11 HG11 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -127.56 -166.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.778 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -143.9 88.48 1.98 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.86 -1.15 . . . . 0.0 110.056 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.44 -146.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.393 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 20.6 t0 -97.72 85.94 3.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.3 tttm 86.28 -25.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.273 0.558 . . . . 0.0 109.526 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.17 135.43 52.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.173 -0.955 . . . . 0.0 109.719 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.846 HG13 ' O ' ' A' ' 39' ' ' ILE . 41.2 t -118.77 105.31 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 109.408 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.841 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.99 179.86 7.37 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.272 -0.892 . . . . 0.0 109.349 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 48' ' ' VAL . 22.9 mt-10 -134.82 -148.9 0.33 Allowed 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.958 -1.089 . . . . 0.0 110.566 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.863 ' HB ' HG12 ' A' ' 37' ' ' VAL . 11.9 t -154.89 69.74 5.73 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.327 -0.858 . . . . 0.0 109.29 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.79 104.5 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.592 2.195 . . . . 0.0 111.023 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.069 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -83.27 -178.53 7.11 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.6 p -121.93 24.47 9.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.093 -1.629 . . . . 0.0 111.338 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.71 160.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.213 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.723 ' O ' HG12 ' A' ' 30' ' ' VAL . 2.5 t0 61.43 -139.39 0.51 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.04 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 115.29 -8.26 20.64 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.796 HG23 ' HA2' ' A' ' 27' ' ' GLY . 10.7 mt -42.39 98.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.029 HD12 HD22 ' A' ' 76' ' ' LEU . 9.6 tp -48.82 90.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.595 0.712 . . . . 0.0 109.648 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.8 t0 -82.18 -58.11 3.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.946 -0.471 . . . . 0.0 110.001 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -149.88 95.68 2.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.768 -1.207 . . . . 0.0 111.091 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.516 HG22 HD11 ' A' ' 56' ' ' LEU . 2.9 t -79.74 101.89 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.437 HD11 ' HD3' ' A' ' 75' ' ' ARG . 44.9 mt -69.15 -27.12 65.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 110.29 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 41.2 mm-40 -121.86 59.93 0.98 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -37.92 140.91 0.23 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.486 0.66 . . . . 0.0 109.691 -179.07 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.624 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -39.99 139.35 0.69 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.57 -0.706 . . . . 0.0 110.644 -179.424 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.26 -12.34 33.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.72 174.48 9.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.241 . . . . 0.0 109.633 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.6 m -93.36 154.44 17.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.964 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.77 168.96 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 1.088 HG22 ' CG ' ' A' ' 71' ' ' GLN . 15.0 t -133.39 -136.07 0.17 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.739 ' N ' HG23 ' A' ' 68' ' ' THR . 9.6 m -68.96 -119.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.592 -1.317 . . . . 0.0 108.015 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.817 ' CG ' HD22 ' A' ' 6' ' ' LEU . 8.0 ttm105 -72.89 80.68 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.678 -1.263 . . . . 0.0 109.786 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 1.088 ' CG ' HG22 ' A' ' 68' ' ' THR . 0.5 OUTLIER -98.43 -101.82 0.21 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.054 -1.028 . . . . 0.0 108.397 179.253 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 72' ' ' ILE . 19.1 tt 177.72 112.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 110.264 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.078 HD21 HG21 ' A' ' 37' ' ' VAL . 10.5 tp -79.7 -39.42 31.29 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.821 -1.174 . . . . 0.0 108.206 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.69 158.61 8.97 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.211 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.756 ' C ' HD23 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -101.03 148.57 24.89 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.373 -1.075 . . . . 0.0 109.559 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.029 HD22 HD12 ' A' ' 56' ' ' LEU . 5.5 mt -113.89 -132.43 0.33 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.732 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.564 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 O-C-N 120.804 -1.185 . . . . 0.0 110.402 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 77' ' ' ARG . 6.4 t -83.82 89.07 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.32 95.82 0.21 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.639 HD13 HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -103.76 129.76 55.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 109.949 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.859 HD22 ' HG2' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -153.39 -163.16 1.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.792 ' CG2' HD13 ' A' ' 39' ' ' ILE . 11.4 t -121.01 78.23 32.26 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.874 -1.142 . . . . 0.0 108.982 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 36.7 Cg_endo -80.4 53.52 4.8 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.803 2.335 . . . . 0.0 110.815 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 1.009 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.304 -1.377 0 O-C-N 121.076 -1.015 . . . . 0.0 109.717 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.731 ' HB2' ' OG1' ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 40' ' ' GLU . 93.3 m -156.63 148.81 23.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.125 -0.984 . . . . 0.0 109.643 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 73' ' ' LEU . 2.3 t -78.73 147.24 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 108.636 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -118.83 -55.14 2.21 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.772 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.624 HG23 ' OE2' ' A' ' 63' ' ' GLU . 1.3 m -167.45 123.03 1.07 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.246 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.904 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.2 m95 -68.25 -167.41 0.08 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.583 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.4 m-70 -152.31 24.18 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.664 ' HB3' HD13 ' A' ' 56' ' ' LEU . 6.5 tppt? -118.52 132.04 56.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.77 -0.581 . . . . 0.0 109.728 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.591 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -79.62 177.31 3.0 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.9 Cg_endo -70.26 101.63 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.731 1.62 . . . . 0.0 111.615 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.656 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 82.37 37.66 14.25 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.554 ' CB ' ' HD2' ' A' ' 24' ' ' LYS . 1.2 m-20 -59.3 -165.38 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.878 -1.366 . . . . 0.0 110.103 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -165.11 78.17 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 108.979 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -79.54 -173.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.554 -179.011 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.749 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.6 OUTLIER -125.41 -97.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 109.836 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 47.6 mtp180 -103.28 45.14 0.97 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.644 -1.285 . . . . 0.0 109.345 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.781 ' O ' HG21 ' A' ' 30' ' ' VAL . 6.3 m-20 171.87 94.86 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.0 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -93.1 -166.56 1.55 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.922 -1.112 . . . . 0.0 111.542 -178.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.759 HG12 ' CD ' ' A' ' 34' ' ' GLU . 2.5 p -52.74 164.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 122.058 0.932 . . . . 0.0 111.393 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.581 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.61 65.97 1.39 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.379 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.145 HG12 HG12 ' A' ' 48' ' ' VAL . 4.1 p -38.0 164.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.582 0.706 . . . . 0.0 110.354 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.617 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -122.88 101.49 7.47 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 -178.761 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.001 HD11 HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -85.63 -159.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.81 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -154.59 99.03 2.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.609 -1.307 . . . . 0.0 110.265 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.731 ' OG1' ' HB2' ' A' ' 17' ' ' ALA . 10.0 m -116.64 90.11 3.26 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' THR . 11.2 t0 71.7 -143.33 0.05 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.372 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -17.27 57.52 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.99 150.23 3.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.521 -0.737 . . . . 0.0 109.886 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 39' ' ' ILE . 7.2 p -130.39 105.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.009 HD13 ' HB2' ' A' ' 9' ' ' ASP . 1.3 mt -85.94 159.22 19.71 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.231 -0.918 . . . . 0.0 109.021 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 5.1 pt-20 -127.29 -164.75 1.39 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.053 -1.029 . . . . 0.0 110.314 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.145 HG12 HG12 ' A' ' 37' ' ' VAL . 14.6 p -146.49 88.05 6.27 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.339 -0.851 . . . . 0.0 110.025 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.44 104.79 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.566 2.177 . . . . 0.0 111.181 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.0 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -74.86 -165.71 0.4 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 19.2 m -141.46 24.81 2.07 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.325 -1.485 . . . . 0.0 110.648 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 156.12 165.63 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.27 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER 66.75 -88.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.615 -0.678 . . . . 0.0 109.585 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.729 ' HA2' HG21 ' A' ' 3' ' ' VAL . . . 63.32 -8.63 0.26 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.013 -1.055 . . . . 0.0 111.808 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.656 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.84 96.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.849 -1.383 . . . . 0.0 107.994 179.435 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.944 HD12 HD22 ' A' ' 76' ' ' LEU . 8.8 tp -51.66 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.469 -0.769 . . . . 0.0 109.376 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' ILE . 10.9 t0 -108.11 -35.52 6.56 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.583 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.487 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -142.11 85.97 1.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.494 -1.379 . . . . 0.0 111.736 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.573 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 2.5 t -101.14 77.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.0 mt -69.66 -2.81 12.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 110.946 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.552 ' O ' HD11 ' A' ' 73' ' ' LEU . 18.9 mt-10 -136.16 51.49 2.02 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.882 -1.136 . . . . 0.0 109.283 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.488 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.6 m-20 -50.23 151.19 2.16 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.274 -0.891 . . . . 0.0 109.751 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.624 ' OE2' HG23 ' A' ' 21' ' ' THR . 0.1 OUTLIER -32.92 141.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.411 0.624 . . . . 0.0 110.818 -179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.58 -18.65 32.18 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.591 HG22 ' H ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -83.57 -179.72 7.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -1.194 . . . . 0.0 109.874 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 65' ' ' THR . 4.0 m -113.3 153.82 27.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 109.715 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.001 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -151.25 169.72 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 1.019 HG22 ' HG3' ' A' ' 71' ' ' GLN . 7.8 t -127.6 -124.6 0.23 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.612 ' N ' HG23 ' A' ' 68' ' ' THR . 6.0 p -69.63 -114.95 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.337 -1.477 . . . . 0.0 108.967 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.859 ' HG2' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -83.28 52.98 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.903 -1.123 . . . . 0.0 110.8 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 1.019 ' HG3' HG22 ' A' ' 68' ' ' THR . 4.4 mm100 -65.25 -111.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.75 -1.219 . . . . 0.0 108.293 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.682 HG23 ' O ' ' A' ' 72' ' ' ILE . 16.2 tt 178.33 116.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.83 -1.168 . . . . 0.0 110.474 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.908 ' CD2' HG21 ' A' ' 37' ' ' VAL . 14.0 tp -77.38 -17.36 58.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.941 -1.099 . . . . 0.0 108.456 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' HB ' ' A' ' 5' ' ' ILE . . . 135.33 162.43 9.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.491 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.61 149.11 31.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -1.141 . . . . 0.0 109.495 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.944 HD22 HD12 ' A' ' 56' ' ' LEU . 8.2 mt -117.52 -78.31 0.58 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.444 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.987 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.833 0 O-C-N 121.305 -0.872 . . . . 0.0 109.268 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.552 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 68.1 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.034 HG21 ' OE1' ' A' ' 34' ' ' GLU . 70.1 t -76.99 77.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 109.207 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 0.5 OUTLIER -73.6 84.83 1.57 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.946 HG12 HG22 ' A' ' 48' ' ' VAL . 2.1 tp -106.57 151.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.347 -0.846 . . . . 0.0 110.985 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -134.09 -166.06 1.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.757 HG21 ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -126.04 72.81 70.83 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.144 -0.973 . . . . 0.0 109.625 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 36.9 Cg_endo -80.99 27.33 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.719 2.279 . . . . 0.0 110.955 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 17.6 m-20 . . . . . 0 C--N 1.307 -1.256 0 O-C-N 120.899 -1.126 . . . . 0.0 109.856 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.61 ' C ' HG13 ' A' ' 67' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 39' ' ' ILE . 17.7 m -155.15 126.14 7.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.178 -0.951 . . . . 0.0 110.457 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.654 HG22 HD11 ' A' ' 39' ' ' ILE . 3.3 t -67.33 93.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.338 -0.851 . . . . 0.0 108.999 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -58.02 -59.35 5.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.151 -0.968 . . . . 0.0 110.763 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.651 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 34.8 m -166.68 125.71 1.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.574 -1.329 . . . . 0.0 111.982 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.982 ' HA ' HG23 ' A' ' 37' ' ' VAL . 24.0 m95 -67.76 -165.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.586 ' HB2' HG23 ' A' ' 35' ' ' VAL . 52.8 m-70 -154.67 51.61 0.63 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.588 ' CB ' HD21 ' A' ' 56' ' ' LEU . 2.2 mmpt? -134.26 175.19 9.73 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.024 0.916 . . . . 0.0 110.995 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.653 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 2.1 mmmt -127.62 -174.86 0.39 Allowed Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.76 106.4 1.47 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.14 1.227 . . . . 0.0 111.242 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.551 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 65.21 45.84 89.81 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.548 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 1.4 m-20 -54.13 -167.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.885 -1.362 . . . . 0.0 110.198 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.89 80.81 0.42 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.401 -0.812 . . . . 0.0 108.927 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.815 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.06 -173.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.506 -0.746 . . . . 0.0 110.596 -178.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.703 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -132.65 -96.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.641 -0.662 . . . . 0.0 110.014 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.492 ' H ' HG23 ' A' ' 31' ' ' VAL . 3.2 mtt180 -99.8 36.03 1.89 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.686 -1.259 . . . . 0.0 109.472 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.763 ' O ' HG21 ' A' ' 30' ' ' VAL . 18.8 m-20 -179.57 81.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.591 -0.693 . . . . 0.0 109.162 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.113 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -69.5 -160.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.998 -1.064 . . . . 0.0 111.621 -178.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.922 HG12 ' OE2' ' A' ' 34' ' ' GLU . 7.2 p -62.95 163.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.613 0.721 . . . . 0.0 110.542 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.567 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -138.47 59.76 1.63 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 178.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.982 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.4 p -38.48 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.54 0.686 . . . . 0.0 109.913 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -124.02 140.76 52.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.674 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.06 -177.05 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.375 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.674 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.7 mm-40 -138.71 115.77 10.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.92 . . . . 0.0 109.374 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 2.8 t -110.03 -27.97 8.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 0.0 110.002 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 7.3 t0 161.28 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.597 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.9 tttp 85.85 -24.92 0.12 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 41' ' ' THR . 58.0 t -104.01 136.81 35.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 0.0 109.227 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 39' ' ' ILE . 46.5 t -116.67 109.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.918 . . . . 0.0 109.739 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 9' ' ' ASP . 4.2 mm? -79.78 -168.57 1.64 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.15 -0.969 . . . . 0.0 108.719 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.3 pt-20 -144.36 -166.81 2.47 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.075 -1.016 . . . . 0.0 110.717 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.946 HG22 HG12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -155.95 82.91 3.55 Favored Pre-proline 0 N--CA 1.489 1.484 0 CA-C-O 122.076 0.941 . . . . 0.0 109.583 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.2 Cg_endo -81.81 117.88 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.77 2.313 . . . . 0.0 111.749 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.113 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -89.41 178.84 6.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.712 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 18.3 p -122.72 72.85 1.1 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 120.532 -1.355 . . . . 0.0 110.436 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 93.23 169.37 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.118 0.485 . . . . 0.0 110.132 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 13.2 m-20 69.74 -101.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 55' ' ' ILE . . . 68.6 -16.56 0.54 Allowed Glycine 0 N--CA 1.496 2.638 0 O-C-N 120.433 -1.417 . . . . 0.0 111.902 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.551 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.9 OUTLIER -36.03 99.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.104 1.452 . . . . 0.0 109.438 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.608 HD22 HD23 ' A' ' 76' ' ' LEU . 1.4 mm? -48.61 104.82 0.07 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.634 0.73 . . . . 0.0 109.936 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.455 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 9.3 t70 -108.16 -48.03 3.44 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.19 86.45 1.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.775 -1.203 . . . . 0.0 111.404 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 1.6 t -79.81 87.66 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 177.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.46 -3.92 16.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.934 . . . . 0.0 110.414 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 3.1 mt-10 -132.58 51.77 2.13 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.9 m-20 -40.58 131.11 2.34 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.744 0.783 . . . . 0.0 109.749 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.651 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -36.12 123.39 0.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.481 0.658 . . . . 0.0 111.079 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.13 -11.07 8.21 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.38 162.7 15.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -1.13 . . . . 0.0 109.501 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 67' ' ' VAL . 80.2 m -72.2 162.49 29.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 109.603 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.757 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.19 173.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.473 -0.767 . . . . 0.0 109.097 -178.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.923 HG22 ' CG ' ' A' ' 71' ' ' GLN . 5.7 t -145.66 -162.29 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.357 -0.839 . . . . 0.0 109.098 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.544 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 2.7 p -85.58 37.41 0.69 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.035 -1.041 . . . . 0.0 109.816 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER 168.63 34.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.598 -0.689 . . . . 0.0 109.212 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.923 ' CG ' HG22 ' A' ' 68' ' ' THR . 3.1 mm-40 -97.61 103.04 14.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.921 -1.112 . . . . 0.0 109.287 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.607 HG23 ' O ' ' A' ' 72' ' ' ILE . 9.1 tt -56.72 109.22 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.848 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.8 HD22 HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -51.37 -42.72 61.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.72 -155.45 26.56 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.722 ' C ' HD12 ' A' ' 76' ' ' LEU . 10.8 ptt85 -138.21 137.37 37.5 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.098 -1.237 . . . . 0.0 109.945 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 76' ' ' LEU . 5.8 mp -106.16 -95.93 0.35 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.455 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.552 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 2.7 tpm_? . . . . . 0 C--N 1.297 -1.702 0 O-C-N 121.443 -0.786 . . . . 0.0 109.243 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.747 ' O ' HG12 ' A' ' 3' ' ' VAL . 2.4 t -69.67 87.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.039 -1.038 . . . . 0.0 108.807 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.08 103.71 3.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.904 HG23 HG21 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -104.25 140.1 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.089 -1.007 . . . . 0.0 110.59 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.849 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -149.54 -162.19 1.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.101 HG21 HG21 ' A' ' 67' ' ' VAL . 60.1 t -133.63 56.61 21.09 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.957 -1.09 . . . . 0.0 110.373 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -81.16 34.37 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.507 2.138 . . . . 0.0 110.83 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.717 ' OD2' HD12 ' A' ' 46' ' ' LEU . 16.8 m-20 . . . . . 0 C--N 1.307 -1.248 0 O-C-N 120.711 -1.243 . . . . 0.0 110.256 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.015 ' HB2' HG23 ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.488 ' C ' HG13 ' A' ' 39' ' ' ILE . 45.2 m -160.13 121.99 3.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.229 -0.92 . . . . 0.0 110.137 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.0 HG12 ' OE1' ' A' ' 63' ' ' GLU . 2.1 t -50.59 147.47 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -126.25 -48.11 1.59 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.945 -1.097 . . . . 0.0 110.749 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.56 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 45.4 m -159.87 109.03 1.79 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.558 -1.339 . . . . 0.0 112.08 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.727 ' HA ' HG23 ' A' ' 37' ' ' VAL . 22.3 m95 -67.5 -163.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.66 ' HB2' HG23 ' A' ' 35' ' ' VAL . 64.6 m-70 -159.35 42.52 0.23 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.893 ' CB ' HD23 ' A' ' 56' ' ' LEU . 3.1 mmmt -132.19 124.08 28.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.594 -0.691 . . . . 0.0 110.707 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -70.56 -178.17 0.51 Allowed Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 27.9 Cg_endo -66.82 93.23 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.107 1.205 . . . . 0.0 111.143 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.651 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 68.53 47.85 54.36 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.729 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 17.4 m-20 -56.96 -112.61 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.056 -1.261 . . . . 0.0 110.039 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 161.96 99.66 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.758 -1.214 . . . . 0.0 109.151 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.089 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -100.58 175.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.084 -1.01 . . . . 0.0 110.359 -179.411 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.691 HG13 ' H ' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -134.07 -70.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.434 -0.791 . . . . 0.0 110.048 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.691 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -127.45 64.8 1.33 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.814 -1.179 . . . . 0.0 109.681 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 15.5 m-20 144.94 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.089 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -93.01 -176.7 4.26 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.426 1.108 . . . . 0.0 112.196 -177.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.862 HG12 ' CD ' ' A' ' 34' ' ' GLU . 7.4 p -39.35 159.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.136 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.636 HD23 ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -139.91 62.47 1.51 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.024 HG12 HG12 ' A' ' 48' ' ' VAL . 5.2 p -37.96 163.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.687 0.756 . . . . 0.0 110.139 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.795 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.1 mm-40 -122.57 100.06 6.73 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.216 -0.928 . . . . 0.0 108.857 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.789 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -84.82 -165.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.561 -0.712 . . . . 0.0 109.358 -179.295 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.789 ' N ' HG23 ' A' ' 39' ' ' ILE . 16.5 mm-40 -150.83 88.31 1.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.016 . . . . 0.0 110.074 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 1.015 HG23 ' HB2' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -83.2 -179.92 7.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.296 -0.878 . . . . 0.0 109.31 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.588 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.6 t0 -80.12 99.96 8.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 4.7 ttpm? 84.98 -21.52 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.807 -0.558 . . . . 0.0 109.628 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.685 HG12 HD23 ' A' ' 46' ' ' LEU . 97.8 t -118.23 146.27 23.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.204 -0.935 . . . . 0.0 109.954 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -134.45 100.96 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.865 . . . . 0.0 109.09 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.717 HD12 ' OD2' ' A' ' 9' ' ' ASP . 3.4 mm? -94.97 -169.43 2.0 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.214 -0.929 . . . . 0.0 110.058 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.516 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 2.3 pt-20 -147.66 -156.07 0.68 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.557 -0.714 . . . . 0.0 109.278 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.024 HG12 HG12 ' A' ' 37' ' ' VAL . 7.8 p -157.62 79.9 3.34 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.868 -1.145 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.636 ' HB3' HD23 ' A' ' 36' ' ' LEU . 36.3 Cg_endo -80.31 104.09 1.6 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.416 2.077 . . . . 0.0 110.337 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.994 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -73.81 -175.1 1.99 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.722 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.4 p -130.83 23.37 4.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.455 -1.403 . . . . 0.0 110.218 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.55 161.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.557 -0.714 . . . . 0.0 109.203 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.677 ' O ' HG12 ' A' ' 30' ' ' VAL . 7.2 m-20 67.25 -137.76 0.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.497 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 101.88 -7.84 55.53 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.33 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.651 HG23 ' CA ' ' A' ' 27' ' ' GLY . 4.5 mt -47.63 96.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.025 -1.279 . . . . 0.0 107.673 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.893 HD23 ' CB ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -42.48 100.36 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.687 0.756 . . . . 0.0 109.574 -178.473 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.463 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 6.9 t0 -104.13 -53.33 2.76 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.966 -0.459 . . . . 0.0 109.871 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.99 103.66 3.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.682 -1.261 . . . . 0.0 110.979 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.46 88.12 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.305 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.796 HD21 ' HA2' ' A' ' 74' ' ' GLY . 0.4 OUTLIER -69.2 -7.1 33.41 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.127 -0.983 . . . . 0.0 110.172 -178.551 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.52 ' CB ' ' HA ' ' A' ' 73' ' ' LEU . 1.3 mm-40 -119.24 37.85 4.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.133 -0.979 . . . . 0.0 108.381 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.515 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.2 m-20 -40.25 135.23 1.47 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.678 -0.639 . . . . 0.0 110.106 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 1.0 ' OE1' HG12 ' A' ' 19' ' ' VAL . 67.1 mm-40 -22.93 141.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.54 0.686 . . . . 0.0 111.783 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.1 -11.27 67.63 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 62' ' ' ASP . 1.3 m -84.47 156.18 21.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -1.154 . . . . 0.0 109.583 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 m -77.73 158.28 29.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.913 . . . . 0.0 109.525 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.101 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.7 171.39 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -139.66 -145.91 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.004 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 3.3 m -99.48 52.16 0.94 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.103 -0.998 . . . . 0.0 109.467 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER 161.01 -19.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.419 -0.801 . . . . 0.0 110.031 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.474 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 2.2 mm-40 -48.44 125.87 10.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.328 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 72' ' ' ILE . 5.3 tt -80.18 111.8 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.738 HD12 HG21 ' A' ' 5' ' ' ILE . 30.4 mt -47.02 -37.53 9.4 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.796 ' HA2' HD21 ' A' ' 60' ' ' LEU . . . 157.01 -158.53 28.92 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.857 ' C ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -137.69 145.16 42.26 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.203 -1.175 . . . . 0.0 110.0 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.857 HD23 ' C ' ' A' ' 75' ' ' ARG . 2.1 mt -106.48 -128.4 0.26 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.588 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 120.645 -1.284 . . . . 0.0 109.817 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.456 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.042 HG12 HG23 ' A' ' 5' ' ' ILE . 28.9 t -81.5 73.44 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.036 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -83.2 68.12 9.47 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.56 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.042 HG23 HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -80.96 165.34 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.755 0.788 . . . . 0.0 112.579 -177.309 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.839 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -139.61 -164.48 1.69 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.613 ' CG2' HD13 ' A' ' 39' ' ' ILE . 45.4 t -136.55 66.88 58.6 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.948 . . . . 0.0 109.935 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 36.5 Cg_endo -80.38 38.84 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.715 2.276 . . . . 0.0 110.655 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.559 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.307 -1.269 0 O-C-N 120.988 -1.07 . . . . 0.0 110.289 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.356 0.598 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 90.0 m -151.61 131.24 13.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.307 -0.87 . . . . 0.0 110.525 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.808 ' CG2' HD11 ' A' ' 73' ' ' LEU . 2.1 t -70.15 85.35 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 109.089 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -47.33 -63.79 0.95 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.934 -1.104 . . . . 0.0 110.404 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.644 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 36.3 m -165.83 127.13 1.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.539 -1.351 . . . . 0.0 111.9 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 1.036 ' HA ' HG23 ' A' ' 37' ' ' VAL . 15.1 m95 -67.4 -163.08 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.598 ' HB2' HG23 ' A' ' 35' ' ' VAL . 52.5 m-70 -156.21 30.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.767 ' HG2' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -116.83 159.1 22.87 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.7 0.762 . . . . 0.0 110.264 -179.077 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.598 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -106.14 -176.98 0.45 Allowed Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.0 Cg_endo -68.6 111.04 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.179 1.252 . . . . 0.0 110.768 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.532 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 57.65 43.51 94.33 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 8.6 m-20 -57.9 -164.27 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.831 -1.393 . . . . 0.0 110.209 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.16 87.52 0.5 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 53' ' ' ASP . 0.6 OUTLIER -78.91 -177.27 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -0.826 . . . . 0.0 110.654 -178.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.678 ' H ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -123.28 -80.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.577 ' H ' HG23 ' A' ' 31' ' ' VAL . 11.8 mtt180 -123.77 40.3 3.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.108 -0.995 . . . . 0.0 108.681 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.829 ' O ' HG21 ' A' ' 30' ' ' VAL . 10.9 m-20 178.05 83.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.048 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -81.5 -170.58 2.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 111.375 -178.254 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.754 HG12 ' CD ' ' A' ' 34' ' ' GLU . 7.6 p -48.98 161.53 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 121.87 0.843 . . . . 0.0 111.431 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.685 HD23 ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -141.2 62.21 1.47 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.322 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.036 HG23 ' HA ' ' A' ' 22' ' ' TRP . 2.5 p -38.15 165.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.688 0.756 . . . . 0.0 110.619 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -127.39 131.69 50.27 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.842 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -117.35 -172.28 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.277 -0.89 . . . . 0.0 109.315 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.72 ' N ' HG23 ' A' ' 39' ' ' ILE . 2.3 mt-10 -133.4 123.98 26.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.001 -1.062 . . . . 0.0 110.206 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.625 ' OG1' HG13 ' A' ' 44' ' ' VAL . 4.6 p -119.63 -104.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.327 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 28.9 t0 -130.32 75.11 1.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.326 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 87.46 -22.75 0.14 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.473 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.625 HG13 ' OG1' ' A' ' 41' ' ' THR . 12.1 p -103.8 144.65 13.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.411 -0.806 . . . . 0.0 109.479 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 39' ' ' ILE . 2.3 t -120.14 105.63 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 109.702 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.566 ' N ' HD22 ' A' ' 46' ' ' LEU . 4.0 mm? -79.99 -179.38 6.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.291 -0.881 . . . . 0.0 109.049 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.2 pt-20 -150.65 -163.19 1.72 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.027 -1.046 . . . . 0.0 110.219 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.998 HG12 HG12 ' A' ' 37' ' ' VAL . 9.7 p -154.96 81.0 4.29 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.133 -0.979 . . . . 0.0 110.216 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.685 ' HB3' HD23 ' A' ' 36' ' ' LEU . 36.6 Cg_endo -80.79 113.49 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.587 2.192 . . . . 0.0 110.81 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.048 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -80.7 -168.01 1.59 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.731 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.3 p -133.37 16.34 4.07 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.361 -1.462 . . . . 0.0 110.806 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.63 160.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.513 -0.742 . . . . 0.0 109.16 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.896 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.2 t70 64.96 -140.09 0.23 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.326 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.548 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 112.23 -12.71 26.27 Favored Glycine 0 N--CA 1.489 2.209 0 O-C-N 120.508 -1.37 . . . . 0.0 109.851 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.549 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -34.82 97.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.744 -0.857 . . . . 0.0 109.59 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.767 HD23 ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -45.06 104.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -113.93 -47.18 2.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.532 -0.73 . . . . 0.0 110.195 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -142.36 77.59 1.58 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.785 -1.197 . . . . 0.0 111.106 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.622 ' CG2' HD13 ' A' ' 56' ' ' LEU . 56.0 t -81.79 86.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.6 mt -69.63 -0.94 7.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -0.783 . . . . 0.0 111.255 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 21.1 mt-10 -134.54 55.44 1.89 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.778 -1.201 . . . . 0.0 108.199 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 63' ' ' GLU . 6.5 m-20 -43.93 127.06 5.13 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.702 0.763 . . . . 0.0 109.746 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.644 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -35.7 127.14 0.66 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.469 0.652 . . . . 0.0 111.284 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.48 -9.78 13.03 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.605 HG22 ' N ' ' A' ' 66' ' ' THR . 86.5 m -94.46 167.84 11.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -1.148 . . . . 0.0 109.386 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.605 ' N ' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -81.62 158.93 24.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.683 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.571 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.31 171.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.862 HG22 ' HG3' ' A' ' 71' ' ' GLN . 5.3 t -134.14 -161.48 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 0.0 109.237 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.524 ' N ' HG23 ' A' ' 68' ' ' THR . 29.9 t -85.91 40.88 0.88 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.629 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 69' ' ' SER . 4.8 ttm180 168.11 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.572 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.862 ' HG3' HG22 ' A' ' 68' ' ' THR . 1.6 mm-40 -105.61 97.59 7.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.94 . . . . 0.0 109.233 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.1 tt -42.25 112.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.463 -0.773 . . . . 0.0 109.86 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.808 HD11 ' CG2' ' A' ' 19' ' ' VAL . 10.3 tp -57.71 -42.67 84.26 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . 165.47 158.1 10.39 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.864 -1.636 . . . . 0.0 110.442 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.689 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -102.17 139.32 37.94 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.513 -0.993 . . . . 0.0 108.913 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.896 HD23 ' OE2' ' A' ' 34' ' ' GLU . 2.9 mp -105.14 -105.5 0.31 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.376 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.549 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.8 tpt180 . . . . . 0 C--N 1.301 -1.53 0 O-C-N 120.988 -1.07 . . . . 0.0 109.461 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 1.3 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.748 ' O ' HG12 ' A' ' 3' ' ' VAL . 16.5 t -79.75 76.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.417 ' CG ' ' HB3' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -80.61 77.46 7.43 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.228 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.791 HG12 HG13 ' A' ' 48' ' ' VAL . 5.2 tp -91.89 154.04 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.372 -0.83 . . . . 0.0 111.283 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.882 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -140.46 -157.93 0.81 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.608 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 67' ' ' VAL . 2.9 t -131.14 54.57 15.06 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 120.868 -1.145 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.708 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.6 Cg_endo -81.21 40.85 1.04 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.238 1.959 . . . . 0.0 110.008 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.543 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 O-C-N 121.016 -1.052 . . . . 0.0 110.176 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.519 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 16.1 m -161.05 127.55 3.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.087 -1.008 . . . . 0.0 110.162 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.598 HG22 HD11 ' A' ' 39' ' ' ILE . 2.5 t -53.87 157.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 108.708 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -127.42 -58.63 1.25 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.418 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 22.2 m -162.08 119.43 2.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.981 -1.074 . . . . 0.0 110.903 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.966 ' HA ' HG23 ' A' ' 37' ' ' VAL . 25.0 m95 -68.7 -170.58 0.22 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.867 0.842 . . . . 0.0 109.189 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.551 ' HB2' HG23 ' A' ' 35' ' ' VAL . 29.4 m-70 -152.81 38.77 0.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.871 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -130.97 115.98 17.23 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.541 -178.167 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.582 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -65.41 177.32 0.69 Allowed Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.17 93.54 0.4 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.793 1.662 . . . . 0.0 111.464 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.864 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 80.15 47.91 6.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 4.0 m-20 -58.58 -134.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.285 -1.127 . . . . 0.0 110.394 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 170.54 95.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.913 -1.117 . . . . 0.0 108.929 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.795 HG12 ' OE2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -103.25 -170.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.083 -1.01 . . . . 0.0 109.424 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.777 ' N ' HG13 ' A' ' 30' ' ' VAL . 4.2 m -134.18 -112.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 108.903 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 8.2 mmt-85 -87.08 64.68 8.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.758 -1.214 . . . . 0.0 108.721 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.4 m-20 150.73 102.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.091 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -101.52 -167.66 1.45 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.075 -1.016 . . . . 0.0 111.928 -178.236 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.627 HG22 ' N ' ' A' ' 36' ' ' LEU . 3.7 p -53.88 166.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.105 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.627 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -144.92 65.23 1.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 178.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.105 HG11 ' CD1' ' A' ' 73' ' ' LEU . 6.2 p -40.36 170.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.665 0.745 . . . . 0.0 110.117 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.759 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 21.5 mt-10 -123.56 107.92 12.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.003 -1.061 . . . . 0.0 108.903 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.775 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -91.71 -162.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 121.421 -0.799 . . . . 0.0 109.159 -179.339 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.775 ' N ' HG23 ' A' ' 39' ' ' ILE . 39.4 mt-10 -153.06 102.18 2.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 110.105 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.581 HG22 ' N ' ' A' ' 42' ' ' ASP . 88.2 m -97.81 -112.2 0.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.271 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.581 ' N ' HG22 ' A' ' 41' ' ' THR . 8.1 t70 -126.56 87.73 2.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.918 -1.114 . . . . 0.0 109.391 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.3 tptp 85.2 -28.5 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.25 145.79 23.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.232 -0.917 . . . . 0.0 109.231 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 39' ' ' ILE . 1.8 p -123.39 122.44 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.486 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.65 170.91 15.86 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.173 -0.954 . . . . 0.0 108.864 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -122.16 179.66 4.47 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.106 -0.996 . . . . 0.0 110.406 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.9 HG21 HD12 ' A' ' 73' ' ' LEU . 3.2 t -130.83 73.18 81.38 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.491 -0.756 . . . . 0.0 109.013 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.2 Cg_endo -80.6 104.0 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.585 2.19 . . . . 0.0 111.527 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.091 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -79.1 -156.87 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.756 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.1 p -144.33 13.31 1.59 Allowed 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.695 -1.253 . . . . 0.0 110.733 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 158.93 155.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.393 -0.817 . . . . 0.0 110.216 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 75.34 -81.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.501 -0.749 . . . . 0.0 110.659 179.293 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.529 ' N ' ' OE2' ' A' ' 34' ' ' GLU . . . 55.34 6.52 1.0 Allowed Glycine 0 N--CA 1.494 2.539 0 O-C-N 121.111 -0.993 . . . . 0.0 111.434 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.864 HG23 ' HA2' ' A' ' 27' ' ' GLY . 3.3 mt -54.97 98.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.643 -1.504 . . . . 0.0 108.061 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 24' ' ' LYS . 9.5 tp -51.21 90.14 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.536 -0.728 . . . . 0.0 109.328 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.5 t0 -99.11 -40.62 7.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.608 -0.683 . . . . 0.0 110.049 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.646 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -142.64 107.55 4.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.804 -1.185 . . . . 0.0 111.0 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.626 HG12 ' OD1' ' A' ' 62' ' ' ASP . 2.0 t -118.91 107.26 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mt -98.43 -31.9 11.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.025 . . . . 0.0 110.014 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.534 ' O ' HG21 ' A' ' 19' ' ' VAL . 3.0 mt-10 -98.61 35.44 1.82 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.626 ' OD1' HG12 ' A' ' 59' ' ' VAL . 2.2 m-20 -43.67 157.16 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.605 -0.684 . . . . 0.0 110.162 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -38.85 140.39 0.37 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.353 0.597 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.28 -19.86 47.02 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -86.18 161.51 18.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -82.74 163.27 21.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.571 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.51 169.2 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.419 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.523 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -145.71 -147.75 0.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.57 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 13.3 p -89.83 33.29 0.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.354 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER 171.82 26.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.528 -0.733 . . . . 0.0 110.268 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 13.7 mm100 -87.51 121.47 29.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.666 -1.271 . . . . 0.0 109.183 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 4.0 tt -69.2 111.36 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.609 -0.682 . . . . 0.0 110.581 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.105 ' CD1' HG11 ' A' ' 37' ' ' VAL . 3.8 mt -55.43 -36.25 66.31 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.438 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 154.82 164.31 12.84 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.799 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -111.96 140.68 46.42 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.37 -1.076 . . . . 0.0 108.997 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 76' ' ' LEU . 3.9 mp -116.2 -133.87 0.34 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.582 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 120.659 -1.276 . . . . 0.0 109.118 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.467 ' HB3' ' CA ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.722 HG21 ' HA2' ' A' ' 54' ' ' GLY . 8.6 t -69.81 90.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.182 -0.949 . . . . 0.0 109.246 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.97 78.74 5.4 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.898 ' CG1' HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -93.64 137.85 21.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.405 -0.809 . . . . 0.0 111.239 -176.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -136.02 -164.27 1.53 Allowed 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.779 HG23 HD21 ' A' ' 73' ' ' LEU . 54.6 t -132.32 66.44 77.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.995 -1.066 . . . . 0.0 109.325 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' SER . 36.5 Cg_endo -80.24 41.61 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.733 2.289 . . . . 0.0 110.589 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.917 ' CB ' HD13 ' A' ' 46' ' ' LEU . 2.4 m-20 . . . . . 0 C--N 1.305 -1.34 0 O-C-N 121.035 -1.041 . . . . 0.0 110.113 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.465 ' C ' HG13 ' A' ' 39' ' ' ILE . 12.5 m -150.42 117.18 5.84 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.103 -0.998 . . . . 0.0 110.165 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.019 HG12 ' OE1' ' A' ' 63' ' ' GLU . 2.1 t -50.77 151.27 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.53 ' N ' ' OE1' ' A' ' 63' ' ' GLU . . . -134.67 -43.0 0.75 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.105 -0.997 . . . . 0.0 110.924 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.577 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -164.03 108.91 1.01 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.106 -1.438 . . . . 0.0 112.578 -179.152 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.954 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.4 m95 -67.84 -165.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.732 ' HB2' HG23 ' A' ' 35' ' ' VAL . 48.5 m80 -149.97 28.57 0.75 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.582 ' CD ' ' HB ' ' A' ' 35' ' ' VAL . 12.3 mmmm -123.57 146.59 48.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.641 -0.662 . . . . 0.0 110.393 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.659 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -97.73 -170.6 0.22 Allowed Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.243 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.1 Cg_endo -68.6 84.06 0.5 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 120.839 1.026 . . . . 0.0 111.321 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.754 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 78.15 48.48 7.56 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.746 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.4 m-20 -56.48 -114.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.113 -1.228 . . . . 0.0 110.363 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 158.18 100.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.848 -1.158 . . . . 0.0 108.27 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -102.64 -175.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.838 -1.164 . . . . 0.0 110.292 -178.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -129.29 -98.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 109.899 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.457 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -100.74 38.53 1.51 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.974 -1.078 . . . . 0.0 109.826 -179.588 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.716 ' O ' HG21 ' A' ' 30' ' ' VAL . 4.0 m-20 -178.01 89.42 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.059 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 9.6 tp10 -87.7 168.35 13.06 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.281 1.039 . . . . 0.0 111.647 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.935 HG12 ' HG3' ' A' ' 34' ' ' GLU . 4.6 p -33.08 157.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 122.128 0.966 . . . . 0.0 112.471 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.33 62.1 1.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.954 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.3 p -38.01 166.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.773 0.797 . . . . 0.0 110.385 -177.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -118.7 150.74 39.24 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.979 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -138.34 -171.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.369 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.729 ' N ' HG23 ' A' ' 39' ' ' ILE . 19.7 mt-10 -126.86 119.92 27.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.039 -1.038 . . . . 0.0 109.892 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.2 -143.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.429 -0.795 . . . . 0.0 109.128 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 65.1 t0 -90.62 72.14 6.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 109.607 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.4 tttt 87.21 -23.32 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 45' ' ' VAL . 72.8 t -100.63 160.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.38 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.979 HG13 ' O ' ' A' ' 39' ' ' ILE . 36.2 t -127.73 106.24 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.324 -0.86 . . . . 0.0 109.738 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.917 HD13 ' CB ' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -79.44 166.3 22.15 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.22 -0.925 . . . . 0.0 108.92 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -126.99 -163.75 1.28 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.091 -1.006 . . . . 0.0 110.258 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.898 HG22 ' CG1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -152.79 91.52 3.47 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.679 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.5 Cg_endo -83.5 123.57 3.4 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.759 2.306 . . . . 0.0 111.894 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.059 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -97.6 173.54 7.09 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.727 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 19.8 p -120.14 75.3 1.09 Allowed 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.205 -1.398 . . . . 0.0 110.315 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 90.65 164.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.5 0.667 . . . . 0.0 110.105 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.2 m-20 67.65 -100.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.713 -0.617 . . . . 0.0 110.618 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.722 ' HA2' HG21 ' A' ' 3' ' ' VAL . . . 54.79 5.58 0.59 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 120.911 -1.118 . . . . 0.0 111.543 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.754 HG23 ' CA ' ' A' ' 27' ' ' GLY . 7.2 mt -47.41 98.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.47 -1.606 . . . . 0.0 108.021 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.886 HD12 ' HG ' ' A' ' 76' ' ' LEU . 5.2 tp -43.88 108.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.618 0.723 . . . . 0.0 110.287 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 2.5 t0 -131.91 -35.15 1.26 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.618 -0.676 . . . . 0.0 110.031 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.805 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -135.61 62.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.68 -1.262 . . . . 0.0 111.014 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.595 ' CG2' HD11 ' A' ' 56' ' ' LEU . 26.2 t -79.7 83.33 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.759 -1.213 . . . . 0.0 108.467 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 mt -73.56 -6.66 47.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.277 -0.889 . . . . 0.0 110.741 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 4.1 mt-10 -124.15 47.88 2.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.876 -1.14 . . . . 0.0 108.371 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -48.73 139.01 10.24 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.628 -0.67 . . . . 0.0 109.966 -179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 1.019 ' OE1' HG12 ' A' ' 19' ' ' VAL . 69.7 mm-40 -26.86 145.57 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.436 0.636 . . . . 0.0 111.414 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.11 -12.78 67.95 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.3 m -90.12 154.18 19.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -1.178 . . . . 0.0 109.661 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.15 161.31 28.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.597 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.63 174.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.02 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.89 HG22 ' CG ' ' A' ' 71' ' ' GLN . 3.6 t -135.09 -166.35 1.82 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.069 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -90.62 36.29 0.89 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.196 -0.94 . . . . 0.0 108.886 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' N ' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER 172.0 33.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.493 -0.754 . . . . 0.0 109.452 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.89 ' CG ' HG22 ' A' ' 68' ' ' THR . 5.1 mm-40 -107.02 145.57 32.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 109.182 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.5 tt -86.77 112.25 22.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.982 -1.074 . . . . 0.0 110.346 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.779 HD21 HG23 ' A' ' 7' ' ' VAL . 16.6 mt -54.04 -24.3 16.64 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 141.11 -168.31 25.4 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.805 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 9.5 ptt85 -127.64 146.78 50.44 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.283 -1.128 . . . . 0.0 109.443 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.886 ' HG ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -99.31 -92.77 0.27 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.361 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.551 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.772 0 O-C-N 121.279 -0.888 . . . . 0.0 109.972 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.563 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.738 ' O ' HG12 ' A' ' 3' ' ' VAL . 18.8 t -75.26 79.48 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 108.5 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.36 83.91 1.94 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.076 ' CG1' HG22 ' A' ' 48' ' ' VAL . 3.6 tp -104.45 147.5 10.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.849 -177.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.833 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -139.06 -158.83 0.89 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.505 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.88 HG21 HD13 ' A' ' 39' ' ' ILE . 41.6 t -129.02 65.37 73.73 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.947 -1.096 . . . . 0.0 109.6 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HG3' HD13 ' A' ' 6' ' ' LEU . 36.5 Cg_endo -79.72 61.79 8.3 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.805 2.337 . . . . 0.0 110.387 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.566 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.303 -1.414 0 O-C-N 121.014 -1.054 . . . . 0.0 109.732 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.663 ' HB3' HG22 ' A' ' 67' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 17.5 m -152.88 137.16 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.913 ' CG2' HD11 ' A' ' 73' ' ' LEU . 2.2 t -72.94 84.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.41 -0.807 . . . . 0.0 109.252 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -46.61 -63.52 0.99 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.059 -1.025 . . . . 0.0 110.537 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.903 HG23 ' OE1' ' A' ' 63' ' ' GLU . 96.8 m -165.44 124.94 1.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.589 -1.319 . . . . 0.0 111.781 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 1.072 ' HA ' HG23 ' A' ' 37' ' ' VAL . 15.7 m95 -67.75 -168.48 0.09 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.564 ' HB2' HG23 ' A' ' 35' ' ' VAL . 30.1 m-70 -153.3 24.15 0.54 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.777 ' HB3' HD13 ' A' ' 56' ' ' LEU . 6.1 tppt? -115.4 120.21 38.82 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.382 0.61 . . . . 0.0 109.593 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -67.1 175.61 1.43 Allowed Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.443 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 30.6 Cg_endo -71.31 94.66 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.073 1.849 . . . . 0.0 111.057 -178.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.646 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 85.33 37.42 9.81 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.58 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 8.9 m-20 -63.13 -162.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.784 -1.421 . . . . 0.0 109.61 178.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -162.85 79.36 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.92 -1.112 . . . . 0.0 110.069 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.783 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -78.9 -173.55 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 0.0 109.541 179.797 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.837 HG22 ' N ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -134.07 -86.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 0.0 109.36 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.837 ' N ' HG22 ' A' ' 31' ' ' VAL . 2.6 tpt180 -107.88 61.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.939 -1.101 . . . . 0.0 109.725 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.568 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.3 m-20 147.81 91.02 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.005 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -88.68 -166.91 1.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 111.336 -178.7 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.761 HG12 ' CD ' ' A' ' 34' ' ' GLU . 2.5 p -49.63 164.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.805 0.812 . . . . 0.0 111.311 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.594 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -140.17 63.64 1.47 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.603 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.072 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.3 p -38.59 166.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.701 0.762 . . . . 0.0 110.398 -177.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.647 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.4 mt-10 -128.05 112.63 14.83 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.263 -0.898 . . . . 0.0 108.729 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.88 HD13 HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -96.05 -167.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.498 -0.751 . . . . 0.0 109.03 -179.341 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.773 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.5 mt-10 -135.46 136.72 41.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 0.0 110.065 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.433 ' HB ' HG13 ' A' ' 44' ' ' VAL . 2.1 m -135.81 -136.32 0.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.6 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 23.5 t0 -96.0 74.21 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.907 -1.121 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.6 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.7 tmtt? 86.74 -23.3 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.788 -0.57 . . . . 0.0 109.543 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 45' ' ' VAL . 2.3 p -105.11 164.36 4.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.82 HG13 ' O ' ' A' ' 39' ' ' ILE . 44.5 t -144.39 112.77 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.373 -0.829 . . . . 0.0 109.454 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.866 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.82 168.54 19.15 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.136 -0.977 . . . . 0.0 108.869 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.472 ' OE1' ' O ' ' A' ' 36' ' ' LEU . 3.0 mm-40 -116.79 -171.4 2.01 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.927 -1.108 . . . . 0.0 110.639 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.076 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -147.55 77.32 10.54 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-O 122.409 1.099 . . . . 0.0 108.622 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.0 Cg_endo -81.62 113.02 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.781 2.321 . . . . 0.0 112.14 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.005 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -80.17 -160.18 0.27 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 177.472 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.725 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -139.62 11.92 2.51 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.497 -1.377 . . . . 0.0 110.891 -179.53 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.725 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.19 169.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.318 -0.864 . . . . 0.0 109.995 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER 67.85 -87.87 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.426 -0.796 . . . . 0.0 109.323 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 65.55 -13.57 0.28 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.219 -0.926 . . . . 0.0 112.15 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.646 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -42.83 96.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 119.124 1.462 . . . . 0.0 108.181 179.475 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.008 HD12 ' CD2' ' A' ' 76' ' ' LEU . 7.8 tp -54.11 97.12 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.47 -0.769 . . . . 0.0 109.64 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.401 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 17.7 t70 -109.0 -39.9 5.16 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.796 -0.565 . . . . 0.0 110.002 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -139.0 90.4 2.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.69 -1.256 . . . . 0.0 110.877 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.843 HG21 HD21 ' A' ' 56' ' ' LEU . 6.6 t -94.71 91.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 60' ' ' LEU . 27.7 mt -70.08 -1.76 10.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 110.887 -178.533 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 5.7 mt-10 -137.41 55.26 1.81 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.024 -1.048 . . . . 0.0 108.449 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 63' ' ' GLU . 24.0 m-20 -43.79 126.01 4.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.526 -0.733 . . . . 0.0 109.452 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.903 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -33.94 122.5 0.46 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.626 0.727 . . . . 0.0 111.435 -179.236 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.49 -6.03 12.87 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.6 -172.75 3.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -1.132 . . . . 0.0 109.317 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -93.84 153.13 18.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.835 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.663 HG22 ' HB3' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -150.35 171.4 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.378 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.87 HG22 ' CG ' ' A' ' 71' ' ' GLN . 13.7 t -148.04 -137.65 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 108.83 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.724 ' N ' HG23 ' A' ' 68' ' ' THR . 6.2 p -69.2 -110.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.691 -1.256 . . . . 0.0 108.021 179.326 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.519 ' CG ' ' HB3' ' A' ' 8' ' ' PRO . 3.4 mtm180 -71.3 79.4 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 109.419 179.141 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.87 ' CG ' HG22 ' A' ' 68' ' ' THR . 2.7 mm-40 -115.63 96.28 5.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.121 -0.987 . . . . 0.0 108.451 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 72' ' ' ILE . 4.0 tt -42.26 109.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.341 -0.85 . . . . 0.0 110.194 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.953 HD22 HG11 ' A' ' 37' ' ' VAL . 10.7 tp -62.23 -27.86 69.29 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 59' ' ' VAL . . . 154.46 154.82 7.0 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.126 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.812 ' C ' HD12 ' A' ' 76' ' ' LEU . 5.2 ptt180 -104.41 136.84 43.23 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.429 -1.042 . . . . 0.0 109.489 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.008 ' CD2' HD12 ' A' ' 56' ' ' LEU . 4.0 mp -112.86 -103.87 0.4 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.478 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.563 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 109.391 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.406 0.622 . . . . 0.0 109.59 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.722 ' O ' HG12 ' A' ' 3' ' ' VAL . 24.9 t -80.93 75.96 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.395 -0.815 . . . . 0.0 109.189 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -81.51 94.17 6.81 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.781 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.813 HG12 HG13 ' A' ' 48' ' ' VAL . 5.7 tp -106.57 159.3 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.344 -177.657 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.841 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -141.35 -161.03 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.367 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 67' ' ' VAL . 48.2 t -130.75 50.07 5.57 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.754 -1.216 . . . . 0.0 111.501 -179.183 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.714 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.9 Cg_endo -82.63 39.91 0.9 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.072 1.848 . . . . 0.0 109.757 178.793 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.936 ' HB2' HD13 ' A' ' 46' ' ' LEU . 4.2 m-20 . . . . . 0 C--N 1.306 -1.286 0 O-C-N 121.125 -0.984 . . . . 0.0 111.186 -178.397 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.829 ' HB2' HG22 ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.375 0.607 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.546 ' N ' HG13 ' A' ' 67' ' ' VAL . 92.5 m -160.23 130.35 5.36 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.33 -0.856 . . . . 0.0 110.068 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.739 ' CG2' HD11 ' A' ' 73' ' ' LEU . 4.2 t -68.05 111.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.335 -0.853 . . . . 0.0 109.031 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -76.61 -57.53 3.8 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.144 -0.973 . . . . 0.0 109.901 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.58 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 17.9 m -170.75 126.83 0.74 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.682 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 1.049 ' HA ' HG23 ' A' ' 37' ' ' VAL . 14.8 m95 -68.84 -168.56 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 108.819 177.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.579 ' HB2' HG23 ' A' ' 35' ' ' VAL . 31.6 m-70 -151.22 39.05 0.66 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.628 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.779 ' HB3' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -130.86 138.81 50.0 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.673 0.749 . . . . 0.0 110.867 -178.509 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.596 ' CB ' ' OD1' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -88.79 179.41 1.63 Allowed Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.039 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.8 Cg_endo -66.03 105.31 0.81 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.561 1.508 . . . . 0.0 112.284 -178.044 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.625 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 60.35 48.0 88.33 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.115 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.728 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 3.6 m-20 -59.52 -119.44 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.046 -1.267 . . . . 0.0 110.363 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 159.67 99.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.056 -1.027 . . . . 0.0 109.035 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -103.41 -178.99 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 109.62 -179.546 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.698 ' N ' HG13 ' A' ' 30' ' ' VAL . 3.2 m -127.48 -110.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 14.3 mtp180 -90.2 66.68 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.778 -1.201 . . . . 0.0 108.785 179.295 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 15.0 m-20 150.59 103.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -179.17 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.997 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -108.17 -171.46 1.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.391 1.091 . . . . 0.0 111.959 -178.21 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.763 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 9.0 p -45.8 169.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.145 0.974 . . . . 0.0 111.389 -179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.596 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -149.71 59.14 1.0 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.049 HG23 ' HA ' ' A' ' 22' ' ' TRP . 2.7 p -39.3 165.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.807 0.813 . . . . 0.0 110.192 -178.122 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.845 ' OE1' HG11 ' A' ' 45' ' ' VAL . 1.6 mm-40 -123.48 146.53 47.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.739 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -134.5 -173.72 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.272 -179.262 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.715 ' N ' HG23 ' A' ' 39' ' ' ILE . 8.9 mt-10 -146.73 95.91 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.672 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.829 HG22 ' HB2' ' A' ' 17' ' ' ALA . 27.0 p -86.94 -48.8 7.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 109.725 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 55.1 t0 176.7 77.6 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.636 -0.665 . . . . 0.0 109.295 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER 87.28 -26.47 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.419 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.46 154.98 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.337 -0.852 . . . . 0.0 109.34 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.845 HG11 ' OE1' ' A' ' 38' ' ' GLU . 57.8 t -125.27 114.92 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -0.974 . . . . 0.0 109.822 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.936 HD13 ' HB2' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -79.67 159.3 26.75 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.299 -0.875 . . . . 0.0 108.755 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.53 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -121.96 -178.6 3.89 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.035 -1.041 . . . . 0.0 110.502 -179.298 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.828 ' O ' HG12 ' A' ' 48' ' ' VAL . 11.4 t -142.91 68.26 18.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.4 Cg_endo -80.31 106.41 1.88 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.679 2.253 . . . . 0.0 110.886 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.997 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -89.38 -161.73 0.8 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.757 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.2 p -142.95 17.21 1.95 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.748 -1.22 . . . . 0.0 110.888 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.35 163.3 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.115 -0.991 . . . . 0.0 110.668 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER 78.26 -77.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.646 179.64 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.504 ' O ' ' HD3' ' A' ' 24' ' ' LYS . . . 40.34 22.4 0.04 OUTLIER Glycine 0 N--CA 1.489 2.216 0 O-C-N 121.442 -0.786 . . . . 0.0 111.634 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.625 HG23 ' CA ' ' A' ' 27' ' ' GLY . 2.9 mt -83.61 94.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.549 -1.559 . . . . 0.0 107.329 178.256 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.126 HD12 ' CD1' ' A' ' 76' ' ' LEU . 2.1 tp -43.73 115.99 0.89 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.579 -0.701 . . . . 0.0 110.179 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 1.2 t0 -132.11 -42.73 0.98 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.491 -0.755 . . . . 0.0 109.895 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.944 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -132.82 76.65 1.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.785 -1.197 . . . . 0.0 110.873 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.557 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 60.6 t -93.33 81.52 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.406 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.775 HD11 HG23 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -69.04 -27.92 66.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.397 -0.814 . . . . 0.0 110.658 -178.423 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.535 ' CG ' HD12 ' A' ' 60' ' ' LEU . 7.7 mt-10 -106.73 47.79 0.86 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.473 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -39.14 139.31 0.51 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.597 0.713 . . . . 0.0 109.712 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.58 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -37.87 135.72 0.63 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.626 0.727 . . . . 0.0 110.999 -179.249 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.41 -6.37 36.17 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -95.72 158.38 15.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.244 . . . . 0.0 109.701 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.65 162.02 28.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.257 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.41 174.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.359 -0.838 . . . . 0.0 109.004 -178.802 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.689 HG23 ' N ' ' A' ' 69' ' ' SER . 4.8 t -150.26 -152.86 0.46 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 108.975 179.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.689 ' N ' HG23 ' A' ' 68' ' ' THR . 12.5 p -89.48 54.96 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.064 -1.022 . . . . 0.0 109.558 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' A' ' 69' ' ' SER . 3.5 mtp85 159.36 -12.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.565 -0.709 . . . . 0.0 110.654 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.633 ' CG ' HG22 ' A' ' 68' ' ' THR . 1.5 mt-30 -54.2 102.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.943 -1.098 . . . . 0.0 109.641 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.775 HG23 HD11 ' A' ' 60' ' ' LEU . 3.1 tt -54.94 111.5 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.039 HD22 HG11 ' A' ' 37' ' ' VAL . 8.4 tp -54.32 -29.89 49.38 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.502 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 144.69 153.34 5.84 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.944 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -93.99 145.39 24.68 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.515 -0.991 . . . . 0.0 108.332 179.181 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.126 ' CD1' HD12 ' A' ' 56' ' ' LEU . 3.4 mm? -85.45 -111.7 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.73 -178.932 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.548 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 3.4 ttp85 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 120.732 -1.23 . . . . 0.0 110.479 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 62.3 t -81.56 70.55 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 108.798 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -74.07 84.04 1.79 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.407 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.822 HG12 HG13 ' A' ' 48' ' ' VAL . 8.0 tp -99.73 163.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 111.297 -177.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.859 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -147.31 -159.86 1.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.313 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.815 HG21 ' CG2' ' A' ' 67' ' ' VAL . 2.1 t -133.15 56.11 20.09 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.121 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -80.58 35.94 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.5 2.134 . . . . 0.0 110.824 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.568 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.1 m-20 . . . . . 0 C--N 1.306 -1.283 0 O-C-N 120.801 -1.187 . . . . 0.0 109.966 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 121.167 0.508 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.485 ' N ' HG13 ' A' ' 67' ' ' VAL . 46.8 m -155.55 124.15 5.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 110.54 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.938 HG22 HD11 ' A' ' 39' ' ' ILE . 17.0 t -65.52 107.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.23 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -73.8 -59.62 2.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.614 -179.314 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.586 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.6 m -168.69 128.52 1.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.628 -1.295 . . . . 0.0 111.775 -179.086 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.995 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.6 m95 -69.2 -166.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.661 0.743 . . . . 0.0 109.24 178.346 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.1 m80 -152.7 26.47 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.549 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.6 tppt? -119.36 137.91 53.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.69 -0.631 . . . . 0.0 110.132 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.599 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.28 179.29 1.71 Allowed Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.676 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -69.64 104.91 1.37 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.664 1.576 . . . . 0.0 111.62 -178.267 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 75.03 39.52 37.49 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 4.8 m-20 -59.45 -166.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.718 -1.46 . . . . 0.0 109.597 178.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.17 78.56 0.45 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.08 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.698 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -79.55 169.26 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.009 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -110.06 -95.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 1.6 mtm180 -107.2 51.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.961 -1.087 . . . . 0.0 109.63 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.698 ' O ' HG21 ' A' ' 30' ' ' VAL . 4.2 m-20 173.04 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.949 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 10.3 tp10 -102.29 163.62 12.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.058 -1.026 . . . . 0.0 111.008 -178.235 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.598 HG12 ' HG3' ' A' ' 34' ' ' GLU . 2.5 p -30.36 160.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.57 1.176 . . . . 0.0 112.581 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.533 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.12 67.63 1.37 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.087 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.995 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.1 p -38.59 165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.102 -177.394 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.27 145.71 46.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.938 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -134.77 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.334 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.722 ' N ' HG23 ' A' ' 39' ' ' ILE . 13.1 mt-10 -149.35 138.51 21.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.923 -1.11 . . . . 0.0 109.708 -179.262 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 5.9 t -132.72 26.22 4.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 41' ' ' THR . 2.2 t70 87.34 15.31 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.341 0.591 . . . . 0.0 110.459 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 160.52 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 1.1 t -103.99 148.57 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.613 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 39' ' ' ILE . 51.2 t -136.93 96.76 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.685 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.769 ' N ' HD22 ' A' ' 46' ' ' LEU . 2.9 mm? -79.88 -176.0 5.21 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.309 -0.869 . . . . 0.0 108.728 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 1.3 pt-20 -142.39 -161.36 1.23 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.718 -1.239 . . . . 0.0 111.463 -178.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.822 HG13 HG12 ' A' ' 5' ' ' ILE . 6.0 t -143.47 75.5 16.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.7 Cg_endo -80.73 110.82 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.487 2.125 . . . . 0.0 110.931 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.949 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -91.79 -169.38 2.26 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.137 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.1 p -132.36 14.68 4.57 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.265 -1.522 . . . . 0.0 111.183 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.62 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 109.951 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER 60.63 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 179.816 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.548 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 64.95 -13.65 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 O-C-N 121.324 -0.86 . . . . 0.0 112.093 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.651 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.81 96.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.674 -1.486 . . . . 0.0 108.551 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.925 HD12 ' HG ' ' A' ' 76' ' ' LEU . 7.8 tp -49.87 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ILE . 46.6 t0 -98.6 -41.59 7.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.97 -0.456 . . . . 0.0 110.544 -178.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -147.37 78.71 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.577 -1.327 . . . . 0.0 111.677 -179.081 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.74 ' CG2' HD11 ' A' ' 56' ' ' LEU . 60.7 t -80.86 82.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.722 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.37 -10.8 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 109.709 -178.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 4.8 mm-40 -123.74 50.93 1.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.196 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -40.8 134.12 1.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.586 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.05 134.51 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.597 0.713 . . . . 0.0 111.015 -178.897 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.75 -13.96 24.64 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -84.98 156.19 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -1.135 . . . . 0.0 109.405 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.41 166.43 20.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.681 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.815 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.04 169.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.242 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -147.78 -148.31 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 -179.652 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 9.3 p -90.28 36.18 0.87 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mtt180 163.55 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.4 mt-30 -84.49 87.69 7.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 0.0 109.102 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.4 tt -45.0 108.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 48' ' ' VAL . 10.6 mt -53.91 -42.86 69.21 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 156.55 -159.79 29.76 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.549 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -134.68 134.49 41.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.151 -1.206 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.925 ' HG ' HD12 ' A' ' 56' ' ' LEU . 4.4 mp -98.09 -96.72 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.34 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.542 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.776 ' O ' HG12 ' A' ' 3' ' ' VAL . 3.0 t -75.94 79.76 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -86.73 80.47 8.52 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.031 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.795 HG12 HG22 ' A' ' 48' ' ' VAL . 6.0 tp -86.98 161.7 2.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 111.738 -177.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.85 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -144.69 -166.02 2.29 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.133 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.662 ' CG2' HD21 ' A' ' 73' ' ' LEU . 38.9 t -133.31 57.11 24.62 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.15 -0.969 . . . . 0.0 110.005 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.0 Cg_endo -79.97 38.33 0.74 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.392 2.061 . . . . 0.0 110.534 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.564 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.292 0 O-C-N 120.869 -1.145 . . . . 0.0 109.962 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.48 ' C ' HG13 ' A' ' 39' ' ' ILE . 77.0 m -161.16 113.98 1.92 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.293 -0.88 . . . . 0.0 110.116 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.001 HG12 ' OE1' ' A' ' 63' ' ' GLU . 2.3 t -46.78 137.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.182 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.841 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -116.73 -51.14 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.985 -1.072 . . . . 0.0 110.958 -178.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.555 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -158.55 109.89 2.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.563 -1.335 . . . . 0.0 112.066 -179.214 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.866 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.7 m95 -68.11 -164.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.646 ' HB2' HG23 ' A' ' 35' ' ' VAL . 24.7 m-70 -155.23 30.44 0.39 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 177.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.58 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 1.3 tppm? -124.4 139.23 54.09 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.407 0.622 . . . . 0.0 110.513 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.597 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -89.26 -176.4 0.66 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.015 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.597 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.6 Cg_endo -66.13 90.14 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.917 1.078 . . . . 0.0 111.321 -178.536 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.807 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 72.92 47.65 24.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.735 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 14.6 m-20 -58.4 -113.4 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.057 -1.261 . . . . 0.0 110.388 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 158.9 102.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.96 -1.088 . . . . 0.0 108.574 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.777 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -101.93 -173.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.05 . . . . 0.0 109.929 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.777 ' N ' HG13 ' A' ' 30' ' ' VAL . 5.7 m -131.86 -114.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.183 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.566 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -87.41 64.62 8.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.691 -1.256 . . . . 0.0 109.182 179.735 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 5.0 m-20 149.65 99.16 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.05 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -95.04 -176.06 3.72 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.414 1.102 . . . . 0.0 111.898 -178.22 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.738 HG12 ' OE2' ' A' ' 34' ' ' GLU . 11.5 p -39.7 166.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.953 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.6 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -147.32 61.97 1.16 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 179.017 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.866 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.3 p -39.29 166.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.683 0.754 . . . . 0.0 110.273 -177.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.841 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 4.1 mt-10 -128.75 95.26 4.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.192 -0.943 . . . . 0.0 109.146 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.801 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -79.62 -167.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 109.123 -179.658 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.748 ' N ' HG23 ' A' ' 39' ' ' ILE . 24.3 mt-10 -153.75 121.24 5.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.922 -1.111 . . . . 0.0 110.193 -179.191 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -116.26 -95.19 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.434 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 31.1 t0 -146.15 86.73 1.71 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.385 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 16.5 tttt 86.72 -24.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.07 161.61 5.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 39' ' ' ILE . 54.1 t -150.85 98.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.842 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.59 168.91 18.76 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.213 -0.929 . . . . 0.0 108.864 179.945 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -124.94 -162.89 1.13 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.001 -1.062 . . . . 0.0 110.819 -178.78 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.861 ' HB ' HG12 ' A' ' 37' ' ' VAL . 3.8 t -144.23 74.57 15.74 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.525 -0.735 . . . . 0.0 109.289 -179.345 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.9 Cg_endo -82.19 101.84 1.15 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.887 2.392 . . . . 0.0 111.316 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.05 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -80.19 -161.36 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.021 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.726 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.4 p -135.1 10.14 3.54 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.466 -1.396 . . . . 0.0 111.275 -179.225 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.18 157.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.079 -1.013 . . . . 0.0 110.295 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER 79.1 -73.41 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.675 -0.641 . . . . 0.0 110.518 179.05 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.589 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 43.54 17.85 0.06 OUTLIER Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.154 -0.966 . . . . 0.0 111.315 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.807 HG23 ' CA ' ' A' ' 27' ' ' GLY . 20.5 mt -68.85 91.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.596 -1.532 . . . . 0.0 107.285 179.058 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.896 HD22 HG22 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -44.17 91.34 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.639 0.733 . . . . 0.0 110.366 -178.291 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 55' ' ' ILE . 36.3 t70 -87.29 -53.86 4.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.738 -0.601 . . . . 0.0 109.732 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.35 104.66 3.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.794 -1.191 . . . . 0.0 110.71 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.896 HG22 HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -90.91 92.12 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.553 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.56 -5.55 25.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.186 -0.946 . . . . 0.0 110.076 -178.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 73' ' ' LEU . 2.9 mt-10 -128.89 41.93 3.4 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 108.7 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.513 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.0 m-20 -42.72 131.13 4.06 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.596 -0.69 . . . . 0.0 109.593 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 1.001 ' OE1' HG12 ' A' ' 19' ' ' VAL . 67.2 mm-40 -20.91 140.05 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.661 0.743 . . . . 0.0 112.322 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.25 -15.61 61.12 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -80.07 162.82 24.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -1.232 . . . . 0.0 109.528 179.942 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 67' ' ' VAL . 8.1 m -90.61 162.83 14.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 109.721 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.56 171.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.214 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.695 HG23 ' N ' ' A' ' 69' ' ' SER . 5.1 t -137.98 -152.31 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.05 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.695 ' N ' HG23 ' A' ' 68' ' ' THR . 84.3 p -89.3 39.39 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 0.0 109.174 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.495 ' CG ' ' C ' ' A' ' 69' ' ' SER . 4.7 ptt180 165.78 34.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.95 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' A' ' 68' ' ' THR . 6.4 mm-40 -97.37 119.44 35.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.287 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 72' ' ' ILE . 1.9 tt -70.14 111.33 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -0.925 . . . . 0.0 110.032 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.843 ' CD1' HG21 ' A' ' 48' ' ' VAL . 13.8 mt -47.97 -42.23 27.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 162.04 -165.72 36.0 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.818 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.9 ptt-85 -129.22 149.25 51.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.293 -1.122 . . . . 0.0 109.364 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.874 HD22 HD23 ' A' ' 56' ' ' LEU . 4.5 mt -116.01 -132.21 0.32 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.403 -179.164 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.571 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 11.1 tpt85 . . . . . 0 N--CA 1.495 1.782 0 O-C-N 120.584 -1.323 . . . . 0.0 110.313 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.566 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 3.7 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.69 HG21 ' HA2' ' A' ' 54' ' ' GLY . 37.4 t -69.48 83.38 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.133 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.35 84.24 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.178 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.046 ' CG1' HG22 ' A' ' 48' ' ' VAL . 4.9 tp -110.55 143.82 19.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.291 -177.138 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.676 ' O ' HG23 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -128.48 -134.82 0.23 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.306 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 7' ' ' VAL . 45.9 t -161.85 67.41 2.13 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.717 -1.239 . . . . 0.0 109.168 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD3' ' HG ' ' A' ' 6' ' ' LEU . 35.4 Cg_endo -77.25 67.03 7.78 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.551 2.167 . . . . 0.0 110.584 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.982 ' HB2' HD13 ' A' ' 46' ' ' LEU . 1.2 m-20 . . . . . 0 C--N 1.305 -1.337 0 O-C-N 121.284 -0.885 . . . . 0.0 109.416 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.247 0.546 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 40' ' ' GLU . 24.1 m -157.38 137.53 12.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.113 -0.992 . . . . 0.0 110.72 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 79.0 t -67.18 86.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.424 -0.797 . . . . 0.0 109.46 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -42.76 -62.97 0.86 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.216 -0.927 . . . . 0.0 109.938 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 2.6 m -166.91 130.05 1.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.482 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 1.031 ' HA ' HG23 ' A' ' 37' ' ' VAL . 22.0 m95 -68.78 -167.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.423 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CD2' ' HA ' ' A' ' 37' ' ' VAL . 62.6 m-70 -149.3 24.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.011 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.752 ' HB3' HD13 ' A' ' 56' ' ' LEU . 10.7 tppt? -119.78 126.11 50.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.683 -0.636 . . . . 0.0 109.959 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.652 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 3.1 mmmt -79.99 -171.84 0.31 Allowed Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.652 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -68.45 104.94 1.17 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.026 1.151 . . . . 0.0 112.123 -177.282 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.732 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 57.97 48.5 82.14 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.27 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -56.35 -115.9 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.192 -1.181 . . . . 0.0 110.486 179.628 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 162.0 100.39 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.761 -1.212 . . . . 0.0 108.312 -178.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.998 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -102.08 173.95 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 111.082 -178.75 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.573 ' H ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -123.62 -92.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.068 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.539 ' H ' HG23 ' A' ' 31' ' ' VAL . 6.7 mtp180 -112.18 66.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.08 -1.013 . . . . 0.0 108.396 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.69 ' O ' HG21 ' A' ' 30' ' ' VAL . 8.2 m-20 155.13 80.55 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.084 ' OE1' HG12 ' A' ' 35' ' ' VAL . 1.1 tm-20 -87.81 175.08 7.99 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.179 0.99 . . . . 0.0 112.365 -177.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.084 HG12 ' OE1' ' A' ' 34' ' ' GLU . 2.4 p -32.14 156.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.93 0.871 . . . . 0.0 112.114 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.551 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -141.9 59.98 1.47 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.218 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.031 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.4 p -38.57 169.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.685 0.755 . . . . 0.0 110.571 -177.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.744 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 14.2 mt-10 -133.43 102.75 5.65 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.163 -0.961 . . . . 0.0 108.724 -179.294 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.926 HD11 ' CG1' ' A' ' 67' ' ' VAL . 2.1 tt -81.01 -165.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.327 -0.858 . . . . 0.0 109.411 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.783 ' N ' HG23 ' A' ' 39' ' ' ILE . 19.6 mm-40 -141.61 89.91 2.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.029 -1.044 . . . . 0.0 110.004 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 41' ' ' THR . 87.8 m -90.95 28.97 1.44 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.296 -0.878 . . . . 0.0 109.335 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.8 t70 77.6 73.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.685 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.2 tttt 87.24 -26.58 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.458 ' O ' ' HB ' ' A' ' 41' ' ' THR . 41.1 t -105.44 94.12 2.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.242 -0.911 . . . . 0.0 109.5 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.917 HG13 ' O ' ' A' ' 39' ' ' ILE . 81.4 t -94.77 104.72 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.409 -0.807 . . . . 0.0 109.443 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.982 HD13 ' HB2' ' A' ' 9' ' ' ASP . 0.8 OUTLIER -79.5 174.45 11.56 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.225 -0.922 . . . . 0.0 108.865 -179.759 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 8.4 pm0 -118.05 -179.58 3.8 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.994 -1.066 . . . . 0.0 110.758 -178.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.046 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -144.19 79.08 13.21 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-O 122.331 1.062 . . . . 0.0 108.381 179.666 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.58 120.18 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.826 2.35 . . . . 0.0 111.888 -178.453 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.941 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -96.45 169.84 9.63 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.07 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.704 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 22.9 p -118.32 77.9 1.21 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 120.354 -1.466 . . . . 0.0 110.242 -178.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.824 ' HA ' HG13 ' A' ' 30' ' ' VAL . . . 94.48 168.45 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.563 ' O ' HG12 ' A' ' 30' ' ' VAL . 59.4 m-20 61.96 -126.4 0.76 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.709 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.69 ' HA2' HG21 ' A' ' 3' ' ' VAL . . . 84.56 -7.7 71.96 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.055 -1.545 . . . . 0.0 109.704 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.732 HG23 ' CA ' ' A' ' 27' ' ' GLY . 8.2 mt -42.97 98.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.413 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.875 HD12 ' CD2' ' A' ' 76' ' ' LEU . 6.0 tp -43.44 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.666 0.746 . . . . 0.0 110.318 -177.751 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' ILE . 23.0 t70 -106.35 -36.37 6.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.704 -0.622 . . . . 0.0 109.327 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.658 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -147.35 100.12 3.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.071 . . . . 0.0 110.383 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.528 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 13.5 t -107.55 90.3 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.0 mt -69.63 -4.82 20.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.071 -179.153 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 10.9 mt-10 -127.63 52.34 1.85 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.7 m-20 -49.45 125.28 10.87 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.734 -0.604 . . . . 0.0 110.77 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.549 ' C ' ' O ' ' A' ' 62' ' ' ASP . 5.1 mt-10 -7.55 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.477 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 65' ' ' THR . . . 128.74 -38.09 2.11 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.439 178.641 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.494 ' OG1' ' HA ' ' A' ' 61' ' ' GLU . 5.6 m -43.1 145.38 0.52 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -1.189 . . . . 0.0 109.442 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 m -86.72 141.1 29.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.967 . . . . 0.0 110.189 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.926 ' CG1' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.8 168.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.757 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.589 HG23 ' N ' ' A' ' 69' ' ' SER . 5.2 t -120.4 -47.66 2.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 68' ' ' THR . 0.5 OUTLIER -170.31 -75.27 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.728 0.775 . . . . 0.0 109.714 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -78.95 37.18 0.3 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.672 -0.643 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HG3' HG22 ' A' ' 68' ' ' THR . 3.7 mt-30 -103.34 97.53 7.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.185 . . . . 0.0 108.543 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.52 HG23 ' O ' ' A' ' 72' ' ' ILE . 3.7 tt -40.6 111.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.795 . . . . 0.0 110.404 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.707 ' CD1' HG11 ' A' ' 37' ' ' VAL . 12.0 mt -55.47 -41.2 72.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.84 167.99 21.2 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.875 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.7 ptt180 -109.87 138.77 45.76 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.109 -1.23 . . . . 0.0 109.833 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.875 ' CD2' HD12 ' A' ' 56' ' ' LEU . 4.3 mp -115.72 -101.87 0.42 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.795 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.566 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 109.51 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.544 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -148.39 169.27 20.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 109.475 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.797 HG21 ' OE1' ' A' ' 34' ' ' GLU . 40.1 t -69.43 85.96 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.116 -0.99 . . . . 0.0 108.666 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.7 83.44 1.6 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.026 ' CG1' HG22 ' A' ' 48' ' ' VAL . 1.8 tp -105.68 138.31 31.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.342 -0.849 . . . . 0.0 110.443 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.822 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -134.17 -157.75 0.83 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.854 ' CG2' HD21 ' A' ' 73' ' ' LEU . 42.2 t -127.55 68.75 74.53 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 37.3 Cg_endo -81.85 19.97 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.774 2.316 . . . . 0.0 110.712 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.547 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -86.06 16.59 4.13 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.013 -1.054 . . . . 0.0 110.038 -179.381 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.564 ' CA ' ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -39.98 100.44 0.22 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.426 -0.796 . . . . 0.0 109.979 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 9' ' ' ASP . 36.2 Cg_endo -79.08 -84.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.587 2.191 . . . . 0.0 110.3 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -148.83 33.91 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 109.52 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.0 t -164.74 144.46 7.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -0.942 . . . . 0.0 109.524 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 14' ' ' VAL . 5.2 p -131.01 51.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.915 . . . . 0.0 109.448 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 16' ' ' ASP . . . -90.0 36.61 0.87 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.219 -0.925 . . . . 0.0 109.453 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 1.8 m-20 70.86 -174.75 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.882 . . . . 0.0 109.422 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -170.46 -164.87 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.645 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.499 ' C ' HG12 ' A' ' 39' ' ' ILE . 18.4 m -158.21 133.34 8.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.992 . . . . 0.0 110.906 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.598 HG21 ' HB3' ' A' ' 61' ' ' GLU . 29.5 t -71.12 84.04 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.463 -0.773 . . . . 0.0 109.633 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -39.44 -60.58 0.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.897 . . . . 0.0 110.361 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 22' ' ' TRP . 20.1 m -169.13 129.6 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.665 -1.272 . . . . 0.0 111.446 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 1.033 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.7 m95 -69.55 -167.54 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.545 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.4 m-70 -152.68 23.65 0.59 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.582 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 7.1 tppt? -114.99 127.42 55.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.739 -0.6 . . . . 0.0 109.759 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.565 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -72.38 175.93 2.81 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.9 Cg_endo -70.46 95.62 0.62 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.957 1.771 . . . . 0.0 111.103 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.626 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 83.43 39.64 9.66 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.582 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 7.6 m-20 -65.5 -163.52 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.984 -1.304 . . . . 0.0 110.094 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.43 82.21 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.401 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.809 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -79.35 -170.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 110.203 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.809 ' N ' HG13 ' A' ' 30' ' ' VAL . 2.6 m -133.61 -106.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 6.9 mtt180 -92.38 62.03 3.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.695 -1.253 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.659 ' O ' HG21 ' A' ' 30' ' ' VAL . 7.6 m-20 153.7 96.06 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.085 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -94.18 -165.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.03 -1.043 . . . . 0.0 111.701 -178.429 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.823 HG12 ' OE2' ' A' ' 34' ' ' GLU . 7.3 p -51.88 162.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.758 0.79 . . . . 0.0 110.951 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.577 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -139.77 59.83 1.58 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.033 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.4 p -39.04 168.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-O 121.678 0.751 . . . . 0.0 110.616 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.5 mt-10 -131.66 111.15 11.44 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 108.721 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.856 ' O ' HG22 ' A' ' 45' ' ' VAL . 1.7 tt -95.06 -164.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 109.449 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.784 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.3 mt-10 -141.37 99.69 3.62 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.155 -0.966 . . . . 0.0 109.677 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.892 ' HB ' HG23 ' A' ' 44' ' ' VAL . 25.2 m -102.55 44.39 1.02 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.703 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 6.4 t70 76.49 65.61 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.9 ttmt 86.51 -25.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.827 -0.546 . . . . 0.0 109.708 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.892 HG23 ' HB ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -102.93 97.15 5.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.807 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.856 HG22 ' O ' ' A' ' 39' ' ' ILE . 42.8 t -89.87 112.56 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.852 . . . . 0.0 109.167 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.78 ' H ' HD22 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -81.6 -175.74 5.69 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.157 -0.964 . . . . 0.0 109.424 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 28.5 mt-10 -127.02 -178.42 4.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.238 -0.914 . . . . 0.0 109.649 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.026 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -149.5 79.0 8.24 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-O 122.266 1.031 . . . . 0.0 108.976 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.3 Cg_endo -82.5 106.41 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.916 2.41 . . . . 0.0 112.009 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.085 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -75.31 -160.5 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.2 p -138.52 12.8 2.76 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.423 -1.423 . . . . 0.0 110.818 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.43 165.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.937 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 69.81 -86.5 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.496 -0.752 . . . . 0.0 109.625 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.515 ' O ' HD23 ' A' ' 76' ' ' LEU . . . 63.04 -9.76 0.16 Allowed Glycine 0 N--CA 1.496 2.635 0 O-C-N 120.886 -1.134 . . . . 0.0 111.879 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.626 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -41.93 98.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 118.927 1.363 . . . . 0.0 108.356 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.949 HD12 ' HG ' ' A' ' 76' ' ' LEU . 9.9 tp -54.92 98.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.503 -0.748 . . . . 0.0 109.628 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -112.69 -41.49 3.8 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.706 -0.621 . . . . 0.0 109.721 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -136.8 93.97 2.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.836 -1.165 . . . . 0.0 110.409 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.623 HG22 HD11 ' A' ' 56' ' ' LEU . 4.9 t -102.13 88.22 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.058 . . . . 0.0 108.381 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.77 -4.6 20.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.281 -0.887 . . . . 0.0 110.25 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.598 ' HB3' HG21 ' A' ' 19' ' ' VAL . 3.7 mt-10 -127.35 50.7 1.97 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.071 -1.018 . . . . 0.0 108.846 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.8 m-20 -53.6 109.41 0.45 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.56 -0.713 . . . . 0.0 110.494 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.536 ' C ' ' O ' ' A' ' 62' ' ' ASP . 3.2 mp0 8.63 109.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' THR . . . 116.46 -35.37 4.25 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.561 ' CB ' ' HA ' ' A' ' 61' ' ' GLU . 71.4 m -45.08 146.05 0.92 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -1.186 . . . . 0.0 109.169 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.52 131.04 35.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.719 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.804 ' CG1' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.57 171.25 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.766 HG22 ' HG3' ' A' ' 71' ' ' GLN . 4.9 t -139.68 -149.43 0.28 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.232 -0.918 . . . . 0.0 109.279 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.747 ' N ' HG23 ' A' ' 68' ' ' THR . 62.7 p -98.91 74.85 2.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.114 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER 159.4 -21.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.766 ' HG3' HG22 ' A' ' 68' ' ' THR . 4.3 mt-30 -71.37 -171.65 0.64 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.551 -0.718 . . . . 0.0 109.106 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.9 tt -126.44 128.4 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.854 HD21 ' CG2' ' A' ' 7' ' ' VAL . 7.9 mt -64.53 -40.53 95.78 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.27 176.22 23.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.815 ' C ' HD12 ' A' ' 76' ' ' LEU . 1.4 ptm180 -117.22 142.63 46.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.217 -1.167 . . . . 0.0 110.171 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.949 ' HG ' HD12 ' A' ' 56' ' ' LEU . 3.8 mp -112.36 -101.65 0.41 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.544 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.3 OUTLIER -143.59 164.42 30.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 109.068 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.474 ' HA ' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -166.73 -170.5 1.6 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.608 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 80' ' ' ASN . . . -148.8 -145.32 4.12 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 79' ' ' GLY . 31.4 t-20 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.197 -1.178 . . . . 0.0 109.55 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.479 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -161.49 179.14 8.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.659 ' O ' HG12 ' A' ' 3' ' ' VAL . 25.0 t -71.48 82.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.031 . . . . 0.0 108.785 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.89 82.86 2.18 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.065 ' CG1' HG22 ' A' ' 48' ' ' VAL . 3.9 tp -101.19 137.29 29.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.728 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.841 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -131.12 -148.22 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.565 ' CG1' ' HA ' ' A' ' 69' ' ' SER . 93.7 t -129.88 92.14 37.87 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.264 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.49 17.97 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.774 2.316 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.84 ' O ' HG11 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -95.25 45.52 1.1 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.871 -1.143 . . . . 0.0 110.152 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.708 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -53.25 -45.02 98.57 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 111.09 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 33.8 Cg_endo -76.89 -177.61 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.76 1.64 . . . . 0.0 110.472 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 11' ' ' PRO . 4.6 tp10 73.67 33.11 1.07 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.37 -0.831 . . . . 0.0 109.67 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.9 t 55.05 98.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.304 -0.873 . . . . 0.0 109.922 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.84 HG11 ' O ' ' A' ' 9' ' ' ASP . 13.9 p -161.43 72.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.933 . . . . 0.0 109.551 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 16' ' ' ASP . . . -78.41 3.45 15.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.818 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.997 ' HA ' HG23 ' A' ' 68' ' ' THR . 4.0 p-10 170.98 165.75 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.144 -0.973 . . . . 0.0 109.487 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 41' ' ' THR . . . -164.65 -165.65 0.96 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.862 HG23 ' O ' ' A' ' 65' ' ' THR . 87.5 m -160.77 136.28 7.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.908 . . . . 0.0 110.07 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.8 t -58.87 143.28 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 108.974 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.811 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -115.24 -53.92 2.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.212 -0.93 . . . . 0.0 109.185 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.681 ' O ' HG23 ' A' ' 21' ' ' THR . 6.6 t -164.41 116.91 1.32 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.26 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.987 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.7 m95 -68.35 -167.5 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.582 ' HB2' HG23 ' A' ' 35' ' ' VAL . 19.4 m80 -152.47 23.65 0.61 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.976 ' O ' HD22 ' A' ' 56' ' ' LEU . 5.7 tppt? -120.4 108.12 13.73 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.789 -0.569 . . . . 0.0 109.713 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -59.55 177.39 0.27 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 29.6 Cg_endo -69.8 96.02 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.812 1.675 . . . . 0.0 111.378 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 85.07 40.87 7.79 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.613 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 5.4 m-20 -57.95 -154.66 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.21 -1.171 . . . . 0.0 109.948 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.89 87.34 0.51 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.569 -1.332 . . . . 0.0 109.461 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.004 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -96.24 178.76 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.329 -0.857 . . . . 0.0 109.725 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.683 HG13 ' H ' ' A' ' 32' ' ' ARG . 1.3 p -135.76 -60.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.106 -0.996 . . . . 0.0 109.901 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.683 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -138.98 65.6 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.078 -1.014 . . . . 0.0 108.928 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 12.9 m-20 146.68 80.45 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.014 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -86.19 -171.48 3.58 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.083 0.944 . . . . 0.0 112.003 -177.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.818 HG12 ' CD ' ' A' ' 34' ' ' GLU . 3.1 p -41.97 159.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 122.066 0.936 . . . . 0.0 111.88 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.88 62.09 1.58 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.3 p -38.87 168.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.876 0.846 . . . . 0.0 110.744 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.811 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -127.41 98.59 5.3 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.783 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -80.12 -163.83 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.502 -0.749 . . . . 0.0 109.278 -179.485 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.783 ' N ' HG23 ' A' ' 39' ' ' ILE . 3.8 mm-40 -152.85 104.99 2.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.892 -1.13 . . . . 0.0 110.007 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.819 HG21 HD21 ' A' ' 46' ' ' LEU . 1.2 p -99.31 -58.18 1.99 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.08 -1.013 . . . . 0.0 109.988 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.596 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 12.8 t0 176.77 83.55 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.2 tttp 86.12 -26.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 44' ' ' VAL . 11.5 m -119.47 132.42 69.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.288 -0.883 . . . . 0.0 109.4 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 39' ' ' ILE . 42.8 t -118.07 114.58 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.31 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.862 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -80.46 147.57 30.86 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.233 -0.917 . . . . 0.0 109.02 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -92.11 179.39 5.59 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.326 -0.859 . . . . 0.0 110.682 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.065 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -141.02 73.95 26.11 Favored Pre-proline 0 N--CA 1.489 1.511 0 CA-C-O 122.414 1.102 . . . . 0.0 108.366 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.28 107.63 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.873 2.382 . . . . 0.0 111.919 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.014 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -73.83 -165.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.715 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.9 OUTLIER -137.96 23.32 2.83 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.484 -1.385 . . . . 0.0 110.194 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.58 161.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.699 ' O ' HG12 ' A' ' 30' ' ' VAL . 6.4 m-20 60.85 -132.92 0.73 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.034 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.664 ' O ' HD23 ' A' ' 76' ' ' LEU . . . 114.87 -18.71 16.45 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.941 HG23 ' HA2' ' A' ' 27' ' ' GLY . 10.6 mt -36.04 99.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.989 HD12 ' HG ' ' A' ' 76' ' ' LEU . 10.9 tp -56.71 98.71 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.561 0.696 . . . . 0.0 109.712 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.402 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 20.1 t70 -117.68 -38.3 3.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.673 -0.642 . . . . 0.0 109.901 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -133.97 91.19 2.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.862 -1.148 . . . . 0.0 110.515 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.523 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 2.4 t -106.97 84.5 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.703 HD12 ' HA2' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -69.98 -3.86 18.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 110.368 -178.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.523 ' OE1' ' CG1' ' A' ' 67' ' ' VAL . 7.7 mt-10 -127.06 46.25 2.55 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.083 -1.011 . . . . 0.0 108.982 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.9 m-20 -51.13 127.23 18.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.454 -0.779 . . . . 0.0 109.707 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' A' ' 62' ' ' ASP . 0.3 OUTLIER -17.62 132.98 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.321 0.582 . . . . 0.0 111.414 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.41 -31.35 7.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.862 ' O ' HG23 ' A' ' 18' ' ' THR . 24.1 m -70.19 170.54 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -1.162 . . . . 0.0 109.539 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.574 ' N ' HG22 ' A' ' 65' ' ' THR . 95.0 m -108.75 140.22 42.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.445 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.727 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -151.1 160.95 3.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.997 HG23 ' HA ' ' A' ' 16' ' ' ASP . 1.3 m -117.44 -144.15 0.38 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.601 ' CB ' ' HA ' ' A' ' 10' ' ' LEU . 7.9 m -106.07 78.39 1.31 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.134 -0.979 . . . . 0.0 108.588 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 6.0 ttm180 159.34 -21.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.575 ' HB2' HG23 ' A' ' 67' ' ' VAL . 11.0 mm-40 -72.99 131.77 42.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 72' ' ' ILE . 4.7 tt -79.18 111.92 16.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 110.098 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.685 ' CD1' HG11 ' A' ' 37' ' ' VAL . 13.1 mt -46.29 -38.99 9.34 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.703 ' HA2' HD12 ' A' ' 60' ' ' LEU . . . 154.17 169.96 19.57 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.785 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 2.1 ptm180 -110.94 137.06 49.04 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.304 -1.115 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.989 ' HG ' HD12 ' A' ' 56' ' ' LEU . 4.3 mp -102.69 -96.7 0.29 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.068 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.585 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -146.86 152.45 38.73 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.45 ' HA ' ' CG ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -136.02 -163.15 1.36 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.298 -0.876 . . . . 0.0 109.537 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.75 -73.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.447 ' OXT' ' ND2' ' A' ' 80' ' ' ASN . 1.2 t30 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.237 -1.155 . . . . 0.0 109.391 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 37.2 m -141.18 175.26 9.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.284 -0.885 . . . . 0.0 109.562 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.057 HG21 ' OE2' ' A' ' 34' ' ' GLU . 7.7 t -73.98 80.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 108.95 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.58 81.26 2.59 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.076 ' CG1' HG22 ' A' ' 48' ' ' VAL . 6.6 tp -99.34 152.18 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.027 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.962 HD22 ' HG2' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -139.97 -161.65 1.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.081 HG21 HD13 ' A' ' 39' ' ' ILE . 96.5 t -130.97 67.24 80.62 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.045 -1.034 . . . . 0.0 109.484 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.518 ' HG3' HD13 ' A' ' 6' ' ' LEU . 36.1 Cg_endo -79.08 57.75 6.62 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.751 2.301 . . . . 0.0 110.878 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 1.003 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.8 OUTLIER -116.38 11.2 14.9 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.14 -0.975 . . . . 0.0 109.493 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -32.48 108.92 0.3 Allowed Pre-proline 0 N--CA 1.501 2.117 0 O-C-N 121.831 -0.543 . . . . 0.0 110.5 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.46 -45.78 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.304 2.002 . . . . 0.0 110.131 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.61 -88.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.582 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 m -51.53 177.84 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.499 -0.75 . . . . 0.0 109.535 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 14' ' ' VAL . 6.1 p -116.48 48.58 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.346 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -68.93 -6.67 28.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.865 . . . . 0.0 109.788 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 4.9 m-20 68.77 -159.03 0.19 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -170.67 -165.08 0.42 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.283 -0.886 . . . . 0.0 109.165 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 65' ' ' THR . 17.6 m -160.75 143.83 13.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.001 -1.062 . . . . 0.0 110.693 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.941 HG12 ' OE1' ' A' ' 63' ' ' GLU . 1.9 t -65.73 149.09 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -126.96 -47.22 1.51 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.953 -1.092 . . . . 0.0 110.309 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.521 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -162.7 109.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.749 -1.219 . . . . 0.0 111.674 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.964 ' HA ' HG23 ' A' ' 37' ' ' VAL . 15.9 m95 -67.65 -162.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 0.0 108.503 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.747 ' HB2' HG23 ' A' ' 35' ' ' VAL . 33.4 m80 -158.1 34.82 0.25 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.906 ' CB ' HD23 ' A' ' 56' ' ' LEU . 4.7 mmpt? -119.64 108.48 14.51 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.32 0.581 . . . . 0.0 110.376 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -59.56 -178.12 0.12 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.4 Cg_endo -67.99 89.99 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.105 1.203 . . . . 0.0 110.764 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.549 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 78.07 46.04 9.7 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 10.8 m-20 -59.55 -161.48 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.721 -1.458 . . . . 0.0 109.335 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.38 85.42 0.72 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.959 -1.088 . . . . 0.0 109.147 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.013 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.12 -176.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.357 -0.84 . . . . 0.0 109.894 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.687 HG13 ' H ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -142.47 -72.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.359 -0.838 . . . . 0.0 109.599 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.687 ' H ' HG13 ' A' ' 31' ' ' VAL . 8.3 mmt180 -121.5 63.85 0.9 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.001 -1.062 . . . . 0.0 109.519 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 6.1 m-20 145.04 84.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.066 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 21.5 tt0 -84.89 170.15 13.39 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.218 1.009 . . . . 0.0 112.002 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.747 HG23 ' HB2' ' A' ' 23' ' ' HIS . 3.5 p -31.08 155.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.912 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.771 ' H ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -136.32 64.83 1.54 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 178.262 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.964 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.3 p -38.67 170.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.783 0.802 . . . . 0.0 110.725 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.801 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.8 mm-40 -125.8 96.59 4.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.132 -0.98 . . . . 0.0 109.098 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.081 HD13 HG21 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -79.88 -159.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.059 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.795 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.9 mm-40 -147.03 101.46 3.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.789 -1.194 . . . . 0.0 109.992 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -93.47 -152.0 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.337 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 20.4 t0 -94.16 88.0 5.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER 85.61 -23.85 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.755 -0.591 . . . . 0.0 109.612 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 41' ' ' THR . 23.0 t -116.33 137.12 51.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.236 -0.915 . . . . 0.0 109.503 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 39' ' ' ILE . 2.2 p -113.11 107.17 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.003 HD13 ' HB2' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -79.49 179.19 7.6 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.183 -0.948 . . . . 0.0 108.935 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -126.65 -163.75 1.27 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.981 -1.074 . . . . 0.0 110.269 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.076 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -151.26 75.76 7.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-O 122.278 1.037 . . . . 0.0 108.833 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.5 Cg_endo -81.01 115.32 2.99 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.801 2.334 . . . . 0.0 112.009 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.066 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -83.7 -167.65 1.81 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.73 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.0 p -131.54 18.09 4.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.129 -1.607 . . . . 0.0 111.135 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.46 160.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.869 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.5 t70 64.7 -140.39 0.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 55' ' ' ILE . . . 116.71 -15.98 14.11 Favored Glycine 0 N--CA 1.489 2.22 0 O-C-N 120.218 -1.551 . . . . 0.0 110.671 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.575 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -32.01 94.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 117.884 0.842 . . . . 0.0 109.449 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.927 HD11 HG21 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -46.69 100.78 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.521 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.6 t70 -120.56 -46.02 2.39 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.201 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -135.55 107.55 7.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.749 -1.219 . . . . 0.0 110.818 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.927 HG21 HD11 ' A' ' 56' ' ' LEU . 1.4 t -113.17 90.86 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.81 -4.6 20.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.217 -0.927 . . . . 0.0 110.022 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 3.1 mt-10 -128.22 39.37 3.85 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.6 m-20 -40.67 136.15 1.44 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.732 -0.605 . . . . 0.0 109.699 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.941 ' OE1' HG12 ' A' ' 19' ' ' VAL . 67.4 mm-40 -27.82 146.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.537 0.684 . . . . 0.0 111.494 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.14 -2.11 87.62 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 18' ' ' THR . 24.2 m -94.15 154.96 17.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.165 -1.197 . . . . 0.0 109.352 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.53 148.46 22.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.179 -0.951 . . . . 0.0 109.644 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.733 HG11 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -150.32 155.33 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.46 -0.775 . . . . 0.0 108.931 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.791 HG23 ' N ' ' A' ' 69' ' ' SER . 7.4 t -100.78 -142.15 0.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.791 ' N ' HG23 ' A' ' 68' ' ' THR . 72.5 m -68.87 -99.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.779 -1.201 . . . . 0.0 108.239 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.962 ' HG2' HD22 ' A' ' 6' ' ' LEU . 7.4 ttp180 -75.11 76.22 2.28 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.376 -0.827 . . . . 0.0 109.88 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.636 ' HB2' HG23 ' A' ' 67' ' ' VAL . 2.3 mm-40 -113.92 95.34 5.26 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 72' ' ' ILE . 7.9 tt -38.7 109.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.649 -0.657 . . . . 0.0 110.807 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.927 HD21 HG23 ' A' ' 7' ' ' VAL . 12.1 mt -56.7 -39.94 74.74 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.98 -179.4 35.55 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -118.18 135.67 54.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.218 -1.166 . . . . 0.0 110.122 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.927 ' HG ' HD22 ' A' ' 56' ' ' LEU . 2.1 mp -99.25 -91.65 0.28 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.575 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 10.4 tpp180 -153.84 152.98 31.29 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.508 -0.745 . . . . 0.0 109.282 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.474 ' HA ' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -161.39 -170.4 2.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.604 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.61 -148.27 7.99 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.23 -1.159 . . . . 0.0 109.431 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -167.71 -179.04 4.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 62.3 t -81.56 70.55 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 108.798 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -74.07 84.04 1.79 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.822 HG12 HG13 ' A' ' 48' ' ' VAL . 8.0 tp -99.73 163.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 111.297 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.859 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -147.31 -159.86 1.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.815 HG21 ' CG2' ' A' ' 67' ' ' VAL . 2.1 t -133.15 56.11 20.09 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.121 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -80.58 35.94 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.5 2.134 . . . . 0.0 110.824 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.568 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.1 m-20 -102.95 -2.68 27.28 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.801 -1.187 . . . . 0.0 109.966 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.506 HD11 ' C ' ' A' ' 68' ' ' THR . 0.7 OUTLIER -128.19 66.54 72.89 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 9' ' ' ASP . 35.7 Cg_endo -77.55 -58.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.583 2.189 . . . . 0.0 110.373 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' PRO . 7.0 mm-40 -43.94 154.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.357 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.49 ' C ' HG23 ' A' ' 14' ' ' VAL . 1.6 p 44.5 -155.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.293 -0.879 . . . . 0.0 109.232 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 13' ' ' SER . 15.9 t -157.03 58.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.509 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.75 -11.21 58.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.146 -0.971 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 0.6 OUTLIER 60.89 -153.16 0.38 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.33 -0.856 . . . . 0.0 108.796 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -170.15 -159.76 0.21 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.036 -1.04 . . . . 0.0 109.844 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.485 ' N ' HG13 ' A' ' 67' ' ' VAL . 46.8 m -155.55 124.15 5.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 110.54 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.938 HG22 HD11 ' A' ' 39' ' ' ILE . 17.0 t -65.52 107.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.23 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -73.8 -59.62 2.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.614 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.586 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.6 m -168.69 128.52 1.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.628 -1.295 . . . . 0.0 111.775 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.995 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.6 m95 -69.2 -166.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.661 0.743 . . . . 0.0 109.24 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.1 m80 -152.7 26.47 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.549 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.6 tppt? -119.36 137.91 53.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.69 -0.631 . . . . 0.0 110.132 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.599 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.28 179.29 1.71 Allowed Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -69.64 104.91 1.37 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.664 1.576 . . . . 0.0 111.62 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 75.03 39.52 37.49 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 4.8 m-20 -59.45 -166.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.718 -1.46 . . . . 0.0 109.597 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.17 78.56 0.45 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.08 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.698 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -79.55 169.26 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.009 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -110.06 -95.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 1.6 mtm180 -107.2 51.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.961 -1.087 . . . . 0.0 109.63 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.698 ' O ' HG21 ' A' ' 30' ' ' VAL . 4.2 m-20 173.04 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.949 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 10.3 tp10 -102.29 163.62 12.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.058 -1.026 . . . . 0.0 111.008 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.598 HG12 ' HG3' ' A' ' 34' ' ' GLU . 2.5 p -30.36 160.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.57 1.176 . . . . 0.0 112.581 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.533 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.12 67.63 1.37 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.087 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.995 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.1 p -38.59 165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.102 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.27 145.71 46.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.938 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -134.77 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.722 ' N ' HG23 ' A' ' 39' ' ' ILE . 13.1 mt-10 -149.35 138.51 21.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.923 -1.11 . . . . 0.0 109.708 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 5.9 t -132.72 26.22 4.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 41' ' ' THR . 2.2 t70 87.34 15.31 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.341 0.591 . . . . 0.0 110.459 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 160.52 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 1.1 t -103.99 148.57 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.613 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 39' ' ' ILE . 51.2 t -136.93 96.76 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.685 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.769 ' N ' HD22 ' A' ' 46' ' ' LEU . 2.9 mm? -79.88 -176.0 5.21 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.309 -0.869 . . . . 0.0 108.728 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 1.3 pt-20 -142.39 -161.36 1.23 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.718 -1.239 . . . . 0.0 111.463 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.822 HG13 HG12 ' A' ' 5' ' ' ILE . 6.0 t -143.47 75.5 16.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.7 Cg_endo -80.73 110.82 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.487 2.125 . . . . 0.0 110.931 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.949 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -91.79 -169.38 2.26 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.1 p -132.36 14.68 4.57 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.265 -1.522 . . . . 0.0 111.183 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.62 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 109.951 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER 60.63 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.548 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 64.95 -13.65 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 O-C-N 121.324 -0.86 . . . . 0.0 112.093 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.651 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.81 96.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.674 -1.486 . . . . 0.0 108.551 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.925 HD12 ' HG ' ' A' ' 76' ' ' LEU . 7.8 tp -49.87 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ILE . 46.6 t0 -98.6 -41.59 7.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.97 -0.456 . . . . 0.0 110.544 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -147.37 78.71 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.577 -1.327 . . . . 0.0 111.677 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.74 ' CG2' HD11 ' A' ' 56' ' ' LEU . 60.7 t -80.86 82.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.37 -10.8 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 109.709 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 4.8 mm-40 -123.74 50.93 1.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -40.8 134.12 1.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.586 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.05 134.51 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.597 0.713 . . . . 0.0 111.015 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.75 -13.96 24.64 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -84.98 156.19 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -1.135 . . . . 0.0 109.405 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.41 166.43 20.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.681 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.815 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.04 169.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -147.78 -148.31 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 9.3 p -90.28 36.18 0.87 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mtt180 163.55 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.4 mt-30 -84.49 87.69 7.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 0.0 109.102 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.4 tt -45.0 108.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 48' ' ' VAL . 10.6 mt -53.91 -42.86 69.21 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 156.55 -159.79 29.76 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.549 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -134.68 134.49 41.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.151 -1.206 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.925 ' HG ' HD12 ' A' ' 56' ' ' LEU . 4.4 mp -98.09 -96.72 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.34 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -153.73 163.19 40.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.542 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.49 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 1.1 tt0 -160.81 -163.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 121.63 2.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.246 -1.149 . . . . 0.0 109.507 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.436 ' CA ' ' HG3' ' A' ' 78' ' ' GLU . 5.4 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.534 ' N ' ' HB2' ' A' ' 78' ' ' GLU . 35.3 m -69.78 -165.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.398 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.873 HG21 ' OE1' ' A' ' 34' ' ' GLU . 8.8 t -78.96 77.52 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.2 -0.937 . . . . 0.0 109.317 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.79 83.86 2.75 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.85 HG12 HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -101.24 149.19 6.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.325 -0.859 . . . . 0.0 111.628 -177.032 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.849 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.43 -158.59 0.9 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.101 ' CG2' HD21 ' A' ' 73' ' ' LEU . 72.7 t -136.04 58.09 21.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.084 -1.01 . . . . 0.0 110.247 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.1 Cg_endo -80.7 19.81 1.06 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.39 2.06 . . . . 0.0 111.124 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.578 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 1.5 m-20 -109.46 62.45 0.6 Allowed 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.769 -1.207 . . . . 0.0 109.913 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' A' ' 17' ' ' ALA . 22.5 mt -135.5 140.14 33.25 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.24 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.07 135.98 14.28 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.455 2.103 . . . . 0.0 110.35 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 13' ' ' SER . 8.3 mt-10 -67.4 102.3 1.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER 171.63 -26.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.378 -0.826 . . . . 0.0 109.815 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.7 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 74.0 t -85.69 -97.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.419 -0.801 . . . . 0.0 109.601 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 14' ' ' VAL . . . 162.23 -22.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.754 . . . . 0.0 109.651 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 67' ' ' VAL . 0.6 OUTLIER 172.37 144.38 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.648 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.676 ' HB2' HD21 ' A' ' 10' ' ' LEU . . . -97.48 -151.57 0.37 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.309 -0.87 . . . . 0.0 109.371 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 21.2 m -160.33 121.78 3.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.335 -0.853 . . . . 0.0 109.934 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.667 HG22 HD11 ' A' ' 39' ' ' ILE . 13.4 t -63.97 91.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.135 -0.978 . . . . 0.0 109.108 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -54.65 -57.83 9.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 110.707 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.626 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 40.3 m -166.5 122.88 1.25 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.709 -1.244 . . . . 0.0 111.654 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 1.027 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.4 m95 -67.85 -165.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.681 ' HB2' HG23 ' A' ' 35' ' ' VAL . 75.5 m-70 -148.92 22.03 0.98 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.521 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.59 154.36 31.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.676 -0.64 . . . . 0.0 109.678 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.642 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -105.61 -173.41 0.28 Allowed Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.642 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.84 83.73 0.53 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.075 1.183 . . . . 0.0 111.247 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.711 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 81.11 48.08 6.21 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.757 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.2 m-20 -55.83 -113.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -1.182 . . . . 0.0 110.005 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 163.05 72.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.448 -1.408 . . . . 0.0 109.98 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.981 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -79.66 157.09 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.112 -0.992 . . . . 0.0 110.652 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 2.6 m -97.51 -107.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 12.8 ttt-85 -104.9 74.84 1.15 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.693 -1.254 . . . . 0.0 108.965 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.594 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 11.4 m-20 143.96 102.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.981 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -112.21 -173.3 2.22 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.533 -177.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.775 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 13.1 p -27.68 153.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.953 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.1 58.82 1.7 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 178.019 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.027 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.1 p -37.75 168.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.731 0.776 . . . . 0.0 110.761 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.413 ' H ' HG22 ' A' ' 37' ' ' VAL . 2.7 mt-10 -126.67 142.18 51.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.889 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -128.14 -179.63 3.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 121.276 -0.89 . . . . 0.0 109.387 -179.038 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.638 ' N ' HG23 ' A' ' 39' ' ' ILE . 15.4 mt-10 -137.83 127.63 25.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.782 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 44' ' ' VAL . 8.5 t -132.13 25.89 4.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 0.0 109.49 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.3 t0 81.32 87.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.709 -0.62 . . . . 0.0 110.544 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.9 tttp 85.72 -27.62 0.08 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.869 -0.519 . . . . 0.0 110.403 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.57 ' O ' HG22 ' A' ' 41' ' ' THR . 0.2 OUTLIER -114.81 142.19 28.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.961 -1.087 . . . . 0.0 109.964 -179.753 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.889 HG13 ' O ' ' A' ' 39' ' ' ILE . 39.8 t -139.32 100.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.138 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 3.3 mm? -81.65 -166.45 1.2 Allowed 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.537 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -143.45 -161.8 1.33 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.182 -0.949 . . . . 0.0 110.122 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.85 HG22 HG12 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -156.02 77.2 4.56 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 109.948 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.5 Cg_endo -79.89 107.63 2.12 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.419 2.079 . . . . 0.0 110.031 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.888 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . . . -76.11 -167.22 0.71 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -143.06 24.02 1.84 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.461 -1.4 . . . . 0.0 110.819 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.69 118.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.73 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.63 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 66.0 m-20 106.65 -117.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.559 ' CA ' ' OE1' ' A' ' 34' ' ' GLU . . . 100.28 -26.79 23.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.797 HD12 ' HD3' ' A' ' 77' ' ' ARG . 6.1 mt -43.78 98.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 108.089 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.109 HD12 HD22 ' A' ' 76' ' ' LEU . 10.6 tp -51.57 100.92 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.391 -0.818 . . . . 0.0 109.698 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.446 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 33.4 t0 -101.2 -46.75 4.95 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.754 -0.591 . . . . 0.0 109.598 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.64 96.79 2.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.884 -1.135 . . . . 0.0 110.529 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.923 HG21 HD21 ' A' ' 56' ' ' LEU . 2.6 t -94.71 90.9 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.965 . . . . 0.0 108.505 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.982 HD12 ' HA2' ' A' ' 74' ' ' GLY . 1.6 mt -71.23 -2.04 14.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.849 . . . . 0.0 110.329 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.513 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 7.7 mt-10 -135.61 54.3 1.92 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.155 -0.965 . . . . 0.0 108.471 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.4 m-20 -43.91 130.36 5.78 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.488 -0.758 . . . . 0.0 109.553 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -34.63 116.34 0.31 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.343 0.592 . . . . 0.0 110.953 -179.366 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.09 -6.39 7.27 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 m -95.18 162.92 13.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -1.179 . . . . 0.0 109.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -78.43 156.96 29.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.243 -0.911 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.801 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.74 174.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.584 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -143.82 -164.92 1.99 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 108.81 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.554 ' H ' HG22 ' A' ' 68' ' ' THR . 60.2 p -85.76 63.31 7.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.047 -1.033 . . . . 0.0 109.185 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.551 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.8 mmm-85 159.81 -16.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.606 -0.684 . . . . 0.0 109.923 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HB2' HG23 ' A' ' 67' ' ' VAL . 21.1 mm100 -53.27 143.74 17.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.422 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 72' ' ' ILE . 16.8 tt -95.59 112.06 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.3 -0.875 . . . . 0.0 109.682 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.101 HD21 ' CG2' ' A' ' 7' ' ' VAL . 9.3 mt -53.13 -31.46 42.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.982 ' HA2' HD12 ' A' ' 60' ' ' LEU . . . 139.63 -166.63 25.54 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.517 ' C ' HD23 ' A' ' 76' ' ' LEU . 1.5 ptt85 -128.84 140.23 51.8 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.27 -1.135 . . . . 0.0 109.534 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.109 HD22 HD12 ' A' ' 56' ' ' LEU . 8.2 mt -100.74 -121.66 0.16 Allowed 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.128 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.797 ' HD3' HD12 ' A' ' 55' ' ' ILE . 19.2 ttt-85 -114.8 163.78 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.595 -1.316 . . . . 0.0 110.015 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.534 ' HB2' ' N ' ' A' ' 2' ' ' SER . 2.2 tm-20 -110.72 147.0 35.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 0.0 109.363 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 53' ' ' ASP . . . -71.09 -151.74 0.9 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.423 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.464 ' CB ' ' HG2' ' A' ' 78' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.55 ' CA ' ' HB2' ' A' ' 78' ' ' GLU . 5.6 m -69.81 -171.25 0.39 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.385 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.123 HG12 ' CD1' ' A' ' 5' ' ' ILE . 15.7 t -88.91 63.22 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.292 -0.88 . . . . 0.0 109.652 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -85.26 89.44 7.65 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.123 ' CD1' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -103.18 171.79 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 120.849 -1.157 . . . . 0.0 112.231 -177.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.869 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -142.12 -156.56 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.168 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 67' ' ' VAL . 59.9 t -129.35 54.38 14.21 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.036 -1.04 . . . . 0.0 110.724 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.695 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -80.3 28.02 0.54 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.473 2.115 . . . . 0.0 110.561 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.851 ' CB ' HD13 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -112.39 -2.48 14.74 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 120.972 -1.08 . . . . 0.0 109.707 -179.288 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.791 ' HB3' HG11 ' A' ' 14' ' ' VAL . 55.3 mt -68.09 140.29 93.31 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.219 -0.926 . . . . 0.0 109.608 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 10' ' ' LEU . 36.2 Cg_endo -78.82 -159.88 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.517 2.145 . . . . 0.0 110.416 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.02 21.32 9.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.433 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -136.7 58.49 1.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 109.338 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.811 HG13 ' O ' ' A' ' 14' ' ' VAL . 14.6 p -159.67 84.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.235 -0.916 . . . . 0.0 109.403 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' VAL . . . -43.12 -26.09 0.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 14' ' ' VAL . 2.7 p30 -178.7 158.9 1.06 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.393 -0.817 . . . . 0.0 109.773 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -120.74 -163.48 1.02 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.487 ' C ' HG13 ' A' ' 39' ' ' ILE . 96.7 m -159.39 139.76 12.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.126 -0.984 . . . . 0.0 110.174 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.543 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 14.2 t -73.2 91.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.402 -0.811 . . . . 0.0 109.373 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -52.65 -62.92 1.34 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.389 -0.82 . . . . 0.0 110.431 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.611 HG23 ' OE1' ' A' ' 63' ' ' GLU . 2.9 m -161.62 122.67 2.75 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.499 -1.28 . . . . 0.0 111.812 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.99 ' HA ' HG23 ' A' ' 37' ' ' VAL . 13.7 m95 -67.93 -165.56 0.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.412 -0.805 . . . . 0.0 109.034 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.716 ' HB2' HG23 ' A' ' 35' ' ' VAL . 33.8 m80 -150.24 31.39 0.68 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.563 ' HG2' ' HB ' ' A' ' 35' ' ' VAL . 2.8 mtpp -122.16 177.84 5.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.925 0.869 . . . . 0.0 110.844 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.681 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 8.2 mmmt -131.98 -177.62 0.72 Allowed Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.681 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -69.25 86.0 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.166 1.244 . . . . 0.0 110.646 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.817 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 86.07 47.36 5.02 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.567 ' O ' ' CG1' ' A' ' 55' ' ' ILE . 12.8 m-20 -54.31 -158.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -1.095 . . . . 0.0 110.055 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.33 86.74 0.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.54 -1.35 . . . . 0.0 109.179 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.044 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -95.13 170.46 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 110.011 -179.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.667 HG13 ' H ' ' A' ' 32' ' ' ARG . 1.5 p -133.88 -57.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.317 -0.865 . . . . 0.0 109.386 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.667 ' H ' HG13 ' A' ' 31' ' ' VAL . 3.2 mtp180 -141.18 64.16 1.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 108.82 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 11.6 m-20 149.6 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.044 ' HA ' HG21 ' A' ' 30' ' ' VAL . 11.9 tt0 -94.1 167.77 11.37 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.328 1.061 . . . . 0.0 111.726 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.716 HG23 ' HB2' ' A' ' 23' ' ' HIS . 2.4 p -31.16 156.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 122.174 0.987 . . . . 0.0 112.168 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.543 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.98 64.57 1.5 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 177.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.99 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.0 p -37.86 165.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.729 0.776 . . . . 0.0 110.268 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.4 mm-40 -128.37 98.47 5.07 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 108.806 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.93 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -79.75 -168.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.743 ' N ' HG23 ' A' ' 39' ' ' ILE . 8.5 mt-10 -136.59 114.58 11.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.951 -1.093 . . . . 0.0 110.275 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.574 HG23 HD22 ' A' ' 10' ' ' LEU . 98.1 m -106.33 -103.23 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.23 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 2.3 t70 -144.85 95.16 2.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.102 -0.998 . . . . 0.0 108.99 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.571 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 23.1 tttm 85.66 -28.02 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.307 0.575 . . . . 0.0 109.452 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 45' ' ' VAL . 2.0 t -118.95 -177.05 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.126 -0.984 . . . . 0.0 109.223 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 39' ' ' ILE . 44.4 t -148.64 120.42 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 109.577 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.851 HD13 ' CB ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -79.43 159.46 27.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 4.4 mt-10 -124.07 -173.45 2.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.058 -1.026 . . . . 0.0 110.132 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.987 HG22 HG21 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -148.86 66.49 8.84 Favored Pre-proline 0 N--CA 1.487 1.409 0 CA-C-O 121.911 0.862 . . . . 0.0 109.041 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 33.8 Cg_endo -75.15 115.7 4.34 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.679 2.253 . . . . 0.0 110.998 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.02 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -91.91 -177.0 4.6 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.72 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 51.5 p -129.68 21.32 5.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.747 -1.221 . . . . 0.0 110.07 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 162.69 161.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.432 -0.792 . . . . 0.0 109.076 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.716 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.8 m-20 75.82 -145.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 117.03 -18.91 12.19 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 120.475 -1.391 . . . . 0.0 110.256 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.817 HG23 ' HA2' ' A' ' 27' ' ' GLY . 18.9 mt -46.61 95.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.136 -1.214 . . . . 0.0 107.77 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.101 HD12 ' CD1' ' A' ' 76' ' ' LEU . 7.2 tp -53.27 109.42 0.43 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.375 -0.828 . . . . 0.0 109.398 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 20.1 t70 -113.54 -53.87 2.66 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.741 -0.599 . . . . 0.0 110.358 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.666 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -132.64 79.51 1.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.694 -1.254 . . . . 0.0 110.952 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.921 HG21 HD21 ' A' ' 56' ' ' LEU . 10.1 t -81.07 87.98 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.76 -1.6 12.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.465 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 51.8 mt-10 -134.03 52.51 2.06 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.013 -1.055 . . . . 0.0 108.456 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -43.5 131.59 4.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.599 -0.688 . . . . 0.0 109.769 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.611 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.2 OUTLIER -36.1 111.38 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.327 0.584 . . . . 0.0 110.587 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.86 4.31 7.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -101.74 162.11 13.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -1.2 . . . . 0.0 109.596 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.23 151.61 36.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.595 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.98 173.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.931 HG22 ' HG2' ' A' ' 71' ' ' GLN . 5.2 t -140.33 -157.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 108.829 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.596 ' N ' HG23 ' A' ' 68' ' ' THR . 88.7 p -90.32 63.87 5.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.977 -1.077 . . . . 0.0 109.406 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.518 ' CB ' ' O ' ' A' ' 69' ' ' SER . 4.2 ttt180 159.54 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.648 -0.658 . . . . 0.0 109.458 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.931 ' HG2' HG22 ' A' ' 68' ' ' THR . 19.0 mm-40 -48.79 138.44 11.13 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.414 -0.804 . . . . 0.0 109.444 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 72' ' ' ILE . 5.8 tt -87.55 114.36 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.383 -0.823 . . . . 0.0 109.818 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.588 HD13 HG11 ' A' ' 37' ' ' VAL . 5.2 mt -49.35 -39.64 32.61 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 146.86 -173.99 26.85 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.666 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -117.87 140.98 48.94 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.159 -1.2 . . . . 0.0 109.317 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.101 ' CD1' HD12 ' A' ' 56' ' ' LEU . 3.6 mm? -88.17 -92.33 0.11 Allowed 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.334 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.576 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -161.41 174.47 13.43 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 110.022 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' HB2' ' CA ' ' A' ' 2' ' ' SER . 7.8 tp10 -174.69 124.9 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 109.662 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.527 ' O ' ' CZ ' ' A' ' 77' ' ' ARG . . . 43.76 -94.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 78' ' ' GLU . 53.2 p-10 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 109.446 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.309 0.576 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.533 ' N ' ' HB2' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -167.53 168.88 12.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.421 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.77 ' O ' HG12 ' A' ' 3' ' ' VAL . 34.7 t -88.81 72.82 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.901 . . . . 0.0 109.411 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.63 80.99 4.09 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.791 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -94.32 156.7 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.28 -0.887 . . . . 0.0 111.327 -177.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.886 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -139.57 -155.54 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.993 ' CG1' HD12 ' A' ' 46' ' ' LEU . 16.5 t -136.9 63.68 46.16 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.955 -1.091 . . . . 0.0 109.84 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HB3' ' CG ' ' A' ' 70' ' ' ARG . 36.5 Cg_endo -80.59 43.22 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.78 2.32 . . . . 0.0 110.252 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.983 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.8 OUTLIER -128.37 31.05 5.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.179 -0.951 . . . . 0.0 109.957 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.067 HD22 ' CB ' ' A' ' 69' ' ' SER . 1.8 pt? -70.99 144.79 90.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.003 . . . . 0.0 109.898 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.596 ' HG2' HG23 ' A' ' 14' ' ' VAL . 36.5 Cg_endo -80.53 -11.17 13.06 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.631 2.221 . . . . 0.0 110.187 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 63.43 16.66 9.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.347 -0.846 . . . . 0.0 109.453 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.8 m -135.11 6.21 3.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 99.0 t -108.45 -97.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.434 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 14' ' ' VAL . . . 166.45 -21.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.155 -0.966 . . . . 0.0 110.512 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -175.97 -163.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.084 -1.01 . . . . 0.0 109.996 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -167.76 -171.78 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.303 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 16.0 m -159.69 134.91 8.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 110.546 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.568 ' HA ' HG13 ' A' ' 39' ' ' ILE . 23.8 t -70.42 84.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.455 -0.778 . . . . 0.0 109.251 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -41.18 -62.81 0.77 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.313 -0.867 . . . . 0.0 110.327 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.865 HG23 ' OE1' ' A' ' 63' ' ' GLU . 22.5 m -164.95 128.05 2.29 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.564 -1.255 . . . . 0.0 111.456 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 1.022 ' HA ' HG23 ' A' ' 37' ' ' VAL . 16.4 m95 -68.54 -167.69 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.632 ' HB2' HG23 ' A' ' 35' ' ' VAL . 60.9 m-70 -149.56 35.38 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.665 ' HB3' HD13 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -131.62 168.51 17.58 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.511 0.672 . . . . 0.0 110.195 -179.049 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.648 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -121.5 -171.09 0.21 Allowed Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 178.365 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.648 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -68.45 84.91 0.46 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 120.831 1.021 . . . . 0.0 111.262 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.758 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 77.05 48.86 8.0 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.715 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 20.8 m-20 -54.5 -112.13 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.253 -1.145 . . . . 0.0 110.911 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 157.48 103.63 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.975 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -104.35 176.51 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 120.672 -1.268 . . . . 0.0 111.688 -177.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.617 ' H ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -114.37 -137.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -80.69 76.86 7.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.833 -1.167 . . . . 0.0 108.19 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 4.4 m-20 150.22 79.15 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.004 ' OE1' HG12 ' A' ' 35' ' ' VAL . 2.7 tm-20 -83.26 171.36 13.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 0.0 112.438 -177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.004 HG12 ' OE1' ' A' ' 34' ' ' GLU . 2.0 p -31.49 156.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.745 0.784 . . . . 0.0 111.687 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.539 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.05 63.27 1.34 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 178.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.022 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.2 p -39.38 168.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.681 0.753 . . . . 0.0 110.2 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.684 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.3 mt-10 -131.17 103.51 6.53 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 109.015 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.816 HG23 ' N ' ' A' ' 40' ' ' GLU . 2.8 tt -84.14 -159.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.369 -0.832 . . . . 0.0 109.425 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.816 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.8 mm-40 -139.8 127.48 21.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.928 -1.108 . . . . 0.0 109.801 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 41' ' ' THR . 84.8 m -132.69 16.62 4.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.852 . . . . 0.0 109.665 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 15.2 t0 72.19 85.49 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.161 -0.962 . . . . 0.0 109.684 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 86.38 -27.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.24 0.543 . . . . 0.0 109.59 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.9 t -115.47 144.97 21.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.143 -0.973 . . . . 0.0 109.281 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 39' ' ' ILE . 38.1 t -133.17 118.54 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.758 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.993 HD12 ' CG1' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -79.55 159.75 26.74 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.159 -0.963 . . . . 0.0 108.632 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -119.0 172.29 7.65 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.009 -1.057 . . . . 0.0 110.315 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.901 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.0 t -137.55 70.75 52.56 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.5 Cg_endo -79.72 116.3 3.47 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.838 2.358 . . . . 0.0 111.465 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.794 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -98.42 172.49 7.5 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 20.0 p -116.04 77.93 1.14 Allowed 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.087 -1.445 . . . . 0.0 110.618 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 88.81 160.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.245 0.545 . . . . 0.0 109.919 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.6 m-20 79.97 -76.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.699 -0.625 . . . . 0.0 110.219 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.561 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 40.94 22.51 0.06 OUTLIER Glycine 0 N--CA 1.493 2.455 0 O-C-N 121.033 -1.042 . . . . 0.0 110.788 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.758 HG23 ' CA ' ' A' ' 27' ' ' GLY . 12.5 mt -72.21 94.57 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.912 -1.346 . . . . 0.0 108.064 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.936 HD21 HG21 ' A' ' 59' ' ' VAL . 5.1 tp -47.78 91.28 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.752 0.787 . . . . 0.0 110.389 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.2 t70 -84.0 -50.56 7.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.49 99.91 2.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.979 -1.076 . . . . 0.0 110.627 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.936 HG21 HD21 ' A' ' 56' ' ' LEU . 4.0 t -83.35 90.73 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 60' ' ' LEU . 55.4 mt -69.09 -7.37 35.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 0.0 109.693 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 73' ' ' LEU . 2.9 mt-10 -131.72 52.76 2.04 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 63' ' ' GLU . 7.0 m-20 -40.93 134.17 2.0 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.46 0.648 . . . . 0.0 109.689 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.865 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -36.08 125.7 0.75 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.485 0.66 . . . . 0.0 110.82 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.23 -4.57 21.95 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 66' ' ' THR . 21.5 m -84.15 166.33 17.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.227 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.604 ' N ' HG22 ' A' ' 65' ' ' THR . 90.0 m -93.73 137.58 32.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.731 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.849 HG21 HG21 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -150.22 153.54 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.492 HG23 ' H ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -116.22 -97.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.057 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 1.067 ' CB ' HD22 ' A' ' 10' ' ' LEU . 28.7 p -94.99 -125.68 0.12 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.54 ' CG ' ' HB3' ' A' ' 8' ' ' PRO . 51.7 mtp180 -56.59 84.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.008 -1.058 . . . . 0.0 110.032 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -118.07 85.13 2.29 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.7 tt -34.25 107.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.885 -0.51 . . . . 0.0 111.107 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.874 ' CD1' HG21 ' A' ' 48' ' ' VAL . 15.7 mt -57.3 -38.36 73.87 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.79 -160.49 31.98 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.806 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -135.76 145.98 47.15 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.253 -1.145 . . . . 0.0 109.775 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.806 HD23 ' O ' ' A' ' 75' ' ' ARG . 2.4 mt -129.45 -137.0 0.22 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.568 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -118.48 151.62 37.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.779 -1.201 . . . . 0.0 109.228 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.533 ' HB2' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -137.56 -166.47 1.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.72 -153.76 30.04 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.302 -1.117 . . . . 0.0 109.496 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.455 ' C ' ' HB3' ' A' ' 78' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.551 ' CA ' ' HB2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -170.13 166.66 8.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.309 -0.87 . . . . 0.0 109.49 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 8.0 t -69.43 98.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 108.733 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -71.91 85.65 0.97 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.903 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -81.17 121.35 34.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.545 -0.722 . . . . 0.0 109.904 -178.475 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.88 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -145.47 -165.64 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.94 HG21 HG21 ' A' ' 67' ' ' VAL . 29.2 t -134.78 56.9 18.81 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.232 -0.918 . . . . 0.0 109.924 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.668 ' CD ' HD13 ' A' ' 6' ' ' LEU . 37.1 Cg_endo -80.48 36.82 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.495 2.13 . . . . 0.0 110.517 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.549 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -89.97 -15.28 32.29 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.948 -1.095 . . . . 0.0 109.593 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.546 ' CD2' ' HB2' ' A' ' 69' ' ' SER . 1.0 OUTLIER 28.05 59.9 0.64 Allowed Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.27 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.743 ' HG3' HD21 ' A' ' 46' ' ' LEU . 36.4 Cg_endo -79.32 -74.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.534 2.156 . . . . 0.0 110.059 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 11' ' ' PRO . 29.4 mt-10 -157.63 27.63 0.28 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.529 ' CA ' ' OG1' ' A' ' 41' ' ' THR . 22.8 t -45.71 151.2 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.446 -0.784 . . . . 0.0 109.843 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 15' ' ' ALA . 71.3 t -95.25 -91.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 109.281 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.556 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -102.47 -4.11 25.89 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.509 -0.744 . . . . 0.0 109.633 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 3.0 p30 162.24 152.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.392 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.708 ' HB3' HG22 ' A' ' 67' ' ' VAL . . . -100.04 -168.03 1.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 20.4 m -153.39 131.71 12.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.375 -0.828 . . . . 0.0 110.317 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.741 HG22 HD11 ' A' ' 39' ' ' ILE . 11.4 t -70.18 83.69 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.386 -0.822 . . . . 0.0 109.493 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 19' ' ' VAL . . . -41.96 -63.27 0.76 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 110.493 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 5.4 m -166.94 129.05 1.71 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.59 -1.319 . . . . 0.0 111.479 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.903 ' CZ2' HG21 ' A' ' 5' ' ' ILE . 21.9 m95 -69.66 -167.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.531 0.682 . . . . 0.0 109.292 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.601 ' HB2' HG23 ' A' ' 35' ' ' VAL . 50.3 m-70 -151.83 28.26 0.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.551 ' CE ' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -118.1 167.52 11.4 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.714 0.768 . . . . 0.0 110.434 -178.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.636 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -115.54 -179.83 0.68 Allowed Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -70.74 87.23 0.68 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.426 1.417 . . . . 0.0 110.932 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.605 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 88.2 41.71 6.13 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD1' ' CG ' ' A' ' 25' ' ' LYS . 13.6 m-20 -55.52 -164.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.995 -1.297 . . . . 0.0 109.685 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.43 77.67 0.62 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.019 -1.051 . . . . 0.0 109.391 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.977 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -79.5 -179.06 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.373 -0.829 . . . . 0.0 109.609 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.634 ' N ' HG13 ' A' ' 30' ' ' VAL . 1.5 m -139.1 -48.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.098 -1.001 . . . . 0.0 110.241 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.563 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -150.83 62.27 0.93 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.4 m-20 150.73 75.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.024 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.55 -170.41 3.04 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.298 1.047 . . . . 0.0 111.871 -177.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.849 HG12 ' CD ' ' A' ' 34' ' ' GLU . 3.8 p -50.46 161.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.929 0.871 . . . . 0.0 111.639 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -140.2 61.4 1.53 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.08 HG12 HG12 ' A' ' 48' ' ' VAL . 4.2 p -38.52 168.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.773 0.797 . . . . 0.0 110.736 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.662 ' HB3' HG11 ' A' ' 45' ' ' VAL . 8.2 mt-10 -129.13 125.23 36.66 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.905 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -111.36 -172.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.298 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.706 ' N ' HG23 ' A' ' 39' ' ' ILE . 6.1 mt-10 -134.98 128.78 33.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.998 . . . . 0.0 109.586 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 44' ' ' VAL . 12.4 t -125.92 -32.08 2.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 110.042 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.591 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.1 t70 158.94 70.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.591 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.9 tttm 85.79 -25.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 41' ' ' THR . 92.7 t -108.27 133.78 52.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.34 -0.85 . . . . 0.0 109.267 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.905 HG13 ' O ' ' A' ' 39' ' ' ILE . 55.9 t -118.36 112.52 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.117 -0.989 . . . . 0.0 109.729 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.827 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.29 -179.85 7.0 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.294 -0.878 . . . . 0.0 108.678 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 51.5 mt-10 -141.47 -171.38 3.29 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.86 -1.15 . . . . 0.0 110.451 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.08 HG12 HG12 ' A' ' 37' ' ' VAL . 14.8 p -146.35 75.4 12.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.388 -0.82 . . . . 0.0 109.678 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.749 ' HB3' HD23 ' A' ' 36' ' ' LEU . 35.0 Cg_endo -77.48 105.27 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.225 1.95 . . . . 0.0 110.385 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.024 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -77.56 -177.98 5.04 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.709 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.2 t -130.22 26.61 5.14 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.384 -1.448 . . . . 0.0 110.282 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.1 160.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.512 -0.743 . . . . 0.0 109.246 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.758 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.4 m-20 62.24 -136.32 0.48 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.263 -0.898 . . . . 0.0 108.956 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.745 ' O ' HD23 ' A' ' 76' ' ' LEU . . . 111.9 -17.83 24.66 Favored Glycine 0 N--CA 1.488 2.162 0 O-C-N 120.505 -1.372 . . . . 0.0 109.723 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.605 HG22 ' HA2' ' A' ' 27' ' ' GLY . 1.2 mt -34.24 102.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.789 -0.83 . . . . 0.0 109.371 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.876 HD12 ' HG ' ' A' ' 76' ' ' LEU . 12.2 tp -58.43 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.526 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -114.11 -29.49 6.96 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.405 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.851 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -138.69 106.57 5.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.831 -1.168 . . . . 0.0 110.506 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.809 ' CG2' HD11 ' A' ' 56' ' ' LEU . 18.2 t -127.56 76.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.78 -4.15 18.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.554 -0.716 . . . . 0.0 110.563 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.59 ' HG2' HG21 ' A' ' 65' ' ' THR . 10.0 mt-10 -128.32 50.37 2.09 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 108.787 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 63' ' ' GLU . 7.2 m-20 -51.18 118.2 3.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.568 -0.707 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 62' ' ' ASP . 1.6 mp0 5.56 113.25 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.21 -32.3 6.2 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.59 HG21 ' HG2' ' A' ' 61' ' ' GLU . 78.9 m -54.3 153.23 5.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -1.135 . . . . 0.0 109.276 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.408 ' O ' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -69.82 155.56 40.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.367 -0.833 . . . . 0.0 109.588 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.94 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -149.6 174.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.233 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -139.83 -172.2 3.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.013 . . . . 0.0 109.408 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.604 ' H ' HG22 ' A' ' 68' ' ' THR . 0.2 OUTLIER -86.19 46.76 1.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 109.133 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER 158.88 32.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 6' ' ' LEU . 77.2 mm-40 -112.94 149.89 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.992 -1.067 . . . . 0.0 109.125 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.2 tt -97.07 113.22 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.483 -0.761 . . . . 0.0 110.686 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.578 HD12 HG13 ' A' ' 5' ' ' ILE . 1.3 mt -47.56 -36.99 11.36 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.691 ' O ' HG22 ' A' ' 5' ' ' ILE . . . 163.99 -162.08 34.87 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.851 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 1.1 ptt180 -136.12 150.09 48.95 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.625 -1.514 . . . . 0.0 110.053 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.876 ' HG ' HD12 ' A' ' 56' ' ' LEU . 5.3 mp -111.07 -115.03 0.31 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.544 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 20.3 ttt-85 -134.38 153.69 51.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.863 -1.148 . . . . 0.0 109.304 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.551 ' HB2' ' CA ' ' A' ' 2' ' ' SER . 45.4 tt0 -141.61 164.63 29.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 109.461 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.419 ' N ' ' HG2' ' A' ' 78' ' ' GLU . . . 67.65 133.92 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.29 -1.124 . . . . 0.0 109.421 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.464 ' C ' ' HB3' ' A' ' 78' ' ' GLU . 20.5 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.489 ' N ' ' HB3' ' A' ' 78' ' ' GLU . 1.5 m -69.97 -168.22 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.519 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.773 HG21 ' OE1' ' A' ' 34' ' ' GLU . 43.3 t -84.42 68.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.842 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -71.72 85.82 0.92 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.51 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.857 HG12 HG13 ' A' ' 48' ' ' VAL . 0.7 OUTLIER -102.93 158.48 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.247 -0.908 . . . . 0.0 111.586 -177.33 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.848 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -137.62 -151.8 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 7' ' ' VAL . 85.6 t -132.25 54.32 13.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.864 -1.148 . . . . 0.0 109.688 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 36.6 Cg_endo -77.04 67.0 7.67 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.557 2.171 . . . . 0.0 110.637 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 1.016 ' HB2' HD13 ' A' ' 46' ' ' LEU . 1.1 m-20 -129.11 -4.58 5.0 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.086 -1.009 . . . . 0.0 109.831 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.56 HD21 ' HA ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -133.28 73.96 73.16 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.265 -0.897 . . . . 0.0 109.351 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.0 42.73 1.37 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.88 2.387 . . . . 0.0 110.853 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 12' ' ' GLU . 5.9 mm-40 -146.01 -116.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.071 -1.018 . . . . 0.0 109.52 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 12' ' ' GLU . 14.2 t -43.29 165.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.944 -1.097 . . . . 0.0 109.766 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.32 64.11 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.06 1.6 53.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.598 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 0.9 OUTLIER 67.6 -170.06 0.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.578 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -166.05 -171.9 2.14 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.229 -0.92 . . . . 0.0 109.585 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.484 ' C ' HG13 ' A' ' 39' ' ' ILE . 19.6 m -148.04 132.41 17.56 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.922 . . . . 0.0 110.192 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.657 HG22 HD11 ' A' ' 39' ' ' ILE . 16.6 t -69.0 87.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.937 . . . . 0.0 109.063 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -51.01 -63.48 1.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 111.08 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.909 HG23 ' OE1' ' A' ' 63' ' ' GLU . 1.8 m -161.61 123.61 2.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.574 -1.329 . . . . 0.0 112.019 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 1.036 ' HA ' HG23 ' A' ' 37' ' ' VAL . 16.9 m95 -68.6 -166.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.766 ' CD2' HD12 ' A' ' 36' ' ' LEU . 33.6 m-70 -154.45 28.84 0.44 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.693 ' O ' HD22 ' A' ' 56' ' ' LEU . 4.9 tppt? -123.07 122.89 39.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.714 -0.616 . . . . 0.0 110.247 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.593 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -71.3 179.06 1.01 Allowed Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -68.17 89.88 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.597 1.532 . . . . 0.0 111.672 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.666 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 78.86 45.15 9.43 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.754 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 13.6 m-20 -59.43 -117.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.077 -1.249 . . . . 0.0 110.331 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 159.1 101.79 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.772 -1.205 . . . . 0.0 108.534 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.93 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -102.16 -179.4 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.938 -1.101 . . . . 0.0 109.971 -179.36 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.716 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -105.09 -91.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 0.0 110.048 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.519 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -117.9 43.83 2.33 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.034 -1.041 . . . . 0.0 109.068 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.565 ' C ' HG11 ' A' ' 30' ' ' VAL . 17.8 m-20 171.74 99.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.93 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -97.97 -160.38 0.8 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.348 -177.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.942 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 6.3 p -34.95 165.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.496 1.141 . . . . 0.0 112.94 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.766 HD12 ' CD2' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -148.74 58.11 1.05 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.036 HG23 ' HA ' ' A' ' 22' ' ' TRP . 2.3 p -39.39 167.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.88 0.848 . . . . 0.0 110.836 -177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.577 ' HB3' HG11 ' A' ' 45' ' ' VAL . 24.1 mt-10 -130.81 121.61 25.65 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.952 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -103.97 -170.17 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.313 -0.867 . . . . 0.0 109.483 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.753 ' N ' HG23 ' A' ' 39' ' ' ILE . 2.5 mt-10 -153.2 101.37 2.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.122 -0.986 . . . . 0.0 109.767 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -97.12 -35.3 10.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.905 . . . . 0.0 109.9 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 11.4 t70 171.62 72.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.725 . . . . 0.0 109.704 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.4 tmmt? 85.8 -24.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.96 131.17 57.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.232 -0.917 . . . . 0.0 109.578 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.952 HG13 ' O ' ' A' ' 39' ' ' ILE . 94.3 t -113.84 123.31 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.838 . . . . 0.0 109.475 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD13 ' HB2' ' A' ' 9' ' ' ASP . 5.9 mt -86.44 178.24 7.18 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.163 -0.961 . . . . 0.0 108.816 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 27.2 mt-10 -126.58 175.84 7.64 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.811 -1.181 . . . . 0.0 110.835 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.916 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.9 t -139.46 71.99 37.86 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.3 Cg_endo -79.29 116.27 3.59 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.534 2.156 . . . . 0.0 109.797 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 34' ' ' GLU . . . -97.29 -175.66 3.29 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.945 -1.097 . . . . 0.0 108.524 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.7 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 12.3 p -131.5 70.16 1.47 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.644 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 98.53 136.95 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 121.253 0.549 . . . . 0.0 112.029 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.638 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 8.3 t0 101.34 -76.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.504 0.669 . . . . 0.0 110.019 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.605 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . 43.27 21.6 0.15 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.666 HG23 ' CA ' ' A' ' 27' ' ' GLY . 6.7 mt -77.65 90.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.835 -1.391 . . . . 0.0 107.583 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.889 HD12 ' HG ' ' A' ' 76' ' ' LEU . 7.2 tp -44.0 111.2 0.27 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.447 0.641 . . . . 0.0 110.144 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 12.5 t70 -134.28 -29.88 1.21 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.608 -0.682 . . . . 0.0 110.245 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -137.65 39.56 2.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.622 -1.299 . . . . 0.0 110.964 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 59' ' ' VAL . 9.1 p -83.82 71.52 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.53 0.38 10.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 110.756 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 73' ' ' LEU . 9.1 mm-40 -105.08 41.54 1.33 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.2 m-20 -37.94 124.83 1.17 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.422 0.63 . . . . 0.0 110.005 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.909 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.2 OUTLIER -29.47 122.14 0.15 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.498 0.666 . . . . 0.0 111.35 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.35 -13.35 8.35 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.445 ' HB ' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -83.37 174.43 10.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -1.062 . . . . 0.0 109.367 179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -96.19 144.89 26.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 110.021 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.612 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.69 169.44 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.544 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -127.49 -143.14 0.28 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.56 ' HA ' HD21 ' A' ' 10' ' ' LEU . 11.1 t -69.67 -102.09 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.008 -1.057 . . . . 0.0 108.972 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 71' ' ' GLN . 3.7 mtt180 -78.07 36.7 0.23 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.127 -0.983 . . . . 0.0 111.377 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.518 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 61.4 mm-40 -61.73 -113.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.49 -1.381 . . . . 0.0 107.991 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 72' ' ' ILE . 16.0 tt 179.34 115.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.694 -1.254 . . . . 0.0 110.725 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.65 ' CD1' HG21 ' A' ' 48' ' ' VAL . 7.8 mt -71.84 -44.47 63.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.38 -159.76 28.79 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.772 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 13.6 mtt180 -135.34 135.39 40.69 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.263 -1.14 . . . . 0.0 108.903 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.889 ' HG ' HD12 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -85.33 -105.23 0.05 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.353 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.541 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -142.5 163.68 32.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.928 -1.108 . . . . 0.0 109.799 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.511 ' CA ' ' OD2' ' A' ' 53' ' ' ASP . 8.9 pt-20 -119.72 -173.38 2.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.693 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.26 143.54 10.65 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.173 -1.192 . . . . 0.0 109.405 -179.97 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.326 0.584 . . . . 0.0 109.456 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.484 ' CB ' ' HB2' ' A' ' 75' ' ' ARG . 7.6 m -166.92 162.16 15.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.927 . . . . 0.0 109.525 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.869 HG21 ' OE1' ' A' ' 34' ' ' GLU . 14.1 t -80.58 75.62 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 108.916 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.584 ' OD2' HD11 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -78.74 78.17 5.2 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.814 HG12 HG13 ' A' ' 48' ' ' VAL . 4.5 tp -88.1 154.28 3.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.259 -0.901 . . . . 0.0 110.799 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.843 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.82 -151.44 0.45 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.334 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.1 HG21 HG21 ' A' ' 67' ' ' VAL . 59.6 t -133.63 60.59 47.78 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.034 -1.041 . . . . 0.0 110.167 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -81.14 34.02 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.538 2.159 . . . . 0.0 110.521 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 1.008 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -107.83 22.26 16.22 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.008 -1.057 . . . . 0.0 109.689 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.055 HD21 HD11 ' A' ' 46' ' ' LEU . 5.4 mt -130.26 70.44 82.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.323 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' SER . 35.7 Cg_endo -77.98 -171.41 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.692 2.261 . . . . 0.0 110.532 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 39.05 -93.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.67 -0.644 . . . . 0.0 110.217 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' PRO . 5.5 m -71.0 174.29 6.41 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.342 -0.849 . . . . 0.0 109.52 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.6 t -143.37 74.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 109.377 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' O ' ' CG ' ' A' ' 16' ' ' ASP . . . -85.74 14.0 6.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.646 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 1.2 p30 48.37 -163.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.389 -0.819 . . . . 0.0 109.194 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -170.37 -164.4 0.39 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.306 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.522 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 33.6 m -160.1 119.11 2.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.862 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.8 t -48.43 134.11 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 108.996 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -106.76 -57.43 2.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.676 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 32.5 m -160.88 119.14 2.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.849 -1.157 . . . . 0.0 111.208 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.901 ' HA ' HG23 ' A' ' 37' ' ' VAL . 21.2 m95 -68.94 -165.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.521 ' CD2' HD12 ' A' ' 36' ' ' LEU . 38.2 m-70 -156.17 48.22 0.48 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.774 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.12 119.72 13.23 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.493 -0.754 . . . . 0.0 110.179 -179.215 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.607 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -62.0 -179.25 0.22 Allowed Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.295 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.1 Cg_endo -67.69 88.88 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.277 1.318 . . . . 0.0 111.111 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.698 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 76.05 46.89 12.21 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.742 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.3 m-20 -59.1 -115.63 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.888 -1.36 . . . . 0.0 109.543 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.742 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 163.23 98.56 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.565 -1.334 . . . . 0.0 109.422 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.921 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -92.74 -176.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.111 -0.993 . . . . 0.0 109.742 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.712 HG13 ' H ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -141.79 -62.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.43 -0.794 . . . . 0.0 109.471 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.712 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -132.52 58.72 1.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -0.979 . . . . 0.0 108.986 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.732 ' O ' HG21 ' A' ' 30' ' ' VAL . 14.8 m-20 151.51 76.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.056 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -71.94 -173.64 1.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.348 1.07 . . . . 0.0 111.773 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.761 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 14.0 p -45.2 168.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.603 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -147.96 61.37 1.12 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.939 HG12 ' HB ' ' A' ' 48' ' ' VAL . 2.7 p -39.46 166.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.728 0.775 . . . . 0.0 110.404 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.844 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 5.1 mm-40 -128.72 97.3 4.63 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.776 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.72 -165.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.473 -0.767 . . . . 0.0 109.254 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.776 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -139.68 141.03 37.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.937 -1.102 . . . . 0.0 110.097 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.76 HG22 ' O ' ' A' ' 41' ' ' THR . 97.5 m -146.4 21.28 1.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.44 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 18.8 t0 64.73 88.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 109.568 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 86.15 -26.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.443 ' O ' ' HB ' ' A' ' 41' ' ' THR . 55.3 t -116.22 142.21 30.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 39' ' ' ILE . 96.9 t -136.21 118.03 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.055 HD11 HD21 ' A' ' 10' ' ' LEU . 3.9 mt -82.77 162.47 21.7 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.307 -0.871 . . . . 0.0 108.969 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -119.54 175.44 5.84 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.039 -1.038 . . . . 0.0 110.176 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.939 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.8 t -140.54 68.69 31.6 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 109.182 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.51 110.13 2.15 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.633 2.222 . . . . 0.0 110.399 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.056 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -89.84 179.27 6.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.672 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -125.71 72.4 1.28 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.552 -1.343 . . . . 0.0 110.215 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 101.58 162.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.507 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.857 ' O ' HG12 ' A' ' 30' ' ' VAL . 11.9 m-20 64.78 -142.01 0.24 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.641 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 101.11 -7.41 56.89 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.077 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.698 HG23 ' CA ' ' A' ' 27' ' ' GLY . 6.1 mt -41.18 96.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.836 ' CD1' HG22 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -41.58 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.761 0.791 . . . . 0.0 109.416 -178.234 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ILE . 51.8 t0 -101.59 -52.24 3.26 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.699 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.93 105.42 3.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.895 -1.128 . . . . 0.0 110.531 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.836 HG22 ' CD1' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -102.02 90.03 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 mt -69.79 -5.01 22.54 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 110.083 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' A' ' 73' ' ' LEU . 3.6 mt-10 -124.51 40.96 3.62 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.156 -0.965 . . . . 0.0 108.922 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.6 m-20 -42.22 128.73 3.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.58 -0.7 . . . . 0.0 109.554 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.545 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -26.89 121.7 0.09 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.317 0.58 . . . . 0.0 110.972 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.86 -16.2 7.82 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 66' ' ' THR . 73.0 m -88.14 160.06 17.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -1.17 . . . . 0.0 109.58 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.498 ' N ' HG22 ' A' ' 65' ' ' THR . 58.2 m -78.74 157.54 28.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 109.546 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.1 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.59 169.68 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.144 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.725 HG22 ' CG ' ' A' ' 71' ' ' GLN . 5.4 t -141.38 -152.05 0.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.362 -0.836 . . . . 0.0 109.123 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.677 ' N ' HG23 ' A' ' 68' ' ' THR . 12.8 p -93.38 58.68 2.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.051 -1.03 . . . . 0.0 109.624 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.7 mtp-105 160.3 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.542 -0.724 . . . . 0.0 109.755 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.725 ' CG ' HG22 ' A' ' 68' ' ' THR . 8.2 mm-40 -46.87 133.92 10.54 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.668 HG23 ' O ' ' A' ' 72' ' ' ILE . 11.5 tt -86.32 110.72 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.827 ' CD1' HG21 ' A' ' 48' ' ' VAL . 18.5 mt -50.17 -44.87 52.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.015 -1.053 . . . . 0.0 108.205 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.51 -175.36 34.16 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.746 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.6 ptt180 -118.46 143.75 46.48 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.248 -1.148 . . . . 0.0 109.804 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.888 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 6.4 mt -114.8 -79.75 0.59 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.935 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -160.75 141.63 11.71 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.257 -0.902 . . . . 0.0 109.251 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.486 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 4.3 tt0 -164.42 74.98 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.127 -0.983 . . . . 0.0 109.565 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.36 -141.29 11.21 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.232 -1.158 . . . . 0.0 109.455 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.301 0.572 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.543 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 8.6 m -160.89 173.8 14.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.352 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.707 ' O ' HG12 ' A' ' 3' ' ' VAL . 9.6 t -69.53 84.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.046 -1.034 . . . . 0.0 108.464 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 2.5 m-20 -74.61 83.42 2.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.101 ' CG1' HG22 ' A' ' 48' ' ' VAL . 3.5 tp -104.31 146.27 11.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.172 -177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.784 ' O ' HG23 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -134.85 -164.63 1.55 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.592 HG21 HD12 ' A' ' 39' ' ' ILE . 20.9 t -133.03 86.96 41.17 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.979 -1.076 . . . . 0.0 110.418 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.532 ' CA ' ' HG2' ' A' ' 70' ' ' ARG . 36.8 Cg_endo -81.44 54.56 5.2 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.578 2.185 . . . . 0.0 110.082 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.926 ' CB ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -119.55 7.14 11.08 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.101 -0.999 . . . . 0.0 110.256 -179.167 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.574 ' HB3' ' CB ' ' A' ' 69' ' ' SER . 1.1 pp -41.38 115.0 1.3 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 109.77 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.81 -159.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.402 2.068 . . . . 0.0 110.381 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -89.0 36.19 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.525 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -153.81 149.95 27.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 14' ' ' VAL . 4.2 p -102.42 54.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.422 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.12 6.43 32.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.494 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 61.22 -163.25 0.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.179 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -170.09 -171.36 1.13 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.107 -0.995 . . . . 0.0 109.925 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 16.0 m -153.21 138.49 17.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 110.347 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.587 ' HA ' HG13 ' A' ' 39' ' ' ILE . 11.2 t -76.79 99.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 0.0 109.53 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -57.49 -54.9 41.58 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 110.606 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.597 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 21.7 m -168.87 131.03 1.26 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.605 -1.31 . . . . 0.0 111.815 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 1.052 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.5 m95 -68.65 -162.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.7 ' HB2' HG23 ' A' ' 35' ' ' VAL . 71.1 m-70 -155.14 34.13 0.38 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.927 ' CB ' HD23 ' A' ' 56' ' ' LEU . 1.6 mmmt -124.59 128.4 48.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.85 -0.531 . . . . 0.0 110.317 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.638 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -79.91 -174.68 0.51 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.37 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.5 Cg_endo -68.25 84.14 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.069 1.179 . . . . 0.0 111.564 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.559 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 78.83 47.46 7.75 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.742 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.0 m-20 -55.34 -110.74 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.047 -1.266 . . . . 0.0 110.426 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.742 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 157.86 99.78 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.926 -1.109 . . . . 0.0 108.67 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.828 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -102.56 -177.35 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.831 -1.168 . . . . 0.0 109.718 -179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.725 ' N ' HG13 ' A' ' 30' ' ' VAL . 5.8 m -130.03 -113.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.146 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 4.9 mtt180 -87.11 63.6 7.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.827 -1.171 . . . . 0.0 109.175 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 4.1 m-20 150.66 101.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.028 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -97.73 -174.05 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.247 1.023 . . . . 0.0 111.656 -178.507 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.866 HG12 ' OE2' ' A' ' 34' ' ' GLU . 3.7 p -44.23 157.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-O 121.978 0.894 . . . . 0.0 111.704 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -134.55 63.38 1.62 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 178.119 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.052 HG23 ' HA ' ' A' ' 22' ' ' TRP . 5.5 p -38.92 168.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.78 0.8 . . . . 0.0 110.178 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' N ' HG22 ' A' ' 37' ' ' VAL . 4.8 mt-10 -123.19 139.61 53.87 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.933 HD11 HG21 ' A' ' 67' ' ' VAL . 1.9 tt -121.94 -163.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.978 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.802 ' N ' HG23 ' A' ' 39' ' ' ILE . 21.8 mm-40 -141.36 117.41 10.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.853 -1.154 . . . . 0.0 109.964 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.634 HG21 HD21 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -115.13 -64.17 1.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.566 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 49.0 t0 177.98 82.53 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.2 tttt 86.84 -26.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 41' ' ' THR . 1.9 t -113.18 163.31 10.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.309 -0.87 . . . . 0.0 109.201 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 39' ' ' ILE . 43.9 t -131.75 122.85 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.926 HD13 ' CB ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -79.66 158.91 26.9 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.317 -0.864 . . . . 0.0 108.734 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.5 pm0 -120.82 178.15 4.82 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.007 -1.058 . . . . 0.0 110.226 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.101 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -145.04 77.97 12.76 Favored Pre-proline 0 N--CA 1.489 1.518 0 CA-C-O 122.285 1.04 . . . . 0.0 108.778 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.0 Cg_endo -81.24 108.84 2.05 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.89 2.393 . . . . 0.0 111.966 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.028 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -78.02 -157.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.739 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.2 p -140.37 10.92 2.32 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.541 -1.349 . . . . 0.0 111.196 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.04 159.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER 78.91 -73.82 0.07 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.459 0.647 . . . . 0.0 110.272 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.551 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 45.3 16.88 0.1 Allowed Glycine 0 N--CA 1.489 2.194 0 O-C-N 121.212 -0.93 . . . . 0.0 111.655 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.56 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 2.2 mt -68.6 88.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.678 -1.483 . . . . 0.0 108.041 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.927 HD23 ' CB ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -40.81 103.45 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.438 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 1.1 t0 -123.21 -52.01 1.86 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 111.018 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -136.15 82.61 1.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.512 -1.368 . . . . 0.0 111.155 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.859 ' CG2' HD11 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -79.9 103.2 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.563 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 29.4 mt -69.34 -11.82 61.14 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.093 -1.005 . . . . 0.0 109.533 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 9.5 mm-40 -132.42 56.09 1.85 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 61' ' ' GLU . 3.2 m-20 -40.74 136.18 1.46 Allowed 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.579 -0.7 . . . . 0.0 109.715 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.597 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -39.49 125.56 1.74 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.426 0.632 . . . . 0.0 110.822 -179.248 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.76 -4.64 19.07 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -97.75 153.07 18.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -1.134 . . . . 0.0 109.365 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.75 155.48 40.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.932 . . . . 0.0 109.446 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.933 HG21 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.32 162.43 3.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.557 -0.715 . . . . 0.0 109.279 -179.178 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.423 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 2.8 m -116.34 -133.24 0.33 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.48 -0.762 . . . . 0.0 109.328 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.574 ' CB ' ' HB3' ' A' ' 10' ' ' LEU . 7.3 p -69.59 -104.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.883 -1.136 . . . . 0.0 109.63 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.588 ' HD2' HD22 ' A' ' 6' ' ' LEU . 4.9 mtm180 -80.21 39.9 0.46 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.55 ' HB2' HG23 ' A' ' 67' ' ' VAL . 2.3 mm-40 -62.6 107.04 0.87 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.757 -1.214 . . . . 0.0 108.896 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.7 tt -43.28 110.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.011 ' CD1' HG11 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -52.91 -36.9 60.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 154.32 165.58 14.02 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.729 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.48 137.2 45.95 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.241 -1.153 . . . . 0.0 109.781 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.772 HD12 ' N ' ' A' ' 76' ' ' LEU . 5.5 mp -106.87 -94.11 0.38 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.552 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.56 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 4.2 tpt180 -150.63 157.77 43.37 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HA ' ' OD2' ' A' ' 53' ' ' ASP . 32.4 tt0 -150.59 163.12 39.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.913 . . . . 0.0 109.573 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.445 ' O ' ' OXT' ' A' ' 80' ' ' ASN . . . -159.76 22.64 0.28 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.445 ' OXT' ' O ' ' A' ' 79' ' ' GLY . 4.2 m120 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.296 -1.12 . . . . 0.0 109.475 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 78' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 72.5 m -168.37 162.7 12.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.414 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 76' ' ' LEU . 57.9 t -72.69 81.03 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.59 78.51 6.13 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.775 HG12 HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -92.26 149.71 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.479 -0.763 . . . . 0.0 111.161 -177.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -132.8 -158.67 0.91 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.04 ' CG1' HD12 ' A' ' 46' ' ' LEU . 60.3 t -130.49 59.84 48.45 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 120.866 -1.146 . . . . 0.0 110.145 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.9 Cg_endo -81.41 19.92 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.589 2.193 . . . . 0.0 110.531 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 1.033 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -80.68 9.43 6.19 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.891 -1.131 . . . . 0.0 110.579 -179.059 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.595 HD22 ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -39.69 100.59 0.22 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.298 -0.876 . . . . 0.0 109.949 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HD2' HG21 ' A' ' 14' ' ' VAL . 36.2 Cg_endo -78.51 -40.57 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.473 2.115 . . . . 0.0 109.947 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 13' ' ' SER . 1.5 tt0 -165.38 -94.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.411 -0.806 . . . . 0.0 109.014 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.574 ' O ' HG23 ' A' ' 14' ' ' VAL . 83.8 p -87.91 130.81 34.8 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 109.164 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 13' ' ' SER . 71.1 t -159.61 83.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.958 . . . . 0.0 109.345 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' CB ' ' A' ' 16' ' ' ASP . . . -71.44 -3.19 19.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.902 . . . . 0.0 109.931 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER 164.5 -174.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.139 -0.976 . . . . 0.0 109.809 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -168.11 -171.25 1.49 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.856 . . . . 0.0 109.342 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.539 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 79.5 m -158.76 134.79 9.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 110.681 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.639 HG22 ' CD1' ' A' ' 39' ' ' ILE . 22.0 t -69.18 84.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.412 -0.805 . . . . 0.0 109.231 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -43.6 -63.16 0.89 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.092 -1.005 . . . . 0.0 110.245 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.608 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 87.3 m -164.19 124.19 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.648 -1.283 . . . . 0.0 111.658 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.997 ' HA ' HG23 ' A' ' 37' ' ' VAL . 19.1 m95 -68.44 -167.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.636 ' HB2' HG23 ' A' ' 35' ' ' VAL . 38.8 m-70 -152.14 24.1 0.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.544 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 2.2 tppm? -118.45 128.18 54.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.793 -0.567 . . . . 0.0 109.941 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.569 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -78.94 178.61 2.18 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.647 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.4 Cg_endo -69.21 93.26 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.644 1.562 . . . . 0.0 111.466 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.685 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 78.28 43.13 13.62 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.756 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 12.5 m-20 -61.36 -120.24 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.002 -1.293 . . . . 0.0 109.651 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 159.58 79.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.73 -1.231 . . . . 0.0 108.843 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.851 HG12 ' OE2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -79.73 -168.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.12 -0.987 . . . . 0.0 109.652 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.817 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -134.99 -99.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.31 -0.869 . . . . 0.0 109.845 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.469 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 16.3 ttt-85 -98.37 38.5 1.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.871 -1.143 . . . . 0.0 109.522 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.731 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.6 m-20 178.5 91.42 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.108 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -83.37 -170.24 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.263 1.03 . . . . 0.0 112.102 -178.041 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.636 HG23 ' HB2' ' A' ' 23' ' ' HIS . 3.1 p -55.97 164.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.453 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.568 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -142.08 62.07 1.44 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.011 HG12 ' HB ' ' A' ' 48' ' ' VAL . 3.3 p -38.95 165.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-O 121.682 0.753 . . . . 0.0 110.204 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.787 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.3 mt-10 -128.37 97.58 4.78 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.786 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.76 -164.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 O-C-N 121.397 -0.814 . . . . 0.0 108.976 -179.48 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.786 ' N ' HG23 ' A' ' 39' ' ' ILE . 3.9 mm-40 -134.48 112.83 11.23 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.974 -1.079 . . . . 0.0 109.775 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.556 ' OG1' HD21 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -108.16 -145.58 0.39 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -0.87 . . . . 0.0 109.196 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 6.8 t70 -96.73 83.24 3.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.086 -1.009 . . . . 0.0 109.592 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.2 tmtt? 85.98 -22.23 0.19 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.223 0.535 . . . . 0.0 109.585 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 45' ' ' VAL . 95.2 t -113.61 164.74 9.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.307 -0.871 . . . . 0.0 109.612 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.59 HG11 ' OE1' ' A' ' 38' ' ' GLU . 54.9 t -127.64 125.64 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.04 HD12 ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -79.62 155.34 28.14 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.297 -0.877 . . . . 0.0 108.823 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -112.17 172.65 6.78 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.043 -1.036 . . . . 0.0 110.594 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.011 ' HB ' HG12 ' A' ' 37' ' ' VAL . 8.6 t -142.2 70.35 22.62 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.27 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.24 113.45 2.67 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.72 2.28 . . . . 0.0 111.288 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.108 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -88.5 -164.52 1.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.675 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 10.0 p -141.09 60.06 1.52 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.548 -1.261 . . . . 0.0 110.623 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.675 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 105.43 160.99 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.412 0.625 . . . . 0.0 110.658 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 74.95 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.619 -0.676 . . . . 0.0 110.188 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' OE2' ' A' ' 34' ' ' GLU . . . 54.56 8.51 1.28 Allowed Glycine 0 N--CA 1.495 2.582 0 O-C-N 121.051 -1.03 . . . . 0.0 111.778 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.685 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -55.11 92.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 120.612 -1.522 . . . . 0.0 107.797 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.871 HD12 ' HG ' ' A' ' 76' ' ' LEU . 8.8 tp -44.7 112.88 0.47 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.468 -0.77 . . . . 0.0 109.527 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -118.84 -43.36 2.67 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.653 -0.654 . . . . 0.0 110.07 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.552 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -143.06 78.12 1.59 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.858 -1.151 . . . . 0.0 110.776 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.815 HG21 HD21 ' A' ' 56' ' ' LEU . 8.4 t -79.46 87.59 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.8 mt -69.55 -4.42 18.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 0.0 110.334 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.502 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 2.5 mt-10 -129.21 50.89 2.1 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.0 m-20 -42.58 127.43 3.84 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.696 -0.627 . . . . 0.0 109.489 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.608 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.12 121.05 0.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.449 0.642 . . . . 0.0 111.079 -179.199 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.89 -1.45 19.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 66' ' ' THR . 22.5 m -97.89 159.98 14.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -1.137 . . . . 0.0 109.347 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.492 ' N ' HG22 ' A' ' 65' ' ' THR . 0.2 OUTLIER -70.99 149.33 46.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.64 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.724 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.24 169.45 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.537 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -138.63 -176.39 4.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.365 -0.834 . . . . 0.0 109.052 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.595 ' O ' HD22 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -83.69 69.52 10.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.231 -0.918 . . . . 0.0 109.329 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 69' ' ' SER . 10.3 ttm180 158.61 -22.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.6 mm-40 -57.62 159.17 5.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.876 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 72' ' ' ILE . 15.8 tt -103.81 113.25 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.696 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.877 ' CD1' HG21 ' A' ' 48' ' ' VAL . 9.3 mt -49.86 -47.1 51.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 108.269 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.72 -166.36 34.37 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.552 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.86 141.6 51.51 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.322 -1.104 . . . . 0.0 109.681 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.871 ' HG ' HD12 ' A' ' 56' ' ' LEU . 2.8 mp -101.29 -104.19 0.25 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.295 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.554 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -154.66 158.91 40.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.873 -1.142 . . . . 0.0 109.984 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.464 ' HA ' ' CG ' ' A' ' 53' ' ' ASP . 5.1 tt0 179.35 71.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.418 ' O ' ' ND2' ' A' ' 80' ' ' ASN . . . -84.34 -49.67 4.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 79' ' ' GLY . 20.2 m120 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.453 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.275 0.56 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 15.4 m -159.91 -179.74 8.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.374 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 77' ' ' ARG . 38.5 t -78.03 77.85 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.01 . . . . 0.0 108.52 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.71 85.88 0.92 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.012 HG12 HG22 ' A' ' 48' ' ' VAL . 3.5 tp -110.09 141.0 26.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 111.058 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.855 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -127.47 -145.54 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.52 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.91 HG23 HD21 ' A' ' 73' ' ' LEU . 69.1 t -132.94 58.82 38.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.957 -1.09 . . . . 0.0 109.315 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 34.5 Cg_endo -75.8 68.33 6.41 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.616 2.21 . . . . 0.0 111.108 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -123.17 -8.23 8.22 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.179 -0.951 . . . . 0.0 109.346 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 10' ' ' LEU . 6.4 mt 35.8 84.49 0.18 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.741 -0.6 . . . . 0.0 110.421 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.437 ' CB ' HG21 ' A' ' 41' ' ' THR . 35.3 Cg_endo -77.84 164.14 28.01 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.578 2.186 . . . . 0.0 110.242 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.68 39.91 3.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.686 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.694 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -122.94 -10.91 8.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.935 . . . . 0.0 109.618 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.765 HG12 ' N ' ' A' ' 15' ' ' ALA . 48.3 t -161.51 -97.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -0.816 . . . . 0.0 109.514 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.765 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 163.31 41.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 109.413 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.3 p30 176.42 -168.03 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.356 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -170.46 -175.11 1.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.397 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 65' ' ' THR . 18.4 m -160.23 125.9 4.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.398 -0.814 . . . . 0.0 109.519 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 61' ' ' GLU . 2.6 t -52.54 141.62 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 109.071 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -117.7 -50.07 2.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.114 -0.991 . . . . 0.0 109.877 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.501 ' N ' ' HB3' ' A' ' 63' ' ' GLU . 52.6 m -164.56 114.12 1.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.885 -1.135 . . . . 0.0 111.128 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.902 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.2 m95 -68.56 -162.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.833 . . . . 0.0 108.756 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.492 ' CG ' ' O ' ' A' ' 22' ' ' TRP . 39.8 m-70 -160.08 26.14 0.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.867 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -114.63 114.5 25.76 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.595 -178.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.651 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 11.3 mmmt -59.55 173.34 0.52 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -66.92 96.5 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.516 1.477 . . . . 0.0 110.829 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.816 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 80.72 50.33 5.32 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 3.0 m-20 -55.72 -150.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.485 -1.009 . . . . 0.0 110.382 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -175.39 96.61 0.07 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.541 -1.349 . . . . 0.0 108.57 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.657 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -110.58 -176.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.891 -179.004 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.657 ' N ' HG13 ' A' ' 30' ' ' VAL . 2.1 p -125.72 -49.6 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.598 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -157.13 61.49 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.367 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.598 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.5 m-20 146.0 100.6 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.145 ' CG ' ' HB3' ' A' ' 50' ' ' ALA . 1.9 pt-20 -131.39 -164.07 1.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.938 -1.101 . . . . 0.0 112.028 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.826 HG21 ' HE3' ' A' ' 22' ' ' TRP . 4.0 p -13.58 136.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.068 0.937 . . . . 0.0 113.309 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -130.55 62.86 1.58 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.902 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.2 p -37.56 166.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.891 0.853 . . . . 0.0 110.807 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.0 mt-10 -125.03 95.61 4.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.938 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -79.86 -160.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 121.419 -0.8 . . . . 0.0 109.18 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.814 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -136.62 151.55 49.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.872 -1.143 . . . . 0.0 109.973 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 41' ' ' THR . 98.4 m -156.41 31.8 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.593 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 10.8 t0 47.78 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 109.637 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 85.27 -27.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.845 -0.535 . . . . 0.0 109.741 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.476 ' HB ' ' HB ' ' A' ' 41' ' ' THR . 1.8 t -120.85 152.43 24.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.154 -0.966 . . . . 0.0 109.538 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.938 HG13 ' O ' ' A' ' 39' ' ' ILE . 24.1 t -149.38 97.57 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.384 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.854 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.67 164.65 23.59 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.211 -0.931 . . . . 0.0 109.153 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 48.0 mt-10 -112.37 -165.92 1.03 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.211 -0.93 . . . . 0.0 109.761 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.012 HG22 HG12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -152.69 78.37 6.18 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 122.154 0.978 . . . . 0.0 109.187 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.66 110.08 2.35 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.838 2.359 . . . . 0.0 111.178 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.145 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . . . -74.14 -162.67 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -148.48 33.9 0.79 Allowed 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.975 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 155.89 151.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.932 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 79' ' ' GLY . 0.6 OUTLIER 65.84 -93.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.52 -0.738 . . . . 0.0 110.541 179.071 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 74.18 -9.73 9.11 Favored Glycine 0 N--CA 1.486 2.001 0 O-C-N 120.674 -1.267 . . . . 0.0 110.466 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.816 HG23 ' HA2' ' A' ' 27' ' ' GLY . 1.1 mp -40.29 94.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.555 1.178 . . . . 0.0 108.541 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.895 HD11 HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -50.47 92.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.2 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 55' ' ' ILE . 8.6 t70 -111.69 -44.78 3.44 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.815 -0.553 . . . . 0.0 110.776 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -138.72 98.26 3.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.554 -1.342 . . . . 0.0 111.14 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 56' ' ' LEU . 1.7 t -109.74 88.96 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 mt -69.48 -4.03 17.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 110.592 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.685 ' O ' HG21 ' A' ' 19' ' ' VAL . 10.0 mt-10 -127.16 44.32 2.94 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.113 -0.992 . . . . 0.0 108.564 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -46.07 136.34 6.8 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.465 -0.772 . . . . 0.0 109.32 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.54 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -31.9 107.2 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.418 0.628 . . . . 0.0 110.481 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.41 -7.78 3.41 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.776 ' O ' HG23 ' A' ' 18' ' ' THR . 0.1 OUTLIER -100.01 178.83 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -1.17 . . . . 0.0 109.748 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 m -99.97 151.24 21.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.85 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.882 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.89 171.18 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.359 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.558 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 1.4 m -134.29 -141.38 0.19 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 108.975 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 7' ' ' VAL . 2.2 p -69.35 -104.48 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.945 -1.097 . . . . 0.0 109.054 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.709 ' HG2' HD22 ' A' ' 6' ' ' LEU . 28.0 ttp180 -79.2 37.86 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.066 . . . . 0.0 110.755 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.766 ' O ' HD23 ' A' ' 6' ' ' LEU . 12.6 mm100 -63.92 -112.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.76 -1.212 . . . . 0.0 108.582 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 72' ' ' ILE . 12.4 tt -179.0 116.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.836 -1.165 . . . . 0.0 110.392 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.91 HD21 HG23 ' A' ' 7' ' ' VAL . 9.7 mt -72.96 -49.94 26.31 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.13 -0.981 . . . . 0.0 108.4 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 59' ' ' VAL . . . 161.57 169.73 25.27 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.723 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -110.73 138.57 46.95 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.13 -1.218 . . . . 0.0 110.089 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.778 HD12 ' N ' ' A' ' 76' ' ' LEU . 5.0 mp -106.47 -88.63 0.45 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.702 ' O ' HG23 ' A' ' 3' ' ' VAL . 5.5 ttt180 -158.33 161.18 37.61 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.568 -0.708 . . . . 0.0 109.453 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 53' ' ' ASP . 56.3 tt0 -166.07 46.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.518 ' N ' ' OD2' ' A' ' 53' ' ' ASP . . . -66.47 -60.8 5.9 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 79' ' ' GLY . 2.2 t-20 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.25 -1.147 . . . . 0.0 109.52 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 77' ' ' ARG . 46.3 m . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.563 ' CA ' ' HB3' ' A' ' 78' ' ' GLU . 66.3 m -170.1 155.2 5.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.251 -0.906 . . . . 0.0 109.366 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.785 ' O ' HG12 ' A' ' 3' ' ' VAL . 4.7 t -77.96 77.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -83.6 84.11 7.66 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.827 HG12 HG13 ' A' ' 48' ' ' VAL . 6.5 tp -89.48 158.04 2.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.375 -0.828 . . . . 0.0 111.583 -177.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.858 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -137.44 -151.56 0.4 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.683 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 67' ' ' VAL . 33.2 t -138.21 57.25 12.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.7 -1.25 . . . . 0.0 110.085 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -79.94 47.56 2.57 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.617 2.211 . . . . 0.0 110.843 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.563 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 3.0 m-20 -119.87 -1.04 10.54 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.945 -1.097 . . . . 0.0 109.616 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.973 HD23 ' HB3' ' A' ' 15' ' ' ALA . 5.6 mp -86.22 133.54 40.5 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.876 . . . . 0.0 109.552 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 12' ' ' GLU . 36.1 Cg_endo -78.88 -53.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.556 2.171 . . . . 0.0 110.177 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -49.91 177.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 109.398 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.0 m -88.7 -11.28 45.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.125 -0.985 . . . . 0.0 109.368 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.841 HG22 ' OD1' ' A' ' 16' ' ' ASP . 9.8 p -170.02 54.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.828 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.973 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -65.1 -11.03 35.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.174 -0.954 . . . . 0.0 109.257 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.841 ' OD1' HG22 ' A' ' 14' ' ' VAL . 3.8 m-20 55.64 163.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.776 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -166.39 179.73 5.43 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.514 ' C ' HG12 ' A' ' 39' ' ' ILE . 1.1 m -134.74 129.06 34.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.17 -0.956 . . . . 0.0 110.233 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.988 ' CG1' HD11 ' A' ' 73' ' ' LEU . 7.0 t -75.61 103.93 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.378 -0.827 . . . . 0.0 109.188 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -65.02 -62.15 1.73 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.747 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.624 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 52.9 m -168.65 132.29 1.47 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.276 -1.37 . . . . 0.0 112.289 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 1.067 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.4 m95 -68.99 -168.77 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.582 ' HB2' HG23 ' A' ' 35' ' ' VAL . 38.7 m-70 -150.91 30.98 0.63 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.745 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -122.38 123.78 42.14 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.706 -0.621 . . . . 0.0 110.389 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.595 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -74.57 -178.87 0.88 Allowed Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.271 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -68.18 90.55 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.282 1.321 . . . . 0.0 111.001 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.796 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 76.47 46.23 12.47 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.727 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 14.1 m-20 -59.7 -118.07 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.933 -1.333 . . . . 0.0 109.794 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 162.91 100.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.583 -1.323 . . . . 0.0 109.493 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.884 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -100.99 -175.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.185 -0.947 . . . . 0.0 109.987 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.719 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -141.15 -73.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 109.608 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.676 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -119.81 61.55 0.84 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.055 -1.028 . . . . 0.0 109.426 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.608 ' O ' HG21 ' A' ' 30' ' ' VAL . 3.7 m-20 145.32 84.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.069 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -76.1 -168.78 0.99 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.001 0.905 . . . . 0.0 111.533 -178.032 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.862 HG12 ' OE2' ' A' ' 34' ' ' GLU . 7.5 p -49.54 166.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.572 0.701 . . . . 0.0 110.836 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.618 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -144.85 59.05 1.31 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.078 HG21 HD21 ' A' ' 73' ' ' LEU . 2.7 p -39.18 166.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.63 0.728 . . . . 0.0 110.296 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -127.52 142.7 51.32 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.964 HD11 HG11 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -127.56 -166.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.778 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -143.9 88.48 1.98 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.86 -1.15 . . . . 0.0 110.056 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.851 HG23 HD21 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -84.44 -146.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.393 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 20.6 t0 -97.72 85.94 3.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.3 tttm 86.28 -25.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.273 0.558 . . . . 0.0 109.526 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.17 135.43 52.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.173 -0.955 . . . . 0.0 109.719 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.846 HG13 ' O ' ' A' ' 39' ' ' ILE . 41.2 t -118.77 105.31 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 109.408 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.841 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.99 179.86 7.37 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.272 -0.892 . . . . 0.0 109.349 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 48' ' ' VAL . 22.9 mt-10 -134.82 -148.9 0.33 Allowed 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.958 -1.089 . . . . 0.0 110.566 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.863 ' HB ' HG12 ' A' ' 37' ' ' VAL . 11.9 t -154.89 69.74 5.73 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.327 -0.858 . . . . 0.0 109.29 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.79 104.5 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.592 2.195 . . . . 0.0 111.023 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.069 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -83.27 -178.53 7.11 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.6 p -121.93 24.47 9.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.093 -1.629 . . . . 0.0 111.338 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.71 160.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.213 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.723 ' O ' HG12 ' A' ' 30' ' ' VAL . 2.5 t0 61.43 -139.39 0.51 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.04 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 115.29 -8.26 20.64 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.796 HG23 ' HA2' ' A' ' 27' ' ' GLY . 10.7 mt -42.39 98.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.029 HD12 HD22 ' A' ' 76' ' ' LEU . 9.6 tp -48.82 90.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.595 0.712 . . . . 0.0 109.648 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.8 t0 -82.18 -58.11 3.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.946 -0.471 . . . . 0.0 110.001 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -149.88 95.68 2.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.768 -1.207 . . . . 0.0 111.091 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.516 HG22 HD11 ' A' ' 56' ' ' LEU . 2.9 t -79.74 101.89 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.437 HD11 ' HD3' ' A' ' 75' ' ' ARG . 44.9 mt -69.15 -27.12 65.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 110.29 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 41.2 mm-40 -121.86 59.93 0.98 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -37.92 140.91 0.23 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.486 0.66 . . . . 0.0 109.691 -179.07 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.624 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -39.99 139.35 0.69 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.57 -0.706 . . . . 0.0 110.644 -179.424 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.26 -12.34 33.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.72 174.48 9.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.241 . . . . 0.0 109.633 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.6 m -93.36 154.44 17.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.964 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.77 168.96 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 1.088 HG22 ' CG ' ' A' ' 71' ' ' GLN . 15.0 t -133.39 -136.07 0.17 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.942 ' HA ' HD13 ' A' ' 10' ' ' LEU . 9.6 m -68.96 -119.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.592 -1.317 . . . . 0.0 108.015 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.817 ' CG ' HD22 ' A' ' 6' ' ' LEU . 8.0 ttm105 -72.89 80.68 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.678 -1.263 . . . . 0.0 109.786 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 1.088 ' CG ' HG22 ' A' ' 68' ' ' THR . 0.5 OUTLIER -98.43 -101.82 0.21 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.054 -1.028 . . . . 0.0 108.397 179.253 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 72' ' ' ILE . 19.1 tt 177.72 112.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 110.264 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.078 HD21 HG21 ' A' ' 37' ' ' VAL . 10.5 tp -79.7 -39.42 31.29 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.821 -1.174 . . . . 0.0 108.206 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.69 158.61 8.97 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.211 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.756 ' C ' HD23 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -101.03 148.57 24.89 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.373 -1.075 . . . . 0.0 109.559 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.029 HD22 HD12 ' A' ' 56' ' ' LEU . 5.5 mt -113.89 -132.43 0.33 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.732 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.564 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -109.52 -51.2 2.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.804 -1.185 . . . . 0.0 110.402 -179.333 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.569 ' HA ' ' CB ' ' A' ' 53' ' ' ASP . 13.7 tt0 54.26 170.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.951 -1.093 . . . . 0.0 109.428 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' OD2' ' A' ' 53' ' ' ASP . . . 51.7 -134.85 34.55 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.5 m120 . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.233 -1.157 . . . . 0.0 109.442 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 0.8 OUTLIER -153.45 -179.57 7.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 109.447 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 77' ' ' ARG . 6.4 t -83.82 89.07 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.32 95.82 0.21 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.639 HD13 HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -103.76 129.76 55.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 109.949 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.859 HD22 ' HG2' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -153.39 -163.16 1.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.792 ' CG2' HD13 ' A' ' 39' ' ' ILE . 11.4 t -121.01 78.23 32.26 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.874 -1.142 . . . . 0.0 108.982 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 36.7 Cg_endo -80.4 53.52 4.8 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.803 2.335 . . . . 0.0 110.815 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 1.009 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -122.21 -5.72 8.88 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.076 -1.015 . . . . 0.0 109.717 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER 38.89 84.82 0.17 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.578 -0.701 . . . . 0.0 110.131 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 1.005 ' HB3' HG21 ' A' ' 41' ' ' THR . 35.8 Cg_endo -78.44 141.84 18.18 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.567 2.178 . . . . 0.0 110.274 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -133.96 168.57 18.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 109.661 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 23.9 t 65.77 8.73 5.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.389 -0.819 . . . . 0.0 109.668 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' N ' ' A' ' 15' ' ' ALA . 1.3 p -126.95 -97.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.296 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.78 ' N ' HG22 ' A' ' 14' ' ' VAL . . . 165.24 -24.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.775 -1.203 . . . . 0.0 109.911 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.556 ' H ' HG22 ' A' ' 14' ' ' VAL . 16.8 p30 174.37 -163.55 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 109.238 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.731 ' HB2' ' OG1' ' A' ' 41' ' ' THR . . . -149.63 -167.1 2.73 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.145 -0.972 . . . . 0.0 109.016 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 40' ' ' GLU . 93.3 m -156.63 148.81 23.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.125 -0.984 . . . . 0.0 109.643 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 73' ' ' LEU . 2.3 t -78.73 147.24 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 108.636 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -118.83 -55.14 2.21 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.772 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.624 HG23 ' OE2' ' A' ' 63' ' ' GLU . 1.3 m -167.45 123.03 1.07 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.246 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.904 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.2 m95 -68.25 -167.41 0.08 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.583 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.4 m-70 -152.31 24.18 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.664 ' HB3' HD13 ' A' ' 56' ' ' LEU . 6.5 tppt? -118.52 132.04 56.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.77 -0.581 . . . . 0.0 109.728 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.591 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -79.62 177.31 3.0 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.9 Cg_endo -70.26 101.63 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.731 1.62 . . . . 0.0 111.615 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.656 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 82.37 37.66 14.25 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.554 ' CB ' ' HD2' ' A' ' 24' ' ' LYS . 1.2 m-20 -59.3 -165.38 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.878 -1.366 . . . . 0.0 110.103 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -165.11 78.17 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 108.979 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -79.54 -173.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.554 -179.011 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.749 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.6 OUTLIER -125.41 -97.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 109.836 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 47.6 mtp180 -103.28 45.14 0.97 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.644 -1.285 . . . . 0.0 109.345 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.781 ' O ' HG21 ' A' ' 30' ' ' VAL . 6.3 m-20 171.87 94.86 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.0 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -93.1 -166.56 1.55 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.922 -1.112 . . . . 0.0 111.542 -178.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.759 HG12 ' CD ' ' A' ' 34' ' ' GLU . 2.5 p -52.74 164.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 122.058 0.932 . . . . 0.0 111.393 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.581 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.61 65.97 1.39 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.379 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.145 HG12 HG12 ' A' ' 48' ' ' VAL . 4.1 p -38.0 164.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.582 0.706 . . . . 0.0 110.354 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.617 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -122.88 101.49 7.47 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 -178.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.001 HD11 HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -85.63 -159.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.81 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -154.59 99.03 2.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.609 -1.307 . . . . 0.0 110.265 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 1.005 HG21 ' HB3' ' A' ' 11' ' ' PRO . 10.0 m -116.64 90.11 3.26 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' THR . 11.2 t0 71.7 -143.33 0.05 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.372 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -17.27 57.52 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.99 150.23 3.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.521 -0.737 . . . . 0.0 109.886 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 39' ' ' ILE . 7.2 p -130.39 105.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.009 HD13 ' HB2' ' A' ' 9' ' ' ASP . 1.3 mt -85.94 159.22 19.71 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.231 -0.918 . . . . 0.0 109.021 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 5.1 pt-20 -127.29 -164.75 1.39 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.053 -1.029 . . . . 0.0 110.314 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.145 HG12 HG12 ' A' ' 37' ' ' VAL . 14.6 p -146.49 88.05 6.27 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.339 -0.851 . . . . 0.0 110.025 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.44 104.79 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.566 2.177 . . . . 0.0 111.181 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.0 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -74.86 -165.71 0.4 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 19.2 m -141.46 24.81 2.07 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.325 -1.485 . . . . 0.0 110.648 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 156.12 165.63 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.27 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.517 ' OD2' ' N ' ' A' ' 78' ' ' GLU . 0.5 OUTLIER 66.75 -88.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.615 -0.678 . . . . 0.0 109.585 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.729 ' HA2' HG21 ' A' ' 3' ' ' VAL . . . 63.32 -8.63 0.26 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.013 -1.055 . . . . 0.0 111.808 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.656 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.84 96.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.849 -1.383 . . . . 0.0 107.994 179.435 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.944 HD12 HD22 ' A' ' 76' ' ' LEU . 8.8 tp -51.66 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.469 -0.769 . . . . 0.0 109.376 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' ILE . 10.9 t0 -108.11 -35.52 6.56 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.583 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.487 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -142.11 85.97 1.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.494 -1.379 . . . . 0.0 111.736 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.573 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 2.5 t -101.14 77.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.0 mt -69.66 -2.81 12.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 110.946 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.552 ' O ' HD11 ' A' ' 73' ' ' LEU . 18.9 mt-10 -136.16 51.49 2.02 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.882 -1.136 . . . . 0.0 109.283 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.488 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.6 m-20 -50.23 151.19 2.16 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.274 -0.891 . . . . 0.0 109.751 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.624 ' OE2' HG23 ' A' ' 21' ' ' THR . 0.1 OUTLIER -32.92 141.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.411 0.624 . . . . 0.0 110.818 -179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.58 -18.65 32.18 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.591 HG22 ' H ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -83.57 -179.72 7.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -1.194 . . . . 0.0 109.874 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 65' ' ' THR . 4.0 m -113.3 153.82 27.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 109.715 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.001 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -151.25 169.72 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 1.019 HG22 ' HG3' ' A' ' 71' ' ' GLN . 7.8 t -127.6 -124.6 0.23 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.612 ' N ' HG23 ' A' ' 68' ' ' THR . 6.0 p -69.63 -114.95 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.337 -1.477 . . . . 0.0 108.967 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.859 ' HG2' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -83.28 52.98 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.903 -1.123 . . . . 0.0 110.8 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 1.019 ' HG3' HG22 ' A' ' 68' ' ' THR . 4.4 mm100 -65.25 -111.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.75 -1.219 . . . . 0.0 108.293 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.682 HG23 ' O ' ' A' ' 72' ' ' ILE . 16.2 tt 178.33 116.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.83 -1.168 . . . . 0.0 110.474 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.908 ' CD2' HG21 ' A' ' 37' ' ' VAL . 14.0 tp -77.38 -17.36 58.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.941 -1.099 . . . . 0.0 108.456 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' HB ' ' A' ' 5' ' ' ILE . . . 135.33 162.43 9.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.491 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.61 149.11 31.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -1.141 . . . . 0.0 109.495 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.944 HD22 HD12 ' A' ' 56' ' ' LEU . 8.2 mt -117.52 -78.31 0.58 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.444 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.987 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -163.28 157.25 19.99 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.305 -0.872 . . . . 0.0 109.268 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.517 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 4.1 tp10 179.29 111.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.33 -61.36 0.05 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.184 -1.186 . . . . 0.0 109.484 179.986 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.292 0.567 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.552 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 68.1 m -154.51 173.5 16.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.034 HG21 ' OE1' ' A' ' 34' ' ' GLU . 70.1 t -76.99 77.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 109.207 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 0.5 OUTLIER -73.6 84.83 1.57 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.946 HG12 HG22 ' A' ' 48' ' ' VAL . 2.1 tp -106.57 151.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.347 -0.846 . . . . 0.0 110.985 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -134.09 -166.06 1.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.757 HG21 ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -126.04 72.81 70.83 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.144 -0.973 . . . . 0.0 109.625 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 36.9 Cg_endo -80.99 27.33 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.719 2.279 . . . . 0.0 110.955 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 17.6 m-20 -113.64 72.22 0.77 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 120.899 -1.126 . . . . 0.0 109.856 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.936 HD12 ' C ' ' A' ' 68' ' ' THR . 92.3 mt -154.29 62.04 3.55 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.943 . . . . 0.0 109.822 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 10' ' ' LEU . 36.0 Cg_endo -78.59 -159.27 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.572 2.181 . . . . 0.0 110.476 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.01 -163.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.557 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.3 m -85.49 47.18 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 25.4 t -144.05 75.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.213 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.4 47.91 1.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.764 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 0.6 OUTLIER -158.8 144.39 16.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.937 . . . . 0.0 109.765 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.732 ' HB2' HD21 ' A' ' 10' ' ' LEU . . . -149.27 -157.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.455 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 39' ' ' ILE . 17.7 m -155.15 126.14 7.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.178 -0.951 . . . . 0.0 110.457 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.654 HG22 HD11 ' A' ' 39' ' ' ILE . 3.3 t -67.33 93.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.338 -0.851 . . . . 0.0 108.999 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -58.02 -59.35 5.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.151 -0.968 . . . . 0.0 110.763 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.651 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 34.8 m -166.68 125.71 1.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.574 -1.329 . . . . 0.0 111.982 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.982 ' HA ' HG23 ' A' ' 37' ' ' VAL . 24.0 m95 -67.76 -165.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.586 ' HB2' HG23 ' A' ' 35' ' ' VAL . 52.8 m-70 -154.67 51.61 0.63 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.588 ' CB ' HD21 ' A' ' 56' ' ' LEU . 2.2 mmpt? -134.26 175.19 9.73 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.024 0.916 . . . . 0.0 110.995 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.653 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 2.1 mmmt -127.62 -174.86 0.39 Allowed Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.76 106.4 1.47 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.14 1.227 . . . . 0.0 111.242 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.551 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 65.21 45.84 89.81 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.548 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 1.4 m-20 -54.13 -167.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.885 -1.362 . . . . 0.0 110.198 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.89 80.81 0.42 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.401 -0.812 . . . . 0.0 108.927 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.815 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.06 -173.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.506 -0.746 . . . . 0.0 110.596 -178.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.703 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -132.65 -96.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.641 -0.662 . . . . 0.0 110.014 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.492 ' H ' HG23 ' A' ' 31' ' ' VAL . 3.2 mtt180 -99.8 36.03 1.89 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.686 -1.259 . . . . 0.0 109.472 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.763 ' O ' HG21 ' A' ' 30' ' ' VAL . 18.8 m-20 -179.57 81.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.591 -0.693 . . . . 0.0 109.162 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.113 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -69.5 -160.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.998 -1.064 . . . . 0.0 111.621 -178.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.922 HG12 ' OE2' ' A' ' 34' ' ' GLU . 7.2 p -62.95 163.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.613 0.721 . . . . 0.0 110.542 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.567 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -138.47 59.76 1.63 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 178.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.982 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.4 p -38.48 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.54 0.686 . . . . 0.0 109.913 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -124.02 140.76 52.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.674 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.06 -177.05 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.375 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.674 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.7 mm-40 -138.71 115.77 10.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.92 . . . . 0.0 109.374 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.535 ' HB ' ' CD2' ' A' ' 10' ' ' LEU . 2.8 t -110.03 -27.97 8.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 0.0 110.002 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 7.3 t0 161.28 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.597 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.9 tttp 85.85 -24.92 0.12 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 41' ' ' THR . 58.0 t -104.01 136.81 35.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 0.0 109.227 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 39' ' ' ILE . 46.5 t -116.67 109.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.918 . . . . 0.0 109.739 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 9' ' ' ASP . 4.2 mm? -79.78 -168.57 1.64 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.15 -0.969 . . . . 0.0 108.719 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.3 pt-20 -144.36 -166.81 2.47 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.075 -1.016 . . . . 0.0 110.717 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.946 HG22 HG12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -155.95 82.91 3.55 Favored Pre-proline 0 N--CA 1.489 1.484 0 CA-C-O 122.076 0.941 . . . . 0.0 109.583 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.2 Cg_endo -81.81 117.88 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.77 2.313 . . . . 0.0 111.749 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.113 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -89.41 178.84 6.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.712 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 18.3 p -122.72 72.85 1.1 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 120.532 -1.355 . . . . 0.0 110.436 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 93.23 169.37 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.118 0.485 . . . . 0.0 110.132 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 13.2 m-20 69.74 -101.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 55' ' ' ILE . . . 68.6 -16.56 0.54 Allowed Glycine 0 N--CA 1.496 2.638 0 O-C-N 120.433 -1.417 . . . . 0.0 111.902 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.551 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.9 OUTLIER -36.03 99.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.104 1.452 . . . . 0.0 109.438 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.608 HD22 HD23 ' A' ' 76' ' ' LEU . 1.4 mm? -48.61 104.82 0.07 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.634 0.73 . . . . 0.0 109.936 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.455 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 9.3 t70 -108.16 -48.03 3.44 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.19 86.45 1.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.775 -1.203 . . . . 0.0 111.404 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 1.6 t -79.81 87.66 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 177.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.46 -3.92 16.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.934 . . . . 0.0 110.414 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 3.1 mt-10 -132.58 51.77 2.13 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.9 m-20 -40.58 131.11 2.34 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.744 0.783 . . . . 0.0 109.749 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.651 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -36.12 123.39 0.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.481 0.658 . . . . 0.0 111.079 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.13 -11.07 8.21 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.38 162.7 15.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -1.13 . . . . 0.0 109.501 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 67' ' ' VAL . 80.2 m -72.2 162.49 29.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 109.603 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.757 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.19 173.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.473 -0.767 . . . . 0.0 109.097 -178.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.936 ' C ' HD12 ' A' ' 10' ' ' LEU . 5.7 t -145.66 -162.29 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.357 -0.839 . . . . 0.0 109.098 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.544 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 2.7 p -85.58 37.41 0.69 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.035 -1.041 . . . . 0.0 109.816 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER 168.63 34.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.598 -0.689 . . . . 0.0 109.212 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.923 ' CG ' HG22 ' A' ' 68' ' ' THR . 3.1 mm-40 -97.61 103.04 14.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.921 -1.112 . . . . 0.0 109.287 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.607 HG23 ' O ' ' A' ' 72' ' ' ILE . 9.1 tt -56.72 109.22 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.848 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.8 HD22 HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -51.37 -42.72 61.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.72 -155.45 26.56 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.722 ' C ' HD12 ' A' ' 76' ' ' LEU . 10.8 ptt85 -138.21 137.37 37.5 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.098 -1.237 . . . . 0.0 109.945 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 76' ' ' LEU . 5.8 mp -106.16 -95.93 0.35 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.455 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.552 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 2.7 tpm_? -149.83 144.17 25.81 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.443 -0.786 . . . . 0.0 109.243 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.526 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 36.8 tt0 -157.88 145.81 18.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 109.515 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 80' ' ' ASN . . . 109.86 123.05 4.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' ' 79' ' ' GLY . 6.8 t-20 . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.247 -1.149 . . . . 0.0 109.537 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.47 ' C ' ' HB3' ' A' ' 78' ' ' GLU . 2.5 m . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -170.81 177.38 3.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.747 ' O ' HG12 ' A' ' 3' ' ' VAL . 2.4 t -69.67 87.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.039 -1.038 . . . . 0.0 108.807 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.08 103.71 3.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.904 HG23 HG21 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -104.25 140.1 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.089 -1.007 . . . . 0.0 110.59 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.849 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -149.54 -162.19 1.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.101 HG21 HG21 ' A' ' 67' ' ' VAL . 60.1 t -133.63 56.61 21.09 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.957 -1.09 . . . . 0.0 110.373 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -81.16 34.37 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.507 2.138 . . . . 0.0 110.83 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.717 ' OD2' HD12 ' A' ' 46' ' ' LEU . 16.8 m-20 -99.21 9.33 43.63 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 120.711 -1.243 . . . . 0.0 110.256 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.041 ' CD2' HG21 ' A' ' 41' ' ' THR . 1.0 OUTLIER -130.55 108.6 15.92 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.986 -1.071 . . . . 0.0 109.606 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 12' ' ' GLU . 35.4 Cg_endo -77.8 -85.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.41 2.073 . . . . 0.0 110.471 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 11' ' ' PRO . 6.2 mt-10 -44.56 160.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.49 131.42 36.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.905 . . . . 0.0 109.486 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.758 HG12 ' N ' ' A' ' 15' ' ' ALA . 46.4 t -124.34 -97.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.564 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.758 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -141.02 -68.59 0.4 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.905 ' OD1' HG23 ' A' ' 68' ' ' THR . 0.5 OUTLIER 164.15 -178.14 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.711 -0.618 . . . . 0.0 109.53 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.015 ' HB2' HG23 ' A' ' 41' ' ' THR . . . -140.92 -167.09 2.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.283 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.488 ' C ' HG13 ' A' ' 39' ' ' ILE . 45.2 m -160.13 121.99 3.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.229 -0.92 . . . . 0.0 110.137 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.0 HG12 ' OE1' ' A' ' 63' ' ' GLU . 2.1 t -50.59 147.47 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -126.25 -48.11 1.59 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.945 -1.097 . . . . 0.0 110.749 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.56 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 45.4 m -159.87 109.03 1.79 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.558 -1.339 . . . . 0.0 112.08 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.727 ' HA ' HG23 ' A' ' 37' ' ' VAL . 22.3 m95 -67.5 -163.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.66 ' HB2' HG23 ' A' ' 35' ' ' VAL . 64.6 m-70 -159.35 42.52 0.23 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.893 ' CB ' HD23 ' A' ' 56' ' ' LEU . 3.1 mmmt -132.19 124.08 28.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.594 -0.691 . . . . 0.0 110.707 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -70.56 -178.17 0.51 Allowed Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 27.9 Cg_endo -66.82 93.23 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.107 1.205 . . . . 0.0 111.143 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.651 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 68.53 47.85 54.36 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.729 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 17.4 m-20 -56.96 -112.61 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.056 -1.261 . . . . 0.0 110.039 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 161.96 99.66 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.758 -1.214 . . . . 0.0 109.151 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.089 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -100.58 175.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.084 -1.01 . . . . 0.0 110.359 -179.411 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.691 HG13 ' H ' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -134.07 -70.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.434 -0.791 . . . . 0.0 110.048 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.691 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -127.45 64.8 1.33 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.814 -1.179 . . . . 0.0 109.681 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 15.5 m-20 144.94 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.089 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -93.01 -176.7 4.26 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.426 1.108 . . . . 0.0 112.196 -177.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.862 HG12 ' CD ' ' A' ' 34' ' ' GLU . 7.4 p -39.35 159.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.136 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.636 HD23 ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -139.91 62.47 1.51 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.024 HG12 HG12 ' A' ' 48' ' ' VAL . 5.2 p -37.96 163.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.687 0.756 . . . . 0.0 110.139 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.795 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.1 mm-40 -122.57 100.06 6.73 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.216 -0.928 . . . . 0.0 108.857 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.789 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -84.82 -165.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.561 -0.712 . . . . 0.0 109.358 -179.295 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.789 ' N ' HG23 ' A' ' 39' ' ' ILE . 16.5 mm-40 -150.83 88.31 1.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.016 . . . . 0.0 110.074 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 1.041 HG21 ' CD2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -83.2 -179.92 7.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.296 -0.878 . . . . 0.0 109.31 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.588 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.6 t0 -80.12 99.96 8.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 4.7 ttpm? 84.98 -21.52 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.807 -0.558 . . . . 0.0 109.628 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.685 HG12 HD23 ' A' ' 46' ' ' LEU . 97.8 t -118.23 146.27 23.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.204 -0.935 . . . . 0.0 109.954 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -134.45 100.96 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.865 . . . . 0.0 109.09 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.717 HD12 ' OD2' ' A' ' 9' ' ' ASP . 3.4 mm? -94.97 -169.43 2.0 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.214 -0.929 . . . . 0.0 110.058 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.516 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 2.3 pt-20 -147.66 -156.07 0.68 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.557 -0.714 . . . . 0.0 109.278 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.024 HG12 HG12 ' A' ' 37' ' ' VAL . 7.8 p -157.62 79.9 3.34 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.868 -1.145 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.636 ' HB3' HD23 ' A' ' 36' ' ' LEU . 36.3 Cg_endo -80.31 104.09 1.6 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.416 2.077 . . . . 0.0 110.337 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.994 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -73.81 -175.1 1.99 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.722 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.4 p -130.83 23.37 4.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.455 -1.403 . . . . 0.0 110.218 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.55 161.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.557 -0.714 . . . . 0.0 109.203 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.677 ' O ' HG12 ' A' ' 30' ' ' VAL . 7.2 m-20 67.25 -137.76 0.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.497 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 101.88 -7.84 55.53 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.33 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.651 HG23 ' CA ' ' A' ' 27' ' ' GLY . 4.5 mt -47.63 96.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.025 -1.279 . . . . 0.0 107.673 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.893 HD23 ' CB ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -42.48 100.36 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.687 0.756 . . . . 0.0 109.574 -178.473 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.463 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 6.9 t0 -104.13 -53.33 2.76 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.966 -0.459 . . . . 0.0 109.871 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.99 103.66 3.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.682 -1.261 . . . . 0.0 110.979 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.46 88.12 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.305 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.796 HD21 ' HA2' ' A' ' 74' ' ' GLY . 0.4 OUTLIER -69.2 -7.1 33.41 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.127 -0.983 . . . . 0.0 110.172 -178.551 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.52 ' CB ' ' HA ' ' A' ' 73' ' ' LEU . 1.3 mm-40 -119.24 37.85 4.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.133 -0.979 . . . . 0.0 108.381 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.2 m-20 -40.25 135.23 1.47 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.678 -0.639 . . . . 0.0 110.106 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 1.0 ' OE1' HG12 ' A' ' 19' ' ' VAL . 67.1 mm-40 -22.93 141.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.54 0.686 . . . . 0.0 111.783 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.1 -11.27 67.63 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 62' ' ' ASP . 1.3 m -84.47 156.18 21.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -1.154 . . . . 0.0 109.583 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 m -77.73 158.28 29.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.913 . . . . 0.0 109.525 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.101 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.7 171.39 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.905 HG23 ' OD1' ' A' ' 16' ' ' ASP . 0.6 OUTLIER -139.66 -145.91 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.004 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.578 ' HA ' HD13 ' A' ' 10' ' ' LEU . 3.3 m -99.48 52.16 0.94 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.103 -0.998 . . . . 0.0 109.467 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER 161.01 -19.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.419 -0.801 . . . . 0.0 110.031 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.474 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 2.2 mm-40 -48.44 125.87 10.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.328 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 72' ' ' ILE . 5.3 tt -80.18 111.8 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.738 HD12 HG21 ' A' ' 5' ' ' ILE . 30.4 mt -47.02 -37.53 9.4 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.796 ' HA2' HD21 ' A' ' 60' ' ' LEU . . . 157.01 -158.53 28.92 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.857 ' C ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -137.69 145.16 42.26 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.203 -1.175 . . . . 0.0 110.0 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.857 HD23 ' C ' ' A' ' 75' ' ' ARG . 2.1 mt -106.48 -128.4 0.26 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.588 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -123.32 177.8 5.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.645 -1.284 . . . . 0.0 109.817 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 30.6 tt0 -169.67 133.75 1.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.353 -0.842 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 80' ' ' ASN . . . -92.95 -151.6 28.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 18.9 t30 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.26 -1.141 . . . . 0.0 109.475 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.432 ' C ' ' HB2' ' A' ' 78' ' ' GLU . 4.1 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.248 0.547 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.536 ' N ' ' HB2' ' A' ' 78' ' ' GLU . 0.5 OUTLIER -169.19 170.25 8.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.881 . . . . 0.0 109.43 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.042 HG12 HG23 ' A' ' 5' ' ' ILE . 28.9 t -81.5 73.44 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.036 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -83.2 68.12 9.47 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.56 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.042 HG23 HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -80.96 165.34 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.755 0.788 . . . . 0.0 112.579 -177.309 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.839 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -139.61 -164.48 1.69 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.613 ' CG2' HD13 ' A' ' 39' ' ' ILE . 45.4 t -136.55 66.88 58.6 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.948 . . . . 0.0 109.935 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 36.5 Cg_endo -80.38 38.84 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.715 2.276 . . . . 0.0 110.655 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.559 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -124.14 81.71 1.95 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.988 -1.07 . . . . 0.0 110.289 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' A' ' 69' ' ' SER . 20.7 mt -122.45 146.84 48.45 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 109.532 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.529 ' HG2' ' HB ' ' A' ' 14' ' ' VAL . 36.0 Cg_endo -78.64 -158.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.684 2.256 . . . . 0.0 110.432 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -112.05 -6.17 14.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 109.814 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.3 m -115.44 15.78 16.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.24 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 13' ' ' SER . 24.1 t -164.83 89.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.29 45.13 1.0 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 0.0 109.913 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.85 145.03 12.07 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.264 -0.897 . . . . 0.0 108.98 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -135.9 -166.07 1.81 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.721 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 90.0 m -151.61 131.24 13.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.307 -0.87 . . . . 0.0 110.525 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.808 ' CG2' HD11 ' A' ' 73' ' ' LEU . 2.1 t -70.15 85.35 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 109.089 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -47.33 -63.79 0.95 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.934 -1.104 . . . . 0.0 110.404 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.644 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 36.3 m -165.83 127.13 1.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.539 -1.351 . . . . 0.0 111.9 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 1.036 ' HA ' HG23 ' A' ' 37' ' ' VAL . 15.1 m95 -67.4 -163.08 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.598 ' HB2' HG23 ' A' ' 35' ' ' VAL . 52.5 m-70 -156.21 30.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.767 ' HG2' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -116.83 159.1 22.87 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.7 0.762 . . . . 0.0 110.264 -179.077 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.598 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -106.14 -176.98 0.45 Allowed Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.0 Cg_endo -68.6 111.04 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.179 1.252 . . . . 0.0 110.768 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.532 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 57.65 43.51 94.33 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 8.6 m-20 -57.9 -164.27 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.831 -1.393 . . . . 0.0 110.209 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.16 87.52 0.5 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 53' ' ' ASP . 0.6 OUTLIER -78.91 -177.27 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -0.826 . . . . 0.0 110.654 -178.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.678 ' H ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -123.28 -80.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.577 ' H ' HG23 ' A' ' 31' ' ' VAL . 11.8 mtt180 -123.77 40.3 3.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.108 -0.995 . . . . 0.0 108.681 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.829 ' O ' HG21 ' A' ' 30' ' ' VAL . 10.9 m-20 178.05 83.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.048 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -81.5 -170.58 2.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 111.375 -178.254 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.754 HG12 ' CD ' ' A' ' 34' ' ' GLU . 7.6 p -48.98 161.53 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 121.87 0.843 . . . . 0.0 111.431 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.685 HD23 ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -141.2 62.21 1.47 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.322 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.036 HG23 ' HA ' ' A' ' 22' ' ' TRP . 2.5 p -38.15 165.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.688 0.756 . . . . 0.0 110.619 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -127.39 131.69 50.27 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.842 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -117.35 -172.28 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.277 -0.89 . . . . 0.0 109.315 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.72 ' N ' HG23 ' A' ' 39' ' ' ILE . 2.3 mt-10 -133.4 123.98 26.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.001 -1.062 . . . . 0.0 110.206 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.625 ' OG1' HG13 ' A' ' 44' ' ' VAL . 4.6 p -119.63 -104.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.327 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 28.9 t0 -130.32 75.11 1.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.326 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 87.46 -22.75 0.14 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.473 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.625 HG13 ' OG1' ' A' ' 41' ' ' THR . 12.1 p -103.8 144.65 13.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.411 -0.806 . . . . 0.0 109.479 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 39' ' ' ILE . 2.3 t -120.14 105.63 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 109.702 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.566 ' N ' HD22 ' A' ' 46' ' ' LEU . 4.0 mm? -79.99 -179.38 6.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.291 -0.881 . . . . 0.0 109.049 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.2 pt-20 -150.65 -163.19 1.72 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.027 -1.046 . . . . 0.0 110.219 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.998 HG12 HG12 ' A' ' 37' ' ' VAL . 9.7 p -154.96 81.0 4.29 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.133 -0.979 . . . . 0.0 110.216 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.685 ' HB3' HD23 ' A' ' 36' ' ' LEU . 36.6 Cg_endo -80.79 113.49 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.587 2.192 . . . . 0.0 110.81 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.048 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -80.7 -168.01 1.59 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.731 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.3 p -133.37 16.34 4.07 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.361 -1.462 . . . . 0.0 110.806 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.63 160.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.513 -0.742 . . . . 0.0 109.16 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.896 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.2 t70 64.96 -140.09 0.23 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.326 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.548 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 112.23 -12.71 26.27 Favored Glycine 0 N--CA 1.489 2.209 0 O-C-N 120.508 -1.37 . . . . 0.0 109.851 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.549 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -34.82 97.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.744 -0.857 . . . . 0.0 109.59 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.767 HD23 ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -45.06 104.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -113.93 -47.18 2.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.532 -0.73 . . . . 0.0 110.195 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -142.36 77.59 1.58 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.785 -1.197 . . . . 0.0 111.106 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.622 ' CG2' HD13 ' A' ' 56' ' ' LEU . 56.0 t -81.79 86.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.6 mt -69.63 -0.94 7.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -0.783 . . . . 0.0 111.255 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 21.1 mt-10 -134.54 55.44 1.89 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.778 -1.201 . . . . 0.0 108.199 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 63' ' ' GLU . 6.5 m-20 -43.93 127.06 5.13 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.702 0.763 . . . . 0.0 109.746 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.644 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -35.7 127.14 0.66 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.469 0.652 . . . . 0.0 111.284 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.48 -9.78 13.03 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.605 HG22 ' N ' ' A' ' 66' ' ' THR . 86.5 m -94.46 167.84 11.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -1.148 . . . . 0.0 109.386 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.605 ' N ' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -81.62 158.93 24.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.683 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.571 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.31 171.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.862 HG22 ' HG3' ' A' ' 71' ' ' GLN . 5.3 t -134.14 -161.48 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 0.0 109.237 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.55 ' HB2' HD12 ' A' ' 10' ' ' LEU . 29.9 t -85.91 40.88 0.88 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.629 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 69' ' ' SER . 4.8 ttm180 168.11 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.572 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.862 ' HG3' HG22 ' A' ' 68' ' ' THR . 1.6 mm-40 -105.61 97.59 7.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.94 . . . . 0.0 109.233 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.1 tt -42.25 112.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.463 -0.773 . . . . 0.0 109.86 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.808 HD11 ' CG2' ' A' ' 19' ' ' VAL . 10.3 tp -57.71 -42.67 84.26 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . 165.47 158.1 10.39 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.864 -1.636 . . . . 0.0 110.442 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.689 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -102.17 139.32 37.94 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.513 -0.993 . . . . 0.0 108.913 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.896 HD23 ' OE2' ' A' ' 34' ' ' GLU . 2.9 mp -105.14 -105.5 0.31 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.376 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.549 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.8 tpt180 -152.65 153.59 33.61 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.988 -1.07 . . . . 0.0 109.461 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 2' ' ' SER . 3.7 tm-20 -149.95 45.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 109.426 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.26 164.55 38.93 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.214 -1.168 . . . . 0.0 109.43 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.406 ' C ' ' HB3' ' A' ' 78' ' ' GLU . 1.1 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 1.3 p -169.18 166.43 10.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.592 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.748 ' O ' HG12 ' A' ' 3' ' ' VAL . 16.5 t -79.75 76.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.417 ' CG ' ' HB3' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -80.61 77.46 7.43 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.228 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.791 HG12 HG13 ' A' ' 48' ' ' VAL . 5.2 tp -91.89 154.04 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.372 -0.83 . . . . 0.0 111.283 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.882 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -140.46 -157.93 0.81 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.608 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 67' ' ' VAL . 2.9 t -131.14 54.57 15.06 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 120.868 -1.145 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.708 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.6 Cg_endo -81.21 40.85 1.04 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.238 1.959 . . . . 0.0 110.008 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -104.33 -1.42 26.95 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.016 -1.052 . . . . 0.0 110.176 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.84 HD21 ' O ' ' A' ' 68' ' ' THR . 0.8 OUTLIER -120.12 93.34 47.89 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.081 -1.012 . . . . 0.0 109.781 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.39 -90.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.531 2.154 . . . . 0.0 110.131 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' SER . 39.5 mm-40 -60.09 175.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 109.002 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' GLU . 31.2 t 51.35 98.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.987 . . . . 0.0 109.227 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.616 ' O ' HG12 ' A' ' 14' ' ' VAL . 41.1 t -84.16 44.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.818 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.72 -17.23 64.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.239 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.637 ' OD1' HG23 ' A' ' 68' ' ' THR . 11.4 m-20 66.55 -161.28 0.25 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.428 -0.795 . . . . 0.0 109.252 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -163.56 -162.42 0.73 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.259 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.519 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 16.1 m -161.05 127.55 3.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.087 -1.008 . . . . 0.0 110.162 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.598 HG22 HD11 ' A' ' 39' ' ' ILE . 2.5 t -53.87 157.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 108.708 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -127.42 -58.63 1.25 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.418 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 22.2 m -162.08 119.43 2.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.981 -1.074 . . . . 0.0 110.903 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.966 ' HA ' HG23 ' A' ' 37' ' ' VAL . 25.0 m95 -68.7 -170.58 0.22 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.867 0.842 . . . . 0.0 109.189 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.551 ' HB2' HG23 ' A' ' 35' ' ' VAL . 29.4 m-70 -152.81 38.77 0.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.871 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -130.97 115.98 17.23 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.541 -178.167 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.582 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -65.41 177.32 0.69 Allowed Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.17 93.54 0.4 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.793 1.662 . . . . 0.0 111.464 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.864 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 80.15 47.91 6.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 4.0 m-20 -58.58 -134.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.285 -1.127 . . . . 0.0 110.394 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 170.54 95.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.913 -1.117 . . . . 0.0 108.929 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.795 HG12 ' OE2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -103.25 -170.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.083 -1.01 . . . . 0.0 109.424 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.777 ' N ' HG13 ' A' ' 30' ' ' VAL . 4.2 m -134.18 -112.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 108.903 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 8.2 mmt-85 -87.08 64.68 8.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.758 -1.214 . . . . 0.0 108.721 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.4 m-20 150.73 102.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.091 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -101.52 -167.66 1.45 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.075 -1.016 . . . . 0.0 111.928 -178.236 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.627 HG22 ' N ' ' A' ' 36' ' ' LEU . 3.7 p -53.88 166.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.105 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.627 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -144.92 65.23 1.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 178.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.105 HG11 ' CD1' ' A' ' 73' ' ' LEU . 6.2 p -40.36 170.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.665 0.745 . . . . 0.0 110.117 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.759 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 21.5 mt-10 -123.56 107.92 12.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.003 -1.061 . . . . 0.0 108.903 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.775 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -91.71 -162.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 121.421 -0.799 . . . . 0.0 109.159 -179.339 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.775 ' N ' HG23 ' A' ' 39' ' ' ILE . 39.4 mt-10 -153.06 102.18 2.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 110.105 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.581 HG22 ' N ' ' A' ' 42' ' ' ASP . 88.2 m -97.81 -112.2 0.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.271 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.581 ' N ' HG22 ' A' ' 41' ' ' THR . 8.1 t70 -126.56 87.73 2.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.918 -1.114 . . . . 0.0 109.391 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.3 tptp 85.2 -28.5 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.25 145.79 23.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.232 -0.917 . . . . 0.0 109.231 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 39' ' ' ILE . 1.8 p -123.39 122.44 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.486 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.65 170.91 15.86 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.173 -0.954 . . . . 0.0 108.864 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -122.16 179.66 4.47 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.106 -0.996 . . . . 0.0 110.406 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.9 HG21 HD12 ' A' ' 73' ' ' LEU . 3.2 t -130.83 73.18 81.38 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.491 -0.756 . . . . 0.0 109.013 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.2 Cg_endo -80.6 104.0 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.585 2.19 . . . . 0.0 111.527 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.091 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -79.1 -156.87 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.756 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.1 p -144.33 13.31 1.59 Allowed 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.695 -1.253 . . . . 0.0 110.733 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 158.93 155.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.393 -0.817 . . . . 0.0 110.216 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER 75.34 -81.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.501 -0.749 . . . . 0.0 110.659 179.293 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.529 ' N ' ' OE2' ' A' ' 34' ' ' GLU . . . 55.34 6.52 1.0 Allowed Glycine 0 N--CA 1.494 2.539 0 O-C-N 121.111 -0.993 . . . . 0.0 111.434 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.864 HG23 ' HA2' ' A' ' 27' ' ' GLY . 3.3 mt -54.97 98.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.643 -1.504 . . . . 0.0 108.061 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 24' ' ' LYS . 9.5 tp -51.21 90.14 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.536 -0.728 . . . . 0.0 109.328 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.5 t0 -99.11 -40.62 7.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.608 -0.683 . . . . 0.0 110.049 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.646 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -142.64 107.55 4.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.804 -1.185 . . . . 0.0 111.0 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.626 HG12 ' OD1' ' A' ' 62' ' ' ASP . 2.0 t -118.91 107.26 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mt -98.43 -31.9 11.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.025 . . . . 0.0 110.014 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.534 ' O ' HG21 ' A' ' 19' ' ' VAL . 3.0 mt-10 -98.61 35.44 1.82 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.626 ' OD1' HG12 ' A' ' 59' ' ' VAL . 2.2 m-20 -43.67 157.16 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.605 -0.684 . . . . 0.0 110.162 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -38.85 140.39 0.37 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.353 0.597 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.28 -19.86 47.02 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -86.18 161.51 18.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -82.74 163.27 21.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.571 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.51 169.2 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.419 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.84 ' O ' HD21 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -145.71 -147.75 0.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.57 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.53 ' HB3' ' CD1' ' A' ' 10' ' ' LEU . 13.3 p -89.83 33.29 0.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.354 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER 171.82 26.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.528 -0.733 . . . . 0.0 110.268 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 13.7 mm100 -87.51 121.47 29.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.666 -1.271 . . . . 0.0 109.183 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 4.0 tt -69.2 111.36 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.609 -0.682 . . . . 0.0 110.581 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.105 ' CD1' HG11 ' A' ' 37' ' ' VAL . 3.8 mt -55.43 -36.25 66.31 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.438 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 154.82 164.31 12.84 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.799 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -111.96 140.68 46.42 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.37 -1.076 . . . . 0.0 108.997 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 76' ' ' LEU . 3.9 mp -116.2 -133.87 0.34 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.582 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -113.07 166.19 11.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.659 -1.276 . . . . 0.0 109.118 179.58 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.52 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 1.1 tm-20 -170.77 43.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.92 . . . . 0.0 109.404 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 50.26 -168.71 0.29 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.27 -1.135 . . . . 0.0 109.609 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.529 ' CA ' ' HG3' ' A' ' 78' ' ' GLU . 66.2 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.531 ' N ' ' HB2' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -69.64 -169.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.722 HG21 ' HA2' ' A' ' 54' ' ' GLY . 8.6 t -69.81 90.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.182 -0.949 . . . . 0.0 109.246 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.97 78.74 5.4 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.898 ' CG1' HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -93.64 137.85 21.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.405 -0.809 . . . . 0.0 111.239 -176.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -136.02 -164.27 1.53 Allowed 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.779 HG23 HD21 ' A' ' 73' ' ' LEU . 54.6 t -132.32 66.44 77.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.995 -1.066 . . . . 0.0 109.325 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' SER . 36.5 Cg_endo -80.24 41.61 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.733 2.289 . . . . 0.0 110.589 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.917 ' CB ' HD13 ' A' ' 46' ' ' LEU . 2.4 m-20 -92.55 47.99 1.35 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.035 -1.041 . . . . 0.0 110.113 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.724 HD22 ' CB ' ' A' ' 69' ' ' SER . 3.2 mm? -26.37 97.77 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 122.11 -0.369 . . . . 0.0 111.199 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' CG ' ' HB ' ' A' ' 14' ' ' VAL . 35.7 Cg_endo -77.95 -176.73 3.4 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.613 2.209 . . . . 0.0 110.548 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -5.08 18.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 109.609 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -165.22 58.95 0.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 109.346 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.676 HG21 HG22 ' A' ' 41' ' ' THR . 99.4 t -159.52 84.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.308 -0.87 . . . . 0.0 109.098 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.06 -18.74 2.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.834 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 2.6 p-10 -163.11 147.59 11.25 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.712 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -108.71 -160.48 0.72 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.397 -0.814 . . . . 0.0 108.825 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.465 ' C ' HG13 ' A' ' 39' ' ' ILE . 12.5 m -150.42 117.18 5.84 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.103 -0.998 . . . . 0.0 110.165 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.019 HG12 ' OE1' ' A' ' 63' ' ' GLU . 2.1 t -50.77 151.27 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.53 ' N ' ' OE1' ' A' ' 63' ' ' GLU . . . -134.67 -43.0 0.75 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.105 -0.997 . . . . 0.0 110.924 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.577 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -164.03 108.91 1.01 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.106 -1.438 . . . . 0.0 112.578 -179.152 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.954 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.4 m95 -67.84 -165.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.732 ' HB2' HG23 ' A' ' 35' ' ' VAL . 48.5 m80 -149.97 28.57 0.75 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.582 ' CD ' ' HB ' ' A' ' 35' ' ' VAL . 12.3 mmmm -123.57 146.59 48.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.641 -0.662 . . . . 0.0 110.393 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.659 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -97.73 -170.6 0.22 Allowed Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.243 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.1 Cg_endo -68.6 84.06 0.5 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 120.839 1.026 . . . . 0.0 111.321 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.754 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 78.15 48.48 7.56 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.746 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.4 m-20 -56.48 -114.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.113 -1.228 . . . . 0.0 110.363 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 158.18 100.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.848 -1.158 . . . . 0.0 108.27 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -102.64 -175.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.838 -1.164 . . . . 0.0 110.292 -178.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -129.29 -98.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 109.899 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.457 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -100.74 38.53 1.51 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.974 -1.078 . . . . 0.0 109.826 -179.588 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.716 ' O ' HG21 ' A' ' 30' ' ' VAL . 4.0 m-20 -178.01 89.42 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.059 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 9.6 tp10 -87.7 168.35 13.06 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.281 1.039 . . . . 0.0 111.647 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.935 HG12 ' HG3' ' A' ' 34' ' ' GLU . 4.6 p -33.08 157.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 122.128 0.966 . . . . 0.0 112.471 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.33 62.1 1.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.954 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.3 p -38.01 166.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.773 0.797 . . . . 0.0 110.385 -177.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -118.7 150.74 39.24 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.979 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -138.34 -171.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.369 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.729 ' N ' HG23 ' A' ' 39' ' ' ILE . 19.7 mt-10 -126.86 119.92 27.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.039 -1.038 . . . . 0.0 109.892 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.676 HG22 HG21 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -120.2 -143.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.429 -0.795 . . . . 0.0 109.128 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 65.1 t0 -90.62 72.14 6.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 109.607 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.4 tttt 87.21 -23.32 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 45' ' ' VAL . 72.8 t -100.63 160.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.38 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.979 HG13 ' O ' ' A' ' 39' ' ' ILE . 36.2 t -127.73 106.24 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.324 -0.86 . . . . 0.0 109.738 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.917 HD13 ' CB ' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -79.44 166.3 22.15 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.22 -0.925 . . . . 0.0 108.92 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -126.99 -163.75 1.28 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.091 -1.006 . . . . 0.0 110.258 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.898 HG22 ' CG1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -152.79 91.52 3.47 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.679 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.5 Cg_endo -83.5 123.57 3.4 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.759 2.306 . . . . 0.0 111.894 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.059 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -97.6 173.54 7.09 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.727 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 19.8 p -120.14 75.3 1.09 Allowed 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.205 -1.398 . . . . 0.0 110.315 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 90.65 164.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.5 0.667 . . . . 0.0 110.105 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.2 m-20 67.65 -100.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.713 -0.617 . . . . 0.0 110.618 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.722 ' HA2' HG21 ' A' ' 3' ' ' VAL . . . 54.79 5.58 0.59 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 120.911 -1.118 . . . . 0.0 111.543 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.754 HG23 ' CA ' ' A' ' 27' ' ' GLY . 7.2 mt -47.41 98.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.47 -1.606 . . . . 0.0 108.021 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.886 HD12 ' HG ' ' A' ' 76' ' ' LEU . 5.2 tp -43.88 108.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.618 0.723 . . . . 0.0 110.287 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 2.5 t0 -131.91 -35.15 1.26 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.618 -0.676 . . . . 0.0 110.031 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.805 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -135.61 62.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.68 -1.262 . . . . 0.0 111.014 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.595 ' CG2' HD11 ' A' ' 56' ' ' LEU . 26.2 t -79.7 83.33 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.759 -1.213 . . . . 0.0 108.467 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 mt -73.56 -6.66 47.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.277 -0.889 . . . . 0.0 110.741 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 4.1 mt-10 -124.15 47.88 2.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.876 -1.14 . . . . 0.0 108.371 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -48.73 139.01 10.24 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.628 -0.67 . . . . 0.0 109.966 -179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 1.019 ' OE1' HG12 ' A' ' 19' ' ' VAL . 69.7 mm-40 -26.86 145.57 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.436 0.636 . . . . 0.0 111.414 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.11 -12.78 67.95 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.3 m -90.12 154.18 19.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -1.178 . . . . 0.0 109.661 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.15 161.31 28.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.597 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.63 174.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.02 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.89 HG22 ' CG ' ' A' ' 71' ' ' GLN . 3.6 t -135.09 -166.35 1.82 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.069 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.724 ' CB ' HD22 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -90.62 36.29 0.89 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.196 -0.94 . . . . 0.0 108.886 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.533 ' N ' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER 172.0 33.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.493 -0.754 . . . . 0.0 109.452 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.89 ' CG ' HG22 ' A' ' 68' ' ' THR . 5.1 mm-40 -107.02 145.57 32.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 109.182 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.5 tt -86.77 112.25 22.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.982 -1.074 . . . . 0.0 110.346 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.779 HD21 HG23 ' A' ' 7' ' ' VAL . 16.6 mt -54.04 -24.3 16.64 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 141.11 -168.31 25.4 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.805 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 9.5 ptt85 -127.64 146.78 50.44 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.283 -1.128 . . . . 0.0 109.443 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.886 ' HG ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -99.31 -92.77 0.27 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.361 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.551 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -144.84 157.98 43.96 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.279 -0.888 . . . . 0.0 109.972 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.531 ' HB2' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -110.63 156.92 20.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 109.374 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.48 ' N ' ' OE1' ' A' ' 78' ' ' GLU . . . -156.41 107.97 0.34 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.5 p30 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 0.0 109.492 179.978 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.491 ' CA ' ' HB3' ' A' ' 78' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.294 0.569 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.563 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 1.0 OUTLIER -149.41 159.19 44.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.484 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.738 ' O ' HG12 ' A' ' 3' ' ' VAL . 18.8 t -75.26 79.48 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 108.5 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.36 83.91 1.94 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.076 ' CG1' HG22 ' A' ' 48' ' ' VAL . 3.6 tp -104.45 147.5 10.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.849 -177.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.833 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -139.06 -158.83 0.89 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.505 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.88 HG21 HD13 ' A' ' 39' ' ' ILE . 41.6 t -129.02 65.37 73.73 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.947 -1.096 . . . . 0.0 109.6 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HG3' HD13 ' A' ' 6' ' ' LEU . 36.5 Cg_endo -79.72 61.79 8.3 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.805 2.337 . . . . 0.0 110.387 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.566 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -114.27 -19.9 11.09 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.014 -1.054 . . . . 0.0 109.732 -179.777 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 9' ' ' ASP . 0.8 OUTLIER 31.93 97.34 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 122.194 -0.316 . . . . 0.0 110.988 179.021 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.703 ' HG3' HG21 ' A' ' 41' ' ' THR . 34.5 Cg_endo -77.07 -167.25 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.483 2.122 . . . . 0.0 110.422 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.41 13.09 7.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -147.69 169.15 20.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.952 . . . . 0.0 109.496 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 14' ' ' VAL . 3.6 p -125.69 56.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.537 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 16' ' ' ASP . . . -95.3 14.91 20.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.946 . . . . 0.0 109.046 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 76.65 -154.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.344 -0.847 . . . . 0.0 109.533 179.901 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.663 ' HB3' HG22 ' A' ' 67' ' ' VAL . . . -170.61 -170.6 0.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.866 . . . . 0.0 109.308 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 17.5 m -152.88 137.16 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.913 ' CG2' HD11 ' A' ' 73' ' ' LEU . 2.2 t -72.94 84.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.41 -0.807 . . . . 0.0 109.252 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -46.61 -63.52 0.99 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.059 -1.025 . . . . 0.0 110.537 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.903 HG23 ' OE1' ' A' ' 63' ' ' GLU . 96.8 m -165.44 124.94 1.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.589 -1.319 . . . . 0.0 111.781 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 1.072 ' HA ' HG23 ' A' ' 37' ' ' VAL . 15.7 m95 -67.75 -168.48 0.09 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.564 ' HB2' HG23 ' A' ' 35' ' ' VAL . 30.1 m-70 -153.3 24.15 0.54 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.777 ' HB3' HD13 ' A' ' 56' ' ' LEU . 6.1 tppt? -115.4 120.21 38.82 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.382 0.61 . . . . 0.0 109.593 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -67.1 175.61 1.43 Allowed Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.443 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 30.6 Cg_endo -71.31 94.66 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.073 1.849 . . . . 0.0 111.057 -178.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.646 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 85.33 37.42 9.81 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.58 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 8.9 m-20 -63.13 -162.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.784 -1.421 . . . . 0.0 109.61 178.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -162.85 79.36 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.92 -1.112 . . . . 0.0 110.069 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.783 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -78.9 -173.55 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 0.0 109.541 179.797 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.837 HG22 ' N ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -134.07 -86.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 0.0 109.36 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.837 ' N ' HG22 ' A' ' 31' ' ' VAL . 2.6 tpt180 -107.88 61.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.939 -1.101 . . . . 0.0 109.725 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.568 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.3 m-20 147.81 91.02 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.005 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -88.68 -166.91 1.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 111.336 -178.7 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.761 HG12 ' CD ' ' A' ' 34' ' ' GLU . 2.5 p -49.63 164.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.805 0.812 . . . . 0.0 111.311 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.594 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -140.17 63.64 1.47 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.603 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.072 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.3 p -38.59 166.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.701 0.762 . . . . 0.0 110.398 -177.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.647 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.4 mt-10 -128.05 112.63 14.83 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.263 -0.898 . . . . 0.0 108.729 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.88 HD13 HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -96.05 -167.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.498 -0.751 . . . . 0.0 109.03 -179.341 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.773 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.5 mt-10 -135.46 136.72 41.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 0.0 110.065 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.703 HG21 ' HG3' ' A' ' 11' ' ' PRO . 2.1 m -135.81 -136.32 0.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.6 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 23.5 t0 -96.0 74.21 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.907 -1.121 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.7 tmtt? 86.74 -23.3 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.788 -0.57 . . . . 0.0 109.543 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 45' ' ' VAL . 2.3 p -105.11 164.36 4.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.82 HG13 ' O ' ' A' ' 39' ' ' ILE . 44.5 t -144.39 112.77 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.373 -0.829 . . . . 0.0 109.454 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.866 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.82 168.54 19.15 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.136 -0.977 . . . . 0.0 108.869 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' OE1' ' O ' ' A' ' 36' ' ' LEU . 3.0 mm-40 -116.79 -171.4 2.01 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.927 -1.108 . . . . 0.0 110.639 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.076 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -147.55 77.32 10.54 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-O 122.409 1.099 . . . . 0.0 108.622 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.0 Cg_endo -81.62 113.02 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.781 2.321 . . . . 0.0 112.14 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.005 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -80.17 -160.18 0.27 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 177.472 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.725 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -139.62 11.92 2.51 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.497 -1.377 . . . . 0.0 110.891 -179.53 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.725 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.19 169.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.318 -0.864 . . . . 0.0 109.995 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER 67.85 -87.87 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.426 -0.796 . . . . 0.0 109.323 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 65.55 -13.57 0.28 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.219 -0.926 . . . . 0.0 112.15 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.646 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -42.83 96.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 119.124 1.462 . . . . 0.0 108.181 179.475 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.008 HD12 ' CD2' ' A' ' 76' ' ' LEU . 7.8 tp -54.11 97.12 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.47 -0.769 . . . . 0.0 109.64 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.401 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 17.7 t70 -109.0 -39.9 5.16 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.796 -0.565 . . . . 0.0 110.002 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -139.0 90.4 2.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.69 -1.256 . . . . 0.0 110.877 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.843 HG21 HD21 ' A' ' 56' ' ' LEU . 6.6 t -94.71 91.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 60' ' ' LEU . 27.7 mt -70.08 -1.76 10.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 110.887 -178.533 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 5.7 mt-10 -137.41 55.26 1.81 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.024 -1.048 . . . . 0.0 108.449 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 63' ' ' GLU . 24.0 m-20 -43.79 126.01 4.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.526 -0.733 . . . . 0.0 109.452 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.903 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -33.94 122.5 0.46 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.626 0.727 . . . . 0.0 111.435 -179.236 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.49 -6.03 12.87 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.6 -172.75 3.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -1.132 . . . . 0.0 109.317 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -93.84 153.13 18.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.835 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.663 HG22 ' HB3' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -150.35 171.4 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.378 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.87 HG22 ' CG ' ' A' ' 71' ' ' GLN . 13.7 t -148.04 -137.65 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 108.83 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.724 ' N ' HG23 ' A' ' 68' ' ' THR . 6.2 p -69.2 -110.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.691 -1.256 . . . . 0.0 108.021 179.326 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.519 ' CG ' ' HB3' ' A' ' 8' ' ' PRO . 3.4 mtm180 -71.3 79.4 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 109.419 179.141 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.87 ' CG ' HG22 ' A' ' 68' ' ' THR . 2.7 mm-40 -115.63 96.28 5.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.121 -0.987 . . . . 0.0 108.451 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 72' ' ' ILE . 4.0 tt -42.26 109.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.341 -0.85 . . . . 0.0 110.194 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.953 HD22 HG11 ' A' ' 37' ' ' VAL . 10.7 tp -62.23 -27.86 69.29 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 59' ' ' VAL . . . 154.46 154.82 7.0 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.126 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.812 ' C ' HD12 ' A' ' 76' ' ' LEU . 5.2 ptt180 -104.41 136.84 43.23 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.429 -1.042 . . . . 0.0 109.489 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.008 ' CD2' HD12 ' A' ' 56' ' ' LEU . 4.0 mp -112.86 -103.87 0.4 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.478 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.563 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -138.06 164.45 29.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 109.391 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.52 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 1.9 tt0 -141.86 146.95 36.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.528 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 53' ' ' ASP . . . -48.59 -92.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.19 -1.182 . . . . 0.0 109.49 179.978 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.438 ' HB3' ' HG3' ' A' ' 78' ' ' GLU . 1.2 t . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.195 0.521 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.57 ' CB ' ' HB2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -86.29 160.63 19.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.59 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.722 ' O ' HG12 ' A' ' 3' ' ' VAL . 24.9 t -80.93 75.96 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.395 -0.815 . . . . 0.0 109.189 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -81.51 94.17 6.81 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.781 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.813 HG12 HG13 ' A' ' 48' ' ' VAL . 5.7 tp -106.57 159.3 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.344 -177.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.841 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -141.35 -161.03 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.367 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 67' ' ' VAL . 48.2 t -130.75 50.07 5.57 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.754 -1.216 . . . . 0.0 111.501 -179.183 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.714 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.9 Cg_endo -82.63 39.91 0.9 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.072 1.848 . . . . 0.0 109.757 178.793 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.936 ' HB2' HD13 ' A' ' 46' ' ' LEU . 4.2 m-20 -115.13 -17.04 11.51 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.125 -0.984 . . . . 0.0 111.186 -178.397 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.89 HD11 ' CB ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -42.58 102.82 0.28 Allowed Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.268 -0.895 . . . . 0.0 109.727 -179.309 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 9' ' ' ASP . 36.2 Cg_endo -78.82 80.3 3.11 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.463 2.109 . . . . 0.0 110.42 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 23.0 tt0 58.27 61.41 2.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.177 -0.952 . . . . 0.0 109.528 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.494 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 8.6 m -90.21 -148.29 0.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.723 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 76.7 t -81.82 -28.42 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.191 -0.943 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 14' ' ' VAL . . . 159.79 -21.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.488 0.661 . . . . 0.0 109.43 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 2.8 p30 -158.32 -164.37 1.47 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.469 -0.769 . . . . 0.0 109.445 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.829 ' HB2' HG22 ' A' ' 41' ' ' THR . . . -146.47 -155.19 0.6 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.154 -0.966 . . . . 0.0 109.619 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.546 ' N ' HG13 ' A' ' 67' ' ' VAL . 92.5 m -160.23 130.35 5.36 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.33 -0.856 . . . . 0.0 110.068 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.739 ' CG2' HD11 ' A' ' 73' ' ' LEU . 4.2 t -68.05 111.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.335 -0.853 . . . . 0.0 109.031 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -76.61 -57.53 3.8 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.144 -0.973 . . . . 0.0 109.901 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.58 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 17.9 m -170.75 126.83 0.74 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.682 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 1.049 ' HA ' HG23 ' A' ' 37' ' ' VAL . 14.8 m95 -68.84 -168.56 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 108.819 177.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.579 ' HB2' HG23 ' A' ' 35' ' ' VAL . 31.6 m-70 -151.22 39.05 0.66 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.628 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.779 ' HB3' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -130.86 138.81 50.0 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.673 0.749 . . . . 0.0 110.867 -178.509 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.596 ' CB ' ' OD1' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -88.79 179.41 1.63 Allowed Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.039 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.8 Cg_endo -66.03 105.31 0.81 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.561 1.508 . . . . 0.0 112.284 -178.044 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.625 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 60.35 48.0 88.33 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.115 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.728 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 3.6 m-20 -59.52 -119.44 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.046 -1.267 . . . . 0.0 110.363 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 159.67 99.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.056 -1.027 . . . . 0.0 109.035 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -103.41 -178.99 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 109.62 -179.546 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.698 ' N ' HG13 ' A' ' 30' ' ' VAL . 3.2 m -127.48 -110.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 14.3 mtp180 -90.2 66.68 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.778 -1.201 . . . . 0.0 108.785 179.295 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 15.0 m-20 150.59 103.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -179.17 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.997 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -108.17 -171.46 1.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.391 1.091 . . . . 0.0 111.959 -178.21 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.763 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 9.0 p -45.8 169.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.145 0.974 . . . . 0.0 111.389 -179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.596 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -149.71 59.14 1.0 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.049 HG23 ' HA ' ' A' ' 22' ' ' TRP . 2.7 p -39.3 165.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.807 0.813 . . . . 0.0 110.192 -178.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.845 ' OE1' HG11 ' A' ' 45' ' ' VAL . 1.6 mm-40 -123.48 146.53 47.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.739 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -134.5 -173.72 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.272 -179.262 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.715 ' N ' HG23 ' A' ' 39' ' ' ILE . 8.9 mt-10 -146.73 95.91 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.672 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.829 HG22 ' HB2' ' A' ' 17' ' ' ALA . 27.0 p -86.94 -48.8 7.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 109.725 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 55.1 t0 176.7 77.6 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.636 -0.665 . . . . 0.0 109.295 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER 87.28 -26.47 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.419 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.46 154.98 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.337 -0.852 . . . . 0.0 109.34 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.845 HG11 ' OE1' ' A' ' 38' ' ' GLU . 57.8 t -125.27 114.92 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -0.974 . . . . 0.0 109.822 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.936 HD13 ' HB2' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -79.67 159.3 26.75 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.299 -0.875 . . . . 0.0 108.755 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.53 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -121.96 -178.6 3.89 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.035 -1.041 . . . . 0.0 110.502 -179.298 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.828 ' O ' HG12 ' A' ' 48' ' ' VAL . 11.4 t -142.91 68.26 18.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.4 Cg_endo -80.31 106.41 1.88 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.679 2.253 . . . . 0.0 110.886 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.997 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -89.38 -161.73 0.8 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.757 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.2 p -142.95 17.21 1.95 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.748 -1.22 . . . . 0.0 110.888 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.35 163.3 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.115 -0.991 . . . . 0.0 110.668 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER 78.26 -77.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.646 179.64 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.504 ' O ' ' HD3' ' A' ' 24' ' ' LYS . . . 40.34 22.4 0.04 OUTLIER Glycine 0 N--CA 1.489 2.216 0 O-C-N 121.442 -0.786 . . . . 0.0 111.634 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.625 HG23 ' CA ' ' A' ' 27' ' ' GLY . 2.9 mt -83.61 94.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.549 -1.559 . . . . 0.0 107.329 178.256 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.126 HD12 ' CD1' ' A' ' 76' ' ' LEU . 2.1 tp -43.73 115.99 0.89 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.579 -0.701 . . . . 0.0 110.179 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 1.2 t0 -132.11 -42.73 0.98 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.491 -0.755 . . . . 0.0 109.895 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.944 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -132.82 76.65 1.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.785 -1.197 . . . . 0.0 110.873 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.557 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 60.6 t -93.33 81.52 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.406 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.775 HD11 HG23 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -69.04 -27.92 66.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.397 -0.814 . . . . 0.0 110.658 -178.423 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.535 ' CG ' HD12 ' A' ' 60' ' ' LEU . 7.7 mt-10 -106.73 47.79 0.86 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -39.14 139.31 0.51 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.597 0.713 . . . . 0.0 109.712 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.58 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -37.87 135.72 0.63 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.626 0.727 . . . . 0.0 110.999 -179.249 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.41 -6.37 36.17 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -95.72 158.38 15.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.244 . . . . 0.0 109.701 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.65 162.02 28.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.257 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.41 174.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.359 -0.838 . . . . 0.0 109.004 -178.802 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.689 HG23 ' N ' ' A' ' 69' ' ' SER . 4.8 t -150.26 -152.86 0.46 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 108.975 179.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.89 ' CB ' HD11 ' A' ' 10' ' ' LEU . 12.5 p -89.48 54.96 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.064 -1.022 . . . . 0.0 109.558 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' A' ' 69' ' ' SER . 3.5 mtp85 159.36 -12.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.565 -0.709 . . . . 0.0 110.654 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.633 ' CG ' HG22 ' A' ' 68' ' ' THR . 1.5 mt-30 -54.2 102.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.943 -1.098 . . . . 0.0 109.641 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.775 HG23 HD11 ' A' ' 60' ' ' LEU . 3.1 tt -54.94 111.5 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.039 HD22 HG11 ' A' ' 37' ' ' VAL . 8.4 tp -54.32 -29.89 49.38 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.502 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 144.69 153.34 5.84 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.944 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -93.99 145.39 24.68 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.515 -0.991 . . . . 0.0 108.332 179.181 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.126 ' CD1' HD12 ' A' ' 56' ' ' LEU . 3.4 mm? -85.45 -111.7 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.73 -178.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.548 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 3.4 ttp85 -116.8 157.42 25.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.732 -1.23 . . . . 0.0 110.479 -179.227 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.57 ' HB2' ' CB ' ' A' ' 2' ' ' SER . 22.6 tt0 -178.61 138.24 0.16 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.165 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.85 -157.61 22.48 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.247 -1.149 . . . . 0.0 109.418 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -167.71 -179.04 4.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 62.3 t -81.56 70.55 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 108.798 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -74.07 84.04 1.79 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.407 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.822 HG12 HG13 ' A' ' 48' ' ' VAL . 8.0 tp -99.73 163.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 111.297 -177.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.859 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -147.31 -159.86 1.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.313 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.815 HG21 ' CG2' ' A' ' 67' ' ' VAL . 2.1 t -133.15 56.11 20.09 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.121 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -80.58 35.94 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.5 2.134 . . . . 0.0 110.824 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.568 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.1 m-20 -102.95 -2.68 27.28 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.801 -1.187 . . . . 0.0 109.966 -179.565 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.506 HD11 ' C ' ' A' ' 68' ' ' THR . 0.7 OUTLIER -128.19 66.54 72.89 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.925 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 9' ' ' ASP . 35.7 Cg_endo -77.55 -58.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.583 2.189 . . . . 0.0 110.373 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' PRO . 7.0 mm-40 -43.94 154.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.357 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.49 ' C ' HG23 ' A' ' 14' ' ' VAL . 1.6 p 44.5 -155.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.293 -0.879 . . . . 0.0 109.232 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 13' ' ' SER . 15.9 t -157.03 58.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.509 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.75 -11.21 58.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.146 -0.971 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 0.6 OUTLIER 60.89 -153.16 0.38 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.33 -0.856 . . . . 0.0 108.796 -179.85 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -170.15 -159.76 0.21 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.036 -1.04 . . . . 0.0 109.844 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.485 ' N ' HG13 ' A' ' 67' ' ' VAL . 46.8 m -155.55 124.15 5.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 110.54 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.938 HG22 HD11 ' A' ' 39' ' ' ILE . 17.0 t -65.52 107.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.23 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -73.8 -59.62 2.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.614 -179.314 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.586 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.6 m -168.69 128.52 1.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.628 -1.295 . . . . 0.0 111.775 -179.086 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.995 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.6 m95 -69.2 -166.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.661 0.743 . . . . 0.0 109.24 178.346 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.1 m80 -152.7 26.47 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.549 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.6 tppt? -119.36 137.91 53.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.69 -0.631 . . . . 0.0 110.132 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.599 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.28 179.29 1.71 Allowed Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.676 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -69.64 104.91 1.37 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.664 1.576 . . . . 0.0 111.62 -178.267 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 75.03 39.52 37.49 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 4.8 m-20 -59.45 -166.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.718 -1.46 . . . . 0.0 109.597 178.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.17 78.56 0.45 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.08 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.698 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -79.55 169.26 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.009 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -110.06 -95.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 1.6 mtm180 -107.2 51.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.961 -1.087 . . . . 0.0 109.63 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.698 ' O ' HG21 ' A' ' 30' ' ' VAL . 4.2 m-20 173.04 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.949 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 10.3 tp10 -102.29 163.62 12.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.058 -1.026 . . . . 0.0 111.008 -178.235 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.598 HG12 ' HG3' ' A' ' 34' ' ' GLU . 2.5 p -30.36 160.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.57 1.176 . . . . 0.0 112.581 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.533 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.12 67.63 1.37 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.087 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.995 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.1 p -38.59 165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.102 -177.394 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.27 145.71 46.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.938 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -134.77 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.334 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.722 ' N ' HG23 ' A' ' 39' ' ' ILE . 13.1 mt-10 -149.35 138.51 21.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.923 -1.11 . . . . 0.0 109.708 -179.262 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 5.9 t -132.72 26.22 4.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 41' ' ' THR . 2.2 t70 87.34 15.31 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.341 0.591 . . . . 0.0 110.459 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 160.52 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 1.1 t -103.99 148.57 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.613 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 39' ' ' ILE . 51.2 t -136.93 96.76 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.685 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.769 ' N ' HD22 ' A' ' 46' ' ' LEU . 2.9 mm? -79.88 -176.0 5.21 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.309 -0.869 . . . . 0.0 108.728 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 1.3 pt-20 -142.39 -161.36 1.23 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.718 -1.239 . . . . 0.0 111.463 -178.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.822 HG13 HG12 ' A' ' 5' ' ' ILE . 6.0 t -143.47 75.5 16.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.7 Cg_endo -80.73 110.82 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.487 2.125 . . . . 0.0 110.931 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.949 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -91.79 -169.38 2.26 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.137 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.1 p -132.36 14.68 4.57 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.265 -1.522 . . . . 0.0 111.183 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.62 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 109.951 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER 60.63 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 179.816 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.548 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 64.95 -13.65 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 O-C-N 121.324 -0.86 . . . . 0.0 112.093 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.651 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.81 96.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.674 -1.486 . . . . 0.0 108.551 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.925 HD12 ' HG ' ' A' ' 76' ' ' LEU . 7.8 tp -49.87 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ILE . 46.6 t0 -98.6 -41.59 7.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.97 -0.456 . . . . 0.0 110.544 -178.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -147.37 78.71 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.577 -1.327 . . . . 0.0 111.677 -179.081 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.74 ' CG2' HD11 ' A' ' 56' ' ' LEU . 60.7 t -80.86 82.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.722 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.37 -10.8 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 109.709 -178.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 4.8 mm-40 -123.74 50.93 1.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.196 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -40.8 134.12 1.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.586 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.05 134.51 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.597 0.713 . . . . 0.0 111.015 -178.897 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.75 -13.96 24.64 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -84.98 156.19 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -1.135 . . . . 0.0 109.405 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.41 166.43 20.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.681 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.815 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.04 169.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.242 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -147.78 -148.31 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 -179.652 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 9.3 p -90.28 36.18 0.87 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mtt180 163.55 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.4 mt-30 -84.49 87.69 7.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 0.0 109.102 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.4 tt -45.0 108.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 48' ' ' VAL . 10.6 mt -53.91 -42.86 69.21 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 156.55 -159.79 29.76 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.549 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -134.68 134.49 41.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.151 -1.206 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.925 ' HG ' HD12 ' A' ' 56' ' ' LEU . 4.4 mp -98.09 -96.72 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.34 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -153.73 163.19 40.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.542 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.49 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 1.1 tt0 -160.81 -163.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 121.63 2.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.246 -1.149 . . . . 0.0 109.507 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.502 ' HA ' ' CB ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -170.04 158.65 7.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 0.0 109.562 -179.985 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.776 ' O ' HG12 ' A' ' 3' ' ' VAL . 3.0 t -75.94 79.76 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -86.73 80.47 8.52 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.031 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.795 HG12 HG22 ' A' ' 48' ' ' VAL . 6.0 tp -86.98 161.7 2.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 111.738 -177.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.85 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -144.69 -166.02 2.29 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.133 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.662 ' CG2' HD21 ' A' ' 73' ' ' LEU . 38.9 t -133.31 57.11 24.62 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.15 -0.969 . . . . 0.0 110.005 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.0 Cg_endo -79.97 38.33 0.74 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.392 2.061 . . . . 0.0 110.534 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.564 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -111.1 34.8 3.84 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.869 -1.145 . . . . 0.0 109.962 -179.46 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.599 HD11 HG12 ' A' ' 7' ' ' VAL . 2.6 mp -141.51 77.92 18.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 12' ' ' GLU . 35.7 Cg_endo -78.34 -37.64 0.7 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.614 2.21 . . . . 0.0 110.745 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.512 ' HB2' HG12 ' A' ' 14' ' ' VAL . 5.7 mt-10 -53.52 -172.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.682 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.0 t -73.4 -2.27 21.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 14' ' ' VAL . 7.4 p -100.85 57.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.285 -0.884 . . . . 0.0 108.865 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.592 ' HB1' ' HB3' ' A' ' 69' ' ' SER . . . -83.38 44.76 0.98 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.587 -0.696 . . . . 0.0 110.007 -179.582 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -136.89 141.5 42.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.103 -0.998 . . . . 0.0 109.545 179.728 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 41' ' ' THR . . . -147.83 -161.17 1.28 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 0.0 109.254 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.48 ' C ' HG13 ' A' ' 39' ' ' ILE . 77.0 m -161.16 113.98 1.92 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.293 -0.88 . . . . 0.0 110.116 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.001 HG12 ' OE1' ' A' ' 63' ' ' GLU . 2.3 t -46.78 137.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.182 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.841 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -116.73 -51.14 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.985 -1.072 . . . . 0.0 110.958 -178.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.555 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -158.55 109.89 2.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.563 -1.335 . . . . 0.0 112.066 -179.214 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.866 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.7 m95 -68.11 -164.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.646 ' HB2' HG23 ' A' ' 35' ' ' VAL . 24.7 m-70 -155.23 30.44 0.39 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 177.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.58 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 1.3 tppm? -124.4 139.23 54.09 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.407 0.622 . . . . 0.0 110.513 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.597 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -89.26 -176.4 0.66 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.015 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.597 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.6 Cg_endo -66.13 90.14 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.917 1.078 . . . . 0.0 111.321 -178.536 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.807 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 72.92 47.65 24.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.735 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 14.6 m-20 -58.4 -113.4 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.057 -1.261 . . . . 0.0 110.388 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 158.9 102.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.96 -1.088 . . . . 0.0 108.574 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.777 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -101.93 -173.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.05 . . . . 0.0 109.929 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.777 ' N ' HG13 ' A' ' 30' ' ' VAL . 5.7 m -131.86 -114.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.183 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.566 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -87.41 64.62 8.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.691 -1.256 . . . . 0.0 109.182 179.735 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 5.0 m-20 149.65 99.16 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.05 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -95.04 -176.06 3.72 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.414 1.102 . . . . 0.0 111.898 -178.22 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.738 HG12 ' OE2' ' A' ' 34' ' ' GLU . 11.5 p -39.7 166.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.953 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.6 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -147.32 61.97 1.16 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 179.017 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.866 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.3 p -39.29 166.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.683 0.754 . . . . 0.0 110.273 -177.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.841 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 4.1 mt-10 -128.75 95.26 4.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.192 -0.943 . . . . 0.0 109.146 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.801 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -79.62 -167.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 109.123 -179.658 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.748 ' N ' HG23 ' A' ' 39' ' ' ILE . 24.3 mt-10 -153.75 121.24 5.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.922 -1.111 . . . . 0.0 110.193 -179.191 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.547 ' HB ' HD21 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -116.26 -95.19 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.434 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 31.1 t0 -146.15 86.73 1.71 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.385 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 16.5 tttt 86.72 -24.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.07 161.61 5.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 39' ' ' ILE . 54.1 t -150.85 98.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.842 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.59 168.91 18.76 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.213 -0.929 . . . . 0.0 108.864 179.945 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -124.94 -162.89 1.13 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.001 -1.062 . . . . 0.0 110.819 -178.78 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.861 ' HB ' HG12 ' A' ' 37' ' ' VAL . 3.8 t -144.23 74.57 15.74 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.525 -0.735 . . . . 0.0 109.289 -179.345 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.9 Cg_endo -82.19 101.84 1.15 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.887 2.392 . . . . 0.0 111.316 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.05 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -80.19 -161.36 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.021 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.726 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.4 p -135.1 10.14 3.54 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.466 -1.396 . . . . 0.0 111.275 -179.225 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.18 157.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.079 -1.013 . . . . 0.0 110.295 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.548 ' CB ' ' HA ' ' A' ' 78' ' ' GLU . 0.5 OUTLIER 79.1 -73.41 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.675 -0.641 . . . . 0.0 110.518 179.05 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.589 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 43.54 17.85 0.06 OUTLIER Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.154 -0.966 . . . . 0.0 111.315 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.807 HG23 ' CA ' ' A' ' 27' ' ' GLY . 20.5 mt -68.85 91.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.596 -1.532 . . . . 0.0 107.285 179.058 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.896 HD22 HG22 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -44.17 91.34 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.639 0.733 . . . . 0.0 110.366 -178.291 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 55' ' ' ILE . 36.3 t70 -87.29 -53.86 4.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.738 -0.601 . . . . 0.0 109.732 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.35 104.66 3.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.794 -1.191 . . . . 0.0 110.71 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.896 HG22 HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -90.91 92.12 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.553 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.56 -5.55 25.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.186 -0.946 . . . . 0.0 110.076 -178.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 73' ' ' LEU . 2.9 mt-10 -128.89 41.93 3.4 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 108.7 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.513 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.0 m-20 -42.72 131.13 4.06 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.596 -0.69 . . . . 0.0 109.593 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 1.001 ' OE1' HG12 ' A' ' 19' ' ' VAL . 67.2 mm-40 -20.91 140.05 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.661 0.743 . . . . 0.0 112.322 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.25 -15.61 61.12 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -80.07 162.82 24.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -1.232 . . . . 0.0 109.528 179.942 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 67' ' ' VAL . 8.1 m -90.61 162.83 14.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 109.721 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.56 171.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.214 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.695 HG23 ' N ' ' A' ' 69' ' ' SER . 5.1 t -137.98 -152.31 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.05 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.695 ' N ' HG23 ' A' ' 68' ' ' THR . 84.3 p -89.3 39.39 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 0.0 109.174 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.495 ' CG ' ' C ' ' A' ' 69' ' ' SER . 4.7 ptt180 165.78 34.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.95 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' A' ' 68' ' ' THR . 6.4 mm-40 -97.37 119.44 35.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.287 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 72' ' ' ILE . 1.9 tt -70.14 111.33 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -0.925 . . . . 0.0 110.032 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.843 ' CD1' HG21 ' A' ' 48' ' ' VAL . 13.8 mt -47.97 -42.23 27.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 162.04 -165.72 36.0 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.818 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.9 ptt-85 -129.22 149.25 51.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.293 -1.122 . . . . 0.0 109.364 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.874 HD22 HD23 ' A' ' 56' ' ' LEU . 4.5 mt -116.01 -132.21 0.32 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.403 -179.164 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.571 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 11.1 tpt85 -106.26 -51.28 2.99 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.584 -1.323 . . . . 0.0 110.313 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER 44.97 -169.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 -179.641 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.3 -143.58 18.75 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.4 t30 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.236 -1.156 . . . . 0.0 109.465 179.946 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.301 0.572 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.566 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 3.7 p -158.22 164.64 36.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.599 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.69 HG21 ' HA2' ' A' ' 54' ' ' GLY . 37.4 t -69.48 83.38 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.133 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.35 84.24 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.178 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.046 ' CG1' HG22 ' A' ' 48' ' ' VAL . 4.9 tp -110.55 143.82 19.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.291 -177.138 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.676 ' O ' HG23 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -128.48 -134.82 0.23 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.306 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 7' ' ' VAL . 45.9 t -161.85 67.41 2.13 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.717 -1.239 . . . . 0.0 109.168 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD3' ' HG ' ' A' ' 6' ' ' LEU . 35.4 Cg_endo -77.25 67.03 7.78 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.551 2.167 . . . . 0.0 110.584 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.982 ' HB2' HD13 ' A' ' 46' ' ' LEU . 1.2 m-20 -132.18 13.28 4.68 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.284 -0.885 . . . . 0.0 109.416 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' N ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -33.04 94.91 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.941 -0.474 . . . . 0.0 110.467 -179.638 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.96 ' CG ' HG21 ' A' ' 41' ' ' THR . 36.1 Cg_endo -79.05 -156.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.667 2.245 . . . . 0.0 110.03 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.705 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -41.96 124.04 2.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -43.22 108.23 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.719 -179.818 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 12' ' ' GLU . 60.8 t -109.7 -83.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.867 . . . . 0.0 109.423 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -171.28 -33.04 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.656 -0.653 . . . . 0.0 109.941 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER 170.57 -154.94 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.518 -0.739 . . . . 0.0 109.352 179.932 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -168.21 -169.51 1.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -0.999 . . . . 0.0 109.546 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 40' ' ' GLU . 24.1 m -157.38 137.53 12.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.113 -0.992 . . . . 0.0 110.72 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 79.0 t -67.18 86.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.424 -0.797 . . . . 0.0 109.46 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -42.76 -62.97 0.86 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.216 -0.927 . . . . 0.0 109.938 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 2.6 m -166.91 130.05 1.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.482 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 1.031 ' HA ' HG23 ' A' ' 37' ' ' VAL . 22.0 m95 -68.78 -167.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.423 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CD2' ' HA ' ' A' ' 37' ' ' VAL . 62.6 m-70 -149.3 24.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.011 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.752 ' HB3' HD13 ' A' ' 56' ' ' LEU . 10.7 tppt? -119.78 126.11 50.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.683 -0.636 . . . . 0.0 109.959 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.652 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 3.1 mmmt -79.99 -171.84 0.31 Allowed Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.652 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -68.45 104.94 1.17 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.026 1.151 . . . . 0.0 112.123 -177.282 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.732 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 57.97 48.5 82.14 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.27 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -56.35 -115.9 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.192 -1.181 . . . . 0.0 110.486 179.628 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 162.0 100.39 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.761 -1.212 . . . . 0.0 108.312 -178.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.998 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -102.08 173.95 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 111.082 -178.75 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.573 ' H ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -123.62 -92.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.068 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.539 ' H ' HG23 ' A' ' 31' ' ' VAL . 6.7 mtp180 -112.18 66.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.08 -1.013 . . . . 0.0 108.396 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.69 ' O ' HG21 ' A' ' 30' ' ' VAL . 8.2 m-20 155.13 80.55 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.084 ' OE1' HG12 ' A' ' 35' ' ' VAL . 1.1 tm-20 -87.81 175.08 7.99 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.179 0.99 . . . . 0.0 112.365 -177.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.084 HG12 ' OE1' ' A' ' 34' ' ' GLU . 2.4 p -32.14 156.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.93 0.871 . . . . 0.0 112.114 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.551 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -141.9 59.98 1.47 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.218 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.031 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.4 p -38.57 169.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.685 0.755 . . . . 0.0 110.571 -177.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.744 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 14.2 mt-10 -133.43 102.75 5.65 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.163 -0.961 . . . . 0.0 108.724 -179.294 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.926 HD11 ' CG1' ' A' ' 67' ' ' VAL . 2.1 tt -81.01 -165.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.327 -0.858 . . . . 0.0 109.411 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.783 ' N ' HG23 ' A' ' 39' ' ' ILE . 19.6 mm-40 -141.61 89.91 2.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.029 -1.044 . . . . 0.0 110.004 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.96 HG21 ' CG ' ' A' ' 11' ' ' PRO . 87.8 m -90.95 28.97 1.44 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.296 -0.878 . . . . 0.0 109.335 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.8 t70 77.6 73.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.685 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.2 tttt 87.24 -26.58 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.458 ' O ' ' HB ' ' A' ' 41' ' ' THR . 41.1 t -105.44 94.12 2.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.242 -0.911 . . . . 0.0 109.5 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.917 HG13 ' O ' ' A' ' 39' ' ' ILE . 81.4 t -94.77 104.72 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.409 -0.807 . . . . 0.0 109.443 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.982 HD13 ' HB2' ' A' ' 9' ' ' ASP . 0.8 OUTLIER -79.5 174.45 11.56 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.225 -0.922 . . . . 0.0 108.865 -179.759 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 8.4 pm0 -118.05 -179.58 3.8 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.994 -1.066 . . . . 0.0 110.758 -178.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.046 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -144.19 79.08 13.21 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-O 122.331 1.062 . . . . 0.0 108.381 179.666 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.58 120.18 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.826 2.35 . . . . 0.0 111.888 -178.453 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.941 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -96.45 169.84 9.63 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.07 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.704 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 22.9 p -118.32 77.9 1.21 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 120.354 -1.466 . . . . 0.0 110.242 -178.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.824 ' HA ' HG13 ' A' ' 30' ' ' VAL . . . 94.48 168.45 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.563 ' O ' HG12 ' A' ' 30' ' ' VAL . 59.4 m-20 61.96 -126.4 0.76 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.69 ' HA2' HG21 ' A' ' 3' ' ' VAL . . . 84.56 -7.7 71.96 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.055 -1.545 . . . . 0.0 109.704 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.732 HG23 ' CA ' ' A' ' 27' ' ' GLY . 8.2 mt -42.97 98.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.413 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.875 HD12 ' CD2' ' A' ' 76' ' ' LEU . 6.0 tp -43.44 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.666 0.746 . . . . 0.0 110.318 -177.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' ILE . 23.0 t70 -106.35 -36.37 6.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.704 -0.622 . . . . 0.0 109.327 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.658 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -147.35 100.12 3.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.071 . . . . 0.0 110.383 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.528 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 13.5 t -107.55 90.3 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.0 mt -69.63 -4.82 20.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.071 -179.153 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 10.9 mt-10 -127.63 52.34 1.85 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.7 m-20 -49.45 125.28 10.87 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.734 -0.604 . . . . 0.0 110.77 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.549 ' C ' ' O ' ' A' ' 62' ' ' ASP . 5.1 mt-10 -7.55 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.477 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 65' ' ' THR . . . 128.74 -38.09 2.11 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.439 178.641 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.494 ' OG1' ' HA ' ' A' ' 61' ' ' GLU . 5.6 m -43.1 145.38 0.52 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -1.189 . . . . 0.0 109.442 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 m -86.72 141.1 29.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.967 . . . . 0.0 110.189 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.926 ' CG1' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.8 168.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.757 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.589 HG23 ' N ' ' A' ' 69' ' ' SER . 5.2 t -120.4 -47.66 2.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 68' ' ' THR . 0.5 OUTLIER -170.31 -75.27 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.728 0.775 . . . . 0.0 109.714 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -78.95 37.18 0.3 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.672 -0.643 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HG3' HG22 ' A' ' 68' ' ' THR . 3.7 mt-30 -103.34 97.53 7.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.185 . . . . 0.0 108.543 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.52 HG23 ' O ' ' A' ' 72' ' ' ILE . 3.7 tt -40.6 111.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.795 . . . . 0.0 110.404 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.707 ' CD1' HG11 ' A' ' 37' ' ' VAL . 12.0 mt -55.47 -41.2 72.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.84 167.99 21.2 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.875 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.7 ptt180 -109.87 138.77 45.76 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.109 -1.23 . . . . 0.0 109.833 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.875 ' CD2' HD12 ' A' ' 56' ' ' LEU . 4.3 mp -115.72 -101.87 0.42 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.795 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.566 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -129.59 153.46 48.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 109.51 -179.715 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.519 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 1.9 tp10 -160.21 -164.79 1.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.58 -170.25 13.85 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.228 -1.16 . . . . 0.0 109.398 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.544 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.797 HG21 ' OE1' ' A' ' 34' ' ' GLU . 40.1 t -69.43 85.96 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.116 -0.99 . . . . 0.0 108.666 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.7 83.44 1.6 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.026 ' CG1' HG22 ' A' ' 48' ' ' VAL . 1.8 tp -105.68 138.31 31.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.342 -0.849 . . . . 0.0 110.443 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.822 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -134.17 -157.75 0.83 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.854 ' CG2' HD21 ' A' ' 73' ' ' LEU . 42.2 t -127.55 68.75 74.53 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 37.3 Cg_endo -81.85 19.97 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.774 2.316 . . . . 0.0 110.712 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.547 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.306 -1.326 0 O-C-N 121.013 -1.054 . . . . 0.0 110.038 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.499 ' C ' HG12 ' A' ' 39' ' ' ILE . 18.4 m -158.21 133.34 8.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.992 . . . . 0.0 110.906 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.598 HG21 ' HB3' ' A' ' 61' ' ' GLU . 29.5 t -71.12 84.04 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.463 -0.773 . . . . 0.0 109.633 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -39.44 -60.58 0.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.897 . . . . 0.0 110.361 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 22' ' ' TRP . 20.1 m -169.13 129.6 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.665 -1.272 . . . . 0.0 111.446 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 1.033 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.7 m95 -69.55 -167.54 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.608 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 16.9 m80 -152.68 23.65 0.59 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.582 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 7.1 tppt? -114.99 127.42 55.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.739 -0.6 . . . . 0.0 109.759 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.565 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -72.38 175.93 2.81 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.9 Cg_endo -70.46 95.62 0.62 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.957 1.771 . . . . 0.0 111.103 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.626 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 83.43 39.64 9.66 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.582 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 7.6 m-20 -65.5 -163.52 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.984 -1.304 . . . . 0.0 110.094 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.43 82.21 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.401 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.809 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -79.35 -170.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 110.203 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.809 ' N ' HG13 ' A' ' 30' ' ' VAL . 2.6 m -133.61 -106.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 6.9 mtt180 -92.38 62.03 3.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.695 -1.253 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.659 ' O ' HG21 ' A' ' 30' ' ' VAL . 7.6 m-20 153.7 96.06 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.085 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -94.18 -165.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.03 -1.043 . . . . 0.0 111.701 -178.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.823 HG12 ' OE2' ' A' ' 34' ' ' GLU . 7.3 p -51.88 162.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.758 0.79 . . . . 0.0 110.951 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.577 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -139.77 59.83 1.58 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.033 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.4 p -39.04 168.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-O 121.678 0.751 . . . . 0.0 110.616 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.5 mt-10 -131.66 111.15 11.44 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 108.721 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.856 ' O ' HG22 ' A' ' 45' ' ' VAL . 1.7 tt -95.06 -164.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 109.449 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.784 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.3 mt-10 -141.37 99.69 3.62 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.155 -0.966 . . . . 0.0 109.677 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.892 ' HB ' HG23 ' A' ' 44' ' ' VAL . 25.2 m -102.55 44.39 1.02 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.703 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 6.4 t70 76.49 65.61 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.9 ttmt 86.51 -25.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.827 -0.546 . . . . 0.0 109.708 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.892 HG23 ' HB ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -102.93 97.15 5.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.807 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.856 HG22 ' O ' ' A' ' 39' ' ' ILE . 42.8 t -89.87 112.56 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.852 . . . . 0.0 109.167 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.78 ' H ' HD22 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -81.6 -175.74 5.69 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.157 -0.964 . . . . 0.0 109.424 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 28.5 mt-10 -127.02 -178.42 4.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.238 -0.914 . . . . 0.0 109.649 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.026 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -149.5 79.0 8.24 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-O 122.266 1.031 . . . . 0.0 108.976 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.3 Cg_endo -82.5 106.41 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.916 2.41 . . . . 0.0 112.009 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.085 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -75.31 -160.5 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.2 p -138.52 12.8 2.76 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.423 -1.423 . . . . 0.0 110.818 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.43 165.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.937 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 69.81 -86.5 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.496 -0.752 . . . . 0.0 109.625 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.515 ' O ' HD23 ' A' ' 76' ' ' LEU . . . 63.04 -9.76 0.16 Allowed Glycine 0 N--CA 1.496 2.635 0 O-C-N 120.886 -1.134 . . . . 0.0 111.879 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.626 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -41.93 98.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 118.927 1.363 . . . . 0.0 108.356 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.949 HD12 ' HG ' ' A' ' 76' ' ' LEU . 9.9 tp -54.92 98.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.503 -0.748 . . . . 0.0 109.628 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -112.69 -41.49 3.8 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.706 -0.621 . . . . 0.0 109.721 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -136.8 93.97 2.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.836 -1.165 . . . . 0.0 110.409 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.623 HG22 HD11 ' A' ' 56' ' ' LEU . 4.9 t -102.13 88.22 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.058 . . . . 0.0 108.381 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.77 -4.6 20.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.281 -0.887 . . . . 0.0 110.25 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.598 ' HB3' HG21 ' A' ' 19' ' ' VAL . 3.7 mt-10 -127.35 50.7 1.97 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.071 -1.018 . . . . 0.0 108.846 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.8 m-20 -53.6 109.41 0.45 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.56 -0.713 . . . . 0.0 110.494 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.536 ' C ' ' O ' ' A' ' 62' ' ' ASP . 3.2 mp0 8.63 109.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' THR . . . 116.46 -35.37 4.25 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.561 ' CB ' ' HA ' ' A' ' 61' ' ' GLU . 71.4 m -45.08 146.05 0.92 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -1.186 . . . . 0.0 109.169 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.52 131.04 35.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.719 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.804 ' CG1' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.57 171.25 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.766 HG22 ' HG3' ' A' ' 71' ' ' GLN . 4.9 t -139.68 -149.43 0.28 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.232 -0.918 . . . . 0.0 109.279 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.747 ' N ' HG23 ' A' ' 68' ' ' THR . 62.7 p -98.91 74.85 2.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.114 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER 159.4 -21.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.766 ' HG3' HG22 ' A' ' 68' ' ' THR . 4.3 mt-30 -71.37 -171.65 0.64 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.551 -0.718 . . . . 0.0 109.106 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.9 tt -126.44 128.4 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.854 HD21 ' CG2' ' A' ' 7' ' ' VAL . 7.9 mt -64.53 -40.53 95.78 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.27 176.22 23.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.815 ' C ' HD12 ' A' ' 76' ' ' LEU . 1.4 ptm180 -117.22 142.63 46.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.217 -1.167 . . . . 0.0 110.171 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.949 ' HG ' HD12 ' A' ' 56' ' ' LEU . 3.8 mp -112.36 -101.65 0.41 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.544 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 109.068 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.479 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.659 ' O ' HG12 ' A' ' 3' ' ' VAL . 25.0 t -71.48 82.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.031 . . . . 0.0 108.785 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.89 82.86 2.18 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.065 ' CG1' HG22 ' A' ' 48' ' ' VAL . 3.9 tp -101.19 137.29 29.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.728 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.841 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -131.12 -148.22 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.565 ' CG1' ' HA ' ' A' ' 69' ' ' SER . 93.7 t -129.88 92.14 37.87 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.264 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.49 17.97 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.774 2.316 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.584 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 O-C-N 120.871 -1.143 . . . . 0.0 110.152 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.862 HG23 ' O ' ' A' ' 65' ' ' THR . 87.5 m -160.77 136.28 7.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.908 . . . . 0.0 110.07 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.8 t -58.87 143.28 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 108.974 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.811 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -115.24 -53.92 2.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.212 -0.93 . . . . 0.0 109.185 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.681 ' O ' HG23 ' A' ' 21' ' ' THR . 6.6 t -164.41 116.91 1.32 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.26 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.987 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.7 m95 -68.35 -167.5 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.582 ' HB2' HG23 ' A' ' 35' ' ' VAL . 19.4 m80 -152.47 23.65 0.61 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.976 ' O ' HD22 ' A' ' 56' ' ' LEU . 5.7 tppt? -120.4 108.12 13.73 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.789 -0.569 . . . . 0.0 109.713 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -59.55 177.39 0.27 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 29.6 Cg_endo -69.8 96.02 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.812 1.675 . . . . 0.0 111.378 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 85.07 40.87 7.79 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.613 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 5.4 m-20 -57.95 -154.66 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.21 -1.171 . . . . 0.0 109.948 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.89 87.34 0.51 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.569 -1.332 . . . . 0.0 109.461 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.004 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -96.24 178.76 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.329 -0.857 . . . . 0.0 109.725 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.683 HG13 ' H ' ' A' ' 32' ' ' ARG . 1.3 p -135.76 -60.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.106 -0.996 . . . . 0.0 109.901 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.683 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -138.98 65.6 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.078 -1.014 . . . . 0.0 108.928 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 12.9 m-20 146.68 80.45 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.014 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -86.19 -171.48 3.58 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.083 0.944 . . . . 0.0 112.003 -177.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.818 HG12 ' CD ' ' A' ' 34' ' ' GLU . 3.1 p -41.97 159.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 122.066 0.936 . . . . 0.0 111.88 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.88 62.09 1.58 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.3 p -38.87 168.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.876 0.846 . . . . 0.0 110.744 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.811 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -127.41 98.59 5.3 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.783 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -80.12 -163.83 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.502 -0.749 . . . . 0.0 109.278 -179.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.783 ' N ' HG23 ' A' ' 39' ' ' ILE . 3.8 mm-40 -152.85 104.99 2.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.892 -1.13 . . . . 0.0 110.007 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.819 HG21 HD21 ' A' ' 46' ' ' LEU . 1.2 p -99.31 -58.18 1.99 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.08 -1.013 . . . . 0.0 109.988 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.596 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 12.8 t0 176.77 83.55 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.2 tttp 86.12 -26.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 44' ' ' VAL . 11.5 m -119.47 132.42 69.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.288 -0.883 . . . . 0.0 109.4 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 39' ' ' ILE . 42.8 t -118.07 114.58 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.31 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.862 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -80.46 147.57 30.86 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.233 -0.917 . . . . 0.0 109.02 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -92.11 179.39 5.59 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.326 -0.859 . . . . 0.0 110.682 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.065 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -141.02 73.95 26.11 Favored Pre-proline 0 N--CA 1.489 1.511 0 CA-C-O 122.414 1.102 . . . . 0.0 108.366 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.28 107.63 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.873 2.382 . . . . 0.0 111.919 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.014 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -73.83 -165.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.715 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.9 OUTLIER -137.96 23.32 2.83 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.484 -1.385 . . . . 0.0 110.194 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.58 161.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.699 ' O ' HG12 ' A' ' 30' ' ' VAL . 6.4 m-20 60.85 -132.92 0.73 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.034 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.664 ' O ' HD23 ' A' ' 76' ' ' LEU . . . 114.87 -18.71 16.45 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.941 HG23 ' HA2' ' A' ' 27' ' ' GLY . 10.6 mt -36.04 99.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.989 HD12 ' HG ' ' A' ' 76' ' ' LEU . 10.9 tp -56.71 98.71 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.561 0.696 . . . . 0.0 109.712 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.402 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 20.1 t70 -117.68 -38.3 3.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.673 -0.642 . . . . 0.0 109.901 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -133.97 91.19 2.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.862 -1.148 . . . . 0.0 110.515 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.523 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 2.4 t -106.97 84.5 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.703 HD12 ' HA2' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -69.98 -3.86 18.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 110.368 -178.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.523 ' OE1' ' CG1' ' A' ' 67' ' ' VAL . 7.7 mt-10 -127.06 46.25 2.55 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.083 -1.011 . . . . 0.0 108.982 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.9 m-20 -51.13 127.23 18.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.454 -0.779 . . . . 0.0 109.707 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' A' ' 62' ' ' ASP . 0.3 OUTLIER -17.62 132.98 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.321 0.582 . . . . 0.0 111.414 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.41 -31.35 7.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.862 ' O ' HG23 ' A' ' 18' ' ' THR . 24.1 m -70.19 170.54 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -1.162 . . . . 0.0 109.539 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.574 ' N ' HG22 ' A' ' 65' ' ' THR . 95.0 m -108.75 140.22 42.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.445 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.727 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -151.1 160.95 3.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.491 ' O ' ' HB ' ' A' ' 7' ' ' VAL . 1.3 m -117.44 -144.15 0.38 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.565 ' HA ' ' CG1' ' A' ' 7' ' ' VAL . 7.9 m -106.07 78.39 1.31 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.134 -0.979 . . . . 0.0 108.588 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 6.0 ttm180 159.34 -21.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.575 ' HB2' HG23 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -72.99 131.77 42.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 72' ' ' ILE . 4.7 tt -79.18 111.92 16.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 110.098 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.685 ' CD1' HG11 ' A' ' 37' ' ' VAL . 13.1 mt -46.29 -38.99 9.34 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.703 ' HA2' HD12 ' A' ' 60' ' ' LEU . . . 154.17 169.96 19.57 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.785 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 2.1 ptm180 -110.94 137.06 49.04 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.304 -1.115 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.989 ' HG ' HD12 ' A' ' 56' ' ' LEU . 4.3 mp -102.69 -96.7 0.29 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.068 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.585 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 37.2 m . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.057 HG21 ' OE2' ' A' ' 34' ' ' GLU . 7.7 t -73.98 80.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 108.95 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.58 81.26 2.59 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.076 ' CG1' HG22 ' A' ' 48' ' ' VAL . 6.6 tp -99.34 152.18 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.027 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.962 HD22 ' HG2' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -139.97 -161.65 1.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.081 HG21 HD13 ' A' ' 39' ' ' ILE . 96.5 t -130.97 67.24 80.62 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.045 -1.034 . . . . 0.0 109.484 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.518 ' HG3' HD13 ' A' ' 6' ' ' LEU . 36.1 Cg_endo -79.08 57.75 6.62 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.751 2.301 . . . . 0.0 110.878 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 1.003 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.343 0 O-C-N 121.14 -0.975 . . . . 0.0 109.493 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 65' ' ' THR . 17.6 m -160.75 143.83 13.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.001 -1.062 . . . . 0.0 110.693 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.941 HG12 ' OE1' ' A' ' 63' ' ' GLU . 1.9 t -65.73 149.09 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -126.96 -47.22 1.51 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.953 -1.092 . . . . 0.0 110.309 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.521 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -162.7 109.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.749 -1.219 . . . . 0.0 111.674 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.964 ' HA ' HG23 ' A' ' 37' ' ' VAL . 15.9 m95 -67.65 -162.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 0.0 108.503 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.747 ' HB2' HG23 ' A' ' 35' ' ' VAL . 33.4 m80 -158.1 34.82 0.25 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.906 ' CB ' HD23 ' A' ' 56' ' ' LEU . 4.7 mmpt? -119.64 108.48 14.51 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.32 0.581 . . . . 0.0 110.376 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -59.56 -178.12 0.12 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.4 Cg_endo -67.99 89.99 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.105 1.203 . . . . 0.0 110.764 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.549 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 78.07 46.04 9.7 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 10.8 m-20 -59.55 -161.48 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.721 -1.458 . . . . 0.0 109.335 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.38 85.42 0.72 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.959 -1.088 . . . . 0.0 109.147 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.013 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.12 -176.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.357 -0.84 . . . . 0.0 109.894 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.687 HG13 ' H ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -142.47 -72.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.359 -0.838 . . . . 0.0 109.599 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.687 ' H ' HG13 ' A' ' 31' ' ' VAL . 8.3 mmt180 -121.5 63.85 0.9 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.001 -1.062 . . . . 0.0 109.519 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 6.1 m-20 145.04 84.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.066 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 21.5 tt0 -84.89 170.15 13.39 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.218 1.009 . . . . 0.0 112.002 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.747 HG23 ' HB2' ' A' ' 23' ' ' HIS . 3.5 p -31.08 155.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.912 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.771 ' H ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -136.32 64.83 1.54 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 178.262 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.964 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.3 p -38.67 170.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.783 0.802 . . . . 0.0 110.725 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.801 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.8 mm-40 -125.8 96.59 4.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.132 -0.98 . . . . 0.0 109.098 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.081 HD13 HG21 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -79.88 -159.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.059 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.795 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.9 mm-40 -147.03 101.46 3.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.789 -1.194 . . . . 0.0 109.992 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -93.47 -152.0 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.337 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 20.4 t0 -94.16 88.0 5.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER 85.61 -23.85 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.755 -0.591 . . . . 0.0 109.612 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 41' ' ' THR . 23.0 t -116.33 137.12 51.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.236 -0.915 . . . . 0.0 109.503 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 39' ' ' ILE . 2.2 p -113.11 107.17 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.003 HD13 ' HB2' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -79.49 179.19 7.6 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.183 -0.948 . . . . 0.0 108.935 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -126.65 -163.75 1.27 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.981 -1.074 . . . . 0.0 110.269 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.076 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -151.26 75.76 7.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-O 122.278 1.037 . . . . 0.0 108.833 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.5 Cg_endo -81.01 115.32 2.99 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.801 2.334 . . . . 0.0 112.009 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.066 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -83.7 -167.65 1.81 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.73 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.0 p -131.54 18.09 4.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.129 -1.607 . . . . 0.0 111.135 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.46 160.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.869 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.5 t70 64.7 -140.39 0.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 55' ' ' ILE . . . 116.71 -15.98 14.11 Favored Glycine 0 N--CA 1.489 2.22 0 O-C-N 120.218 -1.551 . . . . 0.0 110.671 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.575 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -32.01 94.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 117.884 0.842 . . . . 0.0 109.449 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.927 HD11 HG21 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -46.69 100.78 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.6 t70 -120.56 -46.02 2.39 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.201 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -135.55 107.55 7.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.749 -1.219 . . . . 0.0 110.818 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.927 HG21 HD11 ' A' ' 56' ' ' LEU . 1.4 t -113.17 90.86 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.81 -4.6 20.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.217 -0.927 . . . . 0.0 110.022 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 3.1 mt-10 -128.22 39.37 3.85 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.6 m-20 -40.67 136.15 1.44 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.732 -0.605 . . . . 0.0 109.699 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.941 ' OE1' HG12 ' A' ' 19' ' ' VAL . 67.4 mm-40 -27.82 146.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.537 0.684 . . . . 0.0 111.494 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.14 -2.11 87.62 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 18' ' ' THR . 24.2 m -94.15 154.96 17.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.165 -1.197 . . . . 0.0 109.352 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.53 148.46 22.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.179 -0.951 . . . . 0.0 109.644 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.733 HG11 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -150.32 155.33 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.46 -0.775 . . . . 0.0 108.931 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.791 HG23 ' N ' ' A' ' 69' ' ' SER . 7.4 t -100.78 -142.15 0.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.791 ' N ' HG23 ' A' ' 68' ' ' THR . 72.5 m -68.87 -99.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.779 -1.201 . . . . 0.0 108.239 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.962 ' HG2' HD22 ' A' ' 6' ' ' LEU . 7.4 ttp180 -75.11 76.22 2.28 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.376 -0.827 . . . . 0.0 109.88 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.636 ' HB2' HG23 ' A' ' 67' ' ' VAL . 2.3 mm-40 -113.92 95.34 5.26 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 72' ' ' ILE . 7.9 tt -38.7 109.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.649 -0.657 . . . . 0.0 110.807 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.927 HD21 HG23 ' A' ' 7' ' ' VAL . 12.1 mt -56.7 -39.94 74.74 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.98 -179.4 35.55 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -118.18 135.67 54.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.218 -1.166 . . . . 0.0 110.122 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.927 ' HG ' HD22 ' A' ' 56' ' ' LEU . 2.1 mp -99.25 -91.65 0.28 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.575 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 10.4 tpp180 . . . . . 0 C--N 1.295 -1.771 0 O-C-N 121.508 -0.745 . . . . 0.0 109.282 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 62.3 t -81.56 70.55 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 108.798 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -74.07 84.04 1.79 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.822 HG12 HG13 ' A' ' 48' ' ' VAL . 8.0 tp -99.73 163.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 111.297 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.859 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -147.31 -159.86 1.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.815 HG21 ' CG2' ' A' ' 67' ' ' VAL . 2.1 t -133.15 56.11 20.09 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.121 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -80.58 35.94 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.5 2.134 . . . . 0.0 110.824 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.568 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.1 m-20 . . . . . 0 C--N 1.306 -1.283 0 O-C-N 120.801 -1.187 . . . . 0.0 109.966 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 121.167 0.508 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.485 ' N ' HG13 ' A' ' 67' ' ' VAL . 46.8 m -155.55 124.15 5.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 110.54 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.938 HG22 HD11 ' A' ' 39' ' ' ILE . 17.0 t -65.52 107.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.23 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -73.8 -59.62 2.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.614 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.586 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.6 m -168.69 128.52 1.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.628 -1.295 . . . . 0.0 111.775 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.995 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.6 m95 -69.2 -166.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.661 0.743 . . . . 0.0 109.24 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.1 m80 -152.7 26.47 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.549 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.6 tppt? -119.36 137.91 53.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.69 -0.631 . . . . 0.0 110.132 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.599 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.28 179.29 1.71 Allowed Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -69.64 104.91 1.37 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.664 1.576 . . . . 0.0 111.62 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 75.03 39.52 37.49 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 4.8 m-20 -59.45 -166.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.718 -1.46 . . . . 0.0 109.597 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.17 78.56 0.45 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.08 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.698 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -79.55 169.26 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -110.06 -95.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 1.6 mtm180 -107.2 51.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.961 -1.087 . . . . 0.0 109.63 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.698 ' O ' HG21 ' A' ' 30' ' ' VAL . 4.2 m-20 173.04 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.949 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 10.3 tp10 -102.29 163.62 12.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.058 -1.026 . . . . 0.0 111.008 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.598 HG12 ' HG3' ' A' ' 34' ' ' GLU . 2.5 p -30.36 160.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.57 1.176 . . . . 0.0 112.581 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.533 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.12 67.63 1.37 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.995 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.1 p -38.59 165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.102 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.27 145.71 46.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.938 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -134.77 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.722 ' N ' HG23 ' A' ' 39' ' ' ILE . 13.1 mt-10 -149.35 138.51 21.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.923 -1.11 . . . . 0.0 109.708 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 5.9 t -132.72 26.22 4.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 41' ' ' THR . 2.2 t70 87.34 15.31 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.341 0.591 . . . . 0.0 110.459 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 160.52 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 1.1 t -103.99 148.57 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.613 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 39' ' ' ILE . 51.2 t -136.93 96.76 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.685 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.769 ' N ' HD22 ' A' ' 46' ' ' LEU . 2.9 mm? -79.88 -176.0 5.21 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.309 -0.869 . . . . 0.0 108.728 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 1.3 pt-20 -142.39 -161.36 1.23 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.718 -1.239 . . . . 0.0 111.463 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.822 HG13 HG12 ' A' ' 5' ' ' ILE . 6.0 t -143.47 75.5 16.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.7 Cg_endo -80.73 110.82 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.487 2.125 . . . . 0.0 110.931 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.949 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -91.79 -169.38 2.26 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.1 p -132.36 14.68 4.57 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.265 -1.522 . . . . 0.0 111.183 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.62 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 109.951 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER 60.63 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.548 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 64.95 -13.65 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 O-C-N 121.324 -0.86 . . . . 0.0 112.093 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.651 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.81 96.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.674 -1.486 . . . . 0.0 108.551 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.925 HD12 ' HG ' ' A' ' 76' ' ' LEU . 7.8 tp -49.87 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ILE . 46.6 t0 -98.6 -41.59 7.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.97 -0.456 . . . . 0.0 110.544 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -147.37 78.71 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.577 -1.327 . . . . 0.0 111.677 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.74 ' CG2' HD11 ' A' ' 56' ' ' LEU . 60.7 t -80.86 82.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.37 -10.8 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 109.709 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 4.8 mm-40 -123.74 50.93 1.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -40.8 134.12 1.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.586 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.05 134.51 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.597 0.713 . . . . 0.0 111.015 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.75 -13.96 24.64 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -84.98 156.19 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -1.135 . . . . 0.0 109.405 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.41 166.43 20.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.681 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.815 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.04 169.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -147.78 -148.31 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 9.3 p -90.28 36.18 0.87 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mtt180 163.55 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.4 mt-30 -84.49 87.69 7.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 0.0 109.102 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.4 tt -45.0 108.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 48' ' ' VAL . 10.6 mt -53.91 -42.86 69.21 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 156.55 -159.79 29.76 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.549 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -134.68 134.49 41.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.151 -1.206 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.925 ' HG ' HD12 ' A' ' 56' ' ' LEU . 4.4 mp -98.09 -96.72 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.34 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.542 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 77' ' ' ARG . 35.3 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.873 HG21 ' OE1' ' A' ' 34' ' ' GLU . 8.8 t -78.96 77.52 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.2 -0.937 . . . . 0.0 109.317 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.79 83.86 2.75 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.85 HG12 HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -101.24 149.19 6.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.325 -0.859 . . . . 0.0 111.628 -177.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.849 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.43 -158.59 0.9 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.101 ' CG2' HD21 ' A' ' 73' ' ' LEU . 72.7 t -136.04 58.09 21.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.084 -1.01 . . . . 0.0 110.247 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.1 Cg_endo -80.7 19.81 1.06 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.39 2.06 . . . . 0.0 111.124 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.578 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 1.5 m-20 . . . . . 0 C--N 1.308 -1.201 0 O-C-N 120.769 -1.207 . . . . 0.0 109.913 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.588 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 21.2 m -160.33 121.78 3.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.335 -0.853 . . . . 0.0 109.934 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.667 HG22 HD11 ' A' ' 39' ' ' ILE . 13.4 t -63.97 91.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.135 -0.978 . . . . 0.0 109.108 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -54.65 -57.83 9.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 110.707 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.626 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 40.3 m -166.5 122.88 1.25 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.709 -1.244 . . . . 0.0 111.654 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 1.027 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.4 m95 -67.85 -165.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.681 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.9 m80 -148.92 22.03 0.98 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.521 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.59 154.36 31.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.676 -0.64 . . . . 0.0 109.678 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.642 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -105.61 -173.41 0.28 Allowed Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.642 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.84 83.73 0.53 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.075 1.183 . . . . 0.0 111.247 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.711 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 81.11 48.08 6.21 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.757 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.2 m-20 -55.83 -113.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -1.182 . . . . 0.0 110.005 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 163.05 72.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.448 -1.408 . . . . 0.0 109.98 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.981 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -79.66 157.09 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.112 -0.992 . . . . 0.0 110.652 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 2.6 m -97.51 -107.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 12.8 ttt-85 -104.9 74.84 1.15 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.693 -1.254 . . . . 0.0 108.965 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.594 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 11.4 m-20 143.96 102.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.981 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -112.21 -173.3 2.22 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.533 -177.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.775 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 13.1 p -27.68 153.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.953 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.1 58.82 1.7 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 178.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.027 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.1 p -37.75 168.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.731 0.776 . . . . 0.0 110.761 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.413 ' H ' HG22 ' A' ' 37' ' ' VAL . 2.7 mt-10 -126.67 142.18 51.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.889 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -128.14 -179.63 3.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 121.276 -0.89 . . . . 0.0 109.387 -179.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.638 ' N ' HG23 ' A' ' 39' ' ' ILE . 15.4 mt-10 -137.83 127.63 25.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.782 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 44' ' ' VAL . 8.5 t -132.13 25.89 4.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 0.0 109.49 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.3 t0 81.32 87.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.709 -0.62 . . . . 0.0 110.544 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.9 tttp 85.72 -27.62 0.08 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.869 -0.519 . . . . 0.0 110.403 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.57 ' O ' HG22 ' A' ' 41' ' ' THR . 0.2 OUTLIER -114.81 142.19 28.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.961 -1.087 . . . . 0.0 109.964 -179.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.889 HG13 ' O ' ' A' ' 39' ' ' ILE . 39.8 t -139.32 100.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.138 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 3.3 mm? -81.65 -166.45 1.2 Allowed 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.537 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -143.45 -161.8 1.33 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.182 -0.949 . . . . 0.0 110.122 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.85 HG22 HG12 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -156.02 77.2 4.56 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 109.948 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.5 Cg_endo -79.89 107.63 2.12 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.419 2.079 . . . . 0.0 110.031 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.888 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . . . -76.11 -167.22 0.71 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -143.06 24.02 1.84 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.461 -1.4 . . . . 0.0 110.819 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.69 118.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.73 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.63 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 66.0 m-20 106.65 -117.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.559 ' CA ' ' OE1' ' A' ' 34' ' ' GLU . . . 100.28 -26.79 23.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.797 HD12 ' HD3' ' A' ' 77' ' ' ARG . 6.1 mt -43.78 98.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 108.089 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.109 HD12 HD22 ' A' ' 76' ' ' LEU . 10.6 tp -51.57 100.92 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.391 -0.818 . . . . 0.0 109.698 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.446 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 33.4 t0 -101.2 -46.75 4.95 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.754 -0.591 . . . . 0.0 109.598 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.64 96.79 2.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.884 -1.135 . . . . 0.0 110.529 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.923 HG21 HD21 ' A' ' 56' ' ' LEU . 2.6 t -94.71 90.9 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.965 . . . . 0.0 108.505 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.982 HD12 ' HA2' ' A' ' 74' ' ' GLY . 1.6 mt -71.23 -2.04 14.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.849 . . . . 0.0 110.329 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.513 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 7.7 mt-10 -135.61 54.3 1.92 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.155 -0.965 . . . . 0.0 108.471 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.4 m-20 -43.91 130.36 5.78 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.488 -0.758 . . . . 0.0 109.553 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -34.63 116.34 0.31 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.343 0.592 . . . . 0.0 110.953 -179.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.09 -6.39 7.27 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 m -95.18 162.92 13.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -1.179 . . . . 0.0 109.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -78.43 156.96 29.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.243 -0.911 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.801 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.74 174.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.584 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -143.82 -164.92 1.99 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 108.81 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.554 ' H ' HG22 ' A' ' 68' ' ' THR . 60.2 p -85.76 63.31 7.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.047 -1.033 . . . . 0.0 109.185 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.551 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.8 mmm-85 159.81 -16.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.606 -0.684 . . . . 0.0 109.923 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HB2' HG23 ' A' ' 67' ' ' VAL . 21.1 mm100 -53.27 143.74 17.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.422 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 72' ' ' ILE . 16.8 tt -95.59 112.06 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.3 -0.875 . . . . 0.0 109.682 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.101 HD21 ' CG2' ' A' ' 7' ' ' VAL . 9.3 mt -53.13 -31.46 42.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.982 ' HA2' HD12 ' A' ' 60' ' ' LEU . . . 139.63 -166.63 25.54 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.517 ' C ' HD23 ' A' ' 76' ' ' LEU . 1.5 ptt85 -128.84 140.23 51.8 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.27 -1.135 . . . . 0.0 109.534 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.109 HD22 HD12 ' A' ' 56' ' ' LEU . 8.2 mt -100.74 -121.66 0.16 Allowed 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.128 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.797 ' HD3' HD12 ' A' ' 55' ' ' ILE . 19.2 ttt-85 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 120.595 -1.316 . . . . 0.0 110.015 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.123 HG12 ' CD1' ' A' ' 5' ' ' ILE . 15.7 t -88.91 63.22 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.292 -0.88 . . . . 0.0 109.652 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -85.26 89.44 7.65 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.123 ' CD1' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -103.18 171.79 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 120.849 -1.157 . . . . 0.0 112.231 -177.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.869 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -142.12 -156.56 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 67' ' ' VAL . 59.9 t -129.35 54.38 14.21 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.036 -1.04 . . . . 0.0 110.724 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.695 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -80.3 28.02 0.54 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.473 2.115 . . . . 0.0 110.561 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.851 ' CB ' HD13 ' A' ' 46' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.307 -1.25 0 O-C-N 120.972 -1.08 . . . . 0.0 109.707 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.487 ' C ' HG13 ' A' ' 39' ' ' ILE . 96.7 m -159.39 139.76 12.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.126 -0.984 . . . . 0.0 110.174 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.543 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 14.2 t -73.2 91.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.402 -0.811 . . . . 0.0 109.373 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -52.65 -62.92 1.34 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.389 -0.82 . . . . 0.0 110.431 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.611 HG23 ' OE1' ' A' ' 63' ' ' GLU . 2.9 m -161.62 122.67 2.75 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.499 -1.28 . . . . 0.0 111.812 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.99 ' HA ' HG23 ' A' ' 37' ' ' VAL . 13.7 m95 -67.93 -165.56 0.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.412 -0.805 . . . . 0.0 109.034 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.716 ' HB2' HG23 ' A' ' 35' ' ' VAL . 33.8 m80 -150.24 31.39 0.68 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.563 ' HG2' ' HB ' ' A' ' 35' ' ' VAL . 2.8 mtpp -122.16 177.84 5.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.925 0.869 . . . . 0.0 110.844 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.681 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 8.2 mmmt -131.98 -177.62 0.72 Allowed Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.681 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -69.25 86.0 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.166 1.244 . . . . 0.0 110.646 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.817 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 86.07 47.36 5.02 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.567 ' O ' ' CG1' ' A' ' 55' ' ' ILE . 12.8 m-20 -54.31 -158.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -1.095 . . . . 0.0 110.055 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.33 86.74 0.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.54 -1.35 . . . . 0.0 109.179 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.044 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -95.13 170.46 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 110.011 -179.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.667 HG13 ' H ' ' A' ' 32' ' ' ARG . 1.5 p -133.88 -57.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.317 -0.865 . . . . 0.0 109.386 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.667 ' H ' HG13 ' A' ' 31' ' ' VAL . 3.2 mtp180 -141.18 64.16 1.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 108.82 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 11.6 m-20 149.6 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.044 ' HA ' HG21 ' A' ' 30' ' ' VAL . 11.9 tt0 -94.1 167.77 11.37 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.328 1.061 . . . . 0.0 111.726 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.716 HG23 ' HB2' ' A' ' 23' ' ' HIS . 2.4 p -31.16 156.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 122.174 0.987 . . . . 0.0 112.168 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.543 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.98 64.57 1.5 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 177.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.99 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.0 p -37.86 165.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.729 0.776 . . . . 0.0 110.268 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.4 mm-40 -128.37 98.47 5.07 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 108.806 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.93 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -79.75 -168.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.743 ' N ' HG23 ' A' ' 39' ' ' ILE . 8.5 mt-10 -136.59 114.58 11.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.951 -1.093 . . . . 0.0 110.275 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.532 HG22 ' N ' ' A' ' 42' ' ' ASP . 98.1 m -106.33 -103.23 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.23 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 2.3 t70 -144.85 95.16 2.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.102 -0.998 . . . . 0.0 108.99 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.571 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 23.1 tttm 85.66 -28.02 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.307 0.575 . . . . 0.0 109.452 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 45' ' ' VAL . 2.0 t -118.95 -177.05 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.126 -0.984 . . . . 0.0 109.223 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 39' ' ' ILE . 44.4 t -148.64 120.42 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 109.577 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.851 HD13 ' CB ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -79.43 159.46 27.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 4.4 mt-10 -124.07 -173.45 2.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.058 -1.026 . . . . 0.0 110.132 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.987 HG22 HG21 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -148.86 66.49 8.84 Favored Pre-proline 0 N--CA 1.487 1.409 0 CA-C-O 121.911 0.862 . . . . 0.0 109.041 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 33.8 Cg_endo -75.15 115.7 4.34 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.679 2.253 . . . . 0.0 110.998 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.02 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -91.91 -177.0 4.6 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.72 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 51.5 p -129.68 21.32 5.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.747 -1.221 . . . . 0.0 110.07 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 162.69 161.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.432 -0.792 . . . . 0.0 109.076 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.716 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.8 m-20 75.82 -145.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 117.03 -18.91 12.19 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 120.475 -1.391 . . . . 0.0 110.256 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.817 HG23 ' HA2' ' A' ' 27' ' ' GLY . 18.9 mt -46.61 95.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.136 -1.214 . . . . 0.0 107.77 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.101 HD12 ' CD1' ' A' ' 76' ' ' LEU . 7.2 tp -53.27 109.42 0.43 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.375 -0.828 . . . . 0.0 109.398 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 20.1 t70 -113.54 -53.87 2.66 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.741 -0.599 . . . . 0.0 110.358 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.666 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -132.64 79.51 1.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.694 -1.254 . . . . 0.0 110.952 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.921 HG21 HD21 ' A' ' 56' ' ' LEU . 10.1 t -81.07 87.98 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.76 -1.6 12.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.465 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 51.8 mt-10 -134.03 52.51 2.06 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.013 -1.055 . . . . 0.0 108.456 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -43.5 131.59 4.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.599 -0.688 . . . . 0.0 109.769 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.611 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.2 OUTLIER -36.1 111.38 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.327 0.584 . . . . 0.0 110.587 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.86 4.31 7.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -101.74 162.11 13.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -1.2 . . . . 0.0 109.596 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.23 151.61 36.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.595 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.98 173.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.931 HG22 ' HG2' ' A' ' 71' ' ' GLN . 5.2 t -140.33 -157.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 108.829 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.596 ' N ' HG23 ' A' ' 68' ' ' THR . 88.7 p -90.32 63.87 5.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.977 -1.077 . . . . 0.0 109.406 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.518 ' CB ' ' O ' ' A' ' 69' ' ' SER . 4.2 ttt180 159.54 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.648 -0.658 . . . . 0.0 109.458 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.931 ' HG2' HG22 ' A' ' 68' ' ' THR . 19.0 mm-40 -48.79 138.44 11.13 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.414 -0.804 . . . . 0.0 109.444 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 72' ' ' ILE . 5.8 tt -87.55 114.36 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.383 -0.823 . . . . 0.0 109.818 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.588 HD13 HG11 ' A' ' 37' ' ' VAL . 5.2 mt -49.35 -39.64 32.61 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 146.86 -173.99 26.85 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.666 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -117.87 140.98 48.94 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.159 -1.2 . . . . 0.0 109.317 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.101 ' CD1' HD12 ' A' ' 56' ' ' LEU . 3.6 mm? -88.17 -92.33 0.11 Allowed 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.334 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.576 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 110.022 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.77 ' O ' HG12 ' A' ' 3' ' ' VAL . 34.7 t -88.81 72.82 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.901 . . . . 0.0 109.411 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.63 80.99 4.09 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.791 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -94.32 156.7 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.28 -0.887 . . . . 0.0 111.327 -177.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.886 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -139.57 -155.54 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.993 ' CG1' HD12 ' A' ' 46' ' ' LEU . 16.5 t -136.9 63.68 46.16 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.955 -1.091 . . . . 0.0 109.84 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HB3' ' CG ' ' A' ' 70' ' ' ARG . 36.5 Cg_endo -80.59 43.22 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.78 2.32 . . . . 0.0 110.252 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.983 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 O-C-N 121.179 -0.951 . . . . 0.0 109.957 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 16.0 m -159.69 134.91 8.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 110.546 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.568 ' HA ' HG13 ' A' ' 39' ' ' ILE . 23.8 t -70.42 84.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.455 -0.778 . . . . 0.0 109.251 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -41.18 -62.81 0.77 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.313 -0.867 . . . . 0.0 110.327 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.865 HG23 ' OE1' ' A' ' 63' ' ' GLU . 22.5 m -164.95 128.05 2.29 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.564 -1.255 . . . . 0.0 111.456 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 1.022 ' HA ' HG23 ' A' ' 37' ' ' VAL . 16.4 m95 -68.54 -167.69 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.632 ' HB2' HG23 ' A' ' 35' ' ' VAL . 23.4 m80 -149.56 35.38 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.665 ' HB3' HD13 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -131.62 168.51 17.58 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.511 0.672 . . . . 0.0 110.195 -179.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.648 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -121.5 -171.09 0.21 Allowed Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 178.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.648 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -68.45 84.91 0.46 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 120.831 1.021 . . . . 0.0 111.262 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.758 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 77.05 48.86 8.0 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.715 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 20.8 m-20 -54.5 -112.13 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.253 -1.145 . . . . 0.0 110.911 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 157.48 103.63 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.975 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -104.35 176.51 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 120.672 -1.268 . . . . 0.0 111.688 -177.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.617 ' H ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -114.37 -137.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -80.69 76.86 7.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.833 -1.167 . . . . 0.0 108.19 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 4.4 m-20 150.22 79.15 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.004 ' OE1' HG12 ' A' ' 35' ' ' VAL . 2.7 tm-20 -83.26 171.36 13.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 0.0 112.438 -177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.004 HG12 ' OE1' ' A' ' 34' ' ' GLU . 2.0 p -31.49 156.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.745 0.784 . . . . 0.0 111.687 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.539 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.05 63.27 1.34 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 178.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.022 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.2 p -39.38 168.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.681 0.753 . . . . 0.0 110.2 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.684 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.3 mt-10 -131.17 103.51 6.53 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 109.015 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.816 HG23 ' N ' ' A' ' 40' ' ' GLU . 2.8 tt -84.14 -159.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.369 -0.832 . . . . 0.0 109.425 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.816 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.8 mm-40 -139.8 127.48 21.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.928 -1.108 . . . . 0.0 109.801 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 41' ' ' THR . 84.8 m -132.69 16.62 4.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.852 . . . . 0.0 109.665 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 15.2 t0 72.19 85.49 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.161 -0.962 . . . . 0.0 109.684 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 86.38 -27.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.24 0.543 . . . . 0.0 109.59 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.9 t -115.47 144.97 21.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.143 -0.973 . . . . 0.0 109.281 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 39' ' ' ILE . 38.1 t -133.17 118.54 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.758 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.993 HD12 ' CG1' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -79.55 159.75 26.74 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.159 -0.963 . . . . 0.0 108.632 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -119.0 172.29 7.65 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.009 -1.057 . . . . 0.0 110.315 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.901 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.0 t -137.55 70.75 52.56 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.5 Cg_endo -79.72 116.3 3.47 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.838 2.358 . . . . 0.0 111.465 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.794 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -98.42 172.49 7.5 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 20.0 p -116.04 77.93 1.14 Allowed 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.087 -1.445 . . . . 0.0 110.618 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 88.81 160.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.245 0.545 . . . . 0.0 109.919 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.6 m-20 79.97 -76.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.699 -0.625 . . . . 0.0 110.219 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.561 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 40.94 22.51 0.06 OUTLIER Glycine 0 N--CA 1.493 2.455 0 O-C-N 121.033 -1.042 . . . . 0.0 110.788 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.758 HG23 ' CA ' ' A' ' 27' ' ' GLY . 12.5 mt -72.21 94.57 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.912 -1.346 . . . . 0.0 108.064 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.936 HD21 HG21 ' A' ' 59' ' ' VAL . 5.1 tp -47.78 91.28 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.752 0.787 . . . . 0.0 110.389 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.2 t70 -84.0 -50.56 7.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.49 99.91 2.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.979 -1.076 . . . . 0.0 110.627 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.936 HG21 HD21 ' A' ' 56' ' ' LEU . 4.0 t -83.35 90.73 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 60' ' ' LEU . 55.4 mt -69.09 -7.37 35.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 0.0 109.693 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 73' ' ' LEU . 2.9 mt-10 -131.72 52.76 2.04 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 63' ' ' GLU . 7.0 m-20 -40.93 134.17 2.0 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.46 0.648 . . . . 0.0 109.689 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.865 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -36.08 125.7 0.75 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.485 0.66 . . . . 0.0 110.82 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.23 -4.57 21.95 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 66' ' ' THR . 21.5 m -84.15 166.33 17.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.227 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.604 ' N ' HG22 ' A' ' 65' ' ' THR . 90.0 m -93.73 137.58 32.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.731 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.849 HG21 HG21 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -150.22 153.54 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.492 HG23 ' H ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -116.22 -97.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.057 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.492 ' H ' HG23 ' A' ' 68' ' ' THR . 28.7 p -94.99 -125.68 0.12 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.54 ' CG ' ' HB3' ' A' ' 8' ' ' PRO . 51.7 mtp180 -56.59 84.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.008 -1.058 . . . . 0.0 110.032 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -118.07 85.13 2.29 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.7 tt -34.25 107.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.885 -0.51 . . . . 0.0 111.107 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.874 ' CD1' HG21 ' A' ' 48' ' ' VAL . 15.7 mt -57.3 -38.36 73.87 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.79 -160.49 31.98 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.806 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -135.76 145.98 47.15 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.253 -1.145 . . . . 0.0 109.775 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.806 HD23 ' O ' ' A' ' 75' ' ' ARG . 2.4 mt -129.45 -137.0 0.22 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.568 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 120.779 -1.201 . . . . 0.0 109.228 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.463 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 8.0 t -69.43 98.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 108.733 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -71.91 85.65 0.97 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.903 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -81.17 121.35 34.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.545 -0.722 . . . . 0.0 109.904 -178.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.88 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -145.47 -165.64 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.94 HG21 HG21 ' A' ' 67' ' ' VAL . 29.2 t -134.78 56.9 18.81 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.232 -0.918 . . . . 0.0 109.924 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.668 ' CD ' HD13 ' A' ' 6' ' ' LEU . 37.1 Cg_endo -80.48 36.82 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.495 2.13 . . . . 0.0 110.517 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.549 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.304 -1.392 0 O-C-N 120.948 -1.095 . . . . 0.0 109.593 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.708 ' HB3' HG22 ' A' ' 67' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.292 0.568 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 20.4 m -153.39 131.71 12.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.375 -0.828 . . . . 0.0 110.317 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.741 HG22 HD11 ' A' ' 39' ' ' ILE . 11.4 t -70.18 83.69 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.386 -0.822 . . . . 0.0 109.493 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 19' ' ' VAL . . . -41.96 -63.27 0.76 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 110.493 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 5.4 m -166.94 129.05 1.71 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.59 -1.319 . . . . 0.0 111.479 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.903 ' CZ2' HG21 ' A' ' 5' ' ' ILE . 21.9 m95 -69.66 -167.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.531 0.682 . . . . 0.0 109.292 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.602 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 24.5 m80 -151.83 28.26 0.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.551 ' CE ' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -118.1 167.52 11.4 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.714 0.768 . . . . 0.0 110.434 -178.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.636 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -115.54 -179.83 0.68 Allowed Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -70.74 87.23 0.68 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.426 1.417 . . . . 0.0 110.932 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.605 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 88.2 41.71 6.13 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD1' ' CG ' ' A' ' 25' ' ' LYS . 13.6 m-20 -55.52 -164.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.995 -1.297 . . . . 0.0 109.685 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.43 77.67 0.62 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.019 -1.051 . . . . 0.0 109.391 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.977 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -79.5 -179.06 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.373 -0.829 . . . . 0.0 109.609 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.634 ' N ' HG13 ' A' ' 30' ' ' VAL . 1.5 m -139.1 -48.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.098 -1.001 . . . . 0.0 110.241 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.563 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -150.83 62.27 0.93 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.4 m-20 150.73 75.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.024 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.55 -170.41 3.04 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.298 1.047 . . . . 0.0 111.871 -177.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.849 HG12 ' CD ' ' A' ' 34' ' ' GLU . 3.8 p -50.46 161.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.929 0.871 . . . . 0.0 111.639 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -140.2 61.4 1.53 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.08 HG12 HG12 ' A' ' 48' ' ' VAL . 4.2 p -38.52 168.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.773 0.797 . . . . 0.0 110.736 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.662 ' HB3' HG11 ' A' ' 45' ' ' VAL . 8.2 mt-10 -129.13 125.23 36.66 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.905 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -111.36 -172.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.298 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.706 ' N ' HG23 ' A' ' 39' ' ' ILE . 6.1 mt-10 -134.98 128.78 33.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.998 . . . . 0.0 109.586 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 44' ' ' VAL . 12.4 t -125.92 -32.08 2.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 110.042 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.591 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.1 t70 158.94 70.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.591 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.9 tttm 85.79 -25.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 41' ' ' THR . 92.7 t -108.27 133.78 52.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.34 -0.85 . . . . 0.0 109.267 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.905 HG13 ' O ' ' A' ' 39' ' ' ILE . 55.9 t -118.36 112.52 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.117 -0.989 . . . . 0.0 109.729 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.827 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.29 -179.85 7.0 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.294 -0.878 . . . . 0.0 108.678 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 51.5 mt-10 -141.47 -171.38 3.29 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.86 -1.15 . . . . 0.0 110.451 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.08 HG12 HG12 ' A' ' 37' ' ' VAL . 14.8 p -146.35 75.4 12.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.388 -0.82 . . . . 0.0 109.678 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.749 ' HB3' HD23 ' A' ' 36' ' ' LEU . 35.0 Cg_endo -77.48 105.27 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.225 1.95 . . . . 0.0 110.385 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.024 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -77.56 -177.98 5.04 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.709 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.2 t -130.22 26.61 5.14 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.384 -1.448 . . . . 0.0 110.282 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.1 160.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.512 -0.743 . . . . 0.0 109.246 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.758 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.4 m-20 62.24 -136.32 0.48 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.263 -0.898 . . . . 0.0 108.956 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.745 ' O ' HD23 ' A' ' 76' ' ' LEU . . . 111.9 -17.83 24.66 Favored Glycine 0 N--CA 1.488 2.162 0 O-C-N 120.505 -1.372 . . . . 0.0 109.723 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.605 HG22 ' HA2' ' A' ' 27' ' ' GLY . 1.2 mt -34.24 102.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.789 -0.83 . . . . 0.0 109.371 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.876 HD12 ' HG ' ' A' ' 76' ' ' LEU . 12.2 tp -58.43 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.526 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -114.11 -29.49 6.96 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.405 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.851 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -138.69 106.57 5.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.831 -1.168 . . . . 0.0 110.506 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.809 ' CG2' HD11 ' A' ' 56' ' ' LEU . 18.2 t -127.56 76.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.78 -4.15 18.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.554 -0.716 . . . . 0.0 110.563 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.59 ' HG2' HG21 ' A' ' 65' ' ' THR . 10.0 mt-10 -128.32 50.37 2.09 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 108.787 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 63' ' ' GLU . 7.2 m-20 -51.18 118.2 3.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.568 -0.707 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 62' ' ' ASP . 1.6 mp0 5.56 113.25 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.21 -32.3 6.2 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.59 HG21 ' HG2' ' A' ' 61' ' ' GLU . 78.9 m -54.3 153.23 5.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -1.135 . . . . 0.0 109.276 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.408 ' O ' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -69.82 155.56 40.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.367 -0.833 . . . . 0.0 109.588 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.94 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -149.6 174.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -139.83 -172.2 3.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.013 . . . . 0.0 109.408 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.604 ' H ' HG22 ' A' ' 68' ' ' THR . 0.2 OUTLIER -86.19 46.76 1.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 109.133 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER 158.88 32.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 6' ' ' LEU . 77.2 mm-40 -112.94 149.89 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.992 -1.067 . . . . 0.0 109.125 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.2 tt -97.07 113.22 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.483 -0.761 . . . . 0.0 110.686 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.578 HD12 HG13 ' A' ' 5' ' ' ILE . 1.3 mt -47.56 -36.99 11.36 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.691 ' O ' HG22 ' A' ' 5' ' ' ILE . . . 163.99 -162.08 34.87 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.851 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 1.1 ptt180 -136.12 150.09 48.95 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.625 -1.514 . . . . 0.0 110.053 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.876 ' HG ' HD12 ' A' ' 56' ' ' LEU . 5.3 mp -111.07 -115.03 0.31 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.544 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 20.3 ttt-85 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 120.863 -1.148 . . . . 0.0 109.304 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.463 ' HB3' ' N ' ' A' ' 77' ' ' ARG . 1.5 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.773 HG21 ' OE1' ' A' ' 34' ' ' GLU . 43.3 t -84.42 68.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.842 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -71.72 85.82 0.92 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.857 HG12 HG13 ' A' ' 48' ' ' VAL . 0.7 OUTLIER -102.93 158.48 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.247 -0.908 . . . . 0.0 111.586 -177.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.848 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -137.62 -151.8 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 7' ' ' VAL . 85.6 t -132.25 54.32 13.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.864 -1.148 . . . . 0.0 109.688 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 36.6 Cg_endo -77.04 67.0 7.67 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.557 2.171 . . . . 0.0 110.637 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 1.016 ' HB2' HD13 ' A' ' 46' ' ' LEU . 1.1 m-20 . . . . . 0 C--N 1.303 -1.434 0 O-C-N 121.086 -1.009 . . . . 0.0 109.831 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.357 0.599 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.484 ' C ' HG13 ' A' ' 39' ' ' ILE . 19.6 m -148.04 132.41 17.56 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.922 . . . . 0.0 110.192 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.657 HG22 HD11 ' A' ' 39' ' ' ILE . 16.6 t -69.0 87.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.937 . . . . 0.0 109.063 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -51.01 -63.48 1.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 111.08 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.909 HG23 ' OE1' ' A' ' 63' ' ' GLU . 1.8 m -161.61 123.61 2.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.574 -1.329 . . . . 0.0 112.019 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 1.036 ' HA ' HG23 ' A' ' 37' ' ' VAL . 16.9 m95 -68.6 -166.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.598 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 20.0 m80 -154.45 28.84 0.44 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.693 ' O ' HD22 ' A' ' 56' ' ' LEU . 4.9 tppt? -123.07 122.89 39.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.714 -0.616 . . . . 0.0 110.247 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.593 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -71.3 179.06 1.01 Allowed Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -68.17 89.88 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.597 1.532 . . . . 0.0 111.672 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.666 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 78.86 45.15 9.43 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.754 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 13.6 m-20 -59.43 -117.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.077 -1.249 . . . . 0.0 110.331 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 159.1 101.79 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.772 -1.205 . . . . 0.0 108.534 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.93 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -102.16 -179.4 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.938 -1.101 . . . . 0.0 109.971 -179.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.716 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -105.09 -91.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 0.0 110.048 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.519 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -117.9 43.83 2.33 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.034 -1.041 . . . . 0.0 109.068 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.565 ' C ' HG11 ' A' ' 30' ' ' VAL . 17.8 m-20 171.74 99.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.93 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -97.97 -160.38 0.8 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.348 -177.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.942 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 6.3 p -34.95 165.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.496 1.141 . . . . 0.0 112.94 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.566 HD12 ' ND1' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -148.74 58.11 1.05 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.036 HG23 ' HA ' ' A' ' 22' ' ' TRP . 2.3 p -39.39 167.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.88 0.848 . . . . 0.0 110.836 -177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.577 ' HB3' HG11 ' A' ' 45' ' ' VAL . 24.1 mt-10 -130.81 121.61 25.65 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.952 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -103.97 -170.17 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.313 -0.867 . . . . 0.0 109.483 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.753 ' N ' HG23 ' A' ' 39' ' ' ILE . 2.5 mt-10 -153.2 101.37 2.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.122 -0.986 . . . . 0.0 109.767 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -97.12 -35.3 10.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.905 . . . . 0.0 109.9 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 11.4 t70 171.62 72.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.725 . . . . 0.0 109.704 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.4 tmmt? 85.8 -24.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.96 131.17 57.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.232 -0.917 . . . . 0.0 109.578 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.952 HG13 ' O ' ' A' ' 39' ' ' ILE . 94.3 t -113.84 123.31 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.838 . . . . 0.0 109.475 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD13 ' HB2' ' A' ' 9' ' ' ASP . 5.9 mt -86.44 178.24 7.18 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.163 -0.961 . . . . 0.0 108.816 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 27.2 mt-10 -126.58 175.84 7.64 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.811 -1.181 . . . . 0.0 110.835 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.916 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.9 t -139.46 71.99 37.86 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.3 Cg_endo -79.29 116.27 3.59 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.534 2.156 . . . . 0.0 109.797 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 34' ' ' GLU . . . -97.29 -175.66 3.29 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.945 -1.097 . . . . 0.0 108.524 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.7 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 12.3 p -131.5 70.16 1.47 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.644 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 98.53 136.95 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 121.253 0.549 . . . . 0.0 112.029 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.638 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 8.3 t0 101.34 -76.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.504 0.669 . . . . 0.0 110.019 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.605 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . 43.27 21.6 0.15 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.666 HG23 ' CA ' ' A' ' 27' ' ' GLY . 6.7 mt -77.65 90.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.835 -1.391 . . . . 0.0 107.583 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.889 HD12 ' HG ' ' A' ' 76' ' ' LEU . 7.2 tp -44.0 111.2 0.27 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.447 0.641 . . . . 0.0 110.144 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 12.5 t70 -134.28 -29.88 1.21 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.608 -0.682 . . . . 0.0 110.245 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -137.65 39.56 2.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.622 -1.299 . . . . 0.0 110.964 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 59' ' ' VAL . 9.1 p -83.82 71.52 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.53 0.38 10.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 110.756 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 73' ' ' LEU . 9.1 mm-40 -105.08 41.54 1.33 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.2 m-20 -37.94 124.83 1.17 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.422 0.63 . . . . 0.0 110.005 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.909 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.2 OUTLIER -29.47 122.14 0.15 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.498 0.666 . . . . 0.0 111.35 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.35 -13.35 8.35 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.445 ' HB ' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -83.37 174.43 10.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -1.062 . . . . 0.0 109.367 179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -96.19 144.89 26.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 110.021 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.612 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.69 169.44 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.544 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -127.49 -143.14 0.28 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 7' ' ' VAL . 11.1 t -69.67 -102.09 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.008 -1.057 . . . . 0.0 108.972 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 71' ' ' GLN . 3.7 mtt180 -78.07 36.7 0.23 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.127 -0.983 . . . . 0.0 111.377 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.518 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 61.4 mm-40 -61.73 -113.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.49 -1.381 . . . . 0.0 107.991 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 72' ' ' ILE . 16.0 tt 179.34 115.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.694 -1.254 . . . . 0.0 110.725 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.65 ' CD1' HG21 ' A' ' 48' ' ' VAL . 7.8 mt -71.84 -44.47 63.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.38 -159.76 28.79 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.772 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 13.6 mtt180 -135.34 135.39 40.69 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.263 -1.14 . . . . 0.0 108.903 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.889 ' HG ' HD12 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -85.33 -105.23 0.05 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.353 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.541 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 120.928 -1.108 . . . . 0.0 109.799 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.484 ' CB ' ' HB2' ' A' ' 75' ' ' ARG . 7.6 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.869 HG21 ' OE1' ' A' ' 34' ' ' GLU . 14.1 t -80.58 75.62 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 108.916 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.584 ' OD2' HD11 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -78.74 78.17 5.2 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.814 HG12 HG13 ' A' ' 48' ' ' VAL . 4.5 tp -88.1 154.28 3.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.259 -0.901 . . . . 0.0 110.799 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.843 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.82 -151.44 0.45 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.334 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.1 HG21 HG21 ' A' ' 67' ' ' VAL . 59.6 t -133.63 60.59 47.78 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.034 -1.041 . . . . 0.0 110.167 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -81.14 34.02 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.538 2.159 . . . . 0.0 110.521 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 1.008 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.307 -1.269 0 O-C-N 121.008 -1.057 . . . . 0.0 109.689 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.522 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 33.6 m -160.1 119.11 2.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.862 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.8 t -48.43 134.11 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 108.996 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -106.76 -57.43 2.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.676 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 32.5 m -160.88 119.14 2.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.849 -1.157 . . . . 0.0 111.208 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.901 ' HA ' HG23 ' A' ' 37' ' ' VAL . 21.2 m95 -68.94 -165.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 18.6 m80 -156.17 48.22 0.48 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.774 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.12 119.72 13.23 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.493 -0.754 . . . . 0.0 110.179 -179.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.607 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -62.0 -179.25 0.22 Allowed Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.1 Cg_endo -67.69 88.88 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.277 1.318 . . . . 0.0 111.111 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.698 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 76.05 46.89 12.21 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.742 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.3 m-20 -59.1 -115.63 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.888 -1.36 . . . . 0.0 109.543 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.742 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 163.23 98.56 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.565 -1.334 . . . . 0.0 109.422 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.921 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -92.74 -176.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.111 -0.993 . . . . 0.0 109.742 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.712 HG13 ' H ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -141.79 -62.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.43 -0.794 . . . . 0.0 109.471 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.712 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -132.52 58.72 1.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -0.979 . . . . 0.0 108.986 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.732 ' O ' HG21 ' A' ' 30' ' ' VAL . 14.8 m-20 151.51 76.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.056 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -71.94 -173.64 1.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.348 1.07 . . . . 0.0 111.773 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.761 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 14.0 p -45.2 168.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.603 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -147.96 61.37 1.12 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.939 HG12 ' HB ' ' A' ' 48' ' ' VAL . 2.7 p -39.46 166.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.728 0.775 . . . . 0.0 110.404 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.844 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 5.1 mm-40 -128.72 97.3 4.63 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.776 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.72 -165.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.473 -0.767 . . . . 0.0 109.254 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.776 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -139.68 141.03 37.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.937 -1.102 . . . . 0.0 110.097 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.76 HG22 ' O ' ' A' ' 41' ' ' THR . 97.5 m -146.4 21.28 1.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.44 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 18.8 t0 64.73 88.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 109.568 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 86.15 -26.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.443 ' O ' ' HB ' ' A' ' 41' ' ' THR . 55.3 t -116.22 142.21 30.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 39' ' ' ILE . 96.9 t -136.21 118.03 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD13 ' HB2' ' A' ' 9' ' ' ASP . 3.9 mt -82.77 162.47 21.7 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.307 -0.871 . . . . 0.0 108.969 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -119.54 175.44 5.84 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.039 -1.038 . . . . 0.0 110.176 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.939 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.8 t -140.54 68.69 31.6 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 109.182 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.51 110.13 2.15 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.633 2.222 . . . . 0.0 110.399 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.056 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -89.84 179.27 6.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.672 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -125.71 72.4 1.28 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.552 -1.343 . . . . 0.0 110.215 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 101.58 162.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.507 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.857 ' O ' HG12 ' A' ' 30' ' ' VAL . 11.9 m-20 64.78 -142.01 0.24 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.641 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 101.11 -7.41 56.89 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.077 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.698 HG23 ' CA ' ' A' ' 27' ' ' GLY . 6.1 mt -41.18 96.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.836 ' CD1' HG22 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -41.58 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.761 0.791 . . . . 0.0 109.416 -178.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ILE . 51.8 t0 -101.59 -52.24 3.26 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.699 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.93 105.42 3.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.895 -1.128 . . . . 0.0 110.531 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.836 HG22 ' CD1' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -102.02 90.03 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 mt -69.79 -5.01 22.54 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 110.083 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' A' ' 73' ' ' LEU . 3.6 mt-10 -124.51 40.96 3.62 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.156 -0.965 . . . . 0.0 108.922 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.6 m-20 -42.22 128.73 3.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.58 -0.7 . . . . 0.0 109.554 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.545 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -26.89 121.7 0.09 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.317 0.58 . . . . 0.0 110.972 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.86 -16.2 7.82 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 66' ' ' THR . 73.0 m -88.14 160.06 17.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -1.17 . . . . 0.0 109.58 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.498 ' N ' HG22 ' A' ' 65' ' ' THR . 58.2 m -78.74 157.54 28.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 109.546 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.1 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.59 169.68 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.725 HG22 ' CG ' ' A' ' 71' ' ' GLN . 5.4 t -141.38 -152.05 0.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.362 -0.836 . . . . 0.0 109.123 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.677 ' N ' HG23 ' A' ' 68' ' ' THR . 12.8 p -93.38 58.68 2.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.051 -1.03 . . . . 0.0 109.624 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.7 mtp-105 160.3 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.542 -0.724 . . . . 0.0 109.755 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.725 ' CG ' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -46.87 133.92 10.54 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.668 HG23 ' O ' ' A' ' 72' ' ' ILE . 11.5 tt -86.32 110.72 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.827 ' CD1' HG21 ' A' ' 48' ' ' VAL . 18.5 mt -50.17 -44.87 52.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.015 -1.053 . . . . 0.0 108.205 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.51 -175.36 34.16 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.746 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.6 ptt180 -118.46 143.75 46.48 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.248 -1.148 . . . . 0.0 109.804 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.888 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 6.4 mt -114.8 -79.75 0.59 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.935 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.784 0 O-C-N 121.257 -0.902 . . . . 0.0 109.251 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.543 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 8.6 m . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.707 ' O ' HG12 ' A' ' 3' ' ' VAL . 9.6 t -69.53 84.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.046 -1.034 . . . . 0.0 108.464 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 2.5 m-20 -74.61 83.42 2.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.101 ' CG1' HG22 ' A' ' 48' ' ' VAL . 3.5 tp -104.31 146.27 11.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.172 -177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.784 ' O ' HG23 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -134.85 -164.63 1.55 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.592 HG21 HD12 ' A' ' 39' ' ' ILE . 20.9 t -133.03 86.96 41.17 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.979 -1.076 . . . . 0.0 110.418 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.532 ' CA ' ' HG2' ' A' ' 70' ' ' ARG . 36.8 Cg_endo -81.44 54.56 5.2 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.578 2.185 . . . . 0.0 110.082 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.926 ' CB ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.288 0 O-C-N 121.101 -0.999 . . . . 0.0 110.256 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.321 0.582 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 16.0 m -153.21 138.49 17.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 110.347 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.587 ' HA ' HG13 ' A' ' 39' ' ' ILE . 11.2 t -76.79 99.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 0.0 109.53 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -57.49 -54.9 41.58 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 110.606 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.597 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 21.7 m -168.87 131.03 1.26 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.605 -1.31 . . . . 0.0 111.815 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 1.052 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.5 m95 -68.65 -162.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.7 ' HB2' HG23 ' A' ' 35' ' ' VAL . 26.3 m80 -155.14 34.13 0.38 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.927 ' CB ' HD23 ' A' ' 56' ' ' LEU . 1.6 mmmt -124.59 128.4 48.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.85 -0.531 . . . . 0.0 110.317 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.638 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -79.91 -174.68 0.51 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.5 Cg_endo -68.25 84.14 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.069 1.179 . . . . 0.0 111.564 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.559 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 78.83 47.46 7.75 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.742 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.0 m-20 -55.34 -110.74 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.047 -1.266 . . . . 0.0 110.426 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.742 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 157.86 99.78 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.926 -1.109 . . . . 0.0 108.67 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.828 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -102.56 -177.35 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.831 -1.168 . . . . 0.0 109.718 -179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.725 ' N ' HG13 ' A' ' 30' ' ' VAL . 5.8 m -130.03 -113.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.146 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 4.9 mtt180 -87.11 63.6 7.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.827 -1.171 . . . . 0.0 109.175 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 4.1 m-20 150.66 101.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.028 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -97.73 -174.05 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.247 1.023 . . . . 0.0 111.656 -178.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.866 HG12 ' OE2' ' A' ' 34' ' ' GLU . 3.7 p -44.23 157.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-O 121.978 0.894 . . . . 0.0 111.704 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -134.55 63.38 1.62 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 178.119 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.052 HG23 ' HA ' ' A' ' 22' ' ' TRP . 5.5 p -38.92 168.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.78 0.8 . . . . 0.0 110.178 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' N ' HG22 ' A' ' 37' ' ' VAL . 4.8 mt-10 -123.19 139.61 53.87 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.933 HD11 HG21 ' A' ' 67' ' ' VAL . 1.9 tt -121.94 -163.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.978 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.802 ' N ' HG23 ' A' ' 39' ' ' ILE . 21.8 mm-40 -141.36 117.41 10.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.853 -1.154 . . . . 0.0 109.964 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.634 HG21 HD21 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -115.13 -64.17 1.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.566 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 49.0 t0 177.98 82.53 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.2 tttt 86.84 -26.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 41' ' ' THR . 1.9 t -113.18 163.31 10.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.309 -0.87 . . . . 0.0 109.201 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 39' ' ' ILE . 43.9 t -131.75 122.85 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.926 HD13 ' CB ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -79.66 158.91 26.9 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.317 -0.864 . . . . 0.0 108.734 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.5 pm0 -120.82 178.15 4.82 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.007 -1.058 . . . . 0.0 110.226 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.101 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -145.04 77.97 12.76 Favored Pre-proline 0 N--CA 1.489 1.518 0 CA-C-O 122.285 1.04 . . . . 0.0 108.778 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.0 Cg_endo -81.24 108.84 2.05 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.89 2.393 . . . . 0.0 111.966 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.028 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -78.02 -157.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.739 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.2 p -140.37 10.92 2.32 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.541 -1.349 . . . . 0.0 111.196 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.04 159.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER 78.91 -73.82 0.07 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.459 0.647 . . . . 0.0 110.272 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.551 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 45.3 16.88 0.1 Allowed Glycine 0 N--CA 1.489 2.194 0 O-C-N 121.212 -0.93 . . . . 0.0 111.655 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.56 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 2.2 mt -68.6 88.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.678 -1.483 . . . . 0.0 108.041 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.927 HD23 ' CB ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -40.81 103.45 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 1.1 t0 -123.21 -52.01 1.86 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 111.018 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -136.15 82.61 1.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.512 -1.368 . . . . 0.0 111.155 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.859 ' CG2' HD11 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -79.9 103.2 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 29.4 mt -69.34 -11.82 61.14 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.093 -1.005 . . . . 0.0 109.533 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 9.5 mm-40 -132.42 56.09 1.85 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 61' ' ' GLU . 3.2 m-20 -40.74 136.18 1.46 Allowed 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.579 -0.7 . . . . 0.0 109.715 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.597 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -39.49 125.56 1.74 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.426 0.632 . . . . 0.0 110.822 -179.248 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.76 -4.64 19.07 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -97.75 153.07 18.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -1.134 . . . . 0.0 109.365 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.75 155.48 40.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.932 . . . . 0.0 109.446 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.933 HG21 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.32 162.43 3.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.557 -0.715 . . . . 0.0 109.279 -179.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.423 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 2.8 m -116.34 -133.24 0.33 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.48 -0.762 . . . . 0.0 109.328 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 7' ' ' VAL . 7.3 p -69.59 -104.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.883 -1.136 . . . . 0.0 109.63 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.588 ' HD2' HD22 ' A' ' 6' ' ' LEU . 4.9 mtm180 -80.21 39.9 0.46 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.55 ' HB2' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -62.6 107.04 0.87 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.757 -1.214 . . . . 0.0 108.896 179.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.7 tt -43.28 110.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.011 ' CD1' HG11 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -52.91 -36.9 60.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 154.32 165.58 14.02 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.729 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.48 137.2 45.95 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.241 -1.153 . . . . 0.0 109.781 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.772 HD12 ' N ' ' A' ' 76' ' ' LEU . 5.5 mp -106.87 -94.11 0.38 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.552 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.56 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 4.2 tpt180 . . . . . 0 C--N 1.299 -1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 72.5 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 76' ' ' LEU . 57.9 t -72.69 81.03 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.59 78.51 6.13 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.775 HG12 HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -92.26 149.71 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.479 -0.763 . . . . 0.0 111.161 -177.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -132.8 -158.67 0.91 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.04 ' CG1' HD12 ' A' ' 46' ' ' LEU . 60.3 t -130.49 59.84 48.45 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 120.866 -1.146 . . . . 0.0 110.145 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.9 Cg_endo -81.41 19.92 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.589 2.193 . . . . 0.0 110.531 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 1.033 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.298 0 O-C-N 120.891 -1.131 . . . . 0.0 110.579 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.539 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 79.5 m -158.76 134.79 9.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 110.681 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.639 HG22 ' CD1' ' A' ' 39' ' ' ILE . 22.0 t -69.18 84.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.412 -0.805 . . . . 0.0 109.231 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -43.6 -63.16 0.89 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.092 -1.005 . . . . 0.0 110.245 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.608 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 87.3 m -164.19 124.19 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.648 -1.283 . . . . 0.0 111.658 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.997 ' HA ' HG23 ' A' ' 37' ' ' VAL . 19.1 m95 -68.44 -167.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.636 ' HB2' HG23 ' A' ' 35' ' ' VAL . 17.3 m80 -152.14 24.1 0.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.544 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 2.2 tppm? -118.45 128.18 54.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.793 -0.567 . . . . 0.0 109.941 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.569 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -78.94 178.61 2.18 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.4 Cg_endo -69.21 93.26 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.644 1.562 . . . . 0.0 111.466 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.685 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 78.28 43.13 13.62 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.756 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 12.5 m-20 -61.36 -120.24 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.002 -1.293 . . . . 0.0 109.651 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 159.58 79.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.73 -1.231 . . . . 0.0 108.843 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.851 HG12 ' OE2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -79.73 -168.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.12 -0.987 . . . . 0.0 109.652 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.817 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -134.99 -99.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.31 -0.869 . . . . 0.0 109.845 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.469 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 16.3 ttt-85 -98.37 38.5 1.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.871 -1.143 . . . . 0.0 109.522 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.731 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.6 m-20 178.5 91.42 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.108 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -83.37 -170.24 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.263 1.03 . . . . 0.0 112.102 -178.041 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.636 HG23 ' HB2' ' A' ' 23' ' ' HIS . 3.1 p -55.97 164.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.453 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.568 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -142.08 62.07 1.44 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.011 HG12 ' HB ' ' A' ' 48' ' ' VAL . 3.3 p -38.95 165.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-O 121.682 0.753 . . . . 0.0 110.204 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.787 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.3 mt-10 -128.37 97.58 4.78 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.786 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.76 -164.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 O-C-N 121.397 -0.814 . . . . 0.0 108.976 -179.48 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.786 ' N ' HG23 ' A' ' 39' ' ' ILE . 3.9 mm-40 -134.48 112.83 11.23 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.974 -1.079 . . . . 0.0 109.775 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.556 ' OG1' HD21 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -108.16 -145.58 0.39 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -0.87 . . . . 0.0 109.196 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 6.8 t70 -96.73 83.24 3.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.086 -1.009 . . . . 0.0 109.592 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.2 tmtt? 85.98 -22.23 0.19 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.223 0.535 . . . . 0.0 109.585 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 45' ' ' VAL . 95.2 t -113.61 164.74 9.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.307 -0.871 . . . . 0.0 109.612 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.59 HG11 ' OE1' ' A' ' 38' ' ' GLU . 54.9 t -127.64 125.64 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.04 HD12 ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -79.62 155.34 28.14 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.297 -0.877 . . . . 0.0 108.823 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -112.17 172.65 6.78 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.043 -1.036 . . . . 0.0 110.594 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.011 ' HB ' HG12 ' A' ' 37' ' ' VAL . 8.6 t -142.2 70.35 22.62 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.27 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.24 113.45 2.67 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.72 2.28 . . . . 0.0 111.288 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.108 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -88.5 -164.52 1.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.675 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 10.0 p -141.09 60.06 1.52 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.548 -1.261 . . . . 0.0 110.623 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.675 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 105.43 160.99 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.412 0.625 . . . . 0.0 110.658 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 74.95 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.619 -0.676 . . . . 0.0 110.188 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' OE2' ' A' ' 34' ' ' GLU . . . 54.56 8.51 1.28 Allowed Glycine 0 N--CA 1.495 2.582 0 O-C-N 121.051 -1.03 . . . . 0.0 111.778 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.685 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -55.11 92.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 120.612 -1.522 . . . . 0.0 107.797 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.871 HD12 ' HG ' ' A' ' 76' ' ' LEU . 8.8 tp -44.7 112.88 0.47 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.468 -0.77 . . . . 0.0 109.527 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -118.84 -43.36 2.67 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.653 -0.654 . . . . 0.0 110.07 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.552 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -143.06 78.12 1.59 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.858 -1.151 . . . . 0.0 110.776 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.815 HG21 HD21 ' A' ' 56' ' ' LEU . 8.4 t -79.46 87.59 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.8 mt -69.55 -4.42 18.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 0.0 110.334 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.502 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 2.5 mt-10 -129.21 50.89 2.1 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.0 m-20 -42.58 127.43 3.84 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.696 -0.627 . . . . 0.0 109.489 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.608 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.12 121.05 0.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.449 0.642 . . . . 0.0 111.079 -179.199 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.89 -1.45 19.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 66' ' ' THR . 22.5 m -97.89 159.98 14.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -1.137 . . . . 0.0 109.347 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.492 ' N ' HG22 ' A' ' 65' ' ' THR . 0.2 OUTLIER -70.99 149.33 46.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.64 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.724 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.24 169.45 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.537 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -138.63 -176.39 4.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.365 -0.834 . . . . 0.0 109.052 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -83.69 69.52 10.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.231 -0.918 . . . . 0.0 109.329 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 69' ' ' SER . 10.3 ttm180 158.61 -22.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.6 mm-40 -57.62 159.17 5.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.876 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 72' ' ' ILE . 15.8 tt -103.81 113.25 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.696 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.877 ' CD1' HG21 ' A' ' 48' ' ' VAL . 9.3 mt -49.86 -47.1 51.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 108.269 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.72 -166.36 34.37 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.552 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.86 141.6 51.51 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.322 -1.104 . . . . 0.0 109.681 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.871 ' HG ' HD12 ' A' ' 56' ' ' LEU . 2.8 mp -101.29 -104.19 0.25 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.295 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.554 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 O-C-N 120.873 -1.142 . . . . 0.0 109.984 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 15.4 m . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 77' ' ' ARG . 38.5 t -78.03 77.85 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.01 . . . . 0.0 108.52 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.71 85.88 0.92 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.012 HG12 HG22 ' A' ' 48' ' ' VAL . 3.5 tp -110.09 141.0 26.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 111.058 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.855 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -127.47 -145.54 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.91 HG23 HD21 ' A' ' 73' ' ' LEU . 69.1 t -132.94 58.82 38.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.957 -1.09 . . . . 0.0 109.315 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 34.5 Cg_endo -75.8 68.33 6.41 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.616 2.21 . . . . 0.0 111.108 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.543 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.304 -1.383 0 O-C-N 121.179 -0.951 . . . . 0.0 109.346 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.447 0.641 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 65' ' ' THR . 18.4 m -160.23 125.9 4.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.398 -0.814 . . . . 0.0 109.519 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 61' ' ' GLU . 2.6 t -52.54 141.62 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 109.071 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -117.7 -50.07 2.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.114 -0.991 . . . . 0.0 109.877 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.501 ' N ' ' HB3' ' A' ' 63' ' ' GLU . 52.6 m -164.56 114.12 1.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.885 -1.135 . . . . 0.0 111.128 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.902 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.2 m95 -68.56 -162.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.833 . . . . 0.0 108.756 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.608 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 20.8 m80 -160.08 26.14 0.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.867 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -114.63 114.5 25.76 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.595 -178.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.651 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 11.3 mmmt -59.55 173.34 0.52 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -66.92 96.5 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.516 1.477 . . . . 0.0 110.829 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.816 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 80.72 50.33 5.32 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 3.0 m-20 -55.72 -150.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.485 -1.009 . . . . 0.0 110.382 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -175.39 96.61 0.07 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.541 -1.349 . . . . 0.0 108.57 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.657 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -110.58 -176.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.891 -179.004 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.657 ' N ' HG13 ' A' ' 30' ' ' VAL . 2.1 p -125.72 -49.6 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.598 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -157.13 61.49 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.367 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.598 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.5 m-20 146.0 100.6 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.145 ' CG ' ' HB3' ' A' ' 50' ' ' ALA . 1.9 pt-20 -131.39 -164.07 1.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.938 -1.101 . . . . 0.0 112.028 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.826 HG21 ' HE3' ' A' ' 22' ' ' TRP . 4.0 p -13.58 136.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.068 0.937 . . . . 0.0 113.309 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -130.55 62.86 1.58 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.902 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.2 p -37.56 166.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.891 0.853 . . . . 0.0 110.807 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.0 mt-10 -125.03 95.61 4.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.938 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -79.86 -160.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 121.419 -0.8 . . . . 0.0 109.18 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.814 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -136.62 151.55 49.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.872 -1.143 . . . . 0.0 109.973 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 41' ' ' THR . 98.4 m -156.41 31.8 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.593 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 10.8 t0 47.78 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 109.637 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 85.27 -27.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.845 -0.535 . . . . 0.0 109.741 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.476 ' HB ' ' HB ' ' A' ' 41' ' ' THR . 1.8 t -120.85 152.43 24.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.154 -0.966 . . . . 0.0 109.538 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.938 HG13 ' O ' ' A' ' 39' ' ' ILE . 24.1 t -149.38 97.57 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.384 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.854 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.67 164.65 23.59 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.211 -0.931 . . . . 0.0 109.153 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 48.0 mt-10 -112.37 -165.92 1.03 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.211 -0.93 . . . . 0.0 109.761 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.012 HG22 HG12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -152.69 78.37 6.18 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 122.154 0.978 . . . . 0.0 109.187 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.66 110.08 2.35 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.838 2.359 . . . . 0.0 111.178 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.145 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . . . -74.14 -162.67 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -148.48 33.9 0.79 Allowed 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.975 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 155.89 151.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.932 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.6 OUTLIER 65.84 -93.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.52 -0.738 . . . . 0.0 110.541 179.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 74.18 -9.73 9.11 Favored Glycine 0 N--CA 1.486 2.001 0 O-C-N 120.674 -1.267 . . . . 0.0 110.466 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.816 HG23 ' HA2' ' A' ' 27' ' ' GLY . 1.1 mp -40.29 94.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.555 1.178 . . . . 0.0 108.541 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.895 HD11 HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -50.47 92.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 55' ' ' ILE . 8.6 t70 -111.69 -44.78 3.44 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.815 -0.553 . . . . 0.0 110.776 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -138.72 98.26 3.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.554 -1.342 . . . . 0.0 111.14 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 56' ' ' LEU . 1.7 t -109.74 88.96 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 mt -69.48 -4.03 17.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 110.592 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.685 ' O ' HG21 ' A' ' 19' ' ' VAL . 10.0 mt-10 -127.16 44.32 2.94 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.113 -0.992 . . . . 0.0 108.564 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -46.07 136.34 6.8 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.465 -0.772 . . . . 0.0 109.32 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.54 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -31.9 107.2 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.418 0.628 . . . . 0.0 110.481 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.41 -7.78 3.41 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.776 ' O ' HG23 ' A' ' 18' ' ' THR . 0.1 OUTLIER -100.01 178.83 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -1.17 . . . . 0.0 109.748 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 m -99.97 151.24 21.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.85 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.882 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.89 171.18 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.359 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.558 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 1.4 m -134.29 -141.38 0.19 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 108.975 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 7' ' ' VAL . 2.2 p -69.35 -104.48 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.945 -1.097 . . . . 0.0 109.054 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.709 ' HG2' HD22 ' A' ' 6' ' ' LEU . 28.0 ttp180 -79.2 37.86 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.066 . . . . 0.0 110.755 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.766 ' O ' HD23 ' A' ' 6' ' ' LEU . 12.6 mm100 -63.92 -112.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.76 -1.212 . . . . 0.0 108.582 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 72' ' ' ILE . 12.4 tt -179.0 116.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.836 -1.165 . . . . 0.0 110.392 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.91 HD21 HG23 ' A' ' 7' ' ' VAL . 9.7 mt -72.96 -49.94 26.31 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.13 -0.981 . . . . 0.0 108.4 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 59' ' ' VAL . . . 161.57 169.73 25.27 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.723 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -110.73 138.57 46.95 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.13 -1.218 . . . . 0.0 110.089 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.778 HD12 ' N ' ' A' ' 76' ' ' LEU . 5.0 mp -106.47 -88.63 0.45 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.702 ' O ' HG23 ' A' ' 3' ' ' VAL . 5.5 ttt180 . . . . . 0 C--N 1.296 -1.758 0 O-C-N 121.568 -0.708 . . . . 0.0 109.453 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 77' ' ' ARG . 66.3 m . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.785 ' O ' HG12 ' A' ' 3' ' ' VAL . 4.7 t -77.96 77.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -83.6 84.11 7.66 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.827 HG12 HG13 ' A' ' 48' ' ' VAL . 6.5 tp -89.48 158.04 2.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.375 -0.828 . . . . 0.0 111.583 -177.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.858 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -137.44 -151.56 0.4 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 67' ' ' VAL . 33.2 t -138.21 57.25 12.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.7 -1.25 . . . . 0.0 110.085 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -79.94 47.56 2.57 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.617 2.211 . . . . 0.0 110.843 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.563 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 3.0 m-20 . . . . . 0 C--N 1.304 -1.388 0 O-C-N 120.945 -1.097 . . . . 0.0 109.616 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.514 ' C ' HG12 ' A' ' 39' ' ' ILE . 1.1 m -134.74 129.06 34.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.17 -0.956 . . . . 0.0 110.233 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.988 ' CG1' HD11 ' A' ' 73' ' ' LEU . 7.0 t -75.61 103.93 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.378 -0.827 . . . . 0.0 109.188 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -65.02 -62.15 1.73 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.747 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.624 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 52.9 m -168.65 132.29 1.47 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.276 -1.37 . . . . 0.0 112.289 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 1.067 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.4 m95 -68.99 -168.77 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.61 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.8 m80 -150.91 30.98 0.63 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.745 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -122.38 123.78 42.14 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.706 -0.621 . . . . 0.0 110.389 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.595 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -74.57 -178.87 0.88 Allowed Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -68.18 90.55 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.282 1.321 . . . . 0.0 111.001 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.796 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 76.47 46.23 12.47 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.727 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 14.1 m-20 -59.7 -118.07 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.933 -1.333 . . . . 0.0 109.794 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 162.91 100.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.583 -1.323 . . . . 0.0 109.493 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.884 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -100.99 -175.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.185 -0.947 . . . . 0.0 109.987 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.719 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -141.15 -73.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 109.608 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.676 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -119.81 61.55 0.84 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.055 -1.028 . . . . 0.0 109.426 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.608 ' O ' HG21 ' A' ' 30' ' ' VAL . 3.7 m-20 145.32 84.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.069 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -76.1 -168.78 0.99 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.001 0.905 . . . . 0.0 111.533 -178.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.862 HG12 ' OE2' ' A' ' 34' ' ' GLU . 7.5 p -49.54 166.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.572 0.701 . . . . 0.0 110.836 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.618 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -144.85 59.05 1.31 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.078 HG21 HD21 ' A' ' 73' ' ' LEU . 2.7 p -39.18 166.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.63 0.728 . . . . 0.0 110.296 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -127.52 142.7 51.32 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.964 HD11 HG11 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -127.56 -166.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.778 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -143.9 88.48 1.98 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.86 -1.15 . . . . 0.0 110.056 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.44 -146.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.393 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 20.6 t0 -97.72 85.94 3.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.3 tttm 86.28 -25.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.273 0.558 . . . . 0.0 109.526 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.17 135.43 52.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.173 -0.955 . . . . 0.0 109.719 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.846 HG13 ' O ' ' A' ' 39' ' ' ILE . 41.2 t -118.77 105.31 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 109.408 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.841 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.99 179.86 7.37 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.272 -0.892 . . . . 0.0 109.349 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 48' ' ' VAL . 22.9 mt-10 -134.82 -148.9 0.33 Allowed 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.958 -1.089 . . . . 0.0 110.566 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.863 ' HB ' HG12 ' A' ' 37' ' ' VAL . 11.9 t -154.89 69.74 5.73 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.327 -0.858 . . . . 0.0 109.29 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.79 104.5 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.592 2.195 . . . . 0.0 111.023 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.069 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -83.27 -178.53 7.11 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.6 p -121.93 24.47 9.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.093 -1.629 . . . . 0.0 111.338 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.71 160.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.213 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.723 ' O ' HG12 ' A' ' 30' ' ' VAL . 2.5 t0 61.43 -139.39 0.51 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.04 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 115.29 -8.26 20.64 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.796 HG23 ' HA2' ' A' ' 27' ' ' GLY . 10.7 mt -42.39 98.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.029 HD12 HD22 ' A' ' 76' ' ' LEU . 9.6 tp -48.82 90.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.595 0.712 . . . . 0.0 109.648 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.8 t0 -82.18 -58.11 3.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.946 -0.471 . . . . 0.0 110.001 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -149.88 95.68 2.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.768 -1.207 . . . . 0.0 111.091 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.516 HG22 HD11 ' A' ' 56' ' ' LEU . 2.9 t -79.74 101.89 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.437 HD11 ' HD3' ' A' ' 75' ' ' ARG . 44.9 mt -69.15 -27.12 65.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 110.29 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 41.2 mm-40 -121.86 59.93 0.98 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -37.92 140.91 0.23 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.486 0.66 . . . . 0.0 109.691 -179.07 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.624 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -39.99 139.35 0.69 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.57 -0.706 . . . . 0.0 110.644 -179.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.26 -12.34 33.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.72 174.48 9.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.241 . . . . 0.0 109.633 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.6 m -93.36 154.44 17.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.964 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.77 168.96 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 1.088 HG22 ' CG ' ' A' ' 71' ' ' GLN . 15.0 t -133.39 -136.07 0.17 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.739 ' N ' HG23 ' A' ' 68' ' ' THR . 9.6 m -68.96 -119.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.592 -1.317 . . . . 0.0 108.015 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.817 ' CG ' HD22 ' A' ' 6' ' ' LEU . 8.0 ttm105 -72.89 80.68 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.678 -1.263 . . . . 0.0 109.786 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 1.088 ' CG ' HG22 ' A' ' 68' ' ' THR . 0.5 OUTLIER -98.43 -101.82 0.21 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.054 -1.028 . . . . 0.0 108.397 179.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 72' ' ' ILE . 19.1 tt 177.72 112.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 110.264 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.078 HD21 HG21 ' A' ' 37' ' ' VAL . 10.5 tp -79.7 -39.42 31.29 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.821 -1.174 . . . . 0.0 108.206 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.69 158.61 8.97 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.211 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.756 ' C ' HD23 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -101.03 148.57 24.89 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.373 -1.075 . . . . 0.0 109.559 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.029 HD22 HD12 ' A' ' 56' ' ' LEU . 5.5 mt -113.89 -132.43 0.33 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.732 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.564 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 O-C-N 120.804 -1.185 . . . . 0.0 110.402 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 77' ' ' ARG . 6.4 t -83.82 89.07 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.32 95.82 0.21 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.639 HD13 HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -103.76 129.76 55.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 109.949 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.859 HD22 ' HG2' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -153.39 -163.16 1.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.792 ' CG2' HD13 ' A' ' 39' ' ' ILE . 11.4 t -121.01 78.23 32.26 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.874 -1.142 . . . . 0.0 108.982 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 36.7 Cg_endo -80.4 53.52 4.8 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.803 2.335 . . . . 0.0 110.815 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 1.009 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.304 -1.377 0 O-C-N 121.076 -1.015 . . . . 0.0 109.717 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.731 ' HB2' ' OG1' ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 40' ' ' GLU . 93.3 m -156.63 148.81 23.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.125 -0.984 . . . . 0.0 109.643 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 73' ' ' LEU . 2.3 t -78.73 147.24 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 108.636 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -118.83 -55.14 2.21 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.772 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.624 HG23 ' OE2' ' A' ' 63' ' ' GLU . 1.3 m -167.45 123.03 1.07 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.246 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.904 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.2 m95 -68.25 -167.41 0.08 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.583 ' HB2' HG23 ' A' ' 35' ' ' VAL . 16.3 m80 -152.31 24.18 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.664 ' HB3' HD13 ' A' ' 56' ' ' LEU . 6.5 tppt? -118.52 132.04 56.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.77 -0.581 . . . . 0.0 109.728 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.591 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -79.62 177.31 3.0 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.9 Cg_endo -70.26 101.63 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.731 1.62 . . . . 0.0 111.615 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.656 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 82.37 37.66 14.25 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.554 ' CB ' ' HD2' ' A' ' 24' ' ' LYS . 1.2 m-20 -59.3 -165.38 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.878 -1.366 . . . . 0.0 110.103 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -165.11 78.17 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 108.979 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -79.54 -173.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.554 -179.011 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.749 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.6 OUTLIER -125.41 -97.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 109.836 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 47.6 mtp180 -103.28 45.14 0.97 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.644 -1.285 . . . . 0.0 109.345 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.781 ' O ' HG21 ' A' ' 30' ' ' VAL . 6.3 m-20 171.87 94.86 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.0 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -93.1 -166.56 1.55 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.922 -1.112 . . . . 0.0 111.542 -178.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.759 HG12 ' CD ' ' A' ' 34' ' ' GLU . 2.5 p -52.74 164.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 122.058 0.932 . . . . 0.0 111.393 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.581 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.61 65.97 1.39 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.379 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.145 HG12 HG12 ' A' ' 48' ' ' VAL . 4.1 p -38.0 164.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.582 0.706 . . . . 0.0 110.354 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.617 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -122.88 101.49 7.47 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 -178.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.001 HD11 HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -85.63 -159.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.81 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -154.59 99.03 2.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.609 -1.307 . . . . 0.0 110.265 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.731 ' OG1' ' HB2' ' A' ' 17' ' ' ALA . 10.0 m -116.64 90.11 3.26 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' THR . 11.2 t0 71.7 -143.33 0.05 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.372 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -17.27 57.52 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.99 150.23 3.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.521 -0.737 . . . . 0.0 109.886 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 39' ' ' ILE . 7.2 p -130.39 105.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.009 HD13 ' HB2' ' A' ' 9' ' ' ASP . 1.3 mt -85.94 159.22 19.71 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.231 -0.918 . . . . 0.0 109.021 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 5.1 pt-20 -127.29 -164.75 1.39 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.053 -1.029 . . . . 0.0 110.314 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.145 HG12 HG12 ' A' ' 37' ' ' VAL . 14.6 p -146.49 88.05 6.27 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.339 -0.851 . . . . 0.0 110.025 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.44 104.79 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.566 2.177 . . . . 0.0 111.181 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.0 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -74.86 -165.71 0.4 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 19.2 m -141.46 24.81 2.07 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.325 -1.485 . . . . 0.0 110.648 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 156.12 165.63 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.27 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER 66.75 -88.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.615 -0.678 . . . . 0.0 109.585 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.729 ' HA2' HG21 ' A' ' 3' ' ' VAL . . . 63.32 -8.63 0.26 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.013 -1.055 . . . . 0.0 111.808 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.656 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.84 96.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.849 -1.383 . . . . 0.0 107.994 179.435 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.944 HD12 HD22 ' A' ' 76' ' ' LEU . 8.8 tp -51.66 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.469 -0.769 . . . . 0.0 109.376 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' ILE . 10.9 t0 -108.11 -35.52 6.56 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.583 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.487 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -142.11 85.97 1.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.494 -1.379 . . . . 0.0 111.736 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.573 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 2.5 t -101.14 77.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.0 mt -69.66 -2.81 12.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 110.946 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.552 ' O ' HD11 ' A' ' 73' ' ' LEU . 18.9 mt-10 -136.16 51.49 2.02 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.882 -1.136 . . . . 0.0 109.283 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.488 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.6 m-20 -50.23 151.19 2.16 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.274 -0.891 . . . . 0.0 109.751 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.624 ' OE2' HG23 ' A' ' 21' ' ' THR . 0.1 OUTLIER -32.92 141.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.411 0.624 . . . . 0.0 110.818 -179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.58 -18.65 32.18 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.591 HG22 ' H ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -83.57 -179.72 7.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -1.194 . . . . 0.0 109.874 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 65' ' ' THR . 4.0 m -113.3 153.82 27.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 109.715 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.001 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -151.25 169.72 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 1.019 HG22 ' HG3' ' A' ' 71' ' ' GLN . 7.8 t -127.6 -124.6 0.23 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.612 ' N ' HG23 ' A' ' 68' ' ' THR . 6.0 p -69.63 -114.95 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.337 -1.477 . . . . 0.0 108.967 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.859 ' HG2' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -83.28 52.98 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.903 -1.123 . . . . 0.0 110.8 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 1.019 ' HG3' HG22 ' A' ' 68' ' ' THR . 1.3 mm-40 -65.25 -111.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.75 -1.219 . . . . 0.0 108.293 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.682 HG23 ' O ' ' A' ' 72' ' ' ILE . 16.2 tt 178.33 116.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.83 -1.168 . . . . 0.0 110.474 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.908 ' CD2' HG21 ' A' ' 37' ' ' VAL . 14.0 tp -77.38 -17.36 58.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.941 -1.099 . . . . 0.0 108.456 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' HB ' ' A' ' 5' ' ' ILE . . . 135.33 162.43 9.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.491 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.61 149.11 31.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -1.141 . . . . 0.0 109.495 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.944 HD22 HD12 ' A' ' 56' ' ' LEU . 8.2 mt -117.52 -78.31 0.58 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.444 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.987 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.833 0 O-C-N 121.305 -0.872 . . . . 0.0 109.268 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.552 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 68.1 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.034 HG21 ' OE1' ' A' ' 34' ' ' GLU . 70.1 t -76.99 77.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 109.207 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 0.5 OUTLIER -73.6 84.83 1.57 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.946 HG12 HG22 ' A' ' 48' ' ' VAL . 2.1 tp -106.57 151.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.347 -0.846 . . . . 0.0 110.985 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -134.09 -166.06 1.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.757 HG21 ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -126.04 72.81 70.83 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.144 -0.973 . . . . 0.0 109.625 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 36.9 Cg_endo -80.99 27.33 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.719 2.279 . . . . 0.0 110.955 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 17.6 m-20 . . . . . 0 C--N 1.307 -1.256 0 O-C-N 120.899 -1.126 . . . . 0.0 109.856 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.61 ' C ' HG13 ' A' ' 67' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 39' ' ' ILE . 17.7 m -155.15 126.14 7.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.178 -0.951 . . . . 0.0 110.457 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.654 HG22 HD11 ' A' ' 39' ' ' ILE . 3.3 t -67.33 93.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.338 -0.851 . . . . 0.0 108.999 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -58.02 -59.35 5.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.151 -0.968 . . . . 0.0 110.763 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.651 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 34.8 m -166.68 125.71 1.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.574 -1.329 . . . . 0.0 111.982 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.982 ' HA ' HG23 ' A' ' 37' ' ' VAL . 24.0 m95 -67.76 -165.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.586 ' HB2' HG23 ' A' ' 35' ' ' VAL . 21.9 m80 -154.67 51.61 0.63 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.588 ' CB ' HD21 ' A' ' 56' ' ' LEU . 2.2 mmpt? -134.26 175.19 9.73 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.024 0.916 . . . . 0.0 110.995 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.653 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 2.1 mmmt -127.62 -174.86 0.39 Allowed Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.76 106.4 1.47 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.14 1.227 . . . . 0.0 111.242 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.551 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 65.21 45.84 89.81 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.548 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 1.4 m-20 -54.13 -167.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.885 -1.362 . . . . 0.0 110.198 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.89 80.81 0.42 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.401 -0.812 . . . . 0.0 108.927 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.815 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.06 -173.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.506 -0.746 . . . . 0.0 110.596 -178.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.703 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -132.65 -96.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.641 -0.662 . . . . 0.0 110.014 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.492 ' H ' HG23 ' A' ' 31' ' ' VAL . 3.2 mtt180 -99.8 36.03 1.89 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.686 -1.259 . . . . 0.0 109.472 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.763 ' O ' HG21 ' A' ' 30' ' ' VAL . 18.8 m-20 -179.57 81.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.591 -0.693 . . . . 0.0 109.162 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.113 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -69.5 -160.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.998 -1.064 . . . . 0.0 111.621 -178.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.922 HG12 ' OE2' ' A' ' 34' ' ' GLU . 7.2 p -62.95 163.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.613 0.721 . . . . 0.0 110.542 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.567 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -138.47 59.76 1.63 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 178.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.982 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.4 p -38.48 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.54 0.686 . . . . 0.0 109.913 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -124.02 140.76 52.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.674 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.06 -177.05 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.375 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.674 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.7 mm-40 -138.71 115.77 10.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.92 . . . . 0.0 109.374 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 2.8 t -110.03 -27.97 8.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 0.0 110.002 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 7.3 t0 161.28 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.597 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.9 tttp 85.85 -24.92 0.12 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 41' ' ' THR . 58.0 t -104.01 136.81 35.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 0.0 109.227 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 39' ' ' ILE . 46.5 t -116.67 109.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.918 . . . . 0.0 109.739 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 9' ' ' ASP . 4.2 mm? -79.78 -168.57 1.64 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.15 -0.969 . . . . 0.0 108.719 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.3 pt-20 -144.36 -166.81 2.47 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.075 -1.016 . . . . 0.0 110.717 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.946 HG22 HG12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -155.95 82.91 3.55 Favored Pre-proline 0 N--CA 1.489 1.484 0 CA-C-O 122.076 0.941 . . . . 0.0 109.583 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.2 Cg_endo -81.81 117.88 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.77 2.313 . . . . 0.0 111.749 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.113 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -89.41 178.84 6.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.712 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 18.3 p -122.72 72.85 1.1 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 120.532 -1.355 . . . . 0.0 110.436 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 93.23 169.37 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.118 0.485 . . . . 0.0 110.132 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 13.2 m-20 69.74 -101.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 55' ' ' ILE . . . 68.6 -16.56 0.54 Allowed Glycine 0 N--CA 1.496 2.638 0 O-C-N 120.433 -1.417 . . . . 0.0 111.902 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.551 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.9 OUTLIER -36.03 99.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.104 1.452 . . . . 0.0 109.438 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.608 HD22 HD23 ' A' ' 76' ' ' LEU . 1.4 mm? -48.61 104.82 0.07 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.634 0.73 . . . . 0.0 109.936 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.455 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 9.3 t70 -108.16 -48.03 3.44 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.19 86.45 1.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.775 -1.203 . . . . 0.0 111.404 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 1.6 t -79.81 87.66 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 177.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.46 -3.92 16.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.934 . . . . 0.0 110.414 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 3.1 mt-10 -132.58 51.77 2.13 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.9 m-20 -40.58 131.11 2.34 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.744 0.783 . . . . 0.0 109.749 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.651 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -36.12 123.39 0.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.481 0.658 . . . . 0.0 111.079 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.13 -11.07 8.21 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.38 162.7 15.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -1.13 . . . . 0.0 109.501 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 67' ' ' VAL . 80.2 m -72.2 162.49 29.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 109.603 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.757 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.19 173.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.473 -0.767 . . . . 0.0 109.097 -178.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.923 HG22 ' CG ' ' A' ' 71' ' ' GLN . 5.7 t -145.66 -162.29 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.357 -0.839 . . . . 0.0 109.098 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.544 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 2.7 p -85.58 37.41 0.69 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.035 -1.041 . . . . 0.0 109.816 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER 168.63 34.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.598 -0.689 . . . . 0.0 109.212 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.923 ' CG ' HG22 ' A' ' 68' ' ' THR . 3.1 mm-40 -97.61 103.04 14.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.921 -1.112 . . . . 0.0 109.287 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.607 HG23 ' O ' ' A' ' 72' ' ' ILE . 9.1 tt -56.72 109.22 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.848 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.8 HD22 HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -51.37 -42.72 61.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.72 -155.45 26.56 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.722 ' C ' HD12 ' A' ' 76' ' ' LEU . 10.8 ptt85 -138.21 137.37 37.5 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.098 -1.237 . . . . 0.0 109.945 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 76' ' ' LEU . 5.8 mp -106.16 -95.93 0.35 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.455 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.552 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 2.7 tpm_? . . . . . 0 C--N 1.297 -1.702 0 O-C-N 121.443 -0.786 . . . . 0.0 109.243 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.747 ' O ' HG12 ' A' ' 3' ' ' VAL . 2.4 t -69.67 87.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.039 -1.038 . . . . 0.0 108.807 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.08 103.71 3.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.904 HG23 HG21 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -104.25 140.1 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.089 -1.007 . . . . 0.0 110.59 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.849 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -149.54 -162.19 1.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.101 HG21 HG21 ' A' ' 67' ' ' VAL . 60.1 t -133.63 56.61 21.09 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.957 -1.09 . . . . 0.0 110.373 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -81.16 34.37 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.507 2.138 . . . . 0.0 110.83 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.717 ' OD2' HD12 ' A' ' 46' ' ' LEU . 16.8 m-20 . . . . . 0 C--N 1.307 -1.248 0 O-C-N 120.711 -1.243 . . . . 0.0 110.256 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.015 ' HB2' HG23 ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.488 ' C ' HG13 ' A' ' 39' ' ' ILE . 45.2 m -160.13 121.99 3.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.229 -0.92 . . . . 0.0 110.137 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.0 HG12 ' OE1' ' A' ' 63' ' ' GLU . 2.1 t -50.59 147.47 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -126.25 -48.11 1.59 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.945 -1.097 . . . . 0.0 110.749 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.56 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 45.4 m -159.87 109.03 1.79 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.558 -1.339 . . . . 0.0 112.08 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.727 ' HA ' HG23 ' A' ' 37' ' ' VAL . 22.3 m95 -67.5 -163.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.66 ' HB2' HG23 ' A' ' 35' ' ' VAL . 33.3 m80 -159.35 42.52 0.23 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.893 ' CB ' HD23 ' A' ' 56' ' ' LEU . 3.1 mmmt -132.19 124.08 28.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.594 -0.691 . . . . 0.0 110.707 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -70.56 -178.17 0.51 Allowed Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 27.9 Cg_endo -66.82 93.23 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.107 1.205 . . . . 0.0 111.143 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.651 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 68.53 47.85 54.36 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.729 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 17.4 m-20 -56.96 -112.61 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.056 -1.261 . . . . 0.0 110.039 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 161.96 99.66 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.758 -1.214 . . . . 0.0 109.151 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.089 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -100.58 175.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.084 -1.01 . . . . 0.0 110.359 -179.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.691 HG13 ' H ' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -134.07 -70.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.434 -0.791 . . . . 0.0 110.048 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.691 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -127.45 64.8 1.33 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.814 -1.179 . . . . 0.0 109.681 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 15.5 m-20 144.94 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.089 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -93.01 -176.7 4.26 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.426 1.108 . . . . 0.0 112.196 -177.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.862 HG12 ' CD ' ' A' ' 34' ' ' GLU . 7.4 p -39.35 159.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.136 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.636 HD23 ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -139.91 62.47 1.51 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.024 HG12 HG12 ' A' ' 48' ' ' VAL . 5.2 p -37.96 163.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.687 0.756 . . . . 0.0 110.139 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.795 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.1 mm-40 -122.57 100.06 6.73 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.216 -0.928 . . . . 0.0 108.857 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.789 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -84.82 -165.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.561 -0.712 . . . . 0.0 109.358 -179.295 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.789 ' N ' HG23 ' A' ' 39' ' ' ILE . 16.5 mm-40 -150.83 88.31 1.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.016 . . . . 0.0 110.074 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 1.015 HG23 ' HB2' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -83.2 -179.92 7.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.296 -0.878 . . . . 0.0 109.31 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.588 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.6 t0 -80.12 99.96 8.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 4.7 ttpm? 84.98 -21.52 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.807 -0.558 . . . . 0.0 109.628 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.685 HG12 HD23 ' A' ' 46' ' ' LEU . 97.8 t -118.23 146.27 23.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.204 -0.935 . . . . 0.0 109.954 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -134.45 100.96 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.865 . . . . 0.0 109.09 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.717 HD12 ' OD2' ' A' ' 9' ' ' ASP . 3.4 mm? -94.97 -169.43 2.0 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.214 -0.929 . . . . 0.0 110.058 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.516 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 2.3 pt-20 -147.66 -156.07 0.68 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.557 -0.714 . . . . 0.0 109.278 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.024 HG12 HG12 ' A' ' 37' ' ' VAL . 7.8 p -157.62 79.9 3.34 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.868 -1.145 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.636 ' HB3' HD23 ' A' ' 36' ' ' LEU . 36.3 Cg_endo -80.31 104.09 1.6 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.416 2.077 . . . . 0.0 110.337 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.994 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -73.81 -175.1 1.99 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.722 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.4 p -130.83 23.37 4.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.455 -1.403 . . . . 0.0 110.218 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.55 161.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.557 -0.714 . . . . 0.0 109.203 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.677 ' O ' HG12 ' A' ' 30' ' ' VAL . 7.2 m-20 67.25 -137.76 0.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.497 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 101.88 -7.84 55.53 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.33 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.651 HG23 ' CA ' ' A' ' 27' ' ' GLY . 4.5 mt -47.63 96.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.025 -1.279 . . . . 0.0 107.673 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.893 HD23 ' CB ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -42.48 100.36 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.687 0.756 . . . . 0.0 109.574 -178.473 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.463 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 6.9 t0 -104.13 -53.33 2.76 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.966 -0.459 . . . . 0.0 109.871 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.99 103.66 3.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.682 -1.261 . . . . 0.0 110.979 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.46 88.12 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.305 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.796 HD21 ' HA2' ' A' ' 74' ' ' GLY . 0.4 OUTLIER -69.2 -7.1 33.41 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.127 -0.983 . . . . 0.0 110.172 -178.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.52 ' CB ' ' HA ' ' A' ' 73' ' ' LEU . 1.3 mm-40 -119.24 37.85 4.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.133 -0.979 . . . . 0.0 108.381 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.515 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.2 m-20 -40.25 135.23 1.47 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.678 -0.639 . . . . 0.0 110.106 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 1.0 ' OE1' HG12 ' A' ' 19' ' ' VAL . 67.1 mm-40 -22.93 141.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.54 0.686 . . . . 0.0 111.783 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.1 -11.27 67.63 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 62' ' ' ASP . 1.3 m -84.47 156.18 21.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -1.154 . . . . 0.0 109.583 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 m -77.73 158.28 29.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.913 . . . . 0.0 109.525 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.101 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.7 171.39 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -139.66 -145.91 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.004 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 3.3 m -99.48 52.16 0.94 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.103 -0.998 . . . . 0.0 109.467 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER 161.01 -19.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.419 -0.801 . . . . 0.0 110.031 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.474 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 2.2 mm-40 -48.44 125.87 10.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.328 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 72' ' ' ILE . 5.3 tt -80.18 111.8 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.738 HD12 HG21 ' A' ' 5' ' ' ILE . 30.4 mt -47.02 -37.53 9.4 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.796 ' HA2' HD21 ' A' ' 60' ' ' LEU . . . 157.01 -158.53 28.92 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.857 ' C ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -137.69 145.16 42.26 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.203 -1.175 . . . . 0.0 110.0 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.857 HD23 ' C ' ' A' ' 75' ' ' ARG . 2.1 mt -106.48 -128.4 0.26 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.588 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 120.645 -1.284 . . . . 0.0 109.817 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.456 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.042 HG12 HG23 ' A' ' 5' ' ' ILE . 28.9 t -81.5 73.44 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.036 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -83.2 68.12 9.47 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.56 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.042 HG23 HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -80.96 165.34 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.755 0.788 . . . . 0.0 112.579 -177.309 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.839 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -139.61 -164.48 1.69 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.613 ' CG2' HD13 ' A' ' 39' ' ' ILE . 45.4 t -136.55 66.88 58.6 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.948 . . . . 0.0 109.935 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 36.5 Cg_endo -80.38 38.84 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.715 2.276 . . . . 0.0 110.655 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.559 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.307 -1.269 0 O-C-N 120.988 -1.07 . . . . 0.0 110.289 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.356 0.598 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 90.0 m -151.61 131.24 13.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.307 -0.87 . . . . 0.0 110.525 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.808 ' CG2' HD11 ' A' ' 73' ' ' LEU . 2.1 t -70.15 85.35 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 109.089 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -47.33 -63.79 0.95 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.934 -1.104 . . . . 0.0 110.404 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.644 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 36.3 m -165.83 127.13 1.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.539 -1.351 . . . . 0.0 111.9 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 1.036 ' HA ' HG23 ' A' ' 37' ' ' VAL . 15.1 m95 -67.4 -163.08 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.598 ' HB2' HG23 ' A' ' 35' ' ' VAL . 22.5 m80 -156.21 30.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.767 ' HG2' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -116.83 159.1 22.87 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.7 0.762 . . . . 0.0 110.264 -179.077 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.598 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -106.14 -176.98 0.45 Allowed Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.0 Cg_endo -68.6 111.04 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.179 1.252 . . . . 0.0 110.768 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.532 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 57.65 43.51 94.33 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 8.6 m-20 -57.9 -164.27 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.831 -1.393 . . . . 0.0 110.209 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.16 87.52 0.5 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 53' ' ' ASP . 0.6 OUTLIER -78.91 -177.27 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -0.826 . . . . 0.0 110.654 -178.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.678 ' H ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -123.28 -80.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.577 ' H ' HG23 ' A' ' 31' ' ' VAL . 11.8 mtt180 -123.77 40.3 3.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.108 -0.995 . . . . 0.0 108.681 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.829 ' O ' HG21 ' A' ' 30' ' ' VAL . 10.9 m-20 178.05 83.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.048 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -81.5 -170.58 2.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 111.375 -178.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.754 HG12 ' CD ' ' A' ' 34' ' ' GLU . 7.6 p -48.98 161.53 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 121.87 0.843 . . . . 0.0 111.431 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.685 HD23 ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -141.2 62.21 1.47 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.036 HG23 ' HA ' ' A' ' 22' ' ' TRP . 2.5 p -38.15 165.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.688 0.756 . . . . 0.0 110.619 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -127.39 131.69 50.27 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.842 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -117.35 -172.28 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.277 -0.89 . . . . 0.0 109.315 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.72 ' N ' HG23 ' A' ' 39' ' ' ILE . 2.3 mt-10 -133.4 123.98 26.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.001 -1.062 . . . . 0.0 110.206 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.625 ' OG1' HG13 ' A' ' 44' ' ' VAL . 4.6 p -119.63 -104.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.327 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 28.9 t0 -130.32 75.11 1.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.326 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 87.46 -22.75 0.14 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.625 HG13 ' OG1' ' A' ' 41' ' ' THR . 12.1 p -103.8 144.65 13.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.411 -0.806 . . . . 0.0 109.479 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 39' ' ' ILE . 2.3 t -120.14 105.63 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 109.702 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.566 ' N ' HD22 ' A' ' 46' ' ' LEU . 4.0 mm? -79.99 -179.38 6.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.291 -0.881 . . . . 0.0 109.049 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.2 pt-20 -150.65 -163.19 1.72 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.027 -1.046 . . . . 0.0 110.219 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.998 HG12 HG12 ' A' ' 37' ' ' VAL . 9.7 p -154.96 81.0 4.29 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.133 -0.979 . . . . 0.0 110.216 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.685 ' HB3' HD23 ' A' ' 36' ' ' LEU . 36.6 Cg_endo -80.79 113.49 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.587 2.192 . . . . 0.0 110.81 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.048 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -80.7 -168.01 1.59 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.731 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.3 p -133.37 16.34 4.07 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.361 -1.462 . . . . 0.0 110.806 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.63 160.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.513 -0.742 . . . . 0.0 109.16 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.896 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.2 t70 64.96 -140.09 0.23 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.326 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.548 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 112.23 -12.71 26.27 Favored Glycine 0 N--CA 1.489 2.209 0 O-C-N 120.508 -1.37 . . . . 0.0 109.851 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.549 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -34.82 97.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.744 -0.857 . . . . 0.0 109.59 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.767 HD23 ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -45.06 104.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -113.93 -47.18 2.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.532 -0.73 . . . . 0.0 110.195 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -142.36 77.59 1.58 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.785 -1.197 . . . . 0.0 111.106 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.622 ' CG2' HD13 ' A' ' 56' ' ' LEU . 56.0 t -81.79 86.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.6 mt -69.63 -0.94 7.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -0.783 . . . . 0.0 111.255 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 21.1 mt-10 -134.54 55.44 1.89 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.778 -1.201 . . . . 0.0 108.199 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 63' ' ' GLU . 6.5 m-20 -43.93 127.06 5.13 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.702 0.763 . . . . 0.0 109.746 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.644 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -35.7 127.14 0.66 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.469 0.652 . . . . 0.0 111.284 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.48 -9.78 13.03 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.605 HG22 ' N ' ' A' ' 66' ' ' THR . 86.5 m -94.46 167.84 11.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -1.148 . . . . 0.0 109.386 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.605 ' N ' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -81.62 158.93 24.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.683 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.571 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.31 171.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.862 HG22 ' HG3' ' A' ' 71' ' ' GLN . 5.3 t -134.14 -161.48 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 0.0 109.237 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.524 ' N ' HG23 ' A' ' 68' ' ' THR . 29.9 t -85.91 40.88 0.88 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.629 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 69' ' ' SER . 4.8 ttm180 168.11 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.572 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.862 ' HG3' HG22 ' A' ' 68' ' ' THR . 1.6 mm-40 -105.61 97.59 7.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.94 . . . . 0.0 109.233 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.1 tt -42.25 112.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.463 -0.773 . . . . 0.0 109.86 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.808 HD11 ' CG2' ' A' ' 19' ' ' VAL . 10.3 tp -57.71 -42.67 84.26 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . 165.47 158.1 10.39 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.864 -1.636 . . . . 0.0 110.442 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.689 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -102.17 139.32 37.94 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.513 -0.993 . . . . 0.0 108.913 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.896 HD23 ' OE2' ' A' ' 34' ' ' GLU . 2.9 mp -105.14 -105.5 0.31 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.376 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.549 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.8 tpt180 . . . . . 0 C--N 1.301 -1.53 0 O-C-N 120.988 -1.07 . . . . 0.0 109.461 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 1.3 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.748 ' O ' HG12 ' A' ' 3' ' ' VAL . 16.5 t -79.75 76.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.417 ' CG ' ' HB3' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -80.61 77.46 7.43 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.228 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.791 HG12 HG13 ' A' ' 48' ' ' VAL . 5.2 tp -91.89 154.04 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.372 -0.83 . . . . 0.0 111.283 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.882 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -140.46 -157.93 0.81 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 67' ' ' VAL . 2.9 t -131.14 54.57 15.06 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 120.868 -1.145 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.708 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.6 Cg_endo -81.21 40.85 1.04 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.238 1.959 . . . . 0.0 110.008 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.543 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 O-C-N 121.016 -1.052 . . . . 0.0 110.176 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.519 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 16.1 m -161.05 127.55 3.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.087 -1.008 . . . . 0.0 110.162 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.598 HG22 HD11 ' A' ' 39' ' ' ILE . 2.5 t -53.87 157.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 108.708 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -127.42 -58.63 1.25 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.418 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 22.2 m -162.08 119.43 2.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.981 -1.074 . . . . 0.0 110.903 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.966 ' HA ' HG23 ' A' ' 37' ' ' VAL . 25.0 m95 -68.7 -170.58 0.22 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.867 0.842 . . . . 0.0 109.189 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.601 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 10.6 m80 -152.81 38.77 0.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.871 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -130.97 115.98 17.23 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.541 -178.167 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.582 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -65.41 177.32 0.69 Allowed Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.17 93.54 0.4 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.793 1.662 . . . . 0.0 111.464 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.864 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 80.15 47.91 6.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 4.0 m-20 -58.58 -134.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.285 -1.127 . . . . 0.0 110.394 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 170.54 95.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.913 -1.117 . . . . 0.0 108.929 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.795 HG12 ' OE2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -103.25 -170.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.083 -1.01 . . . . 0.0 109.424 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.777 ' N ' HG13 ' A' ' 30' ' ' VAL . 4.2 m -134.18 -112.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 108.903 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 8.2 mmt-85 -87.08 64.68 8.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.758 -1.214 . . . . 0.0 108.721 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.4 m-20 150.73 102.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.091 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -101.52 -167.66 1.45 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.075 -1.016 . . . . 0.0 111.928 -178.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.627 HG22 ' N ' ' A' ' 36' ' ' LEU . 3.7 p -53.88 166.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.105 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.627 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -144.92 65.23 1.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 178.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.105 HG11 ' CD1' ' A' ' 73' ' ' LEU . 6.2 p -40.36 170.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.665 0.745 . . . . 0.0 110.117 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.759 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 21.5 mt-10 -123.56 107.92 12.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.003 -1.061 . . . . 0.0 108.903 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.775 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -91.71 -162.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 121.421 -0.799 . . . . 0.0 109.159 -179.339 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.775 ' N ' HG23 ' A' ' 39' ' ' ILE . 39.4 mt-10 -153.06 102.18 2.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 110.105 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.581 HG22 ' N ' ' A' ' 42' ' ' ASP . 88.2 m -97.81 -112.2 0.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.271 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.581 ' N ' HG22 ' A' ' 41' ' ' THR . 8.1 t70 -126.56 87.73 2.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.918 -1.114 . . . . 0.0 109.391 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.3 tptp 85.2 -28.5 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.25 145.79 23.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.232 -0.917 . . . . 0.0 109.231 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 39' ' ' ILE . 1.8 p -123.39 122.44 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.486 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.65 170.91 15.86 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.173 -0.954 . . . . 0.0 108.864 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -122.16 179.66 4.47 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.106 -0.996 . . . . 0.0 110.406 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.9 HG21 HD12 ' A' ' 73' ' ' LEU . 3.2 t -130.83 73.18 81.38 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.491 -0.756 . . . . 0.0 109.013 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.2 Cg_endo -80.6 104.0 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.585 2.19 . . . . 0.0 111.527 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.091 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -79.1 -156.87 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.756 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.1 p -144.33 13.31 1.59 Allowed 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.695 -1.253 . . . . 0.0 110.733 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 158.93 155.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.393 -0.817 . . . . 0.0 110.216 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 75.34 -81.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.501 -0.749 . . . . 0.0 110.659 179.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.529 ' N ' ' OE2' ' A' ' 34' ' ' GLU . . . 55.34 6.52 1.0 Allowed Glycine 0 N--CA 1.494 2.539 0 O-C-N 121.111 -0.993 . . . . 0.0 111.434 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.864 HG23 ' HA2' ' A' ' 27' ' ' GLY . 3.3 mt -54.97 98.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.643 -1.504 . . . . 0.0 108.061 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 24' ' ' LYS . 9.5 tp -51.21 90.14 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.536 -0.728 . . . . 0.0 109.328 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.5 t0 -99.11 -40.62 7.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.608 -0.683 . . . . 0.0 110.049 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.646 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -142.64 107.55 4.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.804 -1.185 . . . . 0.0 111.0 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.626 HG12 ' OD1' ' A' ' 62' ' ' ASP . 2.0 t -118.91 107.26 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mt -98.43 -31.9 11.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.025 . . . . 0.0 110.014 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.534 ' O ' HG21 ' A' ' 19' ' ' VAL . 3.0 mt-10 -98.61 35.44 1.82 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.626 ' OD1' HG12 ' A' ' 59' ' ' VAL . 2.2 m-20 -43.67 157.16 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.605 -0.684 . . . . 0.0 110.162 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -38.85 140.39 0.37 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.353 0.597 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.28 -19.86 47.02 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -86.18 161.51 18.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -82.74 163.27 21.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.571 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.51 169.2 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.419 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.523 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -145.71 -147.75 0.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.57 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 13.3 p -89.83 33.29 0.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.354 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER 171.82 26.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.528 -0.733 . . . . 0.0 110.268 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 13.7 mm100 -87.51 121.47 29.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.666 -1.271 . . . . 0.0 109.183 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 4.0 tt -69.2 111.36 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.609 -0.682 . . . . 0.0 110.581 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.105 ' CD1' HG11 ' A' ' 37' ' ' VAL . 3.8 mt -55.43 -36.25 66.31 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.438 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 154.82 164.31 12.84 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.799 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -111.96 140.68 46.42 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.37 -1.076 . . . . 0.0 108.997 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 76' ' ' LEU . 3.9 mp -116.2 -133.87 0.34 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.582 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 120.659 -1.276 . . . . 0.0 109.118 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.467 ' HB3' ' CA ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.722 HG21 ' HA2' ' A' ' 54' ' ' GLY . 8.6 t -69.81 90.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.182 -0.949 . . . . 0.0 109.246 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.97 78.74 5.4 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.898 ' CG1' HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -93.64 137.85 21.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.405 -0.809 . . . . 0.0 111.239 -176.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -136.02 -164.27 1.53 Allowed 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.779 HG23 HD21 ' A' ' 73' ' ' LEU . 54.6 t -132.32 66.44 77.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.995 -1.066 . . . . 0.0 109.325 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' SER . 36.5 Cg_endo -80.24 41.61 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.733 2.289 . . . . 0.0 110.589 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.917 ' CB ' HD13 ' A' ' 46' ' ' LEU . 2.4 m-20 . . . . . 0 C--N 1.305 -1.34 0 O-C-N 121.035 -1.041 . . . . 0.0 110.113 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.465 ' C ' HG13 ' A' ' 39' ' ' ILE . 12.5 m -150.42 117.18 5.84 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.103 -0.998 . . . . 0.0 110.165 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.019 HG12 ' OE1' ' A' ' 63' ' ' GLU . 2.1 t -50.77 151.27 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.53 ' N ' ' OE1' ' A' ' 63' ' ' GLU . . . -134.67 -43.0 0.75 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.105 -0.997 . . . . 0.0 110.924 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.577 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -164.03 108.91 1.01 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.106 -1.438 . . . . 0.0 112.578 -179.152 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.954 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.4 m95 -67.84 -165.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.732 ' HB2' HG23 ' A' ' 35' ' ' VAL . 48.5 m80 -149.97 28.57 0.75 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.582 ' CD ' ' HB ' ' A' ' 35' ' ' VAL . 12.3 mmmm -123.57 146.59 48.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.641 -0.662 . . . . 0.0 110.393 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.659 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -97.73 -170.6 0.22 Allowed Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.1 Cg_endo -68.6 84.06 0.5 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 120.839 1.026 . . . . 0.0 111.321 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.754 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 78.15 48.48 7.56 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.746 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.4 m-20 -56.48 -114.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.113 -1.228 . . . . 0.0 110.363 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 158.18 100.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.848 -1.158 . . . . 0.0 108.27 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -102.64 -175.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.838 -1.164 . . . . 0.0 110.292 -178.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -129.29 -98.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 109.899 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.457 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -100.74 38.53 1.51 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.974 -1.078 . . . . 0.0 109.826 -179.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.716 ' O ' HG21 ' A' ' 30' ' ' VAL . 4.0 m-20 -178.01 89.42 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.059 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 9.6 tp10 -87.7 168.35 13.06 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.281 1.039 . . . . 0.0 111.647 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.935 HG12 ' HG3' ' A' ' 34' ' ' GLU . 4.6 p -33.08 157.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 122.128 0.966 . . . . 0.0 112.471 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.33 62.1 1.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.954 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.3 p -38.01 166.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.773 0.797 . . . . 0.0 110.385 -177.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -118.7 150.74 39.24 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.979 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -138.34 -171.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.369 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.729 ' N ' HG23 ' A' ' 39' ' ' ILE . 19.7 mt-10 -126.86 119.92 27.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.039 -1.038 . . . . 0.0 109.892 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.2 -143.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.429 -0.795 . . . . 0.0 109.128 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 65.1 t0 -90.62 72.14 6.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 109.607 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.4 tttt 87.21 -23.32 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 45' ' ' VAL . 72.8 t -100.63 160.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.38 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.979 HG13 ' O ' ' A' ' 39' ' ' ILE . 36.2 t -127.73 106.24 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.324 -0.86 . . . . 0.0 109.738 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.917 HD13 ' CB ' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -79.44 166.3 22.15 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.22 -0.925 . . . . 0.0 108.92 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -126.99 -163.75 1.28 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.091 -1.006 . . . . 0.0 110.258 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.898 HG22 ' CG1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -152.79 91.52 3.47 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.679 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.5 Cg_endo -83.5 123.57 3.4 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.759 2.306 . . . . 0.0 111.894 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.059 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -97.6 173.54 7.09 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.727 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 19.8 p -120.14 75.3 1.09 Allowed 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.205 -1.398 . . . . 0.0 110.315 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 90.65 164.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.5 0.667 . . . . 0.0 110.105 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.2 m-20 67.65 -100.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.713 -0.617 . . . . 0.0 110.618 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.722 ' HA2' HG21 ' A' ' 3' ' ' VAL . . . 54.79 5.58 0.59 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 120.911 -1.118 . . . . 0.0 111.543 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.754 HG23 ' CA ' ' A' ' 27' ' ' GLY . 7.2 mt -47.41 98.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.47 -1.606 . . . . 0.0 108.021 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.886 HD12 ' HG ' ' A' ' 76' ' ' LEU . 5.2 tp -43.88 108.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.618 0.723 . . . . 0.0 110.287 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 2.5 t0 -131.91 -35.15 1.26 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.618 -0.676 . . . . 0.0 110.031 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.805 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -135.61 62.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.68 -1.262 . . . . 0.0 111.014 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.595 ' CG2' HD11 ' A' ' 56' ' ' LEU . 26.2 t -79.7 83.33 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.759 -1.213 . . . . 0.0 108.467 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 mt -73.56 -6.66 47.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.277 -0.889 . . . . 0.0 110.741 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 4.1 mt-10 -124.15 47.88 2.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.876 -1.14 . . . . 0.0 108.371 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -48.73 139.01 10.24 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.628 -0.67 . . . . 0.0 109.966 -179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 1.019 ' OE1' HG12 ' A' ' 19' ' ' VAL . 69.7 mm-40 -26.86 145.57 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.436 0.636 . . . . 0.0 111.414 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.11 -12.78 67.95 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.3 m -90.12 154.18 19.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -1.178 . . . . 0.0 109.661 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.15 161.31 28.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.597 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.63 174.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.89 HG22 ' CG ' ' A' ' 71' ' ' GLN . 3.6 t -135.09 -166.35 1.82 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.069 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -90.62 36.29 0.89 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.196 -0.94 . . . . 0.0 108.886 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' N ' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER 172.0 33.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.493 -0.754 . . . . 0.0 109.452 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.89 ' CG ' HG22 ' A' ' 68' ' ' THR . 5.1 mm-40 -107.02 145.57 32.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 109.182 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.5 tt -86.77 112.25 22.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.982 -1.074 . . . . 0.0 110.346 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.779 HD21 HG23 ' A' ' 7' ' ' VAL . 16.6 mt -54.04 -24.3 16.64 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 141.11 -168.31 25.4 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.805 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 9.5 ptt85 -127.64 146.78 50.44 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.283 -1.128 . . . . 0.0 109.443 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.886 ' HG ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -99.31 -92.77 0.27 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.361 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.551 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.772 0 O-C-N 121.279 -0.888 . . . . 0.0 109.972 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.563 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.738 ' O ' HG12 ' A' ' 3' ' ' VAL . 18.8 t -75.26 79.48 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 108.5 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.36 83.91 1.94 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.076 ' CG1' HG22 ' A' ' 48' ' ' VAL . 3.6 tp -104.45 147.5 10.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.849 -177.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.833 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -139.06 -158.83 0.89 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.505 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.88 HG21 HD13 ' A' ' 39' ' ' ILE . 41.6 t -129.02 65.37 73.73 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.947 -1.096 . . . . 0.0 109.6 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HG3' HD13 ' A' ' 6' ' ' LEU . 36.5 Cg_endo -79.72 61.79 8.3 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.805 2.337 . . . . 0.0 110.387 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.566 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.303 -1.414 0 O-C-N 121.014 -1.054 . . . . 0.0 109.732 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.663 ' HB3' HG22 ' A' ' 67' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 17.5 m -152.88 137.16 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.913 ' CG2' HD11 ' A' ' 73' ' ' LEU . 2.2 t -72.94 84.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.41 -0.807 . . . . 0.0 109.252 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -46.61 -63.52 0.99 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.059 -1.025 . . . . 0.0 110.537 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.903 HG23 ' OE1' ' A' ' 63' ' ' GLU . 96.8 m -165.44 124.94 1.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.589 -1.319 . . . . 0.0 111.781 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 1.072 ' HA ' HG23 ' A' ' 37' ' ' VAL . 15.7 m95 -67.75 -168.48 0.09 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.587 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 12.0 m80 -153.3 24.15 0.54 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.777 ' HB3' HD13 ' A' ' 56' ' ' LEU . 6.1 tppt? -115.4 120.21 38.82 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.382 0.61 . . . . 0.0 109.593 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -67.1 175.61 1.43 Allowed Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.443 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 30.6 Cg_endo -71.31 94.66 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.073 1.849 . . . . 0.0 111.057 -178.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.646 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 85.33 37.42 9.81 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.58 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 8.9 m-20 -63.13 -162.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.784 -1.421 . . . . 0.0 109.61 178.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -162.85 79.36 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.92 -1.112 . . . . 0.0 110.069 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.783 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -78.9 -173.55 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 0.0 109.541 179.797 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.837 HG22 ' N ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -134.07 -86.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 0.0 109.36 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.837 ' N ' HG22 ' A' ' 31' ' ' VAL . 2.6 tpt180 -107.88 61.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.939 -1.101 . . . . 0.0 109.725 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.568 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.3 m-20 147.81 91.02 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.005 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -88.68 -166.91 1.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 111.336 -178.7 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.761 HG12 ' CD ' ' A' ' 34' ' ' GLU . 2.5 p -49.63 164.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.805 0.812 . . . . 0.0 111.311 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.594 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -140.17 63.64 1.47 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.603 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.072 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.3 p -38.59 166.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.701 0.762 . . . . 0.0 110.398 -177.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.647 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.4 mt-10 -128.05 112.63 14.83 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.263 -0.898 . . . . 0.0 108.729 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.88 HD13 HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -96.05 -167.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.498 -0.751 . . . . 0.0 109.03 -179.341 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.773 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.5 mt-10 -135.46 136.72 41.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 0.0 110.065 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.433 ' HB ' HG13 ' A' ' 44' ' ' VAL . 2.1 m -135.81 -136.32 0.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.6 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 23.5 t0 -96.0 74.21 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.907 -1.121 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.6 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.7 tmtt? 86.74 -23.3 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.788 -0.57 . . . . 0.0 109.543 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 45' ' ' VAL . 2.3 p -105.11 164.36 4.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.82 HG13 ' O ' ' A' ' 39' ' ' ILE . 44.5 t -144.39 112.77 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.373 -0.829 . . . . 0.0 109.454 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.866 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.82 168.54 19.15 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.136 -0.977 . . . . 0.0 108.869 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.472 ' OE1' ' O ' ' A' ' 36' ' ' LEU . 3.0 mm-40 -116.79 -171.4 2.01 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.927 -1.108 . . . . 0.0 110.639 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.076 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -147.55 77.32 10.54 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-O 122.409 1.099 . . . . 0.0 108.622 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.0 Cg_endo -81.62 113.02 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.781 2.321 . . . . 0.0 112.14 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.005 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -80.17 -160.18 0.27 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 177.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.725 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -139.62 11.92 2.51 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.497 -1.377 . . . . 0.0 110.891 -179.53 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.725 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.19 169.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.318 -0.864 . . . . 0.0 109.995 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER 67.85 -87.87 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.426 -0.796 . . . . 0.0 109.323 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 65.55 -13.57 0.28 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.219 -0.926 . . . . 0.0 112.15 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.646 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -42.83 96.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 119.124 1.462 . . . . 0.0 108.181 179.475 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.008 HD12 ' CD2' ' A' ' 76' ' ' LEU . 7.8 tp -54.11 97.12 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.47 -0.769 . . . . 0.0 109.64 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.401 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 17.7 t70 -109.0 -39.9 5.16 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.796 -0.565 . . . . 0.0 110.002 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -139.0 90.4 2.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.69 -1.256 . . . . 0.0 110.877 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.843 HG21 HD21 ' A' ' 56' ' ' LEU . 6.6 t -94.71 91.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 60' ' ' LEU . 27.7 mt -70.08 -1.76 10.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 110.887 -178.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 5.7 mt-10 -137.41 55.26 1.81 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.024 -1.048 . . . . 0.0 108.449 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 63' ' ' GLU . 24.0 m-20 -43.79 126.01 4.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.526 -0.733 . . . . 0.0 109.452 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.903 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -33.94 122.5 0.46 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.626 0.727 . . . . 0.0 111.435 -179.236 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.49 -6.03 12.87 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.6 -172.75 3.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -1.132 . . . . 0.0 109.317 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -93.84 153.13 18.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.835 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.663 HG22 ' HB3' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -150.35 171.4 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.378 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.87 HG22 ' CG ' ' A' ' 71' ' ' GLN . 13.7 t -148.04 -137.65 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 108.83 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.724 ' N ' HG23 ' A' ' 68' ' ' THR . 6.2 p -69.2 -110.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.691 -1.256 . . . . 0.0 108.021 179.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.519 ' CG ' ' HB3' ' A' ' 8' ' ' PRO . 3.4 mtm180 -71.3 79.4 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 109.419 179.141 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.87 ' CG ' HG22 ' A' ' 68' ' ' THR . 2.7 mm-40 -115.63 96.28 5.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.121 -0.987 . . . . 0.0 108.451 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 72' ' ' ILE . 4.0 tt -42.26 109.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.341 -0.85 . . . . 0.0 110.194 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.953 HD22 HG11 ' A' ' 37' ' ' VAL . 10.7 tp -62.23 -27.86 69.29 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 59' ' ' VAL . . . 154.46 154.82 7.0 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.126 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.812 ' C ' HD12 ' A' ' 76' ' ' LEU . 5.2 ptt180 -104.41 136.84 43.23 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.429 -1.042 . . . . 0.0 109.489 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.008 ' CD2' HD12 ' A' ' 56' ' ' LEU . 4.0 mp -112.86 -103.87 0.4 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.478 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.563 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 109.391 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.406 0.622 . . . . 0.0 109.59 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.722 ' O ' HG12 ' A' ' 3' ' ' VAL . 24.9 t -80.93 75.96 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.395 -0.815 . . . . 0.0 109.189 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -81.51 94.17 6.81 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.781 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.813 HG12 HG13 ' A' ' 48' ' ' VAL . 5.7 tp -106.57 159.3 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.344 -177.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.841 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -141.35 -161.03 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.367 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 67' ' ' VAL . 48.2 t -130.75 50.07 5.57 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.754 -1.216 . . . . 0.0 111.501 -179.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.714 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.9 Cg_endo -82.63 39.91 0.9 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.072 1.848 . . . . 0.0 109.757 178.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.936 ' HB2' HD13 ' A' ' 46' ' ' LEU . 4.2 m-20 . . . . . 0 C--N 1.306 -1.286 0 O-C-N 121.125 -0.984 . . . . 0.0 111.186 -178.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.829 ' HB2' HG22 ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.375 0.607 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.546 ' N ' HG13 ' A' ' 67' ' ' VAL . 92.5 m -160.23 130.35 5.36 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.33 -0.856 . . . . 0.0 110.068 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.739 ' CG2' HD11 ' A' ' 73' ' ' LEU . 4.2 t -68.05 111.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.335 -0.853 . . . . 0.0 109.031 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -76.61 -57.53 3.8 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.144 -0.973 . . . . 0.0 109.901 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.58 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 17.9 m -170.75 126.83 0.74 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.682 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 1.049 ' HA ' HG23 ' A' ' 37' ' ' VAL . 14.8 m95 -68.84 -168.56 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 108.819 177.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.588 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 13.9 m80 -151.22 39.05 0.66 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.779 ' HB3' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -130.86 138.81 50.0 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.673 0.749 . . . . 0.0 110.867 -178.509 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.596 ' CB ' ' OD1' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -88.79 179.41 1.63 Allowed Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.039 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.8 Cg_endo -66.03 105.31 0.81 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.561 1.508 . . . . 0.0 112.284 -178.044 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.625 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 60.35 48.0 88.33 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.728 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 3.6 m-20 -59.52 -119.44 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.046 -1.267 . . . . 0.0 110.363 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 159.67 99.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.056 -1.027 . . . . 0.0 109.035 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -103.41 -178.99 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 109.62 -179.546 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.698 ' N ' HG13 ' A' ' 30' ' ' VAL . 3.2 m -127.48 -110.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 14.3 mtp180 -90.2 66.68 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.778 -1.201 . . . . 0.0 108.785 179.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 15.0 m-20 150.59 103.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -179.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.997 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -108.17 -171.46 1.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.391 1.091 . . . . 0.0 111.959 -178.21 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.763 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 9.0 p -45.8 169.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.145 0.974 . . . . 0.0 111.389 -179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.596 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -149.71 59.14 1.0 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.049 HG23 ' HA ' ' A' ' 22' ' ' TRP . 2.7 p -39.3 165.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.807 0.813 . . . . 0.0 110.192 -178.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.845 ' OE1' HG11 ' A' ' 45' ' ' VAL . 1.6 mm-40 -123.48 146.53 47.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.739 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -134.5 -173.72 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.272 -179.262 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.715 ' N ' HG23 ' A' ' 39' ' ' ILE . 8.9 mt-10 -146.73 95.91 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.672 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.829 HG22 ' HB2' ' A' ' 17' ' ' ALA . 27.0 p -86.94 -48.8 7.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 109.725 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 55.1 t0 176.7 77.6 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.636 -0.665 . . . . 0.0 109.295 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER 87.28 -26.47 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.419 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.46 154.98 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.337 -0.852 . . . . 0.0 109.34 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.845 HG11 ' OE1' ' A' ' 38' ' ' GLU . 57.8 t -125.27 114.92 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -0.974 . . . . 0.0 109.822 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.936 HD13 ' HB2' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -79.67 159.3 26.75 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.299 -0.875 . . . . 0.0 108.755 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.53 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -121.96 -178.6 3.89 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.035 -1.041 . . . . 0.0 110.502 -179.298 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.828 ' O ' HG12 ' A' ' 48' ' ' VAL . 11.4 t -142.91 68.26 18.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.4 Cg_endo -80.31 106.41 1.88 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.679 2.253 . . . . 0.0 110.886 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.997 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -89.38 -161.73 0.8 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.757 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.2 p -142.95 17.21 1.95 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.748 -1.22 . . . . 0.0 110.888 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.35 163.3 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.115 -0.991 . . . . 0.0 110.668 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER 78.26 -77.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.646 179.64 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.504 ' O ' ' HD3' ' A' ' 24' ' ' LYS . . . 40.34 22.4 0.04 OUTLIER Glycine 0 N--CA 1.489 2.216 0 O-C-N 121.442 -0.786 . . . . 0.0 111.634 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.625 HG23 ' CA ' ' A' ' 27' ' ' GLY . 2.9 mt -83.61 94.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.549 -1.559 . . . . 0.0 107.329 178.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.126 HD12 ' CD1' ' A' ' 76' ' ' LEU . 2.1 tp -43.73 115.99 0.89 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.579 -0.701 . . . . 0.0 110.179 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 1.2 t0 -132.11 -42.73 0.98 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.491 -0.755 . . . . 0.0 109.895 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.944 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -132.82 76.65 1.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.785 -1.197 . . . . 0.0 110.873 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.557 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 60.6 t -93.33 81.52 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.775 HD11 HG23 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -69.04 -27.92 66.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.397 -0.814 . . . . 0.0 110.658 -178.423 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.535 ' CG ' HD12 ' A' ' 60' ' ' LEU . 7.7 mt-10 -106.73 47.79 0.86 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.473 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -39.14 139.31 0.51 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.597 0.713 . . . . 0.0 109.712 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.58 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -37.87 135.72 0.63 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.626 0.727 . . . . 0.0 110.999 -179.249 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.41 -6.37 36.17 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -95.72 158.38 15.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.244 . . . . 0.0 109.701 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.65 162.02 28.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.257 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.41 174.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.359 -0.838 . . . . 0.0 109.004 -178.802 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.689 HG23 ' N ' ' A' ' 69' ' ' SER . 4.8 t -150.26 -152.86 0.46 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 108.975 179.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.689 ' N ' HG23 ' A' ' 68' ' ' THR . 12.5 p -89.48 54.96 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.064 -1.022 . . . . 0.0 109.558 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' A' ' 69' ' ' SER . 3.5 mtp85 159.36 -12.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.565 -0.709 . . . . 0.0 110.654 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.633 ' CG ' HG22 ' A' ' 68' ' ' THR . 1.5 mt-30 -54.2 102.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.943 -1.098 . . . . 0.0 109.641 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.775 HG23 HD11 ' A' ' 60' ' ' LEU . 3.1 tt -54.94 111.5 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.039 HD22 HG11 ' A' ' 37' ' ' VAL . 8.4 tp -54.32 -29.89 49.38 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.502 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 144.69 153.34 5.84 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.944 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -93.99 145.39 24.68 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.515 -0.991 . . . . 0.0 108.332 179.181 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.126 ' CD1' HD12 ' A' ' 56' ' ' LEU . 3.4 mm? -85.45 -111.7 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.73 -178.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.548 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 3.4 ttp85 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 120.732 -1.23 . . . . 0.0 110.479 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 62.3 t -81.56 70.55 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 108.798 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -74.07 84.04 1.79 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.407 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.822 HG12 HG13 ' A' ' 48' ' ' VAL . 8.0 tp -99.73 163.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 111.297 -177.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.859 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -147.31 -159.86 1.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.313 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.815 HG21 ' CG2' ' A' ' 67' ' ' VAL . 2.1 t -133.15 56.11 20.09 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.121 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -80.58 35.94 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.5 2.134 . . . . 0.0 110.824 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.568 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.1 m-20 . . . . . 0 C--N 1.306 -1.283 0 O-C-N 120.801 -1.187 . . . . 0.0 109.966 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 121.167 0.508 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.485 ' N ' HG13 ' A' ' 67' ' ' VAL . 46.8 m -155.55 124.15 5.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 110.54 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.938 HG22 HD11 ' A' ' 39' ' ' ILE . 17.0 t -65.52 107.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.23 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -73.8 -59.62 2.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.614 -179.314 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.586 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.6 m -168.69 128.52 1.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.628 -1.295 . . . . 0.0 111.775 -179.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.995 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.6 m95 -69.2 -166.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.661 0.743 . . . . 0.0 109.24 178.346 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.1 m80 -152.7 26.47 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.549 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.6 tppt? -119.36 137.91 53.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.69 -0.631 . . . . 0.0 110.132 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.599 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.28 179.29 1.71 Allowed Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.676 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -69.64 104.91 1.37 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.664 1.576 . . . . 0.0 111.62 -178.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 75.03 39.52 37.49 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 4.8 m-20 -59.45 -166.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.718 -1.46 . . . . 0.0 109.597 178.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.17 78.56 0.45 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.08 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.698 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -79.55 169.26 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.009 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -110.06 -95.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 1.6 mtm180 -107.2 51.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.961 -1.087 . . . . 0.0 109.63 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.698 ' O ' HG21 ' A' ' 30' ' ' VAL . 4.2 m-20 173.04 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.949 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 10.3 tp10 -102.29 163.62 12.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.058 -1.026 . . . . 0.0 111.008 -178.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.598 HG12 ' HG3' ' A' ' 34' ' ' GLU . 2.5 p -30.36 160.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.57 1.176 . . . . 0.0 112.581 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.533 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.12 67.63 1.37 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.087 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.995 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.1 p -38.59 165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.102 -177.394 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.27 145.71 46.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.938 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -134.77 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.334 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.722 ' N ' HG23 ' A' ' 39' ' ' ILE . 13.1 mt-10 -149.35 138.51 21.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.923 -1.11 . . . . 0.0 109.708 -179.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 5.9 t -132.72 26.22 4.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 41' ' ' THR . 2.2 t70 87.34 15.31 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.341 0.591 . . . . 0.0 110.459 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 160.52 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 1.1 t -103.99 148.57 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.613 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 39' ' ' ILE . 51.2 t -136.93 96.76 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.685 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.769 ' N ' HD22 ' A' ' 46' ' ' LEU . 2.9 mm? -79.88 -176.0 5.21 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.309 -0.869 . . . . 0.0 108.728 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 1.3 pt-20 -142.39 -161.36 1.23 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.718 -1.239 . . . . 0.0 111.463 -178.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.822 HG13 HG12 ' A' ' 5' ' ' ILE . 6.0 t -143.47 75.5 16.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.7 Cg_endo -80.73 110.82 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.487 2.125 . . . . 0.0 110.931 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.949 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -91.79 -169.38 2.26 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.137 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.1 p -132.36 14.68 4.57 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.265 -1.522 . . . . 0.0 111.183 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.62 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 109.951 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER 60.63 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 179.816 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.548 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 64.95 -13.65 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 O-C-N 121.324 -0.86 . . . . 0.0 112.093 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.651 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.81 96.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.674 -1.486 . . . . 0.0 108.551 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.925 HD12 ' HG ' ' A' ' 76' ' ' LEU . 7.8 tp -49.87 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ILE . 46.6 t0 -98.6 -41.59 7.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.97 -0.456 . . . . 0.0 110.544 -178.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -147.37 78.71 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.577 -1.327 . . . . 0.0 111.677 -179.081 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.74 ' CG2' HD11 ' A' ' 56' ' ' LEU . 60.7 t -80.86 82.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.37 -10.8 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 109.709 -178.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 4.8 mm-40 -123.74 50.93 1.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -40.8 134.12 1.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.586 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.05 134.51 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.597 0.713 . . . . 0.0 111.015 -178.897 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.75 -13.96 24.64 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -84.98 156.19 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -1.135 . . . . 0.0 109.405 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.41 166.43 20.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.681 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.815 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.04 169.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.242 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -147.78 -148.31 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 -179.652 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 9.3 p -90.28 36.18 0.87 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mtt180 163.55 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.4 mt-30 -84.49 87.69 7.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 0.0 109.102 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.4 tt -45.0 108.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 48' ' ' VAL . 10.6 mt -53.91 -42.86 69.21 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 156.55 -159.79 29.76 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.549 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -134.68 134.49 41.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.151 -1.206 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.925 ' HG ' HD12 ' A' ' 56' ' ' LEU . 4.4 mp -98.09 -96.72 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.34 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.542 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.776 ' O ' HG12 ' A' ' 3' ' ' VAL . 3.0 t -75.94 79.76 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -86.73 80.47 8.52 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.031 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.795 HG12 HG22 ' A' ' 48' ' ' VAL . 6.0 tp -86.98 161.7 2.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 111.738 -177.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.85 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -144.69 -166.02 2.29 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.133 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.662 ' CG2' HD21 ' A' ' 73' ' ' LEU . 38.9 t -133.31 57.11 24.62 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.15 -0.969 . . . . 0.0 110.005 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.0 Cg_endo -79.97 38.33 0.74 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.392 2.061 . . . . 0.0 110.534 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.564 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.292 0 O-C-N 120.869 -1.145 . . . . 0.0 109.962 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 41' ' ' THR . . . . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.48 ' C ' HG13 ' A' ' 39' ' ' ILE . 77.0 m -161.16 113.98 1.92 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.293 -0.88 . . . . 0.0 110.116 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.001 HG12 ' OE1' ' A' ' 63' ' ' GLU . 2.3 t -46.78 137.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.182 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.841 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -116.73 -51.14 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.985 -1.072 . . . . 0.0 110.958 -178.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.555 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -158.55 109.89 2.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.563 -1.335 . . . . 0.0 112.066 -179.214 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.866 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.7 m95 -68.11 -164.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.646 ' HB2' HG23 ' A' ' 35' ' ' VAL . 17.2 m80 -155.23 30.44 0.39 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 177.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.58 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 1.3 tppm? -124.4 139.23 54.09 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.407 0.622 . . . . 0.0 110.513 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.597 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -89.26 -176.4 0.66 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.015 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.597 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.6 Cg_endo -66.13 90.14 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.917 1.078 . . . . 0.0 111.321 -178.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.807 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 72.92 47.65 24.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.735 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 14.6 m-20 -58.4 -113.4 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.057 -1.261 . . . . 0.0 110.388 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 158.9 102.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.96 -1.088 . . . . 0.0 108.574 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.777 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -101.93 -173.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.05 . . . . 0.0 109.929 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.777 ' N ' HG13 ' A' ' 30' ' ' VAL . 5.7 m -131.86 -114.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.183 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.566 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -87.41 64.62 8.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.691 -1.256 . . . . 0.0 109.182 179.735 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 5.0 m-20 149.65 99.16 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.05 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -95.04 -176.06 3.72 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.414 1.102 . . . . 0.0 111.898 -178.22 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.738 HG12 ' OE2' ' A' ' 34' ' ' GLU . 11.5 p -39.7 166.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.953 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.6 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -147.32 61.97 1.16 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 179.017 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.866 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.3 p -39.29 166.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.683 0.754 . . . . 0.0 110.273 -177.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.841 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 4.1 mt-10 -128.75 95.26 4.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.192 -0.943 . . . . 0.0 109.146 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.801 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -79.62 -167.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 109.123 -179.658 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.748 ' N ' HG23 ' A' ' 39' ' ' ILE . 24.3 mt-10 -153.75 121.24 5.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.922 -1.111 . . . . 0.0 110.193 -179.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -116.26 -95.19 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.434 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 31.1 t0 -146.15 86.73 1.71 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.385 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 16.5 tttt 86.72 -24.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.07 161.61 5.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 39' ' ' ILE . 54.1 t -150.85 98.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.842 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.59 168.91 18.76 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.213 -0.929 . . . . 0.0 108.864 179.945 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -124.94 -162.89 1.13 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.001 -1.062 . . . . 0.0 110.819 -178.78 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.861 ' HB ' HG12 ' A' ' 37' ' ' VAL . 3.8 t -144.23 74.57 15.74 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.525 -0.735 . . . . 0.0 109.289 -179.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.9 Cg_endo -82.19 101.84 1.15 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.887 2.392 . . . . 0.0 111.316 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.05 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -80.19 -161.36 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.726 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.4 p -135.1 10.14 3.54 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.466 -1.396 . . . . 0.0 111.275 -179.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.18 157.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.079 -1.013 . . . . 0.0 110.295 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER 79.1 -73.41 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.675 -0.641 . . . . 0.0 110.518 179.05 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.589 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 43.54 17.85 0.06 OUTLIER Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.154 -0.966 . . . . 0.0 111.315 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.807 HG23 ' CA ' ' A' ' 27' ' ' GLY . 20.5 mt -68.85 91.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.596 -1.532 . . . . 0.0 107.285 179.058 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.896 HD22 HG22 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -44.17 91.34 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.639 0.733 . . . . 0.0 110.366 -178.291 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 55' ' ' ILE . 36.3 t70 -87.29 -53.86 4.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.738 -0.601 . . . . 0.0 109.732 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.35 104.66 3.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.794 -1.191 . . . . 0.0 110.71 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.896 HG22 HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -90.91 92.12 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.553 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.56 -5.55 25.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.186 -0.946 . . . . 0.0 110.076 -178.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 73' ' ' LEU . 2.9 mt-10 -128.89 41.93 3.4 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 108.7 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.513 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.0 m-20 -42.72 131.13 4.06 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.596 -0.69 . . . . 0.0 109.593 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 1.001 ' OE1' HG12 ' A' ' 19' ' ' VAL . 67.2 mm-40 -20.91 140.05 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.661 0.743 . . . . 0.0 112.322 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.25 -15.61 61.12 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -80.07 162.82 24.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -1.232 . . . . 0.0 109.528 179.942 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 67' ' ' VAL . 8.1 m -90.61 162.83 14.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 109.721 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.56 171.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.214 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.695 HG23 ' N ' ' A' ' 69' ' ' SER . 5.1 t -137.98 -152.31 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.05 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.695 ' N ' HG23 ' A' ' 68' ' ' THR . 84.3 p -89.3 39.39 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 0.0 109.174 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.495 ' CG ' ' C ' ' A' ' 69' ' ' SER . 4.7 ptt180 165.78 34.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.95 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' A' ' 68' ' ' THR . 6.4 mm-40 -97.37 119.44 35.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.287 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 72' ' ' ILE . 1.9 tt -70.14 111.33 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -0.925 . . . . 0.0 110.032 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.843 ' CD1' HG21 ' A' ' 48' ' ' VAL . 13.8 mt -47.97 -42.23 27.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 162.04 -165.72 36.0 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.818 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.9 ptt-85 -129.22 149.25 51.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.293 -1.122 . . . . 0.0 109.364 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.874 HD22 HD23 ' A' ' 56' ' ' LEU . 4.5 mt -116.01 -132.21 0.32 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.403 -179.164 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.571 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 11.1 tpt85 . . . . . 0 N--CA 1.495 1.782 0 O-C-N 120.584 -1.323 . . . . 0.0 110.313 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.566 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 3.7 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.69 HG21 ' HA2' ' A' ' 54' ' ' GLY . 37.4 t -69.48 83.38 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.133 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.35 84.24 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.178 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.046 ' CG1' HG22 ' A' ' 48' ' ' VAL . 4.9 tp -110.55 143.82 19.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.291 -177.138 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.676 ' O ' HG23 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -128.48 -134.82 0.23 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.306 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 7' ' ' VAL . 45.9 t -161.85 67.41 2.13 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.717 -1.239 . . . . 0.0 109.168 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD3' ' HG ' ' A' ' 6' ' ' LEU . 35.4 Cg_endo -77.25 67.03 7.78 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.551 2.167 . . . . 0.0 110.584 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.982 ' HB2' HD13 ' A' ' 46' ' ' LEU . 1.2 m-20 . . . . . 0 C--N 1.305 -1.337 0 O-C-N 121.284 -0.885 . . . . 0.0 109.416 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.247 0.546 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 40' ' ' GLU . 24.1 m -157.38 137.53 12.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.113 -0.992 . . . . 0.0 110.72 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 79.0 t -67.18 86.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.424 -0.797 . . . . 0.0 109.46 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -42.76 -62.97 0.86 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.216 -0.927 . . . . 0.0 109.938 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 2.6 m -166.91 130.05 1.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.482 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 1.031 ' HA ' HG23 ' A' ' 37' ' ' VAL . 22.0 m95 -68.78 -167.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.543 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 29.0 m80 -149.3 24.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.752 ' HB3' HD13 ' A' ' 56' ' ' LEU . 10.7 tppt? -119.78 126.11 50.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.683 -0.636 . . . . 0.0 109.959 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.652 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 3.1 mmmt -79.99 -171.84 0.31 Allowed Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.652 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -68.45 104.94 1.17 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.026 1.151 . . . . 0.0 112.123 -177.282 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.732 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 57.97 48.5 82.14 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -56.35 -115.9 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.192 -1.181 . . . . 0.0 110.486 179.628 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 162.0 100.39 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.761 -1.212 . . . . 0.0 108.312 -178.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.998 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -102.08 173.95 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 111.082 -178.75 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.573 ' H ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -123.62 -92.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.068 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.539 ' H ' HG23 ' A' ' 31' ' ' VAL . 6.7 mtp180 -112.18 66.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.08 -1.013 . . . . 0.0 108.396 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.69 ' O ' HG21 ' A' ' 30' ' ' VAL . 8.2 m-20 155.13 80.55 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.084 ' OE1' HG12 ' A' ' 35' ' ' VAL . 1.1 tm-20 -87.81 175.08 7.99 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.179 0.99 . . . . 0.0 112.365 -177.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.084 HG12 ' OE1' ' A' ' 34' ' ' GLU . 2.4 p -32.14 156.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.93 0.871 . . . . 0.0 112.114 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.551 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -141.9 59.98 1.47 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.218 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.031 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.4 p -38.57 169.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.685 0.755 . . . . 0.0 110.571 -177.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.744 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 14.2 mt-10 -133.43 102.75 5.65 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.163 -0.961 . . . . 0.0 108.724 -179.294 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.926 HD11 ' CG1' ' A' ' 67' ' ' VAL . 2.1 tt -81.01 -165.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.327 -0.858 . . . . 0.0 109.411 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.783 ' N ' HG23 ' A' ' 39' ' ' ILE . 19.6 mm-40 -141.61 89.91 2.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.029 -1.044 . . . . 0.0 110.004 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 41' ' ' THR . 87.8 m -90.95 28.97 1.44 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.296 -0.878 . . . . 0.0 109.335 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.8 t70 77.6 73.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.685 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.2 tttt 87.24 -26.58 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.458 ' O ' ' HB ' ' A' ' 41' ' ' THR . 41.1 t -105.44 94.12 2.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.242 -0.911 . . . . 0.0 109.5 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.917 HG13 ' O ' ' A' ' 39' ' ' ILE . 81.4 t -94.77 104.72 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.409 -0.807 . . . . 0.0 109.443 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.982 HD13 ' HB2' ' A' ' 9' ' ' ASP . 0.8 OUTLIER -79.5 174.45 11.56 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.225 -0.922 . . . . 0.0 108.865 -179.759 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 8.4 pm0 -118.05 -179.58 3.8 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.994 -1.066 . . . . 0.0 110.758 -178.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.046 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -144.19 79.08 13.21 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-O 122.331 1.062 . . . . 0.0 108.381 179.666 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.58 120.18 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.826 2.35 . . . . 0.0 111.888 -178.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.941 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -96.45 169.84 9.63 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.07 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.704 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 22.9 p -118.32 77.9 1.21 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 120.354 -1.466 . . . . 0.0 110.242 -178.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.824 ' HA ' HG13 ' A' ' 30' ' ' VAL . . . 94.48 168.45 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.563 ' O ' HG12 ' A' ' 30' ' ' VAL . 59.4 m-20 61.96 -126.4 0.76 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.69 ' HA2' HG21 ' A' ' 3' ' ' VAL . . . 84.56 -7.7 71.96 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.055 -1.545 . . . . 0.0 109.704 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.732 HG23 ' CA ' ' A' ' 27' ' ' GLY . 8.2 mt -42.97 98.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.875 HD12 ' CD2' ' A' ' 76' ' ' LEU . 6.0 tp -43.44 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.666 0.746 . . . . 0.0 110.318 -177.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' ILE . 23.0 t70 -106.35 -36.37 6.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.704 -0.622 . . . . 0.0 109.327 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.658 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -147.35 100.12 3.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.071 . . . . 0.0 110.383 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.528 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 13.5 t -107.55 90.3 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.0 mt -69.63 -4.82 20.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.071 -179.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 10.9 mt-10 -127.63 52.34 1.85 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.7 m-20 -49.45 125.28 10.87 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.734 -0.604 . . . . 0.0 110.77 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.549 ' C ' ' O ' ' A' ' 62' ' ' ASP . 5.1 mt-10 -7.55 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.477 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 65' ' ' THR . . . 128.74 -38.09 2.11 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.439 178.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.494 ' OG1' ' HA ' ' A' ' 61' ' ' GLU . 5.6 m -43.1 145.38 0.52 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -1.189 . . . . 0.0 109.442 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 m -86.72 141.1 29.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.967 . . . . 0.0 110.189 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.926 ' CG1' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.8 168.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.757 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.589 HG23 ' N ' ' A' ' 69' ' ' SER . 5.2 t -120.4 -47.66 2.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 68' ' ' THR . 0.5 OUTLIER -170.31 -75.27 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.728 0.775 . . . . 0.0 109.714 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -78.95 37.18 0.3 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.672 -0.643 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HG3' HG22 ' A' ' 68' ' ' THR . 3.7 mt-30 -103.34 97.53 7.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.185 . . . . 0.0 108.543 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.52 HG23 ' O ' ' A' ' 72' ' ' ILE . 3.7 tt -40.6 111.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.795 . . . . 0.0 110.404 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.707 ' CD1' HG11 ' A' ' 37' ' ' VAL . 12.0 mt -55.47 -41.2 72.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.84 167.99 21.2 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.875 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.7 ptt180 -109.87 138.77 45.76 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.109 -1.23 . . . . 0.0 109.833 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.875 ' CD2' HD12 ' A' ' 56' ' ' LEU . 4.3 mp -115.72 -101.87 0.42 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.795 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.566 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 109.51 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.544 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -148.39 169.27 20.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 109.475 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.797 HG21 ' OE1' ' A' ' 34' ' ' GLU . 40.1 t -69.43 85.96 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.116 -0.99 . . . . 0.0 108.666 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.7 83.44 1.6 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.026 ' CG1' HG22 ' A' ' 48' ' ' VAL . 1.8 tp -105.68 138.31 31.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.342 -0.849 . . . . 0.0 110.443 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.822 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -134.17 -157.75 0.83 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.854 ' CG2' HD21 ' A' ' 73' ' ' LEU . 42.2 t -127.55 68.75 74.53 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 37.3 Cg_endo -81.85 19.97 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.774 2.316 . . . . 0.0 110.712 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.547 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -86.06 16.59 4.13 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.013 -1.054 . . . . 0.0 110.038 -179.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.564 ' CA ' ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -39.98 100.44 0.22 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.426 -0.796 . . . . 0.0 109.979 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 9' ' ' ASP . 36.2 Cg_endo -79.08 -84.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.587 2.191 . . . . 0.0 110.3 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -148.83 33.91 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 109.52 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.0 t -164.74 144.46 7.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -0.942 . . . . 0.0 109.524 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 14' ' ' VAL . 5.2 p -131.01 51.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.915 . . . . 0.0 109.448 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 16' ' ' ASP . . . -90.0 36.61 0.87 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.219 -0.925 . . . . 0.0 109.453 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 1.8 m-20 70.86 -174.75 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.882 . . . . 0.0 109.422 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -170.46 -164.87 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 109.645 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.499 ' C ' HG12 ' A' ' 39' ' ' ILE . 18.4 m -158.21 133.34 8.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.992 . . . . 0.0 110.906 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.598 HG21 ' HB3' ' A' ' 61' ' ' GLU . 29.5 t -71.12 84.04 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.463 -0.773 . . . . 0.0 109.633 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -39.44 -60.58 0.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.897 . . . . 0.0 110.361 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 22' ' ' TRP . 20.1 m -169.13 129.6 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.665 -1.272 . . . . 0.0 111.446 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 1.033 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.7 m95 -69.55 -167.54 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.608 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 16.9 m80 -152.68 23.65 0.59 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.582 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 7.1 tppt? -114.99 127.42 55.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.739 -0.6 . . . . 0.0 109.759 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.565 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -72.38 175.93 2.81 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.9 Cg_endo -70.46 95.62 0.62 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.957 1.771 . . . . 0.0 111.103 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.626 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 83.43 39.64 9.66 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.582 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 7.6 m-20 -65.5 -163.52 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.984 -1.304 . . . . 0.0 110.094 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.43 82.21 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.401 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.809 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -79.35 -170.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 110.203 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.809 ' N ' HG13 ' A' ' 30' ' ' VAL . 2.6 m -133.61 -106.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 6.9 mtt180 -92.38 62.03 3.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.695 -1.253 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.659 ' O ' HG21 ' A' ' 30' ' ' VAL . 7.6 m-20 153.7 96.06 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.085 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -94.18 -165.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.03 -1.043 . . . . 0.0 111.701 -178.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.823 HG12 ' OE2' ' A' ' 34' ' ' GLU . 7.3 p -51.88 162.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.758 0.79 . . . . 0.0 110.951 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.577 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -139.77 59.83 1.58 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.033 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.4 p -39.04 168.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-O 121.678 0.751 . . . . 0.0 110.616 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.5 mt-10 -131.66 111.15 11.44 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 108.721 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.856 ' O ' HG22 ' A' ' 45' ' ' VAL . 1.7 tt -95.06 -164.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 109.449 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.784 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.3 mt-10 -141.37 99.69 3.62 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.155 -0.966 . . . . 0.0 109.677 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.892 ' HB ' HG23 ' A' ' 44' ' ' VAL . 25.2 m -102.55 44.39 1.02 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 109.703 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 6.4 t70 76.49 65.61 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.9 ttmt 86.51 -25.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.827 -0.546 . . . . 0.0 109.708 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.892 HG23 ' HB ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -102.93 97.15 5.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.807 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.856 HG22 ' O ' ' A' ' 39' ' ' ILE . 42.8 t -89.87 112.56 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.336 -0.852 . . . . 0.0 109.167 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.78 ' H ' HD22 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -81.6 -175.74 5.69 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.157 -0.964 . . . . 0.0 109.424 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 28.5 mt-10 -127.02 -178.42 4.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.238 -0.914 . . . . 0.0 109.649 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.026 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -149.5 79.0 8.24 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-O 122.266 1.031 . . . . 0.0 108.976 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.3 Cg_endo -82.5 106.41 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.916 2.41 . . . . 0.0 112.009 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.085 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -75.31 -160.5 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.2 p -138.52 12.8 2.76 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.423 -1.423 . . . . 0.0 110.818 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.43 165.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.937 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 69.81 -86.5 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.496 -0.752 . . . . 0.0 109.625 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.515 ' O ' HD23 ' A' ' 76' ' ' LEU . . . 63.04 -9.76 0.16 Allowed Glycine 0 N--CA 1.496 2.635 0 O-C-N 120.886 -1.134 . . . . 0.0 111.879 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.626 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -41.93 98.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 118.927 1.363 . . . . 0.0 108.356 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.949 HD12 ' HG ' ' A' ' 76' ' ' LEU . 9.9 tp -54.92 98.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.503 -0.748 . . . . 0.0 109.628 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -112.69 -41.49 3.8 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.706 -0.621 . . . . 0.0 109.721 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -136.8 93.97 2.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.836 -1.165 . . . . 0.0 110.409 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.623 HG22 HD11 ' A' ' 56' ' ' LEU . 4.9 t -102.13 88.22 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.058 . . . . 0.0 108.381 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.77 -4.6 20.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.281 -0.887 . . . . 0.0 110.25 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.598 ' HB3' HG21 ' A' ' 19' ' ' VAL . 3.7 mt-10 -127.35 50.7 1.97 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.071 -1.018 . . . . 0.0 108.846 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.8 m-20 -53.6 109.41 0.45 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.56 -0.713 . . . . 0.0 110.494 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.536 ' C ' ' O ' ' A' ' 62' ' ' ASP . 3.2 mp0 8.63 109.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' THR . . . 116.46 -35.37 4.25 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.561 ' CB ' ' HA ' ' A' ' 61' ' ' GLU . 71.4 m -45.08 146.05 0.92 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -1.186 . . . . 0.0 109.169 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.52 131.04 35.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.719 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.804 ' CG1' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.57 171.25 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.766 HG22 ' HG3' ' A' ' 71' ' ' GLN . 4.9 t -139.68 -149.43 0.28 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.232 -0.918 . . . . 0.0 109.279 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.747 ' N ' HG23 ' A' ' 68' ' ' THR . 62.7 p -98.91 74.85 2.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.114 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER 159.4 -21.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.766 ' HG3' HG22 ' A' ' 68' ' ' THR . 4.3 mt-30 -71.37 -171.65 0.64 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.551 -0.718 . . . . 0.0 109.106 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.9 tt -126.44 128.4 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.854 HD21 ' CG2' ' A' ' 7' ' ' VAL . 7.9 mt -64.53 -40.53 95.78 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.27 176.22 23.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.815 ' C ' HD12 ' A' ' 76' ' ' LEU . 1.4 ptm180 -117.22 142.63 46.81 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.217 -1.167 . . . . 0.0 110.171 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.949 ' HG ' HD12 ' A' ' 56' ' ' LEU . 3.8 mp -112.36 -101.65 0.41 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.544 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.3 OUTLIER -143.59 164.42 30.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 109.068 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.474 ' HA ' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -166.73 -170.5 1.6 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.608 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 80' ' ' ASN . . . -148.8 -145.32 4.12 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 79' ' ' GLY . 31.4 t-20 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.197 -1.178 . . . . 0.0 109.55 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.479 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -161.49 179.14 8.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.659 ' O ' HG12 ' A' ' 3' ' ' VAL . 25.0 t -71.48 82.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.031 . . . . 0.0 108.785 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.89 82.86 2.18 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.065 ' CG1' HG22 ' A' ' 48' ' ' VAL . 3.9 tp -101.19 137.29 29.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.728 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.841 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -131.12 -148.22 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.565 ' CG1' ' HA ' ' A' ' 69' ' ' SER . 93.7 t -129.88 92.14 37.87 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.264 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.49 17.97 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.774 2.316 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.84 ' O ' HG11 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -95.25 45.52 1.1 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.871 -1.143 . . . . 0.0 110.152 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.708 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -53.25 -45.02 98.57 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 111.09 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 33.8 Cg_endo -76.89 -177.61 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.76 1.64 . . . . 0.0 110.472 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 11' ' ' PRO . 4.6 tp10 73.67 33.11 1.07 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.37 -0.831 . . . . 0.0 109.67 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.9 t 55.05 98.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.304 -0.873 . . . . 0.0 109.922 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.84 HG11 ' O ' ' A' ' 9' ' ' ASP . 13.9 p -161.43 72.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.933 . . . . 0.0 109.551 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 16' ' ' ASP . . . -78.41 3.45 15.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.818 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.997 ' HA ' HG23 ' A' ' 68' ' ' THR . 4.0 p-10 170.98 165.75 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.144 -0.973 . . . . 0.0 109.487 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 41' ' ' THR . . . -164.65 -165.65 0.96 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.862 HG23 ' O ' ' A' ' 65' ' ' THR . 87.5 m -160.77 136.28 7.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.908 . . . . 0.0 110.07 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.8 t -58.87 143.28 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 108.974 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.811 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -115.24 -53.92 2.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.212 -0.93 . . . . 0.0 109.185 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.681 ' O ' HG23 ' A' ' 21' ' ' THR . 6.6 t -164.41 116.91 1.32 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.26 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.987 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.7 m95 -68.35 -167.5 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.582 ' HB2' HG23 ' A' ' 35' ' ' VAL . 19.4 m80 -152.47 23.65 0.61 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.976 ' O ' HD22 ' A' ' 56' ' ' LEU . 5.7 tppt? -120.4 108.12 13.73 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.789 -0.569 . . . . 0.0 109.713 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -59.55 177.39 0.27 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 29.6 Cg_endo -69.8 96.02 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.812 1.675 . . . . 0.0 111.378 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 85.07 40.87 7.79 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.613 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 5.4 m-20 -57.95 -154.66 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.21 -1.171 . . . . 0.0 109.948 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.89 87.34 0.51 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.569 -1.332 . . . . 0.0 109.461 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.004 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -96.24 178.76 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.329 -0.857 . . . . 0.0 109.725 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.683 HG13 ' H ' ' A' ' 32' ' ' ARG . 1.3 p -135.76 -60.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.106 -0.996 . . . . 0.0 109.901 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.683 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -138.98 65.6 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.078 -1.014 . . . . 0.0 108.928 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 12.9 m-20 146.68 80.45 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.014 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -86.19 -171.48 3.58 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.083 0.944 . . . . 0.0 112.003 -177.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.818 HG12 ' CD ' ' A' ' 34' ' ' GLU . 3.1 p -41.97 159.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 122.066 0.936 . . . . 0.0 111.88 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.88 62.09 1.58 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.3 p -38.87 168.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.876 0.846 . . . . 0.0 110.744 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.811 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -127.41 98.59 5.3 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.783 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -80.12 -163.83 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 O-C-N 121.502 -0.749 . . . . 0.0 109.278 -179.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.783 ' N ' HG23 ' A' ' 39' ' ' ILE . 3.8 mm-40 -152.85 104.99 2.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.892 -1.13 . . . . 0.0 110.007 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.819 HG21 HD21 ' A' ' 46' ' ' LEU . 1.2 p -99.31 -58.18 1.99 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.08 -1.013 . . . . 0.0 109.988 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.596 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 12.8 t0 176.77 83.55 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.2 tttp 86.12 -26.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 44' ' ' VAL . 11.5 m -119.47 132.42 69.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.288 -0.883 . . . . 0.0 109.4 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 39' ' ' ILE . 42.8 t -118.07 114.58 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.31 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.862 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -80.46 147.57 30.86 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.233 -0.917 . . . . 0.0 109.02 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -92.11 179.39 5.59 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.326 -0.859 . . . . 0.0 110.682 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.065 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -141.02 73.95 26.11 Favored Pre-proline 0 N--CA 1.489 1.511 0 CA-C-O 122.414 1.102 . . . . 0.0 108.366 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.28 107.63 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.873 2.382 . . . . 0.0 111.919 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.014 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -73.83 -165.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.715 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.9 OUTLIER -137.96 23.32 2.83 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.484 -1.385 . . . . 0.0 110.194 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.58 161.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.699 ' O ' HG12 ' A' ' 30' ' ' VAL . 6.4 m-20 60.85 -132.92 0.73 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.034 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.664 ' O ' HD23 ' A' ' 76' ' ' LEU . . . 114.87 -18.71 16.45 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.941 HG23 ' HA2' ' A' ' 27' ' ' GLY . 10.6 mt -36.04 99.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.989 HD12 ' HG ' ' A' ' 76' ' ' LEU . 10.9 tp -56.71 98.71 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.561 0.696 . . . . 0.0 109.712 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.402 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 20.1 t70 -117.68 -38.3 3.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.673 -0.642 . . . . 0.0 109.901 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -133.97 91.19 2.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.862 -1.148 . . . . 0.0 110.515 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.523 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 2.4 t -106.97 84.5 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.703 HD12 ' HA2' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -69.98 -3.86 18.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 110.368 -178.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.523 ' OE1' ' CG1' ' A' ' 67' ' ' VAL . 7.7 mt-10 -127.06 46.25 2.55 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.083 -1.011 . . . . 0.0 108.982 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.9 m-20 -51.13 127.23 18.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.454 -0.779 . . . . 0.0 109.707 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' A' ' 62' ' ' ASP . 0.3 OUTLIER -17.62 132.98 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.321 0.582 . . . . 0.0 111.414 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.41 -31.35 7.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.862 ' O ' HG23 ' A' ' 18' ' ' THR . 24.1 m -70.19 170.54 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -1.162 . . . . 0.0 109.539 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.574 ' N ' HG22 ' A' ' 65' ' ' THR . 95.0 m -108.75 140.22 42.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.445 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.727 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -151.1 160.95 3.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.997 HG23 ' HA ' ' A' ' 16' ' ' ASP . 1.3 m -117.44 -144.15 0.38 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.601 ' CB ' ' HA ' ' A' ' 10' ' ' LEU . 7.9 m -106.07 78.39 1.31 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.134 -0.979 . . . . 0.0 108.588 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 6.0 ttm180 159.34 -21.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.575 ' HB2' HG23 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -72.99 131.77 42.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 72' ' ' ILE . 4.7 tt -79.18 111.92 16.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 110.098 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.685 ' CD1' HG11 ' A' ' 37' ' ' VAL . 13.1 mt -46.29 -38.99 9.34 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.703 ' HA2' HD12 ' A' ' 60' ' ' LEU . . . 154.17 169.96 19.57 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.785 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 2.1 ptm180 -110.94 137.06 49.04 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.304 -1.115 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.989 ' HG ' HD12 ' A' ' 56' ' ' LEU . 4.3 mp -102.69 -96.7 0.29 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.068 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.585 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -146.86 152.45 38.73 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.45 ' HA ' ' CG ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -136.02 -163.15 1.36 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.298 -0.876 . . . . 0.0 109.537 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.75 -73.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.237 -1.155 . . . . 0.0 109.391 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 37.2 m -141.18 175.26 9.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.284 -0.885 . . . . 0.0 109.562 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.057 HG21 ' OE2' ' A' ' 34' ' ' GLU . 7.7 t -73.98 80.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 108.95 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.58 81.26 2.59 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.076 ' CG1' HG22 ' A' ' 48' ' ' VAL . 6.6 tp -99.34 152.18 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.027 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.962 HD22 ' HG2' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -139.97 -161.65 1.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.081 HG21 HD13 ' A' ' 39' ' ' ILE . 96.5 t -130.97 67.24 80.62 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.045 -1.034 . . . . 0.0 109.484 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.518 ' HG3' HD13 ' A' ' 6' ' ' LEU . 36.1 Cg_endo -79.08 57.75 6.62 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.751 2.301 . . . . 0.0 110.878 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 1.003 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.8 OUTLIER -116.38 11.2 14.9 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.14 -0.975 . . . . 0.0 109.493 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -32.48 108.92 0.3 Allowed Pre-proline 0 N--CA 1.501 2.117 0 O-C-N 121.831 -0.543 . . . . 0.0 110.5 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.46 -45.78 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.304 2.002 . . . . 0.0 110.131 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.61 -88.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.582 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 m -51.53 177.84 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.499 -0.75 . . . . 0.0 109.535 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 14' ' ' VAL . 6.1 p -116.48 48.58 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.346 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -68.93 -6.67 28.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.865 . . . . 0.0 109.788 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 4.9 m-20 68.77 -159.03 0.19 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -170.67 -165.08 0.42 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.283 -0.886 . . . . 0.0 109.165 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 65' ' ' THR . 17.6 m -160.75 143.83 13.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.001 -1.062 . . . . 0.0 110.693 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.941 HG12 ' OE1' ' A' ' 63' ' ' GLU . 1.9 t -65.73 149.09 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -126.96 -47.22 1.51 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.953 -1.092 . . . . 0.0 110.309 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.521 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -162.7 109.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.749 -1.219 . . . . 0.0 111.674 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.964 ' HA ' HG23 ' A' ' 37' ' ' VAL . 15.9 m95 -67.65 -162.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 0.0 108.503 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.747 ' HB2' HG23 ' A' ' 35' ' ' VAL . 33.4 m80 -158.1 34.82 0.25 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.906 ' CB ' HD23 ' A' ' 56' ' ' LEU . 4.7 mmpt? -119.64 108.48 14.51 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.32 0.581 . . . . 0.0 110.376 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -59.56 -178.12 0.12 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.4 Cg_endo -67.99 89.99 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.105 1.203 . . . . 0.0 110.764 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.549 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 78.07 46.04 9.7 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 10.8 m-20 -59.55 -161.48 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.721 -1.458 . . . . 0.0 109.335 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.38 85.42 0.72 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.959 -1.088 . . . . 0.0 109.147 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.013 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.12 -176.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.357 -0.84 . . . . 0.0 109.894 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.687 HG13 ' H ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -142.47 -72.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.359 -0.838 . . . . 0.0 109.599 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.687 ' H ' HG13 ' A' ' 31' ' ' VAL . 8.3 mmt180 -121.5 63.85 0.9 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.001 -1.062 . . . . 0.0 109.519 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 6.1 m-20 145.04 84.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.066 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 21.5 tt0 -84.89 170.15 13.39 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.218 1.009 . . . . 0.0 112.002 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.747 HG23 ' HB2' ' A' ' 23' ' ' HIS . 3.5 p -31.08 155.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.912 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.771 ' H ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -136.32 64.83 1.54 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 178.262 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.964 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.3 p -38.67 170.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-O 121.783 0.802 . . . . 0.0 110.725 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.801 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.8 mm-40 -125.8 96.59 4.82 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.132 -0.98 . . . . 0.0 109.098 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.081 HD13 HG21 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -79.88 -159.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.059 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.795 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.9 mm-40 -147.03 101.46 3.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.789 -1.194 . . . . 0.0 109.992 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -93.47 -152.0 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.337 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 20.4 t0 -94.16 88.0 5.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER 85.61 -23.85 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.755 -0.591 . . . . 0.0 109.612 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 41' ' ' THR . 23.0 t -116.33 137.12 51.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.236 -0.915 . . . . 0.0 109.503 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 39' ' ' ILE . 2.2 p -113.11 107.17 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.003 HD13 ' HB2' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -79.49 179.19 7.6 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.183 -0.948 . . . . 0.0 108.935 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -126.65 -163.75 1.27 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.981 -1.074 . . . . 0.0 110.269 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.076 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -151.26 75.76 7.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-O 122.278 1.037 . . . . 0.0 108.833 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.5 Cg_endo -81.01 115.32 2.99 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.801 2.334 . . . . 0.0 112.009 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.066 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -83.7 -167.65 1.81 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.73 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.0 p -131.54 18.09 4.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.129 -1.607 . . . . 0.0 111.135 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.46 160.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.869 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.5 t70 64.7 -140.39 0.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 55' ' ' ILE . . . 116.71 -15.98 14.11 Favored Glycine 0 N--CA 1.489 2.22 0 O-C-N 120.218 -1.551 . . . . 0.0 110.671 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.575 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -32.01 94.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 117.884 0.842 . . . . 0.0 109.449 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.927 HD11 HG21 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -46.69 100.78 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.6 t70 -120.56 -46.02 2.39 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.201 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -135.55 107.55 7.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.749 -1.219 . . . . 0.0 110.818 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.927 HG21 HD11 ' A' ' 56' ' ' LEU . 1.4 t -113.17 90.86 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.81 -4.6 20.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.217 -0.927 . . . . 0.0 110.022 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 3.1 mt-10 -128.22 39.37 3.85 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.6 m-20 -40.67 136.15 1.44 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.732 -0.605 . . . . 0.0 109.699 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.941 ' OE1' HG12 ' A' ' 19' ' ' VAL . 67.4 mm-40 -27.82 146.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.537 0.684 . . . . 0.0 111.494 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.14 -2.11 87.62 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 18' ' ' THR . 24.2 m -94.15 154.96 17.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.165 -1.197 . . . . 0.0 109.352 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.53 148.46 22.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.179 -0.951 . . . . 0.0 109.644 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.733 HG11 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -150.32 155.33 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.46 -0.775 . . . . 0.0 108.931 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.791 HG23 ' N ' ' A' ' 69' ' ' SER . 7.4 t -100.78 -142.15 0.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.791 ' N ' HG23 ' A' ' 68' ' ' THR . 72.5 m -68.87 -99.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.779 -1.201 . . . . 0.0 108.239 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.962 ' HG2' HD22 ' A' ' 6' ' ' LEU . 7.4 ttp180 -75.11 76.22 2.28 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.376 -0.827 . . . . 0.0 109.88 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.636 ' HB2' HG23 ' A' ' 67' ' ' VAL . 2.3 mm-40 -113.92 95.34 5.26 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 72' ' ' ILE . 7.9 tt -38.7 109.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.649 -0.657 . . . . 0.0 110.807 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.927 HD21 HG23 ' A' ' 7' ' ' VAL . 12.1 mt -56.7 -39.94 74.74 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.98 -179.4 35.55 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -118.18 135.67 54.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.218 -1.166 . . . . 0.0 110.122 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.927 ' HG ' HD22 ' A' ' 56' ' ' LEU . 2.1 mp -99.25 -91.65 0.28 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.575 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 10.4 tpp180 -153.84 152.98 31.29 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.508 -0.745 . . . . 0.0 109.282 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.474 ' HA ' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -161.39 -170.4 2.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.604 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.61 -148.27 7.99 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.23 -1.159 . . . . 0.0 109.431 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -167.71 -179.04 4.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 62.3 t -81.56 70.55 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 108.798 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -74.07 84.04 1.79 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.822 HG12 HG13 ' A' ' 48' ' ' VAL . 8.0 tp -99.73 163.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 111.297 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.859 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -147.31 -159.86 1.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.815 HG21 ' CG2' ' A' ' 67' ' ' VAL . 2.1 t -133.15 56.11 20.09 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.121 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -80.58 35.94 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.5 2.134 . . . . 0.0 110.824 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.568 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.1 m-20 -102.95 -2.68 27.28 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.801 -1.187 . . . . 0.0 109.966 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.506 HD11 ' C ' ' A' ' 68' ' ' THR . 0.7 OUTLIER -128.19 66.54 72.89 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 9' ' ' ASP . 35.7 Cg_endo -77.55 -58.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.583 2.189 . . . . 0.0 110.373 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' PRO . 7.0 mm-40 -43.94 154.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.357 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.49 ' C ' HG23 ' A' ' 14' ' ' VAL . 1.6 p 44.5 -155.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.293 -0.879 . . . . 0.0 109.232 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 13' ' ' SER . 15.9 t -157.03 58.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.509 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.75 -11.21 58.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.146 -0.971 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 0.6 OUTLIER 60.89 -153.16 0.38 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.33 -0.856 . . . . 0.0 108.796 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -170.15 -159.76 0.21 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.036 -1.04 . . . . 0.0 109.844 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.485 ' N ' HG13 ' A' ' 67' ' ' VAL . 46.8 m -155.55 124.15 5.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 110.54 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.938 HG22 HD11 ' A' ' 39' ' ' ILE . 17.0 t -65.52 107.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.23 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -73.8 -59.62 2.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.614 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.586 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.6 m -168.69 128.52 1.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.628 -1.295 . . . . 0.0 111.775 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.995 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.6 m95 -69.2 -166.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.661 0.743 . . . . 0.0 109.24 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.1 m80 -152.7 26.47 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.549 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.6 tppt? -119.36 137.91 53.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.69 -0.631 . . . . 0.0 110.132 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.599 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.28 179.29 1.71 Allowed Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -69.64 104.91 1.37 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.664 1.576 . . . . 0.0 111.62 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 75.03 39.52 37.49 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 4.8 m-20 -59.45 -166.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.718 -1.46 . . . . 0.0 109.597 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.17 78.56 0.45 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.08 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.698 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -79.55 169.26 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -110.06 -95.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 1.6 mtm180 -107.2 51.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.961 -1.087 . . . . 0.0 109.63 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.698 ' O ' HG21 ' A' ' 30' ' ' VAL . 4.2 m-20 173.04 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.949 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 10.3 tp10 -102.29 163.62 12.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.058 -1.026 . . . . 0.0 111.008 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.598 HG12 ' HG3' ' A' ' 34' ' ' GLU . 2.5 p -30.36 160.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.57 1.176 . . . . 0.0 112.581 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.533 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.12 67.63 1.37 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.995 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.1 p -38.59 165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.102 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.27 145.71 46.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.938 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -134.77 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.722 ' N ' HG23 ' A' ' 39' ' ' ILE . 13.1 mt-10 -149.35 138.51 21.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.923 -1.11 . . . . 0.0 109.708 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 5.9 t -132.72 26.22 4.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 41' ' ' THR . 2.2 t70 87.34 15.31 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.341 0.591 . . . . 0.0 110.459 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 160.52 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 1.1 t -103.99 148.57 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.613 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 39' ' ' ILE . 51.2 t -136.93 96.76 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.685 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.769 ' N ' HD22 ' A' ' 46' ' ' LEU . 2.9 mm? -79.88 -176.0 5.21 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.309 -0.869 . . . . 0.0 108.728 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 1.3 pt-20 -142.39 -161.36 1.23 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.718 -1.239 . . . . 0.0 111.463 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.822 HG13 HG12 ' A' ' 5' ' ' ILE . 6.0 t -143.47 75.5 16.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.7 Cg_endo -80.73 110.82 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.487 2.125 . . . . 0.0 110.931 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.949 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -91.79 -169.38 2.26 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.1 p -132.36 14.68 4.57 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.265 -1.522 . . . . 0.0 111.183 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.62 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 109.951 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER 60.63 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.548 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 64.95 -13.65 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 O-C-N 121.324 -0.86 . . . . 0.0 112.093 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.651 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.81 96.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.674 -1.486 . . . . 0.0 108.551 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.925 HD12 ' HG ' ' A' ' 76' ' ' LEU . 7.8 tp -49.87 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ILE . 46.6 t0 -98.6 -41.59 7.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.97 -0.456 . . . . 0.0 110.544 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -147.37 78.71 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.577 -1.327 . . . . 0.0 111.677 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.74 ' CG2' HD11 ' A' ' 56' ' ' LEU . 60.7 t -80.86 82.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.37 -10.8 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 109.709 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 4.8 mm-40 -123.74 50.93 1.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -40.8 134.12 1.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.586 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.05 134.51 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.597 0.713 . . . . 0.0 111.015 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.75 -13.96 24.64 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -84.98 156.19 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -1.135 . . . . 0.0 109.405 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.41 166.43 20.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.681 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.815 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.04 169.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -147.78 -148.31 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 9.3 p -90.28 36.18 0.87 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mtt180 163.55 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.4 mt-30 -84.49 87.69 7.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 0.0 109.102 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.4 tt -45.0 108.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 48' ' ' VAL . 10.6 mt -53.91 -42.86 69.21 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 156.55 -159.79 29.76 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.549 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -134.68 134.49 41.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.151 -1.206 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.925 ' HG ' HD12 ' A' ' 56' ' ' LEU . 4.4 mp -98.09 -96.72 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.34 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -153.73 163.19 40.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.542 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.49 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 1.1 tt0 -160.81 -163.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 121.63 2.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.246 -1.149 . . . . 0.0 109.507 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.436 ' CA ' ' HG3' ' A' ' 78' ' ' GLU . 5.4 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.534 ' N ' ' HB2' ' A' ' 78' ' ' GLU . 35.3 m -69.78 -165.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.398 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.873 HG21 ' OE1' ' A' ' 34' ' ' GLU . 8.8 t -78.96 77.52 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.2 -0.937 . . . . 0.0 109.317 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.79 83.86 2.75 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.85 HG12 HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -101.24 149.19 6.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.325 -0.859 . . . . 0.0 111.628 -177.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.849 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.43 -158.59 0.9 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.101 ' CG2' HD21 ' A' ' 73' ' ' LEU . 72.7 t -136.04 58.09 21.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.084 -1.01 . . . . 0.0 110.247 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.1 Cg_endo -80.7 19.81 1.06 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.39 2.06 . . . . 0.0 111.124 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.578 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 1.5 m-20 -109.46 62.45 0.6 Allowed 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.769 -1.207 . . . . 0.0 109.913 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' A' ' 17' ' ' ALA . 22.5 mt -135.5 140.14 33.25 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.24 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.07 135.98 14.28 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.455 2.103 . . . . 0.0 110.35 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 13' ' ' SER . 8.3 mt-10 -67.4 102.3 1.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER 171.63 -26.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.378 -0.826 . . . . 0.0 109.815 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.7 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 74.0 t -85.69 -97.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.419 -0.801 . . . . 0.0 109.601 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 14' ' ' VAL . . . 162.23 -22.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.754 . . . . 0.0 109.651 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 67' ' ' VAL . 0.6 OUTLIER 172.37 144.38 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.648 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.676 ' HB2' HD21 ' A' ' 10' ' ' LEU . . . -97.48 -151.57 0.37 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.309 -0.87 . . . . 0.0 109.371 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 21.2 m -160.33 121.78 3.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.335 -0.853 . . . . 0.0 109.934 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.667 HG22 HD11 ' A' ' 39' ' ' ILE . 13.4 t -63.97 91.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.135 -0.978 . . . . 0.0 109.108 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -54.65 -57.83 9.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 110.707 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.626 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 40.3 m -166.5 122.88 1.25 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.709 -1.244 . . . . 0.0 111.654 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 1.027 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.4 m95 -67.85 -165.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.681 ' HB2' HG23 ' A' ' 35' ' ' VAL . 39.9 m80 -148.92 22.03 0.98 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.521 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.59 154.36 31.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.676 -0.64 . . . . 0.0 109.678 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.642 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -105.61 -173.41 0.28 Allowed Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.642 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.84 83.73 0.53 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.075 1.183 . . . . 0.0 111.247 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.711 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 81.11 48.08 6.21 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.757 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.2 m-20 -55.83 -113.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -1.182 . . . . 0.0 110.005 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 163.05 72.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.448 -1.408 . . . . 0.0 109.98 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.981 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -79.66 157.09 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.112 -0.992 . . . . 0.0 110.652 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 2.6 m -97.51 -107.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 12.8 ttt-85 -104.9 74.84 1.15 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.693 -1.254 . . . . 0.0 108.965 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.594 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 11.4 m-20 143.96 102.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.981 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -112.21 -173.3 2.22 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 117.958 -1.497 . . . . 0.0 113.533 -177.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.775 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 13.1 p -27.68 153.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.953 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.1 58.82 1.7 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 178.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.027 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.1 p -37.75 168.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.731 0.776 . . . . 0.0 110.761 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.413 ' H ' HG22 ' A' ' 37' ' ' VAL . 2.7 mt-10 -126.67 142.18 51.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.889 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -128.14 -179.63 3.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 121.276 -0.89 . . . . 0.0 109.387 -179.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.638 ' N ' HG23 ' A' ' 39' ' ' ILE . 15.4 mt-10 -137.83 127.63 25.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.782 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 44' ' ' VAL . 8.5 t -132.13 25.89 4.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 0.0 109.49 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.3 t0 81.32 87.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.709 -0.62 . . . . 0.0 110.544 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.9 tttp 85.72 -27.62 0.08 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.869 -0.519 . . . . 0.0 110.403 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.57 ' O ' HG22 ' A' ' 41' ' ' THR . 0.2 OUTLIER -114.81 142.19 28.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.961 -1.087 . . . . 0.0 109.964 -179.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.889 HG13 ' O ' ' A' ' 39' ' ' ILE . 39.8 t -139.32 100.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.138 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 3.3 mm? -81.65 -166.45 1.2 Allowed 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.537 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -143.45 -161.8 1.33 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.182 -0.949 . . . . 0.0 110.122 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.85 HG22 HG12 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -156.02 77.2 4.56 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 109.948 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.5 Cg_endo -79.89 107.63 2.12 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.419 2.079 . . . . 0.0 110.031 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.888 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . . . -76.11 -167.22 0.71 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -143.06 24.02 1.84 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.461 -1.4 . . . . 0.0 110.819 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.69 118.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.73 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.63 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 66.0 m-20 106.65 -117.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.559 ' CA ' ' OE1' ' A' ' 34' ' ' GLU . . . 100.28 -26.79 23.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.797 HD12 ' HD3' ' A' ' 77' ' ' ARG . 6.1 mt -43.78 98.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 108.089 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.109 HD12 HD22 ' A' ' 76' ' ' LEU . 10.6 tp -51.57 100.92 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.391 -0.818 . . . . 0.0 109.698 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.446 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 33.4 t0 -101.2 -46.75 4.95 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.754 -0.591 . . . . 0.0 109.598 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.64 96.79 2.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.884 -1.135 . . . . 0.0 110.529 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.923 HG21 HD21 ' A' ' 56' ' ' LEU . 2.6 t -94.71 90.9 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.965 . . . . 0.0 108.505 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.982 HD12 ' HA2' ' A' ' 74' ' ' GLY . 1.6 mt -71.23 -2.04 14.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.849 . . . . 0.0 110.329 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.513 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 7.7 mt-10 -135.61 54.3 1.92 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.155 -0.965 . . . . 0.0 108.471 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.4 m-20 -43.91 130.36 5.78 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.488 -0.758 . . . . 0.0 109.553 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -34.63 116.34 0.31 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.343 0.592 . . . . 0.0 110.953 -179.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.09 -6.39 7.27 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 m -95.18 162.92 13.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -1.179 . . . . 0.0 109.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -78.43 156.96 29.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.243 -0.911 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.801 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.74 174.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.584 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -143.82 -164.92 1.99 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 108.81 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.554 ' H ' HG22 ' A' ' 68' ' ' THR . 60.2 p -85.76 63.31 7.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.047 -1.033 . . . . 0.0 109.185 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.551 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.8 mmm-85 159.81 -16.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.606 -0.684 . . . . 0.0 109.923 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HB2' HG23 ' A' ' 67' ' ' VAL . 21.1 mm100 -53.27 143.74 17.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.422 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 72' ' ' ILE . 16.8 tt -95.59 112.06 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.3 -0.875 . . . . 0.0 109.682 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.101 HD21 ' CG2' ' A' ' 7' ' ' VAL . 9.3 mt -53.13 -31.46 42.41 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.982 ' HA2' HD12 ' A' ' 60' ' ' LEU . . . 139.63 -166.63 25.54 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.517 ' C ' HD23 ' A' ' 76' ' ' LEU . 1.5 ptt85 -128.84 140.23 51.8 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.27 -1.135 . . . . 0.0 109.534 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.109 HD22 HD12 ' A' ' 56' ' ' LEU . 8.2 mt -100.74 -121.66 0.16 Allowed 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.128 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.797 ' HD3' HD12 ' A' ' 55' ' ' ILE . 19.2 ttt-85 -114.8 163.78 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.595 -1.316 . . . . 0.0 110.015 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.534 ' HB2' ' N ' ' A' ' 2' ' ' SER . 2.2 tm-20 -110.72 147.0 35.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 0.0 109.363 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 53' ' ' ASP . . . -71.09 -151.74 0.9 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.423 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.464 ' CB ' ' HG2' ' A' ' 78' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.55 ' CA ' ' HB2' ' A' ' 78' ' ' GLU . 5.6 m -69.81 -171.25 0.39 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.385 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.123 HG12 ' CD1' ' A' ' 5' ' ' ILE . 15.7 t -88.91 63.22 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.292 -0.88 . . . . 0.0 109.652 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -85.26 89.44 7.65 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.123 ' CD1' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -103.18 171.79 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 120.849 -1.157 . . . . 0.0 112.231 -177.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.869 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -142.12 -156.56 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 67' ' ' VAL . 59.9 t -129.35 54.38 14.21 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.036 -1.04 . . . . 0.0 110.724 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.695 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -80.3 28.02 0.54 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.473 2.115 . . . . 0.0 110.561 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.851 ' CB ' HD13 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -112.39 -2.48 14.74 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 120.972 -1.08 . . . . 0.0 109.707 -179.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.791 ' HB3' HG11 ' A' ' 14' ' ' VAL . 55.3 mt -68.09 140.29 93.31 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.219 -0.926 . . . . 0.0 109.608 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 10' ' ' LEU . 36.2 Cg_endo -78.82 -159.88 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.517 2.145 . . . . 0.0 110.416 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.02 21.32 9.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.433 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -136.7 58.49 1.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 109.338 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.811 HG13 ' O ' ' A' ' 14' ' ' VAL . 14.6 p -159.67 84.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.235 -0.916 . . . . 0.0 109.403 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' VAL . . . -43.12 -26.09 0.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 14' ' ' VAL . 2.7 p30 -178.7 158.9 1.06 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.393 -0.817 . . . . 0.0 109.773 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -120.74 -163.48 1.02 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.487 ' C ' HG13 ' A' ' 39' ' ' ILE . 96.7 m -159.39 139.76 12.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.126 -0.984 . . . . 0.0 110.174 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.543 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 14.2 t -73.2 91.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.402 -0.811 . . . . 0.0 109.373 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -52.65 -62.92 1.34 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.389 -0.82 . . . . 0.0 110.431 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.611 HG23 ' OE1' ' A' ' 63' ' ' GLU . 2.9 m -161.62 122.67 2.75 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.499 -1.28 . . . . 0.0 111.812 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.99 ' HA ' HG23 ' A' ' 37' ' ' VAL . 13.7 m95 -67.93 -165.56 0.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.412 -0.805 . . . . 0.0 109.034 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.716 ' HB2' HG23 ' A' ' 35' ' ' VAL . 33.8 m80 -150.24 31.39 0.68 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.563 ' HG2' ' HB ' ' A' ' 35' ' ' VAL . 2.8 mtpp -122.16 177.84 5.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.925 0.869 . . . . 0.0 110.844 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.681 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 8.2 mmmt -131.98 -177.62 0.72 Allowed Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.681 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -69.25 86.0 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.166 1.244 . . . . 0.0 110.646 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.817 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 86.07 47.36 5.02 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.567 ' O ' ' CG1' ' A' ' 55' ' ' ILE . 12.8 m-20 -54.31 -158.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -1.095 . . . . 0.0 110.055 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.33 86.74 0.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.54 -1.35 . . . . 0.0 109.179 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.044 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -95.13 170.46 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 110.011 -179.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.667 HG13 ' H ' ' A' ' 32' ' ' ARG . 1.5 p -133.88 -57.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.317 -0.865 . . . . 0.0 109.386 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.667 ' H ' HG13 ' A' ' 31' ' ' VAL . 3.2 mtp180 -141.18 64.16 1.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 108.82 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 11.6 m-20 149.6 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.044 ' HA ' HG21 ' A' ' 30' ' ' VAL . 11.9 tt0 -94.1 167.77 11.37 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.328 1.061 . . . . 0.0 111.726 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.716 HG23 ' HB2' ' A' ' 23' ' ' HIS . 2.4 p -31.16 156.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 122.174 0.987 . . . . 0.0 112.168 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.543 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.98 64.57 1.5 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 177.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.99 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.0 p -37.86 165.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.729 0.776 . . . . 0.0 110.268 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.4 mm-40 -128.37 98.47 5.07 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 108.806 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.93 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -79.75 -168.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.743 ' N ' HG23 ' A' ' 39' ' ' ILE . 8.5 mt-10 -136.59 114.58 11.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.951 -1.093 . . . . 0.0 110.275 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.574 HG23 HD22 ' A' ' 10' ' ' LEU . 98.1 m -106.33 -103.23 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.23 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 2.3 t70 -144.85 95.16 2.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.102 -0.998 . . . . 0.0 108.99 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.571 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 23.1 tttm 85.66 -28.02 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.307 0.575 . . . . 0.0 109.452 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 45' ' ' VAL . 2.0 t -118.95 -177.05 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.126 -0.984 . . . . 0.0 109.223 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 39' ' ' ILE . 44.4 t -148.64 120.42 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 109.577 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.851 HD13 ' CB ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -79.43 159.46 27.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 4.4 mt-10 -124.07 -173.45 2.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.058 -1.026 . . . . 0.0 110.132 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.987 HG22 HG21 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -148.86 66.49 8.84 Favored Pre-proline 0 N--CA 1.487 1.409 0 CA-C-O 121.911 0.862 . . . . 0.0 109.041 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 33.8 Cg_endo -75.15 115.7 4.34 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.679 2.253 . . . . 0.0 110.998 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.02 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -91.91 -177.0 4.6 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.72 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 51.5 p -129.68 21.32 5.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.747 -1.221 . . . . 0.0 110.07 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 162.69 161.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.432 -0.792 . . . . 0.0 109.076 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.716 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.8 m-20 75.82 -145.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 117.03 -18.91 12.19 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 120.475 -1.391 . . . . 0.0 110.256 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.817 HG23 ' HA2' ' A' ' 27' ' ' GLY . 18.9 mt -46.61 95.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.136 -1.214 . . . . 0.0 107.77 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.101 HD12 ' CD1' ' A' ' 76' ' ' LEU . 7.2 tp -53.27 109.42 0.43 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.375 -0.828 . . . . 0.0 109.398 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 20.1 t70 -113.54 -53.87 2.66 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.741 -0.599 . . . . 0.0 110.358 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.666 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -132.64 79.51 1.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.694 -1.254 . . . . 0.0 110.952 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.921 HG21 HD21 ' A' ' 56' ' ' LEU . 10.1 t -81.07 87.98 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.76 -1.6 12.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.465 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 51.8 mt-10 -134.03 52.51 2.06 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.013 -1.055 . . . . 0.0 108.456 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -43.5 131.59 4.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.599 -0.688 . . . . 0.0 109.769 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.611 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.2 OUTLIER -36.1 111.38 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.327 0.584 . . . . 0.0 110.587 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.86 4.31 7.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -101.74 162.11 13.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -1.2 . . . . 0.0 109.596 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.23 151.61 36.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.595 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.98 173.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.931 HG22 ' HG2' ' A' ' 71' ' ' GLN . 5.2 t -140.33 -157.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 108.829 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.596 ' N ' HG23 ' A' ' 68' ' ' THR . 88.7 p -90.32 63.87 5.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.977 -1.077 . . . . 0.0 109.406 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.518 ' CB ' ' O ' ' A' ' 69' ' ' SER . 4.2 ttt180 159.54 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.648 -0.658 . . . . 0.0 109.458 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.931 ' HG2' HG22 ' A' ' 68' ' ' THR . 19.0 mm-40 -48.79 138.44 11.13 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.414 -0.804 . . . . 0.0 109.444 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 72' ' ' ILE . 5.8 tt -87.55 114.36 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.383 -0.823 . . . . 0.0 109.818 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.588 HD13 HG11 ' A' ' 37' ' ' VAL . 5.2 mt -49.35 -39.64 32.61 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 146.86 -173.99 26.85 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.666 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -117.87 140.98 48.94 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.159 -1.2 . . . . 0.0 109.317 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.101 ' CD1' HD12 ' A' ' 56' ' ' LEU . 3.6 mm? -88.17 -92.33 0.11 Allowed 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.334 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.576 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -161.41 174.47 13.43 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 110.022 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' HB2' ' CA ' ' A' ' 2' ' ' SER . 7.8 tp10 -174.69 124.9 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 109.662 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.527 ' O ' ' CZ ' ' A' ' 77' ' ' ARG . . . 43.76 -94.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 78' ' ' GLU . 53.2 p-10 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 109.446 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.309 0.576 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.533 ' N ' ' HB2' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -167.53 168.88 12.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.421 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.77 ' O ' HG12 ' A' ' 3' ' ' VAL . 34.7 t -88.81 72.82 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.901 . . . . 0.0 109.411 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.63 80.99 4.09 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.791 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -94.32 156.7 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.28 -0.887 . . . . 0.0 111.327 -177.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.886 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -139.57 -155.54 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.993 ' CG1' HD12 ' A' ' 46' ' ' LEU . 16.5 t -136.9 63.68 46.16 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.955 -1.091 . . . . 0.0 109.84 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HB3' ' CG ' ' A' ' 70' ' ' ARG . 36.5 Cg_endo -80.59 43.22 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.78 2.32 . . . . 0.0 110.252 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.983 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.8 OUTLIER -128.37 31.05 5.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.179 -0.951 . . . . 0.0 109.957 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.067 HD22 ' CB ' ' A' ' 69' ' ' SER . 1.8 pt? -70.99 144.79 90.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.003 . . . . 0.0 109.898 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.596 ' HG2' HG23 ' A' ' 14' ' ' VAL . 36.5 Cg_endo -80.53 -11.17 13.06 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.631 2.221 . . . . 0.0 110.187 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 63.43 16.66 9.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.347 -0.846 . . . . 0.0 109.453 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.8 m -135.11 6.21 3.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 99.0 t -108.45 -97.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.434 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 14' ' ' VAL . . . 166.45 -21.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.155 -0.966 . . . . 0.0 110.512 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -175.97 -163.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.084 -1.01 . . . . 0.0 109.996 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -167.76 -171.78 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.303 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 16.0 m -159.69 134.91 8.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 110.546 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.568 ' HA ' HG13 ' A' ' 39' ' ' ILE . 23.8 t -70.42 84.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.455 -0.778 . . . . 0.0 109.251 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -41.18 -62.81 0.77 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.313 -0.867 . . . . 0.0 110.327 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.865 HG23 ' OE1' ' A' ' 63' ' ' GLU . 22.5 m -164.95 128.05 2.29 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.564 -1.255 . . . . 0.0 111.456 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 1.022 ' HA ' HG23 ' A' ' 37' ' ' VAL . 16.4 m95 -68.54 -167.69 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.632 ' HB2' HG23 ' A' ' 35' ' ' VAL . 23.4 m80 -149.56 35.38 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.665 ' HB3' HD13 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -131.62 168.51 17.58 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.511 0.672 . . . . 0.0 110.195 -179.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.648 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -121.5 -171.09 0.21 Allowed Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 178.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.648 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -68.45 84.91 0.46 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 120.831 1.021 . . . . 0.0 111.262 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.758 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 77.05 48.86 8.0 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.715 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 20.8 m-20 -54.5 -112.13 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.253 -1.145 . . . . 0.0 110.911 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 157.48 103.63 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.975 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -104.35 176.51 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 120.672 -1.268 . . . . 0.0 111.688 -177.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.617 ' H ' HG22 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -114.37 -137.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -80.69 76.86 7.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.833 -1.167 . . . . 0.0 108.19 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 4.4 m-20 150.22 79.15 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.004 ' OE1' HG12 ' A' ' 35' ' ' VAL . 2.7 tm-20 -83.26 171.36 13.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.9 . . . . 0.0 112.438 -177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.004 HG12 ' OE1' ' A' ' 34' ' ' GLU . 2.0 p -31.49 156.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.745 0.784 . . . . 0.0 111.687 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.539 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.05 63.27 1.34 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 178.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.022 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.2 p -39.38 168.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.681 0.753 . . . . 0.0 110.2 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.684 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.3 mt-10 -131.17 103.51 6.53 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 109.015 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.816 HG23 ' N ' ' A' ' 40' ' ' GLU . 2.8 tt -84.14 -159.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.369 -0.832 . . . . 0.0 109.425 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.816 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.8 mm-40 -139.8 127.48 21.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.928 -1.108 . . . . 0.0 109.801 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 41' ' ' THR . 84.8 m -132.69 16.62 4.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.852 . . . . 0.0 109.665 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 15.2 t0 72.19 85.49 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.161 -0.962 . . . . 0.0 109.684 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 86.38 -27.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.24 0.543 . . . . 0.0 109.59 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.9 t -115.47 144.97 21.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.143 -0.973 . . . . 0.0 109.281 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 39' ' ' ILE . 38.1 t -133.17 118.54 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.758 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.993 HD12 ' CG1' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -79.55 159.75 26.74 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.159 -0.963 . . . . 0.0 108.632 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -119.0 172.29 7.65 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.009 -1.057 . . . . 0.0 110.315 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.901 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.0 t -137.55 70.75 52.56 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.5 Cg_endo -79.72 116.3 3.47 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.838 2.358 . . . . 0.0 111.465 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.794 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -98.42 172.49 7.5 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 20.0 p -116.04 77.93 1.14 Allowed 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.087 -1.445 . . . . 0.0 110.618 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 88.81 160.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.245 0.545 . . . . 0.0 109.919 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.6 m-20 79.97 -76.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.699 -0.625 . . . . 0.0 110.219 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.561 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 40.94 22.51 0.06 OUTLIER Glycine 0 N--CA 1.493 2.455 0 O-C-N 121.033 -1.042 . . . . 0.0 110.788 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.758 HG23 ' CA ' ' A' ' 27' ' ' GLY . 12.5 mt -72.21 94.57 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.912 -1.346 . . . . 0.0 108.064 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.936 HD21 HG21 ' A' ' 59' ' ' VAL . 5.1 tp -47.78 91.28 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.752 0.787 . . . . 0.0 110.389 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.2 t70 -84.0 -50.56 7.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.49 99.91 2.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.979 -1.076 . . . . 0.0 110.627 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.936 HG21 HD21 ' A' ' 56' ' ' LEU . 4.0 t -83.35 90.73 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 60' ' ' LEU . 55.4 mt -69.09 -7.37 35.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 0.0 109.693 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 73' ' ' LEU . 2.9 mt-10 -131.72 52.76 2.04 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 63' ' ' GLU . 7.0 m-20 -40.93 134.17 2.0 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.46 0.648 . . . . 0.0 109.689 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.865 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -36.08 125.7 0.75 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.485 0.66 . . . . 0.0 110.82 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.23 -4.57 21.95 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 66' ' ' THR . 21.5 m -84.15 166.33 17.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 109.227 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.604 ' N ' HG22 ' A' ' 65' ' ' THR . 90.0 m -93.73 137.58 32.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.731 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.849 HG21 HG21 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -150.22 153.54 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.492 HG23 ' H ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -116.22 -97.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.057 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 1.067 ' CB ' HD22 ' A' ' 10' ' ' LEU . 28.7 p -94.99 -125.68 0.12 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.54 ' CG ' ' HB3' ' A' ' 8' ' ' PRO . 51.7 mtp180 -56.59 84.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.008 -1.058 . . . . 0.0 110.032 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -118.07 85.13 2.29 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.7 tt -34.25 107.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.885 -0.51 . . . . 0.0 111.107 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.874 ' CD1' HG21 ' A' ' 48' ' ' VAL . 15.7 mt -57.3 -38.36 73.87 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.79 -160.49 31.98 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.806 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -135.76 145.98 47.15 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.253 -1.145 . . . . 0.0 109.775 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.806 HD23 ' O ' ' A' ' 75' ' ' ARG . 2.4 mt -129.45 -137.0 0.22 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.568 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -118.48 151.62 37.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.779 -1.201 . . . . 0.0 109.228 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.533 ' HB2' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -137.56 -166.47 1.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.72 -153.76 30.04 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.302 -1.117 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.455 ' C ' ' HB3' ' A' ' 78' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.551 ' CA ' ' HB2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -170.13 166.66 8.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.309 -0.87 . . . . 0.0 109.49 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 8.0 t -69.43 98.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 108.733 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -71.91 85.65 0.97 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.903 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -81.17 121.35 34.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.545 -0.722 . . . . 0.0 109.904 -178.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.88 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -145.47 -165.64 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.94 HG21 HG21 ' A' ' 67' ' ' VAL . 29.2 t -134.78 56.9 18.81 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.232 -0.918 . . . . 0.0 109.924 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.668 ' CD ' HD13 ' A' ' 6' ' ' LEU . 37.1 Cg_endo -80.48 36.82 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.495 2.13 . . . . 0.0 110.517 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.549 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -89.97 -15.28 32.29 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.948 -1.095 . . . . 0.0 109.593 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.546 ' CD2' ' HB2' ' A' ' 69' ' ' SER . 1.0 OUTLIER 28.05 59.9 0.64 Allowed Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.27 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.743 ' HG3' HD21 ' A' ' 46' ' ' LEU . 36.4 Cg_endo -79.32 -74.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.534 2.156 . . . . 0.0 110.059 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 11' ' ' PRO . 29.4 mt-10 -157.63 27.63 0.28 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.529 ' CA ' ' OG1' ' A' ' 41' ' ' THR . 22.8 t -45.71 151.2 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.446 -0.784 . . . . 0.0 109.843 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 15' ' ' ALA . 71.3 t -95.25 -91.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.35 -0.844 . . . . 0.0 109.281 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.556 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -102.47 -4.11 25.89 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.509 -0.744 . . . . 0.0 109.633 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 3.0 p30 162.24 152.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.392 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.708 ' HB3' HG22 ' A' ' 67' ' ' VAL . . . -100.04 -168.03 1.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 20.4 m -153.39 131.71 12.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.375 -0.828 . . . . 0.0 110.317 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.741 HG22 HD11 ' A' ' 39' ' ' ILE . 11.4 t -70.18 83.69 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.386 -0.822 . . . . 0.0 109.493 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 19' ' ' VAL . . . -41.96 -63.27 0.76 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 110.493 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 5.4 m -166.94 129.05 1.71 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.59 -1.319 . . . . 0.0 111.479 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.903 ' CZ2' HG21 ' A' ' 5' ' ' ILE . 21.9 m95 -69.66 -167.08 0.12 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.531 0.682 . . . . 0.0 109.292 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.602 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 24.5 m80 -151.83 28.26 0.61 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.551 ' CE ' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -118.1 167.52 11.4 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.714 0.768 . . . . 0.0 110.434 -178.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.636 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -115.54 -179.83 0.68 Allowed Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.636 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -70.74 87.23 0.68 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.426 1.417 . . . . 0.0 110.932 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.605 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 88.2 41.71 6.13 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD1' ' CG ' ' A' ' 25' ' ' LYS . 13.6 m-20 -55.52 -164.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.995 -1.297 . . . . 0.0 109.685 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.43 77.67 0.62 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.019 -1.051 . . . . 0.0 109.391 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.977 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -79.5 -179.06 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.373 -0.829 . . . . 0.0 109.609 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.634 ' N ' HG13 ' A' ' 30' ' ' VAL . 1.5 m -139.1 -48.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.098 -1.001 . . . . 0.0 110.241 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.563 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -150.83 62.27 0.93 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.4 m-20 150.73 75.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.024 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.55 -170.41 3.04 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.298 1.047 . . . . 0.0 111.871 -177.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.849 HG12 ' CD ' ' A' ' 34' ' ' GLU . 3.8 p -50.46 161.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.929 0.871 . . . . 0.0 111.639 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -140.2 61.4 1.53 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.08 HG12 HG12 ' A' ' 48' ' ' VAL . 4.2 p -38.52 168.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 121.773 0.797 . . . . 0.0 110.736 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.662 ' HB3' HG11 ' A' ' 45' ' ' VAL . 8.2 mt-10 -129.13 125.23 36.66 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.905 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -111.36 -172.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.298 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.706 ' N ' HG23 ' A' ' 39' ' ' ILE . 6.1 mt-10 -134.98 128.78 33.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.998 . . . . 0.0 109.586 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 44' ' ' VAL . 12.4 t -125.92 -32.08 2.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 110.042 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.591 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 8.1 t70 158.94 70.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.591 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.9 tttm 85.79 -25.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 41' ' ' THR . 92.7 t -108.27 133.78 52.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.34 -0.85 . . . . 0.0 109.267 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.905 HG13 ' O ' ' A' ' 39' ' ' ILE . 55.9 t -118.36 112.52 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.117 -0.989 . . . . 0.0 109.729 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.827 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.29 -179.85 7.0 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.294 -0.878 . . . . 0.0 108.678 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 51.5 mt-10 -141.47 -171.38 3.29 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.86 -1.15 . . . . 0.0 110.451 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.08 HG12 HG12 ' A' ' 37' ' ' VAL . 14.8 p -146.35 75.4 12.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.388 -0.82 . . . . 0.0 109.678 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.749 ' HB3' HD23 ' A' ' 36' ' ' LEU . 35.0 Cg_endo -77.48 105.27 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.225 1.95 . . . . 0.0 110.385 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.024 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -77.56 -177.98 5.04 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.709 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.2 t -130.22 26.61 5.14 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.384 -1.448 . . . . 0.0 110.282 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.1 160.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.512 -0.743 . . . . 0.0 109.246 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.758 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.4 m-20 62.24 -136.32 0.48 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.263 -0.898 . . . . 0.0 108.956 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.745 ' O ' HD23 ' A' ' 76' ' ' LEU . . . 111.9 -17.83 24.66 Favored Glycine 0 N--CA 1.488 2.162 0 O-C-N 120.505 -1.372 . . . . 0.0 109.723 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.605 HG22 ' HA2' ' A' ' 27' ' ' GLY . 1.2 mt -34.24 102.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.789 -0.83 . . . . 0.0 109.371 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.876 HD12 ' HG ' ' A' ' 76' ' ' LEU . 12.2 tp -58.43 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.526 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -114.11 -29.49 6.96 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.405 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.851 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -138.69 106.57 5.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.831 -1.168 . . . . 0.0 110.506 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.809 ' CG2' HD11 ' A' ' 56' ' ' LEU . 18.2 t -127.56 76.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.78 -4.15 18.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.554 -0.716 . . . . 0.0 110.563 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.59 ' HG2' HG21 ' A' ' 65' ' ' THR . 10.0 mt-10 -128.32 50.37 2.09 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 108.787 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 63' ' ' GLU . 7.2 m-20 -51.18 118.2 3.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.568 -0.707 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 62' ' ' ASP . 1.6 mp0 5.56 113.25 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.21 -32.3 6.2 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.59 HG21 ' HG2' ' A' ' 61' ' ' GLU . 78.9 m -54.3 153.23 5.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -1.135 . . . . 0.0 109.276 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.408 ' O ' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -69.82 155.56 40.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.367 -0.833 . . . . 0.0 109.588 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.94 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -149.6 174.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -139.83 -172.2 3.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.013 . . . . 0.0 109.408 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.604 ' H ' HG22 ' A' ' 68' ' ' THR . 0.2 OUTLIER -86.19 46.76 1.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 109.133 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER 158.88 32.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 6' ' ' LEU . 77.2 mm-40 -112.94 149.89 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.992 -1.067 . . . . 0.0 109.125 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.2 tt -97.07 113.22 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.483 -0.761 . . . . 0.0 110.686 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.578 HD12 HG13 ' A' ' 5' ' ' ILE . 1.3 mt -47.56 -36.99 11.36 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.691 ' O ' HG22 ' A' ' 5' ' ' ILE . . . 163.99 -162.08 34.87 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.851 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 1.1 ptt180 -136.12 150.09 48.95 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.625 -1.514 . . . . 0.0 110.053 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.876 ' HG ' HD12 ' A' ' 56' ' ' LEU . 5.3 mp -111.07 -115.03 0.31 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.544 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 20.3 ttt-85 -134.38 153.69 51.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.863 -1.148 . . . . 0.0 109.304 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.551 ' HB2' ' CA ' ' A' ' 2' ' ' SER . 45.4 tt0 -141.61 164.63 29.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 109.461 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.419 ' N ' ' HG2' ' A' ' 78' ' ' GLU . . . 67.65 133.92 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.29 -1.124 . . . . 0.0 109.421 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.464 ' C ' ' HB3' ' A' ' 78' ' ' GLU . 20.5 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.489 ' N ' ' HB3' ' A' ' 78' ' ' GLU . 1.5 m -69.97 -168.22 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.519 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.773 HG21 ' OE1' ' A' ' 34' ' ' GLU . 43.3 t -84.42 68.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.842 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -71.72 85.82 0.92 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.857 HG12 HG13 ' A' ' 48' ' ' VAL . 0.7 OUTLIER -102.93 158.48 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.247 -0.908 . . . . 0.0 111.586 -177.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.848 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -137.62 -151.8 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 7' ' ' VAL . 85.6 t -132.25 54.32 13.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.864 -1.148 . . . . 0.0 109.688 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 36.6 Cg_endo -77.04 67.0 7.67 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.557 2.171 . . . . 0.0 110.637 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 1.016 ' HB2' HD13 ' A' ' 46' ' ' LEU . 1.1 m-20 -129.11 -4.58 5.0 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.086 -1.009 . . . . 0.0 109.831 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.56 HD21 ' HA ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -133.28 73.96 73.16 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.265 -0.897 . . . . 0.0 109.351 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.0 42.73 1.37 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.88 2.387 . . . . 0.0 110.853 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 12' ' ' GLU . 5.9 mm-40 -146.01 -116.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.071 -1.018 . . . . 0.0 109.52 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 12' ' ' GLU . 14.2 t -43.29 165.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.944 -1.097 . . . . 0.0 109.766 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.32 64.11 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.06 1.6 53.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 109.598 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 0.9 OUTLIER 67.6 -170.06 0.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.578 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -166.05 -171.9 2.14 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.229 -0.92 . . . . 0.0 109.585 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.484 ' C ' HG13 ' A' ' 39' ' ' ILE . 19.6 m -148.04 132.41 17.56 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.922 . . . . 0.0 110.192 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.657 HG22 HD11 ' A' ' 39' ' ' ILE . 16.6 t -69.0 87.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.937 . . . . 0.0 109.063 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -51.01 -63.48 1.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 111.08 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.909 HG23 ' OE1' ' A' ' 63' ' ' GLU . 1.8 m -161.61 123.61 2.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.574 -1.329 . . . . 0.0 112.019 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 1.036 ' HA ' HG23 ' A' ' 37' ' ' VAL . 16.9 m95 -68.6 -166.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.598 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 20.0 m80 -154.45 28.84 0.44 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.693 ' O ' HD22 ' A' ' 56' ' ' LEU . 4.9 tppt? -123.07 122.89 39.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.714 -0.616 . . . . 0.0 110.247 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.593 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -71.3 179.06 1.01 Allowed Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -68.17 89.88 0.38 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.597 1.532 . . . . 0.0 111.672 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.666 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 78.86 45.15 9.43 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.754 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 13.6 m-20 -59.43 -117.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.077 -1.249 . . . . 0.0 110.331 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 159.1 101.79 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.772 -1.205 . . . . 0.0 108.534 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.93 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -102.16 -179.4 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.938 -1.101 . . . . 0.0 109.971 -179.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.716 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -105.09 -91.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 0.0 110.048 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.519 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -117.9 43.83 2.33 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.034 -1.041 . . . . 0.0 109.068 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.565 ' C ' HG11 ' A' ' 30' ' ' VAL . 17.8 m-20 171.74 99.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.93 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -97.97 -160.38 0.8 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.348 -177.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.942 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 6.3 p -34.95 165.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.496 1.141 . . . . 0.0 112.94 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.566 HD12 ' ND1' ' A' ' 23' ' ' HIS . 0.4 OUTLIER -148.74 58.11 1.05 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.036 HG23 ' HA ' ' A' ' 22' ' ' TRP . 2.3 p -39.39 167.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.88 0.848 . . . . 0.0 110.836 -177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.577 ' HB3' HG11 ' A' ' 45' ' ' VAL . 24.1 mt-10 -130.81 121.61 25.65 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.952 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -103.97 -170.17 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.313 -0.867 . . . . 0.0 109.483 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.753 ' N ' HG23 ' A' ' 39' ' ' ILE . 2.5 mt-10 -153.2 101.37 2.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.122 -0.986 . . . . 0.0 109.767 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -97.12 -35.3 10.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.905 . . . . 0.0 109.9 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 11.4 t70 171.62 72.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.725 . . . . 0.0 109.704 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.4 tmmt? 85.8 -24.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.96 131.17 57.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.232 -0.917 . . . . 0.0 109.578 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.952 HG13 ' O ' ' A' ' 39' ' ' ILE . 94.3 t -113.84 123.31 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.838 . . . . 0.0 109.475 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD13 ' HB2' ' A' ' 9' ' ' ASP . 5.9 mt -86.44 178.24 7.18 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.163 -0.961 . . . . 0.0 108.816 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 27.2 mt-10 -126.58 175.84 7.64 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.811 -1.181 . . . . 0.0 110.835 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.916 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.9 t -139.46 71.99 37.86 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.3 Cg_endo -79.29 116.27 3.59 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.534 2.156 . . . . 0.0 109.797 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 34' ' ' GLU . . . -97.29 -175.66 3.29 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.945 -1.097 . . . . 0.0 108.524 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.7 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 12.3 p -131.5 70.16 1.47 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.452 -1.299 . . . . 0.0 111.644 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 98.53 136.95 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 121.253 0.549 . . . . 0.0 112.029 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.638 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 8.3 t0 101.34 -76.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.504 0.669 . . . . 0.0 110.019 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.605 ' HA2' HD23 ' A' ' 76' ' ' LEU . . . 43.27 21.6 0.15 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.666 HG23 ' CA ' ' A' ' 27' ' ' GLY . 6.7 mt -77.65 90.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.835 -1.391 . . . . 0.0 107.583 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.889 HD12 ' HG ' ' A' ' 76' ' ' LEU . 7.2 tp -44.0 111.2 0.27 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.447 0.641 . . . . 0.0 110.144 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 12.5 t70 -134.28 -29.88 1.21 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.608 -0.682 . . . . 0.0 110.245 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -137.65 39.56 2.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.622 -1.299 . . . . 0.0 110.964 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 59' ' ' VAL . 9.1 p -83.82 71.52 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.53 0.38 10.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.487 -0.758 . . . . 0.0 110.756 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 73' ' ' LEU . 9.1 mm-40 -105.08 41.54 1.33 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.2 m-20 -37.94 124.83 1.17 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.422 0.63 . . . . 0.0 110.005 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.909 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.2 OUTLIER -29.47 122.14 0.15 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.498 0.666 . . . . 0.0 111.35 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.35 -13.35 8.35 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.445 ' HB ' ' OE1' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -83.37 174.43 10.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -1.062 . . . . 0.0 109.367 179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -96.19 144.89 26.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 110.021 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.612 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.69 169.44 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.544 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -127.49 -143.14 0.28 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.56 ' HA ' HD21 ' A' ' 10' ' ' LEU . 11.1 t -69.67 -102.09 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.008 -1.057 . . . . 0.0 108.972 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 71' ' ' GLN . 3.7 mtt180 -78.07 36.7 0.23 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.127 -0.983 . . . . 0.0 111.377 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.518 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 61.4 mm-40 -61.73 -113.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.49 -1.381 . . . . 0.0 107.991 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 72' ' ' ILE . 16.0 tt 179.34 115.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.694 -1.254 . . . . 0.0 110.725 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.65 ' CD1' HG21 ' A' ' 48' ' ' VAL . 7.8 mt -71.84 -44.47 63.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.38 -159.76 28.79 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.772 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 13.6 mtt180 -135.34 135.39 40.69 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.263 -1.14 . . . . 0.0 108.903 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.889 ' HG ' HD12 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -85.33 -105.23 0.05 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.353 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.541 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -142.5 163.68 32.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.928 -1.108 . . . . 0.0 109.799 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.511 ' CA ' ' OD2' ' A' ' 53' ' ' ASP . 8.9 pt-20 -119.72 -173.38 2.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.693 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.26 143.54 10.65 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.5 m120 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.173 -1.192 . . . . 0.0 109.405 -179.97 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.326 0.584 . . . . 0.0 109.456 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.484 ' CB ' ' HB2' ' A' ' 75' ' ' ARG . 7.6 m -166.92 162.16 15.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.927 . . . . 0.0 109.525 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.869 HG21 ' OE1' ' A' ' 34' ' ' GLU . 14.1 t -80.58 75.62 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 108.916 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.584 ' OD2' HD11 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -78.74 78.17 5.2 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.814 HG12 HG13 ' A' ' 48' ' ' VAL . 4.5 tp -88.1 154.28 3.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.259 -0.901 . . . . 0.0 110.799 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.843 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.82 -151.44 0.45 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.334 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.1 HG21 HG21 ' A' ' 67' ' ' VAL . 59.6 t -133.63 60.59 47.78 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.034 -1.041 . . . . 0.0 110.167 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -81.14 34.02 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.538 2.159 . . . . 0.0 110.521 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 1.008 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -107.83 22.26 16.22 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.008 -1.057 . . . . 0.0 109.689 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.055 HD21 HD11 ' A' ' 46' ' ' LEU . 5.4 mt -130.26 70.44 82.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.323 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' SER . 35.7 Cg_endo -77.98 -171.41 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.692 2.261 . . . . 0.0 110.532 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 39.05 -93.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.67 -0.644 . . . . 0.0 110.217 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' PRO . 5.5 m -71.0 174.29 6.41 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.342 -0.849 . . . . 0.0 109.52 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.6 t -143.37 74.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 109.377 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' O ' ' CG ' ' A' ' 16' ' ' ASP . . . -85.74 14.0 6.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.646 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 1.2 p30 48.37 -163.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.389 -0.819 . . . . 0.0 109.194 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -170.37 -164.4 0.39 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.306 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.522 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 33.6 m -160.1 119.11 2.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.862 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 63' ' ' GLU . 2.8 t -48.43 134.11 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.279 -0.888 . . . . 0.0 108.996 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -106.76 -57.43 2.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.676 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 32.5 m -160.88 119.14 2.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.849 -1.157 . . . . 0.0 111.208 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.901 ' HA ' HG23 ' A' ' 37' ' ' VAL . 21.2 m95 -68.94 -165.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 22' ' ' TRP . 18.6 m80 -156.17 48.22 0.48 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.774 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.12 119.72 13.23 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.493 -0.754 . . . . 0.0 110.179 -179.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.607 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -62.0 -179.25 0.22 Allowed Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.1 Cg_endo -67.69 88.88 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.277 1.318 . . . . 0.0 111.111 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.698 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 76.05 46.89 12.21 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.742 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.3 m-20 -59.1 -115.63 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.888 -1.36 . . . . 0.0 109.543 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.742 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 163.23 98.56 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.565 -1.334 . . . . 0.0 109.422 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.921 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -92.74 -176.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.111 -0.993 . . . . 0.0 109.742 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.712 HG13 ' H ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -141.79 -62.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.43 -0.794 . . . . 0.0 109.471 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.712 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -132.52 58.72 1.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -0.979 . . . . 0.0 108.986 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.732 ' O ' HG21 ' A' ' 30' ' ' VAL . 14.8 m-20 151.51 76.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.056 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -71.94 -173.64 1.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.348 1.07 . . . . 0.0 111.773 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.761 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 14.0 p -45.2 168.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.603 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -147.96 61.37 1.12 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.939 HG12 ' HB ' ' A' ' 48' ' ' VAL . 2.7 p -39.46 166.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.728 0.775 . . . . 0.0 110.404 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.844 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 5.1 mm-40 -128.72 97.3 4.63 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.776 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.72 -165.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.473 -0.767 . . . . 0.0 109.254 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.776 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -139.68 141.03 37.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.937 -1.102 . . . . 0.0 110.097 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.76 HG22 ' O ' ' A' ' 41' ' ' THR . 97.5 m -146.4 21.28 1.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.44 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 18.8 t0 64.73 88.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 109.568 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 86.15 -26.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.443 ' O ' ' HB ' ' A' ' 41' ' ' THR . 55.3 t -116.22 142.21 30.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 39' ' ' ILE . 96.9 t -136.21 118.03 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.055 HD11 HD21 ' A' ' 10' ' ' LEU . 3.9 mt -82.77 162.47 21.7 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.307 -0.871 . . . . 0.0 108.969 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -119.54 175.44 5.84 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.039 -1.038 . . . . 0.0 110.176 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.939 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.8 t -140.54 68.69 31.6 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 109.182 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.51 110.13 2.15 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.633 2.222 . . . . 0.0 110.399 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.056 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -89.84 179.27 6.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.672 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -125.71 72.4 1.28 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.552 -1.343 . . . . 0.0 110.215 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 101.58 162.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.507 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.857 ' O ' HG12 ' A' ' 30' ' ' VAL . 11.9 m-20 64.78 -142.01 0.24 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.641 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 101.11 -7.41 56.89 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.077 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.698 HG23 ' CA ' ' A' ' 27' ' ' GLY . 6.1 mt -41.18 96.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.836 ' CD1' HG22 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -41.58 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.761 0.791 . . . . 0.0 109.416 -178.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ILE . 51.8 t0 -101.59 -52.24 3.26 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.699 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.93 105.42 3.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.895 -1.128 . . . . 0.0 110.531 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.836 HG22 ' CD1' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -102.02 90.03 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 mt -69.79 -5.01 22.54 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 110.083 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' A' ' 73' ' ' LEU . 3.6 mt-10 -124.51 40.96 3.62 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.156 -0.965 . . . . 0.0 108.922 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 63' ' ' GLU . 4.6 m-20 -42.22 128.73 3.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.58 -0.7 . . . . 0.0 109.554 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.545 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -26.89 121.7 0.09 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.317 0.58 . . . . 0.0 110.972 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.86 -16.2 7.82 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 66' ' ' THR . 73.0 m -88.14 160.06 17.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -1.17 . . . . 0.0 109.58 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.498 ' N ' HG22 ' A' ' 65' ' ' THR . 58.2 m -78.74 157.54 28.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 109.546 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.1 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.59 169.68 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.725 HG22 ' CG ' ' A' ' 71' ' ' GLN . 5.4 t -141.38 -152.05 0.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.362 -0.836 . . . . 0.0 109.123 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.677 ' N ' HG23 ' A' ' 68' ' ' THR . 12.8 p -93.38 58.68 2.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.051 -1.03 . . . . 0.0 109.624 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.7 mtp-105 160.3 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.542 -0.724 . . . . 0.0 109.755 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.725 ' CG ' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -46.87 133.92 10.54 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.668 HG23 ' O ' ' A' ' 72' ' ' ILE . 11.5 tt -86.32 110.72 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.827 ' CD1' HG21 ' A' ' 48' ' ' VAL . 18.5 mt -50.17 -44.87 52.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.015 -1.053 . . . . 0.0 108.205 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.51 -175.36 34.16 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.746 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.6 ptt180 -118.46 143.75 46.48 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.248 -1.148 . . . . 0.0 109.804 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.888 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 6.4 mt -114.8 -79.75 0.59 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.935 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -160.75 141.63 11.71 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.257 -0.902 . . . . 0.0 109.251 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.486 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 4.3 tt0 -164.42 74.98 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.127 -0.983 . . . . 0.0 109.565 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.36 -141.29 11.21 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.232 -1.158 . . . . 0.0 109.455 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.301 0.572 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.543 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 8.6 m -160.89 173.8 14.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.352 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.707 ' O ' HG12 ' A' ' 3' ' ' VAL . 9.6 t -69.53 84.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.046 -1.034 . . . . 0.0 108.464 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 2.5 m-20 -74.61 83.42 2.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.101 ' CG1' HG22 ' A' ' 48' ' ' VAL . 3.5 tp -104.31 146.27 11.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.172 -177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.784 ' O ' HG23 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -134.85 -164.63 1.55 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.592 HG21 HD12 ' A' ' 39' ' ' ILE . 20.9 t -133.03 86.96 41.17 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.979 -1.076 . . . . 0.0 110.418 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.532 ' CA ' ' HG2' ' A' ' 70' ' ' ARG . 36.8 Cg_endo -81.44 54.56 5.2 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.578 2.185 . . . . 0.0 110.082 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.926 ' CB ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -119.55 7.14 11.08 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.101 -0.999 . . . . 0.0 110.256 -179.167 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.574 ' HB3' ' CB ' ' A' ' 69' ' ' SER . 1.1 pp -41.38 115.0 1.3 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 109.77 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.81 -159.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.402 2.068 . . . . 0.0 110.381 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -89.0 36.19 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.525 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -153.81 149.95 27.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 14' ' ' VAL . 4.2 p -102.42 54.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.422 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.12 6.43 32.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.494 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 61.22 -163.25 0.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.179 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -170.09 -171.36 1.13 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.107 -0.995 . . . . 0.0 109.925 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 16.0 m -153.21 138.49 17.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 110.347 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.587 ' HA ' HG13 ' A' ' 39' ' ' ILE . 11.2 t -76.79 99.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 0.0 109.53 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -57.49 -54.9 41.58 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 110.606 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.597 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 21.7 m -168.87 131.03 1.26 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.605 -1.31 . . . . 0.0 111.815 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 1.052 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.5 m95 -68.65 -162.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.7 ' HB2' HG23 ' A' ' 35' ' ' VAL . 26.3 m80 -155.14 34.13 0.38 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.927 ' CB ' HD23 ' A' ' 56' ' ' LEU . 1.6 mmmt -124.59 128.4 48.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.85 -0.531 . . . . 0.0 110.317 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.638 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -79.91 -174.68 0.51 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.5 Cg_endo -68.25 84.14 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.069 1.179 . . . . 0.0 111.564 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.559 ' HA2' ' CG2' ' A' ' 55' ' ' ILE . . . 78.83 47.46 7.75 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.742 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.0 m-20 -55.34 -110.74 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.047 -1.266 . . . . 0.0 110.426 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.742 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 157.86 99.78 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 O-C-N 120.926 -1.109 . . . . 0.0 108.67 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.828 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -102.56 -177.35 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.831 -1.168 . . . . 0.0 109.718 -179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.725 ' N ' HG13 ' A' ' 30' ' ' VAL . 5.8 m -130.03 -113.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.146 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 4.9 mtt180 -87.11 63.6 7.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.827 -1.171 . . . . 0.0 109.175 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 4.1 m-20 150.66 101.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.028 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -97.73 -174.05 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.247 1.023 . . . . 0.0 111.656 -178.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.866 HG12 ' OE2' ' A' ' 34' ' ' GLU . 3.7 p -44.23 157.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-O 121.978 0.894 . . . . 0.0 111.704 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -134.55 63.38 1.62 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 178.119 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.052 HG23 ' HA ' ' A' ' 22' ' ' TRP . 5.5 p -38.92 168.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.78 0.8 . . . . 0.0 110.178 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' N ' HG22 ' A' ' 37' ' ' VAL . 4.8 mt-10 -123.19 139.61 53.87 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.933 HD11 HG21 ' A' ' 67' ' ' VAL . 1.9 tt -121.94 -163.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.978 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.802 ' N ' HG23 ' A' ' 39' ' ' ILE . 21.8 mm-40 -141.36 117.41 10.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.853 -1.154 . . . . 0.0 109.964 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.634 HG21 HD21 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -115.13 -64.17 1.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.566 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 49.0 t0 177.98 82.53 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.2 tttt 86.84 -26.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 41' ' ' THR . 1.9 t -113.18 163.31 10.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.309 -0.87 . . . . 0.0 109.201 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 39' ' ' ILE . 43.9 t -131.75 122.85 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.926 HD13 ' CB ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -79.66 158.91 26.9 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.317 -0.864 . . . . 0.0 108.734 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.5 pm0 -120.82 178.15 4.82 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.007 -1.058 . . . . 0.0 110.226 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.101 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -145.04 77.97 12.76 Favored Pre-proline 0 N--CA 1.489 1.518 0 CA-C-O 122.285 1.04 . . . . 0.0 108.778 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.0 Cg_endo -81.24 108.84 2.05 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.89 2.393 . . . . 0.0 111.966 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.028 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -78.02 -157.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.739 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.2 p -140.37 10.92 2.32 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.541 -1.349 . . . . 0.0 111.196 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.04 159.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.4 OUTLIER 78.91 -73.82 0.07 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.459 0.647 . . . . 0.0 110.272 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.551 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 45.3 16.88 0.1 Allowed Glycine 0 N--CA 1.489 2.194 0 O-C-N 121.212 -0.93 . . . . 0.0 111.655 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.56 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 2.2 mt -68.6 88.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.678 -1.483 . . . . 0.0 108.041 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.927 HD23 ' CB ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -40.81 103.45 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 1.1 t0 -123.21 -52.01 1.86 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 111.018 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . -136.15 82.61 1.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.512 -1.368 . . . . 0.0 111.155 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.859 ' CG2' HD11 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -79.9 103.2 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 29.4 mt -69.34 -11.82 61.14 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.093 -1.005 . . . . 0.0 109.533 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 9.5 mm-40 -132.42 56.09 1.85 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 61' ' ' GLU . 3.2 m-20 -40.74 136.18 1.46 Allowed 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.579 -0.7 . . . . 0.0 109.715 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.597 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -39.49 125.56 1.74 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.426 0.632 . . . . 0.0 110.822 -179.248 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.76 -4.64 19.07 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -97.75 153.07 18.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -1.134 . . . . 0.0 109.365 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.75 155.48 40.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.932 . . . . 0.0 109.446 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.933 HG21 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.32 162.43 3.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.557 -0.715 . . . . 0.0 109.279 -179.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.423 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 2.8 m -116.34 -133.24 0.33 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.48 -0.762 . . . . 0.0 109.328 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.574 ' CB ' ' HB3' ' A' ' 10' ' ' LEU . 7.3 p -69.59 -104.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.883 -1.136 . . . . 0.0 109.63 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.588 ' HD2' HD22 ' A' ' 6' ' ' LEU . 4.9 mtm180 -80.21 39.9 0.46 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.57 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.55 ' HB2' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -62.6 107.04 0.87 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.757 -1.214 . . . . 0.0 108.896 179.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.7 tt -43.28 110.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.011 ' CD1' HG11 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -52.91 -36.9 60.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 154.32 165.58 14.02 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.729 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.48 137.2 45.95 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.241 -1.153 . . . . 0.0 109.781 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.772 HD12 ' N ' ' A' ' 76' ' ' LEU . 5.5 mp -106.87 -94.11 0.38 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.552 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.56 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 4.2 tpt180 -150.63 157.77 43.37 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.479 ' HA ' ' OD2' ' A' ' 53' ' ' ASP . 32.4 tt0 -150.59 163.12 39.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.913 . . . . 0.0 109.573 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.445 ' O ' ' OXT' ' A' ' 80' ' ' ASN . . . -159.76 22.64 0.28 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.445 ' OXT' ' O ' ' A' ' 79' ' ' GLY . 4.2 m120 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.296 -1.12 . . . . 0.0 109.475 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 78' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 72.5 m -168.37 162.7 12.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.414 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 76' ' ' LEU . 57.9 t -72.69 81.03 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.59 78.51 6.13 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.775 HG12 HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -92.26 149.71 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.479 -0.763 . . . . 0.0 111.161 -177.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -132.8 -158.67 0.91 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.04 ' CG1' HD12 ' A' ' 46' ' ' LEU . 60.3 t -130.49 59.84 48.45 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 120.866 -1.146 . . . . 0.0 110.145 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.9 Cg_endo -81.41 19.92 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.589 2.193 . . . . 0.0 110.531 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 1.033 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -80.68 9.43 6.19 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.891 -1.131 . . . . 0.0 110.579 -179.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.595 HD22 ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -39.69 100.59 0.22 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.298 -0.876 . . . . 0.0 109.949 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HD2' HG21 ' A' ' 14' ' ' VAL . 36.2 Cg_endo -78.51 -40.57 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.473 2.115 . . . . 0.0 109.947 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 13' ' ' SER . 1.5 tt0 -165.38 -94.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.411 -0.806 . . . . 0.0 109.014 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.574 ' O ' HG23 ' A' ' 14' ' ' VAL . 83.8 p -87.91 130.81 34.8 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 109.164 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 13' ' ' SER . 71.1 t -159.61 83.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.958 . . . . 0.0 109.345 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' CB ' ' A' ' 16' ' ' ASP . . . -71.44 -3.19 19.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.902 . . . . 0.0 109.931 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER 164.5 -174.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.139 -0.976 . . . . 0.0 109.809 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -168.11 -171.25 1.49 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.856 . . . . 0.0 109.342 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.539 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 79.5 m -158.76 134.79 9.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 110.681 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.639 HG22 ' CD1' ' A' ' 39' ' ' ILE . 22.0 t -69.18 84.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.412 -0.805 . . . . 0.0 109.231 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -43.6 -63.16 0.89 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.092 -1.005 . . . . 0.0 110.245 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.608 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 87.3 m -164.19 124.19 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.648 -1.283 . . . . 0.0 111.658 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.997 ' HA ' HG23 ' A' ' 37' ' ' VAL . 19.1 m95 -68.44 -167.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.636 ' HB2' HG23 ' A' ' 35' ' ' VAL . 17.3 m80 -152.14 24.1 0.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.544 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 2.2 tppm? -118.45 128.18 54.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.793 -0.567 . . . . 0.0 109.941 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.569 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -78.94 178.61 2.18 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.4 Cg_endo -69.21 93.26 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.644 1.562 . . . . 0.0 111.466 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.685 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 78.28 43.13 13.62 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.756 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 12.5 m-20 -61.36 -120.24 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.002 -1.293 . . . . 0.0 109.651 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 159.58 79.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.73 -1.231 . . . . 0.0 108.843 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.851 HG12 ' OE2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -79.73 -168.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.12 -0.987 . . . . 0.0 109.652 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.817 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -134.99 -99.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.31 -0.869 . . . . 0.0 109.845 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.469 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 16.3 ttt-85 -98.37 38.5 1.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.871 -1.143 . . . . 0.0 109.522 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.731 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.6 m-20 178.5 91.42 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.108 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -83.37 -170.24 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.263 1.03 . . . . 0.0 112.102 -178.041 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.636 HG23 ' HB2' ' A' ' 23' ' ' HIS . 3.1 p -55.97 164.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.453 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.568 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -142.08 62.07 1.44 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.011 HG12 ' HB ' ' A' ' 48' ' ' VAL . 3.3 p -38.95 165.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-O 121.682 0.753 . . . . 0.0 110.204 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.787 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.3 mt-10 -128.37 97.58 4.78 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.786 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -79.76 -164.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 O-C-N 121.397 -0.814 . . . . 0.0 108.976 -179.48 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.786 ' N ' HG23 ' A' ' 39' ' ' ILE . 3.9 mm-40 -134.48 112.83 11.23 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.974 -1.079 . . . . 0.0 109.775 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.556 ' OG1' HD21 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -108.16 -145.58 0.39 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -0.87 . . . . 0.0 109.196 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 6.8 t70 -96.73 83.24 3.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.086 -1.009 . . . . 0.0 109.592 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 1.2 tmtt? 85.98 -22.23 0.19 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.223 0.535 . . . . 0.0 109.585 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 45' ' ' VAL . 95.2 t -113.61 164.74 9.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.307 -0.871 . . . . 0.0 109.612 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.59 HG11 ' OE1' ' A' ' 38' ' ' GLU . 54.9 t -127.64 125.64 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.04 HD12 ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -79.62 155.34 28.14 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.297 -0.877 . . . . 0.0 108.823 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -112.17 172.65 6.78 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.043 -1.036 . . . . 0.0 110.594 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.011 ' HB ' HG12 ' A' ' 37' ' ' VAL . 8.6 t -142.2 70.35 22.62 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.27 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.24 113.45 2.67 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.72 2.28 . . . . 0.0 111.288 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.108 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -88.5 -164.52 1.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.675 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 10.0 p -141.09 60.06 1.52 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.548 -1.261 . . . . 0.0 110.623 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.675 ' CB ' ' O ' ' A' ' 51' ' ' SER . . . 105.43 160.99 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.412 0.625 . . . . 0.0 110.658 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 74.95 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.619 -0.676 . . . . 0.0 110.188 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' OE2' ' A' ' 34' ' ' GLU . . . 54.56 8.51 1.28 Allowed Glycine 0 N--CA 1.495 2.582 0 O-C-N 121.051 -1.03 . . . . 0.0 111.778 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.685 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -55.11 92.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 120.612 -1.522 . . . . 0.0 107.797 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.871 HD12 ' HG ' ' A' ' 76' ' ' LEU . 8.8 tp -44.7 112.88 0.47 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.468 -0.77 . . . . 0.0 109.527 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -118.84 -43.36 2.67 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.653 -0.654 . . . . 0.0 110.07 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.552 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -143.06 78.12 1.59 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.858 -1.151 . . . . 0.0 110.776 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.815 HG21 HD21 ' A' ' 56' ' ' LEU . 8.4 t -79.46 87.59 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.8 mt -69.55 -4.42 18.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 0.0 110.334 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.502 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 2.5 mt-10 -129.21 50.89 2.1 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.463 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.0 m-20 -42.58 127.43 3.84 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.696 -0.627 . . . . 0.0 109.489 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.608 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.12 121.05 0.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.449 0.642 . . . . 0.0 111.079 -179.199 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.89 -1.45 19.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 66' ' ' THR . 22.5 m -97.89 159.98 14.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -1.137 . . . . 0.0 109.347 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.492 ' N ' HG22 ' A' ' 65' ' ' THR . 0.2 OUTLIER -70.99 149.33 46.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.64 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.724 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.24 169.45 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.537 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -138.63 -176.39 4.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.365 -0.834 . . . . 0.0 109.052 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.595 ' O ' HD22 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -83.69 69.52 10.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.231 -0.918 . . . . 0.0 109.329 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 69' ' ' SER . 10.3 ttm180 158.61 -22.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.6 mm-40 -57.62 159.17 5.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.876 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 72' ' ' ILE . 15.8 tt -103.81 113.25 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.696 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.877 ' CD1' HG21 ' A' ' 48' ' ' VAL . 9.3 mt -49.86 -47.1 51.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 108.269 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.72 -166.36 34.37 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.552 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.86 141.6 51.51 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.322 -1.104 . . . . 0.0 109.681 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.871 ' HG ' HD12 ' A' ' 56' ' ' LEU . 2.8 mp -101.29 -104.19 0.25 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.295 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.554 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -154.66 158.91 40.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.873 -1.142 . . . . 0.0 109.984 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.464 ' HA ' ' CG ' ' A' ' 53' ' ' ASP . 5.1 tt0 179.35 71.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.418 ' O ' ' ND2' ' A' ' 80' ' ' ASN . . . -84.34 -49.67 4.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 79' ' ' GLY . 20.2 m120 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.453 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.275 0.56 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 15.4 m -159.91 -179.74 8.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.374 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 77' ' ' ARG . 38.5 t -78.03 77.85 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.01 . . . . 0.0 108.52 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.71 85.88 0.92 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.012 HG12 HG22 ' A' ' 48' ' ' VAL . 3.5 tp -110.09 141.0 26.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 111.058 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.855 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -127.47 -145.54 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.91 HG23 HD21 ' A' ' 73' ' ' LEU . 69.1 t -132.94 58.82 38.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.957 -1.09 . . . . 0.0 109.315 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 34.5 Cg_endo -75.8 68.33 6.41 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.616 2.21 . . . . 0.0 111.108 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -123.17 -8.23 8.22 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.179 -0.951 . . . . 0.0 109.346 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 10' ' ' LEU . 6.4 mt 35.8 84.49 0.18 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.741 -0.6 . . . . 0.0 110.421 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.437 ' CB ' HG21 ' A' ' 41' ' ' THR . 35.3 Cg_endo -77.84 164.14 28.01 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.578 2.186 . . . . 0.0 110.242 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.68 39.91 3.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.686 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.694 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -122.94 -10.91 8.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.935 . . . . 0.0 109.618 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.765 HG12 ' N ' ' A' ' 15' ' ' ALA . 48.3 t -161.51 -97.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -0.816 . . . . 0.0 109.514 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.765 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 163.31 41.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 109.413 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.3 p30 176.42 -168.03 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.356 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . -170.46 -175.11 1.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.397 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 65' ' ' THR . 18.4 m -160.23 125.9 4.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.398 -0.814 . . . . 0.0 109.519 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 61' ' ' GLU . 2.6 t -52.54 141.62 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 109.071 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -117.7 -50.07 2.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.114 -0.991 . . . . 0.0 109.877 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.501 ' N ' ' HB3' ' A' ' 63' ' ' GLU . 52.6 m -164.56 114.12 1.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.885 -1.135 . . . . 0.0 111.128 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.902 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.2 m95 -68.56 -162.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.833 . . . . 0.0 108.756 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.608 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 20.8 m80 -160.08 26.14 0.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.867 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -114.63 114.5 25.76 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.595 -178.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.651 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 11.3 mmmt -59.55 173.34 0.52 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -66.92 96.5 0.38 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.516 1.477 . . . . 0.0 110.829 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.816 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 80.72 50.33 5.32 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 3.0 m-20 -55.72 -150.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.485 -1.009 . . . . 0.0 110.382 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' HD11 ' A' ' 55' ' ' ILE . . . -175.39 96.61 0.07 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.541 -1.349 . . . . 0.0 108.57 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.657 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -110.58 -176.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.891 -179.004 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.657 ' N ' HG13 ' A' ' 30' ' ' VAL . 2.1 p -125.72 -49.6 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.598 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -157.13 61.49 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.367 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.598 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.5 m-20 146.0 100.6 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.145 ' CG ' ' HB3' ' A' ' 50' ' ' ALA . 1.9 pt-20 -131.39 -164.07 1.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.938 -1.101 . . . . 0.0 112.028 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.826 HG21 ' HE3' ' A' ' 22' ' ' TRP . 4.0 p -13.58 136.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.068 0.937 . . . . 0.0 113.309 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -130.55 62.86 1.58 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.902 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.2 p -37.56 166.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.891 0.853 . . . . 0.0 110.807 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.0 mt-10 -125.03 95.61 4.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.938 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -79.86 -160.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 121.419 -0.8 . . . . 0.0 109.18 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.814 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -136.62 151.55 49.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.872 -1.143 . . . . 0.0 109.973 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 41' ' ' THR . 98.4 m -156.41 31.8 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.593 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 10.8 t0 47.78 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 109.637 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 85.27 -27.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.845 -0.535 . . . . 0.0 109.741 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.476 ' HB ' ' HB ' ' A' ' 41' ' ' THR . 1.8 t -120.85 152.43 24.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.154 -0.966 . . . . 0.0 109.538 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.938 HG13 ' O ' ' A' ' 39' ' ' ILE . 24.1 t -149.38 97.57 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.384 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.854 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.67 164.65 23.59 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.211 -0.931 . . . . 0.0 109.153 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 48.0 mt-10 -112.37 -165.92 1.03 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.211 -0.93 . . . . 0.0 109.761 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.012 HG22 HG12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -152.69 78.37 6.18 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 122.154 0.978 . . . . 0.0 109.187 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.66 110.08 2.35 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.838 2.359 . . . . 0.0 111.178 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.145 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . . . -74.14 -162.67 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -148.48 33.9 0.79 Allowed 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.975 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 155.89 151.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.932 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 79' ' ' GLY . 0.6 OUTLIER 65.84 -93.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.52 -0.738 . . . . 0.0 110.541 179.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 74.18 -9.73 9.11 Favored Glycine 0 N--CA 1.486 2.001 0 O-C-N 120.674 -1.267 . . . . 0.0 110.466 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.816 HG23 ' HA2' ' A' ' 27' ' ' GLY . 1.1 mp -40.29 94.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.555 1.178 . . . . 0.0 108.541 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.895 HD11 HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -50.47 92.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 55' ' ' ILE . 8.6 t70 -111.69 -44.78 3.44 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.815 -0.553 . . . . 0.0 110.776 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -138.72 98.26 3.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.554 -1.342 . . . . 0.0 111.14 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 56' ' ' LEU . 1.7 t -109.74 88.96 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 mt -69.48 -4.03 17.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 110.592 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.685 ' O ' HG21 ' A' ' 19' ' ' VAL . 10.0 mt-10 -127.16 44.32 2.94 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.113 -0.992 . . . . 0.0 108.564 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -46.07 136.34 6.8 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.465 -0.772 . . . . 0.0 109.32 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.54 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -31.9 107.2 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.418 0.628 . . . . 0.0 110.481 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.41 -7.78 3.41 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.776 ' O ' HG23 ' A' ' 18' ' ' THR . 0.1 OUTLIER -100.01 178.83 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -1.17 . . . . 0.0 109.748 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.5 m -99.97 151.24 21.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.85 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.882 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.89 171.18 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.359 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.558 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 1.4 m -134.29 -141.38 0.19 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 108.975 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 7' ' ' VAL . 2.2 p -69.35 -104.48 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.945 -1.097 . . . . 0.0 109.054 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.709 ' HG2' HD22 ' A' ' 6' ' ' LEU . 28.0 ttp180 -79.2 37.86 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.066 . . . . 0.0 110.755 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.766 ' O ' HD23 ' A' ' 6' ' ' LEU . 12.6 mm100 -63.92 -112.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.76 -1.212 . . . . 0.0 108.582 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 72' ' ' ILE . 12.4 tt -179.0 116.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.836 -1.165 . . . . 0.0 110.392 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.91 HD21 HG23 ' A' ' 7' ' ' VAL . 9.7 mt -72.96 -49.94 26.31 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.13 -0.981 . . . . 0.0 108.4 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 59' ' ' VAL . . . 161.57 169.73 25.27 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.723 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -110.73 138.57 46.95 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.13 -1.218 . . . . 0.0 110.089 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.778 HD12 ' N ' ' A' ' 76' ' ' LEU . 5.0 mp -106.47 -88.63 0.45 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.702 ' O ' HG23 ' A' ' 3' ' ' VAL . 5.5 ttt180 -158.33 161.18 37.61 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.568 -0.708 . . . . 0.0 109.453 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 53' ' ' ASP . 56.3 tt0 -166.07 46.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.518 ' N ' ' OD2' ' A' ' 53' ' ' ASP . . . -66.47 -60.8 5.9 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 79' ' ' GLY . 2.2 t-20 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.25 -1.147 . . . . 0.0 109.52 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 77' ' ' ARG . 46.3 m . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.563 ' CA ' ' HB3' ' A' ' 78' ' ' GLU . 66.3 m -170.1 155.2 5.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.251 -0.906 . . . . 0.0 109.366 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.785 ' O ' HG12 ' A' ' 3' ' ' VAL . 4.7 t -77.96 77.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -83.6 84.11 7.66 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.827 HG12 HG13 ' A' ' 48' ' ' VAL . 6.5 tp -89.48 158.04 2.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.375 -0.828 . . . . 0.0 111.583 -177.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.858 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -137.44 -151.56 0.4 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 67' ' ' VAL . 33.2 t -138.21 57.25 12.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.7 -1.25 . . . . 0.0 110.085 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 37.0 Cg_endo -79.94 47.56 2.57 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.617 2.211 . . . . 0.0 110.843 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.563 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 3.0 m-20 -119.87 -1.04 10.54 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.945 -1.097 . . . . 0.0 109.616 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.973 HD23 ' HB3' ' A' ' 15' ' ' ALA . 5.6 mp -86.22 133.54 40.5 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.876 . . . . 0.0 109.552 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 12' ' ' GLU . 36.1 Cg_endo -78.88 -53.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.556 2.171 . . . . 0.0 110.177 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -49.91 177.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 109.398 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.0 m -88.7 -11.28 45.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.125 -0.985 . . . . 0.0 109.368 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.841 HG22 ' OD1' ' A' ' 16' ' ' ASP . 9.8 p -170.02 54.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.828 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.973 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -65.1 -11.03 35.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.174 -0.954 . . . . 0.0 109.257 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.841 ' OD1' HG22 ' A' ' 14' ' ' VAL . 3.8 m-20 55.64 163.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.776 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -166.39 179.73 5.43 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.514 ' C ' HG12 ' A' ' 39' ' ' ILE . 1.1 m -134.74 129.06 34.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.17 -0.956 . . . . 0.0 110.233 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.988 ' CG1' HD11 ' A' ' 73' ' ' LEU . 7.0 t -75.61 103.93 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.378 -0.827 . . . . 0.0 109.188 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -65.02 -62.15 1.73 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.747 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.624 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 52.9 m -168.65 132.29 1.47 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.276 -1.37 . . . . 0.0 112.289 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 1.067 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.4 m95 -68.99 -168.77 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.61 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.8 m80 -150.91 30.98 0.63 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.745 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -122.38 123.78 42.14 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.706 -0.621 . . . . 0.0 110.389 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.595 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -74.57 -178.87 0.88 Allowed Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 28.2 Cg_endo -68.18 90.55 0.38 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.282 1.321 . . . . 0.0 111.001 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.796 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 76.47 46.23 12.47 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.727 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 14.1 m-20 -59.7 -118.07 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.933 -1.333 . . . . 0.0 109.794 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 162.91 100.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.583 -1.323 . . . . 0.0 109.493 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.884 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -100.99 -175.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.185 -0.947 . . . . 0.0 109.987 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.719 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -141.15 -73.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 109.608 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.676 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -119.81 61.55 0.84 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.055 -1.028 . . . . 0.0 109.426 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.608 ' O ' HG21 ' A' ' 30' ' ' VAL . 3.7 m-20 145.32 84.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.069 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -76.1 -168.78 0.99 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.001 0.905 . . . . 0.0 111.533 -178.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.862 HG12 ' OE2' ' A' ' 34' ' ' GLU . 7.5 p -49.54 166.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.572 0.701 . . . . 0.0 110.836 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.618 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -144.85 59.05 1.31 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.078 HG21 HD21 ' A' ' 73' ' ' LEU . 2.7 p -39.18 166.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.63 0.728 . . . . 0.0 110.296 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -127.52 142.7 51.32 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.964 HD11 HG11 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -127.56 -166.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.778 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -143.9 88.48 1.98 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.86 -1.15 . . . . 0.0 110.056 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.851 HG23 HD21 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -84.44 -146.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.393 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 20.6 t0 -97.72 85.94 3.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.3 tttm 86.28 -25.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.273 0.558 . . . . 0.0 109.526 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.17 135.43 52.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.173 -0.955 . . . . 0.0 109.719 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.846 HG13 ' O ' ' A' ' 39' ' ' ILE . 41.2 t -118.77 105.31 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 109.408 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.841 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.99 179.86 7.37 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.272 -0.892 . . . . 0.0 109.349 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 48' ' ' VAL . 22.9 mt-10 -134.82 -148.9 0.33 Allowed 'General case' 0 N--CA 1.484 1.269 0 O-C-N 120.958 -1.089 . . . . 0.0 110.566 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.863 ' HB ' HG12 ' A' ' 37' ' ' VAL . 11.9 t -154.89 69.74 5.73 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.327 -0.858 . . . . 0.0 109.29 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.79 104.5 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.592 2.195 . . . . 0.0 111.023 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.069 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -83.27 -178.53 7.11 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 2.6 p -121.93 24.47 9.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.093 -1.629 . . . . 0.0 111.338 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.71 160.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.213 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.723 ' O ' HG12 ' A' ' 30' ' ' VAL . 2.5 t0 61.43 -139.39 0.51 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.04 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 115.29 -8.26 20.64 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.796 HG23 ' HA2' ' A' ' 27' ' ' GLY . 10.7 mt -42.39 98.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.029 HD12 HD22 ' A' ' 76' ' ' LEU . 9.6 tp -48.82 90.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.595 0.712 . . . . 0.0 109.648 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.8 t0 -82.18 -58.11 3.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.946 -0.471 . . . . 0.0 110.001 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -149.88 95.68 2.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.768 -1.207 . . . . 0.0 111.091 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.516 HG22 HD11 ' A' ' 56' ' ' LEU . 2.9 t -79.74 101.89 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.437 HD11 ' HD3' ' A' ' 75' ' ' ARG . 44.9 mt -69.15 -27.12 65.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 110.29 -178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 41.2 mm-40 -121.86 59.93 0.98 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -37.92 140.91 0.23 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.486 0.66 . . . . 0.0 109.691 -179.07 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.624 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -39.99 139.35 0.69 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.57 -0.706 . . . . 0.0 110.644 -179.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.26 -12.34 33.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.72 174.48 9.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.241 . . . . 0.0 109.633 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.6 m -93.36 154.44 17.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.964 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.77 168.96 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 1.088 HG22 ' CG ' ' A' ' 71' ' ' GLN . 15.0 t -133.39 -136.07 0.17 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.942 ' HA ' HD13 ' A' ' 10' ' ' LEU . 9.6 m -68.96 -119.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.592 -1.317 . . . . 0.0 108.015 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.817 ' CG ' HD22 ' A' ' 6' ' ' LEU . 8.0 ttm105 -72.89 80.68 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.678 -1.263 . . . . 0.0 109.786 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 1.088 ' CG ' HG22 ' A' ' 68' ' ' THR . 0.5 OUTLIER -98.43 -101.82 0.21 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.054 -1.028 . . . . 0.0 108.397 179.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 72' ' ' ILE . 19.1 tt 177.72 112.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 110.264 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.078 HD21 HG21 ' A' ' 37' ' ' VAL . 10.5 tp -79.7 -39.42 31.29 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.821 -1.174 . . . . 0.0 108.206 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.69 158.61 8.97 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.211 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.756 ' C ' HD23 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -101.03 148.57 24.89 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.373 -1.075 . . . . 0.0 109.559 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.029 HD22 HD12 ' A' ' 56' ' ' LEU . 5.5 mt -113.89 -132.43 0.33 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.732 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.564 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -109.52 -51.2 2.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.804 -1.185 . . . . 0.0 110.402 -179.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.569 ' HA ' ' CB ' ' A' ' 53' ' ' ASP . 13.7 tt0 54.26 170.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.951 -1.093 . . . . 0.0 109.428 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' OD2' ' A' ' 53' ' ' ASP . . . 51.7 -134.85 34.55 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.5 m120 . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.233 -1.157 . . . . 0.0 109.442 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 0.8 OUTLIER -153.45 -179.57 7.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 109.447 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 77' ' ' ARG . 6.4 t -83.82 89.07 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.32 95.82 0.21 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.639 HD13 HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -103.76 129.76 55.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 109.949 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.859 HD22 ' HG2' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -153.39 -163.16 1.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.792 ' CG2' HD13 ' A' ' 39' ' ' ILE . 11.4 t -121.01 78.23 32.26 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.874 -1.142 . . . . 0.0 108.982 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 36.7 Cg_endo -80.4 53.52 4.8 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.803 2.335 . . . . 0.0 110.815 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 1.009 ' HB2' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -122.21 -5.72 8.88 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.076 -1.015 . . . . 0.0 109.717 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER 38.89 84.82 0.17 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.578 -0.701 . . . . 0.0 110.131 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 1.005 ' HB3' HG21 ' A' ' 41' ' ' THR . 35.8 Cg_endo -78.44 141.84 18.18 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.567 2.178 . . . . 0.0 110.274 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -133.96 168.57 18.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 109.661 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 23.9 t 65.77 8.73 5.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.389 -0.819 . . . . 0.0 109.668 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' N ' ' A' ' 15' ' ' ALA . 1.3 p -126.95 -97.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.296 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.78 ' N ' HG22 ' A' ' 14' ' ' VAL . . . 165.24 -24.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.775 -1.203 . . . . 0.0 109.911 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.556 ' H ' HG22 ' A' ' 14' ' ' VAL . 16.8 p30 174.37 -163.55 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 109.238 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.731 ' HB2' ' OG1' ' A' ' 41' ' ' THR . . . -149.63 -167.1 2.73 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.145 -0.972 . . . . 0.0 109.016 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 40' ' ' GLU . 93.3 m -156.63 148.81 23.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.125 -0.984 . . . . 0.0 109.643 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 73' ' ' LEU . 2.3 t -78.73 147.24 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 108.636 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -118.83 -55.14 2.21 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.772 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.624 HG23 ' OE2' ' A' ' 63' ' ' GLU . 1.3 m -167.45 123.03 1.07 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.246 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.904 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.2 m95 -68.25 -167.41 0.08 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.583 ' HB2' HG23 ' A' ' 35' ' ' VAL . 16.3 m80 -152.31 24.18 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.664 ' HB3' HD13 ' A' ' 56' ' ' LEU . 6.5 tppt? -118.52 132.04 56.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.77 -0.581 . . . . 0.0 109.728 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.591 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -79.62 177.31 3.0 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.9 Cg_endo -70.26 101.63 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.731 1.62 . . . . 0.0 111.615 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.656 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 82.37 37.66 14.25 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.554 ' CB ' ' HD2' ' A' ' 24' ' ' LYS . 1.2 m-20 -59.3 -165.38 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.878 -1.366 . . . . 0.0 110.103 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -165.11 78.17 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 108.979 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -79.54 -173.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.554 -179.011 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.749 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.6 OUTLIER -125.41 -97.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 109.836 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 47.6 mtp180 -103.28 45.14 0.97 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.644 -1.285 . . . . 0.0 109.345 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.781 ' O ' HG21 ' A' ' 30' ' ' VAL . 6.3 m-20 171.87 94.86 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.0 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -93.1 -166.56 1.55 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.922 -1.112 . . . . 0.0 111.542 -178.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.759 HG12 ' CD ' ' A' ' 34' ' ' GLU . 2.5 p -52.74 164.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 122.058 0.932 . . . . 0.0 111.393 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.581 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.61 65.97 1.39 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.379 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.145 HG12 HG12 ' A' ' 48' ' ' VAL . 4.1 p -38.0 164.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.582 0.706 . . . . 0.0 110.354 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.617 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -122.88 101.49 7.47 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 -178.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.001 HD11 HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -85.63 -159.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.81 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -154.59 99.03 2.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.609 -1.307 . . . . 0.0 110.265 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 1.005 HG21 ' HB3' ' A' ' 11' ' ' PRO . 10.0 m -116.64 90.11 3.26 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' THR . 11.2 t0 71.7 -143.33 0.05 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.372 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -17.27 57.52 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.99 150.23 3.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.521 -0.737 . . . . 0.0 109.886 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 39' ' ' ILE . 7.2 p -130.39 105.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.009 HD13 ' HB2' ' A' ' 9' ' ' ASP . 1.3 mt -85.94 159.22 19.71 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.231 -0.918 . . . . 0.0 109.021 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 5.1 pt-20 -127.29 -164.75 1.39 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.053 -1.029 . . . . 0.0 110.314 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.145 HG12 HG12 ' A' ' 37' ' ' VAL . 14.6 p -146.49 88.05 6.27 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.339 -0.851 . . . . 0.0 110.025 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -81.44 104.79 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.566 2.177 . . . . 0.0 111.181 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.0 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -74.86 -165.71 0.4 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 19.2 m -141.46 24.81 2.07 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.325 -1.485 . . . . 0.0 110.648 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 156.12 165.63 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.27 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.517 ' OD2' ' N ' ' A' ' 78' ' ' GLU . 0.5 OUTLIER 66.75 -88.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.615 -0.678 . . . . 0.0 109.585 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.729 ' HA2' HG21 ' A' ' 3' ' ' VAL . . . 63.32 -8.63 0.26 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.013 -1.055 . . . . 0.0 111.808 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.656 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.84 96.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.849 -1.383 . . . . 0.0 107.994 179.435 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.944 HD12 HD22 ' A' ' 76' ' ' LEU . 8.8 tp -51.66 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.469 -0.769 . . . . 0.0 109.376 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' ILE . 10.9 t0 -108.11 -35.52 6.56 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.583 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.487 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -142.11 85.97 1.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.494 -1.379 . . . . 0.0 111.736 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.573 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 2.5 t -101.14 77.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.0 mt -69.66 -2.81 12.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 110.946 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.552 ' O ' HD11 ' A' ' 73' ' ' LEU . 18.9 mt-10 -136.16 51.49 2.02 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.882 -1.136 . . . . 0.0 109.283 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.488 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.6 m-20 -50.23 151.19 2.16 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.274 -0.891 . . . . 0.0 109.751 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.624 ' OE2' HG23 ' A' ' 21' ' ' THR . 0.1 OUTLIER -32.92 141.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.411 0.624 . . . . 0.0 110.818 -179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.58 -18.65 32.18 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.591 HG22 ' H ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -83.57 -179.72 7.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -1.194 . . . . 0.0 109.874 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 65' ' ' THR . 4.0 m -113.3 153.82 27.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 109.715 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.001 HG11 HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -151.25 169.72 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 1.019 HG22 ' HG3' ' A' ' 71' ' ' GLN . 7.8 t -127.6 -124.6 0.23 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.612 ' N ' HG23 ' A' ' 68' ' ' THR . 6.0 p -69.63 -114.95 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.337 -1.477 . . . . 0.0 108.967 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.859 ' HG2' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -83.28 52.98 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.903 -1.123 . . . . 0.0 110.8 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 1.019 ' HG3' HG22 ' A' ' 68' ' ' THR . 1.3 mm-40 -65.25 -111.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.75 -1.219 . . . . 0.0 108.293 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.682 HG23 ' O ' ' A' ' 72' ' ' ILE . 16.2 tt 178.33 116.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.83 -1.168 . . . . 0.0 110.474 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.908 ' CD2' HG21 ' A' ' 37' ' ' VAL . 14.0 tp -77.38 -17.36 58.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.941 -1.099 . . . . 0.0 108.456 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' HB ' ' A' ' 5' ' ' ILE . . . 135.33 162.43 9.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.491 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.61 149.11 31.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -1.141 . . . . 0.0 109.495 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.944 HD22 HD12 ' A' ' 56' ' ' LEU . 8.2 mt -117.52 -78.31 0.58 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.444 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.987 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -163.28 157.25 19.99 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.305 -0.872 . . . . 0.0 109.268 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.517 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 4.1 tp10 179.29 111.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.33 -61.36 0.05 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.184 -1.186 . . . . 0.0 109.484 179.986 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.292 0.567 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.552 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 68.1 m -154.51 173.5 16.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.034 HG21 ' OE1' ' A' ' 34' ' ' GLU . 70.1 t -76.99 77.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 109.207 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 75' ' ' ARG . 0.5 OUTLIER -73.6 84.83 1.57 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.946 HG12 HG22 ' A' ' 48' ' ' VAL . 2.1 tp -106.57 151.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.347 -0.846 . . . . 0.0 110.985 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -134.09 -166.06 1.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.757 HG21 ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -126.04 72.81 70.83 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.144 -0.973 . . . . 0.0 109.625 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 6' ' ' LEU . 36.9 Cg_endo -80.99 27.33 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.719 2.279 . . . . 0.0 110.955 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 17.6 m-20 -113.64 72.22 0.77 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 120.899 -1.126 . . . . 0.0 109.856 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.936 HD12 ' C ' ' A' ' 68' ' ' THR . 92.3 mt -154.29 62.04 3.55 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.943 . . . . 0.0 109.822 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 10' ' ' LEU . 36.0 Cg_endo -78.59 -159.27 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.572 2.181 . . . . 0.0 110.476 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.01 -163.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.557 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.3 m -85.49 47.18 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 25.4 t -144.05 75.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.213 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.4 47.91 1.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.764 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 0.6 OUTLIER -158.8 144.39 16.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.937 . . . . 0.0 109.765 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.732 ' HB2' HD21 ' A' ' 10' ' ' LEU . . . -149.27 -157.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.455 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 39' ' ' ILE . 17.7 m -155.15 126.14 7.11 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.178 -0.951 . . . . 0.0 110.457 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.654 HG22 HD11 ' A' ' 39' ' ' ILE . 3.3 t -67.33 93.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.338 -0.851 . . . . 0.0 108.999 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -58.02 -59.35 5.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.151 -0.968 . . . . 0.0 110.763 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.651 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 34.8 m -166.68 125.71 1.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.574 -1.329 . . . . 0.0 111.982 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.982 ' HA ' HG23 ' A' ' 37' ' ' VAL . 24.0 m95 -67.76 -165.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.586 ' HB2' HG23 ' A' ' 35' ' ' VAL . 21.9 m80 -154.67 51.61 0.63 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.588 ' CB ' HD21 ' A' ' 56' ' ' LEU . 2.2 mmpt? -134.26 175.19 9.73 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.024 0.916 . . . . 0.0 110.995 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.653 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 2.1 mmmt -127.62 -174.86 0.39 Allowed Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.653 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.76 106.4 1.47 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.14 1.227 . . . . 0.0 111.242 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.551 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 65.21 45.84 89.81 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.548 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 1.4 m-20 -54.13 -167.68 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.885 -1.362 . . . . 0.0 110.198 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.89 80.81 0.42 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.401 -0.812 . . . . 0.0 108.927 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.815 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -79.06 -173.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.506 -0.746 . . . . 0.0 110.596 -178.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.703 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -132.65 -96.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.641 -0.662 . . . . 0.0 110.014 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.492 ' H ' HG23 ' A' ' 31' ' ' VAL . 3.2 mtt180 -99.8 36.03 1.89 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.686 -1.259 . . . . 0.0 109.472 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.763 ' O ' HG21 ' A' ' 30' ' ' VAL . 18.8 m-20 -179.57 81.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.591 -0.693 . . . . 0.0 109.162 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.113 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -69.5 -160.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.998 -1.064 . . . . 0.0 111.621 -178.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.922 HG12 ' OE2' ' A' ' 34' ' ' GLU . 7.2 p -62.95 163.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.613 0.721 . . . . 0.0 110.542 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.567 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -138.47 59.76 1.63 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 178.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.982 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.4 p -38.48 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.54 0.686 . . . . 0.0 109.913 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -124.02 140.76 52.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.674 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.06 -177.05 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.375 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.674 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.7 mm-40 -138.71 115.77 10.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.92 . . . . 0.0 109.374 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.535 ' HB ' ' CD2' ' A' ' 10' ' ' LEU . 2.8 t -110.03 -27.97 8.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 0.0 110.002 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 7.3 t0 161.28 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.597 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.9 tttp 85.85 -24.92 0.12 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 41' ' ' THR . 58.0 t -104.01 136.81 35.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 0.0 109.227 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 39' ' ' ILE . 46.5 t -116.67 109.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.918 . . . . 0.0 109.739 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 9' ' ' ASP . 4.2 mm? -79.78 -168.57 1.64 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.15 -0.969 . . . . 0.0 108.719 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.3 pt-20 -144.36 -166.81 2.47 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.075 -1.016 . . . . 0.0 110.717 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.946 HG22 HG12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -155.95 82.91 3.55 Favored Pre-proline 0 N--CA 1.489 1.484 0 CA-C-O 122.076 0.941 . . . . 0.0 109.583 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.2 Cg_endo -81.81 117.88 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.77 2.313 . . . . 0.0 111.749 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.113 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -89.41 178.84 6.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.712 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 18.3 p -122.72 72.85 1.1 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 120.532 -1.355 . . . . 0.0 110.436 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 93.23 169.37 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.118 0.485 . . . . 0.0 110.132 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 13.2 m-20 69.74 -101.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.512 ' O ' ' C ' ' A' ' 55' ' ' ILE . . . 68.6 -16.56 0.54 Allowed Glycine 0 N--CA 1.496 2.638 0 O-C-N 120.433 -1.417 . . . . 0.0 111.902 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.551 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.9 OUTLIER -36.03 99.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.104 1.452 . . . . 0.0 109.438 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.608 HD22 HD23 ' A' ' 76' ' ' LEU . 1.4 mm? -48.61 104.82 0.07 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.634 0.73 . . . . 0.0 109.936 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.455 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 9.3 t70 -108.16 -48.03 3.44 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.19 86.45 1.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.775 -1.203 . . . . 0.0 111.404 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 1.6 t -79.81 87.66 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 177.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.46 -3.92 16.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.934 . . . . 0.0 110.414 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 3.1 mt-10 -132.58 51.77 2.13 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' GLU . 1.9 m-20 -40.58 131.11 2.34 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.744 0.783 . . . . 0.0 109.749 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.651 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -36.12 123.39 0.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.481 0.658 . . . . 0.0 111.079 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.13 -11.07 8.21 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.38 162.7 15.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -1.13 . . . . 0.0 109.501 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 67' ' ' VAL . 80.2 m -72.2 162.49 29.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 109.603 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.757 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.19 173.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.473 -0.767 . . . . 0.0 109.097 -178.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.936 ' C ' HD12 ' A' ' 10' ' ' LEU . 5.7 t -145.66 -162.29 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.357 -0.839 . . . . 0.0 109.098 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.544 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 2.7 p -85.58 37.41 0.69 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.035 -1.041 . . . . 0.0 109.816 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER 168.63 34.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.598 -0.689 . . . . 0.0 109.212 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.923 ' CG ' HG22 ' A' ' 68' ' ' THR . 3.1 mm-40 -97.61 103.04 14.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.921 -1.112 . . . . 0.0 109.287 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.607 HG23 ' O ' ' A' ' 72' ' ' ILE . 9.1 tt -56.72 109.22 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.848 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.8 HD22 HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -51.37 -42.72 61.55 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.72 -155.45 26.56 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.722 ' C ' HD12 ' A' ' 76' ' ' LEU . 10.8 ptt85 -138.21 137.37 37.5 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.098 -1.237 . . . . 0.0 109.945 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 76' ' ' LEU . 5.8 mp -106.16 -95.93 0.35 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.455 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.552 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 2.7 tpm_? -149.83 144.17 25.81 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.443 -0.786 . . . . 0.0 109.243 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.526 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 36.8 tt0 -157.88 145.81 18.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 109.515 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 80' ' ' ASN . . . 109.86 123.05 4.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' ' 79' ' ' GLY . 6.8 t-20 . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.247 -1.149 . . . . 0.0 109.537 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.47 ' C ' ' HB3' ' A' ' 78' ' ' GLU . 2.5 m . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -170.81 177.38 3.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.747 ' O ' HG12 ' A' ' 3' ' ' VAL . 2.4 t -69.67 87.76 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.039 -1.038 . . . . 0.0 108.807 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.08 103.71 3.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.904 HG23 HG21 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -104.25 140.1 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.089 -1.007 . . . . 0.0 110.59 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.849 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -149.54 -162.19 1.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.101 HG21 HG21 ' A' ' 67' ' ' VAL . 60.1 t -133.63 56.61 21.09 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.957 -1.09 . . . . 0.0 110.373 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -81.16 34.37 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.507 2.138 . . . . 0.0 110.83 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.717 ' OD2' HD12 ' A' ' 46' ' ' LEU . 16.8 m-20 -99.21 9.33 43.63 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 120.711 -1.243 . . . . 0.0 110.256 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.041 ' CD2' HG21 ' A' ' 41' ' ' THR . 1.0 OUTLIER -130.55 108.6 15.92 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.986 -1.071 . . . . 0.0 109.606 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 12' ' ' GLU . 35.4 Cg_endo -77.8 -85.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.41 2.073 . . . . 0.0 110.471 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 11' ' ' PRO . 6.2 mt-10 -44.56 160.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.49 131.42 36.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.905 . . . . 0.0 109.486 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.758 HG12 ' N ' ' A' ' 15' ' ' ALA . 46.4 t -124.34 -97.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.564 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.758 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -141.02 -68.59 0.4 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.905 ' OD1' HG23 ' A' ' 68' ' ' THR . 0.5 OUTLIER 164.15 -178.14 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.711 -0.618 . . . . 0.0 109.53 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.015 ' HB2' HG23 ' A' ' 41' ' ' THR . . . -140.92 -167.09 2.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.283 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.488 ' C ' HG13 ' A' ' 39' ' ' ILE . 45.2 m -160.13 121.99 3.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.229 -0.92 . . . . 0.0 110.137 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.0 HG12 ' OE1' ' A' ' 63' ' ' GLU . 2.1 t -50.59 147.47 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -126.25 -48.11 1.59 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.945 -1.097 . . . . 0.0 110.749 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.56 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 45.4 m -159.87 109.03 1.79 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.558 -1.339 . . . . 0.0 112.08 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.727 ' HA ' HG23 ' A' ' 37' ' ' VAL . 22.3 m95 -67.5 -163.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.66 ' HB2' HG23 ' A' ' 35' ' ' VAL . 33.3 m80 -159.35 42.52 0.23 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.893 ' CB ' HD23 ' A' ' 56' ' ' LEU . 3.1 mmmt -132.19 124.08 28.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.594 -0.691 . . . . 0.0 110.707 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -70.56 -178.17 0.51 Allowed Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 25' ' ' LYS . 27.9 Cg_endo -66.82 93.23 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.107 1.205 . . . . 0.0 111.143 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.651 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 68.53 47.85 54.36 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.729 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 17.4 m-20 -56.96 -112.61 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.056 -1.261 . . . . 0.0 110.039 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 161.96 99.66 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.758 -1.214 . . . . 0.0 109.151 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.089 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -100.58 175.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.084 -1.01 . . . . 0.0 110.359 -179.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.691 HG13 ' H ' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -134.07 -70.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.434 -0.791 . . . . 0.0 110.048 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.691 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -127.45 64.8 1.33 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.814 -1.179 . . . . 0.0 109.681 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.583 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 15.5 m-20 144.94 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.089 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -93.01 -176.7 4.26 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.426 1.108 . . . . 0.0 112.196 -177.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.862 HG12 ' CD ' ' A' ' 34' ' ' GLU . 7.4 p -39.35 159.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.136 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.636 HD23 ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -139.91 62.47 1.51 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 178.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.024 HG12 HG12 ' A' ' 48' ' ' VAL . 5.2 p -37.96 163.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.687 0.756 . . . . 0.0 110.139 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.795 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.1 mm-40 -122.57 100.06 6.73 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.216 -0.928 . . . . 0.0 108.857 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.789 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -84.82 -165.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.561 -0.712 . . . . 0.0 109.358 -179.295 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.789 ' N ' HG23 ' A' ' 39' ' ' ILE . 16.5 mm-40 -150.83 88.31 1.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.016 . . . . 0.0 110.074 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 1.041 HG21 ' CD2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -83.2 -179.92 7.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.296 -0.878 . . . . 0.0 109.31 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.588 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.6 t0 -80.12 99.96 8.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 4.7 ttpm? 84.98 -21.52 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.807 -0.558 . . . . 0.0 109.628 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.685 HG12 HD23 ' A' ' 46' ' ' LEU . 97.8 t -118.23 146.27 23.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.204 -0.935 . . . . 0.0 109.954 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.3 t -134.45 100.96 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.865 . . . . 0.0 109.09 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.717 HD12 ' OD2' ' A' ' 9' ' ' ASP . 3.4 mm? -94.97 -169.43 2.0 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.214 -0.929 . . . . 0.0 110.058 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.516 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 2.3 pt-20 -147.66 -156.07 0.68 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.557 -0.714 . . . . 0.0 109.278 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.024 HG12 HG12 ' A' ' 37' ' ' VAL . 7.8 p -157.62 79.9 3.34 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.868 -1.145 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.636 ' HB3' HD23 ' A' ' 36' ' ' LEU . 36.3 Cg_endo -80.31 104.09 1.6 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.416 2.077 . . . . 0.0 110.337 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.994 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -73.81 -175.1 1.99 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.722 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.4 p -130.83 23.37 4.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.455 -1.403 . . . . 0.0 110.218 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 159.55 161.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.557 -0.714 . . . . 0.0 109.203 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.677 ' O ' HG12 ' A' ' 30' ' ' VAL . 7.2 m-20 67.25 -137.76 0.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.497 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 101.88 -7.84 55.53 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.33 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.651 HG23 ' CA ' ' A' ' 27' ' ' GLY . 4.5 mt -47.63 96.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.025 -1.279 . . . . 0.0 107.673 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.893 HD23 ' CB ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -42.48 100.36 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.687 0.756 . . . . 0.0 109.574 -178.473 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.463 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 6.9 t0 -104.13 -53.33 2.76 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.966 -0.459 . . . . 0.0 109.871 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.99 103.66 3.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.682 -1.261 . . . . 0.0 110.979 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -100.46 88.12 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.305 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.796 HD21 ' HA2' ' A' ' 74' ' ' GLY . 0.4 OUTLIER -69.2 -7.1 33.41 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.127 -0.983 . . . . 0.0 110.172 -178.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.52 ' CB ' ' HA ' ' A' ' 73' ' ' LEU . 1.3 mm-40 -119.24 37.85 4.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.133 -0.979 . . . . 0.0 108.381 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.2 m-20 -40.25 135.23 1.47 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.678 -0.639 . . . . 0.0 110.106 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 1.0 ' OE1' HG12 ' A' ' 19' ' ' VAL . 67.1 mm-40 -22.93 141.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.54 0.686 . . . . 0.0 111.783 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.1 -11.27 67.63 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 62' ' ' ASP . 1.3 m -84.47 156.18 21.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -1.154 . . . . 0.0 109.583 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 m -77.73 158.28 29.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.913 . . . . 0.0 109.525 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.101 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.7 171.39 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.905 HG23 ' OD1' ' A' ' 16' ' ' ASP . 0.6 OUTLIER -139.66 -145.91 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.004 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.578 ' HA ' HD13 ' A' ' 10' ' ' LEU . 3.3 m -99.48 52.16 0.94 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.103 -0.998 . . . . 0.0 109.467 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER 161.01 -19.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.419 -0.801 . . . . 0.0 110.031 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.474 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 2.2 mm-40 -48.44 125.87 10.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.328 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 72' ' ' ILE . 5.3 tt -80.18 111.8 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.738 HD12 HG21 ' A' ' 5' ' ' ILE . 30.4 mt -47.02 -37.53 9.4 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.796 ' HA2' HD21 ' A' ' 60' ' ' LEU . . . 157.01 -158.53 28.92 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.857 ' C ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -137.69 145.16 42.26 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.203 -1.175 . . . . 0.0 110.0 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.857 HD23 ' C ' ' A' ' 75' ' ' ARG . 2.1 mt -106.48 -128.4 0.26 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.588 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -123.32 177.8 5.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.645 -1.284 . . . . 0.0 109.817 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 30.6 tt0 -169.67 133.75 1.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.353 -0.842 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 80' ' ' ASN . . . -92.95 -151.6 28.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 18.9 t30 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.26 -1.141 . . . . 0.0 109.475 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.432 ' C ' ' HB2' ' A' ' 78' ' ' GLU . 4.1 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.248 0.547 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.536 ' N ' ' HB2' ' A' ' 78' ' ' GLU . 0.5 OUTLIER -169.19 170.25 8.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.881 . . . . 0.0 109.43 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.042 HG12 HG23 ' A' ' 5' ' ' ILE . 28.9 t -81.5 73.44 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.036 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -83.2 68.12 9.47 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.56 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.042 HG23 HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -80.96 165.34 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.755 0.788 . . . . 0.0 112.579 -177.309 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.839 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -139.61 -164.48 1.69 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.613 ' CG2' HD13 ' A' ' 39' ' ' ILE . 45.4 t -136.55 66.88 58.6 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.948 . . . . 0.0 109.935 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 7' ' ' VAL . 36.5 Cg_endo -80.38 38.84 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.715 2.276 . . . . 0.0 110.655 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.559 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -124.14 81.71 1.95 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.988 -1.07 . . . . 0.0 110.289 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' A' ' 69' ' ' SER . 20.7 mt -122.45 146.84 48.45 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 109.532 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.529 ' HG2' ' HB ' ' A' ' 14' ' ' VAL . 36.0 Cg_endo -78.64 -158.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.684 2.256 . . . . 0.0 110.432 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -112.05 -6.17 14.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 109.814 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.3 m -115.44 15.78 16.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.24 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 13' ' ' SER . 24.1 t -164.83 89.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.29 45.13 1.0 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 0.0 109.913 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.85 145.03 12.07 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.264 -0.897 . . . . 0.0 108.98 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -135.9 -166.07 1.81 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.721 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 90.0 m -151.61 131.24 13.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.307 -0.87 . . . . 0.0 110.525 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.808 ' CG2' HD11 ' A' ' 73' ' ' LEU . 2.1 t -70.15 85.35 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 109.089 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -47.33 -63.79 0.95 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.934 -1.104 . . . . 0.0 110.404 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.644 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 36.3 m -165.83 127.13 1.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.539 -1.351 . . . . 0.0 111.9 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 1.036 ' HA ' HG23 ' A' ' 37' ' ' VAL . 15.1 m95 -67.4 -163.08 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.598 ' HB2' HG23 ' A' ' 35' ' ' VAL . 22.5 m80 -156.21 30.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.767 ' HG2' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -116.83 159.1 22.87 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.7 0.762 . . . . 0.0 110.264 -179.077 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.598 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -106.14 -176.98 0.45 Allowed Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.0 Cg_endo -68.6 111.04 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.179 1.252 . . . . 0.0 110.768 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.532 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 57.65 43.51 94.33 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' OD1' ' CB ' ' A' ' 25' ' ' LYS . 8.6 m-20 -57.9 -164.27 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.831 -1.393 . . . . 0.0 110.209 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.16 87.52 0.5 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 53' ' ' ASP . 0.6 OUTLIER -78.91 -177.27 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.379 -0.826 . . . . 0.0 110.654 -178.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.678 ' H ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -123.28 -80.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.577 ' H ' HG23 ' A' ' 31' ' ' VAL . 11.8 mtt180 -123.77 40.3 3.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.108 -0.995 . . . . 0.0 108.681 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.829 ' O ' HG21 ' A' ' 30' ' ' VAL . 10.9 m-20 178.05 83.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.048 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -81.5 -170.58 2.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 111.375 -178.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.754 HG12 ' CD ' ' A' ' 34' ' ' GLU . 7.6 p -48.98 161.53 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 121.87 0.843 . . . . 0.0 111.431 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.685 HD23 ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -141.2 62.21 1.47 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.036 HG23 ' HA ' ' A' ' 22' ' ' TRP . 2.5 p -38.15 165.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.688 0.756 . . . . 0.0 110.619 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -127.39 131.69 50.27 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.842 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -117.35 -172.28 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.277 -0.89 . . . . 0.0 109.315 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.72 ' N ' HG23 ' A' ' 39' ' ' ILE . 2.3 mt-10 -133.4 123.98 26.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.001 -1.062 . . . . 0.0 110.206 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.625 ' OG1' HG13 ' A' ' 44' ' ' VAL . 4.6 p -119.63 -104.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.327 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 28.9 t0 -130.32 75.11 1.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.326 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 87.46 -22.75 0.14 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.625 HG13 ' OG1' ' A' ' 41' ' ' THR . 12.1 p -103.8 144.65 13.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.411 -0.806 . . . . 0.0 109.479 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 39' ' ' ILE . 2.3 t -120.14 105.63 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 109.702 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.566 ' N ' HD22 ' A' ' 46' ' ' LEU . 4.0 mm? -79.99 -179.38 6.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.291 -0.881 . . . . 0.0 109.049 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.2 pt-20 -150.65 -163.19 1.72 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.027 -1.046 . . . . 0.0 110.219 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.998 HG12 HG12 ' A' ' 37' ' ' VAL . 9.7 p -154.96 81.0 4.29 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.133 -0.979 . . . . 0.0 110.216 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.685 ' HB3' HD23 ' A' ' 36' ' ' LEU . 36.6 Cg_endo -80.79 113.49 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.587 2.192 . . . . 0.0 110.81 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.048 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -80.7 -168.01 1.59 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.731 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.3 p -133.37 16.34 4.07 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.361 -1.462 . . . . 0.0 110.806 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.63 160.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.513 -0.742 . . . . 0.0 109.16 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.896 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.2 t70 64.96 -140.09 0.23 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.326 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.548 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 112.23 -12.71 26.27 Favored Glycine 0 N--CA 1.489 2.209 0 O-C-N 120.508 -1.37 . . . . 0.0 109.851 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.549 ' HB ' ' CB ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -34.82 97.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.744 -0.857 . . . . 0.0 109.59 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.767 HD23 ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -45.06 104.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -113.93 -47.18 2.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.532 -0.73 . . . . 0.0 110.195 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -142.36 77.59 1.58 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.785 -1.197 . . . . 0.0 111.106 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.622 ' CG2' HD13 ' A' ' 56' ' ' LEU . 56.0 t -81.79 86.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.6 mt -69.63 -0.94 7.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -0.783 . . . . 0.0 111.255 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 21.1 mt-10 -134.54 55.44 1.89 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.778 -1.201 . . . . 0.0 108.199 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 63' ' ' GLU . 6.5 m-20 -43.93 127.06 5.13 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.702 0.763 . . . . 0.0 109.746 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.644 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -35.7 127.14 0.66 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.469 0.652 . . . . 0.0 111.284 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.48 -9.78 13.03 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.605 HG22 ' N ' ' A' ' 66' ' ' THR . 86.5 m -94.46 167.84 11.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -1.148 . . . . 0.0 109.386 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.605 ' N ' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -81.62 158.93 24.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.683 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.571 ' CG2' ' N ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -150.31 171.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.862 HG22 ' HG3' ' A' ' 71' ' ' GLN . 5.3 t -134.14 -161.48 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 0.0 109.237 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.55 ' HB2' HD12 ' A' ' 10' ' ' LEU . 29.9 t -85.91 40.88 0.88 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.629 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 69' ' ' SER . 4.8 ttm180 168.11 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.572 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.862 ' HG3' HG22 ' A' ' 68' ' ' THR . 1.6 mm-40 -105.61 97.59 7.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.94 . . . . 0.0 109.233 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 2.1 tt -42.25 112.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.463 -0.773 . . . . 0.0 109.86 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.808 HD11 ' CG2' ' A' ' 19' ' ' VAL . 10.3 tp -57.71 -42.67 84.26 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . 165.47 158.1 10.39 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.864 -1.636 . . . . 0.0 110.442 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.689 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -102.17 139.32 37.94 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.513 -0.993 . . . . 0.0 108.913 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.896 HD23 ' OE2' ' A' ' 34' ' ' GLU . 2.9 mp -105.14 -105.5 0.31 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.376 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.549 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 5.8 tpt180 -152.65 153.59 33.61 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.988 -1.07 . . . . 0.0 109.461 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 2' ' ' SER . 3.7 tm-20 -149.95 45.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 109.426 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.26 164.55 38.93 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.214 -1.168 . . . . 0.0 109.43 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.406 ' C ' ' HB3' ' A' ' 78' ' ' GLU . 1.1 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 1.3 p -169.18 166.43 10.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.592 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.748 ' O ' HG12 ' A' ' 3' ' ' VAL . 16.5 t -79.75 76.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.417 ' CG ' ' HB3' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -80.61 77.46 7.43 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.228 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.791 HG12 HG13 ' A' ' 48' ' ' VAL . 5.2 tp -91.89 154.04 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.372 -0.83 . . . . 0.0 111.283 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.882 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -140.46 -157.93 0.81 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 67' ' ' VAL . 2.9 t -131.14 54.57 15.06 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 120.868 -1.145 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.708 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.6 Cg_endo -81.21 40.85 1.04 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.238 1.959 . . . . 0.0 110.008 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -104.33 -1.42 26.95 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.016 -1.052 . . . . 0.0 110.176 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.84 HD21 ' O ' ' A' ' 68' ' ' THR . 0.8 OUTLIER -120.12 93.34 47.89 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.081 -1.012 . . . . 0.0 109.781 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.39 -90.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.531 2.154 . . . . 0.0 110.131 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' SER . 39.5 mm-40 -60.09 175.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 109.002 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 12' ' ' GLU . 31.2 t 51.35 98.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.987 . . . . 0.0 109.227 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.616 ' O ' HG12 ' A' ' 14' ' ' VAL . 41.1 t -84.16 44.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.818 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.72 -17.23 64.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.239 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.637 ' OD1' HG23 ' A' ' 68' ' ' THR . 11.4 m-20 66.55 -161.28 0.25 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.428 -0.795 . . . . 0.0 109.252 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -163.56 -162.42 0.73 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.259 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.519 ' HA ' ' CG1' ' A' ' 67' ' ' VAL . 16.1 m -161.05 127.55 3.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.087 -1.008 . . . . 0.0 110.162 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.598 HG22 HD11 ' A' ' 39' ' ' ILE . 2.5 t -53.87 157.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 108.708 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -127.42 -58.63 1.25 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.418 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 22.2 m -162.08 119.43 2.13 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.981 -1.074 . . . . 0.0 110.903 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.966 ' HA ' HG23 ' A' ' 37' ' ' VAL . 25.0 m95 -68.7 -170.58 0.22 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.867 0.842 . . . . 0.0 109.189 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.601 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 10.6 m80 -152.81 38.77 0.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.871 ' O ' HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -130.97 115.98 17.23 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.541 -178.167 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.582 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -65.41 177.32 0.69 Allowed Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.8 Cg_endo -68.17 93.54 0.4 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.793 1.662 . . . . 0.0 111.464 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.864 ' HA2' HG23 ' A' ' 55' ' ' ILE . . . 80.15 47.91 6.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 4.0 m-20 -58.58 -134.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.285 -1.127 . . . . 0.0 110.394 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 170.54 95.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.913 -1.117 . . . . 0.0 108.929 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.795 HG12 ' OE2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -103.25 -170.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.083 -1.01 . . . . 0.0 109.424 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.777 ' N ' HG13 ' A' ' 30' ' ' VAL . 4.2 m -134.18 -112.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 108.903 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 8.2 mmt-85 -87.08 64.68 8.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.758 -1.214 . . . . 0.0 108.721 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.4 m-20 150.73 102.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.091 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -101.52 -167.66 1.45 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.075 -1.016 . . . . 0.0 111.928 -178.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.627 HG22 ' N ' ' A' ' 36' ' ' LEU . 3.7 p -53.88 166.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.105 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.627 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -144.92 65.23 1.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 178.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.105 HG11 ' CD1' ' A' ' 73' ' ' LEU . 6.2 p -40.36 170.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.665 0.745 . . . . 0.0 110.117 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.759 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 21.5 mt-10 -123.56 107.92 12.06 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.003 -1.061 . . . . 0.0 108.903 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.775 HG23 ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -91.71 -162.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 121.421 -0.799 . . . . 0.0 109.159 -179.339 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.775 ' N ' HG23 ' A' ' 39' ' ' ILE . 39.4 mt-10 -153.06 102.18 2.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 110.105 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.581 HG22 ' N ' ' A' ' 42' ' ' ASP . 88.2 m -97.81 -112.2 0.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.271 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.581 ' N ' HG22 ' A' ' 41' ' ' THR . 8.1 t70 -126.56 87.73 2.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.918 -1.114 . . . . 0.0 109.391 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.576 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 2.3 tptp 85.2 -28.5 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.25 145.79 23.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.232 -0.917 . . . . 0.0 109.231 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 39' ' ' ILE . 1.8 p -123.39 122.44 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.486 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.65 170.91 15.86 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.173 -0.954 . . . . 0.0 108.864 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -122.16 179.66 4.47 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.106 -0.996 . . . . 0.0 110.406 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.9 HG21 HD12 ' A' ' 73' ' ' LEU . 3.2 t -130.83 73.18 81.38 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.491 -0.756 . . . . 0.0 109.013 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.2 Cg_endo -80.6 104.0 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.585 2.19 . . . . 0.0 111.527 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.091 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -79.1 -156.87 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.756 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.1 p -144.33 13.31 1.59 Allowed 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.695 -1.253 . . . . 0.0 110.733 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 158.93 155.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.393 -0.817 . . . . 0.0 110.216 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER 75.34 -81.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.501 -0.749 . . . . 0.0 110.659 179.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.529 ' N ' ' OE2' ' A' ' 34' ' ' GLU . . . 55.34 6.52 1.0 Allowed Glycine 0 N--CA 1.494 2.539 0 O-C-N 121.111 -0.993 . . . . 0.0 111.434 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.864 HG23 ' HA2' ' A' ' 27' ' ' GLY . 3.3 mt -54.97 98.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.643 -1.504 . . . . 0.0 108.061 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 24' ' ' LYS . 9.5 tp -51.21 90.14 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.536 -0.728 . . . . 0.0 109.328 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.5 t0 -99.11 -40.62 7.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.608 -0.683 . . . . 0.0 110.049 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.646 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -142.64 107.55 4.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.804 -1.185 . . . . 0.0 111.0 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.626 HG12 ' OD1' ' A' ' 62' ' ' ASP . 2.0 t -118.91 107.26 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mt -98.43 -31.9 11.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.025 . . . . 0.0 110.014 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.534 ' O ' HG21 ' A' ' 19' ' ' VAL . 3.0 mt-10 -98.61 35.44 1.82 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.626 ' OD1' HG12 ' A' ' 59' ' ' VAL . 2.2 m-20 -43.67 157.16 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.605 -0.684 . . . . 0.0 110.162 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -38.85 140.39 0.37 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.353 0.597 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.28 -19.86 47.02 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -86.18 161.51 18.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -82.74 163.27 21.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.571 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.51 169.2 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.419 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.84 ' O ' HD21 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -145.71 -147.75 0.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.57 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.53 ' HB3' ' CD1' ' A' ' 10' ' ' LEU . 13.3 p -89.83 33.29 0.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.354 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 70' ' ' ARG . 0.2 OUTLIER 171.82 26.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.528 -0.733 . . . . 0.0 110.268 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 13.7 mm100 -87.51 121.47 29.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.666 -1.271 . . . . 0.0 109.183 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 4.0 tt -69.2 111.36 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.609 -0.682 . . . . 0.0 110.581 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.105 ' CD1' HG11 ' A' ' 37' ' ' VAL . 3.8 mt -55.43 -36.25 66.31 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.438 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 154.82 164.31 12.84 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.799 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -111.96 140.68 46.42 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.37 -1.076 . . . . 0.0 108.997 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 76' ' ' LEU . 3.9 mp -116.2 -133.87 0.34 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.582 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -113.07 166.19 11.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.659 -1.276 . . . . 0.0 109.118 179.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.52 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 1.1 tm-20 -170.77 43.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.92 . . . . 0.0 109.404 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 50.26 -168.71 0.29 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.27 -1.135 . . . . 0.0 109.609 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.529 ' CA ' ' HG3' ' A' ' 78' ' ' GLU . 66.2 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.531 ' N ' ' HB2' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -69.64 -169.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.722 HG21 ' HA2' ' A' ' 54' ' ' GLY . 8.6 t -69.81 90.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.182 -0.949 . . . . 0.0 109.246 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.97 78.74 5.4 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.898 ' CG1' HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -93.64 137.85 21.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.405 -0.809 . . . . 0.0 111.239 -176.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -136.02 -164.27 1.53 Allowed 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.779 HG23 HD21 ' A' ' 73' ' ' LEU . 54.6 t -132.32 66.44 77.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.995 -1.066 . . . . 0.0 109.325 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' SER . 36.5 Cg_endo -80.24 41.61 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.733 2.289 . . . . 0.0 110.589 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.917 ' CB ' HD13 ' A' ' 46' ' ' LEU . 2.4 m-20 -92.55 47.99 1.35 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.035 -1.041 . . . . 0.0 110.113 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.724 HD22 ' CB ' ' A' ' 69' ' ' SER . 3.2 mm? -26.37 97.77 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 122.11 -0.369 . . . . 0.0 111.199 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' CG ' ' HB ' ' A' ' 14' ' ' VAL . 35.7 Cg_endo -77.95 -176.73 3.4 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.613 2.209 . . . . 0.0 110.548 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -5.08 18.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 109.609 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -165.22 58.95 0.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 109.346 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.676 HG21 HG22 ' A' ' 41' ' ' THR . 99.4 t -159.52 84.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.308 -0.87 . . . . 0.0 109.098 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.06 -18.74 2.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.834 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 2.6 p-10 -163.11 147.59 11.25 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.712 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -108.71 -160.48 0.72 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.397 -0.814 . . . . 0.0 108.825 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.465 ' C ' HG13 ' A' ' 39' ' ' ILE . 12.5 m -150.42 117.18 5.84 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.103 -0.998 . . . . 0.0 110.165 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.019 HG12 ' OE1' ' A' ' 63' ' ' GLU . 2.1 t -50.77 151.27 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.53 ' N ' ' OE1' ' A' ' 63' ' ' GLU . . . -134.67 -43.0 0.75 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.105 -0.997 . . . . 0.0 110.924 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.577 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -164.03 108.91 1.01 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.106 -1.438 . . . . 0.0 112.578 -179.152 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.954 ' HA ' HG23 ' A' ' 37' ' ' VAL . 18.4 m95 -67.84 -165.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.732 ' HB2' HG23 ' A' ' 35' ' ' VAL . 48.5 m80 -149.97 28.57 0.75 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.582 ' CD ' ' HB ' ' A' ' 35' ' ' VAL . 12.3 mmmm -123.57 146.59 48.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.641 -0.662 . . . . 0.0 110.393 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.659 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -97.73 -170.6 0.22 Allowed Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.1 Cg_endo -68.6 84.06 0.5 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 120.839 1.026 . . . . 0.0 111.321 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.754 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 78.15 48.48 7.56 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.746 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 18.4 m-20 -56.48 -114.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.113 -1.228 . . . . 0.0 110.363 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 158.18 100.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.848 -1.158 . . . . 0.0 108.27 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -102.64 -175.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.838 -1.164 . . . . 0.0 110.292 -178.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -129.29 -98.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 109.899 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.457 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -100.74 38.53 1.51 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.974 -1.078 . . . . 0.0 109.826 -179.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.716 ' O ' HG21 ' A' ' 30' ' ' VAL . 4.0 m-20 -178.01 89.42 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.059 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 9.6 tp10 -87.7 168.35 13.06 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.281 1.039 . . . . 0.0 111.647 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.935 HG12 ' HG3' ' A' ' 34' ' ' GLU . 4.6 p -33.08 157.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 122.128 0.966 . . . . 0.0 112.471 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -138.33 62.1 1.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.954 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.3 p -38.01 166.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.773 0.797 . . . . 0.0 110.385 -177.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -118.7 150.74 39.24 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.979 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -138.34 -171.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.369 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.729 ' N ' HG23 ' A' ' 39' ' ' ILE . 19.7 mt-10 -126.86 119.92 27.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.039 -1.038 . . . . 0.0 109.892 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.676 HG22 HG21 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -120.2 -143.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.429 -0.795 . . . . 0.0 109.128 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 65.1 t0 -90.62 72.14 6.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 109.607 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.4 tttt 87.21 -23.32 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 45' ' ' VAL . 72.8 t -100.63 160.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.38 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.979 HG13 ' O ' ' A' ' 39' ' ' ILE . 36.2 t -127.73 106.24 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.324 -0.86 . . . . 0.0 109.738 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.917 HD13 ' CB ' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -79.44 166.3 22.15 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.22 -0.925 . . . . 0.0 108.92 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -126.99 -163.75 1.28 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.091 -1.006 . . . . 0.0 110.258 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.898 HG22 ' CG1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -152.79 91.52 3.47 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.679 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.5 Cg_endo -83.5 123.57 3.4 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.759 2.306 . . . . 0.0 111.894 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.059 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -97.6 173.54 7.09 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.727 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 19.8 p -120.14 75.3 1.09 Allowed 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.205 -1.398 . . . . 0.0 110.315 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 51' ' ' SER . . . 90.65 164.93 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.5 0.667 . . . . 0.0 110.105 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 4.2 m-20 67.65 -100.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.713 -0.617 . . . . 0.0 110.618 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.722 ' HA2' HG21 ' A' ' 3' ' ' VAL . . . 54.79 5.58 0.59 Allowed Glycine 0 N--CA 1.494 2.522 0 O-C-N 120.911 -1.118 . . . . 0.0 111.543 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.754 HG23 ' CA ' ' A' ' 27' ' ' GLY . 7.2 mt -47.41 98.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.47 -1.606 . . . . 0.0 108.021 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.886 HD12 ' HG ' ' A' ' 76' ' ' LEU . 5.2 tp -43.88 108.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.618 0.723 . . . . 0.0 110.287 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 2.5 t0 -131.91 -35.15 1.26 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.618 -0.676 . . . . 0.0 110.031 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.805 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -135.61 62.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.68 -1.262 . . . . 0.0 111.014 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.595 ' CG2' HD11 ' A' ' 56' ' ' LEU . 26.2 t -79.7 83.33 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.759 -1.213 . . . . 0.0 108.467 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 mt -73.56 -6.66 47.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.277 -0.889 . . . . 0.0 110.741 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 73' ' ' LEU . 4.1 mt-10 -124.15 47.88 2.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.876 -1.14 . . . . 0.0 108.371 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -48.73 139.01 10.24 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.628 -0.67 . . . . 0.0 109.966 -179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 1.019 ' OE1' HG12 ' A' ' 19' ' ' VAL . 69.7 mm-40 -26.86 145.57 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.436 0.636 . . . . 0.0 111.414 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.11 -12.78 67.95 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.3 m -90.12 154.18 19.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -1.178 . . . . 0.0 109.661 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.15 161.31 28.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.597 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.63 174.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.89 HG22 ' CG ' ' A' ' 71' ' ' GLN . 3.6 t -135.09 -166.35 1.82 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.069 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.724 ' CB ' HD22 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -90.62 36.29 0.89 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.196 -0.94 . . . . 0.0 108.886 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.533 ' N ' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER 172.0 33.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.493 -0.754 . . . . 0.0 109.452 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.89 ' CG ' HG22 ' A' ' 68' ' ' THR . 5.1 mm-40 -107.02 145.57 32.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 109.182 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.5 tt -86.77 112.25 22.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.982 -1.074 . . . . 0.0 110.346 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.779 HD21 HG23 ' A' ' 7' ' ' VAL . 16.6 mt -54.04 -24.3 16.64 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 141.11 -168.31 25.4 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.805 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 9.5 ptt85 -127.64 146.78 50.44 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.283 -1.128 . . . . 0.0 109.443 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.886 ' HG ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -99.31 -92.77 0.27 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.361 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.551 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -144.84 157.98 43.96 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.279 -0.888 . . . . 0.0 109.972 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.531 ' HB2' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -110.63 156.92 20.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 109.374 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.48 ' N ' ' OE1' ' A' ' 78' ' ' GLU . . . -156.41 107.97 0.34 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.5 p30 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 0.0 109.492 179.978 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.491 ' CA ' ' HB3' ' A' ' 78' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.294 0.569 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.563 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 1.0 OUTLIER -149.41 159.19 44.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.484 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.738 ' O ' HG12 ' A' ' 3' ' ' VAL . 18.8 t -75.26 79.48 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 108.5 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.36 83.91 1.94 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.076 ' CG1' HG22 ' A' ' 48' ' ' VAL . 3.6 tp -104.45 147.5 10.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.849 -177.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.833 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -139.06 -158.83 0.89 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.505 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.88 HG21 HD13 ' A' ' 39' ' ' ILE . 41.6 t -129.02 65.37 73.73 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.947 -1.096 . . . . 0.0 109.6 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HG3' HD13 ' A' ' 6' ' ' LEU . 36.5 Cg_endo -79.72 61.79 8.3 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.805 2.337 . . . . 0.0 110.387 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.566 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -114.27 -19.9 11.09 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.014 -1.054 . . . . 0.0 109.732 -179.777 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 9' ' ' ASP . 0.8 OUTLIER 31.93 97.34 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 122.194 -0.316 . . . . 0.0 110.988 179.021 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.703 ' HG3' HG21 ' A' ' 41' ' ' THR . 34.5 Cg_endo -77.07 -167.25 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.483 2.122 . . . . 0.0 110.422 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.41 13.09 7.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -147.69 169.15 20.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.952 . . . . 0.0 109.496 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 14' ' ' VAL . 3.6 p -125.69 56.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.537 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 16' ' ' ASP . . . -95.3 14.91 20.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.946 . . . . 0.0 109.046 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 76.65 -154.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.344 -0.847 . . . . 0.0 109.533 179.901 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.663 ' HB3' HG22 ' A' ' 67' ' ' VAL . . . -170.61 -170.6 0.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.866 . . . . 0.0 109.308 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 17.5 m -152.88 137.16 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.913 ' CG2' HD11 ' A' ' 73' ' ' LEU . 2.2 t -72.94 84.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.41 -0.807 . . . . 0.0 109.252 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -46.61 -63.52 0.99 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.059 -1.025 . . . . 0.0 110.537 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.903 HG23 ' OE1' ' A' ' 63' ' ' GLU . 96.8 m -165.44 124.94 1.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.589 -1.319 . . . . 0.0 111.781 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 1.072 ' HA ' HG23 ' A' ' 37' ' ' VAL . 15.7 m95 -67.75 -168.48 0.09 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.587 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 12.0 m80 -153.3 24.15 0.54 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.777 ' HB3' HD13 ' A' ' 56' ' ' LEU . 6.1 tppt? -115.4 120.21 38.82 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.382 0.61 . . . . 0.0 109.593 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -67.1 175.61 1.43 Allowed Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.443 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 30.6 Cg_endo -71.31 94.66 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.073 1.849 . . . . 0.0 111.057 -178.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.646 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 85.33 37.42 9.81 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.58 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 8.9 m-20 -63.13 -162.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.784 -1.421 . . . . 0.0 109.61 178.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -162.85 79.36 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.92 -1.112 . . . . 0.0 110.069 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.783 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -78.9 -173.55 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 0.0 109.541 179.797 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.837 HG22 ' N ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -134.07 -86.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 0.0 109.36 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.837 ' N ' HG22 ' A' ' 31' ' ' VAL . 2.6 tpt180 -107.88 61.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.939 -1.101 . . . . 0.0 109.725 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.568 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 3.3 m-20 147.81 91.02 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.005 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -88.68 -166.91 1.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 111.336 -178.7 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.761 HG12 ' CD ' ' A' ' 34' ' ' GLU . 2.5 p -49.63 164.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.805 0.812 . . . . 0.0 111.311 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.594 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -140.17 63.64 1.47 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.603 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.072 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.3 p -38.59 166.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.701 0.762 . . . . 0.0 110.398 -177.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.647 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.4 mt-10 -128.05 112.63 14.83 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.263 -0.898 . . . . 0.0 108.729 -179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.88 HD13 HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -96.05 -167.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.498 -0.751 . . . . 0.0 109.03 -179.341 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.773 ' N ' HG23 ' A' ' 39' ' ' ILE . 5.5 mt-10 -135.46 136.72 41.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 0.0 110.065 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.703 HG21 ' HG3' ' A' ' 11' ' ' PRO . 2.1 m -135.81 -136.32 0.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.6 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 23.5 t0 -96.0 74.21 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.907 -1.121 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 7.7 tmtt? 86.74 -23.3 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.788 -0.57 . . . . 0.0 109.543 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 45' ' ' VAL . 2.3 p -105.11 164.36 4.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.82 HG13 ' O ' ' A' ' 39' ' ' ILE . 44.5 t -144.39 112.77 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.373 -0.829 . . . . 0.0 109.454 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.866 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.82 168.54 19.15 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.136 -0.977 . . . . 0.0 108.869 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' OE1' ' O ' ' A' ' 36' ' ' LEU . 3.0 mm-40 -116.79 -171.4 2.01 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.927 -1.108 . . . . 0.0 110.639 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.076 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -147.55 77.32 10.54 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-O 122.409 1.099 . . . . 0.0 108.622 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 37.0 Cg_endo -81.62 113.02 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.781 2.321 . . . . 0.0 112.14 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.005 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -80.17 -160.18 0.27 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 177.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.725 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -139.62 11.92 2.51 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.497 -1.377 . . . . 0.0 110.891 -179.53 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.725 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.19 169.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.318 -0.864 . . . . 0.0 109.995 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER 67.85 -87.87 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.426 -0.796 . . . . 0.0 109.323 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . 65.55 -13.57 0.28 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.219 -0.926 . . . . 0.0 112.15 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.646 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -42.83 96.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-N 119.124 1.462 . . . . 0.0 108.181 179.475 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.008 HD12 ' CD2' ' A' ' 76' ' ' LEU . 7.8 tp -54.11 97.12 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.47 -0.769 . . . . 0.0 109.64 -178.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.401 ' H ' ' HA ' ' A' ' 76' ' ' LEU . 17.7 t70 -109.0 -39.9 5.16 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.796 -0.565 . . . . 0.0 110.002 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 75' ' ' ARG . . . -139.0 90.4 2.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.69 -1.256 . . . . 0.0 110.877 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.843 HG21 HD21 ' A' ' 56' ' ' LEU . 6.6 t -94.71 91.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 60' ' ' LEU . 27.7 mt -70.08 -1.76 10.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 110.887 -178.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 5.7 mt-10 -137.41 55.26 1.81 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.024 -1.048 . . . . 0.0 108.449 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 63' ' ' GLU . 24.0 m-20 -43.79 126.01 4.46 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.526 -0.733 . . . . 0.0 109.452 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.903 ' OE1' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -33.94 122.5 0.46 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.626 0.727 . . . . 0.0 111.435 -179.236 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.49 -6.03 12.87 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.6 -172.75 3.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -1.132 . . . . 0.0 109.317 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 m -93.84 153.13 18.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.835 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.663 HG22 ' HB3' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -150.35 171.4 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.378 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.87 HG22 ' CG ' ' A' ' 71' ' ' GLN . 13.7 t -148.04 -137.65 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 108.83 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.724 ' N ' HG23 ' A' ' 68' ' ' THR . 6.2 p -69.2 -110.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.691 -1.256 . . . . 0.0 108.021 179.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.519 ' CG ' ' HB3' ' A' ' 8' ' ' PRO . 3.4 mtm180 -71.3 79.4 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 109.419 179.141 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.87 ' CG ' HG22 ' A' ' 68' ' ' THR . 2.7 mm-40 -115.63 96.28 5.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.121 -0.987 . . . . 0.0 108.451 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 72' ' ' ILE . 4.0 tt -42.26 109.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.341 -0.85 . . . . 0.0 110.194 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.953 HD22 HG11 ' A' ' 37' ' ' VAL . 10.7 tp -62.23 -27.86 69.29 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 59' ' ' VAL . . . 154.46 154.82 7.0 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.126 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.812 ' C ' HD12 ' A' ' 76' ' ' LEU . 5.2 ptt180 -104.41 136.84 43.23 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.429 -1.042 . . . . 0.0 109.489 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.008 ' CD2' HD12 ' A' ' 56' ' ' LEU . 4.0 mp -112.86 -103.87 0.4 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.478 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.563 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -138.06 164.45 29.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 109.391 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.52 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 1.9 tt0 -141.86 146.95 36.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.528 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 53' ' ' ASP . . . -48.59 -92.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.19 -1.182 . . . . 0.0 109.49 179.978 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.438 ' HB3' ' HG3' ' A' ' 78' ' ' GLU . 1.2 t . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.195 0.521 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.57 ' CB ' ' HB2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -86.29 160.63 19.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.59 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.722 ' O ' HG12 ' A' ' 3' ' ' VAL . 24.9 t -80.93 75.96 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.395 -0.815 . . . . 0.0 109.189 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -81.51 94.17 6.81 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.781 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.813 HG12 HG13 ' A' ' 48' ' ' VAL . 5.7 tp -106.57 159.3 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.344 -177.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.841 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -141.35 -161.03 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.367 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 67' ' ' VAL . 48.2 t -130.75 50.07 5.57 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.754 -1.216 . . . . 0.0 111.501 -179.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.714 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.9 Cg_endo -82.63 39.91 0.9 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.072 1.848 . . . . 0.0 109.757 178.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.936 ' HB2' HD13 ' A' ' 46' ' ' LEU . 4.2 m-20 -115.13 -17.04 11.51 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.125 -0.984 . . . . 0.0 111.186 -178.397 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.89 HD11 ' CB ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -42.58 102.82 0.28 Allowed Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.268 -0.895 . . . . 0.0 109.727 -179.309 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 9' ' ' ASP . 36.2 Cg_endo -78.82 80.3 3.11 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.463 2.109 . . . . 0.0 110.42 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 23.0 tt0 58.27 61.41 2.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.177 -0.952 . . . . 0.0 109.528 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.494 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 8.6 m -90.21 -148.29 0.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.723 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 76.7 t -81.82 -28.42 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.191 -0.943 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 14' ' ' VAL . . . 159.79 -21.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.488 0.661 . . . . 0.0 109.43 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 2.8 p30 -158.32 -164.37 1.47 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.469 -0.769 . . . . 0.0 109.445 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.829 ' HB2' HG22 ' A' ' 41' ' ' THR . . . -146.47 -155.19 0.6 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.154 -0.966 . . . . 0.0 109.619 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.546 ' N ' HG13 ' A' ' 67' ' ' VAL . 92.5 m -160.23 130.35 5.36 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.33 -0.856 . . . . 0.0 110.068 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.739 ' CG2' HD11 ' A' ' 73' ' ' LEU . 4.2 t -68.05 111.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.335 -0.853 . . . . 0.0 109.031 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -76.61 -57.53 3.8 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.144 -0.973 . . . . 0.0 109.901 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.58 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 17.9 m -170.75 126.83 0.74 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.682 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 1.049 ' HA ' HG23 ' A' ' 37' ' ' VAL . 14.8 m95 -68.84 -168.56 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 108.819 177.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.588 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 13.9 m80 -151.22 39.05 0.66 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.779 ' HB3' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -130.86 138.81 50.0 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.673 0.749 . . . . 0.0 110.867 -178.509 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.596 ' CB ' ' OD1' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -88.79 179.41 1.63 Allowed Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.039 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.8 Cg_endo -66.03 105.31 0.81 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.561 1.508 . . . . 0.0 112.284 -178.044 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.625 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 60.35 48.0 88.33 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.728 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 3.6 m-20 -59.52 -119.44 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.046 -1.267 . . . . 0.0 110.363 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 159.67 99.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.056 -1.027 . . . . 0.0 109.035 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -103.41 -178.99 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 109.62 -179.546 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.698 ' N ' HG13 ' A' ' 30' ' ' VAL . 3.2 m -127.48 -110.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 14.3 mtp180 -90.2 66.68 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.778 -1.201 . . . . 0.0 108.785 179.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 15.0 m-20 150.59 103.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -179.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.997 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -108.17 -171.46 1.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.391 1.091 . . . . 0.0 111.959 -178.21 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.763 HG11 ' HZ3' ' A' ' 22' ' ' TRP . 9.0 p -45.8 169.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.145 0.974 . . . . 0.0 111.389 -179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.596 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -149.71 59.14 1.0 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.049 HG23 ' HA ' ' A' ' 22' ' ' TRP . 2.7 p -39.3 165.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.807 0.813 . . . . 0.0 110.192 -178.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.845 ' OE1' HG11 ' A' ' 45' ' ' VAL . 1.6 mm-40 -123.48 146.53 47.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.739 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -134.5 -173.72 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.272 -179.262 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.715 ' N ' HG23 ' A' ' 39' ' ' ILE . 8.9 mt-10 -146.73 95.91 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.672 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.829 HG22 ' HB2' ' A' ' 17' ' ' ALA . 27.0 p -86.94 -48.8 7.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 109.725 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 55.1 t0 176.7 77.6 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.636 -0.665 . . . . 0.0 109.295 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER 87.28 -26.47 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.419 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.46 154.98 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.337 -0.852 . . . . 0.0 109.34 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.845 HG11 ' OE1' ' A' ' 38' ' ' GLU . 57.8 t -125.27 114.92 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -0.974 . . . . 0.0 109.822 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.936 HD13 ' HB2' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -79.67 159.3 26.75 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.299 -0.875 . . . . 0.0 108.755 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.53 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -121.96 -178.6 3.89 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.035 -1.041 . . . . 0.0 110.502 -179.298 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.828 ' O ' HG12 ' A' ' 48' ' ' VAL . 11.4 t -142.91 68.26 18.32 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.4 Cg_endo -80.31 106.41 1.88 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.679 2.253 . . . . 0.0 110.886 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.997 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -89.38 -161.73 0.8 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.757 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.2 p -142.95 17.21 1.95 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.748 -1.22 . . . . 0.0 110.888 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 160.35 163.3 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.115 -0.991 . . . . 0.0 110.668 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER 78.26 -77.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.646 179.64 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.504 ' O ' ' HD3' ' A' ' 24' ' ' LYS . . . 40.34 22.4 0.04 OUTLIER Glycine 0 N--CA 1.489 2.216 0 O-C-N 121.442 -0.786 . . . . 0.0 111.634 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.625 HG23 ' CA ' ' A' ' 27' ' ' GLY . 2.9 mt -83.61 94.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.549 -1.559 . . . . 0.0 107.329 178.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.126 HD12 ' CD1' ' A' ' 76' ' ' LEU . 2.1 tp -43.73 115.99 0.89 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.579 -0.701 . . . . 0.0 110.179 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 1.2 t0 -132.11 -42.73 0.98 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.491 -0.755 . . . . 0.0 109.895 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.944 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -132.82 76.65 1.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.785 -1.197 . . . . 0.0 110.873 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.557 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 60.6 t -93.33 81.52 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.775 HD11 HG23 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -69.04 -27.92 66.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.397 -0.814 . . . . 0.0 110.658 -178.423 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.535 ' CG ' HD12 ' A' ' 60' ' ' LEU . 7.7 mt-10 -106.73 47.79 0.86 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -39.14 139.31 0.51 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.597 0.713 . . . . 0.0 109.712 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.58 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -37.87 135.72 0.63 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.626 0.727 . . . . 0.0 110.999 -179.249 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.41 -6.37 36.17 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -95.72 158.38 15.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.244 . . . . 0.0 109.701 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.65 162.02 28.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.257 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.044 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.41 174.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.359 -0.838 . . . . 0.0 109.004 -178.802 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.689 HG23 ' N ' ' A' ' 69' ' ' SER . 4.8 t -150.26 -152.86 0.46 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 108.975 179.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.89 ' CB ' HD11 ' A' ' 10' ' ' LEU . 12.5 p -89.48 54.96 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.064 -1.022 . . . . 0.0 109.558 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' A' ' 69' ' ' SER . 3.5 mtp85 159.36 -12.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.565 -0.709 . . . . 0.0 110.654 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.633 ' CG ' HG22 ' A' ' 68' ' ' THR . 1.5 mt-30 -54.2 102.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.943 -1.098 . . . . 0.0 109.641 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.775 HG23 HD11 ' A' ' 60' ' ' LEU . 3.1 tt -54.94 111.5 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.039 HD22 HG11 ' A' ' 37' ' ' VAL . 8.4 tp -54.32 -29.89 49.38 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.502 ' N ' HG12 ' A' ' 72' ' ' ILE . . . 144.69 153.34 5.84 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.944 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -93.99 145.39 24.68 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.515 -0.991 . . . . 0.0 108.332 179.181 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.126 ' CD1' HD12 ' A' ' 56' ' ' LEU . 3.4 mm? -85.45 -111.7 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.73 -178.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.548 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 3.4 ttp85 -116.8 157.42 25.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.732 -1.23 . . . . 0.0 110.479 -179.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.57 ' HB2' ' CB ' ' A' ' 2' ' ' SER . 22.6 tt0 -178.61 138.24 0.16 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.165 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.85 -157.61 22.48 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.247 -1.149 . . . . 0.0 109.418 179.954 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' C ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -167.71 -179.04 4.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 76' ' ' LEU . 62.3 t -81.56 70.55 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 108.798 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -74.07 84.04 1.79 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.407 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.822 HG12 HG13 ' A' ' 48' ' ' VAL . 8.0 tp -99.73 163.13 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 111.297 -177.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.859 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -147.31 -159.86 1.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.313 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.815 HG21 ' CG2' ' A' ' 67' ' ' VAL . 2.1 t -133.15 56.11 20.09 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.121 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.4 Cg_endo -80.58 35.94 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.5 2.134 . . . . 0.0 110.824 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.568 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 1.1 m-20 -102.95 -2.68 27.28 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.801 -1.187 . . . . 0.0 109.966 -179.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.506 HD11 ' C ' ' A' ' 68' ' ' THR . 0.7 OUTLIER -128.19 66.54 72.89 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.925 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 9' ' ' ASP . 35.7 Cg_endo -77.55 -58.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.583 2.189 . . . . 0.0 110.373 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' PRO . 7.0 mm-40 -43.94 154.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.357 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.49 ' C ' HG23 ' A' ' 14' ' ' VAL . 1.6 p 44.5 -155.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.293 -0.879 . . . . 0.0 109.232 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 13' ' ' SER . 15.9 t -157.03 58.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.509 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.75 -11.21 58.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.146 -0.971 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 0.6 OUTLIER 60.89 -153.16 0.38 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.33 -0.856 . . . . 0.0 108.796 -179.85 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 40' ' ' GLU . . . -170.15 -159.76 0.21 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.036 -1.04 . . . . 0.0 109.844 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.485 ' N ' HG13 ' A' ' 67' ' ' VAL . 46.8 m -155.55 124.15 5.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 110.54 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.938 HG22 HD11 ' A' ' 39' ' ' ILE . 17.0 t -65.52 107.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.23 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . -73.8 -59.62 2.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.614 -179.314 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.586 ' HA ' ' CB ' ' A' ' 63' ' ' GLU . 22.6 m -168.69 128.52 1.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.628 -1.295 . . . . 0.0 111.775 -179.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.995 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.6 m95 -69.2 -166.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.661 0.743 . . . . 0.0 109.24 178.346 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 19.1 m80 -152.7 26.47 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.549 ' CE ' ' HB ' ' A' ' 35' ' ' VAL . 6.6 tppt? -119.36 137.91 53.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.69 -0.631 . . . . 0.0 110.132 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.599 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.28 179.29 1.71 Allowed Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.676 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 29.5 Cg_endo -69.64 104.91 1.37 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.664 1.576 . . . . 0.0 111.62 -178.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.651 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 75.03 39.52 37.49 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HB2' ' CD ' ' A' ' 24' ' ' LYS . 4.8 m-20 -59.45 -166.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.718 -1.46 . . . . 0.0 109.597 178.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' ASP . . . -163.17 78.56 0.45 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.947 . . . . 0.0 109.08 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.698 HG21 ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -79.55 169.26 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.009 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -110.06 -95.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 33' ' ' ASP . 1.6 mtm180 -107.2 51.43 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.961 -1.087 . . . . 0.0 109.63 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.698 ' O ' HG21 ' A' ' 30' ' ' VAL . 4.2 m-20 173.04 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.949 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 10.3 tp10 -102.29 163.62 12.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.058 -1.026 . . . . 0.0 111.008 -178.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.598 HG12 ' HG3' ' A' ' 34' ' ' GLU . 2.5 p -30.36 160.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.57 1.176 . . . . 0.0 112.581 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.533 ' N ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.12 67.63 1.37 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.087 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.995 HG23 ' HA ' ' A' ' 22' ' ' TRP . 4.1 p -38.59 165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.102 -177.394 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.27 145.71 46.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.938 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -134.77 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.334 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.722 ' N ' HG23 ' A' ' 39' ' ' ILE . 13.1 mt-10 -149.35 138.51 21.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.923 -1.11 . . . . 0.0 109.708 -179.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' CB ' ' A' ' 42' ' ' ASP . 5.9 t -132.72 26.22 4.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' CB ' ' O ' ' A' ' 41' ' ' THR . 2.2 t70 87.34 15.31 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.341 0.591 . . . . 0.0 110.459 179.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 160.52 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HB ' ' CG2' ' A' ' 41' ' ' THR . 1.1 t -103.99 148.57 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.613 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 39' ' ' ILE . 51.2 t -136.93 96.76 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.685 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.769 ' N ' HD22 ' A' ' 46' ' ' LEU . 2.9 mm? -79.88 -176.0 5.21 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.309 -0.869 . . . . 0.0 108.728 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 1.3 pt-20 -142.39 -161.36 1.23 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.718 -1.239 . . . . 0.0 111.463 -178.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.822 HG13 HG12 ' A' ' 5' ' ' ILE . 6.0 t -143.47 75.5 16.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' A' ' 47' ' ' GLU . 36.7 Cg_endo -80.73 110.82 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.487 2.125 . . . . 0.0 110.931 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.949 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -91.79 -169.38 2.26 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.137 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.724 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.1 p -132.36 14.68 4.57 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.265 -1.522 . . . . 0.0 111.183 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.62 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 109.951 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER 60.63 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 179.816 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.548 ' CA ' ' OE2' ' A' ' 34' ' ' GLU . . . 64.95 -13.65 0.2 Allowed Glycine 0 N--CA 1.495 2.628 0 O-C-N 121.324 -0.86 . . . . 0.0 112.093 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.651 HG22 ' HA2' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -44.81 96.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.674 -1.486 . . . . 0.0 108.551 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.925 HD12 ' HG ' ' A' ' 76' ' ' LEU . 7.8 tp -49.87 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ILE . 46.6 t0 -98.6 -41.59 7.66 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.97 -0.456 . . . . 0.0 110.544 -178.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . . . -147.37 78.71 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.577 -1.327 . . . . 0.0 111.677 -179.081 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.74 ' CG2' HD11 ' A' ' 56' ' ' LEU . 60.7 t -80.86 82.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.37 -10.8 57.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 109.709 -178.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' LEU . 4.8 mm-40 -123.74 50.93 1.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.5 m-20 -40.8 134.12 1.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.586 ' CB ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -34.05 134.51 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.597 0.713 . . . . 0.0 111.015 -178.897 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.75 -13.96 24.64 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -84.98 156.19 21.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -1.135 . . . . 0.0 109.405 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.41 166.43 20.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.681 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.815 ' CG2' HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.04 169.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.242 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -147.78 -148.31 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 -179.652 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 70' ' ' ARG . 9.3 p -90.28 36.18 0.87 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mtt180 163.55 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.367 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HG3' ' N ' ' A' ' 68' ' ' THR . 1.4 mt-30 -84.49 87.69 7.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.847 -1.158 . . . . 0.0 109.102 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 5.4 tt -45.0 108.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 48' ' ' VAL . 10.6 mt -53.91 -42.86 69.21 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 156.55 -159.79 29.76 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.549 ' C ' HD12 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -134.68 134.49 41.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.151 -1.206 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.925 ' HG ' HD12 ' A' ' 56' ' ' LEU . 4.4 mp -98.09 -96.72 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.34 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -153.73 163.19 40.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.542 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.49 ' N ' ' OD2' ' A' ' 53' ' ' ASP . 1.1 tt0 -160.81 -163.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.02 121.63 2.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.246 -1.149 . . . . 0.0 109.507 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 77' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.502 ' HA ' ' CB ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -170.04 158.65 7.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 0.0 109.562 -179.985 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.776 ' O ' HG12 ' A' ' 3' ' ' VAL . 3.0 t -75.94 79.76 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -86.73 80.47 8.52 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.031 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.795 HG12 HG22 ' A' ' 48' ' ' VAL . 6.0 tp -86.98 161.7 2.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 111.738 -177.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.85 HD12 ' H ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -144.69 -166.02 2.29 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.133 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.662 ' CG2' HD21 ' A' ' 73' ' ' LEU . 38.9 t -133.31 57.11 24.62 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.15 -0.969 . . . . 0.0 110.005 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HG3' HD13 ' A' ' 6' ' ' LEU . 37.0 Cg_endo -79.97 38.33 0.74 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.392 2.061 . . . . 0.0 110.534 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.564 ' CB ' ' HG ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -111.1 34.8 3.84 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.869 -1.145 . . . . 0.0 109.962 -179.46 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.599 HD11 HG12 ' A' ' 7' ' ' VAL . 2.6 mp -141.51 77.92 18.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 12' ' ' GLU . 35.7 Cg_endo -78.34 -37.64 0.7 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.614 2.21 . . . . 0.0 110.745 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.512 ' HB2' HG12 ' A' ' 14' ' ' VAL . 5.7 mt-10 -53.52 -172.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.941 . . . . 0.0 109.682 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.0 t -73.4 -2.27 21.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 14' ' ' VAL . 7.4 p -100.85 57.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.285 -0.884 . . . . 0.0 108.865 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.592 ' HB1' ' HB3' ' A' ' 69' ' ' SER . . . -83.38 44.76 0.98 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.587 -0.696 . . . . 0.0 110.007 -179.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -136.89 141.5 42.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.103 -0.998 . . . . 0.0 109.545 179.728 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 41' ' ' THR . . . -147.83 -161.17 1.28 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 0.0 109.254 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.48 ' C ' HG13 ' A' ' 39' ' ' ILE . 77.0 m -161.16 113.98 1.92 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.293 -0.88 . . . . 0.0 110.116 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.001 HG12 ' OE1' ' A' ' 63' ' ' GLU . 2.3 t -46.78 137.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.182 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.841 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -116.73 -51.14 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.985 -1.072 . . . . 0.0 110.958 -178.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.555 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -158.55 109.89 2.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.563 -1.335 . . . . 0.0 112.066 -179.214 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.866 ' HA ' HG23 ' A' ' 37' ' ' VAL . 17.7 m95 -68.11 -164.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.646 ' HB2' HG23 ' A' ' 35' ' ' VAL . 17.2 m80 -155.23 30.44 0.39 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 177.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.58 ' CD ' ' HB2' ' A' ' 28' ' ' ASP . 1.3 tppm? -124.4 139.23 54.09 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.407 0.622 . . . . 0.0 110.513 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.597 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -89.26 -176.4 0.66 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.015 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.597 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 27.6 Cg_endo -66.13 90.14 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.917 1.078 . . . . 0.0 111.321 -178.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.807 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 72.92 47.65 24.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.735 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 14.6 m-20 -58.4 -113.4 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.057 -1.261 . . . . 0.0 110.388 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 158.9 102.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.96 -1.088 . . . . 0.0 108.574 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.777 HG13 ' N ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -101.93 -173.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.05 . . . . 0.0 109.929 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.777 ' N ' HG13 ' A' ' 30' ' ' VAL . 5.7 m -131.86 -114.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.183 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.566 ' O ' ' CB ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -87.41 64.62 8.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.691 -1.256 . . . . 0.0 109.182 179.735 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 5.0 m-20 149.65 99.16 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.05 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -95.04 -176.06 3.72 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.414 1.102 . . . . 0.0 111.898 -178.22 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.738 HG12 ' OE2' ' A' ' 34' ' ' GLU . 11.5 p -39.7 166.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.953 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.6 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -147.32 61.97 1.16 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 179.017 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.866 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.3 p -39.29 166.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.683 0.754 . . . . 0.0 110.273 -177.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.841 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 4.1 mt-10 -128.75 95.26 4.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.192 -0.943 . . . . 0.0 109.146 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.801 HD11 HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -79.62 -167.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.479 -0.763 . . . . 0.0 109.123 -179.658 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.748 ' N ' HG23 ' A' ' 39' ' ' ILE . 24.3 mt-10 -153.75 121.24 5.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.922 -1.111 . . . . 0.0 110.193 -179.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.547 ' HB ' HD21 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -116.26 -95.19 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.434 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 31.1 t0 -146.15 86.73 1.71 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.385 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 16.5 tttt 86.72 -24.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.07 161.61 5.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 39' ' ' ILE . 54.1 t -150.85 98.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.842 HD13 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -79.59 168.91 18.76 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.213 -0.929 . . . . 0.0 108.864 179.945 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -124.94 -162.89 1.13 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.001 -1.062 . . . . 0.0 110.819 -178.78 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.861 ' HB ' HG12 ' A' ' 37' ' ' VAL . 3.8 t -144.23 74.57 15.74 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.525 -0.735 . . . . 0.0 109.289 -179.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.9 Cg_endo -82.19 101.84 1.15 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.887 2.392 . . . . 0.0 111.316 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.05 ' HB3' ' CB ' ' A' ' 34' ' ' GLU . . . -80.19 -161.36 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.726 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.4 p -135.1 10.14 3.54 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.466 -1.396 . . . . 0.0 111.275 -179.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 51' ' ' SER . . . 161.18 157.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.079 -1.013 . . . . 0.0 110.295 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.548 ' CB ' ' HA ' ' A' ' 78' ' ' GLU . 0.5 OUTLIER 79.1 -73.41 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.675 -0.641 . . . . 0.0 110.518 179.05 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.589 ' HA3' ' CG ' ' A' ' 34' ' ' GLU . . . 43.54 17.85 0.06 OUTLIER Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.154 -0.966 . . . . 0.0 111.315 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.807 HG23 ' CA ' ' A' ' 27' ' ' GLY . 20.5 mt -68.85 91.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.596 -1.532 . . . . 0.0 107.285 179.058 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.896 HD22 HG22 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -44.17 91.34 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.639 0.733 . . . . 0.0 110.366 -178.291 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 55' ' ' ILE . 36.3 t70 -87.29 -53.86 4.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.738 -0.601 . . . . 0.0 109.732 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.35 104.66 3.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.794 -1.191 . . . . 0.0 110.71 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.896 HG22 HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -90.91 92.12 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.553 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.56 -5.55 25.14 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.186 -0.946 . . . . 0.0 110.076 -178.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 73' ' ' LEU . 2.9 mt-10 -128.89 41.93 3.4 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 108.7 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.513 ' O ' ' C ' ' A' ' 63' ' ' GLU . 3.0 m-20 -42.72 131.13 4.06 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.596 -0.69 . . . . 0.0 109.593 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 1.001 ' OE1' HG12 ' A' ' 19' ' ' VAL . 67.2 mm-40 -20.91 140.05 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.661 0.743 . . . . 0.0 112.322 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.25 -15.61 61.12 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -80.07 162.82 24.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -1.232 . . . . 0.0 109.528 179.942 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 67' ' ' VAL . 8.1 m -90.61 162.83 14.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 109.721 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -150.56 171.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.214 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.695 HG23 ' N ' ' A' ' 69' ' ' SER . 5.1 t -137.98 -152.31 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.05 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.695 ' N ' HG23 ' A' ' 68' ' ' THR . 84.3 p -89.3 39.39 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 0.0 109.174 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.495 ' CG ' ' C ' ' A' ' 69' ' ' SER . 4.7 ptt180 165.78 34.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.95 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' A' ' 68' ' ' THR . 6.4 mm-40 -97.37 119.44 35.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.287 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 72' ' ' ILE . 1.9 tt -70.14 111.33 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -0.925 . . . . 0.0 110.032 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.843 ' CD1' HG21 ' A' ' 48' ' ' VAL . 13.8 mt -47.97 -42.23 27.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 4' ' ' ASP . . . 162.04 -165.72 36.0 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.818 ' C ' HD23 ' A' ' 76' ' ' LEU . 2.9 ptt-85 -129.22 149.25 51.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.293 -1.122 . . . . 0.0 109.364 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.874 HD22 HD23 ' A' ' 56' ' ' LEU . 4.5 mt -116.01 -132.21 0.32 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.403 -179.164 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.571 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 11.1 tpt85 -106.26 -51.28 2.99 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.584 -1.323 . . . . 0.0 110.313 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER 44.97 -169.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 -179.641 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.3 -143.58 18.75 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.4 t30 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.236 -1.156 . . . . 0.0 109.465 179.946 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.301 0.572 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.566 ' HA ' ' CA ' ' A' ' 77' ' ' ARG . 3.7 p -158.22 164.64 36.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.599 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.69 HG21 ' HA2' ' A' ' 54' ' ' GLY . 37.4 t -69.48 83.38 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.133 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.35 84.24 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.178 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.046 ' CG1' HG22 ' A' ' 48' ' ' VAL . 4.9 tp -110.55 143.82 19.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.291 -177.138 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.676 ' O ' HG23 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -128.48 -134.82 0.23 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.306 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 7' ' ' VAL . 45.9 t -161.85 67.41 2.13 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.717 -1.239 . . . . 0.0 109.168 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD3' ' HG ' ' A' ' 6' ' ' LEU . 35.4 Cg_endo -77.25 67.03 7.78 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.551 2.167 . . . . 0.0 110.584 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.982 ' HB2' HD13 ' A' ' 46' ' ' LEU . 1.2 m-20 -132.18 13.28 4.68 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.284 -0.885 . . . . 0.0 109.416 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' N ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -33.04 94.91 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.941 -0.474 . . . . 0.0 110.467 -179.638 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.96 ' CG ' HG21 ' A' ' 41' ' ' THR . 36.1 Cg_endo -79.05 -156.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.667 2.245 . . . . 0.0 110.03 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.705 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -41.96 124.04 2.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -43.22 108.23 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.719 -179.818 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 12' ' ' GLU . 60.8 t -109.7 -83.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.867 . . . . 0.0 109.423 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -171.28 -33.04 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.656 -0.653 . . . . 0.0 109.941 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER 170.57 -154.94 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.518 -0.739 . . . . 0.0 109.352 179.932 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 40' ' ' GLU . . . -168.21 -169.51 1.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -0.999 . . . . 0.0 109.546 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 40' ' ' GLU . 24.1 m -157.38 137.53 12.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.113 -0.992 . . . . 0.0 110.72 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 79.0 t -67.18 86.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.424 -0.797 . . . . 0.0 109.46 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 38' ' ' GLU . . . -42.76 -62.97 0.86 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.216 -0.927 . . . . 0.0 109.938 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 63' ' ' GLU . 2.6 m -166.91 130.05 1.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.482 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 1.031 ' HA ' HG23 ' A' ' 37' ' ' VAL . 22.0 m95 -68.78 -167.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.543 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 29.0 m80 -149.3 24.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.752 ' HB3' HD13 ' A' ' 56' ' ' LEU . 10.7 tppt? -119.78 126.11 50.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.683 -0.636 . . . . 0.0 109.959 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.652 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 3.1 mmmt -79.99 -171.84 0.31 Allowed Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.652 ' HD2' ' CB ' ' A' ' 25' ' ' LYS . 28.6 Cg_endo -68.45 104.94 1.17 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.026 1.151 . . . . 0.0 112.123 -177.282 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.732 ' CA ' HG23 ' A' ' 55' ' ' ILE . . . 57.97 48.5 82.14 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -56.35 -115.9 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.192 -1.181 . . . . 0.0 110.486 179.628 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . 162.0 100.39 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.761 -1.212 . . . . 0.0 108.312 -178.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.998 HG21 ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -102.08 173.95 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 111.082 -178.75 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.573 ' H ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -123.62 -92.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.068 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.539 ' H ' HG23 ' A' ' 31' ' ' VAL . 6.7 mtp180 -112.18 66.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.08 -1.013 . . . . 0.0 108.396 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.69 ' O ' HG21 ' A' ' 30' ' ' VAL . 8.2 m-20 155.13 80.55 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.084 ' OE1' HG12 ' A' ' 35' ' ' VAL . 1.1 tm-20 -87.81 175.08 7.99 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.179 0.99 . . . . 0.0 112.365 -177.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.084 HG12 ' OE1' ' A' ' 34' ' ' GLU . 2.4 p -32.14 156.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.93 0.871 . . . . 0.0 112.114 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.551 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -141.9 59.98 1.47 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.218 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.031 HG23 ' HA ' ' A' ' 22' ' ' TRP . 3.4 p -38.57 169.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.685 0.755 . . . . 0.0 110.571 -177.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.744 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 14.2 mt-10 -133.43 102.75 5.65 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.163 -0.961 . . . . 0.0 108.724 -179.294 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.926 HD11 ' CG1' ' A' ' 67' ' ' VAL . 2.1 tt -81.01 -165.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.327 -0.858 . . . . 0.0 109.411 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.783 ' N ' HG23 ' A' ' 39' ' ' ILE . 19.6 mm-40 -141.61 89.91 2.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.029 -1.044 . . . . 0.0 110.004 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.96 HG21 ' CG ' ' A' ' 11' ' ' PRO . 87.8 m -90.95 28.97 1.44 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.296 -0.878 . . . . 0.0 109.335 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 3.8 t70 77.6 73.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.685 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 6.2 tttt 87.24 -26.58 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.458 ' O ' ' HB ' ' A' ' 41' ' ' THR . 41.1 t -105.44 94.12 2.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.242 -0.911 . . . . 0.0 109.5 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.917 HG13 ' O ' ' A' ' 39' ' ' ILE . 81.4 t -94.77 104.72 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.409 -0.807 . . . . 0.0 109.443 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.982 HD13 ' HB2' ' A' ' 9' ' ' ASP . 0.8 OUTLIER -79.5 174.45 11.56 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.225 -0.922 . . . . 0.0 108.865 -179.759 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 8.4 pm0 -118.05 -179.58 3.8 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.994 -1.066 . . . . 0.0 110.758 -178.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.046 HG22 ' CG1' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -144.19 79.08 13.21 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-O 122.331 1.062 . . . . 0.0 108.381 179.666 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 36.6 Cg_endo -80.58 120.18 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.826 2.35 . . . . 0.0 111.888 -178.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.941 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . . . -96.45 169.84 9.63 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.07 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.704 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 22.9 p -118.32 77.9 1.21 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 120.354 -1.466 . . . . 0.0 110.242 -178.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.824 ' HA ' HG13 ' A' ' 30' ' ' VAL . . . 94.48 168.45 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.563 ' O ' HG12 ' A' ' 30' ' ' VAL . 59.4 m-20 61.96 -126.4 0.76 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.69 ' HA2' HG21 ' A' ' 3' ' ' VAL . . . 84.56 -7.7 71.96 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.055 -1.545 . . . . 0.0 109.704 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.732 HG23 ' CA ' ' A' ' 27' ' ' GLY . 8.2 mt -42.97 98.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.875 HD12 ' CD2' ' A' ' 76' ' ' LEU . 6.0 tp -43.44 92.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.666 0.746 . . . . 0.0 110.318 -177.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' ILE . 23.0 t70 -106.35 -36.37 6.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.704 -0.622 . . . . 0.0 109.327 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.658 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . . . -147.35 100.12 3.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.071 . . . . 0.0 110.383 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.528 ' CG2' ' HG ' ' A' ' 56' ' ' LEU . 13.5 t -107.55 90.3 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.0 mt -69.63 -4.82 20.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.071 -179.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 73' ' ' LEU . 10.9 mt-10 -127.63 52.34 1.85 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 63' ' ' GLU . 2.7 m-20 -49.45 125.28 10.87 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.734 -0.604 . . . . 0.0 110.77 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.549 ' C ' ' O ' ' A' ' 62' ' ' ASP . 5.1 mt-10 -7.55 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.477 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 65' ' ' THR . . . 128.74 -38.09 2.11 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.439 178.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.494 ' OG1' ' HA ' ' A' ' 61' ' ' GLU . 5.6 m -43.1 145.38 0.52 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -1.189 . . . . 0.0 109.442 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 m -86.72 141.1 29.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.967 . . . . 0.0 110.189 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.926 ' CG1' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -150.8 168.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.757 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.589 HG23 ' N ' ' A' ' 69' ' ' SER . 5.2 t -120.4 -47.66 2.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 68' ' ' THR . 0.5 OUTLIER -170.31 -75.27 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.728 0.775 . . . . 0.0 109.714 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -78.95 37.18 0.3 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.672 -0.643 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HG3' HG22 ' A' ' 68' ' ' THR . 3.7 mt-30 -103.34 97.53 7.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.185 . . . . 0.0 108.543 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.52 HG23 ' O ' ' A' ' 72' ' ' ILE . 3.7 tt -40.6 111.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.795 . . . . 0.0 110.404 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.707 ' CD1' HG11 ' A' ' 37' ' ' VAL . 12.0 mt -55.47 -41.2 72.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.84 167.99 21.2 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.875 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.7 ptt180 -109.87 138.77 45.76 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.109 -1.23 . . . . 0.0 109.833 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.875 ' CD2' HD12 ' A' ' 56' ' ' LEU . 4.3 mp -115.72 -101.87 0.42 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.795 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.566 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -129.59 153.46 48.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 109.51 -179.715 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.519 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 1.9 tp10 -160.21 -164.79 1.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.58 -170.25 13.85 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.228 -1.16 . . . . 0.0 109.398 -179.984 . . . . . . . . 0 0 . 1 stop_ save_